PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McConnachie, A; Hunt, K; Emslie, C; Hart, C; Watt, G				McConnachie, A; Hunt, K; Emslie, C; Hart, C; Watt, G			"Unwarranted survivals" and "anomalous deaths" from coronary heart disease: prospective survey of general population	BRITISH MEDICAL JOURNAL			English	Article							LAY EPIDEMIOLOGY; HEALTH-EDUCATION; LIFE-STYLE; RISK; PREVENTION; RENFREW; WOMEN; MEN	Objectives To assess survival in people who are at apparent high risk who do not develop coronary heart disease ("unwarranted survivals") and mortality in people at low risk who die from the disease ("anomalous deaths") and the extent to which these outcomes are explained by other, less visible, risk factors. Design Prospective general population survey. Setting Renfrew and Paisley, Scotland. Participants 6068 men aged 45-64 years at screening in 1972-6, allocated to "visible" risk groups on the basis of body mass index and smoking. Main outcome measures Survival and death from coronary heart disease by age 70 years. Results Visible risk was a good predictor of mortality: 13% (45) of men at low risk and 45% (86) of men at high risk had died by age 70 years. Of these deaths, 12 (4%) and 44 (23%), respectively, were from coronary heart disease. In the group at low visible risk other less visible risk factors accounted for increased risk in 83% (10/12) of men who died from coronary heart disease and 29% (84/292) of men who survived. In the high risk group 81/107 who survived (76%) and 19/44 (43%) who died from coronary heart disease had lower risk after other factors were considered. Different risk factors modified risk (beyond smoking and body mass index) in the two groups. Among men at low visible risk, poor respiratory function, diabetes, previous coronary heart disease, and socioeconomic deprivation modified risk. Among men at high visible risk, height and cholesterol concentration modified risk. Conclusions Differences in survival between these extreme risk groups are dramatic. Health promotion messages would be more credible if they discussed anomalies and the limits of prediction of coronary disease at an individual level.	Univ Glasgow, MRC, Social & Publ Hlth Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Hunt, K (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Unit, Glasgow G12 8RZ, Lanark, Scotland.			Emslie, Carol/0000-0003-2170-2039				Blaxter M., 1990, HLTH LIFESTYLES; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DAVISON C, 1989, Health Education Research, V4, P329, DOI 10.1093/her/4.3.329; DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DONG W, 1997, SCOTLANDS HLTH SCOTT, V1; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; Emslie C, 2001, SOCIOL HEALTH ILL, V23, P203, DOI 10.1111/1467-9566.00248; EMSLIE C, 2001, CORONARY HLTH CARE, V4, P1; FRANKEL S, 1991, BRIT J GEN PRACT, V41, P428; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Hunt K, 2001, INT J EPIDEMIOL, V30, P442, DOI 10.1093/ije/30.3.442; Hunt K, 2001, LANCET, V357, P1168, DOI 10.1016/S0140-6736(00)04334-8; MARTEAU TM, 1995, BRIT J GEN PRACT, V45, P5; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; The Scottish Office, 1999, HLTH SCOTL WHIT PAP; [No title captured]	21	13	13	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1487	1491		10.1136/bmj.323.7327.1487	http://dx.doi.org/10.1136/bmj.323.7327.1487			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751367	Green Accepted, Green Published			2022-12-24	WOS:000172979900028
J	Wyrick, JJ; Aparicio, JG; Chen, T; Barnett, JD; Jennings, EG; Young, RA; Bell, SP; Aparicio, OM				Wyrick, JJ; Aparicio, JG; Chen, T; Barnett, JD; Jennings, EG; Young, RA; Bell, SP; Aparicio, OM			Genome-wide distribution of ORC and MCM proteins in S-cerevisiae: High-resolution mapping of replication origins	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME-VI; DNA-REPLICATION; ARS ELEMENTS; YEAST; IDENTIFICATION; RECOGNITION; INITIATION; EUKARYOTES; SEQUENCE	DNA replication origins are fundamental to chromosome organization and duplication, but understanding of these elements is limited because only a small fraction of these sites have been identified in eukaryotic genomes. Origin Recognition Complex (ORC) and minichromosome maintenance (MCM) proteins form prereplicative complexes at origins of replication. Using these proteins as molecular landmarks for origins, we identified ORC- and MCM-bound sites throughout the yeast genome. Four hundred twenty-nine sites in the yeast genome were predicted to contain replication origins, and similar to 80% of the loci identified on chromosome X demonstrated origin function. A substantial fraction of the predicted origins are associated with repetitive DNA sequences, including subtelomeric elements (X and Y') and transposable element-associated sequences (tong terminal repeats). These findings identify the global set of yeast replication origins and open avenues of investigation into the role(s) ORC and MCM proteins play in chromosomal architecture and dynamics.	Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of Southern California; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Aparicio, OM (corresponding author), Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.	oaparici@usc.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Aparicio, Oscar/0000-0002-5591-0277; Bell, Stephen/0000-0002-2876-610X; Aparicio, Jennifer/0000-0002-6442-3032	NIGMS NIH HHS [GM52339, GM34365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1999, CURRENT PROTOCOLS MO, V4; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Boeke J.D., 1991, MOL CELLULAR BIOL YE, V1, P193; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; Friedman KL, 1995, J CELL SCI, P51; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HSIAO CL, 1979, P NATL ACAD SCI USA, V76, P3829, DOI 10.1073/pnas.76.8.3829; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Newlon C. S., 1996, DNA REPLICATION EUKA, P873; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; NEWLON CS, 1991, GENETICS, V129, P343; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	28	318	328	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2357	2360		10.1126/science.1066101	http://dx.doi.org/10.1126/science.1066101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743203				2022-12-24	WOS:000172817200048
J	Loeffler, JM; Nelson, D; Fischetti, VA				Loeffler, JM; Nelson, D; Fischetti, VA			Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase	SCIENCE			English	Article							CONJUGATE VACCINE; CARRIAGE	Nasopharyngeal carriage is the major reservoir for Streptococcus pneumoniae in the community. Although eliminating this reservoir would greatly reduce disease occurrence, no suitable intervention has been available for this purpose. We show here that seconds after contact, a purified pneumococcal bacteriophage lytic enzyme (Pal) is able to kill 15 common serotypes of pneumococci, including highly penicillin-resistant strains. In vivo, previously colonized mice revealed undetectable pneumococcal titers 5 hours after a single enzyme treatment. Pal enzyme had little or no effect on microorganisms normally found in the human oropharynx, and Pal-resistant pneumococci could not be detected after extensive exposure to the enzyme.	Rockefeller Univ, Lab Bacterial Pathogenesis, New York, NY 10021 USA	Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.		Nelson, Daniel C./I-2198-2012; Loeffler, Jutta M/C-2747-2008	Nelson, Daniel C./0000-0003-3248-4831; 				Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Garcia P, 1997, MICROB DRUG RESIST, V3, P165, DOI 10.1089/mdr.1997.3.165; GILLESPIE SH, 1993, INFECT IMMUN, V61, P3076, DOI 10.1128/IAI.61.7.3076-3077.1993; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pelton SI, 2000, VACCINE, V19, pS96, DOI 10.1016/S0264-410X(00)00286-3; Putnam SD, 2000, CLIN MICROBIOL INFEC, V6, P2, DOI 10.1046/j.1469-0691.2000.00001.x; Roberts RB, 2001, MICROB DRUG RESIST, V7, P137, DOI 10.1089/10766290152045011; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TUOMANEN E, 1991, SCAND J INFECT DIS, V74, P102; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142	18	356	408	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2170	2172		10.1126/science.1066869	http://dx.doi.org/10.1126/science.1066869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739958				2022-12-24	WOS:000172647700052
J	Kobayashi, T; Saito, T; Ohtani, H				Kobayashi, T; Saito, T; Ohtani, H			Real-time spectroscopy of transition states in bacteriorhodopsin during retinal isomerization	NATURE			English	Article							OPTICAL PARAMETRIC AMPLIFICATION; RESONANCE RAMAN-SPECTROSCOPY; LIGHT-INDUCED EVENTS; PULSE GENERATION; PRIMARY STEP; DYNAMICS; PHOTOISOMERIZATION; PHOTOCYCLE; SPECTRA; MODEL	Real-time investigations of the rearrangement of bonds during chemical transformations require femtosecond temporal resolution, so that the atomic vibrations within the reacting molecules can be observed. Following the development of lasers capable of emitting ultrashort laser flashes on this timescale, chemical reactions involving relatively simple molecules have been monitored in detail, revealing the transient existence of intermediate species as reactants are transformed into products(1-3). Here we report the direct observation of nuclear motion in a complex biological system, the retinal chromophore of bacteriorhodopsin (bR(568))(4), as it undergoes the trans-cis photoisomerization that is fundamental to the vision process. By using visible-light pulses of less than 5 femtosecond in duration(5,6), we are able to monitor changes in the vibrational spectra of the transition state and thus show that despite photoexcitation of the anti-bonding molecular orbital involved, isomerization does not occur instantly, but involves transient formation of a so-called 'tumbling state'. Our observations thus agree with growing experimental(7-14) and ab initio evidence(15,16) for a three-state photoisomerization model(8-10,17) and firmly discount the initially suggested two-state model(18-20) for this process.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan	University of Tokyo; Tokyo Institute of Technology	Kobayashi, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.							ATKINSON GH, 1989, CHEM PHYS, V131, P1, DOI 10.1016/0301-0104(89)87077-6; Atkinson GH, 2000, J PHYS CHEM A, V104, P4130, DOI 10.1021/jp9918306; Bardeen CJ, 1998, J PHYS CHEM A, V102, P2759, DOI 10.1021/jp980346k; DILLER R, 1995, CHEM PHYS LETT, V241, P109, DOI 10.1016/0009-2614(95)00598-X; DOIG SJ, 1991, J PHYS CHEM-US, V95, P6372, DOI 10.1021/j100169a054; DU M, 1993, BIOPHYS CHEM, V48, P101, DOI 10.1016/0301-4622(93)85002-Y; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Garavelli M, 1999, J AM CHEM SOC, V121, P1023, DOI 10.1021/ja981719y; Haran G, 1996, CHEM PHYS LETT, V261, P389, DOI 10.1016/0009-2614(96)01017-2; Hasson KC, 1996, P NATL ACAD SCI USA, V93, P15124, DOI 10.1073/pnas.93.26.15124; Humphrey W, 1998, BIOPHYS J, V75, P1689, DOI 10.1016/S0006-3495(98)77611-8; Kobayashi T, 2000, APPL PHYS B-LASERS O, V70, pS239, DOI 10.1007/s003400000325; Kobayashi T, 2000, CHEM PHYS LETT, V321, P385, DOI 10.1016/S0009-2614(00)00282-7; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; MYERS AB, 1983, J CHEM PHYS, V79, P603, DOI 10.1063/1.445807; Oesterhelt D, 1974, Methods Enzymol, V31, P667; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; POLLARD WT, 1992, J PHYS CHEM-US, V96, P6147, DOI 10.1021/j100194a013; ROSE TS, 1989, J CHEM PHYS, V91, P7415, DOI 10.1063/1.457266; ROSE TS, 1988, J CHEM PHYS, V88, P6672, DOI 10.1063/1.454408; Shirakawa A, 1999, APPL PHYS LETT, V74, P2268, DOI 10.1063/1.123820; Shirakawa A, 1998, OPT LETT, V23, P1292, DOI 10.1364/OL.23.001292; SHOENLEIN RW, 1993, J PHYS CHEM-US, V97, P12087; Song L, 1998, J AM CHEM SOC, V120, P8889, DOI 10.1021/ja980390d; VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6; Vreven T, 1997, J AM CHEM SOC, V119, P12687, DOI 10.1021/ja9725763; Ye T, 1999, J PHYS CHEM B, V103, P5122, DOI 10.1021/jp9846227; Zhong Q, 1996, J AM CHEM SOC, V118, P12828, DOI 10.1021/ja961058+	30	348	359	0	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					531	534		10.1038/35107042	http://dx.doi.org/10.1038/35107042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734850				2022-12-24	WOS:000172405900043
J	Belden, WJ; Barlowe, C				Belden, WJ; Barlowe, C			Role of Erv29p in collecting soluble secretory proteins into ER-derived transport vesicles	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; COATED VESICLES; COPII; YEAST; ERGIC-53; PATHWAY; COMPLEX	Proteins are transported from the endoplasmic reticulum (ER) in vesicles formed by coat protein complex II (COPII). Soluble secretory proteins are thought to leave the ER in these vesicles by "bulk flow" or through recognition by hypothetical shuttling receptors. We found that Erv29p, a conserved transmembrane protein, was directly required for packaging glycosylated pro-alpha -factor (gp alphaf) into COPII vesicles in Saccharomyces cerevisiae. Further, an Erv29p-gp alphaf complex was isolated from ER-derived transport vesicles. In vivo, export of gpaf from the ER was saturable and depended on the expression level of Erv29p. These results indicate that membrane receptors can link soluble cargo proteins to the COPII coat.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.							Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; BELDEN WJ, UNPUB; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; REEVES JE, 1995, MOL MEMBR BIOL, V12, P201, DOI 10.3109/09687689509027508; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Warren G, 1999, CELL, V98, P125, DOI 10.1016/S0092-8674(00)81006-5	19	151	155	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1528	1531		10.1126/science.1065224	http://dx.doi.org/10.1126/science.1065224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711675				2022-12-24	WOS:000172240500049
J	Athan, ES; Williamson, J; Ciappa, A; Santana, V; Romas, SN; Lee, JH; Rondon, H; Lantigua, RA; Medrano, M; Torres, M; Arawaka, S; Rogaeva, E; Song, YQ; Sato, C; Kawarai, T; Fafel, KC; Boss, MA; Seltzer, WK; Stern, Y; St George-Hyslop, P; Tycko, B; Mayeux, R				Athan, ES; Williamson, J; Ciappa, A; Santana, V; Romas, SN; Lee, JH; Rondon, H; Lantigua, RA; Medrano, M; Torres, M; Arawaka, S; Rogaeva, E; Song, YQ; Sato, C; Kawarai, T; Fafel, KC; Boss, MA; Seltzer, WK; Stern, Y; St George-Hyslop, P; Tycko, B; Mayeux, R			A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARADIGM-BASED DIAGNOSIS; APOLIPOPROTEIN-E; HETEROGENEOUS POPULATION; MISSENSE MUTATIONS; LINKAGE ANALYSIS; GENE; DEMENTIA; PREVALENCE; RISKS	Context Genetic determinants of Alzheimer disease (AD) have not been comprehensively examined in Caribbean Hispanics, a population in the United States in whom the frequency of AD is higher compared with non-Hispanic whites. Objective: Ta identify variant alleles in genes related to familial early-onset AD among Caribbean Hispanics. Design and Setting Family-based case series conducted in 1998-2001 at an AD research center in New York, NY, and clinics in the Dominican Republic. Patients Among 206 Caribbean Hispanic families with 2 or more living members with AD who were identified, 19 (9.2%) had at least 1 individual with onset of AD before the age of 55 years. Main Outcome Measure The entire coding region of the presenilin 1 gene and exons 16 and 17 of the amyloid precursor protein gene were sequenced in probands from the 19 families and their living relatives. Results A G-to-C nucleotide change resulting in a glycine-alanine amino acid substitution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%) of the 19 families. A Caribbean Hispanic individual with the Gly206Ala mutation and early-onset familial disease was also found by sequencing the corresponding genes of 319 unrelated individuals in New York City. The Gly206Ala mutation was not found in public genetic databases but was reported in 5 individuals from 4 Hispanic: families, with AD referred for genetic testing. None of the members of these families were related to one another, yet all carriers of the Gly206Ala mutation tested shared a variant allele at 2 nearby microsatellite polymorphisms, indicating a common ancestor. No mutations were found in the amyloid precursor protein gene. Conclusions The Gly206Ala mutation was found in 8 of 19 unrelated Caribbean Hispanic families with early-onset familial AD. This genetic change may be a prevalent cause of early-onset familial AD in the Caribbean Hispanic population.	Columbia Univ Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY 10032 USA; Univ Tecnol Santiago, Santiago, Dominican Rep; Univ Toronto, Dept Med, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada; Athena Diagnost Inc, Worcester, MA USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mayeux, R (corresponding author), Columbia Univ Coll Phys & Surg, Gertrude H Sergievsky Ctr, 630 W 168th St, New York, NY 10032 USA.		Song, You-qiang/C-4401-2009; Song, You-Qiang/E-5207-2011; Mayeux, Richard/E-9788-2013; Kawarai, Toshitaka/C-2822-2013; medrano, martin/AAF-8221-2020; Lee, Joseph H/D-2441-2012	Mayeux, Richard/0000-0001-6519-9696; Kawarai, Toshitaka/0000-0003-4547-8131; Lee, Joseph H/0000-0002-2000-4821; Song, You-Qiang/0000-0001-9407-2256; Arawaka, Shigeki/0000-0002-1505-3012; Stern, Yaakov/0000-0001-7542-3241	NATIONAL INSTITUTE ON AGING [R01AG015473, R37AG015473, P01AG007232, P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [AG15473, AG08702, AG07232] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aldudo J, 1999, HUM MUTAT, V14, P433, DOI 10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K; Aldudo J, 1998, NEUROSCI LETT, V240, P174, DOI 10.1016/S0304-3940(97)00950-6; [Anonymous], 2006, SURVIVAL ANAL TECHNI; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Crook R, 1997, ANN NEUROL, V42, P124, DOI 10.1002/ana.410420121; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; De Jonghe C, 1999, HUM MOL GENET, V8, P1529, DOI 10.1093/hmg/8.8.1529; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; HIXSON JE, 1990, J LIPID RES, V31, P545; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; JACQUIER M, 2000, NEUROBIOL AGING, V21, pS176; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lendon CL, 1997, HUM MUTAT, V10, P186; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moya Pons Frank, 1998, DOMINICAN REPUBLIC N; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PITTMAN J, 1992, ARCH NEUROL-CHICAGO, V49, P461, DOI 10.1001/archneur.1992.00530290043010; Ramirez-Duenas MG, 1998, ANN GENET-PARIS, V41, P149; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Stricks L, 1998, J INT NEUROPSYCH SOC, V4, P311, DOI 10.1017/S1355617798003117; Tanahashi H, 1996, NEUROSCI LETT, V218, P139, DOI 10.1016/S0304-3940(96)13138-4; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	45	72	74	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2257	2263		10.1001/jama.286.18.2257	http://dx.doi.org/10.1001/jama.286.18.2257			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710891	Bronze, Green Published			2022-12-24	WOS:000172129700020
J	Maric, M; Arunachalam, B; Phan, UT; Dong, C; Garrett, WS; Cannon, KS; Alfonso, C; Karlsson, L; Flavell, RA; Cresswell, P				Maric, M; Arunachalam, B; Phan, UT; Dong, C; Garrett, WS; Cannon, KS; Alfonso, C; Karlsson, L; Flavell, RA; Cresswell, P			Defective antigen processing in GILT-free mice	SCIENCE			English	Article							THIOL REDUCTASE GILT; T-CELL ACTIVATION; DISULFIDE BONDS; DENDRITIC CELLS; HEN LYSOZYME; LYSOSOMES; CONFORMATION; GENERATION; CYSTEINE; MHC	Processing of proteins for major histocompatibility complex (MHC) class II-restricted presentation to CD4-positive T lymphocytes occurs after they are internalized by antigen-presenting cells (APCs). Antigenic proteins frequently contain disulfide bonds, and their reduction in the endocytic pathway facilitates processing. In humans, a gamma interferon-inducible lysosomal thiol reductase (GILT) is constitutively present in late endocytic compartments of APCs. Here, we identified the mouse homolog of GILT and generated a GILT knockout mouse. GILT facilitated the processing and presentation to antigen-specific T cells of protein antigens containing disulfide bonds. The response to hen egg lysozyme, a model antigen with a compact Structure containing four disulfide bonds, was examined in detail.	Yale Univ, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Yale University; Johnson & Johnson; Johnson & Johnson USA	Cresswell, P (corresponding author), Yale Univ, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA.		dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Garrett, Wendy/0000-0002-5092-0150; Arunachalam, Arun/0000-0001-6486-5722	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081, R01AI023081] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23081] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON H, 1976, FEBS LETT, V10, P3147; ANDERSON WL, 1976, J BIOL CHEM, V251, P3147; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Castellino F, 1998, J IMMUNOL, V161, P4048; COLIGAN JE, 1992, CURRENT PROTOCOLS IM, V1; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; JENSEN PE, 1993, J IMMUNOL, V150, P3347; Kang HK, 2000, J IMMUNOL, V164, P1775, DOI 10.4049/jimmunol.164.4.1775; LEE CL, 1973, BIOCHEMISTRY-US, V12, P2690, DOI 10.1021/bi00738a022; LLOYD JB, 1986, BIOCHEM J, V237, P271, DOI 10.1042/bj2370271; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; SHASTRI N, 1984, J MOL CELL IMMUNOL, V1, P369; So T, 1997, J BIOL CHEM, V272, P32136, DOI 10.1074/jbc.272.51.32136; STREICHER HZ, 1984, P NATL ACAD SCI-BIOL, V81, P6831, DOI 10.1073/pnas.81.21.6831; Tachibana H, 2000, FEBS LETT, V480, P175, DOI 10.1016/S0014-5793(00)01904-9	20	212	216	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1361	1365		10.1126/science.1065500	http://dx.doi.org/10.1126/science.1065500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701933				2022-12-24	WOS:000172130200055
J	Petruk, S; Sedkov, Y; Smith, S; Tillib, S; Kraevski, V; Nakamura, T; Canaani, E; Croce, CM; Mazo, A				Petruk, S; Sedkov, Y; Smith, S; Tillib, S; Kraevski, V; Nakamura, T; Canaani, E; Croce, CM; Mazo, A			Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASES; GROUP PROTEINS; DROSOPHILA; CBP; ACETYLATION; POLYCOMB; INTERACT; DOMAIN; REGION; ASH1	Trithorax (Trx) is a member of the trithorax group (trxG) of epigenetic regulators, which is required to maintain active states of Hox gene expression during development. We have purified from Drosophila embryos a trithorax acetylation complex (TAC1) that contains Trx, dCBP, and Sbf1. Like CBP, TAC1 acetylates core histories in nucleosomes, suggesting that this activity may be important for epigenetic maintenance of gene activity. dCBP and Sbf1 associate with specific sites on salivary gland polytene chromosomes, colocalizing with many Trx binding sites. One of these is the site of the Hox gene Ultrabithorax (Ubx). Mutations in either trx or the gene encoding dCBP reduce expression of the endogenous Ubx gene as well as of transgenes driven by the bxd regulatory region of Ubx. Thus Trx, dCBP, and Sbf1 are closely linked, physically and functionally, in the maintenance of Hox gene expression.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.		Tillib, Sergei/AAT-2293-2020; Young, Richard A/F-6495-2012; Tillib, Sergei/I-4115-2013	Tillib, Sergei/0000-0002-7172-8731; Young, Richard A/0000-0001-8855-8647; Tillib, Sergei/0000-0002-7172-8731	NCI NIH HHS [5PO1 CA50507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Florence B, 1998, GENETICS, V150, P1497; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; KRAJEWSKI WA, 1993, J BIOMOL STRUCT DYN, V10, P1001, DOI 10.1080/07391102.1993.10508692; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; Tie F, 2001, DEVELOPMENT, V128, P275; Tillib S, 1999, MOL CELL BIOL, V19, P5189; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785	19	163	165	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1331	1334		10.1126/science.1065683	http://dx.doi.org/10.1126/science.1065683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701926				2022-12-24	WOS:000172130200046
J	Hypponen, E; Leon, DA; Kenward, MG; Lithell, H				Hypponen, E; Leon, DA; Kenward, MG; Lithell, H			Prenatal growth and risk of occlusive and haemorrhagic stroke in Swedish men and women born 1915-29: historical cohort study	BRITISH MEDICAL JOURNAL			English	Article							SYSTOLIC BLOOD-PRESSURE		Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Uppsala, Dept Publ Hlth & Caring Sci, SE-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Uppsala University	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010; Hypponen, Elina/B-2596-2014	Leon, David A/0000-0001-9747-1762; Hypponen, Elina/0000-0003-3670-9399				Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Leon DA, 2000, AM J EPIDEMIOL, V152, P597, DOI 10.1093/aje/152.7.597; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; *NAT BOARD HLTH WE, HOSP DISCH REG	5	46	46	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1033	1034		10.1136/bmj.323.7320.1033	http://dx.doi.org/10.1136/bmj.323.7320.1033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691760	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000172055900016
J	Scholes, RJ; Noble, IR				Scholes, RJ; Noble, IR			Climate change - Storing carbon on land	SCIENCE			English	Editorial Material									CSIR, Div Water Environm & Forest Technol, ZA-0001 Pretoria, South Africa; Cooperat Res Ctr Greenhouse Accounting, Canberra, ACT, Australia	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR, Div Water Environm & Forest Technol, Box 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za; ian.noble@greenhouse.crc.org.au		Scholes, Robert/0000-0001-5537-6935				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; PRENTICE IC, 2001, IPCC 3 ASS REP, V1, P183; SCHIMEL DS, IN PRESS NATURE; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; WATSON RT, 2000, IPCC SPECIAL REPORT, P12	9	76	97	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1012	1013		10.1126/science.1065307	http://dx.doi.org/10.1126/science.1065307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691975				2022-12-24	WOS:000172013800031
J	Schwetz, BA				Schwetz, BA			Rheumatoid arthritis treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-24	WOS:000172978500006
J	Obernosterer, A; Aschauer, M; Schnedl, W; Lipp, RW				Obernosterer, A; Aschauer, M; Schnedl, W; Lipp, RW			Anomalies of the inferior vena cava in patients with iliac venous thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; LOWER-EXTREMITIES; PELVIC VEINS; APLASIA; ABSENCE	Background: Cases of deep venous thrombosis in the lower extremities triggered by abnormalities of the vena cava have been reported. Objective: To describe anomalies of the inferior vena cava in patients with deep venous thrombosis. Design: Prospective, consecutive case series. Setting: University Hospital, Graz, Austria. Patients: 97 patients with deep venous thrombosis. Intervention: Sonography, venography, or both to diagnose deep venous thrombosis; magnetic resonance angiography to image the inferior vena cava. Measurements: Anomalies of the inferior vena cava imaged by magnetic resonance angiography. Results: 31 of 97 patients showed thrombotic occlusion of iliac veins (common and external iliac vein [n = 29] or external iliac vein [n = 2]). Five of 31 patients (3 men, 2 women) had an anomaly of the inferior vena cava. Anomalies were missing inferior vena cava, hypoplastic hepatic segment, and missing renal or postrenal segments. Patients with anomalies were significantly younger than the 92 patients without (mean age +/- SD, 25 +/- 6 years vs. 53 +/- 19 years; P = 0.002). In 2 patients with anomalies, the thrombotic occlusion was recurrent. Conclusions: An anomaly of the inferior vena cava should be suspected if thrombosis involving the iliac veins is seen in patients 30 years of age or younger. Patients with both an anomaly and thrombosis may be at higher risk for thrombotic recurrence.	Graz Univ, Dept Internal Med, Div Angiol, A-8036 Graz, Austria	University of Graz	Obernosterer, A (corresponding author), Graz Univ, Dept Internal Med, Div Angiol, Auenbruggerpl 15, A-8036 Graz, Austria.	andrea.obernosterer@kfunigraz.ac.at		Schnedl, Wolfgang/0000-0002-5212-5230				BALDRIDGE ED, 1987, ARCH SURG-CHICAGO, V122, P1184; Bergqvist D, 1997, ANN INTERN MED, V126, P454, DOI 10.7326/0003-4819-126-6-199703150-00006; BORUCHOW IB, 1972, SURG GYNECOL OBSTETR, V134, P115; CHUANG VP, 1974, BRIT J RADIOL, V47, P206, DOI 10.1259/0007-1285-47-556-206; Dougherty MJ, 1996, J VASC SURG, V23, P141, DOI 10.1016/S0741-5214(05)80044-8; Hach W, 1985, PHLEBOGRAPHIE BEIN B, P56; HALBMAYER WM, 1993, DEUT MED WOCHENSCHR, V118, P1561, DOI 10.1055/s-2008-1059485; Kellman G M, 1988, Radiographics, V8, P533; Klessen C, 1999, DEUT MED WOCHENSCHR, V124, P523, DOI 10.1055/s-2007-1024354; Mirzaie M, 1999, VASA-J VASCULAR DIS, V28, P293, DOI 10.1024/0301-1526.28.4.293; MUELHEIMS GH, 1962, AM J CARDIOL, V9, P945, DOI 10.1016/0002-9149(62)90225-4; Ordonez FS, 1998, ANGIOLOGY, V49, P951, DOI 10.1177/000331979804901113; POLAK JF, 1992, PERIPHERAL VASCULAR, P155; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; SAITO H, 1995, CARDIOVASC INTER RAD, V18, P410, DOI 10.1007/BF00338312; Shah NL, 1996, SURGERY, V120, P891, DOI 10.1016/S0039-6060(96)80100-0; Thornton MJ, 1999, AM J ROENTGENOL, V173, P999, DOI 10.2214/ajr.173.4.10511166; Tiesenhausen K, 1999, VASA-J VASCULAR DIS, V28, P289, DOI 10.1024/0301-1526.28.4.289; Timmers GJ, 1999, INT J CLIN PRACT, V53, P75; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297	20	129	140	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2002	136	1					37	41		10.7326/0003-4819-136-1-200201010-00009	http://dx.doi.org/10.7326/0003-4819-136-1-200201010-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510BF	11777362				2022-12-24	WOS:000173188300004
J	Grenfell, BT; Bjornstad, ON; Kappey, J				Grenfell, BT; Bjornstad, ON; Kappey, J			Travelling waves and spatial hierarchies in measles epidemics	NATURE			English	Article							PATTERN-FORMATION; DYNAMICS; PERSISTENCE; CHAOS; HETEROGENEITY; PERIODICITY; POPULATIONS; VACCINATION; SYNCHRONY; MODELS	Spatio-temporal travelling waves are striking manifestations of predator-prey and host-parasite dynamics. However, few systems are well enough documented both to detect repeated waves and to explain their interaction with spatio-temporal variations in population structure and demography. Here, we demonstrate recurrent epidemic travelling waves in an exhaustive spatio-temporal data set for measles in England and Wales. We use wavelet phase analysis, which allows for dynamical nonstationarity-a complication in interpreting spatio-temporal patterns in these and many other ecological time series. In the prevaccination era, conspicuous hierarchical waves of infection moved regionally from large cities to small towns; the introduction of measles vaccination restricted but did not eliminate this hierarchical contagion. A mechanistic stochastic model suggests a dynamical explanation for the waves-spread via infective 'sparks' from large 'core' cities to smaller 'satellite' towns. Thus, the spatial hierarchy of host population structure is a prerequisite for these infection waves.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Grenfell, BT (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	b.t.grenfell@zoo.cam.ac.uk	Bjornstad, Ottar N/I-4518-2012					ANDERSON R M, 1991; ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; [Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; BAK P, 1977, NATURE WORKS SCI ORG; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bjornstad ON, 2001, J ANIM ECOL, V70, P924, DOI 10.1046/j.0021-8790.2001.00560.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; BJORNSTAD ON, IN PRESS ECOL MONOGR; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; BRADSHAW GA, 1992, J ECOL, V80, P205, DOI 10.2307/2261007; Breiman L, 1992, PROBABILITY; BULMER MG, 1974, J ANIM ECOL, V43, P701, DOI 10.2307/3532; Cliff A, 1993, MEASLES HIST GEOGRAP, P1840; CLIFF AD, 1992, STAT MED, V11, P1409, DOI 10.1002/sim.4780111102; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; GRENFELL BT, 1995, P ROY SOC B-BIOL SCI, V259, P97, DOI 10.1098/rspb.1995.0015; Grenfell BT, 1998, ECOL LETT, V1, P63; GRENFELL BT, IN PRESS ECOL MONOGR; HALL P, 1994, PROBAB THEORY REL, V99, P399, DOI 10.1007/BF01199899; HANSKI I, 1993, AM NAT, V142, P17, DOI 10.1086/285527; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Jeltsch F, 1997, P ROY SOC B-BIOL SCI, V264, P495, DOI 10.1098/rspb.1997.0071; KENDALL BE, 1993, PHYS LETT A, V177, P13, DOI 10.1016/0375-9601(93)90366-8; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; MOLLISON D, 1986, PHILOS T R SOC B, V314, P675, DOI 10.1098/rstb.1986.0080; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; NEUBERT MG, 1995, THEOR POPUL BIOL, V48, P7, DOI 10.1006/tpbi.1995.1020; Office of Population Censuses and Surveys, 1944, REG GEN WEEKL RET EN; Percival D., 2000, CA ST PR MA; Ranta E, 1997, NATURE, V390, P456, DOI 10.1038/37261; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; SCHWARTZ IB, 1989, BIOMEDICAL MODELLING, P201; Sherratt JA, 2001, ECOL LETT, V4, P30, DOI 10.1046/j.1461-0248.2001.00193.x; SOLE RV, 1992, PHYS LETT A, V166, P123, DOI 10.1016/0375-9601(92)90546-X; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2	50	640	652	0	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					716	723		10.1038/414716a	http://dx.doi.org/10.1038/414716a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742391				2022-12-24	WOS:000172676200039
J	Rodewald, HR; Paul, S; Haller, C; Bluethmann, H; Blum, C				Rodewald, HR; Paul, S; Haller, C; Bluethmann, H; Blum, C			Thymus medulla consisting of epithelial islets each derived from a single progenitor	NATURE			English	Article							CELL DIFFERENTIATION; STEM-CELLS; C-KIT; MICE; EXPANSION	The thymus is organized into medullary and cortical zones that support distinct stages of T-cell development. The formation of medulla and cortex compartments is thought to occur through invagination of an endodermal epithelial sheet into an ectodermal one at the third pharyngeal pouch and cleft, respectively(1-5). Epithelial stem/progenitor cells have been proposed to be involved in thymus development(6,7), but evidence for their existence has been elusive. We have constructed chimaeric mice by injecting embryonic stem (ES) cells into blastocysts using ES cells and blastocysts differing in their major histocompatibility complex (MHC) type. Here we show that the MHC class-II-positive medullary epithelium in these chimaeras is composed of cell clusters, most of which derive from either embryonic stem cell or blastocyst, but not mixed, origin. Thus, the medulla comprises individual epithelial 'islets' each arising from a single progenitor. One thymic lobe has about 300 medullary areas that originate from as few as 900 progenitors. Islet formation can be recapitulated after implantation of 'reaggregated fetal thymic organs'(8) into mice, which shows that medullary 'stem' cells retain their potential until at least day 16.5 in fetal development. Thus, medulla- cortex compartmentalization is established by formation of medullary islets from single progenitors.	Univ Ulm, Dept Immunol, D-89081 Ulm, Germany; Basel Inst Immunol, CH-4005 Basel, Switzerland; F Hoffmann La Roche & Co Ltd, Roche Genet, CH-4070 Basel, Switzerland	Ulm University; Roche Holding	Rodewald, HR (corresponding author), Univ Ulm, Dept Immunol, Albert Einstein Allee 11, D-89081 Ulm, Germany.							ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; BESCHORNER WE, 1987, CELL IMMUNOL, V110, P350, DOI 10.1016/0008-8749(87)90128-6; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; CRISAN C., 1935, ZEITSCHR ANAT U ENTUNCKLUNGSGESCH, V104, P327, DOI 10.1007/BF02118610; GOSGROVE D, 1991, CELL, V66, P1051; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lampert I. A., 1988, THYMUS UPDATE, P5; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; NORRIS EH, 1938, CONTRIB EMBRYOL, V166, P191; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Suniara RK, 1999, EUR J IMMUNOL, V29, P75, DOI 10.1002/(SICI)1521-4141(199901)29:01<75::AID-IMMU75>3.3.CO;2-3; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANEWIJK W, 1980, J HISTOCHEM CYTOCHEM, V28, P1089, DOI 10.1177/28.10.6999083; VONGAUDECKER B, 1991, ANAT EMBRYOL, V183, P1; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	21	159	163	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					763	768		10.1038/414763a	http://dx.doi.org/10.1038/414763a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742403				2022-12-24	WOS:000172676200051
J	Bullock, SL; Ish-Horowicz, D				Bullock, SL; Ish-Horowicz, D			Conserved signals and machinery for RNA transport in Drosophila oogenesis and embryogenesis	NATURE			English	Article							POSTERIOR DETERMINANT NANOS; PAIR-RULE TRANSCRIPTS; OSKAR MESSENGER-RNA; BICAUDAL-D PROTEIN; BICOID RNA; ANTERIOR POLE; EGG CHAMBER; LOCALIZATION; OOCYTE; GENE	Localization of cytoplasmic messenger RNA transcripts is widely used to target proteins within cells. For many transcripts, localization depends on cis-acting elements within the transcripts and on microtubule-based motors; however, little is known about other components of the transport machinery or how these components recognize specific RNA cargoes. Here, we show that in Drosophila the same machinery and RNA signals drive specific accumulation of maternal RNAs in the early oocyte and apical transcript localization in blastoderm embryos. We demonstrate in vivo that Egalitarian (Egl) and Bicaudal D (BicD), maternal proteins required for oocyte determination, are selectively recruited by, and co-transported with, localizing transcripts in blastoderm embryos, and that interfering with the activities of Egl and BicD blocks apical localization. We propose that Egl and BicD are core components of a selective dynein motor complex that drives transcript localization in a variety of tissues.	Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Cancer Research UK	Ish-Horowicz, D (corresponding author), Imperial Canc Res Fund, Dev Genet Lab, POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.		Bullock, Simon/K-6885-2012	Bullock, Simon/0000-0001-9491-4548; Ish-Horowicz, David/0000-0001-5684-7129				Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; ISHHOROWICZ D, 1987, CELL, V51, P405, DOI 10.1016/0092-8674(87)90636-2; KarlinMcginness M, 1996, DEV GENET, V19, P238, DOI 10.1002/(SICI)1520-6408(1996)19:3<238::AID-DVG7>3.0.CO;2-A; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1994, MOL CELL BIOL, V14, P2235, DOI 10.1128/MCB.14.4.2235; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; MACDONALD PM, 1991, GENE DEV, V5, P2455, DOI 10.1101/gad.5.12b.2455; Macdonald PM, 1997, RNA, V3, P1413; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; MOHLER J, 1986, GENETICS, V112, P803; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Oh J, 2000, GENETICS, V154, P713; Oh J, 2001, DEV BIOL, V232, P91, DOI 10.1006/dbio.2001.0170; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; RAN B, 1994, DEVELOPMENT, V120, P1233; Riedl A, 1996, MOL CELL BIOL, V16, P3047; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; SCHUPBACH T, 1991, GENETICS, V129, P1119; SERANO T, 1995, DEVELOPMENT, V121, P3809; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; THEURKAUF WE, 1994, DEV BIOL, V165, P352, DOI 10.1006/dbio.1994.1258; Thio GL, 2000, DEV BIOL, V221, P435, DOI 10.1006/dbio.2000.9690; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	45	199	206	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					611	616		10.1038/414611a	http://dx.doi.org/10.1038/414611a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740552				2022-12-24	WOS:000172535600040
J	Valencia, M; Bentele, M; Vaze, MB; Herrmann, G; Kraus, E; Lee, SE; Schar, P; Haber, JE				Valencia, M; Bentele, M; Vaze, MB; Herrmann, G; Kraus, E; Lee, SE; Schar, P; Haber, JE			NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-LIGASE; MATING-TYPE; ILLEGITIMATE RECOMBINATION; GENE-EXPRESSION; REPAIR; YEAST; KU70; IDENTIFICATION; MUTATIONS	Broken DNA ends are rejoined by non-homologous end-joining (NHEJ) pathways requiring the Ku proteins (Ku70, Ku80), DNA ligase IV and its associated protein Lif1/Xrcc4 (ref. 1). In mammalian meiotic cells, Ku protein levels are much lower than in somatic cells, apparently reducing the capacity of meiotic cells to carry out NHEJ and thereby promoting homologous recombination(2). In Saccharomyces cerevisiae, NHEJ is also downregulated in meiosis-competent MATa/MAT alpha diploid cells in comparison with diploids or haploids expressing only MATa or MAT alpha (3,4). Diploids expressing both MATa and MAT alpha show enhanced mitotic homologous recombination(4). Here we report that mating-type-dependent regulation of NHEJ in budding yeast is caused in part by transcriptional repression of both LIF1 and the gene NEJ1 (YLR265C)-identified from microarray screening of messenger RNAs. Deleting NEJ1 reduces NHEJ 100-fold in MATa or MAT alpha haploids. Constitutive expression of NEJ1, but not expression of LIF1, restores NHEJ in MATa/MAT alpha cells. Nej1 regulates the subcellular distribution of Lif1. A green fluorescent protein (GFP)-Lif1 fusion protein accumulates in the nucleus in cells expressing NEJ1 but is largely cytoplasmic when NEJ1 is repressed.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland	Brandeis University; Brandeis University; University of Zurich	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.		Schär, Primo/G-5967-2012	Schär, Primo/0000-0003-1843-6147; Haber, James/0000-0002-1878-0610				Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; OOI SL, 2001, SCIENCE         1108; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Tsukamoto Y, 1996, GENETICS, V142, P383; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Tsukamoto Y, 1996, NUCLEIC ACIDS RES, V24, P2067, DOI 10.1093/nar/24.11.2067; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	29	174	178	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					666	669		10.1038/414666a	http://dx.doi.org/10.1038/414666a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740566				2022-12-24	WOS:000172535600054
J	Long, J; Allwright, S; Barry, J; Reynolds, SR; Thornton, L; Bradley, F; Parry, JV				Long, J; Allwright, S; Barry, J; Reynolds, SR; Thornton, L; Bradley, F; Parry, JV			Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							FACTOR ELICITATION; SURVEILLANCE; SCOTLAND	Objectives To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in enu-ants to Ir ish prisons and to examine risk factors for infection. Design Cross sectional, anonymous survey, with self completed risk factor questionnaire and oral fluid specimen for antibody testing. Setting Five of seven committal prisons in the Republic of Ireland. Participants 607 of the 718 consecutive prison entrants from 6 April to 1 May 1999. Main outcome measures Prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in prison entrants, and self reported risk factor status. Results Prevalence of antibodies to hepatitis B core antigen was 37/596 (6%; 95% confidence interval 4% to 9%), to hepatitis C virus was 130/596 (22%; 19% to 25%), and to HIV was 12/596 (2%; 1% to 4%). A third of the respondents had never previously been in prison; these had the lowest prevalence of antibodies to hepatitis B core antigen (4/197, 2%), to hepatitis C (6/197, 3%), and to HIV (0/197). In rata 29% of respondents (173/593) reported ever injecting drugs, but only 7% (14/197) of those entering prison for the first tune reported doing so compared with 40% (157/394) of those previously in prison. Use of injected drugs was the most important predictor of antibodies to hepatitis B core antigen acid hepatitis C virus. Conclusions Use of injected drugs and infection with hepatitis C virus are endemic in Irish prisons. A third of prison enu-ants were committed to prison for the first time. Oily a small number of first time entrants were affected with one or more of die viruses. These findings confirm the need for increased infection control and harm reduction measures in Irish prisons.	Adelaide & Meath Hosp, Natl Childrens Hosp, Trinity Coll, Ctr Hlth Sci,Dept Community Hlth & Gen Practice, Dublin 24, Ireland; No Area Hlth Board, Drugs AIDS Serv, Dublin 7, Ireland; Dr Steevens Hosp, Eastern Reg Hlth Author, Dept Publ Hlth, Dublin 8, Ireland; Cent Publ Hlth Lab, PHLS, Sexually Transmitted & Bloodborne Virus Lab, London NW9 5HT, England	Trinity College Dublin; Public Health England	Allwright, S (corresponding author), Adelaide & Meath Hosp, Natl Childrens Hosp, Trinity Coll, Ctr Hlth Sci,Dept Community Hlth & Gen Practice, Dublin 24, Ireland.		Allwright, Shane/A-1537-2012	Allwright, Shane/0000-0003-1841-4781				ABILDGAARD N, 1991, LANCET, V338, P460, DOI 10.1016/0140-6736(91)91095-C; Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; BIRD AG, 1993, BRIT MED J, V307, P228, DOI 10.1136/bmj.307.6898.228; BIRD AG, 1992, AIDS, V6, P725, DOI 10.1097/00002030-199207000-00017; BIRD AG, 1995, AIDS, V9, P801, DOI 10.1097/00002030-199507000-00019; Bird AG, 1997, BRIT MED J, V315, P21, DOI 10.1136/bmj.315.7099.21; Butler TG, 1997, MED J AUSTRALIA, V166, P127, DOI 10.5694/j.1326-5377.1997.tb140041.x; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; Gore SM, 1997, INT J STD AIDS, V8, P166, DOI 10.1258/0956462971919831; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; ROTILY M, 1997, INT J STD AIDS, V8, P735; TURNBULL PJ, 1991, PRISONS HIV AIDS RIS; Weild A R, 2000, Commun Dis Public Health, V3, P121	13	57	63	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1209	1212		10.1136/bmj.323.7323.1209	http://dx.doi.org/10.1136/bmj.323.7323.1209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719410	Green Published, Bronze			2022-12-24	WOS:000172450500013
J	Cortez, D; Guntuku, S; Qin, J; Elledge, SJ				Cortez, D; Guntuku, S; Qin, J; Elledge, SJ			ATR and ATRIP: Partners in checkpoint signaling	SCIENCE			English	Article							EARLY EMBRYONIC LETHALITY; IONIZING-RADIATION; PROTEIN; KINASE; GENE; PHOSPHORYLATION; SENSITIVITY; DISRUPTION; PATHWAY; COMPLEX	The checkpoint kinases ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3 related) transduce genomic stress signals to halt cell cycle progression and promote DNA repair. We report the identification of an ATR-interacting protein (ATRIP) that is phosphorylated by ATR, regulates ATR expression, and is an essential component of the DNA damage checkpoint pathway. ATR and ATRIP both localize to intranuclear foci after DNA damage or inhibition of replication. Deletion of ATR mediated by the Cre recombinase caused the loss of ATR and ATRIP expression, loss of DNA damage checkpoint responses, and cell death. Therefore, ATR is essential for the viability of human somatic cells. Small interfering RNA directed against ATRIP caused the loss of both ATRIP and ATR expression and the toss of checkpoint responses to DNA damage. Thus, ATRIP and ATR are mutually dependent partners in cell cycle checkpoint signaling pathways.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brodsky MH, 2000, GENE DEV, V14, P666; Brown EJ, 2000, GENE DEV, V14, P397; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; CORTEZ D, UNPUB; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Paciotti V, 2000, GENE DEV, V14, P2046; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wang Y, 2000, GENE DEV, V14, P927; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	22	732	769	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1713	1716		10.1126/science.1065521	http://dx.doi.org/10.1126/science.1065521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721054				2022-12-24	WOS:000172307400043
J	Nguyen, VT; Kiss, TS; Michels, AA; Bensaude, O				Nguyen, VT; Kiss, TS; Michels, AA; Bensaude, O			7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE-II; P-TEFB; TERMINAL DOMAIN; MESSENGER-RNA; TRANSCRIPTION; ELONGATION; PHOSPHORYLATION; INITIATION; PATHWAY	The transcription of eukaryotic protein-coding genes involves complex regulation of RNA polymerase (Pol) II activity in response to physiological conditions and developmental cues. One element of this regulation involves phosphorylation of the carboxy-terminal domain (CTD) of the largest polymerase subunit by a transcription elongation factor, P-TEFb, which comprises the kinase CDK9 and cyclin T1 or T2 (ref. 1). Here we report that in human HeLa cells more than half of the P-TEFb is sequestered in larger complexes that also contain 7SK RNA, an abundant, small nuclear RNA (snRNA) of hitherto unknown function(2,3). P-TEFb and 7SK associate in a specific and reversible manner. In contrast to the smaller P-TEFb complexes, which have a high kinase activity, the larger 7SK/P-TEFb complexes show very weak kinase activity. Inhibition of cellular transcription by chemical agents or ultraviolet irradiation trigger the complete disruption of the P-TEFb/7SK complex, and enhance CDK9 activity. The transcription-dependent interaction of P-TEFb with 7SK may therefore contribute to an important feedback loop modulating the activity of RNA Pol II.	Ecole Normale Super, CNRS, UMR 8541, F-75230 Paris 05, France; Univ Toulouse 3, CNRS, Lab Biol Mol Eucaryote, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bensaude, O (corresponding author), Ecole Normale Super, CNRS, UMR 8541, 46 Rue Ulm, F-75230 Paris 05, France.			Kiss, Tamas/0000-0003-0293-3093; Bensaude, Olivier/0000-0002-0259-6608; Michels, Annemieke/0000-0002-1735-1697				Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; EGYHAZI E, 1976, NATURE, V262, P319, DOI 10.1038/262319a0; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; GOODALL GJ, 1990, METHOD ENZYMOL, V181, P148; Hirose Y, 2000, GENE DEV, V14, P1415; IGNOTZ GG, 1981, BIOCHEMISTRY-US, V20, P2550, DOI 10.1021/bi00512a029; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	25	530	552	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					322	325		10.1038/35104581	http://dx.doi.org/10.1038/35104581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713533				2022-12-24	WOS:000172150700047
J	Ni, YH; Chang, MH; Huang, LM; Chen, HL; Hsu, HY; Chiu, TY; Tsai, KS; Chen, DS				Ni, YH; Chang, MH; Huang, LM; Chen, HL; Hsu, HY; Chiu, TY; Tsai, KS; Chen, DS			Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; ANTIGEN; TAIWAN; SEROEPIDEMIOLOGY; PROGRAM; VACCINE; INFANTS; TAIPEI	Background: Hepatitis B virus (HBV) infection is hyperendemic in Taiwan. Before universal HBV immunization was started in Taiwan in 1984, the carrier rate for hepatitis B surface antigen (HBsAg) was 15% to 20% in the general population. Objective: To quantify the population impact of a mass vaccination program for HBV 15 years after its implementation. Design: Descriptive analysis of serologic markers of HBV in healthy children and adolescents. Setting: Chung-Cheng District, Taipei City, Taiwan, in 1999. Participants: 1357 persons younger than 15 years of age, who were born after the implementation of universal HBV vaccination, and 559 persons 15 to 20 years of age, who were borin before the program began. Measurements: Repeated serologic surveys similar to those done before and 5 and 10 years after the national vaccination program was implemented. All participants were tested for serum HBsAg, its antibody (anti-HBs), and hepatitis B core antibody (anti-HBc). Results: During the 15 years since the vaccination program was implemented, the prevalence of HBsAg among persons younger than 15 years of age decreased from 9.8% in 1984 to 0.7% in 1999; among persons 15 to 20 years of age, the 1999 prevalence of HBsAg was 7% (P < 0.001). Hepatitis B core antibody seropositivity, which represents HBV infection, was found in 2.9% of persons younger than 15 years of age and in 20.6% of persons 15 to 20 years of age (P < 0.001); in the same age groups, the rate of anti-HBs seropositivity was 75.8% and 70.7%, respectively (P = 0.02). Conclusions: universal vaccination significantly decreased the HBV carrier rate and infection rate among children and adolescents born since the program began. By decreasing the carrier pool, continuation of the national HBV immunization program should prevent HBV infection in the children of Taiwan, and, subsequently, adults as well.	Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10018, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan S Rd, Taipei 100, Taiwan.	mhchang@ha.mc.ntu.edu.tw		TSAI, KEH-SUNG/0000-0001-8528-1566; CHEN, DING-SHINN/0000-0001-7791-6154; HUANG, LI-MIN/0000-0002-9291-260X; Hsu, Hong-Yuan/0000-0002-5720-4835; Ni, Yen-Hsuan/0000-0002-1158-5249; Chang, Mei Hwei/0000-0002-3648-9261; CHIU, TAI-YUAN/0000-0002-8528-7981				BEASLEY RP, 1982, HEPATOLOGY, V2, pS21; BEASLEY RP, 1981, LANCET, V2, P1129; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chang MH, 2000, J GASTROEN HEPATOL, V15, pE16, DOI 10.1046/j.1440-1746.2000.02096.x; CHEN DS, 1977, NEW ENGL J MED, V297, P668; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Hsu HM, 1999, J INFECT DIS, V179, P367, DOI 10.1086/314585; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Lin H H, 1994, Asia Oceania J Obstet Gynaecol, V20, P141; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; SUNG JL, 1984, CHINESE J GASTROENTE, V1, P1; Tang JR, 1998, J PEDIATR-US, V133, P374, DOI 10.1016/S0022-3476(98)70272-0; TSEN YJ, 1991, J MED VIROL, V34, P96, DOI 10.1002/jmv.1890340205	17	265	281	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					796	800		10.7326/0003-4819-135-9-200111060-00009	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694104	Green Published			2022-12-24	WOS:000172013700004
J	Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD				Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD			Rapid responses of British butterflies to opposing forces of climate and habitat change	NATURE			English	Article							AVAILABILITY; DIVERSITY; ABUNDANCE; RANGES	Habitat degradation and climate change are thought to be altering the distributions and abundances of animals and plants throughout the world, but their combined impacts have not been assessed for any species assemblage(1-4). Here we evaluated changes in the distribution sizes and abundances of 46 species of butterflies that approach their northern climatic range margins in Britain-where changes in climate and habitat are opposing forces. These insects might be expected to have responded positively to climate warming over the past 30 years, yet three-quarters of them declined: negative responses to habitat loss have outweighed positive responses to climate warming. Half of the species that were mobile and habitat generalists increased their distribution sites over this period (consistent with a climate explanation), whereas the other generalists and 89% of the habitat specialists declined in distribution size (consistent with habitat limitation). Changes in population abundances closely matched changes in distributions. The dual forces of habitat modification and climate change are likely to cause specialists to decline, leaving biological communities with reduced numbers of species and dominated by mobile and widespread habitat generalists.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England; Winfrith Technol Ctr, Dorset Lab, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, England; Univ Durham, Dept Biol Sci, Environm Res Ctr, Durham DH1 3LE, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Butterfly Conservat, Wareham BH20 5QP, Dorset, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); Durham University; University of York - UK	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	c.d.thomas@leeds.ac.uk	Willis, Stephen G/F-8503-2015; Hill, Jane K/G-5151-2011; Thomas, Chris D/A-1894-2012; Roy, David/A-6619-2009; Fox, Richard/G-3873-2011; Thomas, Chris D/A-1460-2014; Hill, Jane K./AAJ-3374-2021	Willis, Stephen G/0000-0002-8656-5808; Thomas, Chris D/0000-0003-2822-1334; Roy, David/0000-0002-5147-0331; Thomas, Chris D/0000-0003-2822-1334; Hill, Jane K./0000-0003-1871-7715; Fox, Richard/0000-0001-6992-3522				Asher J, 2001, MILLENNIUM ATLAS BUT; Coope G. R., 1995, P29; Cowley MJR, 1999, P ROY SOC B-BIOL SCI, V266, P1587, DOI 10.1098/rspb.1999.0819; Cowley MJR, 2001, J ANIM ECOL, V70, P410, DOI 10.1046/j.1365-2656.2001.00508.x; Dennis RLH, 1997, BIOL J LINN SOC, V60, P257, DOI 10.1006/bijl.1996.0099; Groombridge B., 1992, GLOBAL BIODIVERSITY; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill Jane K., 2001, Symposia of the Royal Entomological Society of London, V20, P415, DOI 10.1079/9780851994567.0415; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B, 1995, J BIOGEOGR, V22, P967, DOI 10.2307/2845830; Jones Philip D., 1997, CLIMATES BRIT ISLES, P173; Leemans R., 1991, RR9118 IIASA; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; MOSS D, 1993, ECOL ENTOMOL, V18, P77, DOI 10.1111/j.1365-2311.1993.tb01083.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pollard E., 1994, TRENDS ECOLOGY EVOLU, V9, P31; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; Thomas JA, 1999, FUNCT ECOL, V13, P55, DOI 10.1046/j.1365-2435.1999.00008.x; Tolman T, 1997, BUTTERFLIES BRITAIN; Van Swaay C.A.M., 1999, NATURE ENV SERIES, V99	29	925	980	15	593	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					65	69		10.1038/35102054	http://dx.doi.org/10.1038/35102054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689943				2022-12-24	WOS:000171898900042
J	Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP				Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP			An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; MESSENGER-RNA; GENE; INTERFERENCE; IDENTIFICATION; EXPRESSION; SEQUENCE	Two small temporal RNAs (stRNAs), lin-4 and let-7, control developmental timing in Caenorhabditis elegans. We find that these two regulatory RNAs are members of a large class of 21- to 24-nucleotide noncoding RNAs, called microRNAs (miRNAs). We report on 55 previously unknown miRNAs in C. elegans. The miRNAs have diverse expression patterns during development: a let-7 paralog is temporally coexpressed with let-7; miRNAs encoded in a single genomic cluster are coexpressed during embryogenesis; and still other miRNAs are expressed constitutively throughout development. Potential orthologs of several of these miRNA genes were identified in Drosophila and human genomes. The abundance of these tiny RNAs, their expression patterns, and their evolutionary conservation imply that, as a class, miRNAs have broad regulatory functions in animals.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartet@wi.mit.edu		Lau, Nelson/0000-0001-9907-1404				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Malinsky S, 2000, GENETICS, V156, P1147; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	2489	2856	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					858	862		10.1126/science.1065062	http://dx.doi.org/10.1126/science.1065062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679671				2022-12-24	WOS:000171851800048
J	Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A				Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A		Swiss HIV Cohort Study	Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study	LANCET			English	Article							PROTEASE INHIBITORS; THERAPY; LIPODYSTROPHY	Background Data on adverse events to antiretroviral treatment have been recorded in clinical trials, postmarketing analyses, and anecdotal reports. Such data might not be an up-to-date or comprehensive assessment of all possible treatment combinations defined as potent antiretroviral treatment. Methods Using a standard clinical and laboratory method, we assessed prevalence of adverse events in 1160 patients who were receiving antiretroviral treatment. We measured the toxic effects associated with the drug regimen (protease inhibitor [PI], non-nucleoside and nucleoside analogue reverse transcriptase inhibitor) and specific compounds using multivariate analyses. Findings 47% (545 of 1160) of patients presented with clinical and 27% (194 of 712) with laboratory adverse events probably or definitely attributed to antiretroviral treatment. Among these, 9% (47 of 545) and 16% (30 of 194), respectively, were graded as serious or severe. Single-PI and PI-sparing-antiretroviral treatment were associated with a comparable prevalence of adverse events. Compared with single-PI treatment, use of dual-PI-antiretroviral treatment and three-class-antiretroviral treatment was associated with higher prevalence of adverse events (odds ratio [OR] 2.0 [95% CI 1.0-4.0], and 3.9 [1.2-12.9], respectively). Compound specific associations were identified for zidovudine, lamivudine, stavudine, didanosine, abacavir, ritonavir, saquinavir, indinavir, nelfinavir, efavirenz, and nevirapine. Interpretation We recorded a high prevalence of toxic effects attributed to antiretroviral treatment for HIV-1. Such data provides a reference for regimen-specific and compound-specific adverse events and could be useful in postmarketing analyses of toxic effects.	Univ Lausanne Hosp, Lausanne, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; Hosp Lugano, Lugano, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Basel; University of Geneva; Kantonsspital St. Gallen	Telenti, A (corresponding author), Univ Lausanne, CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.	amalio.telenti@chuv.hospvd.ch	Fellay, Jacques/A-6681-2009; Telenti, Amalio/AAY-1674-2021; Greub, Gilbert GG/K-5804-2017; Ledergerber, Bruno/B-5656-2009; Furrer, Hansjakob/G-6768-2013; VALLET, Yannick/F-9979-2011	Fellay, Jacques/0000-0002-8240-939X; Greub, Gilbert GG/0000-0001-9529-3317; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; 				BERGMANN JF, 1993, BRIT MED J, V307, P1397, DOI 10.1136/bmj.307.6916.1397; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; BOUBAKER K, IN PRESS CLIN INFECT; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Clarke S, 2000, INT J STD AIDS, V11, P336, DOI 10.1258/0956462001915831; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Hansel A, 2001, J ACQ IMMUN DEF SYND, V26, P191, DOI 10.1097/00126334-200102010-00016; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; Hurst M, 1999, DRUGS, V58, P919, DOI 10.2165/00003495-199958050-00012; LAMBERT JS, 1990, NEW ENGL J MED, V322, P1333, DOI 10.1056/NEJM199005103221901; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; MCLEOD GX, 1992, ANN INTERN MED, V117, P487, DOI 10.7326/0003-4819-117-6-487; PIKE IM, 1993, CLIN INFECT DIS, V16, pS63, DOI 10.1093/clinids/16.Supplement_1.S63; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Struble Kimberly A., 1997, American Journal of Medicine, V102, P65, DOI 10.1016/S0002-9343(97)00065-X; SUDRE P, 2001, SCHWEIZ MED WOCHENSC, V130, P500	17	240	251	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1322	1327		10.1016/S0140-6736(01)06413-3	http://dx.doi.org/10.1016/S0140-6736(01)06413-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684213				2022-12-24	WOS:000171702500012
J	Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS				Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS			Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer coning	SCIENCE			English	Article							CLONED TRANSGENIC CALVES; SOMATIC-CELLS	The presence of galactose alpha-1,3-galactose residues on the surface of pig cells is a major obstacle to successful xenotransplantation. Here, we report the production of four live pigs in which one allele of the alpha-1,3-galactosyltransferase locus has been knocked out. These pigs were produced by nuclear transfer technology; clonal fetal fibroblast cell lines were used as nuclear donors for embryos reconstructed with enucleated pig oocytes.	Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Immerge BioTherapeut Inc, Charlestown, MA 02129 USA; Kangwon Natl Univ, Coll Anim Resource Sci, Dept Vet Med, Chunchon 200701, South Korea; Natl Livestock Res Inst, Suwon 441350, South Korea	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Kangwon National University	Prather, RS (corresponding author), Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA.	pratherR@missouri.edu	Prather, Randall S/B-4528-2012; Lai, Liangxue/H-4545-2011	Prather, Randall/0000-0002-6012-4035	NATIONAL CENTER FOR RESEARCH RESOURCES [R44RR015198, T32RR007004] Funding Source: NIH RePORTER; NCRR NIH HHS [R44 RR15198, T32 RR07004] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bondioli K, 2001, MOL REPROD DEV, V60, P189, DOI 10.1002/mrd.1076; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Costa C, 1999, FASEB J, V13, P1762, DOI 10.1096/fasebj.13.13.1762; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Evans RW, 2001, XENOTRANSPLANTATION, P29; GALILI U, 2001, CURR OPIN ORGAN T, V6; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; LAI L, UNPUB; Lambrigts D, 1998, TRANSPLANTATION, V66, P547, DOI 10.1097/00007890-199809150-00001; Martin Michael J., 1994, P315; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Miyagawa S, 2001, J BIOL CHEM, V276, P39310, DOI 10.1074/jbc.M104359200; OLDMIXON BA, UNPUB; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; POLGE C, 1966, J REPROD FERTIL, V12, P395, DOI 10.1530/jrf.0.0120395; POLGE C, 1981, CONTROL PIG REPROD, P283; Pope W F, 1990, J Reprod Fertil Suppl, V40, P251; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Tao T, 2000, ZYGOTE, V8, P69, DOI 10.1017/S0967199400000848; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996	24	1022	1254	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1089	1092		10.1126/science.1068228	http://dx.doi.org/10.1126/science.1068228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11778012				2022-12-24	WOS:000173793000071
J	Chang, D; Markman, BS				Chang, D; Markman, BS			Spontaneous resolution of a pubic-symphysis diastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									San Francisco Orthopaed Residency Program, San Francisco, CA 94117 USA		Chang, D (corresponding author), San Francisco Orthopaed Residency Program, San Francisco, CA 94117 USA.								0	4	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					39	39		10.1056/NEJMicm980471	http://dx.doi.org/10.1056/NEJMicm980471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11778001				2022-12-24	WOS:000173033600006
J	Clarfield, AM				Clarfield, AM			In grandfather's room	BRITISH MEDICAL JOURNAL			English	Article									Soroka Hosp Ctr, Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University	Clarfield, AM (corresponding author), Soroka Hosp Ctr, Beer Sheva, Israel.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1496	1497		10.1136/bmj.323.7327.1496	http://dx.doi.org/10.1136/bmj.323.7327.1496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751369	Green Published			2022-12-24	WOS:000172979900030
J	Redelmeier, DA; Singh, SM				Redelmeier, DA; Singh, SM			Longevity of screenwriters who win an academy award: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC-STATUS; HEALTH; MORTALITY; STRESS	Objective To determine whether the link between high success and longevity extends to academy award winning screenwriters. Design Retrospective cohort analysis. Participants All screenwriters ever nominated for an academy award. Main outcome measures Life expectancy and all cause mortality Results A total of 850 writers were nominated; the median duration of follow up from birth was 68 years; and 428 writers died. On average, winners were more successful than nominees, as indicated by a 14% longer career (27.7 v 24.2, P = 0.004), 34% more total films (23.2 v 17.3, P < 0.001), 58% more four star films (4.8 v 3.1, P < 0.001), and 62% more nominations (2.1 v, 1.3, P < 0.001). However, life expectancy was 3.6 years shot-ter for winners than for nominees (74.1 v, 77.7 years. P = 0.004), equivalent to a 37% relative increase in death rates (95% confidence interval 10 to 70). After adjustment for year of birth, sex, and other factors, a 35% relative increase in death rates was found (7%, to 70%). Additional wins were associated with a 22% relative increase in death rates (31% to 44%). Additional nominations and additional other films in a career otherwise caused no significant increase in death rates. Conclusion The link between occupational achievement and longevity is reversed in screenwriters who win academy awards. Doubt is cast on simple biological theories for the survival gradients found for other members of society.	Sunnybrook & Womens Hosp, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Sunnybrook & Womens Hosp, Toronto, ON M4N 3M5, Canada.							Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Detsky AS, 1998, NEW ENGL J MED, V339, P402, DOI 10.1056/NEJM199808063390611; Evans R. G., 1994, WHY ARE SOME PEOPLE; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; GARBER AM, 1989, PATHWAYS HLTH ROLE S, P271; Katz Ephraim, 1998, FILM ENCY; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1984, LANCET, V1, P1003; MYERS J, 1968, DECADE LATER FOLLOW; SAPOLSKY RM, 1990, SCI AM, V262, P116, DOI 10.1038/scientificamerican0190-116; STEWART WT, 1981, INT FILM NECROLOGY; Syme SL, 1998, MILBANK Q, V76, P493, DOI 10.1111/1468-0009.00100; Thomas Nicholas, 1990, INT DICT FILMS FILMM; Vincendeau G., 1995, ENCY EUROPEAN CINEMA; WALKER J, 1997, HALLIWELLS FILMGOERS	20	25	25	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1491	1496		10.1136/bmj.323.7327.1491	http://dx.doi.org/10.1136/bmj.323.7327.1491			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751368	Green Published			2022-12-24	WOS:000172979900029
J	Weijers, D; Geldner, N; Offringa, R; Jurgens, G				Weijers, D; Geldner, N; Offringa, R; Jurgens, G			Seed development - Early paternal gene activity in Arabidopsis	NATURE			English	Article							PATTERN-FORMATION; EMBRYO; PROTEIN		Leiden Univ, Inst Mol Plant Sci, NL-2333 AL Leiden, Netherlands; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Leiden University; Leiden University - Excl LUMC; Eberhard Karls University of Tubingen	Weijers, D (corresponding author), Leiden Univ, Inst Mol Plant Sci, NL-2333 AL Leiden, Netherlands.		Geldner, Niko/Y-2481-2019; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Offringa, Remko/0000-0002-3293-5295				Hamann T, 1999, DEVELOPMENT, V126, P1387; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; MAYER U, 1993, DEVELOPMENT, V117, P149; Springer PS, 2000, DEVELOPMENT, V127, P1815; SURANI MA, 1990, DEVELOPMENT, P89; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2	9	93	98	2	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					709	710		10.1038/414709a	http://dx.doi.org/10.1038/414709a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742384				2022-12-24	WOS:000172676200032
J	Zhen, CL; Sangl, J; Bierman, AS; Miller, MR; Friedman, B; Wickizer, SW; Meyer, GS				Zhen, CL; Sangl, J; Bierman, AS; Miller, MR; Friedman, B; Wickizer, SW; Meyer, GS			Potentially inappropriate medication use in the community-dwelling elderly - Findings from the 1996 Medical Expenditure Panel Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Gerontological-Society-of-America	NOV, 2000	WASHINGTON, D.C.	Gerontol Soc Amer			EXPLICIT CRITERIA; NURSING-HOMES; FACILITIES; RESIDENTS	Context Inappropriate medication use is a major patient safety concerr, especially for the elderly population. Using explicit criteria, prior studies have found that 23.5% and 17.5% of the US community-dwelling elderly population used at least 1 of 20 potentially inappropriate medications in 1987 and 1992, respectively. Objectives To determine the prevalence of potentially inappropriate medication use in community-dwelling elderly persons in 1996, to assess trends over 10 years, categorize inappropriate medication use according to explicit criteria, and to examine risk factors for inappropriate medication use. Design, Setting, and Participants Respondents aged 65 years or older (n=2455) to the 1996 Medical Expenditure Panel Survey, a nationally representative survey of the US noninstitutionalized population were included. A 7-member expert panel was convened to categorize inappropriate medications. Main Outcome Measure Prevalence of use of 33 potentially inappropriate medications. Results In 1996, 21.3% (95% confidence interval [CI], 19.5%-23.1%)of community-dwelling elderly patients in the United States received at least 1 of 33 potentially inappropriate medications. Using the expert panel's classifications, about 2.6% of elderly patients (95% Cl, 2.0%-3.2%) used at least 1 of the 11 medications that should always be avoided by elderly patients; 9.1% (95% Cl, 7.9%-10.3%) used at least 1 cf the 8 that would rarely be appropriate; and 13.3% (95% Cl, 11.7%-14.9%) used at least 1 of the 14 medications that have some indications but are often misused. Use of some inappropriate medications declined between 1987 and 1996. Persons with poor health and more prescriptions had a significantly higher risk of inappropriate medication use. Conclusions Overall inappropriate medication use in elderly patients remains a serious problem. Despite challenges in using explicit criteria for assessing inappropriate medications for elderly patients, such criteria can be applied to population-based surveys to identify opportunities to improve quality of care and patient safety. Enhancements of existing data sources to include dosage, duration, and indication may augment national improvement and monitoring efforts.	Agcy Healthcare Res & Qual, Ctr Qual Improvement & Patient Safety, Rockville, MD 20852 USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA	Agency for Healthcare Research & Quality; Johns Hopkins University; University of Rochester	Zhen, CL (corresponding author), Agcy Healthcare Res & Qual, Ctr Qual Improvement & Patient Safety, 6011 Execut Blvd,Suite 200, Rockville, MD 20852 USA.							Anderson G M, 1997, J Eval Clin Pract, V3, P283, DOI 10.1046/j.1365-2753.1997.t01-1-00005.x; Aparasu RR, 1997, ANN PHARMACOTHER, V31, P823, DOI 10.1177/106002809703100702; Aparasu RR, 1999, AM J HEALTH-SYST PH, V56, P433, DOI 10.1093/ajhp/56.5.433; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; BEERS MH, 1992, ANN INTERN MED, V117, P684, DOI 10.7326/0003-4819-117-8-684; Blazer D, 2000, J AM GERIATR SOC, V48, P1073, DOI 10.1111/j.1532-5415.2000.tb04782.x; Cantrill JA, 2011, INT J PHARM PRACT, V4, P67, DOI DOI 10.1111/J.2042-7174.1996.TB00844.X; COBBS E, 1999, GERIATRICS REV SYLLA, P120; COHEN SB, 1997, 2 MEPS AG HEALTHC RE; Golden AG, 1999, J AM GERIATR SOC, V47, P948, DOI 10.1111/j.1532-5415.1999.tb01289.x; GOSNEY M, 1984, LANCET, V2, P564; GURWITZ JH, 1994, JAMA-J AM MED ASSOC, V272, P316, DOI 10.1001/jama.272.4.316; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; *I MED, 1999, ERR IS HUM BUILD SAF; LEDERLE FA, 1993, ARCH INTERN MED, V153, P705, DOI 10.1001/archinte.153.6.705; LINDLEY CM, 1992, AGE AGEING, V21, P294, DOI 10.1093/ageing/21.4.294; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; MOELLER JF, 2001, HC010A AG HEALTHC RE; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; Mort JR, 2000, ARCH INTERN MED, V160, P2825, DOI 10.1001/archinte.160.18.2825; Nash DB., 2000, WHY ELDERLY NEED IND; Newcomer LN, 2000, HEALTH AFFAIR, V19, P59, DOI 10.1377/hlthaff.19.2.59; RAY WA, 1980, AM J PUBLIC HEALTH, V70, P485, DOI 10.2105/AJPH.70.5.485; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Spore DL, 1997, AM J PUBLIC HEALTH, V87, P404, DOI 10.2105/AJPH.87.3.404; *US GAO, 1995, PRESCR DRUGS ELD MAN; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; WILLIAMS B, 1995, J AM GERIATR SOC, V43, P513, DOI 10.1111/j.1532-5415.1995.tb06098.x	29	150	155	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2823	2829		10.1001/jama.286.22.2823	http://dx.doi.org/10.1001/jama.286.22.2823			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500YC	11735757				2022-12-24	WOS:000172655400030
J	Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H				Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H			Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC-DEVELOPMENT; MICE LACKING; STEM-CELLS; ACTIVATION; GENERATION; SURVIVAL; NEURONS; PROTEIN; DIFFERENTIATION	The mechanisms controlling neural stem cell proliferation are poorly understood. Here we demonstrate that the PTEN tumor suppressor plays an important role in regulating neural stem/progenitor cells in vivo and in vitro. Mice lacking PTEN exhibited enlarged, histoarchitecturally abnormal brains, which resulted from increased cell proliferation, decreased cell death, and enlarged cell size. Neurosphere cultures revealed a greater proliferation capacity for tripotent Pten(-/-) central nervous system stem/progenitor cells, which can be attributed, at Least in part, to a shortened cell cycle. However, cell fate commitments of the progenitors were largely undisturbed. Our results suggest that PTEN negatively regulates neural stem cell proliferation.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Inst Suisse Rech Expt Canc, CH-1066 Epalinges, Switzerland	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, X (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	xliu@mednet.ucla.edu; hwu@mednet.ucla.edu	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Groszer, Matthias/0000-0002-6209-305X; Scripture-Adams, Deirdre/0000-0002-3676-1771	NICHD NIH HHS [U54 HD087101] Funding Source: Medline; NIMH NIH HHS [MH062800-01] Funding Source: Medline; NINDS NIH HHS [NS38489] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH062800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038489] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fazekas de St Groth B, 1999, IMMUNOL CELL BIOL, V77, P530; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gimm O, 2000, HUM MOL GENET, V9, P1633, DOI 10.1093/hmg/9.11.1633; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Morrison SJ, 2000, NEURON, V28, P1, DOI 10.1016/S0896-6273(00)00075-1; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tropepe V, 1997, J NEUROSCI, V17, P7850	24	634	673	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2186	2189		10.1126/science.1065518	http://dx.doi.org/10.1126/science.1065518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11691952				2022-12-24	WOS:000172647700057
J	Kornack, DR; Rakic, P				Kornack, DR; Rakic, P			Cell proliferation without neurogenesis in adult primate neocortex	SCIENCE			English	Article							OLIGODENDROCYTE PROGENITOR CELLS; CEREBRAL-CORTEX; VISUAL-CORTEX; DENTATE GYRUS; DNA-SYNTHESIS; STEM-CELLS; RAT; MIGRATION; NEURONS; TELENCEPHALON	A recent assertion that new neurons are continually added to the neocortex of adult macaque monkeys has profound implications for understanding the cellular mechanisms of higher cognitive functions. Here we searched for neurogenesis in adult macaques by using immunofluorescent triple labeling for the DNA-replication indicator, bromodeoxyuridine (BrdU), and neuronal and glial cell markers. Although numerous BrdU-labeled cells were distributed throughout the cerebral wall, including the neocortex, these were identified as non-neuronal cells; evidence for newly generated neurons was limited to the hippocampus and olfactory bulb. Thus, our results do not substantiate the claim of neurogenesis in normal adult primate neocortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Univ Rochester, Med Ctr, Ctr Aging & Dev Biol, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Yale University; University of Rochester	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	pasko.rakic@yale.edu			NATIONAL EYE INSTITUTE [R01EY002593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NEI NIH HHS [EY02593] Funding Source: Medline; NINDS NIH HHS [NS14841] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Coskun V, 2001, J NEUROSCI, V21, P3092, DOI 10.1523/JNEUROSCI.21-09-03092.2001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAZZANIGA MS, 1999, COGNITIVE NEUROSCIEN; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould E, 2000, SCIENCE, V288, p771a; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Jessel T. M., 1991, PRINCIPLES NEUROSCIE; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; KORR H, 1973, J COMP NEUROL, V150, P169, DOI 10.1002/cne.901500205; Korr H, 1980, Adv Anat Embryol Cell Biol, V61, P1; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MARES V, 1978, J COMP NEUROL, V177, P519, DOI 10.1002/cne.901770310; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCDERMOTT KWG, 1990, DEV BRAIN RES, V57, P269, DOI 10.1016/0165-3806(90)90053-2; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nowakowski R, 2000, SCIENCE, V288, p771a, DOI DOI 10.1126/SCIENCE.288.5467.771A; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAKIC P, 1985, ANN NY ACAD SCI, V457, P193, DOI 10.1111/j.1749-6632.1985.tb20806.x; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 1998, NAT NEUROSCI, V1, P645, DOI 10.1038/3643; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RAKIC P, 1993, RESTORATIVE NEUROLOG, V6, P257; RAKIC P, IN PRESS NATURE REV; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Seress L, 2001, NEUROSCIENCE, V105, P831, DOI 10.1016/S0306-4522(01)00156-7; SMART IHM, 1982, J ANAT, V134, P273; Thomas LB, 1996, GLIA, V17, P1; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	53	467	491	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2127	2130		10.1126/science.1065467	http://dx.doi.org/10.1126/science.1065467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739948				2022-12-24	WOS:000172647700040
J	Yang, Q; Bermingham, NA; Finegold, MJ; Zoghbi, HY				Yang, Q; Bermingham, NA; Finegold, MJ; Zoghbi, HY			Requirement of Math1 for secretory cell lineage commitment in the mouse intestine	SCIENCE			English	Article							TRANSCRIPTION FACTOR; TRANSGENIC MICE; STEM-CELLS; DIFFERENTIATION; PROGENITORS; REGULATOR; REVEALS	The mouse small intestinal epithelium consists of four principal cell types deriving from one multipotent stem cell: enterocytes, goblet, enteroendocrine, and Paneth cells. Previous studies showed that Math1, a basic helix-loop-helix (bHLH) transcription factor, is expressed in the gut. We find that toss of Math1 leads to depletion of goblet, enteroendocrine, and Paneth cells without affecting enterocytes. Colocalization of Math1 with Ki-67 in some proliferating cells suggests that secretory cells (goblet, enteroendocrine, and Paneth cells) arise from a common progenitor that expresses Math1, whereas absorptive cells (enterocytes) arise from a progenitor that is Math1-independent. The continuous rapid renewal of these cells makes the intestinal epithelium a model system for the study of stem cell regeneration and lineage commitment.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.			Zoghbi, Huda/0000-0002-0700-3349				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.0.CO;2-X; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blaugrund E, 1996, DEVELOPMENT, V122, P309; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clatworthy JP, 2001, MECH DEVELOP, V101, P3, DOI 10.1016/S0925-4773(00)00557-8; Darmoul D, 1997, AM J PHYSIOL-GASTR L, V272, pG197, DOI 10.1152/ajpgi.1997.272.1.G197; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Pabst O, 1999, DEVELOPMENT, V126, P2215; Rindi G, 1999, DEVELOPMENT, V126, P4149; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; YANG Q, UNPUB; Zheng JL, 2000, DEVELOPMENT, V127, P4551	24	674	706	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2155	2158		10.1126/science.1065718	http://dx.doi.org/10.1126/science.1065718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739954				2022-12-24	WOS:000172647700048
J	Dean, C; Leakey, MG; Reid, D; Schrenk, F; Schwartz, GT; Stringer, C; Walker, A				Dean, C; Leakey, MG; Reid, D; Schrenk, F; Schwartz, GT; Stringer, C; Walker, A			Growth processes in teeth distinguish modern humans from Homo erectus and earlier hominins	NATURE			English	Article							DENTAL DEVELOPMENT; ENAMEL THICKNESS; FOSSIL HOMINIDS; LIFE-HISTORY; MICROSTRUCTURE; PATTERNS; DEATH; TOOTH; TIME; AGE	A modern human-like sequence of dental development, as a proxy for the pace of life history, is regarded as one of the diagnostic hallmarks of our own genus Homo(1-3). Brain size, age at first reproduction, lifespan and other life-history traits correlate tightly with dental development(4-6). Here we report differences in enamel growth that show the earliest fossils attributed to Homo do not resemble modern humans in their development. We used daily incremental markings in enamel to calculate rates of enamel formation in 13 fossil hominins and identified differences in this key determinant of tooth formation time. Neither australopiths nor fossils currently attributed to early Homo shared the slow trajectory of enamel growth typical of modern humans; rather, both resembled modern and fossil African apes. We then reconstructed tooth formation times in australopiths, in the similar to1.5-Myr-old Homo erectus skeleton from Nariokotome, Kenya(7), and in another Homo erectus specimen, Sangiran S7-37 from Java(8). These times were shorter than those in modern humans. It therefore seems likely that truly modern dental development emerged relatively late in human evolution.	UCL, Dept Anat & Dev Biol, Evolutionary Anat Unit, London WC1E 6BT, England; Natl Museums Kenya, Dept Palaeontol, Nairobi, Kenya; Sch Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; Forschungsinst Senckenberg, D-60325 Frankfurt, Germany; George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Nat Hist Museum, London SW7 5BD, England; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	University of London; University College London; Senckenberg Gesellschaft fur Naturforschung (SGN); George Washington University; Natural History Museum London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dean, C (corresponding author), UCL, Dept Anat & Dev Biol, Evolutionary Anat Unit, Gower St, London WC1E 6BT, England.	ucgacrd@ucl.ac.uk						Allman J, 1999, NEUROBIOL AGING, V20, P447, DOI 10.1016/S0197-4580(99)00076-7; Antoine D., 1999, DENT MORPHOLOGY 1998, P48; BEYNON AD, 1987, ARCH ORAL BIOL, V32, P773, DOI 10.1016/0003-9969(87)90002-1; BEYNON AD, 1986, AM J PHYS ANTHROPOL, V70, P177, DOI 10.1002/ajpa.1330700205; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; BOYDE A, 1990, MG PRIMATOL, V14, P229; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; de Castro JMB, 1999, P NATL ACAD SCI USA, V96, P4210, DOI 10.1073/pnas.96.7.4210; Dean C, 2000, J ANAT, V197, P77, DOI 10.1046/j.1469-7580.2000.19710077.x; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Grine F.E., 1988, P3; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; KELLEY J, HUMAN EVOLUTION DEV; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; MOGGICECCHI J, 2000, ORIGIN HUMANKIND, P35; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Schwartz GT, 2001, INT J PRIMATOL, V22, P837, DOI 10.1023/A:1012073601808; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1994, AM J PHYS ANTHROPOL, V94, P307, DOI 10.1002/ajpa.1330940303; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; WALKER A, 1993, NARIOKOTOME HORNO ER; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B. A., 1991, HOMINID CRANIAL REMA, V4	30	350	361	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					628	631		10.1038/414628a	http://dx.doi.org/10.1038/414628a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498WB	11740557				2022-12-24	WOS:000172535600045
J	Fesik, SW; Shi, YG				Fesik, SW; Shi, YG			Structural biology - Controlling the caspases	SCIENCE			English	Editorial Material							APOPTOSIS PROTEIN XIAP; NMR STRUCTURE; CELL-DEATH; BIR DOMAIN; INHIBITOR; SMAC/DIABLO; ACTIVATION; HID; MUTAGENESIS; BINDING		Abbott Labs, Global Pharmaceut Res & Dev, Canc Res, Abbott Pk, IL 60064 USA; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA	Abbott Laboratories; Princeton University	Fesik, SW (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Canc Res, Abbott Pk, IL 60064 USA.			Shi, Yigong/0000-0003-2030-168X				Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	27	130	147	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1477	1478		10.1126/science.1062236	http://dx.doi.org/10.1126/science.1062236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711663				2022-12-24	WOS:000172240500035
J	Berke, JD; Eichenbaum, HB				Berke, JD; Eichenbaum, HB			Drug addiction and the hippocampus	SCIENCE			English	Editorial Material									Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Berke, JD (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	jberke@bu.edu						DOUGLAS RJ, 1967, PSYCHOL BULL, V67, P416, DOI 10.1037/h0024599; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Holden C, 2001, SCIENCE, V292, P1039; PACKARD MG, 1989, J NEUROSCI, V9, P1465; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043	6	33	33	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701892				2022-12-24	WOS:000172130200001
J	Watts, C				Watts, C			Immunology - Antigen presentation-losing its shine in the absence of GILT	SCIENCE			English	Editorial Material							THIOL REDUCTASE GILT; CLASS-II MOLECULES; DISULFIDE BONDS; LYSOSOMES; COMPLEX; DETERMINANT; PROTEIN; STEP		Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland.			Watts, Colin/0000-0001-6183-2087				Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Arunachalam B, 1998, J IMMUNOL, V160, P5797; COLLINS DS, 1991, J IMMUNOL, V147, P4054; FEENER EP, 1990, J BIOL CHEM, V265, P18780; GAMMON G, 1991, J EXP MED, V173, P609, DOI 10.1084/jem.173.3.609; Jensen P E, 1995, Semin Immunol, V7, P347, DOI 10.1006/smim.1995.0039; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; Kang HK, 2000, J IMMUNOL, V164, P1775, DOI 10.4049/jimmunol.164.4.1775; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; PAPINI E, 1993, J BIOL CHEM, V268, P1567; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; Velazquez C, 2001, J IMMUNOL, V166, P5488, DOI 10.4049/jimmunol.166.9.5488; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	14	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1294	1295		10.1126/science.1066725	http://dx.doi.org/10.1126/science.1066725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701917				2022-12-24	WOS:000172130200034
J	Schlein, Y; Jacobson, RL				Schlein, Y; Jacobson, RL			Parasitic infection - Hunger tolerance and Leishmania in sandflies	NATURE			English	Article							PHLEBOTOMUS-PAPATASI; VECTOR		Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Schlein, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, POB 12272, IL-91120 Jerusalem, Israel.							Ashford R.W., 1987, P365; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Schlein Y, 1999, MED VET ENTOMOL, V13, P65, DOI 10.1046/j.1365-2915.1999.00138.x; Schlein Y, 2000, J MED ENTOMOL, V37, P319, DOI 10.1603/0022-2585(2000)037[0319:PMTPFO]2.0.CO;2; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; SCHLEIN Y, 1983, ACTA TROP, V40, P65; VANHANDE.E, 1967, ANAL BIOCHEM, V19, P193, DOI 10.1016/0003-2697(67)90152-2; Yan G, 1997, EVOLUTION, V51, P441, DOI [10.2307/2411116, 10.1111/j.1558-5646.1997.tb02431.x]; Zar JH, 1999, BIOSTATISTICAL ANAL	11	11	12	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					168	168		10.1038/35102679	http://dx.doi.org/10.1038/35102679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700547				2022-12-24	WOS:000172029100035
J	McMahon, BJ; Holck, P; Bulkow, L; Snowball, M				McMahon, BJ; Holck, P; Bulkow, L; Snowball, M			Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus	ANNALS OF INTERNAL MEDICINE			English	Article							SURFACE-ANTIGEN CARRIERS; HEPATOCELLULAR-CARCINOMA; POSITIVE PATIENTS; INTERFERON THERAPY; NATURAL-HISTORY; LIVER-DISEASE; FOLLOW-UP; SEROCONVERSION; CLEARANCE; ALPHA	Background: Knowledge of the outcome of chronic hepatitis B virus (HBV) infection Is limited. Objective: To determine the incidence of and risk factors for adverse events (hepatocellular carcinoma and end-stage liver disease) and clearance of hepatitis B e antigen (HBeAg) and surface antigen (HBsAg) in carriers of HBV. Design: Population-based cohort study of hepatitis B carriers who were observed for a median of 12.3 years as part of an active surveillance program to detect carriers with hepatocellular carcinoma. Setting: 126 communities in Alaska. Patients: 1536 Alaska Natives with chronic hepatitis B. Measurements: Bivariate comparisons, multivariable models, and other statistical methods were used to examine the relationships of risk factors to outcomes and clearance of HBeAg and HBsAg. Results: 1536 chronic HBV carriers were followed up for 19 430 person-years from their first HBsAg-positive test result. At the first serologic test 641 were HBeAg positive and 893 were anti-HBe positive. Older carriers were more likely than younger carriers to clear HBeAg (P < 0.001). The observed probability of clearing HBeAg within 10 years of diagnosis was 72.5%. Clearance of HBsAg occurred in 106 (7%) of all carriers and was positively associated with older age and positive result on initial anti-HBe test. The incidence of adverse events was 2.3 per 1000 carrier-years, and the incidence of hepatocellular carcinoma was 1.9 per 1000 carrier-years (2.3 in men and 1.2 In women). Risk for hepatocellular carcinoma increased with age, among those of Yupik Eskimo ethnicity, and among carriers who reverted from anti-HBe to HBeAg. Conclusion: in HBsAg-positive carriers, observed clearance of HBeAg was more than 70% during the first 10 years of follow-up.	CDCP, Arctic Invest Program, Viral Hepatitis Program, Alaska Native Med Ctr, Anchorage, AK 99508 USA; CDCP, Arctic Invest Program, Natl Ctr Infect Dis, US Publ Hlth Serv,Dept Hlth & Human Serv, Anchorage, AK 99508 USA; Alaska Native Hlth Board, Anchorage, AK 99508 USA	Alaska Native Medical Center; United States Public Health Service	McMahon, BJ (corresponding author), CDCP, Arctic Invest Program, Viral Hepatitis Program, Alaska Native Med Ctr, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.							ADACHI H, 1992, HEPATOLOGY, V16, P1334, DOI 10.1002/hep.1840160605; Baffis V, 1999, ANN INTERN MED, V131, P696, DOI 10.7326/0003-4819-131-9-199911020-00011; BARRETT DH, 1977, AM J EPIDEMIOL, V105, P118, DOI 10.1093/oxfordjournals.aje.a112362; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; DAVIS GL, 1984, GASTROENTEROLOGY, V86, P230; DEFRANCHIS R, 1993, ANN INTERN MED, V118, P191, DOI 10.7326/0003-4819-118-3-199302010-00006; DEJONGH FE, 1992, GASTROENTEROLOGY, V103, P1630, DOI 10.1016/0016-5085(92)91188-A; DODD RY, 1987, J VIROL METHODS, V17, P81, DOI 10.1016/0166-0934(87)90071-1; DUSHEIKO GM, 1989, AM J EPIDEMIOL, V129, P138, DOI 10.1093/oxfordjournals.aje.a115102; Evans AA, 1997, J INFECT DIS, V176, P845, DOI 10.1086/516538; FATTOVICH G, 1986, HEPATOLOGY, V6, P167, DOI 10.1002/hep.1840060203; Fattovich G, 1997, HEPATOLOGY, V26, P1338; Gandhi MJ, 2000, TRANSFUSION, V40, P910, DOI 10.1046/j.1537-2995.2000.40080910.x; HALL AJ, 1988, VIRAL HEPATITIS LIVE; HEYWARD WL, 1985, JAMA-J AM MED ASSOC, V254, P3052, DOI 10.1001/jama.254.21.3052; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; Huo TI, 1998, HEPATOLOGY, V28, P231, DOI 10.1002/hep.510280130; KIM YI, 1987, CLIN INVEST MED, V10, P383; KORENMAN J, 1991, ANN INTERN MED, V114, P629, DOI 10.7326/0003-4819-114-8-629; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; LIAW YF, 1987, HEPATOLOGY, V7, P20, DOI 10.1002/hep.1840070106; LIAW YF, 1983, GASTROENTEROLOGY, V84, P216; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Mason AL, 1998, HEPATOLOGY, V27, P1736, DOI 10.1002/hep.510270638; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; MCMAHON BJ, 1993, AM J EPIDEMIOL, V138, P544; MCMAHON BJ, 1987, LANCET, V2, P1134; MCMAHON BJ, 1980, J INFECT DIS, V142, P772, DOI 10.1093/infdis/142.5.772; MCMAHON BJ, 1997, VIRAL HEPATITIS, P315; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; SCHREEDER MT, 1983, AM J EPIDEMIOL, V118, P543, DOI 10.1093/oxfordjournals.aje.a113659; SHERMAN M, 1995, HEPATOLOGY, V22, P432, DOI 10.1016/0270-9139(95)90562-6; TOKUDOME S, 1987, HEPATO-GASTROENTEROL, V34, P246; VIOLA LA, 1981, LANCET, V2, P1156; WEISSBERG JI, 1984, ANN INTERN MED, V101, P613, DOI 10.7326/0003-4819-101-5-613; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011	40	298	326	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					759	768		10.7326/0003-4819-135-9-200111060-00006	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694101				2022-12-24	WOS:000172013700001
J	Sweere, U; Eichenberg, K; Lohrmann, J; Mira-Rodado, V; Baurle, I; Kudla, J; Nagy, F; Schafer, E; Harter, K				Sweere, U; Eichenberg, K; Lohrmann, J; Mira-Rodado, V; Baurle, I; Kudla, J; Nagy, F; Schafer, E; Harter, K			Interaction of the response regulator ARR4 with phytochrome B in modulating red light signaling	SCIENCE			English	Article							NUCLEAR IMPORT; ARABIDOPSIS; PHOTORECEPTORS; PROTEIN; GENE	The Arabidopsis thaliana response regulator 4, expressed in response to phytochrome B action, specifically interacts with the extreme amino-terminus of the photoreceptor. The response regulator 4 stabilizes the active Pfr form of phytochrome B in yeast and in planta, thus elevates the level of the active photoreceptor in vivo. Accordingly, transgenic Arabidopsis plants overexpressing the response regulator 4 display hypersensitivity to red tight but not to light of other wavelengths. We propose that the response regulator 4 acts as an output element of a two-component system that modulates red light signaling on the level of the phytochrome B photoreceptor.	Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; Univ Ulm, D-89069 Ulm, Germany; Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	University of Freiburg; Ulm University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Harter, K (corresponding author), Univ Freiburg, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.		Bäurle, Isabel/ABD-6356-2021; Kudla, Jörg/C-2174-2012; Nagy, Ferenc/D-3532-2015	Bäurle, Isabel/0000-0001-5633-8068; Kudla, Jörg/0000-0002-8238-767X; Nagy, Ferenc/0000-0002-6157-9269				Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; EICHENBERG K, 1999, THESIS U FREIBURG; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kircher S, 1999, J CELL BIOL, V144, P201, DOI 10.1083/jcb.144.2.201; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; KUNKEL T, 1993, EUR J BIOCHEM, V215, P587, DOI 10.1111/j.1432-1033.1993.tb18069.x; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; MATSUMURA P, 1984, J BACTERIOL, V160, P36, DOI 10.1128/JB.160.1.36-41.1984; NAGATANI A, 1985, CELL PHYSL, V25, P1059; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Neff MM, 2000, GENE DEV, V14, P257; Park CM, 2000, SEMIN CELL DEV BIOL, V11, P449, DOI 10.1006/scdb.2000.0200; SCHALLER GE, IN PRESS ARABIDOPSIS; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; SWEERE U, 2001, UNPUB U FREIBURG; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	22	224	242	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1108	1111		10.1126/science.1065022	http://dx.doi.org/10.1126/science.1065022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691995				2022-12-24	WOS:000172013800052
J	Archibald, JD; Averianov, AO; Ekdale, EG				Archibald, JD; Averianov, AO; Ekdale, EG			Late Cretaceous relatives of rabbits, rodents, and other extant eutherian mammals	NATURE			English	Article							EVOLUTIONARY; MONGOLIA; ORIGINS	Extant eutherian mammals and their most recent common ancestor constitute the crown group Placentalia. This taxon, plus all extinct taxa that share a more recent common ancestor with placentals than they do with Metatheria (including marsupials), constitute Eutheria(1). The oldest well documented eutherian-dominated fauna in the world is Dzharakuduk, Uzbekistan(2). Among eutherians that it yields is Kulbeckia, an 85-90-Myr-old member of Zalambdalestidae (a family of Late Cretaceous Asian eutherians)(3). This extends Zalambdalestidae back by some 10 million years from sites in the Gobi Desert, Mongolia(4). A phylogenetic analysis of well described Late Cretaceous eutherians strongly supports Zalambdalestidae, less strongly supports 'Zhelestidae' (a Late Cretaceous clade related to Tertiary ungulates), but does not support Asioryctitheria (a group of Late Cretaceous Asian eutherians). A second analysis incorporating placentals from clades that include rodents (Tribosphenomys), lagomorphs (Mimotona) and archaic ungulates (Protungulatum and Oxyprimus) strongly supports Zalambdalestidae in a clade with Glires (rabbits, rodents and extinct relatives) and less strongly 'Zhelestidae' within a clade that includes archaic ungulates ('condylarths'). This argues that some Late Cretaceous eutherians belong within the crown group Placentalia. The ages of these taxa are in line with molecularly based estimates of 64-104 Myr ago (median 84 Myr ago) for the superordinal diversification of some placentals(5), but provide no support for a Late Cretaceous diversification of extant placental orders.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	California State University System; San Diego State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Archibald, JD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	darchibald@sunstroke.sdsu.edu	Averianov, Alexander/M-8490-2013	Averianov, Alexander/0000-0001-5948-0799				Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; ARCHIBALD JD, 1998, NEW MEXICO MUSEUM NA, V14, P21; ARCHIBALD JD, IN PRESS J VERT PALE; ARCHIBALD JD, 1998, TERTIARY MAMMALS N A, V1, P292; Averianov AO, 2001, ACTA PALAEONTOL POL, V46, P431; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Kielan-Jaworowska Z., 1968, PALAEONTOLOGIA POLON, V19, P171; Kielan-Jaworowska Zofia, 2000, P573; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LI CK, 1993, NEW CRANIAL POSTCRAN, P151; LOPATIN AV, IN PRESS NEW MEX MUS; LUCKETT WP, 1985, EVOLUTIONARY RELATIO, P227; MADDISON WP, 1997, MACCLADE 3 07; Marshall L.G., 1990, Current Mammalogy, V2, P433; Martin T, 1997, TOOTH ENAMEL MICROSTRUCTURE, P163; MCKENNA MC, 1997, CLASSIFICATION MAMMA, V284, P104; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NESOV LA, 1997, CRETACEOUS NONMARINE, P168; Nessov L.A., 1994, Trudy Zoologicheskogo Instituta, V249, P105; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; Novacek M. J., 1998, Journal of Vertebrate Paleontology, V18, p67A; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; SZALAY FS, 1994, EVOLUTIONARY HIST MA, V362, P35; VAUGHAN TA, 2000, MAMMALOGY, P73; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2	31	106	114	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					62	65		10.1038/35102048	http://dx.doi.org/10.1038/35102048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689942				2022-12-24	WOS:000171898900041
J	Morais-Cabral, JH; Zhou, YF; MacKinnon, R				Morais-Cabral, JH; Zhou, YF; MacKinnon, R			Energetic optimization of ion conduction rate by the K+ selectivity filter	NATURE			English	Article							ELECTRON-DENSITY MAPS; CHANNEL; SKELETAL; COMPLEX	The K+ selectivity filter catalyses the dehydration, transfer and rehydration of a K+ ion in about ten nanoseconds. This physical process is central to the production of electrical signals in biology. Here we show how nearly diffusion-limited rates are achieved, by analysing ion conduction and the corresponding crystallographic ion distribution in the selectivity filter of the KcsA K+ channel. Measurements with K+ and its slightly larger analogue, Rb+, lead us to conclude that the selectivity filter usually contains two K+ ions separated by one water molecule. The two ions move in a concerted fashion between two configurations, K+-water-K+-water (1,3 conrguration) and water-K+-water-K+ (2,4 conrguration), until a third ion enters, displacing the ion on the opposite side of the queue. For K+, the energy difference between the 1,3 and 2,4 configurations is close to zero, the condition of maximum conduction rate. The energetic balance between these configurations is a clear example of evolutionary optimization of protein function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEGENISICH T, 1980, J GEN PHYSIOL, V76, P83, DOI 10.1085/jgp.76.1.83; BESTERGAARDBOGI.B, 1985, J MEMBRANE BIOL, V88, P67; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUELLO LG, 1988, BIOCHEMISTRY-US, V37, P3229; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; EISENMAN G, 1986, BIOPHYS J, V50, P1025, DOI 10.1016/S0006-3495(86)83546-9; GAMBLIN SJ, 1996, P CCP4 STUD WEEK DAR, P163; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KOONIN SE, 1986, COMPUTATIONAL PHYSIC; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	627	645	8	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					37	42		10.1038/35102000	http://dx.doi.org/10.1038/35102000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689935				2022-12-24	WOS:000171898900034
J	Cho, JY; Tse, MK; Holmes, D; Maleczka, RE; Smith, MR				Cho, JY; Tse, MK; Holmes, D; Maleczka, RE; Smith, MR			Remarkably selective iridium catalysts for the elaboration of aromatic C-H bonds	SCIENCE			English	Article							FUNCTIONALIZATION; ALKANES; COMPLEXES; BORYLATION; BORANES; ROUTE	Arylboron compounds have intriguing properties and are important building blocks for chemical synthesis. A family of Ir catalysts now enables the direct synthesis of arylboron compounds from aromatic hydrocarbons and boranes under "solventless" conditions. The Ir catalysts are highly selective for C-H activation and do not interfere with subsequent in situ transformations, including Pd-mediated cross-couplings with aryl halides. By virtue of their favorable activities and exceptional selectivities, these Ir catalysts impart the synthetic versatility of arylboron reagents to C-H bonds in aromatic and heteroaromatic hydrocarbons.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Smith, MR (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.		Smith, Milton/M-3511-2016	Smith, Milton/0000-0002-8036-4503	NIGMS NIH HHS [R01 GM63188-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063188] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGMAN RG, 1984, SCIENCE, V223, P902, DOI 10.1126/science.223.4639.902; Chemler SR, 2000, ORG LETT, V2, P2695, DOI 10.1021/ol0062547; Chen HY, 1999, ANGEW CHEM INT EDIT, V38, P3391, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3391::AID-ANIE3391>3.0.CO;2-N; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; Diederich F., 1998, METAL CATALYZED CROS; Ezbiansky K, 1998, ORGANOMETALLICS, V17, P1455, DOI 10.1021/om980037g; Frid M, 1999, J AM CHEM SOC, V121, P9469, DOI 10.1021/ja992345r; Iverson CN, 1999, J AM CHEM SOC, V121, P7696, DOI 10.1021/ja991258w; JONES WD, 1989, ACCOUNTS CHEM RES, V22, P91, DOI 10.1021/ar00159a002; Kawamura K, 2001, J AM CHEM SOC, V123, P8422, DOI 10.1021/ja015975d; KIM YH, 1992, MACROMOLECULES, V25, P5561, DOI 10.1021/ma00047a001; MEROLA JS, 1989, ORGANOMETALLICS, V8, P778, DOI 10.1021/om00105a031; MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618; Murata M, 2000, J ORG CHEM, V65, P164, DOI 10.1021/jo991337q; NGUYEN P, 1993, J AM CHEM SOC, V115, P9329, DOI 10.1021/ja00073a075; RABLEN PR, 1994, J AM CHEM SOC, V116, P4121, DOI 10.1021/ja00088a075; Sammelson RE, 2001, CHEM REV, V101, P137, DOI 10.1021/cr000086e; Schluter AD, 2001, J POLYM SCI POL CHEM, V39, P1533, DOI 10.1002/pola.1130; Shimada S, 2001, ANGEW CHEM INT EDIT, V40, P2168, DOI 10.1002/1521-3773(20010601)40:11<2168::AID-ANIE2168>3.0.CO;2-0; Suzuki A, 1999, J ORGANOMET CHEM, V576, P147, DOI 10.1016/S0022-328X(98)01055-9; Tse MK, 2001, ORG LETT, V3, P2831, DOI 10.1021/ol0162668; WALTZ KM, 1995, J AM CHEM SOC, V117, P11357, DOI 10.1021/ja00150a041; Waltz KM, 1997, SCIENCE, V277, P211, DOI 10.1126/science.277.5323.211	24	921	927	10	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					305	308		10.1126/science.1067074	http://dx.doi.org/10.1126/science.1067074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11719693				2022-12-24	WOS:000173278600042
J	Schwetz, BA				Schwetz, BA			Drug for severe adult sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fushers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-24	WOS:000172978500004
J	Tulina, N; Matunis, E				Tulina, N; Matunis, E			Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling	SCIENCE			English	Article							GENE-EXPRESSION; GERMLINE; PROTEIN; DIFFERENTIATION; PROLIFERATION; ENCODES; PATHWAY; KINASE	Stem cells, which regenerate tissue by producing differentiating cells, also produce cells that renew the stem cell population. Signals from regulatory microenvironments (niches) are thought to cause stem cells to retain self-renewing potential. However, the molecular characterization of niches remains an important goat. In Drosophila testes, germ tine and somatic stem cells attach to a cluster of support cells called the hub. The hub specifically expresses Unpaired, a ligand activating the JAK-STAT (Janus kinase-signal transducer and activator of transcription) signaling cascade. Without JAK-STAT signaling, germ line stem cells differentiate but do not self-renew. Conversely, ectopic JAK-STAT signaling greatly expands both stem cell populations. We conclude that the support cells of the hub signal to adjacent stem cells by activation of the JAK-STAT pathway, thereby defining a niche for stem cell self-renewal.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Matunis, E (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD040307, R01HD40307] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Boyle M, 1997, DEVELOPMENT, V124, P971; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GONCZY P, 1992, DEVELOPMENT, V114, P89; GONCZY P, 1995, THESIS ROCKEFELLER U; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hime GR, 1996, J CELL SCI, V109, P2779; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LIN HF, 1994, DEVELOPMENT, V120, P947; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Smith AG, 2001, DEV BIOL, V235, P289; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; TSAI YC, 2001, A DROS RES C, V42, pC585; Van Doren M, 1998, CURR BIOL, V8, P243; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	24	479	498	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2546	2549		10.1126/science.1066700	http://dx.doi.org/10.1126/science.1066700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752575				2022-12-24	WOS:000172927700058
J	Broecker, WS; Clark, E				Broecker, WS; Clark, E			Glacial-to-Holocene redistribution of carbonate ion in the deep sea	SCIENCE			English	Article							IN-SITU MEASUREMENTS; ONTONG-JAVA PLATEAU; EQUATORIAL PACIFIC; CALCITE DISSOLUTION; CACO3 PRESERVATION; NORTH-ATLANTIC; CEARA RISE; SEDIMENTS; OCEAN; O-2	We have reconstructed the glacial-age distribution of carbonate ion concentration in the deep waters of the equatorial ocean on the basis of differences in weight between glacial and Holocene foraminifera shells picked from a series of cores spanning a range of water depth on the western Atlantic's Ceara Rise and the western Pacific's Ontong Java Plateau. The results suggest that unlike today's ocean, sizable vertical gradients in the carbonate ion concentration existed in the glacial-age deep ocean. In the equatorial Pacific, the concentration increased with depth, and in the Atlantic, it decreased with depth. In addition, the contrast between the carbonate ion concentration in deep waters produced in the northern Atlantic and deep water in the Pacific appears to have been larger than in today's ocean.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						ARCHER D, 1989, GEOCHIM COSMOCHIM AC, V53, P2831, DOI 10.1016/0016-7037(89)90161-0; Boyle EA, 1988, PALEOCEANOGRAPHY, V3, P471, DOI 10.1029/PA003i004p00471; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; BROECKER W S, 1971, Quaternary Research (Orlando), V1, P188, DOI 10.1016/0033-5894(71)90041-X; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; BROECKER WS, 1992, NATURE, V356, P587, DOI 10.1038/356587a0; BROECKER WS, 2001, G3 GC000177; BROECKER WS, 2001, G3 GC000151; BROECKER WS, 2000, G3 1 GC000039; BROECKER WS, 1971, LATE CENOZOIC GLACIA; CROWLEY TJ, 1983, MAR GEOL, V51, P1, DOI 10.1016/0025-3227(83)90085-3; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; CURRY WB, 1985, AM GEOPHYS UNION MON, V32, P285; EMERSON SR, 1990, PHILOS T R SOC A, V331, P29, DOI 10.1098/rsta.1990.0054; Farrell JW, 1991, PALEOCEANOGRAPHY, V6, P485, DOI 10.1029/91PA00877; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; Hales B, 1996, GLOBAL BIOGEOCHEM CY, V10, P527, DOI 10.1029/96GB01522; HALES B, 1994, DEEP-SEA RES PT I, V41, P695, DOI 10.1016/0967-0637(94)90050-7; Hales B, 1997, GEOCHIM COSMOCHIM AC, V61, P501, DOI 10.1016/S0016-7037(96)00366-3; HEATH GR, 1970, GEOL SOC AM BULL, V81, P3157, DOI 10.1130/0016-7606(1970)81[3157:CDOSRO]2.0.CO;2; HOWARD WR, 1994, PALEOCEANOGRAPHY, V9, P453, DOI 10.1029/93PA03524; Karlin R, 1992, PALEOCEANOGRAPHY, V7, P43, DOI 10.1029/91PA03077; Le JN, 1992, PALEOCEANOGRAPHY, V7, P21, DOI 10.1029/91PA02854; Lea DW, 1990, PALEOCEANOGRAPHY, V5, P719, DOI 10.1029/PA005i005p00719; LEA DW, 1990, NATURE, V347, P269, DOI 10.1038/347269a0; LOHMANN GP, 1995, PALEOCEANOGRAPHY, V10, P445, DOI 10.1029/95PA00059; Martin WR, 1996, GEOCHIM COSMOCHIM AC, V60, P243, DOI 10.1016/0016-7037(95)00383-5; Matsumoto K, 2001, EARTH PLANET SC LETT, V192, P319, DOI 10.1016/S0012-821X(01)00412-5; MILLERO FJ, 1972, GEOCHIM COSMOCHIM AC, V36, P92, DOI 10.1016/0016-7037(72)90123-8; Peng TH, 1987, GLOBAL BIOGEOCHEM CY, V1, P155, DOI 10.1029/GB001i002p00155; Peterson LC., 1985, GEOPHYS MONOGR SER, P251; PYTKOWICZ RM, 1967, GEOCHEM J, V6, P169; SAYLES FL, 1980, MAR CHEM, V9, P223, DOI 10.1016/0304-4203(80)90026-2; Stephens MP, 1997, PALEOCEANOGRAPHY, V12, P797, DOI 10.1029/97PA02271; WU GP, 1991, MAR GEOL, V99, P135, DOI 10.1016/0025-3227(91)90087-K	35	97	100	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2152	2155		10.1126/science.1064171	http://dx.doi.org/10.1126/science.1064171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739953				2022-12-24	WOS:000172647700047
J	Bliwise, DL; Kutner, NG; Zhang, R; Parker, KP				Bliwise, DL; Kutner, NG; Zhang, R; Parker, KP			Survival by time of day of hemodialysis in an elderly cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; MORTALITY; NONCOMPLIANCE; CHEMOTHERAPY; DURATION; RAT	Context Patients with end-stage renal disease (ESRD) typically undergo hemodialysis (HD) during the morning or afternoon, with time of treatment generally based on space availability or patient preference. No studies have investigated variation in patient survival as a function of the time of day when they receive dialysis. Objective To investigate the association of elderly patients' HD treatment shift with their continued survival, controlling for well-established HD-related mortality risk factors. Design, Setting, and Participants An 11-year follow-up cohort study conducted among 242 ESRD patients aged 60 years or older who underwent HD at 58 dialysis facilities in Georgia either during a morning shift (n=167) or an afternoon shift (n=75) and who completed baseline (1998) and follow-up (1991) interviews. Main Outcome Measure Mortality from all causes occurring through July 7, 1999, as verified by death-certificate reviews, and compared by morning- vs afternoon-shift HD. Results Morning-shift HD patients survived significantly longer than afternoon-shift patients (median survival, 941 days vs 470 days; P<.001), A Cox proportional hazards model indicated that the morning shift was protective (relative risk, 0.71; 95% confidence interval, 0.53-0.95) independent of age, race, sex, body mass index, functional status, diabetic ESRD, cardiovascular comorbidity, weekly hours of dialysis, and months of dialysis. Conclusions Possible explanations for differential survival in association with morning vs afternoon dialysis include salutary effects of sleep in the morning or less efficient biochemical exchange during afternoon dialysis. Results from this cohort study may warrant prospective observational studies and randomized clinical trials that systematically alter the time of day at which HD is administered.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Rehabil Med, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; Emory Univ, Nell Hodgson Woodruff Sch Nursing, Dept Adult & Elder Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University	Bliwise, DL (corresponding author), Emory Univ, Sch Med, Dept Neurol, WMRB 6000,1639 Pierce Dr, Atlanta, GA 30322 USA.	dbliwis@emory.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010643, R01AG006066] Funding Source: NIH RePORTER; NIA NIH HHS [AG06066, AG10643, AG05909] Funding Source: Medline; NIDDK NIH HHS [DK42949] Funding Source: Medline; NINDS NIH HHS [NS35343] Funding Source: Medline; NINR NIH HHS [NR04340] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Baines LS, 2000, NEPHRON, V85, P1, DOI 10.1159/000045622; Bliwise D. L, 2000, PRINCIPLES PRACTICE, P26; Bliwise DL, 1999, LUNG BIOL HEALTH DIS, V133, P487; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; GARFEIN AJ, 1995, J GERONTOL B-PSYCHOL, V50, pS77, DOI 10.1093/geronb/50B.2.S77; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; HELD PJ, 1991, JAMA-J AM MED ASSOC, V265, P871, DOI 10.1001/jama.265.7.871; HRUSHESKY WJM, 1988, SEMIN SURG ONCOL, V4, P110; Kimmel PL, 2000, KIDNEY INT, V57, P1141, DOI 10.1046/j.1523-1755.2000.00941.x; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Kutner N G, 1997, Geriatr Nephrol Urol, V7, P23, DOI 10.1023/A:1008204311582; Kutner Nancy G., 2001, International Urology and Nephrology, V32, P441, DOI 10.1023/A:1017581726362; KUTNER NG, 1991, DIALYSIS TRANSPLANT, V20, P171; KUTNER NG, 1994, AM J KIDNEY DIS, V24, P42, DOI 10.1016/S0272-6386(12)80158-2; KUTNER NG, 1994, RES SOCIOLOGY HLTH C, V11, P127; Kutner NG, 1993, GERIATR NEPHROL UROL, V3, P145; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Levi F, 1999, J PHARM PHARMACOL, V51, P891, DOI 10.1211/0022357991773302; Levi F, 1999, CANCER-AM CANCER SOC, V85, P2532, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2532::AID-CNCR7>3.0.CO;2-1; MATTANA J, 1995, AM J NEPHROL, V15, P208, DOI 10.1159/000168834; *NIH, 2000, US REN DAT SYST USRD; Parker KP, 2000, SLEEP, V23, P887; SCHAEFER K, 1992, AM J KIDNEY DIS, V19, P460, DOI 10.1016/S0272-6386(12)80955-3; WINGARD DL, 1982, AM J EPIDEMIOL, V116, P765, DOI 10.1093/oxfordjournals.aje.a113466; Wood PA, 1996, CRIT REV EUKAR GENE, V6, P299, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.10	26	35	35	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2690	2694		10.1001/jama.286.21.2690	http://dx.doi.org/10.1001/jama.286.21.2690			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730444	Bronze			2022-12-24	WOS:000172488300028
J	Wellings, F; Nanchahal, K; Macdowall, W; McManus, S; Erens, B; Mercer, CH; Johnson, AM; Copas, AJ; Korovessis, C; Fenton, FA; Field, J				Wellings, F; Nanchahal, K; Macdowall, W; McManus, S; Erens, B; Mercer, CH; Johnson, AM; Copas, AJ; Korovessis, C; Fenton, FA; Field, J			Sexual behaviour in Britain: early heterosexual experience	LANCET			English	Article							INTERCOURSE; AGE	Background Relatively high rates of teenage conception and sexually transmitted infection among young people in Britain have focused attention on early sexual behaviour and its determinants. We report the results of the second National Survey of Sexual Attitudes and Lifestyles (Natsal 2000). Methods We did a probability sample survey between 1999 and 2001, of men and women aged 16-44 years in Britain. Participants were interviewed using a combination of computer-assisted face-to-face and self-completion questionnaires, and asked questions regarding first heterosexual intercourse, communication about sex, pregnancy, and sexually transmitted infections (STIs). Findings We recruited 11 161 men and women to the survey (4762 men, 6399 women). The proportion of those aged 16-19 years at interview reporting first heterosexual intercourse at younger than 16 years was 30% for men and 26% for women; median age was 16 years. The proportion of women reporting first intercourse before 16 years increased up to, but not after, the mid-1990s. There has been a sustained increase in condom use and a decline in the proportion of men and women reporting no contraceptive use at first intercourse with decreasing age at interview. Among 16-24 year olds, non-use of contraception increased with declining age at first intercourse; reported by 18% of men and 22% of women aged 13-14 years at occurrence. Early age at first intercourse was significantly associated with pregnancy under 18 years, but not with occurrence of STIs. Low educational attainment was associated with motherhood before 18 years, but not abortion. Interpretation The increase in the proportion of women reporting first intercourse before age 16 years does not appear to have continued throughout the past decade. Only a small minority of teenagers have unprotected first intercourse, and early motherhood is more strongly associated with educational level than with family background. Factors mast strongly associated with risk behaviour and adverse outcomes have considerable potential for preventive intervention.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, London WC1E 7HT, England; Natl Ctr Social Res, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat SCi, Ctr Infect Dis Epidemiol, London, England; Publ Hlth Lab Serv, HIV STI Div, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; Public Health England	Wellings, F (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	McManus, Sally/S-4697-2019; McManus, Sally/HGD-4860-2022	McManus, Sally/0000-0003-2711-0819; Johnson, Anne/0000-0003-1330-7100; Erens, Bob/0000-0002-4430-954X; Macdowall, Wendy/0000-0001-5868-8336; Erens, Robert/0000-0002-3054-504X; Nanchahal, Kiran/0000-0001-8812-7628; Copas, Andrew/0000-0001-8968-5963; Mercer, Catherine/0000-0002-4220-5034				Bozon M, 1998, SOC AS AIDS, P37; COPAS AJ, 1990, IN PRESS ACCURACY RE; Department of Health, 2001, NAT STRAT SEX HLTH H; Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; Edgardh K, 2000, SEX TRANSM INFECT, V76, P98, DOI 10.1136/sti.76.2.98; GIESECKE J, 1992, INT J STD AIDS, V3, P255, DOI 10.1177/095646249200300405; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; KANE R, 1999, REDUCING RATE TEENAG; MICHAEL RT, 2001, SEX LOVE HLTH AM; NICOLL A, 1999, BRIT MED J, V38, P1322; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; Singh S, 1999, FAM PLANN PERSPECT, V31, P212, DOI 10.2307/2991568; *SOC EXCL UN, 1999, TEEN PREGN; StuartSmith S, 1996, BRIT MED J, V312, P390; WELLINGS K, 1994, SEXUAL BEHAV BRIT; WEST P, 1993, J ADOLESCENCE, V16, P367, DOI 10.1006/jado.1993.1031; Wight D, 2000, BRIT MED J, V320, P1243, DOI 10.1136/bmj.320.7244.1243	18	426	431	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1843	1850		10.1016/S0140-6736(01)06885-4	http://dx.doi.org/10.1016/S0140-6736(01)06885-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497NU	11741623				2022-12-24	WOS:000172463000009
J	Quist, D; Chapela, IH				Quist, D; Chapela, IH			Transgenic DNA introgressed into traditional maize landraces in Oaxaca, Mexico	NATURE			English	Article							GENE FLOW; PLANTS	Concerns have been raised about the potential effects of transgenic introductions on the genetic diversity of crop landraces and wild relatives in areas of crop origin and diversification, as this diversity is considered essential for global food security. Direct effects on non-target species(1,2), and the possibility of unintentionally transferring traits of ecological relevance onto landraces and wild relatives have also been sources of concern(3,4). The degree of genetic connectivity between industrial crops and their progenitors in landraces and wild relatives is a principal determinant of the evolutionary history of crops and agroecosystems throughout the world(5,6). Recent introductions of transgenic DNA constructs into agricultural fields provide unique markers to measure such connectivity. For these reasons, the detection of transgenic DNA in crop landraces is of critical importance. Here we report the presence of introgressed transgenic DNA constructs in native maize landraces grown in remote mountains in Oaxaca, Mexico, part of the Mesoamerican centre of origin and diversification of this crop(7-9).	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Chapela, IH (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ichapela@nature.berkeley.edu						DOEBLEY J, 1990, BIOSCIENCE, V40, P443, DOI 10.2307/1311391; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2001, PLANT PHYSIOL, V125, P1543, DOI 10.1104/pp.125.4.1543; Gachet E, 1998, TRENDS FOOD SCI TECH, V9, P380, DOI 10.1016/S0924-2244(99)00002-3; Hartl Daniel L., 1996, V58, P293; ILTIS HH, 1983, SCIENCE, V222, P886, DOI 10.1126/science.222.4626.886; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Matsuoka T, 2000, J FOOD HYG SOC JPN, V41, P137, DOI 10.3358/shokueishi.41.137; Pawlowski WP, 1998, P NATL ACAD SCI USA, V95, P12106, DOI 10.1073/pnas.95.21.12106; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; White S, 1998, TRENDS GENET, V14, P327, DOI 10.1016/S0168-9525(98)01524-8; Zimmermann A, 2000, LEBENSM-WISS TECHNOL, V33, P210, DOI 10.1006/fstl.2000.0637; 1999, SMT4CT962072 EU BUND	15	357	434	0	138	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					541	543		10.1038/35107068	http://dx.doi.org/10.1038/35107068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734853				2022-12-24	WOS:000172405900046
J	Brandstetter, H; Kim, JS; Groll, M; Huber, R				Brandstetter, H; Kim, JS; Groll, M; Huber, R			Crystal structure of the tricorn protease reveals a protein disassembly line	NATURE			English	Article							INHIBITOR	The degradation of cytosolic proteins is carried out predominantly by the proteasome, which generates peptides of 7-9 amino acids long(1). These products need further processing. Recently, a proteolytic system was identified in the model organism Thermoplasma acidophilum that performs this processing(2,3). The hexameric core protein of this modular system, referred to as tricorn protease, is a 720K protease that is able to assemble further into a giant icosahedral capsid, as determined by electron microscopy(4). Here, we present the crystal structure of the tricorn protease at 2.0 Angstrom resolution. The structure reveals a complex mosaic protein whereby five domains combine to form one of six subunits, which further assemble to form the 3-2-symmetric core protein. The structure shows how the individual domains coordinate the specific steps of substrate processing, including channelling of the substrate to, and the product from, the catalytic site. Moreover, the structure shows how accessory protein components might contribute to an even more complex protein machinery that efficiently collects the tricorn-released products.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany	Max Planck Society	Brandstetter, H (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany.	hbs@biochem.mpg.de	Brandstetter, Hans/E-6754-2011; Groll, Michael/C-1174-2010; Groll, Michael/F-5572-2015	Brandstetter, Hans/0000-0002-6089-3045; 				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dryjanski M, 1998, BIOCHEMISTRY-US, V37, P14151, DOI 10.1021/bi981278v; Fulop V, 2000, EMBO REP, V1, P277, DOI 10.1093/embo-reports/kvd048; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HUANG K, 1995, PROTEIN SCI, V4, P1985, DOI 10.1002/pro.5560041004; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Sambrook JFE, 1989, MOL CLONING LAB MANU; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, FEBS LETT, V398, P101, DOI 10.1016/S0014-5793(96)01163-5; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; TURK D, 1992, CHEMISTRY; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Walz J, 1999, J STRUCT BIOL, V128, P65, DOI 10.1006/jsbi.1999.4169; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2	20	78	82	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					466	470		10.1038/35106609	http://dx.doi.org/10.1038/35106609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719810				2022-12-24	WOS:000172304500048
J	Tang, SM; Guo, A				Tang, SM; Guo, A			Choice behavior of Drosophila facing contradictory visual cues	SCIENCE			English	Article							MUSHROOM BODIES; FLIGHT ORIENTATION; DISCOVERY	We studied the underlying neural mechanism of a simple choice behavior between competing alternatives in Drosophila. In a flight simulator, individual flies were conditioned to choose one of two flight paths in response to color and shape cues; after the training, they were tested with Contradictory cues. Wild-type flies made a discrete choice that switched from one alternative to the other as the relative salience of color and shape cues gradually changed, but this ability was greatly diminished in mutant (mbm(1)) flies with miniature mushroom bodies or with hydroxyurea ablation of mushroom bodies. Thus, Drosophila genetics may be useful for elucidating the neural basis of choice behavior.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Biophys, Lab Visual Informat Processing, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, A (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.							Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Dujardin F, 1850, ANN SCI NATURELLES, V3, P195; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1984, VISION DROSOPHILA; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; WOLF R, 1997, LEARN MEMORY, V4, P319	14	147	162	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1543	1547		10.1126/science.1058237	http://dx.doi.org/10.1126/science.1058237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711680				2022-12-24	WOS:000172240500054
J	Kendrick, KM; da Costa, AP; Leigh, AE; Hinton, MR; Peirce, JW				Kendrick, KM; da Costa, AP; Leigh, AE; Hinton, MR; Peirce, JW			Sheep don't forget a face	NATURE			English	Article							TEMPORAL CORTEX; DISCRIMINATION; FAMILIARITY; CELLS		Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Kendrick, KM (corresponding author), Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England.		Peirce, Jonathan Westley/AAA-8603-2020; Peirce, Jonathan/B-1807-2008	Peirce, Jonathan Westley/0000-0002-9504-4342; Peirce, Jonathan/0000-0002-9504-4342; Kendrick, Keith/0000-0002-0371-5904				Broad KD, 2000, EUR J NEUROSCI, V12, P731, DOI 10.1046/j.1460-9568.2000.00934.x; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; KENDRICK KM, 1987, SCIENCE, V236, P448, DOI 10.1126/science.3563521; Kendrick KM, 1998, NATURE, V395, P229, DOI 10.1038/26129; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003	9	206	208	0	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					165	166		10.1038/35102669	http://dx.doi.org/10.1038/35102669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700543				2022-12-24	WOS:000172029100032
J	Dworkin, J; Losick, R				Dworkin, J; Losick, R			Differential gene expression governed by chromosomal spatial asymmetry	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; CELL-SPECIFIC TRANSCRIPTION; ANTI-SIGMA FACTOR; FORESPORE-SPECIFIC TRANSCRIPTION; BACILLUS-SUBTILIS SPORULATION; ESCHERICHIA-COLI; FACTOR SPOIIAB; DIVISION; PROTEIN; ACTIVATION	The activity of the transcription factor sigma (F) is confined to one (the forespore) of two cells created by asymmetric division during sporulation in B. subtilis. We show that sigma (F) activation is partly governed by the position of the gene for the unstable anti-sigma (F) factor SpoIIAB. Because cytokinesis precedes chromosome segregation, most of the chromosome is translocated into the forespore after division. We hypothesize that because spoIIAB; enters the forespore late, SpoIIAB lost to proteolysis is temporarily not replenished. Thus, chromosome asymmetry would be translated into the asymmetric distribution of SpoIIAB. Supporting this idea, transposition of spoIIAB to sites present in the forespore at the time of division impaired sporulation when a second pathway that participates in sigma (F) activation was disabled.	Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NIGMS NIH HHS [5F32-GM19729, GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019729, R01GM018568, R37GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Errington J, 1996, TRENDS GENET, V12, P31, DOI 10.1016/0168-9525(96)81386-2; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 1999, MOL MICROBIOL, V33, P1015, DOI 10.1046/j.1365-2958.1999.01543.x; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Harwood C. R., 1990, MOL BIOL METHODS BAC; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; LEWIS PJ, 1994, P NATL ACAD SCI USA, V91, P3849, DOI 10.1073/pnas.91.9.3849; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; LOSICK R, 1996, HARVEY LECT, V90, P1; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; Niki H, 2000, GENE DEV, V14, P212; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SCHMIDT R, 1990, P NATL ACAD SCI USA, V87, P9221, DOI 10.1073/pnas.87.23.9221; SCHUCH R, 1994, J BACTERIOL, V176, P4104, DOI 10.1128/JB.176.13.4104-4110.1994; SUN DX, 1991, J BACTERIOL, V173, P2977, DOI 10.1128/JB.173.9.2977-2984.1991; SUN DX, 1991, J BACTERIOL, V173, P7867, DOI 10.1128/jb.173.24.7867-7874.1991; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	48	65	71	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					339	346		10.1016/S0092-8674(01)00528-1	http://dx.doi.org/10.1016/S0092-8674(01)00528-1			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701124	Bronze			2022-12-24	WOS:000172022800005
J	Pascual, A; Preat, T				Pascual, A; Preat, T			Localization of long-term memory within the Drosophila mushroom body	SCIENCE			English	Article							EXTRINSIC NEURONS; BODIES; BRAIN; MELANOGASTER; GENE	The mushroom bodies, substructures of the Drosophila brain, are involved in olfactory learning and short-term memory, but their rote in long-term memory is unknown. Here we show that the alpha-lobes-absent (ala) mutant lacks either the two vertical lobes of the mushroom body or two of the three median lobes which contain branches of vertical lobe neurons. This unique phenotype allows analysis of mushroom body function. Long-term memory required the presence of the vertical lobes but not the median lobes. Short-term memory was normal in flies without either vertical lobes or the two median lobes studied.	CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr	IBIS, NEURONAL/O-9910-2015; Pascual, Alberto/L-2014-2019; Pascual, Alberto P/E-9609-2015	Pascual, Alberto/0000-0001-5459-6207; Pascual, Alberto P/0000-0001-5459-6207; Preat, Thomas/0000-0001-9976-1763				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Boquet I, 2000, J NEUROBIOL, V42, P33; BOYNTON S, 1992, GENETICS, V131, P655; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Ito K, 1998, LEARN MEMORY, V5, P52; Lee T, 1999, DEVELOPMENT, V126, P4065; Li YS, 1997, J COMP NEUROL, V387, P631; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nassif C, 1998, J COMP NEUROL, V402, P10; PASCUAL A, UNPUB; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	19	272	276	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1115	1117		10.1126/science.1064200	http://dx.doi.org/10.1126/science.1064200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489VU	11691997				2022-12-24	WOS:000172013800054
J	O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG				O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG			Requirement of borate cross-linking of cell wall rhamnogalacturonan II for Arabidopsis growth	SCIENCE			English	Article							FUCOSE-DEFICIENT MUTANT; PLANT-CELL; PECTIC POLYSACCHARIDE; BORON; THALIANA; ESTER; TRANSFERASE; GLYCANS; DIMER; MUR1	Turgor-driven plant cell growth depends on watt structure. Two allelic L-fucose-deficient Arabidopsis thaliana mutants (mur1-1 and 1-2) are dwarfed and their rosette leaves do not grow normally. mur1 leaf cell watts contain normal amounts of the cell watt pectic polysaccharide rhamnogalacturonan II (RG-II), but only half exists as a borate cross-linked dimer. The altered structure of mur1 RG-II reduces the rate of formation and stability of this cross-link. Exogenous aqueous borate rescues the defect. The reduced cross-linking of RG-II in dwarf mur1 plants indicates that plant growth depends on watt pectic polysaccharide organization.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	O'Neill, MA (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.							Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brown PH, 1997, PLANT SOIL, V196, P211, DOI 10.1023/A:1004245823080; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Duffels A, 2000, BIOORGAN MED CHEM, V8, P2519, DOI 10.1016/S0968-0896(00)00187-5; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; LOOMIS WD, 1992, BIOFACTORS, V3, P229; Matoh T, 1998, J PLANT RES, V111, P179, DOI 10.1007/BF02507164; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 1998, PLANT PHYSIOL BIOCH, V36, P167, DOI 10.1016/S0981-9428(98)80101-0; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; RUEHS B, UNPUB; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; VANZIN GF, COMMUNICATION; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; YORK WS, UNPUB; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808	23	461	489	9	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					846	849		10.1126/science.1062319	http://dx.doi.org/10.1126/science.1062319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679668				2022-12-24	WOS:000171851800045
J	Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM				Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM			Blood transfusion in elderly patients with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC COMPENSATION; MEDICARE PATIENTS; OXYGEN DELIVERY; ANEMIA; HEMATOCRIT; MORTALITY; DISEASE; STRATEGIES; TRIAL; RISK	Background: Anemia may have adverse effects in patients with coronary artery disease. However, the benefit of blood transfusion in elderly patients with acute myocardial infarction and various degrees of anemia is uncertain. Methods: We conducted a retrospective study of data on 78,974 Medicare beneficiaries 65 years old or older who were hospitalized with acute myocardial infarction. Patients were categorized according to the hematocrit on admission (5.0 to 24.0 percent, 24.1 to 27.0 percent, 27.1 to 30.0 percent, 30.1 to 33.0 percent, 33.1 to 36.0 percent, 36.1 to 39.0 percent, or 39.1 to 48.0 percent), and data were evaluated to determine whether there was an association between the use of transfusion and 30-day mortality. Results: Patients with lower hematocrit values on admission had higher 30-day mortality rates. Blood transfusion was associated with a reduction in 30-day mortality among patients whose hematocrit on admission fell into the categories ranging from 5.0 to 24.0 percent (adjusted odds ratio, 0.22; 95 percent confidence interval, 0.11 to 0.45) to 30.1 to 33.0 percent (adjusted odds ratio, 0.69; 95 percent confidence interval, 0.53 to 0.89). It was not associated with a reduction in 30-day mortality among those whose hematocrit values fell in the higher ranges. In one of seven subgroup analyses (among patients who survived at least two days), transfusion was not associated with a reduction in mortality for patients with hematocrit values of 30.1 percent or higher. Conclusions: Blood transfusion is associated with a lower short-term mortality rate among elderly patients with acute myocardial infarction if the hematocrit on admission is 30.0 percent or lower and may be effective in patients with a hematocrit as high as 33.0 percent on admission.	Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Brown University; Yale University; Yale University; Yale University	Wu, WC (corresponding author), Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; BOTTIGER LE, 1980, ATHEROSCLEROSIS, V36, P389, DOI 10.1016/0021-9150(80)90219-1; BRAZIER J, 1974, SURGERY, V75, P508; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chiavetta JA, 1996, TRANSFUSION, V36, P699, DOI 10.1046/j.1537-2995.1996.36896374373.x; CZER LSC, 1978, SURG GYNECOL OBSTET, V147, P363; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; *DEP HLTH HUM SERV, 1989, DHHS PUBL; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Eschbach J, 1997, AM J KIDNEY DIS, V30, pS192; FAUCI AS, 1998, HARRISONS PRINCIPLES, V1; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Friedman BA, 1982, CLIN LABORATORY ANN, V1, P147; Geha A S, 1978, World J Surg, V2, P645; GRINDON AJ, 1985, JAMA-J AM MED ASSOC, V253, P540, DOI 10.1001/jama.253.4.540; HASLEY PB, 1994, TRANSFUSION, V34, P110, DOI 10.1046/j.1537-2995.1994.34294143936.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V274, P944; Innes G, 1998, J Emerg Med, V16, P129; JAN KM, 1977, AM J PHYSIOL, V233, pH106, DOI 10.1152/ajpheart.1977.233.1.H106; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; JOOSTEN E, 1992, GERONTOLOGY, V38, P111, DOI 10.1159/000213315; KALCHTHALER T, 1980, J AM GERIATR SOC, V28, P108, DOI 10.1111/j.1532-5415.1980.tb00242.x; LEVY PS, 1993, AM J PHYSIOL, V265, pH340, DOI 10.1152/ajpheart.1993.265.1.H340; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MOST AS, 1986, CIRCULATION, V74, P1085, DOI 10.1161/01.CIR.74.5.1085; *ROYAL COLL PHYS E, 1994, BRIT J ANAESTH, V73, P857; Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6; Smieja MJ, 1996, CAN MED ASSOC J, V155, P691; SORLIE PD, 1981, AM HEART J, V101, P456, DOI 10.1016/0002-8703(81)90136-8; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V280, P1404; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; WILKERSON DK, 1988, SURGERY, V103, P665; Zimmermann R, 1997, TRANSFUSION, V37, P1075, DOI 10.1046/j.1537-2995.1997.371098016449.x	44	645	675	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1230	1236		10.1056/NEJMoa010615	http://dx.doi.org/10.1056/NEJMoa010615			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680442				2022-12-24	WOS:000171773100002
J	Higashi, H; Tsutsumi, R; Muto, S; Sugiyama, T; Azuma, T; Asaka, M; Hatakeyama, M				Higashi, H; Tsutsumi, R; Muto, S; Sugiyama, T; Azuma, T; Asaka, M; Hatakeyama, M			SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein	SCIENCE			English	Article							GASTRIC EPITHELIAL-CELLS; SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; SH2 DOMAINS; FOCAL ADHESION; IV SECRETION; TRANSLOCATION; SH-PTP2; INVOLVEMENT; ANTIGEN	Helicobacter pylori CagA protein is associated with severe gastritis and gastric carcinoma. CagA is injected from the attached Helicobacter pylori into host cells and undergoes tyrosine phosphorylation. Wild-type but not phosphorylation-resistant CagA induced a growth factor-like response in gastric epithelial cells. Furthermore, CagA formed a physical complex with the SRC homology 2 domain (SH2)-containing tyrosine phosphatase SHP-2 in a phosphorylation-dependent manner and stimulated the phosphatase activity. Disruption of the CagA-SHP-2 complex abolished the CagA-dependent cellular response. Conversely, the CagA effect on cells was reproduced by constitutively active SHP-2. Thus, upon translocation, CagA perturbs cellular functions by deregulating SHP-2.	Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido 0600815, Japan; Fukui Med Univ, Dept Internal Med 2, Fukui 9101193, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Fukui	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan.	mhata@imm.hokudai.ac.jp	Asaka, Masahiro/A-5948-2012; Higashi, Hideaki/F-6872-2012	Tsutsumi, Ryouhei/0000-0002-1704-0362				AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BLASER MJ, 1995, CANCER RES, V55, P2111; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; DECHERT U, 1994, J BIOL CHEM, V269, P5602; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; HIGASHI H, UNPUB; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Manes S, 1999, MOL CELL BIOL, V19, P3125; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	27	769	807	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					683	686		10.1126/science.1067147	http://dx.doi.org/10.1126/science.1067147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11743164				2022-12-24	WOS:000173560900047
J	Sturm, R; Gresenz, CR				Sturm, R; Gresenz, CR			Relations of income inequality and family income to chronic medical conditions and mental health disorders: national survey in USA	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CIVIL-SERVANTS; MORTALITY; DETERMINANTS; DESIGN; CARE	Objectives To analyse the relation between geographical inequalities in income and the prevalence of common chronic medical conditions and mental health disorders, and to compare it with the relation between family income mid these health problems. Design Nationally representative household telephone survey conducted in 1997-8. Setting 60 metropolitan areas or economic areas of the United States. Participants 9585 adults who participated in the community tracking study. Main outcome measures Self report of 17 common chronic medical conditions; current depressive disorder or anxiety disorder assessed by clinical screeners. Results A strong continuous association was seen between health and education or family income. No relation was found between income inequality and the prevalence of chronic medical problems or depressive disorders and anxiety disorders, either across the whole population or among poorer people. Only self reported overall health, the measure used in previous studies, was significantly correlated with inequality at the population level, but this correlation disappeared after adjustment for individual characteristics. Conclusions This study provides no evidence for the hypothesis that income inequality is a major risk factor for common disorders of physical or mental health.	RAND Corp, Santa Monica, CA 90401 USA; RAND Corp, Arlington, VA 22202 USA	RAND Corporation; RAND Corporation	Sturm, R (corresponding author), RAND Corp, 1700 Main St, Santa Monica, CA 90401 USA.	sturm@rand.org			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062124] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH062124, R01-MH62124] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cowell F.A., 1977, MEASURING INEQUALITY; Daly MC, 1998, MILBANK Q, V76, P315, DOI 10.1111/1468-0009.00094; Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724; Fiscella K, 2000, HEALTH SERV RES, V35, P307; FLEGG AT, 1982, POP STUD-J DEMOG, V36, P441, DOI 10.2307/2174055; Jones A.F., 2000, CURRENT POPULATION R; Juster FT, 1997, J AM STAT ASSOC, V92, P1268, DOI 10.2307/2965397; Kahn RS, 2000, BRIT MED J, V321, P1311, DOI 10.1136/bmj.321.7272.1311; KAHN RS, 2000, BRIT MED J, V32, P1311; Kaplan GA, 1996, BRIT MED J, V312, P999; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kennedy BP, 1998, BRIT MED J, V317, P917; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Mellor JM, 2001, J HEALTH POLIT POLIC, V26, P487, DOI 10.1215/03616878-26-3-487; MELLOR JM, IN PRESS J HUM RESOU; RODGERS GB, 1979, POP STUD-J DEMOG, V33, P343, DOI 10.2307/2173539; Sen A., 1973, EC INEQUALITY; Soobader MJ, 1999, SOC SCI MED, V48, P733, DOI 10.1016/S0277-9536(98)00401-8; Sturm R, 1999, INQUIRY-J HEALTH CAR, V36, P221; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weich S, 2001, BRIT J PSYCHIAT, V178, P222, DOI 10.1192/bjp.178.3.222; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; World Health Organization, 1995, COMP INT DIAGN INT V	31	148	151	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2002	324	7328					20	+		10.1136/bmj.324.7328.20	http://dx.doi.org/10.1136/bmj.324.7328.20			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510JV	11777799	Bronze, Green Published			2022-12-24	WOS:000173205700018
J	Wang, W; Thornton, K; Berry, A; Long, MY				Wang, W; Thornton, K; Berry, A; Long, MY			Nucleotide variation along the Drosophila melanogaster fourth chromosome	SCIENCE			English	Article							DNA POLYMORPHISM; SELECTION; DIVERGENCE; PATTERNS; COMPLEX; MODEL; GENES	The Drosophila melanogaster fourth chromosome, believed to be nonrecombining and invariable, is a classic example of the effect of natural selection in eliminating genetic variation in linked loci. However, in a chromosome-wide assay of nucleotide variation in natural populations, we have observed a high level of polymorphism in a similar to 200-kilobase region and marked levels of polymorphism in several other fragments interspersed with regions of little variation, suggesting different evolutionary histories in different chromosomal domains. Statistical tests of neutral evolution showed that a few haplotypes predominate in the 200-kilobase polymorphic region. Finally, contrary to the expectation of no recombination, we identified six recombination events within the chromosome. Thus, positive Darwinian selection and recombination have affected the evolution of this chromosome.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Chicago; University of Chicago; Harvard University	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Wang, Wen/AAP-9873-2020; Wang, Wei/B-5617-2019	Wang, Wen/0000-0002-7801-2066; Thornton, Kevin/0000-0003-0743-4445				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2000, GENETICS, V156, P257; Ashburner M., 1989, LAB HDB; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1992, NATURE, V356, P475, DOI 10.1038/356475a0; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Dobzhansky T, 1943, GENETICS, V28, P162; Freeman S, 1998, EVOLUTIONARY ANAL; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1985, GENETICS, V111, P147; Kimura M, 1985, NEUTRAL THEORY MOL E; KREITMAN M, 1991, GENETICS, V127, P565; MAYANRDSMITH J, 1976, GENET RES, V23, P23; Nurminsky D, 2001, SCIENCE, V291, P128, DOI 10.1126/science.291.5501.128; Powell J.R., 1997, PROGR PROSPECTS EVOL; TAJIMA F, 1989, GENETICS, V123, P585; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413	24	66	74	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					134	137		10.1126/science.1064521	http://dx.doi.org/10.1126/science.1064521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778050				2022-12-24	WOS:000173143100051
J	Meden, T; St John-Larkin, C; Hermes, D; Sommerschield, S				Meden, T; St John-Larkin, C; Hermes, D; Sommerschield, S			Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSERVING SURGERY; PATIENT; WOMEN		Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Meden, T (corresponding author), Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA.							ABE O, 1995, NEW ENGL J MED, V333, P1444; Albain KS, 1996, J CLIN ONCOL, V14, P3009, DOI 10.1200/JCO.1996.14.11.3009; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Kotwall CA, 1996, ANN SURG, V224, P419, DOI 10.1097/00000658-199610000-00001; Lazovich D, 1997, ARCH SURG-CHICAGO, V132, P418; SAMET JM, 1994, CANCER, V73, P2344, DOI 10.1002/1097-0142(19940501)73:9<2344::AID-CNCR2820730917>3.0.CO;2-V; Stafford D, 1998, AM J SURG, V176, P515, DOI 10.1016/S0002-9610(98)00257-8	7	72	72	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					111	111		10.1001/jama.287.1.111	http://dx.doi.org/10.1001/jama.287.1.111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754721	hybrid			2022-12-24	WOS:000172978500037
J	Kramer, A; Yang, FC; Snodgrass, P; Li, XD; Scammell, TE; Davis, FC; Weitz, CJ				Kramer, A; Yang, FC; Snodgrass, P; Li, XD; Scammell, TE; Davis, FC; Weitz, CJ			Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling	SCIENCE			English	Article							GROWTH-FACTOR-ALPHA; SUPRACHIASMATIC NUCLEUS; CIRCADIAN PACEMAKERS; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; PROJECTIONS; EXPRESSION; MASKING; TEMPERATURE; HAMSTERS	The circadian clock in the suprachiasmatic nucleus (SCN) is thought to drive daily rhythms of behavior by secreting factors that act locally within the hypothalamus. in a systematic screen, we identified transforming growth factor-alpha (TGF-alpha) as a likely SCN inhibitor of locomotion. TGF-alpha is expressed rhythmically in the SCN, and when infused into the third ventricle it reversibly inhibited locomotor activity and disrupted circadian sleep-wake cycles. These actions are mediated by epidermal growth factor (EGF) receptors on neurons in the hypothalamic subparaventricular zone. Mice with a hypomorphic EGF receptor mutation exhibited excessive daytime locomotor activity and failed to suppress activity when exposed to light. These results implicate EGF receptor signaling in the daily control of locomotor activity, and identify a neural circuit in the hypothalamus that likely mediates the regulation of behavior both by the SCN and the retina.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Kramer, Achim/0000-0001-9671-6078	NICHD NIH HHS [HD-18686] Funding Source: Medline; NIMH NIH HHS [MH62589] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD018686, R01HD018686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062589] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBERS HE, 1991, J NEUROSCI, V11, P846; DAVIS FC, 1980, AM J PHYSIOL, V239, pR149, DOI 10.1152/ajpregu.1980.239.1.R149; Decoursey PJ, 1998, PHYSIOL BEHAV, V65, P457, DOI 10.1016/S0031-9384(98)00187-5; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KITA H, 1982, BRAIN RES BULL, V8, P249, DOI 10.1016/0361-9230(82)90055-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; KRAMER A, UNPUB; LEE DC, 1995, PHARMACOL REV, V47, P51; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MA YJ, 1992, NEURON, V9, P657; Miller JD, 1996, SLEEP, V19, P641, DOI 10.1093/sleep/19.8.641; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PATEL B, 1994, BRIT J OPHTHALMOL, V78, P714, DOI 10.1136/bjo.78.9.714; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; ROKAL RR, 1995, BIOMETRY; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440	40	388	399	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2511	2515		10.1126/science.1067716	http://dx.doi.org/10.1126/science.1067716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752569				2022-12-24	WOS:000172927700047
J	Narla, G; Heath, KE; Reeves, HL; Li, D; Giono, LE; Kimmelman, AC; Glucksman, MJ; Narla, J; Eng, FJ; Chan, AM; Ferrari, AC; Martignetti, JA; Friedman, SL				Narla, G; Heath, KE; Reeves, HL; Li, D; Giono, LE; Kimmelman, AC; Glucksman, MJ; Narla, J; Eng, FJ; Chan, AM; Ferrari, AC; Martignetti, JA; Friedman, SL			KLF6, a candidate tumor suppressor gene mutated in prostate cancer	SCIENCE			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; ALLELIC LOSS; DNA; PROMOTER	Kruppel-like factor 6 (KLF6) is a zinc finger transcription factor of unknown function. Here, we show that the KLF6 gene is mutated in a subset of human prostate cancer. Loss-of-heterozygosity analysis revealed that one KLF6 allele is deleted in 77% (17 of 22) of primary prostate tumors. Sequence analysis of the retained KLF6 allele revealed mutations in 71% of these tumors. Functional studies confirm that whereas wild-type KLF6 up-regulates p21 (WAF1/CIP1) in a p53-independent manner and significantly reduces cell proliferation, tumor-derived KLF6 mutants do not. Our data suggest that KLF6 is a tumor suppressor gene involved in human prostate cancer.	CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, Div Med Oncol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Reg Med Ctr, San Jose, CA 95116 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Friedman, SL (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, 1425 Madison Ave,Room 1170F,Box 1123, New York, NY 10029 USA.		Heath, K. E./ABG-4658-2020; Narla, Goutham/AAZ-5710-2020; Heath, Karen Elise/K-7760-2014; Chan, Andrew/AAC-1145-2020; Chan, Andrew Man-Lok/J-9497-2013	Heath, K. E./0000-0002-5816-7044; Narla, Goutham/0000-0003-4098-4203; Heath, Karen Elise/0000-0002-5816-7044; Chan, Andrew/0000-0001-9923-5464; Chan, Andrew Man-Lok/0000-0001-9923-5464; Giono, Luciana/0000-0001-6958-6044; Reeves, Helen/0000-0003-0359-9795	NCI NIH HHS [CA79918, CA78207] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [DK37340] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA078207, R21CA079918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037340] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Gumerlock PH, 1997, J NATL CANCER I, V89, P66, DOI 10.1093/jnci/89.1.66; Ittmann M, 1996, CANCER RES, V56, P2143; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kojima S, 2000, BLOOD, V95, P1309; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Latil A, 1998, VIRCHOWS ARCH, V432, P389, DOI 10.1007/s004280050183; MIRCHANDANI D, 1995, AM J PATHOL, V147, P92; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Suzuki T, 1998, J BIOCHEM, V124, P389, DOI 10.1093/oxfordjournals.jbchem.a022124; Trybus TM, 1996, CANCER RES, V56, P2263	15	361	393	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2563	2566		10.1126/science.1066326	http://dx.doi.org/10.1126/science.1066326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752579				2022-12-24	WOS:000172927700063
J	Bansal, A				Bansal, A			Trends in reporting of SNP associations	LANCET			English	Editorial Material							CALPAIN-10		Gemini Genom UK Ltd, Dept Stat, Cambridge CB4 0GH, England		Bansal, A (corresponding author), Gemini Genom UK Ltd, Dept Stat, Cambridge CB4 0GH, England.	Aruna.Bansal@gemini-genomics.com						Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; HOLM S, 1979, SCAND J STAT, V6, P65; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467	8	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2016	2016		10.1016/S0140-6736(01)07139-2	http://dx.doi.org/10.1016/S0140-6736(01)07139-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755606				2022-12-24	WOS:000172722800008
J	Walldius, G; Jungner, I; Holme, I; Aastveit, AH; Kolar, W; Steiner, E				Walldius, G; Jungner, I; Holme, I; Aastveit, AH; Kolar, W; Steiner, E			High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study	LANCET			English	Article							CHEMISTRY STANDARDIZATION PROJECT; CORONARY-ARTERY DISEASE; ISCHEMIC-HEART-DISEASE; INTERNATIONAL-FEDERATION; PLASMA APOLIPOPROTEINS; REFERENCE INTERVALS; SWEDISH MALES; RISK; CHOLESTEROL; VALUES	Background Apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) are thought to be better predictors of acute myocardial infarction than total cholesterol and LDL-cholesterol. We investigated whether apoB and apoA-I are predictors of risk of fatal myocardial infarction. We also aimed to establish whether apoB and apoA-I add further information about risk of fatal myocardial infarction to that obtained with total cholesterol, triglycerides, and LDL-cholesterol. Methods We recruited 175 553 individuals mainly from screening programmes. We measured concentrations of apoB, apoA-I, total cholesterol, and triglycerides, and calculated apoB/apoA-I ratio and concentrations of LDL-cholesterol and HDL-cholesterol. The relation between death from acute myocardial infarction and initial values for apoB, apoA-I, and the other lipids was examined. Findings Mean follow-up was 66.8 months (SD 41.3) for 98 722 men and 64.4 months (41.4) for 76 831 women. 864 men and 359 women had fatal myocardial infarction. In univariate analyses adjusted for age and in multivariate analyses adjusted for age, total cholesterol, and triglycerides, the values for apoB and apoB/apoA-I ratio were strongly and positively related to increased risk of fatal myocardial infarction in men and in women. ApoA-I was noted to be protective. In multivariate analysis, apoB was a stronger predictor of risk than LDL-cholesterol in both sexes. Interpretation Although LDL-cholesterol and HDL-cholesterol are known risk factors, we suggest that apoB, apoB/apoA-I, and apoA-I should also be regarded as highly predictive in evaluation of cardiac risk. Although increased throughout the range of values of LDL-cholesterol, apoB and apoA-I might be of greatest value in diagnosis and treatment in men and women who have common lipid abnormalities, but have normal or low concentrations of LDL-cho le sterol.	AstraZeneca, S-43183 Molndal, Sweden; Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden; St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden; Ulleval Hosp, Ctr Prevent Med, Oslo, Norway; Agr Univ Norway, Dept Math Sci, As, Norway	AstraZeneca; Karolinska Institutet; Saint Goran's Hospital; University of Oslo; Norwegian University of Life Sciences	Walldius, G (corresponding author), AstraZeneca, S-43183 Molndal, Sweden.	goran.walldius@astrazeneca.com						Bachorik PS, 1997, CLIN CHEM, V43, P2364; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Connelly PW, 1999, CAN J CARDIOL, V15, P409; Contois JH, 1996, CLIN CHEM, V42, P515; Contois JH, 1996, CLIN CHEM, V42, P507; Crouse JR, 2000, ARTERIOSCL THROM VAS, V20, P2333, DOI 10.1161/01.ATV.20.11.2333; Francis MC, 2001, ATHEROSCLEROSIS, V155, P165, DOI 10.1016/S0021-9150(00)00528-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GARFAGNINI A, 1995, EUR HEART J, V16, P465, DOI 10.1093/oxfordjournals.eurheartj.a060937; GOTTO A, 2000, ILIB LIPID HDB CLIN; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Graziani MS, 1998, CLIN CHEM, V44, P134; JUNGNER I, 1992, INT J CLIN LAB RES, V21, P247, DOI 10.1007/BF02591655; Jungner I, 1998, CLIN CHEM, V44, P1641; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LEINO A, 1995, CLIN CHEM, V41, P1633; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Mykkanen L, 1999, ARTERIOSCL THROM VAS, V19, P2742, DOI 10.1161/01.ATV.19.11.2742; OBRIEN T, 1995, ARTERIOSCL THROM VAS, V15, P228, DOI 10.1161/01.ATV.15.2.228; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; RADER DJ, 1994, ANN INTERN MED, V120, P1012, DOI 10.7326/0003-4819-120-12-199406150-00008; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Sniderman AD, 1996, CLIN CHEM, V42, P489; Sniderman AD, 2001, CAN MED ASSOC J, V164, P44; Sniderman AD, 1997, CLIN CHEM, V43, P1310; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; WALLDIUS G, 1992, BLOOD PRESS S4, V1, P35; Warnick GR, 2000, CLIN CHEM LAB MED, V38, P287, DOI 10.1515/CCLM.2000.041; Westedt ML, 1998, RHEUMATOL INT, V18, P1, DOI 10.1007/s002960050045; Wood D, 1998, EUR HEART J, V19, P1434	35	923	974	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2026	2033		10.1016/S0140-6736(01)07098-2	http://dx.doi.org/10.1016/S0140-6736(01)07098-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755609				2022-12-24	WOS:000172722800011
J	Colman-Lerner, A; Chin, TE; Brent, R				Colman-Lerner, A; Chin, TE; Brent, R			Yeast Cbk1 and Mob2 activate daughter-specific genetic programs to induce asymmetric cell fates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; HO GENE; TRANSCRIPTION FACTOR; CYCLE CONTROL; EXPRESSION; SWI5; IDENTIFICATION; REGULATORS; INHIBITOR	In Saccharomyces cerevisiae, mothers and daughters have distinct fates. We show that Cbk1 kinase and its interacting protein Mob2 regulate this asymmetry by inducing daughter-specific genetic programs. Daughter-specific expression is due to Cbk1/Mob2-dependent activation and localization of the Ace2 transcription factor to the daughter nucleus. Ectopic localization of active Ace2 to mother nuclei is sufficient to activate daughter-specific genes in mothers. Eight genes are daughter-specific under the tested conditions, while two are daughter-specific only in saturated cultures. Some daughter-specific gene products contribute to cell separation by degrading the cell wall. These experiments define programs of gene expression specific to daughters and describe how those programs are controlled.	Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Colman-Lerner, A (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	colman-lerner@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020	Colman-Lerner, Alejandro/0000-0002-2557-8883				Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dohrmann PR, 1996, MOL CELL BIOL, V16, P1746; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Futcher Bruce, 1999, Methods in Cell Science, V21, P79, DOI 10.1023/A:1009872403440; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geyer CR, 1999, P NATL ACAD SCI USA, V96, P8567, DOI 10.1073/pnas.96.15.8567; Guthrie C., 1991, METHODS ENZYMOLOGY G; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jacobs C, 1998, CURR OPIN GENET DEV, V8, P386, DOI 10.1016/S0959-437X(98)80107-X; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NASMYTH K, 1993, CURR OPIN GENET DEV, V3, P286, DOI 10.1016/0959-437X(93)90036-O; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1983, NATURE, V302, P670, DOI 10.1038/302670a0; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; OSHIMA Y, 1971, GENETICS, V67, P327; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; SIKORSKI RS, 1989, GENETICS, V122, P19; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; SLOAT BF, 1978, SCIENCE, V200, P1171, DOI 10.1126/science.349694; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; TEBB G, 1993, GENE DEV, V7, P517, DOI 10.1101/gad.7.3.517; Toyn JH, 1997, GENETICS, V145, P85; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	50	261	268	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					739	750		10.1016/S0092-8674(01)00596-7	http://dx.doi.org/10.1016/S0092-8674(01)00596-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747810	Bronze			2022-12-24	WOS:000172771800007
J	Karol, KG; McCourt, RM; Cimino, MT; Delwiche, CF				Karol, KG; McCourt, RM; Cimino, MT; Delwiche, CF			The closest living relatives of land plants	SCIENCE			English	Article							GREEN-ALGAE; MESOSTIGMA VIRIDE; PHYLOGENY; ULTRASTRUCTURE; CHAROPHYCEAE; BRYOPHYTES; SEQUENCES; CHARA	The embryophytes (land plants) have long been thought to be related to the green algal group Charophyta, though the nature of this relationship and the origin of the land plants have remained unresolved. A four-gene phytogenetic analysis was conducted to investigate these relationships. This analysis supports the hypothesis that the land plants are placed phylogenetically within the Charophyta, identifies the Charales (stoneworts) as the closest living relatives of plants, and shows the Coleochaetales as sister to this Charales/land plant assemblage. The results also support the unicellular flagellate Mesostigma as the earliest branch of the charophyte lineage. These findings provide insight into the nature of the ancestor of plants, and have broad implications for understanding the transition from aquatic green algae to terrestrial plants.	Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Acad Nat Sci Philadelphia, Dept Bot, Philadelphia, PA 19103 USA	University System of Maryland; University of Maryland College Park; Drexel University	Karol, KG (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.		Delwiche, Charles F/C-6549-2008	Delwiche, Charles F/0000-0001-7854-8584				Bhattacharya D, 1998, J MOL EVOL, V47, P544, DOI 10.1007/PL00006410; Bower F. O., 1908, ORIGIN LAND FLORA TH; CHAPMAN RL, 1998, SYSTEMATICS PLANTS, V2, P508; Cook ME, 1997, AM J BOT, V84, P1169, DOI 10.2307/2446040; Doyle J., 1986, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duncan TM, 1997, PLANT SYST EVOL, V204, P125, DOI 10.1007/BF00989201; Feist M, 1997, NATURE, V385, P401, DOI 10.1038/385401a0; Feist M., 1991, CALCAREOUS ALGAE STR, V11, P189, DOI [10.1007/978-3-642-52335-9, DOI 10.1007/978-3-642-52335-9]; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FRITSCH F.E., 1935, STRUCTURE REPROD ALG, V1; Graham L, 1993, ORIGIN LAND PLANTS; Graham L.E., 2000, ALGAE-SEOUL; GRAHAM LE, 1991, ADV BRYOL, V4, P213; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUELSENBECK JP, 2001, HDB STAT GENETICS; Kenrick P, 1997, ORIGIN EARLY DIVERSI; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; LEMIEUX C, IN PRESS; Marin B, 1999, PROTIST, V150, P399, DOI 10.1016/S1434-4610(99)70041-6; Mattox K.R., 1984, SYSTEMATICS GREEN AL, P29, DOI 10.1017/S0024282985000482; McCourt RM, 2000, J PHYCOL, V36, P747, DOI 10.1046/j.1529-8817.2000.99106.x; MISHLER B D, 1985, Cladistics, V1, P305, DOI 10.1111/j.1096-0031.1985.tb00431.x; MISHLER BD, 1984, BRITTONIA, V36, P406, DOI 10.2307/2806602; PICKETTHEAPS JD, 1972, CYTOBIOS, V6, P255; SLUIMAN HJ, 1985, PLANT SYST EVOL, V149, P217, DOI 10.1007/BF00983308; Sluiman HJ, 1999, J PHYCOL, V35, P395, DOI 10.1046/j.1529-8817.1999.3520395.x; Tappan H, 1980, PALEOBIOLOGY PLANT P	27	428	467	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2351	2353		10.1126/science.1065156	http://dx.doi.org/10.1126/science.1065156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743201				2022-12-24	WOS:000172817200046
J	Stemmann, O; Zou, H; Gerber, SA; Gygi, SP; Kirschner, MW				Stemmann, O; Zou, H; Gerber, SA; Gygi, SP; Kirschner, MW			Dual inhibition of sister chromatid separation at metaphase	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; XENOPUS EGG EXTRACTS; CELL-CYCLE EXTRACTS; MAP KINASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ALIGNMENT; ANAPHASE TRANSITION; CENP-E; YEAST; DESTRUCTION	Separation of sister chromatids in anaphase is mediated by separase, an endopeptidase that cleaves the chromosomal cohesin SCC1. Separase is inhibited by securin, which is degraded at the metaphase-anaphase transition. Using Xenopus egg extracts, we demonstrate that high CDC2 activity inhibits anaphase but not securin degradation. We show that separase is kept inactive under these conditions by a mechanism independent of binding to securin. Mutation of a single phosphorylation site on separase relieves the inhibition and rescues chromatid separation in extracts with high CDC2 activity. Using quantitative mass spectrometry, we show that, in intact cells, there is complete phosphorylation of this site in metaphase and significant dephosphorylation in anaphase. We propose that separase activation at the metaphase-anaphase transition requires the removal of both securin and an inhibitory phosphate.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.			Stemmann, Olaf/0000-0003-3044-2515; Gerber, Scott/0000-0002-2964-5051	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023, R37GM026875, R01GM026875] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00041] Funding Source: Medline; NIGMS NIH HHS [GM26875-17, GM39023-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; ENG J, 1994, J AM SOC MASS SPECTR, V5, P1579; Fang CH, 1998, INT J MOL MED, V1, P163; Foley E, 2001, CURR BIOL, V11, P151, DOI 10.1016/S0960-9822(01)00050-1; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; IMIGER S, 1995, CELL, V81, P269; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; KUMAGAI A, 1991, COLD SPRING HARB SYM, V56, P585; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Meyn MA, 2000, CURR BIOL, V10, P1599, DOI 10.1016/S0960-9822(00)00863-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	46	372	394	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					715	726		10.1016/S0092-8674(01)00603-1	http://dx.doi.org/10.1016/S0092-8674(01)00603-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747808	Bronze			2022-12-24	WOS:000172771800005
J	Patel, SC; Levine, SR; Tilley, BC; Grotta, JC; Lu, M; Frankel, M; Haley, EC; Brott, TG; Broderick, JP; Horowitz, S; Lyden, PD; Lewandowski, CA; Marler, JR; Welch, KMA				Patel, SC; Levine, SR; Tilley, BC; Grotta, JC; Lu, M; Frankel, M; Haley, EC; Brott, TG; Broderick, JP; Horowitz, S; Lyden, PD; Lewandowski, CA; Marler, JR; Welch, KMA		Natl Inst Neurological Disorders	Lack of clinical significance of early ischemic changes on computed tomography in acute stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CT FINDINGS; PLASMINOGEN-ACTIVATOR; CEREBRAL INFARCTION; RT-PA; ALTEPLASE; VARIABILITY; RELIABILITY; AGREEMENT	Context The prevalence and clinical significance of early ischemic changes (EICs) on baseline computed tomography (CT) scan of the head obtained within 3 hours of ischemic stroke are not established. Objective To determine the frequency and significance of EIC on baseline head CT scans in the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA (recombinant tissue plasminogen activator) Stroke Trial. Design and Setting The original study, a randomized controlled trial, took place from January 1991 through October 1994 at 43 sites, during which CT images were obtained within 3 hours of symptom onset and prior to the initiation of rt-PA or placebo. For the current analysis, detailed reevaluation was undertaken after October 1994 of all baseline head CT scans with clinical data available pretreatment (blinded to treatment arm). Patients Of 624 patients enrolled in the trial, baseline CT scans were retrieved and reviewed for 616 (99%). Main Outcome Measures Frequency of EICs on baseline CT scans; association of EIC With other baseline variables; effect of EICs on deterioration at 24 hours (greater than or equal to4 points increase from the baseline National Institutes of Health Stroke Scale [NIHSS] score); clinical outcome (measured by 4 clinical scales) at 3 months, CT lesion volume at 3 months, death at 90 days; and symptomatic intracranial hemorrhage (ICH) within 36 hours of treatment. Results The prevalence of EIC on baseline CT in the combined rt-PA and placebo groups was 31% (n = 194). The EIC was significantly associated with baseline NIHSS score (p=0.23; P<.001) and time from stroke onset to baseline CT scan (p=0.11; P=.007). After adjusting for baseline variables, there was no EIC X treatment interaction detected for any clinical outcome, including deterioration at 24 hours, 4 clinical scales, lesion volume, and death at 90 days (P<greater than or equal to>.25), implying that EIC is unlikely to affect response to rt-PA treatment. After adjusting for NIHSS score (an independent predictor of ICH), no EIC association with symptomatic ICH at 36 hours was detected in the group treated with rt-PA (P greater than or equal to .22). Conclusions Our analysis suggests that EICs are prevalent within 3 hours of stroke onset and correlate with stroke severity. However, EICs are not independently associated with increased risk of adverse outcome after rt-PA treatment. Patients treated with rt-PA did better whether or not they had EICs, suggesting that EICs on CT scan are not critical to the decision to treat otherwise eligible patients with rt-PA within 3 hours of stroke onset.	Henry Ford Hosp & Hlth Sci Ctr, Div Neuroradiol, Detroit, MI 48202 USA; Mt Sinai Sch Med, New York, NY USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Texas, Med Ctr, Houston, TX USA; Emory Univ, Sch Med, Atlanta, GA USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Mayo Clin, Jacksonville, FL 32224 USA; Univ Cincinnati, Cincinnati, OH USA; Univ Missouri, Columbia, MO USA; Univ Calif San Diego, Stroke Ctr, San Diego, CA 92103 USA; NINCDS, NIH, Bethesda, MD 20892 USA; Univ Kansas, Sch Med, Kansas City, KS USA	Henry Ford Health System; Icahn School of Medicine at Mount Sinai; Medical University of South Carolina; University of Texas System; Emory University; University of Virginia; Mayo Clinic; University System of Ohio; University of Cincinnati; University of Missouri System; University of Missouri Columbia; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Kansas; University of Kansas Medical Center	Patel, SC (corresponding author), Henry Ford Hosp & Hlth Sci Ctr, Div Neuroradiol, 2799 W Grand Blvd,K-3, Detroit, MI 48202 USA.	spatel@rad.hfh.edu	Grotta, James/AAH-7423-2021					Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bornstein N, 2000, STROKE, V31, P309; BOZZAO L, 1989, AM J NEURORADIOL, V10, P1215; BOZZAO L, 1991, AM J NEURORADIOL, V12, P1115; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HOROWITZ SH, 1991, STROKE, V22, P1245, DOI 10.1161/01.STR.22.10.1245; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; HSIEH FY, 1989, STAT MED, V8, P795, DOI 10.1002/sim.4780080704; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Levine SR, 2000, STROKE, V31, P2912; Luire DN, 2000, STROKE, V31, P276; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; MAHONEY F I, 1965, Md State Med J, V14, P61; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; MOHR JP, 1995, STROKE, V26, P807, DOI 10.1161/01.STR.26.5.807; Moulin T, 1996, NEUROLOGY, V47, P366, DOI 10.1212/WNL.47.2.366; Rothman K, 1986, MODERN EPIDEMIOLOGY; Schriger DL, 1998, JAMA-J AM MED ASSOC, V279, P1293, DOI 10.1001/jama.279.16.1293; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; TOMURA N, 1988, RADIOLOGY, V168, P463, DOI 10.1148/radiology.168.2.3393665; TRUWIT CL, 1990, RADIOLOGY, V176, P801, DOI 10.1148/radiology.176.3.2389039; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; von Kummer R, 1999, STROKE, V30, P250; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; vonKummer R, 1996, NEURORADIOLOGY, V38, P31, DOI 10.1007/BF00593212; VONKUMMER R, 1995, EARLY CT DIAGNOSIS H, P8; WALL SD, 1982, AM J ROENTGENOL, V138, P307, DOI 10.2214/ajr.138.2.307	39	256	267	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2830	2838		10.1001/jama.286.22.2830	http://dx.doi.org/10.1001/jama.286.22.2830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735758				2022-12-24	WOS:000172655400031
J	Rathore, SS; Chen, J; Wang, YF; Radford, MJ; Voccarino, V; Krumholz, HM				Rathore, SS; Chen, J; Wang, YF; Radford, MJ; Voccarino, V; Krumholz, HM			Sex differences in cardiac catheterization - The role of physician gender	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; HEART-DISEASE; CHEST PAIN; WOMEN; CARE; RACE; MANAGEMENT; BIAS; MEN	Context Many studies indicate that women are less likely than men to undergo cardiac procedures after an acute myocardial infarction (AMI), raising concerns of sexual bias in clinical care. However, no data exist regarding the relationship between patient sex, physician sex, and use of cardiac procedures. Objective To determine whether sex differences in cardiac catheterization after AM] were greater when patients were treated by male attending physicians compared with female attending physicians. Design, Setting, and Patients Analysis of data from the Cooperative Cardiovascular Project, a retrospective medical record-review. A total of 104231 Medicare fee-for-service beneficiaries who were hospitalized In US acute care hospitals for an AM] between January 1994 and February 1995. Main Outcome Measure Use of cardiac catheterization within 60 days of admission, compared between the 4 groups of patient sex-physician sex combinations. Results Women underwent fewer cardiac catheterizations than men when treated by either male physicians (38.6% vs 50.8%; P=.001) or female physicians (34.8% vs 45.8%; P=.001). Sex differences in procedure use were not greater when a patient and physician were of different sexes (P for interaction =.85). After potential confounders in multivariable analysis were accounted for, women were less likely to undergo cardiac catheterization (risk ratio, 0.90 [95% confidence interval {CI}, 0.88-0.92]), regardless of the treating physician's sex. Patients treated by male physicians were more likely to undergo cardiac catheterization (risk ratio, 1.06 [95% CI, 1.02-1.10]) than those treated by female physicians, regardless of patient sex. Conclusions Women who have had an AMI undergo a cardiac catheterization less often than men, whether treated by a male or female physician. These results suggest that factors other than sexual bias by male physicians toward women account for sex differences in cardiac procedure use.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; Qualidigm, Middletown, CT USA	Yale University; Yale University; Yale University; University of Pennsylvania; Pennsylvania Medicine; Emory University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	CIT NIH HHS [500-99-CT01] Funding Source: Medline	CIT NIH HHS		Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; *AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BIRDWELL BG, 1993, ARCH INTERN MED, V153, P1991, DOI 10.1001/archinte.153.17.1991; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; CHERKIN D, 1977, MED CARE, V15, P767; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; COMSTOCK LM, 1982, J MED EDUC, V57, P105; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Dartmouth Medical School Center for the Evaluation of Clinical Sciences Maine Medical Center, 1999, DARTM ATL CARD HLTH; DHOORE W, 1994, AM J PUBLIC HEALTH, V84, P1013, DOI 10.2105/AJPH.84.6.1013; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; FENNEMA K, 1990, J FAM PRACTICE, V30, P441; FRANKS P, 1993, MED CARE, V31, P213, DOI 10.1097/00005650-199303000-00003; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; HALL JA, 1990, MED CARE, V28, P489, DOI 10.1097/00005650-199006000-00002; HARRIS RB, 1991, J CLIN EPIDEMIOL, V44, P1071, DOI 10.1016/0895-4356(91)90009-X; JEZZONI LI, 1994, RISK ADJ MEAS HLTH C; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Levy S, 1992, Fam Med, V24, P58; LINK RN, 1991, J GEN INTERN MED, V6, P466; Lurie N, 1997, J GEN INTERN MED, V12, P34; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MAHEUX B, 1990, MED CARE, V28, P87, DOI 10.1097/00005650-199001000-00009; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Maynard C, 1996, CIRCULATION, V94, P93; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; PEARSON ML, 1992, JAMA-J AM MED ASSOC, V268, P1883, DOI 10.1001/jama.268.14.1883; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; SOFAER S, 1990, WOMEN HEALTH, V16, P47, DOI 10.1300/J013v16n03_04; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; *US BUR CENS, 1991, STAT METR AR DAT BOO; *US DEP HHS, 1988, INT CLASS DIS 9 REV; van Lennep JER, 2000, EUR HEART J, V21, P911, DOI 10.1053/euhj.1999.1941; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wong CC, 1998, AM HEART J, V135, P435, DOI 10.1016/S0002-8703(98)70319-9; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zucker DR, 1997, J GEN INTERN MED, V12, P79, DOI 10.1046/j.1525-1497.1997.00011.x	49	90	91	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2849	2856		10.1001/jama.286.22.2849	http://dx.doi.org/10.1001/jama.286.22.2849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735761				2022-12-24	WOS:000172655400034
J	Westbrook, JI; Duggan, AE; McIntosh, JH				Westbrook, JI; Duggan, AE; McIntosh, JH			Prescriptions for antiulcer drugs in Australia: volume, trends, and costs	BRITISH MEDICAL JOURNAL			English	Article									Univ New S Wales, Ctr Hlth Informat, Kensington, NSW 2052, Australia; John Hunter Hosp, Dept Gastroenterol, New Lambton Hts, NSW 2305, Australia; Univ Sydney, Sch Hlth Informat Management, Lidcombe, NSW 1825, Australia	University of New South Wales Sydney; John Hunter Hospital; University of Sydney	Westbrook, JI (corresponding author), Univ New S Wales, Ctr Hlth Informat, Kensington, NSW 2052, Australia.		Westbrook, Johanna/J-9045-2018	Westbrook, Johanna/0000-0003-1083-8192				BRITT H, 1999, GEN PRACTICIE ACTIVI; LATNER A, 2000, PHARM TIMES; McManus P, 1998, BRIT J CLIN PHARMACO, V46, P409, DOI 10.1046/j.1365-2125.1998.00791.x; *NAT I CLIN EXC, 2000, GUID US PROT PUMP IN; Westbrook JI, 2000, ALIMENT PHARM THER, V14, P1581, DOI 10.1046/j.1365-2036.2000.00878.x	5	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1338	1339		10.1136/bmj.323.7325.1338	http://dx.doi.org/10.1136/bmj.323.7325.1338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739219	Bronze, Green Published			2022-12-24	WOS:000172716900016
J	Smith, DE; Zuber, MT; Neumann, GA				Smith, DE; Zuber, MT; Neumann, GA			Seasonal variations of snow depth on Mars	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; GLOBAL SURVEYOR; GRAVITY-FIELD; WATER-VAPOR; SUMMER TEMPERATURES; CARBON-DIOXIDE; POLAR; ICE; TOPOGRAPHY; EVOLUTION	Using topography collected over one martian year from the Mars Orbiter Laser Altimeter on the Mars Global Surveyor (MGS) spacecraft, we have measured temporal changes in the elevation of the martian surface that correlate with the seasonal cycle of carbon dioxide exchange between the surface and atmosphere. The greatest elevation change (1.5 to 2 meters) occurs at high latitudes ( above 80 degrees), whereas the bulk of the mass exchange occurs at tower latitudes (below 75 degrees N and below 73 degrees S). An unexpected period of sublimation was observed during northern hemisphere autumn, coincident with dust storms in the southern hemisphere. Analysis of MGS Doppler tracking residuals revealed temporal variations in the flattening of Mars that correlate with elevation changes. The combined changes in gravity and elevation constrain the average density of seasonally deposited carbon dioxide to be 910 +/- 230 kilograms per cubic meter, which is considerably denser than terrestrial snow.	NASA, Goddard Space Flight Ctr, Terr Phys Lab, Greenbelt, MD 20771 USA; MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT)	Smith, DE (corresponding author), NASA, Goddard Space Flight Ctr, Terr Phys Lab, Greenbelt, MD 20771 USA.	dsmith@tharsis.gsfc.nasa.gov	Neumann, Gregory A/I-5591-2013	Neumann, Gregory A/0000-0003-0644-9944				Albee AL, 2001, J GEOPHYS RES-PLANET, V106, P23291, DOI 10.1029/2000JE001306; BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; CHAO BF, 1990, J GEOPHYS RES-SOLID, V95, P14755, DOI 10.1029/JB095iB09p14755; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; Foster JL, 1998, J GEOPHYS RES-PLANET, V103, P25839, DOI 10.1029/98JE02493; HABERLE RM, 1993, J GEOPHYS RES-PLANET, V98, P3093, DOI 10.1029/92JE02946; HABERLE RM, UNPUB; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1984, ICARUS, V57, P322, DOI 10.1016/0019-1035(84)90121-0; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; KIEFFER HH, 1968, THESIS CATECH PASADE; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Lemoine FG, 2001, J GEOPHYS RES-PLANET, V106, P23359, DOI 10.1029/2000JE001426; Maass O, 1926, P R SOC LOND A-CONTA, V111, P224, DOI 10.1098/rspa.1926.0065; MCCARTHY JJ, 1994, GEODYN SYSTEMS DESCR; NAUMANN GA, UNPUB; PAIGE DA, 1992, ICARUS, V99, P15, DOI 10.1016/0019-1035(92)90167-6; PAVLIS DE, 2001, GEODYN OPERATIONS MA; Pettengill GH, 2000, GEOPHYS RES LETT, V27, P609, DOI 10.1029/1999GL010896; ROWLANDS DD, 1993, GEODYN 2 SYSTEM DESC; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SMITH DE, 1995, GEOPHYS RES LETT, V22, P2171, DOI 10.1029/95GL01801; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, J GEOPHYS RES-PLANET, V104, P1885, DOI 10.1029/1998JE900024; SMITH DE, 1993, J GEOPHYS RES-PLANET, V98, P20871, DOI 10.1029/93JE01839; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Smith MD, 2001, J GEOPHYS RES-PLANET, V106, P23929, DOI 10.1029/2000JE001321; SUN X, 2001, EOS, V82; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284; Tyler GL, 2001, J GEOPHYS RES-PLANET, V106, P23327, DOI 10.1029/2000JE001348; Wilson RJ, 1997, GEOPHYS RES LETT, V24, P123, DOI 10.1029/96GL03814; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053; Zurek R.W., 1992, MARS, P835	39	176	183	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2141	2146		10.1126/science.1066556	http://dx.doi.org/10.1126/science.1066556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739951				2022-12-24	WOS:000172647700044
J	Schwetz, BA				Schwetz, BA			Oral sodium phosphate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-24	WOS:000172488300005
J	Barker, DJP; Forsen, T; Uutela, A; Osmond, C; Eriksson, JG				Barker, DJP; Forsen, T; Uutela, A; Osmond, C; Eriksson, JG			Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-HEART-DISEASE; DEATH; GROWTH; FETAL; INEQUALITIES; CHILDHOOD; MORTALITY; WEIGHT	Objective To determine whether men who grew slowly in utero or during infancy are more vulnerable to the later effects of poor living conditions on coronary heart disease. Design Follow up study of men for whom there were data on body size at birth and growth and social class during childhood, educational level, and social class and income in adult life. Setting Helsinki, Finland. Participants 3676 men who were born during 1934-44, attended child welfare clinics in Helsinki, were still resident in Finland in 1971, and for whom data from the 1980 census were available. Main outcome measures Hospital admission for or death from coronary heart disease. Results Men who had low social class or low household income in adult life had increased rates of coronary heart disease. The hazard ratio among men with the lowest annual income (< <pound>8400) was 1.71 (95% confidence interval 1.18 to 2.48) compared with 1.00 in men with incomes above pound 15 700. These effects were stronger in men who were thin at birth (ponderal index < 26 kg/m(3)): hazard ratio 2.58 (1.45 to 4.60) for men with lowest annual income. Among the men who were thin at birth the effects of low social class were greater in those who had accelerated weight gain between ages 1 and 12 years. Low social class in childhood further increased risk of disease, partly because it was associated with poor growth during infancy. Low educational attainment was associated with increased risk, and low income had no effect once this was taken into account. Conclusion Men who grow slowly in utero remain biologically different to other men. They are more vulnerable to the effects of low socioeconomic status and low income on coronary heart disease.	Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland	University of Southampton; Finland National Institute for Health & Welfare	Barker, DJP (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	djpb@mrc.soton.ac.uk		Osmond, Clive/0000-0002-9054-4655				Acheson D., 1998, INDEPENDENT INQUIRY; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; Dickens P, 2001, SOCIOLOGY, V35, P93, DOI 10.1017/S0038038501000062; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; HAVEN H, 1998, ED FINLAND; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Macintyre K, 2001, BRIT MED J, V322, P1152, DOI 10.1136/bmj.322.7295.1152; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; MARMOT MG, 1984, LANCET, V1, P1003; MARMOT MG, 1986, LANCET, V2, P274; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; WAALER HT, 1984, ACTA MED SCAND, P1; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	18	175	184	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2001	323	7324					1273	1276		10.1136/bmj.323.7324.1273	http://dx.doi.org/10.1136/bmj.323.7324.1273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731388	Bronze, Green Published			2022-12-24	WOS:000172655800015
J	Fang, YM; Vilella-Bach, M; Bachmann, R; Flanigan, A; Chen, J				Fang, YM; Vilella-Bach, M; Bachmann, R; Flanigan, A; Chen, J			Phosphatidic acid-mediated mitogenic activation of mTOR signaling	SCIENCE			English	Article							PIK-RELATED KINASES; P70 S6 KINASE; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; MAMMALIAN PROTEIN; PHOSPHORYLATION; BINDING; DOMAIN; TARGET; STIMULATION; REGULATORS	The mammalian target of rapamycin (mTOR) governs cell growth and proliferation by mediating the mitogen- and nutrient-dependent signal transduction that regulates messenger RNA translation. We identified phosphatidic acid (PA) as a critical component of mTOR signaling. In our study, mitogenic stimulation of mammalian cells led to a phospholipase D-dependent accumulation of cellular PA, which was required for activation of mTOR downstream effectors. PA directly interacted with the domain in mTOR that is targeted by rapamycin, and this interaction was positively correlated with mTOR's ability to activate downstream effectors. The involvement of PA in mTOR signaling reveals an important function of this lipid in signal transduction and protein synthesis, as well as a direct link between mTOR and mitogens. Furthermore, these studies suggest a potential mechanism for the in vivo actions of the immunosuppressant rapamycin.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Struct Biol, 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@uiuc.edu		Chen, Jie/0000-0002-7887-3747	NIGMS NIH HHS [GM58064] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058064, R55GM058064] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Fang Y., UNPUB; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kuruvilla FG, 1999, CHEM BIOL, V6, pR129, DOI 10.1016/S1074-5521(99)80070-2; Reeves HL, 2000, HEPATOLOGY, V31, P95, DOI 10.1002/hep.510310116; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; SEGREST JP, 1992, J LIPID RES, V33, P141; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; WENG QP, 1995, MOL CELL BIOL, V15, P2333; YANG SF, 1967, J BIOL CHEM, V242, P477	28	822	849	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1942	1945		10.1126/science.1066015	http://dx.doi.org/10.1126/science.1066015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729323				2022-12-24	WOS:000172465000064
J	Lanza, RP; Cibelli, JB; Faber, D; Sweeney, RW; Henderson, B; Nevala, W; West, MD; Wettstein, PJ				Lanza, RP; Cibelli, JB; Faber, D; Sweeney, RW; Henderson, B; Nevala, W; West, MD; Wettstein, PJ			Cloned cattle can be healthy and normal	SCIENCE			English	Article							TRANSGENIC CALVES; CELLS		Adv Cell Technol, Worcester, MA 01605 USA; Trans Ova Genet, Genet Advancement Ctr, Sioux Ctr, IA 51250 USA; Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; Mayo Clin, Dept Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; Em Tran, Elizabethtown, PA 17022 USA	University of Pennsylvania; Mayo Clinic; Mayo Clinic	Lanza, RP (corresponding author), Adv Cell Technol, Worcester, MA 01605 USA.			Cibelli, Jose/0000-0002-2176-3854; West, Michael/0000-0002-4842-5468				BOYCE N, 2001, US NEWS WORLD R 0319; Campbell JDM, 1998, J LEUKOCYTE BIOL, V63, P567, DOI 10.1002/jlb.63.5.567; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; KOLATA G, 2001, NY TIMES        0325; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; *SUBC BEEF CATTL N, 2000, NUTR REQ BEEF CATTL, P40; *USDA NAT AN HLTH, 1996, PART 1 REF 1996 DAIR; VANHORN HH, 1992, LARGE DAIRY HARD MAN, P434; WEISS R, 2001, WASHINGTON POST 0329	13	110	121	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1893	1894		10.1126/science.1063440	http://dx.doi.org/10.1126/science.1063440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729307				2022-12-24	WOS:000172465000048
J	Zeng, HK; Chattarji, S; Barbarosie, M; Rondi-Reig, L; Philpot, BD; Miyakawa, T; Bear, MF; Tonegawa, S				Zeng, HK; Chattarji, S; Barbarosie, M; Rondi-Reig, L; Philpot, BD; Miyakawa, T; Bear, MF; Tonegawa, S			Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory	CELL			English	Article							LONG-TERM DEPRESSION; GLUTAMATE RECEPTORS; PROTEIN PHOSPHATASE; GENE-EXPRESSION; SPATIAL MEMORY; RAT-BRAIN; CALMODULIN; SUBUNIT; PHOSPHORYLATION; POTENTIATION	Calcineurin is a calcium-dependent protein phosphatase that has been implicated in various aspects of synaptic plasticity. By using conditional gene-targeting techniques, we created mice in which calcineurin activity is disrupted specifically in the adult forebrain. At hippocampal Schaffer collateral-CA1 synapses, LTD was significantly diminished, and there was a significant shift in the LTD/LTP modification threshold in mutant mice. Strikingly, although performance was normal in hippocampus-dependent reference memory tasks, including contextual fear conditioning and the Morris water maze, the mutant mice were impaired in hippocampus-dependent working and episodic-like memory tasks, including the delayed matching-to-place task and the radial maze, task. Our results define a critical role for calcineurin in bidirectional synaptic plasticity and suggest a novel mechanistic distinction between working/episodic-like memory and reference memory.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Brown University; Howard Hughes Medical Institute	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Biol, Cambridge, MA 02139 USA.		Rondi-Reig, Laure/M-6141-2016; Rondi-Reig, Laure/G-2816-2011; Miyakawa, Tsuyoshi/A-7741-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Bear, Mark/0000-0002-9903-2541; Rondi-Reig, Laure/0000-0003-1006-0501	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58880-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1983, CANADIAN PSYCHOL; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BECKER JT, 1980, BRAIN RES, V200, P307, DOI 10.1016/0006-8993(80)90922-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Halpain S, 1998, J NEUROSCI, V18, P9835; Jones MV, 1997, J NEUROSCI, V17, P7626; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MERAT DL, 1985, J BIOL CHEM, V260, P1053; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Squire Larry R., 1994, P203; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; TAKAISHI T, 1991, BIOCHEM BIOPH RES CO, V174, P393, DOI 10.1016/0006-291X(91)90533-D; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; ZHANG W, 1995, GENERATION ANAL CALC	57	382	397	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					617	629		10.1016/S0092-8674(01)00585-2	http://dx.doi.org/10.1016/S0092-8674(01)00585-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733061	Bronze			2022-12-24	WOS:000172575300009
J	Krinos, CM; Coyne, MJ; Weinacht, KG; Tzianabos, AO; Kasper, DL; Comstock, LE				Krinos, CM; Coyne, MJ; Weinacht, KG; Tzianabos, AO; Kasper, DL; Comstock, LE			Extensive surface diversity of a commensal microorganism by multiple DNA inversions	NATURE			English	Article							BACTEROIDES-FRAGILIS; REVEALS; GENE	The dynamic interactions between a host and its intestinal microflora that lead to commensalism are unclear. Bacteria that colonize the intestinal tract do so despite the development of a specific immune response by the host(1). The mechanisms used by commensal organisms to circumvent this immune response have yet to be established. Here we demonstrate that the human colonic microorganism, Bacteroides fragilis, is able to modulate its surface antigenicity by producing at least eight distinct capsular polysaccharides-a number greater than any previously reported for a bacterium-and is able to regulate their expression in an on-off manner by the reversible inversion of DNA segments containing the promoters for their expression. This means of generating surface diversity allows the organism to exhibit a wide array of distinct surface polysaccharide combinations, and may have broad implications for how the predominant human colonic microorganisms, the Bacteroides species, maintain an ecological niche in the intestinal tract.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044193] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044193-04, R01 AI044193] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Comstock LE, 1999, INFECT IMMUN, V67, P3525, DOI 10.1128/IAI.67.7.3525-3532.1999; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; KIM J, 1998, INFECT IMMUN, V66, P3303; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; OLSEN PB, 1994, FEMS MICROBIOL LETT, V116, P95; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990	9	219	231	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					555	558		10.1038/35107092	http://dx.doi.org/10.1038/35107092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734857				2022-12-24	WOS:000172405900050
J	Chabas, D; Baranzini, SE; Mitchell, D; Bernard, CCA; Rittling, SR; Denhardt, DT; Sobel, RA; Lock, C; Karpuj, M; Pedotti, R; Heller, R; Oksenberg, JR; Steinman, L				Chabas, D; Baranzini, SE; Mitchell, D; Bernard, CCA; Rittling, SR; Denhardt, DT; Sobel, RA; Lock, C; Karpuj, M; Pedotti, R; Heller, R; Oksenberg, JR; Steinman, L			The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; CELL-MEDIATED-IMMUNITY; GENE-EXPRESSION; MESSENGER-RNA; MICE; ENCEPHALOMYELITIS; INDUCTION; PROTEIN; REVEALS	Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries, derived from plaques dissected from brains of patients with multiple sclerosis (MS), indicated an abundance of transcripts for osteopontin (OPN). Microarray analysis of spinal cords from rats paralyzed by experimental autoimmune encephalomyelitis (EAE), a model of MS, also revealed increased OPN transcripts. Osteopontin-deficient mice were resistant to progressive EAE and had frequent remissions, and myelin-reactive T cells in OPN-/- mice produced more interleukin 10 and less interferon-gamma than in OPN+/+ mice. Osteopontin thus appears to regulate T helper cell-1 (T(H)1)-mediated demyelinating disease, and it may offer a potential target in blocking development of progressive MS.	Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; La Trobe Univ, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3083, Australia; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Stanford Univ, Dept Pathol Neuropathol, Sch Med, Stanford, CA 94305 USA; Roche Biosci, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; La Trobe University; Rutgers State University New Brunswick; Stanford University; Roche Holding	Steinman, L (corresponding author), Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, B002, Stanford, CA 94305 USA.		Baranzini, Sergio/A-9422-2013; Messier, Claude/A-2322-2008	Baranzini, Sergio/0000-0003-0067-194X; Messier, Claude/0000-0002-4791-1763; Sobel, Raymond/0000-0002-0477-9002; Steinman, Lawrence/0000-0002-2437-2250; Lock, Christopher/0000-0002-4087-5894				Aquino DA, 1998, NEUROCHEM RES, V23, P413, DOI 10.1023/A:1022473904335; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Becker KG, 1997, J NEUROIMMUNOL, V77, P27, DOI 10.1016/S0165-5728(97)00045-3; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; CHOI SS, 1995, MAMM GENOME, V6, P653, DOI 10.1007/BF00352374; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DORHEIM MA, 1993, J CELL PHYSIOL, V154, P317, DOI 10.1002/jcp.1041540215; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; GRAINGER C, 1995, NAT MED, V1, P1063; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HWANG S, 1994, J BIOL CHEM, V269, P711; Karin N, 1998, J IMMUNOL, V160, P5188; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; Sasaki N, 1998, GENOMICS, V49, P167, DOI 10.1006/geno.1998.5209; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Shin SL, 1999, NEUROSCI LETT, V273, P73, DOI 10.1016/S0304-3940(99)00516-9; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; SOBEL RA, 1995, J NEUROPATH EXP NEUR, V54, P202, DOI 10.1097/00005072-199503000-00007; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Villarroya H, 1997, J NEUROSCI RES, V49, P592, DOI 10.1002/(SICI)1097-4547(19970901)49:5<592::AID-JNR9>3.0.CO;2-6	33	721	770	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1731	1735		10.1126/science.1062960	http://dx.doi.org/10.1126/science.1062960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721059				2022-12-24	WOS:000172307400049
J	Becher, MW; Morrison, L; Davis, LE; Maki, WC; King, MK; Bicknell, JM; Reinert, BL; Bartolo, C; Bear, DG				Becher, MW; Morrison, L; Davis, LE; Maki, WC; King, MK; Bicknell, JM; Reinert, BL; Bartolo, C; Bear, DG			Oculopharyngeal muscular dystrophy in Hispanic new Mexicans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; NUCLEAR INCLUSIONS; POLY(A) BINDING-PROTEIN-2; REPEAT DISORDERS; PABP2; EXPANSIONS; DISEASE; FAMILIES; PROTEIN; LENGTH	Context Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathy caused by polyalanine triplet repeat expansion in the gene for poly(A) binding protein 2 (PABP2) and is found in isolated cohorts throughout the world. We have observed numerous cases of OPMD in New Mexico. Objective To characterize the clinical, genetic, and demographic features of the OPMD population in New Mexico. Design, Setting, and Participants Cohort study with analysis of outpatient clinic medical records from 1965 to 2001 at the University of New Mexico Hospital and the New Mexico VA Health Care System in Albuquerque, which serve the entire state. Main Outcome Measures Clinical phenotype, supplemented with genetic confirmation (n=10 patients) and in-depth clinical evaluations (n=49 patients). Results We identified 216 cases of OPMD (99 women and 117 men) from 39 kindreds of New Mexicans spanning up to 4 generations. All patients were Hispanic, and the majority of probands came from northern New Mexico. In patients who had both ocular and pharyngeal muscle weakness, ptosis was just as likely to occur before or concurrent with dysphagia. Proximal limb muscle weakness and gait abnormalities were common and occurred later than ocular or pharyngeal weakness. The clinical expression of OPMD caused marked debility, although life-table analysis showed no decrease in life expectancy compared with unaffected family members (P=.81). Ten individuals from different kindreds were found to have an identical polyalanine triplet repeat expansion ([GCG](9)) in the PABP2 gene. Conclusions Individuals in this cohort had clinical and genetic characteristics of classic OPMD. Longevity was not affected, but patients experienced considerable morbidity. The origin of the PABP2 mutation in New Mexican OPMD patients is unclear, although the geographic and genetic isolation of northern New Mexicans with a long ancestry in this region may have contributed to the development of this cohort. This disease cohort represents a large and previously unrecognized health care issue in the state of New Mexico and should serve to raise the awareness of this disorder among clinicians who treat Hispanics in the Southwest and throughout the United States.	Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA; New Mexico VA Hlth Care Syst, Albuquerque, NM USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Bear, DG (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, BMSB 149,915 Camino de Salud NE, Albuquerque, NM 87131 USA.			Morrison, Leslie/0000-0002-0092-193X				Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005; BARBEAU A, 1968, PROGR NEUROOPHTHALMO, V2, P3; BARBEAU A, 1966, S PROGR MUSKELDYSTRO, P102; Becher MW, 2000, ANN NEUROL, V48, P812, DOI 10.1002/1531-8249(200011)48:5<812::AID-ANA20>3.3.CO;2-U; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Blumen SC, 1996, NEUROLOGY, V46, P1324, DOI 10.1212/WNL.46.5.1324; Blumen SC, 1999, ANN NEUROL, V46, P115, DOI 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.3.CO;2-F; Bouchard J-P., 1997, NEUROMUSCULAR DISORD, V7, pS1; BOUCHARD JP, 1989, CAN J NEUROL SCI, V16, P446, DOI 10.1017/S0317167100029565; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BROOK EMH, 1986, CLIN VIEW NEUROMUSCU, P185; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUBOWITZ V, 1973, MUSCLE BIOPSY MODERN, P231; Fardeau M, 1997, NEUROMUSCULAR DISORD, V7, pS30, DOI 10.1016/S0960-8966(97)00078-3; Grewal RP, 1998, NEUROREPORT, V9, P961, DOI 10.1097/00001756-199804200-00002; Grewal RP, 1999, ARCH NEUROL-CHICAGO, V56, P1378, DOI 10.1001/archneur.56.11.1378; Hill ME, 2001, BRAIN, V124, P522, DOI 10.1093/brain/124.3.522; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mirabella M, 2000, NEUROLOGY, V54, P608, DOI 10.1212/WNL.54.3.608; Perie S, 1997, NEUROMUSCULAR DISORD, V7, pS96, DOI 10.1016/S0960-8966(97)00091-6; Porschke H, 1997, NEUROMUSCULAR DISORD, V7, pS57, DOI 10.1016/S0960-8966(97)00084-9; Scacheri PC, 1999, AM J MED GENET, V86, P477, DOI 10.1002/(SICI)1096-8628(19991029)86:5<477::AID-AJMG14>3.3.CO;2-1; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Stajich JM, 1996, ANN NEUROL, V40, P801, DOI 10.1002/ana.410400519; Stajich JM, 1997, NEUROMUSCULAR DISORD, V7, pS75, DOI 10.1016/S0960-8966(97)00087-4; Tome F, 1994, MYOLOGY, P1233; TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226; Uyama E, 2000, MUSCLE NERVE, V23, P1549, DOI 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0; Uyama E, 1996, NEUROLOGY, V46, P773, DOI 10.1212/WNL.46.3.773; VICTOR M, 1962, NEW ENGL J MED, V267, P1267, DOI 10.1056/NEJM196212202672501; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WEBER DJ, 1982, TAOS TRAPPERS FUR TR; WEITZNER S, 1969, ORAL SURG ORAL MED O, V28, P613, DOI 10.1016/0030-4220(69)90272-2; WEITZNER S, 1971, AM J GASTROENTEROL, V56, P378; WEITZNER S, 1969, AM J DIG DIS, V14, P805, DOI 10.1007/BF02235971	40	59	65	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2437	2440		10.1001/jama.286.19.2437	http://dx.doi.org/10.1001/jama.286.19.2437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712939	Bronze			2022-12-24	WOS:000172266100023
J	Mehr, DR; Binder, EF; Kruse, RL; Zweig, SC; Madsen, R; Popejoy, L; D'Agostino, RB				Mehr, DR; Binder, EF; Kruse, RL; Zweig, SC; Madsen, R; Popejoy, L; D'Agostino, RB			Predicting mortality in nursing home residents with lower respiratory tract infection - The Missouri LRI study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM CARE FACILITIES; ACQUIRED PNEUMONIA; RISK-FACTORS; HOSPITALIZATION; DEPRESSION; MDS; SURVEILLANCE; DECISION; 3-YEAR; ISSUES	Context Lower respiratory tract infection (LRI) is a leading cause of mortality and hospitalization in nursing home residents. Treatment decisions may be aided by a clinical prediction rule that identifies residents at low and high risk of mortality. Objective To identify patient characteristics predictive of 30-day mortality in nursing home residents with an LRI. Design, Setting, and Patients Prospective cohort study of 1406 episodes of LRI in 1044 residents of 36 nursing homes in central Missouri and the St Louis, Mo, area between August 15, 1995, and September 30, 1998. Main Outcome Measure Thirty-day all-cause mortality. Results Thirty-day mortality was 14.7% (n=207). In a logistic analysis, using generalized estimating equations to adjust for clustering, we developed an 8-variable model to predict 30-day mortality, including serum urea nitrogen, white blood cell count, body mass index, pulse rate, activities of daily living status, absolute lymphocyte count of less than 800/muL (0.8 x 10(9)/L), male sex, and deterioration in mood over 90 days. In validation testing, the model exhibited reasonable discrimination (c=.76) and calibration (nonsignificant Hosmer-Lemeshow goodness-of-fit statistic, P=.54). A point score based on this model's variables fit to the entire data set closely matched observed mortality. Fifty-two percent of residents had low (score of 0-4) or relatively low (score of 5-6) predicted 30-day mortality, with 2.2% and 6.2% actual mortality, respectively. Conclusions Our model distinguishes nursing home residents at relatively low risk for mortality due to LRI. If independently validated, our findings could help physicians identify nursing home residents in need of different therapeutic approaches for LRI.	Univ Missouri, Dept Family & Community Med, Ctr Family Med Sci, Sch Med, Columbia, MO 65212 USA; Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65212 USA; Washington Univ, Sch Med, Dept Internal Med, Div Geriatr & Gerontol, St Louis, MO 63110 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); Boston University	Mehr, DR (corresponding author), Univ Missouri, Dept Family & Community Med, Ctr Family Med Sci, Sch Med, MA306 Med Sci Bldg, Columbia, MO 65212 USA.			Kruse, Robin/0000-0001-9759-7218; Mehr, David/0000-0002-5194-1383	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008551] Funding Source: NIH RePORTER; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [D15PE010038] Funding Source: NIH RePORTER; AHRQ HHS [HS08551] Funding Source: Medline; BHP HRSA HHS [PE10038] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); BHP HRSA HHS		ANDREWS BE, 1987, Q J MED, V62, P195; Arfken CL, 1999, J GERONTOL A-BIOL, V54, pM152, DOI 10.1093/gerona/54.3.M152; BROOKS S, 1994, ARCH INTERN MED, V154, P902, DOI 10.1001/archinte.154.8.902; Cole MG, 1997, CAN MED ASSOC J, V157, P1055; Covinsky KE, 1999, ANN INTERN MED, V130, P563, DOI 10.7326/0003-4819-130-7-199904060-00004; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; D'Agostino RB, 1997, P BIOM, P253; DAGOSTINO RB, 1995, STAT MED, V14, P1757, DOI 10.1002/sim.4780141605; DEGELAU J, 1995, J AM GERIATR SOC, V43, P245, DOI 10.1111/j.1532-5415.1995.tb07330.x; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FRIED TR, 1995, J GEN INTERN MED, V10, P246, DOI 10.1007/BF02599879; Gabrel C, 2000, Vital Health Stat 13, P1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; *HLTH CAR FIN ADM, 1995, LONG TERM CAR FAC RE; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Houston MS, 1997, ARCH INTERN MED, V157, P2190, DOI 10.1001/archinte.157.19.2190; IRVINE PW, 1984, J AM GERIATR SOC, V32, P103, DOI 10.1111/j.1532-5415.1984.tb05848.x; JACKSON MM, 1992, AM J EPIDEMIOL, V135, P685, DOI 10.1093/oxfordjournals.aje.a116348; KAYSERJONES JS, 1989, GERONTOLOGIST, V29, P502, DOI 10.1093/geront/29.4.502; *MATHS INC DAT AN, 1999, S PLUS 2000; MCGEER A, 1991, AM J INFECT CONTROL, V19, P1, DOI 10.1016/0196-6553(91)90154-5; Medina-Walpole AM, 1998, J AM GERIATR SOC, V46, P187, DOI 10.1111/j.1532-5415.1998.tb02537.x; Mehr DR, 1998, J FAM PRACTICE, V47, P298; MEHR DR, 1992, J FAM PRACTICE, V34, P585; Mehr DR, 2001, J FAM PRACTICE, V50, P931; MORLEY JE, 1995, ANN INTERN MED, V123, P850, DOI 10.7326/0003-4819-123-11-199512010-00008; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; MURTAUGH CM, 1995, GERONTOLOGIST, V35, P35, DOI 10.1093/geront/35.1.35; Mylotte JM, 1998, J AM GERIATR SOC, V46, P1538, DOI 10.1111/j.1532-5415.1998.tb01539.x; Preisser JS, 1997, ANNU REV PUBL HEALTH, V18, P51, DOI 10.1146/annurev.publhealth.18.1.51; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Rubenstein L Z, 1988, Clin Geriatr Med, V4, P471; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; *SAS I INC, 1996, SAS SYST WIND VERS 6; Scott H D, 1988, R I Med J, V71, P69; SINGH MF, 1999, PRINCIPLES GERIATRIC, P81; SMITH WR, 1995, J AM GERIATR SOC, V43, P1052, DOI 10.1111/j.1532-5415.1995.tb05573.x; TERESI JA, 1991, GERONTOLOGIST, V31, P795, DOI 10.1093/geront/31.6.795; ZWEIG S, 1990, J FAM PRACTICE, V30, P153	43	87	87	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2427	2436		10.1001/jama.286.19.2427	http://dx.doi.org/10.1001/jama.286.19.2427			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712938	Bronze			2022-12-24	WOS:000172266100022
J	Martin, DK; Pater, JL; Singer, PA				Martin, DK; Pater, JL; Singer, PA			Priority-setting decisions for new cancer drugs: a qualitative case study	LANCET			English	Article							COST-EFFECTIVENESS; MANAGED CARE; HEALTH; ACCOUNTABILITY; TECHNOLOGIES; OREGON	Background Frameworks for legitimate and fair priority setting emphasise the importance of the rationales for priority setting decisions. However, priority setting rationales, in particular for new cancer drugs, are not well described. We describe the rationales used by a committee making funding decisions for new cancer drugs. Methods We did a qualitative case study of a priority setting committee (Cancer Care Ontario Policy Advisory Committee for the New Drug Funding Program) by analysing documents, interviewing committee members, and observing committee meetings. Findings We identified and described decisions and rationales related to 14 drugs in eight disease conditions over 3 years. Our main findings were that: priority setting existed in relation to resource mobilisation; clinical benefit was the primary factor in decisions; in the context of an expanding budget, rationales changed; rationales could change as costs for individual treatments increased; when all options were reasonable, groups funded a range of options and let patients decide; and priority setting rationales involve clusters of factors, not simple trade-offs. Interpretation Observing priority-setting decisions and their rationales in actual practice reveals lessons not contained in theoretical accounts.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5G 1L4, Canada; Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Queens University - Canada	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada.	peter.singer@utoronto.ca	Embrett, Mark G./H-4466-2014	Embrett, Mark G./0000-0002-3969-0219				AARON HJ, 1984, PAINFUL PRESCRIPTION; BARON J, 1995, J BEHAV DECIS MAKING, V8, P71, DOI 10.1002/bdm.3960080202; BOWLING A, 1993, SOC SCI MED, V37, P851, DOI 10.1016/0277-9536(93)90138-T; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 1998, HASTINGS CENT REP, V28, P27, DOI 10.2307/3527569; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Daniels N, 2000, STATE HLTH SER, P89; EDDY DM, 1994, JAMA-J AM MED ASSOC, V271, P792; ELSTER J, 1992, LOCAL JUSTICE I ALLO, P4; EVANS WK, 1997, ANN CANC CONTROL RES, V7, P481; Foy R, 1999, BRIT MED J, V318, P456, DOI 10.1136/bmj.318.7181.456; GARLAND A, 1997, COMMUNICATION   0730; Giacomini MK, 1999, J HEALTH POLIT POLIC, V24, P715; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; HAM C, 1993, BMJ-BRIT MED J, V307, P435, DOI 10.1136/bmj.307.6901.435; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hope T, 1998, BRIT MED J, V317, P1067; Horton R, 1999, LANCET, V353, P1028, DOI 10.1016/S0140-6736(99)00098-7; Jonsen A. R., 1988, ABUSE CASUISTRY HIST; NAYLOR CD, 1996, ACP J CLUB, V124, pA12; NORD E, 1995, SOC SCI MED, V41, P1429, DOI 10.1016/0277-9536(95)00121-M; Singer PA, 2000, BMJ-BRIT MED J, V321, P1316, DOI 10.1136/bmj.321.7272.1316; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; Ubel PA, 1996, MED DECIS MAKING, V16, P108, DOI 10.1177/0272989X9601600202; Ubel PA, 1996, NEW ENGL J MED, V334, P1174, DOI 10.1056/NEJM199605023341807; Zussman Robert, 1992, INTENSIVE CARE MED E; ZWEIBEL NR, 1993, GERONTOLOGIST, V33, P74, DOI 10.1093/geront/33.1.74; 2001, CANC CARE ONTARIO NE	28	83	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2001	358	9294					1676	1681		10.1016/S0140-6736(01)06714-9	http://dx.doi.org/10.1016/S0140-6736(01)06714-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	495MC	11728542				2022-12-24	WOS:000172344100010
J	Kovacs, A; Wasserman, SS; Burns, D; Wright, DJ; Cohn, J; Landay, A; Weber, K; Cohen, M; Levine, A; Minkoff, H; Miotti, P; Palefsky, J; Young, M; Reichelderfer, P				Kovacs, A; Wasserman, SS; Burns, D; Wright, DJ; Cohn, J; Landay, A; Weber, K; Cohen, M; Levine, A; Minkoff, H; Miotti, P; Palefsky, J; Young, M; Reichelderfer, P		DATRI; WIHS Study Grp	Determinants of HIV-1 shedding in the genital tract of women	LANCET			English	Article; Proceedings Paper	6th Conference on Retroviruses and Opportunistic Infections	JAN 31-FEB 04, 1999	CHICAGO, IL				HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 RNA LEVELS; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; CERVICOVAGINAL SECRETIONS; PERINATAL TRANSMISSION; RISK-FACTORS; BLOOD; ZIDOVUDINE; PLASMA	Background Plasma HIV-1 RNA concentration has been the best predictor for risk of heterosexual and perinatal transmission. However, direct contact with HIV-1 present locally in the genital tract might be necessary for transmission. We aimed to assess the relation between HIV-1 shedding (RNA or culturable virus) in female genital secretions and other factors that might affect HIV-1 shedding. Methods This was a cross-sectional study within the Women's Interagency HIV Study (WIHS), a prospective longitudinal cohort study of HIV-Infected women. We enrolled 311 HIV positive women from Jan 30, 1997 to July 1, 1998. We did clinical assessments, cultured HIV-1, and measured RNA in peripheral blood mononuclear cells (PBMC) and genital secretions. We compared the results with univariate and multivariate analyses. Presence of HIV-1 RNA or culturable virus in genital secretions was defined as HIV-1 shedding. Findings HIV-1 RNA was present in genital secretions of 57% (152/268) of women whereas infectious virus was detected only in 6% (17/271). Genital tract HIV-1 shedding was found in 80% (130/163) of women with detectable plasma RNA and 78% (116/148) of women with positive PBMC cultures. 33% (27/83) of women with less than 500 copies/mL plasma RNA and 39% (35/90) of those with negative PBMC cultures also had genital tract shedding. Interpretation Plasma RNA concentration, both qualitatively and quantitatively, was the most important factor in predicting genital HIV-1 shedding, even among women receiving potent antiretroviral therapy. However, HIV-1 shedding did occur in women with less than 500 copies/mL plasma HIV-1 RNA. This finding suggests that a separate reservoir of HIV-1 replication may exist in some women.	Univ So Calif, Sch Med, Comprehens Maternal Child & Adolescent HIV Manage, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Norris Canc Hosp, Los Angeles, CA 90033 USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA; NICHHD, Bethesda, MD 20892 USA; Westat Corp, Rockville, MD USA; Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA; Cook Cty Hosp, Chicago, IL 60612 USA; Maimonides Hosp, Brooklyn, NY 11219 USA; NIAID, Bethesda, MD 20892 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA	University of Southern California; University of Southern California; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Westat; Wayne State University; Rush University; John H Stroger Junior Hospital Cook County; Maimonides Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; Georgetown University	Kovacs, A (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles Cty Med Ctr, Comprehens Maternal Child & Adolescent HIV Manage, 1640 Marengo St,HRA Bldg, Los Angeles, CA 90033 USA.	akovacs@hsc.usc.edu			NIAID NIH HHS [U01-AI-31834, U01-AI-34994, AI-34989, U01-AI-34993, U01-AI-42590, N01-AI-15123, U01-AI-35004] Funding Source: Medline; NICHD NIH HHS [U01-HD-32632] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015123, U01AI034989, U01AI042590, U01AI034993, U01AI034994, U01AI035004, U01AI031834] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bremer J, 2000, J CLIN MICROBIOL, V38, P2665, DOI 10.1128/JCM.38.7.2665-2669.2000; Chuachoowong R, 2000, J INFECT DIS, V181, P99, DOI 10.1086/315179; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; *DIV AIDS, 1997, VIR MAN HIV LAB; Fiore JR, 1997, AIDS, V11, P1089, DOI 10.1097/00002030-199709000-00002; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Goulston C, 1998, J INFECT DIS, V177, P1100, DOI 10.1086/517404; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; HENIN Y, 1993, J ACQ IMMUN DEF SYND, V6, P72; HILL JA, 1992, AM J OBSTET GYNECOL, V166, P720, DOI 10.1016/0002-9378(92)91703-D; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Kovacs A, 1999, J ACQ IMMUN DEF SYND, V22, P124; KREISS JK, 1989, J INFECT DIS, V160, P380, DOI 10.1093/infdis/160.3.380; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Long EM, 2000, NAT MED, V6, P71; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mostad SB, 1998, AIDS RES HUM RETROV, V14, pS11; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; Nicholson J, 1996, CYTOMETRY, V26, P227, DOI 10.1002/(SICI)1097-0320(19960915)26:3<227::AID-CYTO8>3.0.CO;2-B; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rasheed S, 1996, AM J OBSTET GYNECOL, V175, P122, DOI 10.1016/S0002-9378(96)70261-2; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Uvin SC, 1997, OBSTET GYNECOL, V90, P739, DOI 10.1016/S0029-7844(97)00411-0; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	40	195	201	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2001	358	9293					1593	1601		10.1016/S0140-6736(01)06653-3	http://dx.doi.org/10.1016/S0140-6736(01)06653-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	492VM	11716886				2022-12-24	WOS:000172188300013
J	Hummer, G; Rasaiah, JC; Noworyta, JP				Hummer, G; Rasaiah, JC; Noworyta, JP			Water conduction through the hydrophobic channel of a carbon nanotube	NATURE			English	Article							MOLECULAR-DYNAMICS; SIMULATION; TRANSITION; KINETICS; IONS	Confinement of matter on the nanometre scale can induce phase transitions not seen in bulk systems(1). In the case of water, so-called drying transitions occur on this scale(2-5) as a result of strong hydrogen-bonding between water molecules, which can cause the liquid to recede from nonpolar surfaces to form a vapour layer separating the bulk phase from the surface(6). Here we report molecular dynamics simulations showing spontaneous and continuous filling of a nonpolar carbon nanotube with a one-dimensionally ordered chain of water molecules. Although the molecules forming the chain are in chemical and thermal equilibrium with the surrounding bath, we observe pulse-like transmission of water through the nanotube. These transmission bursts result from the tight hydrogen-bonding network inside the tube, which ensures that density fluctuations in the surrounding bath lead to concerted and rapid motion along the tube axis(7-9). We also rnd that a minute reduction in the attraction between the tube wall and water dramatically affects pore hydration, leading to sharp, two-state transitions between empty and filled states on a nanosecond timescale. These observations suggest that carbon nanotubes, with their rigid nonpolar structures(10,11), might be exploited as unique molecular channels for water and protons, with the channel occupancy and conductivity tunable by changes in the local channel polarity and solvent conditions.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; Univ Maine, Dept Chem, Orono, ME 04469 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Maine System; University of Maine Orono	Hummer, G (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	hummer@helix.nih.gov	Hummer, Gerhard/A-2546-2013; Rasaiah, Jayendran C./AAD-3900-2021	Hummer, Gerhard/0000-0001-7768-746X; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029033, Z01DK029034, Z01DK029033] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AJAYAN PM, 1992, NATURE, V358, P23, DOI 10.1038/358023a0; BECKSTEIN O, IN PRESS J PHYS CH B; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolhuis PG, 2000, J CHEM PHYS, V113, P8154, DOI 10.1063/1.1315997; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gelb LD, 1999, REP PROG PHYS, V62, P1573, DOI 10.1088/0034-4885/62/12/201; Hummer G, 1996, P NATL ACAD SCI USA, V93, P8951, DOI 10.1073/pnas.93.17.8951; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Lum K, 1997, PHYS REV E, V56, pR6283, DOI 10.1103/PhysRevE.56.R6283; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; LyndenBell RM, 1996, J CHEM PHYS, V105, P9266, DOI 10.1063/1.472757; MACKAY DHJ, 1986, J BIOMOL STRUCT DYN, V4, P491, DOI 10.1080/07391102.1986.10506364; Pomes R, 1998, BIOPHYS J, V75, P33, DOI 10.1016/S0006-3495(98)77492-2; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sansom MSP, 2000, TRENDS BIOCHEM SCI, V25, P368, DOI 10.1016/S0968-0004(00)01613-3; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; Wallqvist A, 2001, J PHYS CHEM B, V105, P6745, DOI 10.1021/jp010945i; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; Wilson M, 2001, J AM CHEM SOC, V123, P2101, DOI 10.1021/ja003737x; Zahab A, 2000, PHYS REV B, V62, P10000, DOI 10.1103/PhysRevB.62.10000; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhong QF, 1998, BIOPHYS J, V74, P3, DOI 10.1016/S0006-3495(98)77761-6	28	2835	2910	56	1314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2001	414	6860					188	190		10.1038/35102535	http://dx.doi.org/10.1038/35102535			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700553				2022-12-24	WOS:000172029100042
J	Zhong, TP; Childs, S; Leu, JP; Fishman, MC				Zhong, TP; Childs, S; Leu, JP; Fishman, MC			Gridlock signalling pathway fashions the first embryonic artery	NATURE			English	Article							EARLY EMBRYOGENESIS; REPRESSOR PROTEINS; NOTCH; ZEBRAFISH; TRANSCRIPTION; HAIRY; ENHANCER; HOMOLOG; SPLIT; GENES	Arteries and veins are morphologically, functionally and molecularly very different, but how this distinction is established during vasculogenesis is unknown(1,2). Here we show, by lineage tracking in zebrafish embryos, that angioblast precursors for the trunk artery and vein are spatially mixed in the lateral posterior mesoderm. Progeny of each angioblast, however, are restricted to one of the vessels. This arterial-venous decision is guided by gridlock (grl), an artery-restricted gene that is expressed in the lateral posterior mesoderm(3). Graded reduction of grl expression, by mutation or morpholino antisense, progressively ablates regions of the artery, and expands contiguous regions of the vein, preceded by an increase in expression of the venous marker EphB4 receptor (ephb4)(2) and diminution of expression of the arterial marker ephrin-B2 (efnb2)(2). grl is downstream of notch(4), and interference with notch signalling, by blocking Su(H)(4), similarly reduces the artery and increases the vein. Thus, a notch-grl pathway controls assembly of the first embryonic artery, apparently by adjudicating an arterial versus venous cell fate decision.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Fishman, MC (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.		Childs, Sarah/AAG-5111-2021	Childs, Sarah/0000-0003-2261-580X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Holder N, 1999, DEVELOPMENT, V126, P2033; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2000, GENE DEV, V14, P1343; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	30	404	423	1	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					216	220		10.1038/35102599	http://dx.doi.org/10.1038/35102599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700560				2022-12-24	WOS:000172029100050
J	Ford, N; Davis, A				Ford, N; Davis, A			Chaos in Afghanistan: famine, aide and bombs	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, 124-32 Clerkenwell Rd, London EC1R 5DJ, England.							AHMAD K, 2001, LANCET, V358, P1248; *MSF, 2001, MSF REP NEW AFGH REF; Terry F, 2001, LANCET, V357, P1431, DOI 10.1016/S0140-6736(00)04571-2; 2001, NUTR SURVEILLANCE AF	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2001	358	9292					1543	1544		10.1016/S0140-6736(01)06588-6	http://dx.doi.org/10.1016/S0140-6736(01)06588-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705586				2022-12-24	WOS:000172055800036
J	Nykanen, A; Haley, B; Zamore, PD				Nykanen, A; Haley, B; Zamore, PD			ATP requirements and small interfering RNA structure in the RNA interference pathway	CELL			English	Article							DOUBLE-STRANDED-RNA; GERM-LINE DEVELOPMENT; MESSENGER-RNA; C-ELEGANS; GENETIC INTERFERENCE; DROSOPHILA; TRANSGENE; ARABIDOPSIS; NEUROSPORA; EXPRESSION	We examined the role of ATP in the RNA interference (RNAi) pathway. Our data reveal two ATP-dependent steps and suggest that the RNAi reaction comprises at least four sequential steps: ATP-dependent processing of double-stranded RNA into small interfering RNAs (siRNAs), incorporation of siRNAs into an inactive similar to 360 kDa protein/RNA complex, ATP-dependent unwinding of the siRNA duplex to generate an active complex, and ATP-independent recognition and cleavage of the RNA target. Furthermore, ATP is used to maintain 5' phosphates on siRNAs. A 5' phosphate on the target-complementary strand of the siRNA duplex is required for siRNA function, suggesting that cells check the authenticity of siRNAs and license only bona fide siRNAs to direct target RNA destruction.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 55 Lake Ave N, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618	NIGMS NIH HHS [GM62862-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM062862] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; COGONI C, 1994, ANTON LEEUW INT J G, V65, P205, DOI 10.1007/BF00871948; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dernburg AF, 2000, GENE DEV, V14, P1578; Djikeng A, 2001, RNA, V7, P1522; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELBASHIR SM, 2001, IN PRESS EMBO J; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jensen S, 1999, GENETICS, V153, P1767; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Malinsky S, 2000, GENETICS, V156, P1147; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Worthington C.C., 1988, WORTHINGTON ENZYME M; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	52	747	1087	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					309	321		10.1016/S0092-8674(01)00547-5	http://dx.doi.org/10.1016/S0092-8674(01)00547-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701122	Bronze			2022-12-24	WOS:000172022800003
J	Wang, CT; Grishanin, R; Earles, CA; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB				Wang, CT; Grishanin, R; Earles, CA; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB			Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles	SCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; CALCIUM-CHANNEL; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; SYNAPTIC VESICLES; MEMBRANE-FUSION; PC12 CELLS; DOMAIN; CA2+; IV	In the exocytosis of neurotransmitter, fusion pore opening represents the first instant of fluid contact between the vesicle lumen and extracellular space. The existence of the fusion pore has been established by electrical measurements, but its molecular composition is unknown. The possibility that synaptotagmin regulates fusion pores was investigated with amperometry to monitor exocytosis of single dense-core vesicles. Overexpression of synaptotagmin I prolonged the time from fusion pore opening to dilation, whereas synaptotagmin IV shortened this time. Both synaptotagmin isoforms reduced norepinephrine flux through open fusion pores. Thus, synaptotagmin interacts with fusion pores, possibly by associating with a core complex of membrane proteins and/or lipid.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Wang, Chih-Tien/GRE-8232-2022; Oka, Yoshitaka/C-9670-2010	Wang, Chih-Tien/0000-0001-7639-7508; Oka, Yoshitaka/0000-0002-3482-3051; Chapman, Edwin/0000-0001-9787-8140				BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colquhoun David, 1995, P397; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; EARLES CA, IN PRESS J CELL BIOL; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; Ferguson GD, 1999, J NEUROCHEM, V72, P1821, DOI 10.1046/j.1471-4159.1999.0721821.x; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Haller M, 1998, BIOPHYS J, V74, P2100, DOI 10.1016/S0006-3495(98)77917-2; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53, DOI 10.1113/jphysiol.1996.sp021475; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LLOYD TE, 2000, NEUROTRANSMITTER REL, P352; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Reist NE, 1998, J NEUROSCI, V18, P7662; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Schwarz Thomas L., 1994, Current Opinion in Neurobiology, V4, P633, DOI 10.1016/0959-4388(94)90003-5; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	41	231	239	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1111	1115		10.1126/science.1064002	http://dx.doi.org/10.1126/science.1064002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691996	Green Submitted			2022-12-24	WOS:000172013800053
J	Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A				Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A			Bird migration - Magnetic cues trigger extensive refuelling	NATURE			English	Article							SEA-TURTLES		Swedish Museum Nat Hist, Bird Ringing Ctr, SE-10405 Stockholm, Sweden; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden; Geol Survey Sweden, SE-75128 Uppsala, Sweden	Swedish Museum of Natural History; Stockholm University	Fransson, T (corresponding author), Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden.							ABLE KP, 1993, TRENDS ECOL EVOL, V8, P367, DOI 10.1016/0169-5347(93)90221-A; Alerstam T., 1990, P331; Alerstam T, 1990, BIRD MIGRATION; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; Berthold P., 1996, CONTROL BIRD MIGRATI; FRY CH, 1970, IBIS, V112, P58, DOI 10.1111/j.1474-919X.1970.tb00076.x; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; KULLBERG C, 1996, P R SOC LOND B, V263, P619; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Mandea M, 2000, GEOPHYS J INT, V141, P259; *SWED MUS NAT HIST, ANN REP SWED BIRD RI; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x	13	125	133	2	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					35	36		10.1038/35102115	http://dx.doi.org/10.1038/35102115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689932				2022-12-24	WOS:000171898900031
J	Malin, MC; Caplinger, MA; Davis, SD				Malin, MC; Caplinger, MA; Davis, SD			Observational evidence for an active surface reservoir of solid carbon dioxide on mars	SCIENCE			English	Article							RESIDUAL CO2 FROST; SOUTH POLAR-CAP; SUMMER TEMPERATURES; ASTRONOMICAL THEORY; CHAOTIC OBLIQUITY; WATER-VAPOR; INSOLATION	High-resolution images of the south polar residual cap of Mars acquired in 1999 and 2001 show changes in the configuration of pits, intervening ridges, and isolated mounds. Escarpments have retreated 1 to 3 meters in 1 martian year, changes that are an order of magnitude larger than can be explained by the sublimation of water ice, but close to what is expected for sublimation of carbon dioxide ice. These observations support a 35-year-old conjecture that Mars has a large surface reservoir of solid carbon dioxide. The erosion implies that this reservoir is not in equilibrium with the present environment and that global climate change is occurring on Mars.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.							BRIGGS GA, 1974, ICARUS, V23, P167, DOI 10.1016/0019-1035(74)90004-9; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; DZURISIN D, 1975, J GEOPHYS RES, V80, P3286, DOI 10.1029/JB080i023p03286; FANALE FP, 1974, J GEOPHYS RES, V79, P3397, DOI 10.1029/JC079i024p03397; FANALE FP, 1976, ICARUS, V28, P172; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Hess S. L., 1977, Journal of Geophysical Research, V82, P4559, DOI 10.1029/JS082i028p04559; HESS SL, 1976, SCIENCE, V194, P1352, DOI 10.1126/science.194.4271.1352; HESS SL, 1976, SCIENCE, V194, P78, DOI 10.1126/science.194.4260.78; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1984, ICARUS, V57, P322, DOI 10.1016/0019-1035(84)90121-0; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin M. C., 1991, International Journal of Imaging Systems and Technology, V3, P76, DOI 10.1002/ima.1850030205; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MURRAY BC, 1973, SCIENCE, V182, P437, DOI 10.1126/science.182.4111.437; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; MURRAY BC, 1973, SCIENCE, V180, P638, DOI 10.1126/science.180.4086.638; NEUGEBAUER G, 1971, ASTRON J, V76, P719, DOI 10.1086/111189; PAIGE DA, 1985, SCIENCE, V228, P1160, DOI 10.1126/science.228.4704.1160; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SODERBLOM LA, 1973, J GEOPHYS RES, V78, P4197, DOI 10.1029/JB078i020p04197; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; WARD WR, 1973, SCIENCE, V181, P260, DOI 10.1126/science.181.4096.260; ZUREK RW, 1982, ICARUS, V50, P288, DOI 10.1016/0019-1035(82)90127-0	36	117	117	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2146	2148		10.1126/science.1066416	http://dx.doi.org/10.1126/science.1066416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11768358				2022-12-24	WOS:000172647700045
J	Schumacher, MA; Miller, MC; Grkovic, S; Brown, MH; Skurray, RA; Brennan, RG				Schumacher, MA; Miller, MC; Grkovic, S; Brown, MH; Skurray, RA; Brennan, RG			Structural mechanisms of QacR induction and multidrug recognition	SCIENCE			English	Article							P-GLYCOPROTEIN; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; BINDING; PROTEIN; GENE; TRANSPORTER; REGULATOR; IDENTIFICATION; EXPRESSION	The Staphylococcus aureus multidrug binding protein QacR represses transcription of the qacA multidrug transporter gene and is induced by structurally diverse cationic lipophilic drugs. Here, we report the crystal structures of six QacR-drug complexes. Compared to the DNA bound structure, drug binding elicits a coil-to-helix transition that causes induction and creates an expansive multidrug-binding pocket, containing four glutamates and multiple aromatic and polar residues. These structures indicate the presence of separate but linked drug-binding sites within a single protein. This muttisite drug-binding mechanism is consonant with studies on multidrug resistance transporters.	Oregon Hlth Sci & Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Oregon Health & Science University; University of Sydney	Brennan, RG (corresponding author), Oregon Hlth Sci & Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	brennanr@ohsu.edu	Brown, Melissa/V-2296-2017	Brown, Melissa/0000-0001-6461-7550; Brennan, Richard/0000-0001-7647-485X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 48593] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259; BEHR H, 1994, PATHOL BIOL, V42, P438; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; DOUBLIE S, 1999, METHOD ENZYMOL, V276, P523; GOLDSTEIN LJ, 1992, CRIT REV ONCOL HEMAT, V12, P243, DOI 10.1016/1040-8428(92)90057-W; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; GRKOVIC S, UNPUB; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Lewis K, 2001, J MOL MICROB BIOTECH, V3, P247; Licht T, 1996, ANN HEMATOL, V72, P184, DOI 10.1007/s002770050159; Lovell S, 1999, J CHEM SOC PERK T 2, P2241, DOI 10.1039/a904367e; Mayer S, 2001, J ANTIMICROB CHEMOTH, V47, P896, DOI 10.1093/jac/47.6.896; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1996, P NATL ACAD SCI USA, V93, P3630, DOI 10.1073/pnas.93.8.3630; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; RAYMENT I, 1999, METHOD ENZYMOL, V276, P176; SCHUMACHER MA, UNPUB; TAMAI I, 1991, J BIOL CHEM, V266, P16796; TENNENT JM, 1989, J GEN MICROBIOL, V135, P1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762	41	319	329	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2158	2163		10.1126/science.1066020	http://dx.doi.org/10.1126/science.1066020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739955				2022-12-24	WOS:000172647700049
J	Stern, V				Stern, V			Gynaecological examinations post-Ledward - a private matter	LANCET			English	Editorial Material							CHAPERONES				Stern, V (corresponding author), 30 Goldhurst Terrace, London NW6 3HU, England.	vivien.stern@bushinternet.com						Bignell CJ, 1999, BMJ-BRIT MED J, V319, P137, DOI 10.1136/bmj.319.7203.137; JONES RH, 1983, J ROY COLL GEN PRACT, V33, P25; Morrow J, 1999, BMJ-BRIT MED J, V319, P1266; *ROYAL COLL OBST G, 1997, INT EX REP WORK PART; Torrance CJ, 1999, BRIT MED J, V319, P159, DOI 10.1136/bmj.319.7203.159; Webb R, 1996, CAN FAM PHYSICIAN, V42, P54; WRIGHT O, 2000, TIMES           1221, P5; 2000, REPORT INQUIRY QUALI	8	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1896	1898		10.1016/S0140-6736(01)06892-1	http://dx.doi.org/10.1016/S0140-6736(01)06892-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741649				2022-12-24	WOS:000172463000033
J	Wright, CM; Parker, L; Lamont, D; Craft, AW				Wright, CM; Parker, L; Lamont, D; Craft, AW			Implications of childhood obesity for adult health: findings from thousand families cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; FOLLOW-UP; BRITISH CHILDREN; BIRTH; GROWTH; AGE; OVERWEIGHT; MORTALITY	Objective To determine whether being overweight in childhood increases adult obesity and risk of disease. Design Prospective cohort study. Setting City of Newcastle upon Tyne. Participants 932 members of thousand families 1947 birth cohort, of whom 412 attended for clinical examination age 50. Main outcome measures Blood pressure; carotid artery intima-media thickness; fibrinogen concentration; total, low density lipoprotein, and high density lipoprotein cholesterol concentrations; triglyceride concentration; fasting insulin and 2 hour glucose concentrations; body mass index; and percentage body fat. Results Body mass index at age 9 years was significantly correlated with body mass index age 50 (r = 0.24, P < 0.001) but not with percentage body fat age 50 (r = 0.10, P = 0.07). After adult body mass index had been adjusted for, body mass index at age 9 showed a significant inverse association with measures of lipid and glucose metabolism in both sexes and with blood pressure in women. However, after adjustment for adult percentage fat instead of body mass index, only the inverse associations with triglycerides (regression coefficient = -0.21, P < 0.01) and total cholesterol (-0.17, P < 0.05) in women remained significant. Conclusions Little tracking from childhood overweight to adulthood obesity was found when using a measure of fatness that was independent of build. Only children who were obese at 13 showed in increased risk of obesity as adults. No excess adult health risk from childhood or teenage overweight was found. Being thin in childhood offered no protection against adult fatness, and the thinnest children tended to have the highest adult risk at every level of adult obesity.	Newcastle Univ, Gateshead NE8 1EB, Tyne & Wear, England; Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Wright, CM (corresponding author), Newcastle Univ, Donald Court House, Gateshead NE8 1EB, Tyne & Wear, England.	C.M.Wright@Newcastle.ac.uk		PARKER, LOUISE/0000-0002-5188-8113	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; ALBERMAN E, 1991, ARCH DIS CHILD, V66, P1304, DOI 10.1136/adc.66.11.1304; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; ALTMAN DG, 1991, PRACTICAL STAT MED R, P443; *AUD COMM, 1993, 7 NHS AUD COMM; Blair M, 2001, ARCH DIS CHILD, V84, P1, DOI 10.1136/adc.84.1.1; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; *CLIN STAND ADV GR, 1993, NEON INT CAR; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; CUMBERLEDGE J, 1993, CHANGING CHILDBIRT 1; Dawson C, 1997, ARCH DIS CHILD-FETAL, V77, pF206, DOI 10.1136/fn.77.3.F206; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FOMON SJ, 1982, AM J CLIN NUTR, V35, P1169, DOI 10.1093/ajcn/35.5.1169; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Garrow JS, 2000, HUMAN NUTR DIETETICS, P13; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALL DMB, 1996, HLTH ALL CHILDREN RE; HALL DMB, 1991, HLTH ALL CHILDREN RE; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9; *HOUS COMM HLTH CO, 1992, SESS 1991 2 MAT SERV; JOHNSON A, 1993, BRIT MED J, V306, P1715, DOI 10.1136/bmj.306.6894.1715; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Lamont D, 2000, BMJ-BRIT MED J, V320, P273, DOI 10.1136/bmj.320.7230.273; Lamont DW, 1998, PUBLIC HEALTH, V112, P85, DOI 10.1016/S0033-3506(98)00591-5; LAUER RM, 1988, PEDIATRICS, V82, P309; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; *NAT PER EP UN OXF, 1994, DIS PER CAR MEAS HLT, P2; Netten A, 1999, UNIT COSTS HLTH SOCI; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; SPENCE JC, 1954, 1000 FAMILIES NEWCAS; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Turnbull D, 1998, LANCET, V352, P1875, DOI 10.1016/S0140-6736(05)60392-3; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; WARIYAR UK, 1989, LANCET, V1, P387; *WHITL COUNC HLTH, 1999, ADM CLER STAFFS COUN	44	240	251	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2001	323	7324					1280	1284		10.1136/bmj.323.7324.1280	http://dx.doi.org/10.1136/bmj.323.7324.1280			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731390	Green Published, Bronze			2022-12-24	WOS:000172655800017
J	Watson, R; Pauly, D				Watson, R; Pauly, D			Systematic distortions in world fisheries catch trends	NATURE			English	Article							FISH	Over 75% of the world marine fisheries catch (over 80 million tonnes per year) is sold on international markets, in contrast to other food commodities (such as rice)(1,2). At present, only one institution, the Food and Agriculture Organization of the United Nations (FAO) maintains global fisheries statistics. As an intergovernmental organization, however, FAO must generally rely on the statistics provided by member countries, even if it is doubtful that these correspond to reality. Here we show that misreporting by countries with large fisheries, combined with the large and widely fluctuating catch of species such as the Peruvian anchoveta, can cause globally spurious trends. Such trends influence unwise investment decisions by firms in the fishing sector and by banks, and prevent the effective management of international fisheries.	Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Watson, R (corresponding author), Univ British Columbia, Fisheries Ctr, 2204 Main Mall, Vancouver, BC V6T 1Z4, Canada.		Pauly, Daniel Marc/AAY-2316-2021; Watson, Reg A/F-4850-2012	Watson, Reg A/0000-0001-7201-8865; Pauly, Daniel/0000-0003-3756-4793				ALVERSONS DL, 1994, 339 FAO, P1; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; CHEN W, 1999, 950 FAO, P1; *DAT AN PROD DIV M, 2000, S PLUS GUID STAT, V1; *FOOD AGR ORG, 2000, 961 FAO DAT STAT UN, P1; *FOOD AGR ORG, 2000, FISHSTAT PLUS U SOFT; FROESE R, 2000, FISHBASE 2000 CONCEP; *GLOB MAR BOUND DA, 2000, VER INF SOL 2000; Huang B., 1983, North American Journal of Fisheries Management, V3, P295, DOI 10.1577/1548-8659(1983)3<295:CAAPDO>2.0.CO;2; KWONG L, 1997, POLITICAL EC CORRUPT, P1; LONGHURST A, 1998, ECOLOGICAL GEOGRAPHY, P77; MACLEAN J, 1997, RICE ALMANAC, P31; Muck Peter, 1989, P386; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; PANG L, 2000, 9 U BRIT COL FISH, P1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Tang Q., 1989, AAAS (American Association for the Advancement of Science) Selected Symposium, V111, P7; WATSON R, IN PRESS FISHERIES I	19	419	446	0	107	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					534	536		10.1038/35107050	http://dx.doi.org/10.1038/35107050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734851				2022-12-24	WOS:000172405900044
J	Hartgerink, JD; Beniash, E; Stupp, SI				Hartgerink, JD; Beniash, E; Stupp, SI			Self-assembly and mineralization of peptide-amphiphile nanofibers	SCIENCE			English	Article							IN-VITRO; BONE; NUCLEATION; COLLAGEN; MICROSTRUCTURES; SPECTROSCOPY; SEQUENCES; CRYSTALS	We have used the pH-induced self-assembly of a peptide-amphiphile to make a nanostructured fibrous scaffold reminiscent of extracellular matrix. The design of this peptide-amphiphile allows the nanofibers to be reversibly crosslinked to enhance or decrease their structural integrity. After cross-linking, the fibers are able to direct mineralization of hydroxyapatite to form a composite material in which the crystallographic c axes of hydroxyapatite are aligned with the tong axes of the fibers. This alignment is the same as that observed between Collagen fibrils and hydroxyapatite crystals in bone.	Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Sch Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2225 N Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Hartgerink, Jeffrey D/G-4275-2016; Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009	Hartgerink, Jeffrey D/0000-0002-3186-5395; 				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; [Anonymous], 1992, INTERMOLECULAR SURFA; Archer EA, 2000, J AM CHEM SOC, V122, P5006, DOI 10.1021/ja000777s; ARCHIBALD DD, 1993, NATURE, V364, P430, DOI 10.1038/364430a0; Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Bigi A, 2000, BIOMACROMOLECULES, V1, P752, DOI 10.1021/bm0055854; BOND GM, 1995, J MATER ENG PERFORM, V4, P334, DOI 10.1007/BF02649071; Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p; Burkett SL, 1996, CHEM COMMUN, P321, DOI 10.1039/cc9960000321; Cardullo F, 2000, CHEM COMMUN, P367, DOI 10.1039/a909459h; Clark TD, 1999, CHEM-EUR J, V5, P782, DOI 10.1002/(SICI)1521-3765(19990201)5:2<782::AID-CHEM782>3.0.CO;2-A; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Harris J. R., 1991, ELECT MICROSCOPY BIO, P32; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8; JACKSON DY, 1991, J AM CHEM SOC, V113, P9391, DOI 10.1021/ja00024a067; Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lee KC, 1999, LANGMUIR, V15, P5500, DOI 10.1021/la9900775; Mann S, 1997, J CHEM SOC DALTON, P3953, DOI 10.1039/a704004k; MANN S, 1986, NATURE, V324, P565, DOI 10.1038/324565a0; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Varma HK, 1999, J MATER SCI-MATER M, V10, P395, DOI 10.1023/A:1008970913107; Veis A., 1989, P189; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; YAMADA K, 1984, CHEM LETT, P1713, DOI 10.1246/cl.1984.1713; Yu YC, 1997, METHOD ENZYMOL, V289, P571; Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523	42	3064	3228	27	2022	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1684	1688		10.1126/science.1063187	http://dx.doi.org/10.1126/science.1063187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721046				2022-12-24	WOS:000172307400034
J	Ricklefs, RE; Bermingham, E				Ricklefs, RE; Bermingham, E			Nonequilibrium diversity dynamics of the Lesser Antillean avifauna	SCIENCE			English	Article							ISLAND BIOGEOGRAPHY; EVOLUTION; IMPACT; RATES; SCALE	MacArthur and Wilson's model of island diversity predicts an increase in the number of species until colonization and extinction are balanced at a long-term steady state. We appraise this model on an evolutionary time scale by molecular phylogenetic analysis of the colonization of the Lesser Antilles by small land birds. The pattern of accumulation of species with time, estimated by genetic divergence between island and source lineages, rejects a homogeneous model of colonization and extinction. Rather, our results suggest an abrupt, roughly 10-fold increase in colonization rate or a 90% mass extinction event 0.55 to 0.75 million years ago.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Smithsonian Trop Res Inst, Balboa, Panama; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Missouri System; University of Missouri Saint Louis; Smithsonian Institution; Smithsonian Tropical Research Institute; McGill University	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.							Arendt WJ, 1999, BIRD CONSERV INT, V9, P351, DOI 10.1017/S095927090000352X; BONATTI E, 1973, NATURE, V244, P563, DOI 10.1038/244563a0; BOND J, 1956, CHECKLIST BIRDS W IN; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Gersonde R, 1997, NATURE, V390, P357, DOI 10.1038/37044; Grant PR, 2001, OIKOS, V92, P385, DOI 10.1034/j.1600-0706.2001.920301.x; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Johnson KP, 2000, EVOLUTION, V54, P387; Krajewski C, 1996, MOL BIOL EVOL, V13, P21, DOI 10.1093/oxfordjournals.molbev.a025558; Lack D, 1976, ISLAND BIOL ILLUSTRA; Losos Jonathan B., 1996, P308; MAC ARTHUR ROBERT H., 1967; Pregill Gregory K., 1994, Bulletin of Carnegie Museum of Natural History, V30, P1; RICKLEFS RE, 1972, AM NAT, V106, P195, DOI 10.1086/282762; RICKLEFS RE, 1977, OIKOS, V29, P60, DOI 10.2307/3543293; RUSSELL GJ, 1995, J ANIM ECOL, V64, P628, DOI 10.2307/5805; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Tsikalas F, 1998, J GEOPHYS RES-SOL EA, V103, P30469, DOI 10.1029/97JB03389; Whittaker RJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P75, DOI 10.1046/j.1365-2699.2000.00200.x; WILCOX BA, 1978, SCIENCE, V199, P996, DOI 10.1126/science.199.4332.996; Wiley James W., 1993, Bird Conservation International, V3, P319; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	23	95	99	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1522	1524		10.1126/science.1065005	http://dx.doi.org/10.1126/science.1065005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711673	Green Submitted			2022-12-24	WOS:000172240500047
J	Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A				Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A			ARR1, a transcription factor for genes immediately responsive to cytokinins	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; REGULATORS; EXPRESSION; PLANTS; TARGET	Cytokinins are a class of phytohormones involved in various physiological events of plants. The Arabidopsis sensor histidine kinase CRE1 was recently reported to be a cytokinin receptor. We used asteroid-inducible system to show that the transcription factor-type response regulator ARR1 directs transcriptional activation of the ARR6 gene, which responds to cytokinins without de novo protein synthesis. This fact, together with characteristics of ARR1-over-expressing plants and arr1 mutant plants, indicates that the phosphorelay to ARR1, probably from CRE1, constitutes an intracellular signal transduction occurring immediately after cytokinin perception.	Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Kyoto University; Kazusa DNA Research Institute	Oka, A (corresponding author), Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan.		Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P493, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; SAKAI H, UNPUB; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582	25	354	374	6	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1519	1521		10.1126/science.1065201	http://dx.doi.org/10.1126/science.1065201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11691951				2022-12-24	WOS:000172240500046
J	Schoener, TW; Spiller, DA; Losos, JB				Schoener, TW; Spiller, DA; Losos, JB			Natural restoration of the species-area relation for a lizard after a hurricane	SCIENCE			English	Article							EXTINCTION; TURNOVER; ISLANDS; RATES	We document the decimation and recovery of the commonest lizard species, Anolis sagrei, on 66 islands in the Bahamas that were directly hit by Hurricane Floyd in September 1999. Before the hurricane, an island's area was a better predictor of the occurrence of A. sagrei than was its altitude. Immediately after, altitude was a better predictor: Apparently all Lizards on islands Lower than about 3 meters maximum elevation perished in the storm surge. After about 1 year, area again became the better predictor. By 19 months after the hurricane, A. sagrei populations occurred on 88% of the islands they formerly occupied. Recovery occurred via overwater colonization and propagation from eggs that survived inundation, mechanisms that were enhanced by larger island area. Thus, natural processes first destroyed and then quickly restored a highly regular species-area distribution.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis	Schoener, TW (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.							Brown J.H., 1998, BIOGEOGRAPHY; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; DIAMOND JM, 1977, SCIENCE, V197, P266, DOI 10.1126/science.197.4300.266; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P262, DOI 10.1073/pnas.73.1.262; HAMILTON TH, 1963, SCIENCE, V142, P1575, DOI 10.1126/science.142.3599.1575; Hanski I., 1999, METAPOPULATION ECOLO; Licht P, 1970, U CALIF PUBL ZOOL, V95, P1; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; LOSOS JB, 1986, OECOLOGIA, V68, P338, DOI 10.1007/BF01036735; MAC ARTHUR ROBERT H., 1967; Picket S. T. A, 1985, ECOLOGY NATURAL DIST; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Schoener T. W., 1976, P 16 INT ORNITHOLOGI, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Schoener T.W., 1986, COMMUNITY ECOLOGY, P556; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; Schoener TW, 1999, AM NAT, V153, P347, DOI 10.1086/303177; SCHOENER TW, 1983, J ANIM ECOL, V52, P209, DOI 10.2307/4597; SCHOENER TW, 1987, NATURE, V330, P474, DOI 10.1038/330474a0; SCHOENER TW, 1988, AM NAT, V131, P847, DOI 10.1086/284826; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; THORNTON I, 1996, KRAKATOA; TOWNES DR, 1990, ECOLOGICAL RESTORATI; VANDERVLIET PC, 1990, EUKARYOTIC NUCLEUS, V1, P1; Williamson M. H., 1981, ISLAND POPULATIONS	28	71	78	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1525	1528		10.1126/science.1064396	http://dx.doi.org/10.1126/science.1064396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711674				2022-12-24	WOS:000172240500048
J	Schnupp, JWH; Mrsic-Flogel, TD; King, AJ				Schnupp, JWH; Mrsic-Flogel, TD; King, AJ			Linear processing of spatial cues in primary auditory cortex	NATURE			English	Article							SOUND-LOCALIZATION BEHAVIOR; FERRET MUSTELA-PUTORIUS; BINAURAL STIMULATION; CORTICAL-NEURONS; CAT; RESPONSES; SENSITIVITY; PATHWAYS; LESIONS; CELLS	To determine the direction of a sound source in space, animals must process a variety of auditory spatial cues, including interaural level and time differences, as well as changes in the sound spectrum caused by the direction-dependent filtering of sound by the outer ear(1). Behavioural deficits observed when primary auditory cortex (A1) is damaged have led to the widespread view that A1 may have an essential role in this complex computational task(2-5). Here we show, however, that the spatial selectivity exhibited by the large majority of A1 neurons is well predicted by a simple linear model, which assumes that neurons additively integrate sound levels in each frequency band and ear. The success of this linear model is surprising, given that computing sound source direction is a necessarily nonlinear operation(6-9). However, because linear operations preserve information, our results are consistent with the hypothesis that A1 may also form a gateway to higher, more specialized cortical areas(10,11).	Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England	University of Oxford	Schnupp, JWH (corresponding author), Univ Oxford, Univ Lab Physiol, S Parks Rd, Oxford OX1 3PT, England.	jan.schnupp@physiol.ox.ac.uk	schnupp, jan/A-3006-2012; King, Andrew J/M-6708-2013	King, Andrew J/0000-0001-5180-7179; schnupp, jan w h/0000-0002-2604-0057; Mrsic-Flogel, Tom/0000-0002-8947-408X				BRUGGE JF, 1994, HEARING RES, V73, P67, DOI 10.1016/0378-5955(94)90284-4; CARLILE S, 1990, J ACOUST SOC AM, V88, P2196, DOI 10.1121/1.400116; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; KITZES LM, 1980, J COMP NEUROL, V192, P455, DOI 10.1002/cne.901920306; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Masterton RB, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P1, DOI 10.1007/978-1-4419-8712-9_1; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; PHILLIPS DP, 1988, BRAIN RES, V443, P281, DOI 10.1016/0006-8993(88)91622-8; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Ruggero M. A., 1992, MAMMALIAN AUDITORY P, DOI [10.1007/978-1-4612-2838-7_2, DOI 10.1007/978-1-4612-2838-7_2]; SAMSON FK, 1994, J NEUROPHYSIOL, V71, P2194, DOI 10.1152/jn.1994.71.6.2194; Schreiner CE, 1998, AUDIOL NEURO-OTOL, V3, P104, DOI 10.1159/000013785; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Wightman FL, 1997, J ACOUST SOC AM, V101, P1050, DOI 10.1121/1.418029; WIGHTMAN FL, 1993, HUMAN PSYCHOPHYSICS, P155; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	30	104	106	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2001	414	6860					200	204		10.1038/35102568	http://dx.doi.org/10.1038/35102568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700557				2022-12-24	WOS:000172029100046
J	Preminger, B				Preminger, B			The "Jewish nose" and plastic surgery: Origins and implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Preminger, B (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.							Blair Vilray P., 1936, J AM DENT ASSOC, V23, P236; BLOODGOOD JC, 1927, DELINEATOR       OCT, P60; BLOODGOOD JC, 1927, DELINEATOR       OCT, P20; CARTER WW, 1930, LARYNGOSCOPE, V40, P504; Efron J. M., 1994, DEFENDERS RACE; Gilman Sander., 1991, JEWS BODY; Haiken Elizabeth, 1997, VENUS ENVY HIST COSM; MATORY E, 1998, ETHNIC CONSIDERATION; MILALRD RD, 1996, RHINOPLASTY TETRALOG; Nicolle F.V., 1996, AESTHETIC RHINOPLAST	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2161	2161		10.1001/jama.286.17.2161	http://dx.doi.org/10.1001/jama.286.17.2161			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694162	hybrid			2022-12-24	WOS:000172032100040
J	Peters, AHFM; O'Carroll, D; Scherthan, H; Mechtler, K; Sauer, S; Schofer, C; Weipoltshammer, K; Pagani, M; Lachner, M; Kohlmaier, A; Opravil, S; Doyle, M; Sibilia, M; Jenuwein, T				Peters, AHFM; O'Carroll, D; Scherthan, H; Mechtler, K; Sauer, S; Schofer, C; Weipoltshammer, K; Pagani, M; Lachner, M; Kohlmaier, A; Opravil, S; Doyle, M; Sibilia, M; Jenuwein, T			Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability	CELL			English	Article							POSITION-EFFECT VARIEGATION; CHROMOSOME SEGREGATION; FISSION YEAST; MITOTIC PHOSPHORYLATION; CENTRIC HETEROCHROMATIN; FEMALE MEIOSIS; DROSOPHILA; PROTEIN; H3; CENTROMERES	Histone H3 lysine 9 methylation has been proposed to provide a major "switch" for the functional organization of chromosomal subdomains. Here, we show that the murine Suv39h histone methyltransferases (HMTases) govern H3-K9 methylation at pericentric heterochromatin and induce a specialized histone methylation pattern that differs from the broad H3-K9 methylation present at other chromosomal regions. Suv39h-deficient mice display severely impaired viability and chromosomal instabilities that are associated with an increased tumor risk and perturbed chromosome interactions during male meiosis. These in vivo data assign a crucial role for pericentric H3-K9 methylation in protecting genome stability, and define the: Suv39h HMTases as important epigenetic regulators for mammalian development.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Kaiserslautern, Dept Human Biol, D-67663 Kaiserslautern, Germany; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Kaiserslautern; University of Vienna	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.		jia, xu/A-8386-2016; Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Schofer, Christian/0000-0001-9570-5692; Peters, Antoine/0000-0002-0311-1887; Sibilia, Maria/0000-0001-6129-5613; O'Carroll, Donal/0000-0002-8626-2217				Aagaard L, 2000, J CELL SCI, V113, P817; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; EISSENBERG JC, 1992, GENETICS, V131, P345; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; FOON KA, 1995, BLOOD PRINCIPLES PRA, P783; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; KELLUM R, 1995, J CELL SCI, V108, P1419; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirschmann DA, 2000, CANCER RES, V60, P3359; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAMMERS JHM, 1995, CHROMOSOMA, V104, P154, DOI 10.1007/s004120050103; Lyko F, 2001, TRENDS GENET, V17, P169, DOI 10.1016/S0168-9525(01)02234-X; McKee BD, 2000, GENETICA, V109, P77, DOI 10.1023/A:1026536200594; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; PARDUE ML, 1970, SCIENCE, V168, P1356, DOI 10.1126/science.168.3937.1356; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; THON G, 1994, GENETICS, V138, P29; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; TURNER JM, 2001, IN PRESS J CELL SCI; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; YOSHIDA N, 1998, REC RES DEV FERMEN 1, V1, P1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	58	1290	1337	4	45	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					323	337		10.1016/S0092-8674(01)00542-6	http://dx.doi.org/10.1016/S0092-8674(01)00542-6			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701123	Bronze			2022-12-24	WOS:000172022800004
J	Phillips, DP; Liu, GC; Kwok, K; Jarvinen, JR; Zhang, N; Abramson, IS				Phillips, DP; Liu, GC; Kwok, K; Jarvinen, JR; Zhang, N; Abramson, IS			The Hound of the Baskervilles effect: natural experiment on the influence of psychological stress on timing of death	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY DISEASE; MENTAL STRESS	Objective To determine whether cardiac mortality is abnormally high on days considered unlucky: Chinese and Japan se people consider the number 4 unlucky, white Americans do not. Design Examination of cardiac and non-cardiac mortality on and around the fourth of each month in Chinese and Japanese subjects and white controls. Setting United States. Subjects All Chinese and Japanese (n = 209 908) and white (n = 47 328 762) Americans whose computerised death certificates were recorded between the beginning of January 1973 and the end of December 1998. Main outcome measures Ratio of observed to expected numbers of deaths on the fourth day of the month (expected number was estimated from mortality on other days of the month). Results Cardiac mortality in Chinese and Japanese people peaked on the fourth of the month. The peak was particularly large for deaths from chronic heart disease (ratio of observed to expected deaths = 1.13, 95% confidence interval 1.06 to 1.21) and still larger for deaths from chronic heart disease in California (1.27,1.15 to 1.39). Within this group. inpatients showed a particularly large peak on the fourth day(1.45, 1.19 to 1.81). The peak was not followed by a compensatory drop in number of deaths. White controls, matched on age, sex, marital status, hospital status, location, and cause of death, showed no similar peak in cardiac mortality. Conclusions Our findings of excess cardiac mortality on "unlucky" days are consistent with the hypothesis that cardiac mortality increases on psychologically stressful occasions. The results are inconsistent with nine other possible explanations for the findings-for example, the fourth day peak does not seem to occur because of changes in the patient's diet, alcohol intake, exercise, or drug regimens.	Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Phillips, DP (corresponding author), Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA.							*CA DEP HLTH SERV, MORT FIL; DOYLE AC, 1964, HOUND BASKERVILLES; Gardner M. J., 1989, STAT CONFIDENCE; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; *NAT CTR HLTH STAT, 1997, VIT STAT US 1994 A, V2; *NAT CTR HLTH STAT, 1976, VIT STAT US 1973 1 A, V2; Philips DP, 1999, NEW ENGL J MED, V341, P93, DOI 10.1056/NEJM199907083410206; PHILLIPS DF, 1995, JAMA-J AM MED ASSOC, V273, P1221, DOI 10.1001/jama.273.15.1221; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; PHILLIPS DP, 1993, LANCET, V342, P1142, DOI 10.1016/0140-6736(93)92124-C; PHILLIPS DP, 2000, ENCY PSYCHOL; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Soufer R, 1998, P NATL ACAD SCI USA, V95, P6454, DOI 10.1073/pnas.95.11.6454; STEPTOE A, 1991, CIRCULATION, V83, P14; *US NAT CTR HLTH S, MORT DET FIL; Witte DR, 2000, BMJ-BRIT MED J, V321, P1552, DOI 10.1136/bmj.321.7276.1552; 2000, W CALENDAR CALENDAR; 2000, SCHAUWECKERS GUIDE J	19	53	54	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1443	1446		10.1136/bmj.323.7327.1443	http://dx.doi.org/10.1136/bmj.323.7327.1443			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506PA	11751347	Green Published			2022-12-24	WOS:000172979900006
J	Fored, CM; Ejerblad, E; Lindblad, P; Fryzek, JP; Dickman, PW; Signorello, LB; Lipworth, L; Elinder, C; Blot, WJ; McLaughlin, JK; Zack, MM; Nyren, O				Fored, CM; Ejerblad, E; Lindblad, P; Fryzek, JP; Dickman, PW; Signorello, LB; Lipworth, L; Elinder, C; Blot, WJ; McLaughlin, JK; Zack, MM; Nyren, O			Acetaminophen, aspirin, and chronic renal failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANALGESIC USE; DISEASE; NEPHROPATHY; KIDNEY; PARACETAMOL; RISK	Background: Several epidemiologic studies have demonstrated an association between heavy consumption of nonnarcotic analgesics and the occurrence of chronic renal failure, but it is unclear which is the cause and which is the effect. Methods: In a nationwide, population-based, case-control study of early-stage chronic renal failure in Sweden, face-to-face interviews were conducted with 926 patients with newly diagnosed renal failure and 998 control subjects, of whom 918 and 980, respectively, had complete data. We used logistic-regression models to estimate the relative risks of disease-specific types of chronic renal failure associated with the use of various analgesics. Results: Aspirin and acetaminophen were used regularly by 37 percent and 25 percent, respectively, of the patients with renal failure and by 19 percent and 12 percent, respectively, of the controls. Regular use of either drug in the absence of the other was associated with an increase by a factor of 2.5 in the risk of chronic renal failure from any cause. The relative risks rose with increasing cumulative lifetime doses, rose more consistently with acetaminophen use than with aspirin use, and were increased for most disease-specific types of chronic renal failure. When we disregarded the recent use of analgesics, which could have occurred in response to antecedents of renal disease, the associations were only slightly attenuated. Conclusions: Our results are consistent with the existence of exacerbating effects of acetaminophen and aspirin on chronic renal failure. However, we cannot rule out the possibility of bias due to the triggering of analgesic consumption by predisposing conditions. (N Engl J Med 2001;345:1801-8.) Copyright (C) 2001 Massachusetts Medical Society.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Huddinge Univ Hosp, Dept Renal Med, S-14186 Huddinge, Sweden; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; Int Epidemiol Inst, Rockville, MD USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Karolinska Institutet; Karolinska Institutet; Vanderbilt University; Centers for Disease Control & Prevention - USA	Fored, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.		Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380				BUCKALEW VM, 1986, MEDICINE, V65, P291, DOI 10.1097/00005792-198609000-00002; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delzell E, 1998, MEDICINE, V77, P383; ELSEVIERS M, 1994, THESIS U ANTWERP DEP; Elseviers MM, 1999, DRUG SAFETY, V20, P15, DOI 10.2165/00002018-199920010-00003; Feinstein AR, 2000, KIDNEY INT, V58, P2259, DOI 10.1046/j.1523-1755.2000.00410.x; Goldfarb S, 1998, ANN INTERN MED, V129, P636, DOI 10.7326/0003-4819-129-8-199810150-00012; GRIMLUND K, 1963, ACTA MED SCAND, V405, P1; Henrich WL, 1996, AM J KIDNEY DIS, V27, P162, DOI 10.1016/S0272-6386(96)90046-3; *INT AG RES CANC, 1980, STAT METH CANC RES; MCCREDIE M, 1988, NEPHRON, V49, P296, DOI 10.1159/000185079; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MOULTON LH, 1991, J CLIN EPIDEMIOL, V44, P915, DOI 10.1016/0895-4356(91)90054-D; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; NANRA RS, 1993, ANALGESIC NSAID INDU, P17; PERNEGER TV, 1995, AM J KIDNEY DIS, V25, P722, DOI 10.1016/0272-6386(95)90548-0; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; POMMER W, 1989, AM J NEPHROL, V9, P403, DOI 10.1159/000168002; Rexrode KM, 2001, JAMA-J AM MED ASSOC, V286, P315, DOI 10.1001/jama.286.3.315; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sabatini S, 1996, AM J KIDNEY DIS, V28, pS34, DOI 10.1016/S0272-6386(96)90567-3; Salas M, 1999, AM J EPIDEMIOL, V149, P981; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SEGASOTHY M, 1988, NEPHRON, V50, P50, DOI 10.1159/000185116; SPUHLER O, 1953, Z KLIN MED, V151, P1; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; *USRDS COORD CTR, 2001, 2001 USRDS ADR REF T; WEST SL, 1994, PHARMACOEPIDEM DR S, P549; WING AJ, 1989, TOXICOL LETT, V46, P281, DOI 10.1016/0378-4274(89)90136-7	31	173	180	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1801	1808		10.1056/NEJMoa010323	http://dx.doi.org/10.1056/NEJMoa010323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752356				2022-12-24	WOS:000172794800003
J	Luo, ZC; Karlberg, J				Luo, ZC; Karlberg, J			Timing of birth and infant and early neonatal mortality in Sweden 1973-95: longitudinal birth register study	BRITISH MEDICAL JOURNAL			English	Article							DEATHS; ASPHYXIA	Objective To assess the impact of time of birth on infant mortality and early neonatal mortality in full term and preterm births. Design Analysis of data from the Swedish birth register, 1973-95. Participants 2 102 324 spontaneous live births of infants without congenital malformation. Outcome measurements Absolute and relative risk of infant mortality, early neonatal mortality, and early neonatal mortality related to asphyxia. Results Infant mortality, early neonatal morality, and early neonatal mortality related to asphyxia were higher in infants who were born during the night (9 pm to 9 am) compared with those born during the day for 1973-9, 1980-9, and 1990-5. The difference was more dramatic for preterm infants. The largest difference was observed during 1990-5, when there was a 30% increase in early neonatal morality (relative risk 1.31, 95% confidence interval 1.10 to 1.57) and a 70% increase in early neonatal mortality related to asphyxia (1.70, 1.22 to 2.38) in preterm infants born during the night compared with rates for preterm infants born during the day. A detailed analysis over 24 hours revealed two "high risk" periods: between 5 pm and 1 am and around 9 am. Conclusions Infants born during the night have a greater risk of infant and early neonatal mortality and early neonatal mortality related to asphyxia than those born during th day. There has been no improvement over the past two decades. The problem is more serious for preterm births and was even worse in the 1990s. Shift changes and the hours immediately after such changes are high risk periods for neonatal care.	Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Karlberg, J (corresponding author), Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China.		Luo, Zhong-Cheng/T-3882-2017; Karlberg, Johan Petter Einar/C-4290-2009; Karlberg, Johan/AAZ-7864-2020	Luo, Zhong-Cheng/0000-0002-1794-1312; 				Chalmers JWT, 1998, BRIT MED J, V317, P539; Cheung YB, 2000, AM J EPIDEMIOL, V152, P1107, DOI 10.1093/aje/152.12.1107; Cheung YB, 2001, STAT MED, V20, P2455, DOI 10.1002/sim.858; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Heller G, 2000, BRIT MED J, V321, P274, DOI 10.1136/bmj.321.7256.274; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; *PAN AM HLT ORG, 1998, HLTH AM; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657	8	54	55	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1327	1330		10.1136/bmj.323.7325.1327	http://dx.doi.org/10.1136/bmj.323.7325.1327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739216	Bronze, Green Published			2022-12-24	WOS:000172716900013
J	Nash, P; Tang, XJ; Orlicky, S; Chen, QH; Gertler, FB; Mendenhall, MD; Sicheri, F; Pawson, T; Tyers, M				Nash, P; Tang, XJ; Orlicky, S; Chen, QH; Gertler, FB; Mendenhall, MD; Sicheri, F; Pawson, T; Tyers, M			Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication	NATURE			English	Article							UBIQUITIN-LIGASE COMPLEX; PROTEIN-PROTEIN INTERACTIONS; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; F-BOX; DEPENDENT DEGRADATION; S-PHASE; KAPPA-B; KINASE	SCF ubiquitin ligases target phosphorylated substrates for ubiquitin-dependent proteolysis by means of adapter subunits called F-box proteins. The F-box protein Cdc4 captures phosphorylated forms of the cyclin-dependent kinase inhibitor Sic1 for ubiquitination in late G1 phase, an event necessary for the onset of DNA replication. The WD40 repeat domain of Cdc4 binds with high affinity to a consensus phosphopeptide motif (the Cdc4 phospho-degron, CPD), yet Sic1 itself has many sub-optimal CPD motifs that act in concert to mediate Cdc4 binding. The weak CPD sites in Sic1 establish a phosphorylation threshold that delays degradation in vivo, and thereby establishes a minimal G1 phase period needed to ensure proper DNA replication. Multisite phosphorylation may be a more general mechanism to set thresholds in regulated protein-protein interactions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Kentucky, Dept Biochem, LP Markey Canc Ctr, Lexington, KY 40536 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Kentucky; Massachusetts Institute of Technology (MIT); University of Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca; tyers@mshri.on.ca	Pawson, Tony J/E-4578-2013; Tyers, Michael/ABE-3194-2021; Sicheri, Frank/F-8856-2013	Orlicky, Stephen/0000-0002-8172-2042				Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Guthrie C, 1991, METHODS ENZYMOLOGY; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pawson T, 2000, GENE DEV, V14, P1027; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPENCER F, 1990, GENETICS, V124, P237; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	48	631	639	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					514	521		10.1038/35107009	http://dx.doi.org/10.1038/35107009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734846				2022-12-24	WOS:000172405900039
J	Irgens, HU; Reisaeter, L; Irgens, LM; Lie, RT				Irgens, HU; Reisaeter, L; Irgens, LM; Lie, RT			Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER RISK; REMOTE PROGNOSIS; NORWEGIAN WOMEN; PREGNANCY; PREECLAMPSIA; HYPERTENSION; SMOKING; BIRTH; NORWAY; AGE	Objective To assess whether mothers and fathers have a higher long term risk of death, particularly from cardiovascular disease and cancer, after the mother has had pre-eclampsia. Design Population based cohort study of registry data. Subjects Mothers and fathers of all 626 272 births that were the mothers' first deliveries, retarded in the Norwegian medical birth registry from 1967 to 1992. Parents were divided into two cohorts based on whether the mother had pre-eclampsia during the pregnancy. Subjects were also stratified by whether the birth was term or preterm, given that pre-eclampsia might be more severe in preterm pregnancies. Main outcome measures Total mortality and mortality from cardiovascular causes, cancer, and stroke from 1967 to 1992, from data from the Norwegian registry of causes of death. Results Women who lead pre-eclampsia had a 1.2-fold higher long term risk of death (95% confidence interval 1.02 to 1.37) than women who did not have pre-eclampsia. The risk ill women with pre-eclampsia and a preterm delivery mss 2.71-fold higher (1.99 to 3.68) than in women who did not have pre-eclampsia and whose pregnancies event to term. In particular, the risk of death from cardiovascular causes among women with pre-eclampsia and a preterm delivery was 8.12-fold higher (4.31 to 15.33). However, these women had a 0.36-fold (not significant) decreased risk of cancer. The long term risk of death was no higher among the fathers of the pre-eclamptic pregnancies than the fathers of pregnancies in which pre-eclampsia did not occur. Conclusions Genetic factors that increase the risk of cardiovascular disease may also be linked to pre-eclampsia. A possible genetic contribution from fathers to the risk of pre-eclampsia was not reflected in increased risks of death from cardiovascular causes or cancer among fathers.	Univ Bergen, Haukeland Hosp, Dept Publ Hlth & Primary Hlth Care, Med Birth Registry Norway,Locus Registry Based Ep, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital	Irgens, LM (corresponding author), Univ Bergen, Haukeland Hosp, Dept Publ Hlth & Primary Hlth Care, Med Birth Registry Norway,Locus Registry Based Ep, N-5021 Bergen, Norway.			Reisaeter, Lars/0000-0002-1242-1502				ALBREKTSEN G, 1994, EPIDEMIOLOGY, V5, P604, DOI 10.1097/00001648-199411000-00008; ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; ALBREKTSEN G, 1995, INT J CANCER, V60, P341, DOI 10.1002/ijc.2910600311; CHESLEY LC, 1976, AM J OBSTET GYNECOL, V124, P446, DOI 10.1016/0002-9378(76)90168-X; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; De Groot CJM, 1999, AM J OBSTET GYNECOL, V181, P975, DOI 10.1016/S0002-9378(99)70335-2; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; Innes KE, 1999, EPIDEMIOLOGY, V10, P722, DOI 10.1097/00001648-199911000-00013; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; LINDHEIMER MD, 1985, NEW ENGL J MED, V313, P675, DOI 10.1056/NEJM198509123131107; MARCOUX S, 1989, AM J EPIDEMIOL, V130, P950, DOI 10.1093/oxfordjournals.aje.a115427; *MED BIRTH REG NOR, 1997, BIRTHS NORW 30 YEARS, P1; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1	22	802	824	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1213	1216		10.1136/bmj.323.7323.1213	http://dx.doi.org/10.1136/bmj.323.7323.1213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719411	Green Published, Bronze			2022-12-24	WOS:000172450500015
J	Cukierman, E; Pankov, R; Stevens, DR; Yamada, KM				Cukierman, E; Pankov, R; Stevens, DR; Yamada, KM			Taking cell-matrix adhesions to the third dimension	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; INTEGRINS; DYNAMICS; FIBRONECTIN; MIGRATION	Adhesions between fibroblastic cells and extracellular matrix have been studied extensively in vitro, but tittle is known about their in vivo counterparts. Here, we characterized the composition and function of adhesions in three-dimensional (3D) matrices derived from tissues or cell culture. "3D-matrix adhesions" differ from focal and fibrillar adhesions characterized on 2D substrates in their content of alpha (5)beta (1) and alpha (v)beta (3) integrins, paxillin, other cytoskeletal components, and tyrosine phosphorylation of focal adhesion kinase (FAK). Relative to 2D substrates, 3D-matrix interactions also display enhanced cell biological activities and narrowed integrin usage. These distinctive in vivo 3D-matrix adhesions differ in structure, localization, and function from classically described in vitro adhesions, and as such they may be more biologically relevant to living organisms.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.		cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013; Pankov, Roumen/AAK-3205-2021; Pankov, Roumen G/B-3284-2014; Ladoux, Benoit/A-9879-2013	cukierman, edna/0000-0002-1452-9576; Pankov, Roumen/0000-0002-3157-3659; Pankov, Roumen G/0000-0002-3157-3659; 	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524, Z01DE000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Hayashi K, 1999, J CELL SCI, V112, P1149; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Roskelley CD, 1995, BIOCHEM CELL BIOL, V73, P391, DOI 10.1139/o95-046; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; TURNER DC, 1983, DEV BIOL, V95, P497, DOI 10.1016/0012-1606(83)90052-0; VLODAVSKY I, 1999, CURR PROTOCOLS CELL, V1; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Zamir E, 1999, J CELL SCI, V112, P1655	23	2310	2415	14	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1708	1712		10.1126/science.1064829	http://dx.doi.org/10.1126/science.1064829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721053				2022-12-24	WOS:000172307400042
J	Bartke, A; Wright, JC; Mattison, JA; Ingram, DK; Miller, RA; Roth, GS				Bartke, A; Wright, JC; Mattison, JA; Ingram, DK; Miller, RA; Roth, GS			Longevity - Extending the lifespan of long-lived mice	NATURE			English	Article							AMES DWARF MICE; CALORIC RESTRICTION; GENE		So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; NIA, NIH, Anim Ctr, Poolesville, MD 20837 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Gerontol Res Ctr, Baltimore, MD 21224 USA	Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan	Bartke, A (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.		Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X	NATIONAL INSTITUTE ON AGING [Z01AG000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2000, RES PRO CEL, V29, P181; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618	11	311	322	0	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					412	412		10.1038/35106646	http://dx.doi.org/10.1038/35106646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719795	Green Published, Bronze			2022-12-24	WOS:000172304500033
J	Solomon, CG; Hu, FB; Dunaif, A; Rich-Edwards, J; Willett, WC; Hunter, DJ; Colditz, GA; Speizer, FE; Manson, JE				Solomon, CG; Hu, FB; Dunaif, A; Rich-Edwards, J; Willett, WC; Hunter, DJ; Colditz, GA; Speizer, FE; Manson, JE			Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYCYSTIC-OVARY-SYNDROME; IMPAIRED GLUCOSE-TOLERANCE; PIMA INDIAN WOMEN; INSULIN-RESISTANCE; ORAL-CONTRACEPTIVES; PREVALENCE; HYPERINSULINEMIA; DYSFUNCTION; ANDROGENS; DISEASE	Context Although oligomenorrhea has been associated cross-sectionally with insulin resistance and glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of type 2 diabetes mellitus (DM). Objective To prospectively assess risk of type 2 DM in women with a history of long or highly irregular menstrual cycles. Design and Setting The Nurses' Health Study II, a prospective observational cohort study. Participants A total of 101073 women who had no. prior history of DM and who reported their usual menstrual cycle pattern at age 18 to 22 years on the baseline (1989) questionnaire. Main Outcome Measure Incident reports of DM, with follow-up through 1997, compared among women categorized by menstrual cycle length (5 categories). Results During 564333 person-years of follow-up, there were 507 cases of type 2 DM. Compared with women with a usual cycle length of 26 to 31 days (referent category) at age 18 to 22 years, the relative risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was too irregular to estimate was 2.08 (95% confidence interval [CI], 1.62-2.66), adjusting for body mass index at age 18 years and several other potential confounding variables. The RR of type 2 DM associated with long or highly irregular menstrual cycles was greater in obese women, but was also increased in nonobese women (at body mass indexes at age 18 years of <25,25-29, and <greater than or equal to>30 kg/m(2), RRs were 1.67 [95% CI, 1.14-2.45],1.74 [95% CI, 1.07-2.82], and 3.86 [95% CI, 2.33-6.38], respectively). Conclusion Women with long or highly irregular menstrual cycles have a significantly increased risk for developing type 2 DM that is not completely explained by obesity.	Brigham & Womens Hosp, Dept Med, Div Womens Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Plan, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Solomon, CG (corresponding author), Brigham & Womens Hosp, Dept Med, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NCI NIH HHS [CA-50385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Chang RJ, 1999, ENDOCRIN METAB CLIN, V28, P397, DOI 10.1016/S0889-8529(05)70076-1; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; ChasanTaber L, 1997, DIABETES CARE, V20, P330, DOI 10.2337/diacare.20.3.330; Diamanti-Kandarakis E, 1999, J CLIN ENDOCR METAB, V84, P4006, DOI 10.1210/jc.84.11.4006; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; GODSLAND IF, 1992, J CLIN ENDOCR METAB, V74, P64, DOI 10.1210/jc.74.1.64; HAFFNER SM, 1988, METABOLISM, V37, P683, DOI 10.1016/0026-0495(88)90091-1; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P56, DOI 10.1210/jc.77.1.56; HARRIS M, 1979, DIABETES, V28, P1039; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hosmer DW, 1997, STAT MED, V16, P965; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Legro RS, 1998, AM J OBSTET GYNECOL, V179, pS101, DOI 10.1016/S0002-9378(98)70240-6; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; POLDERMAN KH, 1994, J CLIN ENDOCR METAB, V79, P265, DOI 10.1210/jc.79.1.265; Roumain J, 1998, DIABETES CARE, V21, P346, DOI 10.2337/diacare.21.3.346; SINGH KB, 1981, AM J OBSTET GYNECOL, V140, P299, DOI 10.1016/0002-9378(81)90277-5; TROY LM, 1995, INT J OBESITY, V19, P570; WEISS DJ, 1994, METABOLISM, V43, P803, DOI 10.1016/0026-0495(94)90257-7; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; 2001, DIABETES CARE, V24, pS21	28	239	252	2	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2421	2426		10.1001/jama.286.19.2421	http://dx.doi.org/10.1001/jama.286.19.2421			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712937	Bronze			2022-12-24	WOS:000172266100021
J	Sonnenberg, P; Murray, J; Glynn, JR; Shearer, S; Kambashi, B; Godfrey-Faussett, P				Sonnenberg, P; Murray, J; Glynn, JR; Shearer, S; Kambashi, B; Godfrey-Faussett, P			HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; 2-YEAR FOLLOW-UP; SHORT-COURSE CHEMOTHERAPY; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; EXOGENOUS REINFECTION; MOLECULAR EPIDEMIOLOGY; INFECTED PATIENTS; MORTALITY; THERAPY	Background The proportion of recurrent tuberculosis cases attributable to relapse or reinfection and the risk factors associated with these different mechanisms are poorly understood. We followed up a cohort of 326 South African mineworkers, who had successfully completed treatment for pulmonary tuberculosis in 1995, to determine the rate and mechanisms of recurrence. Methods Patients were examined 3 and 6 months after cure, and then were monitored by the routine tuberculosis surveillance system until December, 1998. IS6110 DNA fingerprints from initial and subsequent episodes of tuberculosis were compared to determine whether recurrence was due to relapse or reinfection All patients gave consent for HIV-1 testing. Findings During follow-up (median 25.1 months, IQR 13.2-33.4), 65 patients (20%) had a recurrent episode of tuberculosis, a recurrence rate of 10.3 episodes per 100 person-years at risk (PYAR)-16.0 per 100 PYAR in HIV-1-positive patients and 6.4 per 100 PYAR in HIV-1-negative patients. Paired DNA fingerprints were available in 39 of 65 recurrences: 25 pairs were identical (relapse) and 14 were different (reinfection). 93% (13/14) of recurrences within the first 6 months were attributable to relapse compared with 48% (12/25) of later recurrences. HIV-1 infection was a risk factor for recurrence (hazard ratio 2.4, 95% CI 1.5-4.0), due to its strong association with disease caused by reinfection (18.7 2.4-143), but not relapse (0.58; 0.24-1.4). Residual cavitation and increasing years of employment at the mine were risk factors for relapse. Interpretation In a setting with a high risk of tuberculous Infection, HIV-1 increases the risk of recurrent tuberculosis because of an Increased risk of reinfection. Interventions to prevent recurrent disease, such as lifelong chemoprophylaxis in HIV-1-positive tuberculosis patients, should be further assessed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ Witwatersrand, Natl Ctr Occupat Hlth, Dept Hlth, Johannesburg, South Africa; Univ Witwatersrand, Natl Ctr Occupat Hlth, Dept Community Hlth, Johannesburg, South Africa; Univ Teaching Hosp, Dept Med, ZAMBART Project, Lusaka, Zambia; Univ Teaching Hosp, Dept Pathol & Microbiol, ZAMBART Project, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Witwatersrand; University of Zambia; University of Zambia	Sonnenberg, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.			Sonnenberg, Pam/0000-0002-1067-1583				ABER V R, 1978, Bulletin of the International Union Against Tuberculosis, V53, P260; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Connolly C, 1999, AIDS, V13, P1543, DOI 10.1097/00002030-199908200-00015; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DAS S, 1993, TUBERCLE LUNG DIS, V74, P47, DOI 10.1016/0962-8479(93)90068-9; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; De Boer AS, 2000, NEW ENGL J MED, V342, P1050; ELLIOTT AM, 1995, J TROP MED HYG, V98, P9; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; HAWKEN M, 1993, LANCET, V342, P332, DOI 10.1016/0140-6736(93)91474-Z; Johnson JL, 1997, INT J TUBERC LUNG D, V1, P446; KASSIM S, 1995, AIDS, V9, P1185, DOI 10.1097/00002030-199510000-00011; Kelly PM, 1999, T ROY SOC TROP MED H, V93, P287, DOI 10.1016/S0035-9203(99)90025-1; Mallory KF, 2000, INT J TUBERC LUNG D, V4, P455; MEDICAL RES. COUNCIL, 1962, Tubercle, V43, P201; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; OYAMA T, 1955, AM REV TUBERC PULM, V72, P613; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; PERRIENS JH, 1991, AM REV RESPIR DIS, V144, P750, DOI 10.1164/ajrccm/144.4.750; Pulido F, 1997, ARCH INTERN MED, V157, P227, DOI 10.1001/archinte.157.2.227; SAHADEVAN R, 1995, J CLIN MICROBIOL, V33, P3037, DOI 10.1128/JCM.33.11.3037-3039.1995; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sonnenberg P, 1998, INT J TUBERC LUNG D, V2, P168; Sterling TR, 1999, AIDS, V13, P1899, DOI 10.1097/00002030-199910010-00012; Sudre P, 1999, INFECTION, V27, P323, DOI 10.1007/s150100050037; TRIPATHY S. P., 1981, Indian Journal of Tuberculosis, V28, P45; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	30	331	337	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1687	1693		10.1016/S0140-6736(01)06712-5	http://dx.doi.org/10.1016/S0140-6736(01)06712-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728545				2022-12-24	WOS:000172344100013
J	Sijen, T; Fleenor, J; Simmer, F; Thijssen, KL; Parrish, S; Timmons, L; Plasterk, RHA; Fire, A				Sijen, T; Fleenor, J; Simmer, F; Thijssen, KL; Parrish, S; Timmons, L; Plasterk, RHA; Fire, A			On the role of RNA amplification in dsRNA-triggered gene silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; MESSENGER-RNA; ANTISENSE RNA; VIRUS-RESISTANCE; TOMATO LEAVES; INTERFERENCE; POLYMERASE; PLANTS	We have investigated the role of trigger RNA amplification during RNA interference (RNAi) in Caenorhabditis elegans. Analysis of small interfering RNAs (siRNAs) produced during RNAi in C. elegans revealed a substantial fraction that cannot derive directly from input dsRNA. Instead, a population of siRNAs (termed secondary siRNAs) appeared to derive from the action of a cellular RNA-directed RNA polymerase (RdRP) on mRNAs. that are being targeted by the RNAi mechanism. The distribution of secondary siRNAs exhibited a distinct polarity (5'-->3' on the antisense strand), suggesting a cyclic amplification process in which RdRP is primed by existing siRNAs. This amplification mechanism substantially augments the potency of RNAi-based surveillance, while ensuring that the RNAi machinery will focus on expressed mRNAs.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Johns Hopkins Univ, Biol Grad Program, Baltimore, MD 21218 USA; Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Johns Hopkins University; Carnegie Institution for Science	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Greiver, Michelle/N-8764-2015; Simmer, Femke/N-2150-2015	Greiver, Michelle/0000-0001-8957-0285; Fire, Andrew/0000-0001-6217-8312	NICHD NIH HHS [HD08353] Funding Source: Medline; NIGMS NIH HHS [GM07231, R01 GM037706, GM37706] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender J, 2001, CELL, V106, P129, DOI 10.1016/S0092-8674(01)00441-X; BENIAN GM, 1993, GENETICS, V134, P1097; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bosher JM, 1999, GENETICS, V153, P1245; BRENNER S, 1974, GENETICS, V77, P71; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DIENER TO, 1991, FASEB J, V5, P2808, DOI 10.1096/fasebj.5.13.1717335; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; FIRE A, 1991, DEVELOPMENT, V113, P503; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; HERMAN RK, 1982, GENETICS, V102, P379; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KIFF JE, 1988, NATURE, V331, P631, DOI 10.1038/331631a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Modahl LE, 2000, MOL CELL BIOL, V20, P6030, DOI 10.1128/MCB.20.16.6030-6039.2000; MOERMAN DG, 1988, GENE DEV, V2, P93, DOI 10.1101/gad.2.1.93; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; PARRISH S, 2001, IN PRESS RNA; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2000, BIOESSAYS, V22, P520, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;520::AID-BIES5&gt;3.0.CO;2-W; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	50	942	1092	5	105	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					465	476		10.1016/S0092-8674(01)00576-1	http://dx.doi.org/10.1016/S0092-8674(01)00576-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719187	Bronze			2022-12-24	WOS:000172272900007
J	Morrow, DA; Antman, EM; Giugliano, RP; Cairns, R; Charlesworth, A; Murphy, SA; de Lemos, JA; McCabe, CH; Braunwald, E				Morrow, DA; Antman, EM; Giugliano, RP; Cairns, R; Charlesworth, A; Murphy, SA; de Lemos, JA; McCabe, CH; Braunwald, E			A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy	LANCET			English	Article							THROMBOLYTIC THERAPY; THROMBIN INHIBITION; MORTALITY; STRATIFICATION; HIRUDIN; PREDICT; SCORE	Background Rapid, effective triage is integral to emergency cardiac care of patients with ST-elevation myocardial infarction (STEMI). Available models for predicting mortality in STEMI include up to 45 variables, but have consistently shown advanced age, Increased heart rate, and decreased blood pressure to be among the strongest predictors. Methods On the basis of observed risk relations among 13 253 patients with STEMI from the InTIME II trial, we developed and assessed a simple risk index using age, heart rate, and systolic blood pressure (SBP) for predicting mortality over 30 days: (heart rate X [age/10](2))/SBP. Findings The risk index was a strong (c statistic=0.78) and independent predictor of mortality risk (p<0.0001). When the risk index was categorised into quintiles for convenient clinical use, it revealed a more than 20-fold gradient of increasing mortality from 0.8 to 17.4%, p<0.0001. The risk Index was also a robust predictor of very early events, including death by 24 h (c statistic=0.81). External validation in patients with STEMI from the TIMI 9 trials (n=3659) showed both a high discriminatory capacity (c statistic=0.79), and excellent concordance between the observed 30-day mortality in each of the five risk groups and the predictions based on InTIME II (goodness-of-fit, p=0.7). Interpretation A simple risk index based on characteristics easily assessed by any paramedical or clinical personnel captures most of the information from more complex tools, and is likely to be useful In the rapid triage of patients with STEMI outside hospital or on first arrival in the hospital.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Trials Grp, Boston, MA 02115 USA; Nottingham Clin Res, Nottingham, England; Harvard Univ, Clin Res Inst, Boston, MA 02115 USA; Univ Texas SW, Dept Med, Dallas, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrow, DA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Trials Grp, 75 Francis St, Boston, MA 02115 USA.		de Lemos, James/ABD-6669-2021; Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675				ANTMAN EM, 1994, CIRCULATION, V90, P1624, DOI 10.1161/01.CIR.90.4.1624; Antman EM, 1996, CIRCULATION, V94, P911, DOI 10.1161/01.CIR.94.5.911; Arntz HR, 1998, EUR HEART J, V19, P1140; Braunwald E, 2000, EUR HEART J, V21, P2005; Cannon CP, 2000, J EMERG MED, V19, p21S, DOI 10.1016/S0736-4679(00)00251-1; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HILLIS LD, 1990, J AM COLL CARDIOL, V16, P313, DOI 10.1016/0735-1097(90)90579-E; Hutter AM, 2000, J AM COLL CARDIOL, V35, P846; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4	17	216	227	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2001	358	9293					1571	1575		10.1016/S0140-6736(01)06649-1	http://dx.doi.org/10.1016/S0140-6736(01)06649-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716882				2022-12-24	WOS:000172188300009
J	Smith, O				Smith, O			Microbiology - Know thine enemy	SCIENCE			English	Editorial Material																		Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998	2	0	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1298	1298		10.1126/science.294.5545.1298	http://dx.doi.org/10.1126/science.294.5545.1298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701920				2022-12-24	WOS:000172130200037
J	Lister, AM; Sher, AV				Lister, AM; Sher, AV			The origin and evolution of the woolly mammoth	SCIENCE			English	Article								The mammoth lineage provides an example of rapid adaptive evolution in response to the changing environments of the Pleistocene. Using welt-dated samples from across the mammoth's Eurasian range, we document geographical and chronological variation in adaptive morphology. This work illustrates an incremental (if mosaic) evolutionary sequence but also reveals a complex interplay of local morphological innovation, migration, and extirpation in the origin and evolution of a mammalian species. In particular, northeastern Siberia is identified as an area of successive allopatric innovations that apparently spread to Europe, where they contributed to a complex pattern of stasis, replacement, and transformation.	UCL, Dept Biol, London WC1E 6BT, England; Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 117071, Russia	University of London; University College London; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Lister, AM (corresponding author), UCL, Dept Biol, London WC1E 6BT, England.	a.lister@ucl.ac.uk		Lister, Adrian/0000-0002-7985-138X				Azzaroli A, 1977, MEMORIE CLASSE SCI F, V14, P149; Carroll RL, 1997, PATTERNS PROCESSES V; Dietrich W.O., 1965, PALAONTOLOGISCHE A A, V2, P521; Dubrovo I. A, 1964, PAL ZH, V3, P82; Dubrovo I.A., 1966, B KOM IZUC CHETV, V32, P63; Ferretti MP, 1999, ECLOGAE GEOL HELV, V92, P503; Foronova Irina V., 1999, Deinsea, V6, P103; GARUTT VE, 1986, P ZOOL I ST PET, V149, P21; GOULD S J, 1977, Paleobiology, V3, P115; ILFORD KS, 1925, Q J GEOL SOC LOND, V81, P62; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KOTSAKIS T, 1978, Geologica Romana, V17, P411; Lister A.M., 1992, P185; Lister Adrian M., 1996, P203; Lister Adrian M., 1993, Quaternary International, V19, P77, DOI 10.1016/1040-6182(93)90026-C; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; Roopnarine PD, 1999, PALEOBIOLOGY, V25, P41; SCHREVE D, IN PRESS FOSSIL MAMM; SHER A, UNPUB; Sher A.V., 1987, Palaeontographia Italica, V74, P97; Sher A.V., 1999, 2 INT MAMM C OFF C P, P58; Sher A.V., 1997, TERRESTRIAL PALEOENV, P3; SHER AV, 1985, DOKL AKAD NAUK SSSR+, V285, P221; STEINHEIM WO, 1912, JAHRESH VER VATERL N, V68, P42; Stuart AJ, 2001, QUATERNARY SCI REV, V20, P1677, DOI 10.1016/S0277-3791(01)00034-8	26	128	145	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1094	1097		10.1126/science.1056370	http://dx.doi.org/10.1126/science.1056370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691991				2022-12-24	WOS:000172013800048
J	Mushlin, AI; Ruchlin, HS; Callahan, MA				Mushlin, AI; Ruchlin, HS; Callahan, MA			Costeffectiveness of diagnostic tests	LANCET			English	Article								We review the principles underlying cost-effectiveness analysis of diagnostic tests and procedures. We use two clinical examples, diagnostic testing for early multiple sclerosis and for Helicobacter pylori to illustrate the methods of analysis and to show how the results can be useful for physicians or payers of health services in making decisions about provision and use of diagnostic services. Economic assessments of diagnostic tests are Inherently more difficult than assessments of therapeutic interventions, mainly because of uncertainty about the relation between diagnosis and end results (outcomes) of care. Nonetheless, because of the increasing Importance of diagnostic technology in medicine and healthcare, only with such assessments will the most value be gained from restricted medical resources.	Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA	Cornell University	Mushlin, AI (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 411 E 69th St, New York, NY 10021 USA.	aim2001@mail.med.cornell						Anderson GF, 2000, HEALTH AFFAIR, V19, P150, DOI 10.1377/hlthaff.19.3.150; *CAN COORD OFF HLT, 1997, GUID EC EV PHARM; *COMM DEP HUM SERV, 1995, GUID PHARM IND PREP; FENDRICK AM, 1995, ANN INTERN MED, V123, P260, DOI 10.7326/0003-4819-123-4-199508150-00003; Garber AM, 2000, HANDB ECON, V17, P181; MOONEY C, 1990, MED DECIS MAKING, V10, P77, DOI 10.1177/0272989X9001000201; MUSHLIN AI, 1994, ARCH NEUROL-CHICAGO, V51, P67, DOI 10.1001/archneur.1994.00540130093017; Mushlin AI, 1997, INT J TECHNOL ASSESS, V13, P21, DOI 10.1017/S0266462300010205; *NAT I CLIN EXC, 2001, APPR NEW EX TECHN IN; Rabin M, 1998, J ECON LIT, V36, P11; 1989, FED REG         0130, V54, P4308	11	42	43	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1353	1355		10.1016/S0140-6736(01)06417-0	http://dx.doi.org/10.1016/S0140-6736(01)06417-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484RC	11684235				2022-12-24	WOS:000171702500032
J	Chandler, WL; Jelacic, S; Boster, DR; Ciol, MA; Williams, GD; Watkins, SL; Igarashi, T; Tarr, PI				Chandler, WL; Jelacic, S; Boster, DR; Ciol, MA; Williams, GD; Watkins, SL; Igarashi, T; Tarr, PI			Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	XVIIIth Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 06-12, 2001	PARIS, FRANCE	Int Soc Thrombosis & Haemostasis			TISSUE-PLASMINOGEN ACTIVATOR; ESCHERICHIA-COLI O157-H7; FIBRINOLYTIC THERAPY; INHIBITOR TYPE-1; FRAGMENT 1+2; D-DIMER; PLASMA; HISTOPATHOLOGY; IMMUNOASSAY; DEGRADATION	Background: The hemolytic-uremic syndrome is a thrombotic complication of Escherichia coli O157:H7 infection. It is not known whether the coagulation abnormalities precede, and potentially cause, this disorder. Methods: In 53 children infected with E. coli O157:H7, we measured a panel of markers indicating activation of the clotting cascade and renal function within four days after the onset of illness. These markers were measured again in as many as possible of the 16 children in whom the hemolytic-uremic syndrome developed. Results: The children in whom the hemolytic-uremic syndrome subsequently developed had significantly higher median plasma concentrations of prothrombin fragment 1+2, tissue plasminogen activator (t-PA) antigen, t-PA-plasminogen-activator inhibitor type 1 (PAI-1) complex, and d-dimer than children with uncomplicated infection. These abnormalities preceded the development of azotemia and thrombocytopenia. When the hemolytic-uremic syndrome developed, the urinary concentrations of beta(2)-microglobulin and N-acetyl-beta -glucosaminidase rose significantly (P=0.03 for both increases); the plasma concentrations of t-PA antigen, t-PA-PAI-1 complex, d-dimer, and plasmin-antiplasmin complex also increased significantly. The concentration of t-PA antigen correlated with that of the t-PA-PAI-1 complex in a linear regression model (squared correlation coefficient, 0.80; P<0.001). Conclusions: In the hemolytic-uremic syndrome, thrombin generation (probably due to accelerated thrombogenesis) and inhibition of fibrinolysis precede renal injury and may be the cause of such injury. (N Engl J Med 2002;346:23-32.) Copyright (C) 2002 Massachusetts Medical Society.	Childrens Hosp & Reg Med Ctr, Div Gastroenterol, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo	Tarr, PI (corresponding author), Childrens Hosp & Reg Med Ctr, Div Gastroenterol, CH-24,4800 Sand Point Way NE, Seattle, WA 98105 USA.			Jelacic, Srdjan/0000-0002-6617-9870; Ciol, Marcia/0000-0001-6406-4706	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052081] Funding Source: NIH RePORTER; NIDDK NIH HHS [1RO1DK52081] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDERMAN MH, 1983, NEW ENGL J MED, V309, P1213, DOI 10.1056/NEJM198311173092004; BELL BP, 1997, PEDIATRICS, V100, P127; BERGSTEIN JM, 1992, NEW ENGL J MED, V327, P755, DOI 10.1056/NEJM199209103271102; BRENNER B, 1990, CIRCULATION, V81, P1818, DOI 10.1161/01.CIR.81.6.1818; Chandler WL, 2000, CLIN CHEM, V46, P38; Chandler WL, 2000, HAEMOSTASIS, V30, P204; Chandler WL, 1997, CIRCULATION, V96, P761; CHART H, 1991, LANCET, V337, P437, DOI 10.1016/0140-6736(91)91222-G; COLDING H, 1992, APMIS, V100, P119, DOI 10.1111/j.1699-0463.1992.tb00849.x; ELMS MJ, 1983, THROMB HAEMOSTASIS, V50, P591; EVRIN PE, 1972, SCAND J CLIN LAB INV, V29, P69, DOI 10.3109/00365517209081057; HABIB R, 1992, HEMOLYTIC UREMIC SYN, P315; Hayashi M, 1997, ACTA OBSTET GYN SCAN, V76, P590, DOI 10.3109/00016349709024590; HOLVOET P, 1986, THROMB HAEMOSTASIS, V56, P124; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; KATZ J, 1971, J PEDIATR-US, V78, P426, DOI 10.1016/S0022-3476(71)80222-6; KNECHT MF, 1992, THROMB RES, V67, P213, DOI 10.1016/0049-3848(92)90140-6; MONNENS L, 1982, CLIN NEPHROL, V17, P284; Nakao H, 2000, J NAT TOXINS, V9, P299; Nevard CHF, 1997, THROMB HAEMOSTASIS, V78, P1450; OKAMOTO K, 1992, HAEMOSTASIS, V22, P17; PELZER H, 1991, THROMB HAEMOSTASIS, V65, P153; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; RIELLA MC, 1976, NEPHRON, V17, P188, DOI 10.1159/000180723; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; Tsai HM, 2001, PEDIATR RES, V49, P653, DOI 10.1203/00006450-200105000-00008; Van Geet C, 1998, KIDNEY INT, V54, P1324, DOI 10.1046/j.1523-1755.1998.00103.x; VANDEKAR NCAJ, 1994, PEDIATR RES, V36, P257, DOI 10.1203/00006450-199408000-00019; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	29	157	166	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					23	32		10.1056/NEJMoa011033	http://dx.doi.org/10.1056/NEJMoa011033			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11777999				2022-12-24	WOS:000173033600004
J	Rojstaczer, S; Sterling, SM; Moore, NJ				Rojstaczer, S; Sterling, SM; Moore, NJ			Human appropriation of photosynthesis products	SCIENCE			English	Article							GLOBAL CARBON-CYCLE; FORESTS; ECOSYSTEMS; STORAGE	Previous global estimates of the human impact on terrestrial photosynthesis products depended heavily on extrapolation from plot-scale measurements. Here, we estimated this impact with the use of recent data, many of which were collected at global and continental scales. Monte Carlo techniques that incorporate known and estimated error in our parameters provided estimates of uncertainty. We estimate that humans appropriate 10 to 55% of terrestrial photosynthesis products. This broad range reflects uncertainty in key parameters and makes it difficult to ascertain whether we are approaching crisis levels in our use of the planet's resources. Improved estimates will require high-resolution global measures within agricultural lands and tropical forests.	Duke Univ, Ctr Hydrol Sci, Durham, NC 27708 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University; Duke University	Rojstaczer, S (corresponding author), Duke Univ, Ctr Hydrol Sci, Durham, NC 27708 USA.		Noojipady, Praveen/B-2511-2010					AJTAY GL, 1979, GLOBAL CARBON CYCLE, P129; ARMENTANO TV, 1980, CAN J FOREST RES, V10, P53, DOI 10.1139/x80-009; BROWN C, 1999, GFPOSWP03 FAO; BROWN S, 1992, INTERCIENCIA, V17, P8; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; FAO, 1995, FOR RES ASS 1990 GLO; *FAO, 1990, 1989 FAO PROD YB; *FAO, 1992, FOR RES TROP ZON MAI; Haberl H, 1997, AMBIO, V26, P143; LIETH H, 1973, HUM ECOL, V1, P303, DOI 10.1007/BF01536729; PANDEY D, 1997, GCPINT628UK FAO FOOD; Pandey D, 1995, 128 FAO; Pimentel D., 1996, FOOD ENERGY SOC; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Scharpenberg R., 1998, GLOBAL FIBRE SUPPLY; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITTAKER RH, 1973, HUM ECOL, V1, P357, DOI 10.1007/BF01536732; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; WRIGHT DH, 1990, AMBIO, V19, P189; [No title captured]	23	173	196	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2549	2552		10.1126/science.1064375	http://dx.doi.org/10.1126/science.1064375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752576				2022-12-24	WOS:000172927700059
J	Roth, JP; Yoder, JC; Won, TJ; Mayer, JM				Roth, JP; Yoder, JC; Won, TJ; Mayer, JM			Application of the Marcus cross relation to hydrogen atom transfer reactions	SCIENCE			English	Article							COUPLED ELECTRON-TRANSFER; PROTON; RADICALS; ABSTRACTION; COMPLEXES; RATES; DNA	The transfer of a hydrogen atom-a proton and an electron-is a fundamental process in chemistry and biology. A variety of hydrogen atom transfer reactions, involving iron complexes, phenols, hydroxylamines, (BuOOH)-Bu-t, toluene, and related radicals, are shown to follow the Marcus cross relation. Thus, the Marcus theory formalism based on ground-state energetics and self-exchange rates, originally developed for electron transfer processes, is also valuable for hydrogen atom transfer. Compounds that undergo slow proton transfer (C-H bonds) or slow electron transfer (cobalt complexes) also undergo slow hydrogen atom transfer. Limitations of this approach are also discussed.	Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mayer, JM (corresponding author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.	mayer@chem.washington.edu	Roth, Justine/B-5488-2013		NIGMS NIH HHS [2 R01 GM50422-05, 1 F32 GM63383-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM063383, R01GM050422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERY WJ, 1980, ANNU REV PHYS CHEM, V31, P227, DOI 10.1146/annurev.pc.31.100180.001303; AVILA DV, 1995, J AM CHEM SOC, V117, P2929, DOI 10.1021/ja00115a029; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; Baskin S., 1997, OXIDANTS ANTIOXIDANT; Bordwell FG, 1996, J AM CHEM SOC, V118, P10819, DOI 10.1021/ja961469q; Borgis D, 1996, J PHYS CHEM-US, V100, P1118, DOI 10.1021/jp9522324; Cabelli DE, 2001, ORGANOMETALLICS, V20, P3729, DOI 10.1021/om0102089; COHEN AO, 1968, J PHYS CHEM-US, V72, P4249, DOI 10.1021/j100858a052; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Donahue NM, 1998, J PHYS CHEM A, V102, P3923, DOI 10.1021/jp980372i; FISCHER H, 1984, LANDOLTBORNSTEIN, V13; FISCHER H, 1984, LANDOLTBORNSTEIN, V18; Iordanova N, 2001, J AM CHEM SOC, V123, P3723, DOI 10.1021/ja0100524; KOCHI JK, 1973, FREE RADICALS, V1, P69; KREILICK RW, 1966, J AM CHEM SOC, V88, P2645, DOI 10.1021/ja00964a004; KRISTJANSDOTTIR SS, 1991, J AM CHEM SOC, V113, P4366, DOI 10.1021/ja00011a070; Lee E, 2000, J PHYS CHEM B, V104, P6894, DOI 10.1021/jp000167e; Lee ISH, 2001, J AM CHEM SOC, V123, P7492, DOI 10.1021/ja004232+; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Marcus RA, 1997, J PHYS CHEM A, V101, P4072, DOI 10.1021/jp963722e; Mayer Jean Francois, UNPUB; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; Mijs W.J., 1986, ORGANIC SYNTHESIS OX; Olah G.A., 1995, HYDROCARBON CHEM; Roth JP, 1999, INORG CHEM, V38, P2760, DOI 10.1021/ic990251c; Roth JP, 2000, J AM CHEM SOC, V122, P5486, DOI 10.1021/ja9941328; RUSSELL GA, 1973, FREE RADICALS, V1, P283; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; SUTIN N, 1983, PROG INORG CHEM, V30, P441, DOI 10.1002/9780470166314.ch9; Tanko JM, 2001, J AM CHEM SOC, V123, P5808, DOI 10.1021/ja005730l; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Weatherly SC, 2001, J AM CHEM SOC, V123, P1236, DOI 10.1021/ja003788u; YODER JC, UNPUB; ZAVELOVICH EB, 1974, CHEM PHYS LETT, V29, P212, DOI 10.1016/0009-2614(74)85015-3	34	181	181	9	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2524	2526		10.1126/science.1066130	http://dx.doi.org/10.1126/science.1066130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752572				2022-12-24	WOS:000172927700051
J	de Groot, BL; Grubmuller, H				de Groot, BL; Grubmuller, H			Water permeation across biological membranes: Mechanism and dynamics of aquaporin-1 and GlpF	SCIENCE			English	Article							MOLECULAR-DYNAMICS; GLYCEROL FACILITATOR; CHANNEL; RECONSTITUTION; LIPOSOMES; VERSION; PORE	"Real time" molecular dynamics simulations of water permeation through human aquaporin-1 (AQP1) and the bacterial glycerol facilitator GlpF are presented. We obtained time-resolved, atomic-resolution models of the permeation mechanism across these highly selective membrane channels. Both proteins act as two-stage filters: Conserved fingerprint [asparagine-proline-alanine (NPA)] motifs form a selectivity-determining region; a second (aromatic/arginine) region is proposed to function as a proton filter. Hydrophobic regions near the NPA motifs are rate-limiting water barriers. In AQP1, a fine-tuned water dipole rotation during passage is essential for water selectivity. In GlpF, a glycerol-mediated "induced fit" gating motion is proposed to generate selectivity for glycerol over water.	Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany	Max Planck Society	Grubmuller, H (corresponding author), Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, Fassberg 11, D-37077 Gottingen, Germany.	hgrubmu@gwdg.de						Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERENDSEN HJC, COMMUNICATION; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; Deen PMT, 1998, CURR OPIN CELL BIOL, V10, P435, DOI 10.1016/S0955-0674(98)80055-0; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; ENGEL A, IN PRESS INT REV CYT; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; JUNG JS, 1994, J BIOL CHEM, V269, P14648; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; MAUREL C, 1994, J BIOL CHEM, V269, P11869; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; SHI LB, 1994, J BIOL CHEM, V269, P10417; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1	39	776	794	6	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2353	2357		10.1126/science.1062459	http://dx.doi.org/10.1126/science.1062459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743202				2022-12-24	WOS:000172817200047
J	Thompson, JR; Gerald, PF; Willoughby, MLN; Armstrong, BK				Thompson, JR; Gerald, PF; Willoughby, MLN; Armstrong, BK			Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study	LANCET			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; NEURAL-TUBE DEFECTS; COLORECTAL-CANCER; COMMON MUTATION; RISK-FACTORS; LEUKEMIA; GENE; SUSCEPTIBILITY; DEFICIENCY; CHILDREN	Background Acute lymphoblastic leukaemia is the most common childhood cancer in more-developed countries but it has few recognised risk factors or preventive measures. We aimed to determine and assess the risk factors associated with this disease. Methods From 1984 to 1992, we investigated known and suspected risk factors for common acute lymphoblastic leukaemia diagnosed in a population-based case-control study of children aged 0-14 years in Western Australia. 83 children in the study group came from the sole referral centre for paediatric cancer in the state and 166 controls matched for age and sex were recruited through a postal survey of people randomly selected from the state electoral roll. We interviewed mothers of 83 study and 166 control children (82% and 74%, respectively, of those eligible). Fathers completed a self-administered questionnaire. Findings We recorded a protective association between iron or folate supplementation in pregnancy and risk of common acute lymphoblastic leukaemia in the child (odds ratio 0.37 [95% CI 0.21-0.65]; p=0.001). For iron alone, the odds ratio was 0.75 (0.37-1.51); only one mother took folate without iron. Further analyses of folate use with or without iron (0.40; 0.21-0.73) showed that the protective effect varies little by time of first use of supplements or for how long they were taken. The association was not weakened by adjustment for potentially confounding variables. Interpretation Our results, though unexpected, suggest that folate supplementation in pregnancy reduces the risk of common acute lymphoblastic leukaemia in the child.	Canc Fdn Western Australia, Perth, WA, Australia; Univ Newcastle, Royal Newcastle Hosp, Sch Populat Hlth Sci, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; Princess Margaret Hosp, Dept Haematol & Oncol, Perth, WA, Australia; New S Wales Canc Council, Sydney, NSW, Australia	University of Newcastle; Cancer Council New South Wales	Thompson, JR (corresponding author), Canc Fdn Western Australia, Perth, WA, Australia.	rickthom@iinet.net.au	Armstrong, Bruce K/K-9464-2015	Armstrong, Bruce K/0000-0001-8940-7525				ARUNDEL SE, 1986, J EPIDEMIOL COMMUN H, V40, P30, DOI 10.1136/jech.40.1.30; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Bower C, 1997, AUST NZ J OBSTET GYN, V37, P267; BUCKLEY JD, 1994, LEUKEMIA, V8, P856; BUNIN GR, 1993, NEW ENGL J MED, V329, P536, DOI 10.1056/NEJM199308193290804; Chen J, 1996, CANCER RES, V56, P4862; CNATTINGIUS S, 1995, J NATL CANCER I, V87, P908, DOI 10.1093/jnci/87.12.908; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Esteller M, 1997, CARCINOGENESIS, V18, P2307, DOI 10.1093/carcin/18.12.2307; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GREAVES MF, 1988, LEUKEMIA, V2, P120; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; KAYE SA, 1991, CANCER-AM CANCER SOC, V68, P1351, DOI 10.1002/1097-0142(19910915)68:6<1351::AID-CNCR2820680627>3.0.CO;2-J; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; KINLEN L, 1988, LANCET, V2, P1323; LOWENGART RA, 1987, J NATL CANCER I, V79, P39; Ma J, 1997, CANCER RES, V57, P1098; MILLER RW, 1963, NEW ENGL J MED, V268, P393, DOI 10.1056/NEJM196302212680801; Parkin DM, 1998, IARC SCI PUBLICATION, V144; Petridou E, 1997, BRIT J CANCER, V76, P1241, DOI 10.1038/bjc.1997.541; Roman E, 1997, BRIT J CANCER, V76, P406, DOI 10.1038/bjc.1997.399; ROSS JA, 1994, EPIDEMIOL REV, V16, P243, DOI 10.1093/oxfordjournals.epirev.a036153; Rozen R, 1999, AM J MED GENET, V83, P142, DOI 10.1002/(SICI)1096-8628(19990312)83:2<142::AID-AJMG12>3.0.CO;2-Y; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Taylor GM, 1996, LEUKEMIA, P210; Ullen H, 1997, CANCER LETT, V114, P215, DOI 10.1016/S0304-3835(97)04666-1; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANSTEENSELMOLL HA, 1985, INT J EPIDEMIOL, V14, P555, DOI 10.1093/ije/14.4.555; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298	31	184	187	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2001	358	9297					1935	1940		10.1016/S0140-6736(01)06959-8	http://dx.doi.org/10.1016/S0140-6736(01)06959-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500HZ	11747917				2022-12-24	WOS:000172622200010
J	Titan, SMO; Bingham, S; Welch, A; Luben, R; Oakes, S; Day, N; Khaw, KT				Titan, SMO; Bingham, S; Welch, A; Luben, R; Oakes, S; Day, N; Khaw, KT			Frequency of eating and concentrations of serum cholesterol in the Norfolk population of the European prospective investigation into cancer (EPIC-Norfolk): cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							INCREASED MEAL FREQUENCY; HEART-DISEASE; PLASMA; LIPIDS	Objectives To examine the relation between self reported eating frequency and serum lipid concentrations in a free living population. Design Cross sectional population based study. Setting Norfolk, England. Participants 14 666 men and women aged 45-75 years from the Norfolk cohort of the European prospective investigation into cancer (EPIC-Norfolk). Main outcome measures Concentrations of blood lipids. Results Mean concentrations of total cholesterol and low density lipoprotein cholesterol decreased in a continuous relation with increasing daily frequency of eating in men and women. No consistent relation was observed for high density lipoprotein cholesterol, body mass index, waist to hip ratio, or blood pressure. Mean cholesterol concentrations differed by about 0.25 mmol/l between people eating more than six times a day and those eating once or twice daily; this difference was reduced to 0.15 mmol/l after adjustment for possible confounding variables, including age, obesity, cigarette smoking, physical activity, and intake of energy, and nutrients (alcohol, fat, fatty acids, protein, and carbohydrate). Conclusions Concentrations of total cholesterol and low density lipoprotein cholesterol are negatively and consistently associated with frequency of eating in a general population. The effects of eating frequency on lipid concentrations induced in short term trials in animals and human volunteers under controlled laboratory conditions can be observed in a free living general population. We need to consider not just what we eat but how often we eat.	Univ Cambridge, Inst Publ Hlth, Cambridge CB2 2SR, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.		Welch, Ailsa Ann/A-4850-2008; Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021	Welch, Ailsa Ann/0000-0002-6702-3704; Luben, Robert N/0000-0002-5088-6343; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNOLD LM, 1993, AM J CLIN NUTR, V57, P446, DOI 10.1093/ajcn/57.3.446; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; COHN C, 1960, METABOLISM, V9, P492; COHN C, 1959, AM J PHYSIOL, V196, P965, DOI 10.1152/ajplegacy.1959.196.5.965; Colhoun H, 1996, SERIES HS; Day N, 1999, BRIT J CANCER, V80, P95; EDELSTEIN SL, 1992, AM J CLIN NUTR, V55, P664, DOI 10.1093/ajcn/55.3.664; FABRY P, 1968, LANCET, V2, P190; FABRY P, 1970, AM J CLIN NUTR, V23, P1059; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GWINUP G, 1963, AM J CLIN NUTR, V13, P209, DOI 10.1093/ajcn/13.4.209; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; MCGRATH SA, 1994, EUR J CLIN NUTR, V48, P402; Murphy MC, 1996, EUR J CLIN NUTR, V50, P491; Powell JT, 1999, J CARDIOVASC RISK, V6, P19; Wald NJ, 1995, ATHEROSCLEROSIS, V118, pS1, DOI 10.1016/0021-9150(95)90067-5; WOLEVER TMS, 1990, METABOLISM, V39, P947, DOI 10.1016/0026-0495(90)90306-W	19	63	64	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2001	323	7324					1286	1288A		10.1136/bmj.323.7324.1286	http://dx.doi.org/10.1136/bmj.323.7324.1286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731392	Green Published, Bronze			2022-12-24	WOS:000172655800019
J	Tang, GL; Minemoto, Y; Dibling, B; Purcell, NH; Li, ZW; Karin, M; Lin, A				Tang, GL; Minemoto, Y; Dibling, B; Purcell, NH; Li, ZW; Karin, M; Lin, A			Inhibition of JNK activation through NF-kappa B target genes	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; TNF RECEPTOR-1; JUN KINASES; CELL-DEATH; IAP GENE; APOPTOSIS; IDENTIFICATION; DOMAIN; INDUCTION	The proinflammatory cytokine tumour necrosis factor-alpha (TNF-alpha) regulates immune responses, inflammation and programmed cell death (apoptosis)(1-4). The ultimate fate of a cell exposed to TNF-alpha is determined by signal integration between its different effectors, including I kappaB kinase (IKK), c-Jun N-terminal protein kinase (JNK) and caspases(1). Activation of caspases is required for apoptotic cell death(5), whereas IKK activation inhibits apoptosis through the transcription factor NF-kappaB, whose target genes include caspase inhibitors(1,6-10). JNK activates the transcription factor c-Jun/AP-1, as well as other targets(11-16). However, the role of JNK activation in apoptosis induced by TNF-alpha is less clear(17,18). It is unknown whether any crosstalk occurs between IKK and JNK, and, if so, how it affects TNF-alpha -induced apoptosis. We investigated this using murine embryonic fibroblasts that are deficient in either the IKK beta catalytic subunit of the IKK complex or the RelA/p65 subunit of NF-kappaB. Here we show that in addition to inhibiting caspases, the IKK/NF-kappaB pathway negatively modulates TNF-alpha -mediated JNK activation, partly through NF-kappaB-induced X-chromosome-linked inhibitor of apoptosis (XIAP)(7,9). This negative crosstalk, which is specific to TNF-alpha signalling and does not affect JNK activation by interleukin-1 (IL-1), contributes to inhibition of apoptosis.	Univ Chicago, Ben May Inst Canc Res, Comm Canc Biol, Chicago, IL 60637 USA; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of Chicago; University of California System; University of California San Diego	Lin, A (corresponding author), Univ Chicago, Ben May Inst Canc Res, Comm Canc Biol, 5841 S Maryland Ave,MC 6027, Chicago, IL 60637 USA.							Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; ROTHWARF DM, 1999, SCIENCE STKE; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TRACEY KJ, 1993, CRITICAL CARE MED, V21, P415; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	30	630	645	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					313	317		10.1038/35104568	http://dx.doi.org/10.1038/35104568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713531				2022-12-24	WOS:000172150700045
J	Barbour, V				Barbour, V			Imatinib for chronic myeloid leukaemia: a NICE mess	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Barbour, V (corresponding author), Lancet, London WC1X 8RR, England.			Barbour, Virginia/0000-0002-2358-2440				Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goldman JM, 2000, LANCET, V355, P1031, DOI 10.1016/S0140-6736(00)02029-8; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538	4	7	9	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2001	358	9292					1478	1478		10.1016/S0140-6736(01)06571-0	http://dx.doi.org/10.1016/S0140-6736(01)06571-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705557				2022-12-24	WOS:000172055800007
J	Tounian, P; Aggoun, Y; Dubern, B; Varille, V; Guy-Grand, B; Sidi, D; Girardet, JP; Bonnet, D				Tounian, P; Aggoun, Y; Dubern, B; Varille, V; Guy-Grand, B; Sidi, D; Girardet, JP; Bonnet, D			Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-FAT DISTRIBUTION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; BLOOD-FLOW; FOLLOW-UP; ADOLESCENTS; ATHEROSCLEROSIS; ASSOCIATION	Background Epidemiological studies suggest that obesity-induced atherosclerosis may start in childhood, but this process has never been demonstrated. We looked for arterial changes and investigated their relation to cardiovascular risk factors in obese children. Methods Non-invasive ultrasonographic measurements were made in 48 severely obese children and 27 controls to investigate arterial mechanics and endothelial function. Plasma lipid concentrations, indices of insulin resistance, and body composition were assessed in the obese children. Findings The obese children had significantly lower arterial compliance than the healthy controls (median 0.132 [0.022-0.273], vs 0.143 [0.112-0.237] mm(2).mm Hg; p=0.02) and lower distensibility (0.60 [0.10-1.00] vs 0.70 [0.50-1.10] mm Hg-1.10(-2); p=0.0001). Conversely, the obese children had higher values than the controls for wall stress (3.36 [2.00-5.01] vs 2.65 [2.13-3.54] mm Hg.10(2); p=0.0001) and incremental elastic modulus (1.68 [0.72-10.8] vs 0.96 [0.64-1.47]; p=0.0001). Endothelium-dependent and independent function were also lower in the obese than in the control children. An android fat distribution was positively correlated with indices of insulin resistance and plasma triglyceride concentrations and was negatively correlated with plasma HDL-cholesterol concentration and arterial compliance. Endothelial dysfunction was correlated with low plasma apolipoprotein A-1 and with insulin resistance indices. Interpretation Severe obesity in children is associated with arterial wall stiffness and endothelial dysfunction. Low plasma apolipoprotein A-1, insulin resistance, and android fat distribution may be the main risk factors for these arterial changes, which are of considerable concern as possible early events in the genesis of atheroma.	Necker Enfants Malad Teaching Hosp, Dept Paediat Cardiol, F-75015 Paris, France; Armand Trousseau Teaching Hosp, Dept Paediat Gastroenterol & Nutr, Paris, France; Hotel Dieu Teaching Hosp, Dept Nutr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Bonnet, D (corresponding author), Necker Enfants Malad Teaching Hosp, Dept Paediat Cardiol, 149 Rue Sevres, F-75015 Paris, France.		Tounian, Patrick/AAF-6226-2021; AGGOUN, Yacine/ABC-7903-2020					Aggoun Y, 2000, HEART, V84, P290, DOI 10.1136/heart.84.3.290; Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070; Arcaro G, 1999, INT J OBESITY, V23, P936, DOI 10.1038/sj.ijo.0801022; Bachorik PS, 1997, CLIN CHEM, V43, P2364; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Bonadonna RC, 1998, CIRCULATION, V98, P234, DOI 10.1161/01.CIR.98.3.234; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Clarkson P, 1996, J CLIN INVEST, V97, P1989, DOI 10.1172/JCI118632; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; GIRARDET JP, 1993, ANN PEDIATR-PARIS, V40, P297; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HARRIS M, 1979, DIABETES, V28, P1039; KANNEL WB, 1987, AM HEART J, V114, P413, DOI 10.1016/0002-8703(87)90511-4; KWITEROVICH PO, 1990, PEDIATR CLIN N AM, V37, P1489; Laine M, 1998, J CLIN INVEST, V101, P1156, DOI 10.1172/JCI1065; Lebuffe G, 1997, BIOCHEM BIOPH RES CO, V241, P205, DOI 10.1006/bbrc.1997.7790; Markus RA, 1997, AM J CLIN NUTR, V65, P1000, DOI 10.1093/ajcn/65.4.1000; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mietus-Snyder M, 1998, J PEDIATR-US, V133, P35, DOI 10.1016/S0022-3476(98)70174-X; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Owens S, 1998, J PEDIATR-US, V133, P41, DOI 10.1016/S0022-3476(98)70175-1; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Toikka JO, 1999, ATHEROSCLEROSIS, V147, P133, DOI 10.1016/S0021-9150(99)00186-0; Tounian P, 1999, INT J OBESITY, V23, P830, DOI 10.1038/sj.ijo.0800959; Wascher TC, 2000, DIABETES, V49, P803, DOI 10.2337/diabetes.49.5.803; Yamamoto M, 1997, INT J OBESITY, V21, P948, DOI 10.1038/sj.ijo.0800501	30	593	624	2	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1400	1404		10.1016/S0140-6736(01)06525-4	http://dx.doi.org/10.1016/S0140-6736(01)06525-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705484				2022-12-24	WOS:000171940100009
J	Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C				Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C			Diversity and productivity in a long-term grassland experiment	SCIENCE			English	Article							ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; PLANT COMPOSITION; BIODIVERSITY; PERFORMANCE; ALTER	Plant diversity and niche complementarity had progressively stronger effects on ecosystem functioning during a 7-year experiment, with 16-species plots attaining 2.7 times greater biomass than monocultures. Diversity effects were neither transients nor explained solely by a few productive or unviable species. Rather, many higher-diversity plots outperformed the best monoculture. These results help resolve debate over biodiversity and ecosystem functioning, show effects at higher than expected diversity levels, and demonstrate, for these ecosystems, that even the best-chosen monocultures cannot achieve greater productivity or carbon stores than higher-diversity sites.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Nat Resource Sci, Lincoln, NE 68583 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Knops, Johannes/AAA-8546-2020; Wedin, David A/K-4093-2012	Reich, Peter/0000-0003-4424-662X				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Guterman L, 2000, CHRON HIGHER EDUC, pA24; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hodgson JG, 1998, FUNCT ECOL, V12, P843, DOI 10.1046/j.1365-2435.1998.00253.x; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; SWIFT MJ, 1993, ECOL STU AN, V99, P15; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	22	1503	1690	43	1034	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					843	845		10.1126/science.1060391	http://dx.doi.org/10.1126/science.1060391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679667	Green Published, Green Submitted			2022-12-24	WOS:000171851800044
J	Vecchione, M; Young, RE; Guerra, A; Lindsay, DJ; Clague, DA; Bernhard, JM; Sager, WW; Gonzalez, AF; Rocha, FJ; Segonzac, M				Vecchione, M; Young, RE; Guerra, A; Lindsay, DJ; Clague, DA; Bernhard, JM; Sager, WW; Gonzalez, AF; Rocha, FJ; Segonzac, M			Worldwide observations of remarkable deep-sea squids	SCIENCE			English	Article									Natl Museum Nat Hist, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20560 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; CSIC, Inst Invest Marinas, ECOBIOMAR, Vigo, Spain; Japan Marine Sci & Technol Ctr, Marine Ecosyst Res Dept, Yokosuka, Kanagawa, Japan; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ S Carolina, Dept Environm Hlth Sci, Columbia, SC 29208 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; IFREMER, CENTOB, Plouzane, France	National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Monterey Bay Aquarium Research Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station; Ifremer	Vecchione, M (corresponding author), Natl Museum Nat Hist, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20560 USA.	vecchione.michael@nmnh.si.edu	Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				ASUBEL J, 1999, OCEANOGRAPHY, V12, P4; Smith CR, 1998, DEEP-SEA RES PT II, V45, P1, DOI 10.1016/S0967-0645(97)00088-X; Vecchione M, 1998, S AFR J MARINE SCI, V20, P429	3	31	35	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2505	2506		10.1126/science.294.5551.2505	http://dx.doi.org/10.1126/science.294.5551.2505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752567	Green Submitted			2022-12-24	WOS:000172927700044
J	Murphy, WJ; Eizirik, E; O'Brien, SJ; Madsen, O; Scally, M; Douady, CJ; Teeling, E; Ryder, OA; Stanhope, MJ; de Jong, WW; Springer, MS				Murphy, WJ; Eizirik, E; O'Brien, SJ; Madsen, O; Scally, M; Douady, CJ; Teeling, E; Ryder, OA; Stanhope, MJ; de Jong, WW; Springer, MS			Resolution of the early placental mammal radiation using Bayesian phylogenetics	SCIENCE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCES; ORIGINS	Molecular phylogenetic studies have resolved placental. mammals into four major groups, but have not established the full hierarchy of interordinal relationships, including the position of the root. The latter is critical for understanding the early biogeographic history of placentals. We investigated placental phylogeny using Bayesian and maximum-likelihood methods and a 16.4-kilobase molecular data set. Interordinal. relationships are almost entirely resolved. The basal split is between Afrotheria and other placentals, at about 103 million years, and may be accounted for by the separation of South America and Africa in the Cretaceous. Crown-group Eutheria may have their most recent common ancestry in the Southern Hemisphere (Gondwana).	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; Queens Univ Belfast, Belfast, Antrim, North Ireland; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Glaxo SmithKline, Collegeville, PA 19426 USA; Inst Systemat & Populat Biol, Amsterdam, Netherlands	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Radboud University Nijmegen; Queens University Belfast; Zoological Society of San Diego; GlaxoSmithKline	O'Brien, SJ (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	obrien@ncifcr.gov; mark.springer@ucr.edu	Madsen, Ole/E-3730-2012; Douady, Christophe J/N-1357-2014; Eizirik, Eduardo/K-8034-2012; Douady, Christophe/N-3069-2019; OBRIEN, STEPHEN/ABD-1346-2020	Madsen, Ole/0000-0001-8082-7881; Douady, Christophe J/0000-0002-4503-8040; Eizirik, Eduardo/0000-0002-9658-0999; Douady, Christophe/0000-0002-4503-8040; OBRIEN, STEPHEN/0000-0001-7857-0757; Teeling, Emma/0000-0002-3309-1346				Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hay WW, 1999, GEOL S AM S, P1; Hillis David M., 1996, P515; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Matthew W. D., 1915, Annals of the New York Academy of Sciences, V24; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 2001, SCIENCE, V292, P2264, DOI 10.1126/science.1059393; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAINGER R, 1991, AGENDA ANTIQUITY HF; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Smith AG, 1994, ATLAS CENOZOIC MESOZ; Springer MS, 2001, MOL BIOL EVOL, V18, P132, DOI 10.1093/oxfordjournals.molbev.a003787; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wallace A. R, 1962, GEOGRAPHICAL DISTRIB; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; [No title captured]	29	974	1020	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2348	2351		10.1126/science.1067179	http://dx.doi.org/10.1126/science.1067179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743200				2022-12-24	WOS:000172817200045
J	Bird, A				Bird, A			Molecular biology - Methylation talk between histones and DNA	SCIENCE			English	Editorial Material							NEUROSPORA-CRASSA; DEACETYLASE; REPRESSION; CHROMATIN; MECP2		Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.			Bird, Adrian/0000-0002-8600-0372				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Irelan JT, 1997, GENETICS, V146, P509; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SELKER EU, 1987, SCIENCE, V238, P48, DOI 10.1126/science.2958937; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508	12	130	159	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2113	2115		10.1126/science.1066726	http://dx.doi.org/10.1126/science.1066726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739943				2022-12-24	WOS:000172647700035
J	Fenton, KA; Korovessis, C; Johnson, AM; McCadden, A; McManus, S; Wellings, K; Mercer, CH; Carder, C; Copas, AJ; Nanchahal, K; Macdowall, W; Ridgway, G; Field, J; Erens, B				Fenton, KA; Korovessis, C; Johnson, AM; McCadden, A; McManus, S; Wellings, K; Mercer, CH; Carder, C; Copas, AJ; Nanchahal, K; Macdowall, W; Ridgway, G; Field, J; Erens, B			Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection	LANCET			English	Article								Background Studies of the epidemiology of sexually transmitted infections (STI) are largely based on surveillance data. As part of a national survey of sexual attitudes and lifestyles (Natsal 2000) in Britain, we estimated the frequency of self-reported STIs, and the prevalence of urinary Chlamydia trachomatis infection. Methods We did a stratified probability sample survey of 11 161 men and women aged 16-44 years in Britain. Computer assisted self-interviews contained items on the nature and timing of previously diagnosed STIs. Half of all sexually experienced respondents aged 18-44 years were invited to provide a urine sample for ligase chain reaction testing for C trachomatis infection. Findings 10.8% of men and 12.6% of women reported ever having an STI, 3.6% of men and 4.1% of women reported ever being diagnosed with genital warts, and 1.4% of men and 3.1% of women reported previous infection with C trachomatis. 76% of men and 57% of women ever diagnosed with an STI had been to a GUM clinic. C trachomatis was found in 2.2% (95% CI 1.5-3.2) of men and 1.5% (95% CI 1.11-2.14) of women with age-specific prevalence being highest among men aged 25-34 (3.1%) and women aged 16-24 years (3.0%). Non-married status, age, and reporting partner concurrency or two or more sexual partners in the past year were independently associated with infection with C trachomatis. Interpretation We show substantial heterogeneity in distribution of reported STIs, and the demographic and behavioural determinants of prevalent genital chlamydial infection. The results have potentially wide application for proposed chlamydia screening programmes which, given the demonstrated prevalence, must now proactively seek to involve men.	Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England; Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Populat Sci, London, England; Royal Free & UCL, Dept Sexually Transmitted Dis, London, England; PHLS Communicable Dis Surveillance Ctr, HIV STI Div, London, England; Natl Ctr Social Res, London, England; UCL Hosp NHS Trust, Dept Microbiol, London, England; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Fenton, KA (corresponding author), Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England.	kfenton@gum.ucl.ac.uk	McManus, Sally/HGD-4860-2022; McManus, Sally/S-4697-2019	McManus, Sally/0000-0003-2711-0819; Johnson, Anne/0000-0003-1330-7100; Erens, Robert/0000-0002-3054-504X; Copas, Andrew/0000-0001-8968-5963; Nanchahal, Kiran/0000-0001-8812-7628; Erens, Bob/0000-0002-4430-954X; Macdowall, Wendy/0000-0001-5868-8336; Mercer, Catherine/0000-0002-4220-5034				BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Carder C, 1999, INT J STD AIDS, V10, P776, DOI 10.1258/0956462991913538; *CHIEF MED OFF MED, 1998, MAIN REP CMOS EXP AD; Department of Health, 2001, NAT STRAT SEX HLTH H, P1; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0	5	312	312	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1851	1854		10.1016/S0140-6736(01)06886-6	http://dx.doi.org/10.1016/S0140-6736(01)06886-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741624				2022-12-24	WOS:000172463000010
J	Rausch, C; Daram, P; Brunner, S; Jansa, J; Laloi, M; Leggewie, G; Amrhein, N; Bucher, M				Rausch, C; Daram, P; Brunner, S; Jansa, J; Laloi, M; Leggewie, G; Amrhein, N; Bucher, M			A phosphate transporter expressed in arbuscule-containing cells in potato	NATURE			English	Article							MYCORRHIZAL FUNGUS; GENE; IDENTIFICATION; ARABIDOPSIS; DIVERSITY; VECTORS; CLONING; PLANTS	Arbuscular mycorrhizas are the most common non-pathogenic symbioses in the roots of plants. It is generally assumed that this symbiosis facilitated the colonization of land by plants(1). In arbuscular mycorrhizas, fungal hyphae often extend between the root cells and tuft-like branched structures (arbuscules) form within the cell lumina that act as the functional interface for nutrient exchange. In the mutualistic arbuscular-mycorrhizal symbiosis the host plant derives mainly phosphorus from the fungus, which in turn benefits from plant-based glucose(2). The molecular basis of the establishment and functioning of the arbuscular-mycorrhizal symbiosis is largely not understood. Here we identify the phosphate transporter gene StPT3 in potato (Solanum tuberosum). Functionality of the encoded protein was confirmed by yeast complementation. RNA localization and reporter gene expression indicated expression of StPT3 in root sectors where mycorrhizal structures are formed. A sequence motif in the StPT3 promoter is similar to transposon-like elements, suggesting that the mutualistic symbiosis evolved by genetic rearrangements in the StPT3 promoter.	ETH Zurich, Fed Inst Technol, Inst Plant Sci, Expt Stn Eschikon 33, CH-8315 Lindau, Switzerland; Max Planck Inst Plant Mol Physiol, D-14424 Potsdam, Germany; ETH Zurich, Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bucher, M (corresponding author), ETH Zurich, Fed Inst Technol, Inst Plant Sci, Expt Stn Eschikon 33, CH-8315 Lindau, Switzerland.		Bucher, Marcel/D-4596-2013; Jansa, Jan/H-3161-2014	Bucher, Marcel/0000-0003-1680-9413; Jansa, Jan/0000-0002-0331-1774				BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Bucher M, 2001, J PLANT NUTR SOIL SC, V164, P209, DOI 10.1002/1522-2624(200104)164:2<209::AID-JPLN209>3.0.CO;2-F; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Gianinazzi-Pearson V, 2000, PLANTA, V211, P609, DOI 10.1007/s004250000323; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hoagland DR, 1936, PLANT PHYSIOL, V11, P471, DOI 10.1104/pp.11.3.471; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; LOCKETT TJ, 1990, ANAL BIOCHEM, V185, P230, DOI 10.1016/0003-2697(90)90284-G; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; MERRYWEATHER JW, 1991, MYCOL RES, V95, P1435, DOI 10.1016/S0953-7562(09)80399-7; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Rosewarne GM, 1999, NEW PHYTOL, V144, P507, DOI 10.1046/j.1469-8137.1999.00536.x; Selinger DA, 1999, P NATL ACAD SCI USA, V96, P15007, DOI 10.1073/pnas.96.26.15007; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VARMA A, 1999, ENDOMYCORRHIZA, P521; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X	30	305	349	2	106	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					462	466		10.1038/35106601	http://dx.doi.org/10.1038/35106601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719809				2022-12-24	WOS:000172304500047
J	Reusch, TBH; Haberli, MA; Aeschlimann, PB; Milinski, M				Reusch, TBH; Haberli, MA; Aeschlimann, PB; Milinski, M			Female sticklebacks count alleles in a strategy of sexual selection explaining MHC polymorphism	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATE CHOICE; MATING PREFERENCES; GENES; MOLECULES; EVOLUTION; ODOR; MICE	The origin and maintenance of polymorphism in major histocompatibility complex (MHC) genes in natural populations is still unresolved(1). Sexual selection, frequency-dependent selection by parasites and pathogens, and heterozygote advantage have been suggested to explain the maintenance of high allele diversity at MHC genes(2-4). Here we argue that there are two (non-exclusive) strategies for MHC-related sexual selection, representing solutions to two different problems: inbreeding avoidance and parasite resistance. In species prone to inadvertent inbreeding, partners should prefer dissimilar MHC genotypes to similar ones. But if the goal is to maximize the resistance of offspring towards potential infections, the choosing sex should prefer mates with a higher diversity of MHC alleles. This latter strategy should apply when there are several MHC loci, as is the case in most vertebrates(2,5). We tested the relative importance of an 'allele counting' strategy compared to a disassortative mating strategy using wild-caught three-spined sticklebacks (Gasterosteus aculeatus) from an interconnected system of lakes. Here we show that gravid female fish preferred the odour of males with a large number of MHC class-IIB alleles to that of males with fewer alleles. Females did not prefer male genotypes dissimilar to their own.	Max Planck Inst Limnol, Dept Evolutionary Ecol, D-24306 Plon, Germany	Max Planck Society	Reusch, TBH (corresponding author), Max Planck Inst Limnol, Dept Evolutionary Ecol, Postfach 165, D-24306 Plon, Germany.	reusch@mpil-ploen.mpg.de	Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Reusch, Thorsten B. H./0000-0002-8961-4337				Andersson Malte, 1994; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Binz T, 2001, J FISH BIOL, V58, P887, DOI 10.1006/jfbi.2000.1485; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; BROWN RE, 1989, BEHAV GENET, V19, P658, DOI 10.1007/BF01066029; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Darwin Charles, 1859, ORIGIN SPECIES MEANS, P88; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; KLEIN J, 1986, NATURAL HIST MAJOR H, P615; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Largiader CR, 1999, MOL ECOL, V8, P342; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; POTTS WK, 1995, IMMUNOL REV, V143, P181, DOI 10.1111/j.1600-065X.1995.tb00675.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Steck N, 1999, BEHAV ECOL, V10, P493, DOI 10.1093/beheco/10.5.493; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WOOTTEN RJ, 1976, BIOL STICKLEBACK, P75; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818	28	362	371	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					300	302		10.1038/35104547	http://dx.doi.org/10.1038/35104547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713527				2022-12-24	WOS:000172150700041
J	Farmer, JA				Farmer, JA			Learning from the cerivastatin experience	LANCET			English	Editorial Material							SIMVASTATIN; LOVASTATIN; PRAVASTATIN; ACID		Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Farmer, JA (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	jfarmer@bcm.tmc.edu						Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Davidson M H, 2000, Curr Atheroscler Rep, V2, P14, DOI 10.1007/s11883-000-0090-4; Downs JR, 2001, AM J CARDIOL, V87, P1074, DOI 10.1016/S0002-9149(01)01464-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Flint OP, 1997, TOXICOL APPL PHARM, V145, P99, DOI 10.1006/taap.1997.8174; GADBUT AP, 1995, J MOL CELL CARDIOL, V27, P2397, DOI 10.1016/S0022-2828(95)92163-X; Graham DJ, 2001, JAMA-J AM MED ASSOC, V286, P831, DOI 10.1001/jama.286.7.831; Gruer PJK, 1999, AM J CARDIOL, V84, P811, DOI 10.1016/S0002-9149(99)00442-7; Lofberg M, 1998, ACTA NEUROL SCAND, V98, P268, DOI 10.1111/j.1600-0404.1998.tb07307.x; Miller DB, 1998, CLIN PHARMACOKINET, V34, P155, DOI 10.2165/00003088-199834020-00003; PEDERSEN TR, 1994, LANCET, V344, P1383; Pfeffer MA, 2001, EUR HEART J, V22, P271; Stein E, 1998, AM J CARDIOL, V82, p40J, DOI 10.1016/S0002-9149(98)00436-6; WATTS GF, 1993, J CLIN PATHOL, V46, P1055, DOI 10.1136/jcp.46.11.1055	14	88	92	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2001	358	9291					1383	1385		10.1016/S0140-6736(01)06489-3	http://dx.doi.org/10.1016/S0140-6736(01)06489-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705478				2022-12-24	WOS:000171940100003
J	Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN				Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN			Germ cell survival through carbohydrate-mediated interaction with Sertoli cells	SCIENCE			English	Article							ALPHA-D-MANNOSIDASE; SPERM PLASMA-MEMBRANES; LINKED OLIGOSACCHARIDES; BIOSYNTHESIS; EXPRESSION; EPIDIDYMIS	Spermatogenesis is a precisely regulated process in which the germ cells closely interact with Sertoli cells. The molecular basis of this cell-cell adhesion is unknown. Here, we demonstrate that targeted disruption of Man2a2, a gene encoding alpha -mannosidase IIx (MX), an enzyme that forms intermediate asparagine-linked carbohydrates (N-glycans), results in Man2a2 null mates that are largely infertile. The Man2a2 null spermatogenic cells fail to adhere to Sertoli cells and are prematurely released from the testis to epididymis. We identified an N-glycan structure that plays a key role in germ cell-Sertoli cell adhesion and showed that a specific carbohydrate was required for spermatogenesis.	Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA; Burnham Inst, Stem Cell Program, La Jolla, CA 92037 USA; Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido, Japan; Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; Tohoku Univ, Dept Urol, Sendai, Miyagi 980, Japan; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Hokkaido University; Keio University; Tohoku University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia	Fukuda, MN (corresponding author), Burnham Inst, Glycobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Moremen, Kelley/AAD-4661-2019; Nishimura, Shinichiro/F-5277-2011; Millan, Jose Luis/B-6580-2008		NCI NIH HHS [CA71932, CA 42595] Funding Source: Medline; NCRR NIH HHS [RR05351] Funding Source: Medline; NICHD NIH HHS [HD05863, U54 HD035041] Funding Source: Medline; NIGMS NIH HHS [GM47533] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042595, P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAMA T, UNPUB; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEPHILIP RM, 1987, BIOL REPROD, V37, P1271, DOI 10.1095/biolreprod37.5.1271; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Hiramoto S, 1997, BIOCHEM BIOPH RES CO, V241, P439, DOI 10.1006/bbrc.1997.7768; Igdoura SA, 1999, EUR J CELL BIOL, V78, P441, DOI 10.1016/S0171-9335(99)80071-5; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; KERR JB, 1995, MICROSC RES TECHNIQ, V32, P364, DOI 10.1002/jemt.1070320503; KOHNO S, 1983, J REPROD IMMUNOL, V5, P339, DOI 10.1016/0165-0378(83)90243-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MOREMEN KW, 2000, COMPREHENSIVE HDB, P81; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P138; Oh-eda M, 2001, EUR J BIOCHEM, V268, P1280, DOI 10.1046/j.1432-1327.2001.01992.x; Panter KE, 1999, J NAT TOXINS, V8, P53; SKUDLAREK MD, 1991, BIOCHEM J, V277, P213, DOI 10.1042/bj2770213; STAMENKOVIC I, 1992, CELL, V68, P1003, DOI 10.1016/0092-8674(92)90071-J; TAKAHASHI N, 1992, HDB ENDOGLYCOSIDASES, P199; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; TULSIANI DRP, 1989, J CELL BIOL, V109, P1257, DOI 10.1083/jcb.109.3.1257; TULSIANI DRP, 1990, BIOL REPROD, V42, P843, DOI 10.1095/biolreprod42.5.843; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936	28	115	118	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					124	127		10.1126/science.1065570	http://dx.doi.org/10.1126/science.1065570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778047				2022-12-24	WOS:000173143100048
J	Schwetz, BA				Schwetz, BA			Breast tissue ablation device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-24	WOS:000172978500005
J	Leveille, SG; Ling, S; Hochberg, MC; Resnick, HE; Bandeen-Roche, KJ; Won, A; Guralnik, JM				Leveille, SG; Ling, S; Hochberg, MC; Resnick, HE; Bandeen-Roche, KJ; Won, A; Guralnik, JM			Widespread musculoskeletal pain and the progression of disability in older disabled women	ANNALS OF INTERNAL MEDICINE			English	Article							GENERAL-POPULATION; OSTEO-ARTHRITIS; UNITED-STATES; OSTEOARTHRITIS; KNEE; PREVALENCE; HEALTH; HIP; FIBROMYALGIA; ASSOCIATION	Background: Widespread musculoskeletal pain is a poorly understood but common problem in older adults. Little is known about the progression of disability related to this condition. Objective: To determine whether widespread musculoskeletal pain increases the risk for worsening disability in older women with disabilities. Design: Prospective cohort study. Setting: The Women's Health and Aging Study. Participants: 1002 community-dwelling women 65 years of age or older with disability. Measurements: Widespread musculoskeletal pain was defined as pain in the upper and lower extremities and axial pain with moderate or severe pain in at least one of the three regions. Worsening disability was defined as progression from no or mild difficulty to severe difficulty or inability to perform activities of daily living (ADLs), walk one-quarter mile, or lift 10 lbs. Results: At baseline, 24% of participants had widespread pain and 25% had no pain or only mild pain in a single site. Women with widespread pain were 2.5 to 3.5 times more likely to have severe difficulty with ADLs, walking, or lifting at baseline compared with women who had no or mild pain. In women without severe difficulty initially, widespread pain nearly doubled the risk for progression to severe difficulty in each of the tasks, after adjustment for age, body mass index, comorbid illness, and other confounders. Conclusion: Widespread musculoskeletal pain is frequent among community-dwelling older women with disability and appears to predict the progression of disability. Efforts to better understand the cause of this pain and its treatment might reduce the overall burden of disability.	Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Univ Maryland, Baltimore, MD 21201 USA; Maryland Vet Affairs Hlth Care Syst, Baltimore, MD USA; NIA, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Leveille, SG (corresponding author), Hebrew Rehabil Ctr Aged, Res & Training Inst, 1200 Ctr St, Boston, MA 02131 USA.	leveille@mall.hrca.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580	NATIONAL INSTITUTE ON AGING [N01AG012112] Funding Source: NIH RePORTER; NIA NIH HHS [N01-AG12112] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett Robert, 1998, Current Opinion in Rheumatology, V10, P95, DOI 10.1097/00002281-199803000-00002; Brattberg G, 1996, PAIN, V67, P29, DOI 10.1016/0304-3959(96)03047-3; Cooper C, 1996, J RHEUMATOL, V23, P1938; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; CROFT P, 1993, J RHEUMATOL, V20, P710; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; FELSON DT, 1995, J RHEUMATOL, V22, P7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIED LP, 2000, WOMENS HLTH AGING ST; GURALNIK JM, 2001, WOMENS HLTH AGING ST; Hirsch R, 1996, ANN RHEUM DIS, V55, P25, DOI 10.1136/ard.55.1.25; HOCHBERG MC, 1989, SEMIN ARTHRITIS RHEU, V18, P4, DOI 10.1016/0049-0172(89)90008-5; HOCHBERG MC, 1995, J RHEUMATOL, V22, P2291; Kasper JD, 1999, ANN EPIDEMIOL, V9, P498, DOI 10.1016/S1047-2797(99)00026-5; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWLESS JF, 1982, STAT MODELS METHODS, P376; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leveille SG, 1999, J GERONTOL A-BIOL, V54, pM487, DOI 10.1093/gerona/54.10.M487; Lichtenstein MJ, 1998, J GERONTOL A-BIOL, V53, pM361; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; *NAT CTR HLTH STAT, 1999, HLTH AG CHARTB; NORRIS JT, 1987, J AM GERIATR SOC, V35, P989, DOI 10.1111/j.1532-5415.1987.tb04001.x; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Scudds RJ, 2000, J GERONTOL A-BIOL, V55, pM393, DOI 10.1093/gerona/55.7.M393; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Won A, 1999, J AM GERIATR SOC, V47, P936, DOI 10.1111/j.1532-5415.1999.tb01287.x	34	142	144	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1038	1046		10.7326/0003-4819-135-12-200112180-00007	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747382				2022-12-24	WOS:000172759700003
J	Siani, G; Paterne, M; Michel, E; Sulpizio, R; Sbrana, A; Arnold, M; Haddad, G				Siani, G; Paterne, M; Michel, E; Sulpizio, R; Sbrana, A; Arnold, M; Haddad, G			Mediterranean Sea surface radiocarbon reservoir age changes since the last glacial maximum	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; DEGLACIATION; C-14; PERIOD; EVENT; VENTILATION; CALIBRATION; RECORDS; ISOTOPE; BP	Sea surface reservoir ages must be known to establish a common chronological framework for marine, continental, and cryospheric paleoproxies, and are crucial for understanding ocean-continent climatic relationships and the paleoventilation of the ocean. Radiocarbon dates of planktonic foraminifera and tephra contemporaneously deposited over Mediterranean marine and terrestrial regions reveal that the reservoir ages were similar to the modern one (similar to 400 years) during most of the past 18,000 carbon-14 years. However, reservoir ages increased by a factor of 2 at the beginning of the last deglaciation. This is attributed to changes of the North Atlantic thermohaline circulation during the massive ice discharge event Heinrich 1.	CNRS, Lab Sci Climat & Environm, F-91118 Gif Sur Yvette, France; CNRS, Unite Mixte Serv, F-91118 Gif Sur Yvette, France; CNR, Ctr Studio Geol Strutturale & Dinam Appennino, I-56126 Pisa, Italy; CNR, Dipartimento Sci Terra, I-56126 Pisa, Italy; TotalFina Elf, Ctr Sci Jean Feger, F-64018 Pau, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Total SA; Centre Scientifique et Technique Jean Feger (CSTJF)	Paterne, M (corresponding author), CNRS, Lab Sci Climat & Environm, Ave Terrasse, F-91118 Gif Sur Yvette, France.		Sulpizio, Roberto/S-2133-2019	Sulpizio, Roberto/0000-0002-3930-5421; SBRANA, ALESSANDRO/0000-0003-1373-0603; Siani, Giuseppe/0000-0002-2090-5320				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bard E., 1987, CLIM DYNAM, V1, P101, DOI 10.1007/BF01054479; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Broecker WS, 1988, PALEOCEANOGRAPHY, V3, P659, DOI 10.1029/PA003i006p00659; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; BROECKER WS, 1969, LIMNOL OCEANOGR, V14, P883, DOI 10.4319/lo.1969.14.6.0883; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Combourieu-Nebout N, 1998, QUATERNARY SCI REV, V17, P303, DOI 10.1016/S0277-3791(97)00039-5; Facorellis Y, 1998, RADIOCARBON, V40, P963; Hughen KA, 1998, RADIOCARBON, V40, P483; Kallel N, 1997, PALAEOGEOGR PALAEOCL, V135, P97, DOI 10.1016/S0031-0182(97)00021-7; Mercone D, 2000, PALEOCEANOGRAPHY, V15, P336, DOI 10.1029/1999PA000397; MICHEL E, 1995, PALEOCEANOGRAPHY, V10, P927, DOI 10.1029/95PA00978; OSTLUND HG, 1987, GEOSECS ATLANTIC PAC, P7; RUDDIMAN WF, 1981, PALAEOGEOGR PALAEOCL, V35, P145; SAMTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209; Siani G, 2000, RADIOCARBON, V42, P271, DOI 10.1017/S0033822200059075; SIANI G, 1999, THESIS U PARIS SUD O; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Stocker TF, 1998, RADIOCARBON, V40, P359; STUIVER M, 1991, QUATERNARY RES, V35, P1, DOI 10.1016/0033-5894(91)90091-I; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Vidal L, 1999, CLIM DYNAM, V15, P909, DOI 10.1007/s003820050321; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581; Zahn R, 1987, PALEOCEANOGRAPHY, V2, P543, DOI 10.1029/PA002i006p00543	29	244	248	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1917	1920		10.1126/science.1063649	http://dx.doi.org/10.1126/science.1063649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729315				2022-12-24	WOS:000172465000056
J	Makino, Y; Cao, RH; Svensson, K; Bertilsson, GR; Asman, M; Tanaka, H; Cao, YH; Berkenstam, A; Poellinger, L				Makino, Y; Cao, RH; Svensson, K; Bertilsson, GR; Asman, M; Tanaka, H; Cao, YH; Berkenstam, A; Poellinger, L			Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression	NATURE			English	Article							TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; FACTOR 1-ALPHA; ANGIOGENESIS; FACTOR-1; GROWTH; ALPHA; PROTEOLYSIS; INDUCTION	Alteration of gene expression is a crucial component of adaptive responses to hypoxia. These responses are mediated by hypoxia-inducible transcription factors (HIFs)(1,2). Here we describe an inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, which is a basic helix-loop-helix (bHLH)/PAS protein structurally related to HIFs. IPAS contains no endogenous transactivation function but demonstrates dominant negative regulation of HIF-mediated control of gene expression. Ectopic expression of IPAS in hepatoma cells selectively impairs induction of genes involved in adaptation to a hypoxic environment, notably the vascular endothelial growth factor (VEGF) gene, and results in retarded tumour growth and tumour vascular density in vivo. In mice, IPAS was predominantly expressed in Purkinje cells of the cerebellum and in corneal epithelium of the eye. Expression of IPAS in the cornea correlates with low levels of expression of the VEGF gene under hypoxic conditions. Application of an IPAS antisense oligonucleotide to the mouse cornea induced angiogenesis under normal oxygen conditions, and demonstrated hypoxia-dependent induction of VEGF gene expression in hypoxic corneal cells. These results indicate a previously unknown mechanism for negative regulation of angiogenesis and maintenance of an avascular phenotype.	Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan; Pharmacia Corp, S-12287 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Tokyo; Pfizer; Pharmacia Corporation	Poellinger, L (corresponding author), Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	lorenz.poellinger@cmb.ki.se	Berkenstam, Anders/E-7136-2012					Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Ravi R, 2000, GENE DEV, V14, P34; Sack RA, 1999, CURR EYE RES, V18, P186, DOI 10.1076/ceyr.18.3.186.5367; Semenza GL, 2000, GENE DEV, V14, P1983; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thakur A, 1998, J CLIN IMMUNOL, V18, P61, DOI 10.1023/A:1023291921695; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 2000, J EXP BIOL, V203, P1253; WIESENDANGER R, 1992, SCANNING TUNNELING M, V1, P1; Zundel W, 2000, GENE DEV, V14, P391; [No title captured]	24	491	522	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					550	554		10.1038/35107085	http://dx.doi.org/10.1038/35107085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734856				2022-12-24	WOS:000172405900049
J	Blanco, P; Palucka, AK; Gill, M; Pascual, V; Banchereau, J				Blanco, P; Palucka, AK; Gill, M; Pascual, V; Banchereau, J			Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus	SCIENCE			English	Article							SOLUBLE CD40 LIGAND; B-LYMPHOCYTES; INTERFERON; DISEASE; ENHANCE; SERUM	Dendritic cells (DCs) are important in regulating both immunity and tolerance. Hence, we hypothesized that systemic lupus erythematosus (SLE), an autoimmune disease characterized by autoreactive B and T cells, may be caused by alterations in the functions of DCs. Consistent with this, monocytes from SLE patients' blood were found to function as antigen-presenting cells, in vitro. Furthermore, serum from SLE patients induced normal monocytes to differentiate into DCs. These DCs could capture antigens from dying cells and present them to CD4-positive T cells. The capacity of SLE patients' serum to induce DC differentiation correlated with disease activity and depended on the actions of interferon-alpha (IFN-alpha). Thus, unabated induction of DCs by IFN-alpha may drive the autoimmune response in SLE.	Baylor Inst Immunol Res, Dallas, TX 75204 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Baylor Scott & White Health; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Banchereau, J (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.		Pascual, Virginia/ABD-3099-2020		NIAMS NIH HHS [R01 AR46589] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046589] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BLANCO PT, UNPUB; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Galibert L, 1996, J EXP MED, V183, P77, DOI 10.1084/jem.183.1.77; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Herrmann M, 2000, IMMUNOL TODAY, V21, P424, DOI 10.1016/S0167-5699(00)01675-3; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; LAHITA RG, 1999, SYSTEMIC LUPUD ERYTH; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Lu LJ, 1999, J CLIN INVEST, V104, P345, DOI 10.1172/JCI6801; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Tsokos GC, 2000, CURR OPIN RHEUMATOL, V12, P355, DOI 10.1097/00002281-200009000-00001; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Vallin H, 1999, CLIN EXP IMMUNOL, V115, P196; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1	26	982	1071	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1540	1543		10.1126/science.1064890	http://dx.doi.org/10.1126/science.1064890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711679				2022-12-24	WOS:000172240500053
J	Cheskin, LJ; Donze, LF				Cheskin, LJ; Donze, LF			Appearance vs health as motivators for weight loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXERCISE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cheskin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030				Brink PJ, 1998, WESTERN J NURS RES, V20, P84, DOI 10.1177/019394599802000106; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P199; CRAWFORD S, 1994, J SPORT EXERCISE PSY, V16, P70, DOI 10.1123/jsep.16.1.70; GILLETT PA, 1988, NURS RES, V37, P25; Green KL, 1997, CAN MED ASSOC J, V157, pS17; LEVY AS, 1993, ANN INTERN MED, V119, P661, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00007; Ryan RM, 1997, INT J SPORT PSYCHOL, V28, P335; WILSON GT, 1994, ADV BEHAV RES THER, V16, P31, DOI 10.1016/0146-6402(94)90002-7; Zayat EN, 1999, OBES RES, V7, P223, DOI 10.1002/j.1550-8528.1999.tb00705.x	9	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2160	2160		10.1001/jama.286.17.2160	http://dx.doi.org/10.1001/jama.286.17.2160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490CD	11694161				2022-12-24	WOS:000172032100039
J	de Noronha, CMC; Sherman, MP; Lin, HW; Cavrois, MV; Moir, RD; Goldman, RD; Greene, WC				de Noronha, CMC; Sherman, MP; Lin, HW; Cavrois, MV; Moir, RD; Goldman, RD; Greene, WC			Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; PORE COMPLEXES; PREINTEGRATION COMPLEXES; LOCALIZATION SIGNAL; MUTATIONAL ANALYSIS; NONDIVIDING CELLS; GOLGI-APPARATUS; MATRIX PROTEIN; IN-VIVO	Human immunodeficiency virus-1 (HIV-1) Vpr expression halts the proliferation of human cells at or near the G(2) cell-cycle checkpoint. The transition from G(2) to mitosis is normally controlled by changes in the state of phosphorylation and subcellular compartmentalization of key cell-cycle regulatory proteins. In studies of the intracellular trafficking of these regulators, we unexpectedly found that wild-type Vpr, but not Vpr mutants impaired for G(2) arrest, induced transient, localized herniations in the nuclear envelope (NE). These herniations were associated with defects in the nuclear lamina. Intermittently, these herniations ruptured, resulting in the mixing of nuclear and cytoplasmic components. These Vpr-induced NE changes probably contribute to the observed cell-cycle arrest.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94103 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94103 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI145234, KO8 AI01866] Funding Source: Medline; NIMH NIH HHS [P30 MH59037] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DENORONHA CM, UNPUB; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P333, DOI 10.1089/aid.1994.10.333; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hrimech M, 1999, J VIROL, V73, P4101, DOI 10.1128/JVI.73.5.4101-4109.1999; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Mahalingam S, 1998, P NATL ACAD SCI USA, V95, P3419, DOI 10.1073/pnas.95.7.3419; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Paddy MR, 1996, J CELL SCI, V109, P591; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; REFAELI Y, 1995, P NATL ACAD SCI USA, V92, P3621, DOI 10.1073/pnas.92.8.3621; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; WENTE SR, 1994, J CELL BIOL, V125, P955, DOI 10.1083/jcb.125.5.955; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	45	216	218	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1105	1108		10.1126/science.1063957	http://dx.doi.org/10.1126/science.1063957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691994				2022-12-24	WOS:000172013800051
J	Rehm, J; Gschwend, P; Steffen, T; Gutzwiller, F; Dobler-Mikola, A; Uchtenhagen, A				Rehm, J; Gschwend, P; Steffen, T; Gutzwiller, F; Dobler-Mikola, A; Uchtenhagen, A			Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study	LANCET			English	Article							TRIAL	Background Heroin-assisted substitution treatment for severely opioid-dependent drug users has been available in Switzerland since 1994. Our aim was to ascertain the feasibility, safety, and efficacy of this treatment. Methods We did a cohort study in 21 community outpatient treatment centres. We assessed 1969 opioid-dependent drug users, who began heroin-assisted substitution treatment between January, 1994, and December, 2000, to ascertain admission and discharge patterns, and patient characteristics. We also followed up a subset of 237 patients who began treatment between Jan 1, 1994, and March 31, 1995, and who stayed with the programme for at least 18 months. We used questionnaires, interviews, and medical examinations done at entry and after 6, 12, and 18 months to assess somatic and mental health, social integration, and treatment outcomes. Findings More than 70% (1378) of patients remained in treatment for more than a year. Treatment showed positive effects with respect to health and social outcomes. A long stay in treatment was related to a higher chance of starting abstinence-oriented therapy than a short stay. Interpretation: Heroin-assisted substitution treatment might be an effective option for chronically addicted patients for whom other treatments have failed.	Res Inst Addict, CH-8031 Zurich, Switzerland; Ctr Addict & Mental Hlth, Toronto, ON, Canada; Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Zurich	Rehm, J (corresponding author), Res Inst Addict, CH-8031 Zurich, Switzerland.	jtrehm@aol.com	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012	Rehm, Jürgen/0000-0001-5665-0385				ALI R, 1999, SUCHT, V45, P160; Bammer G, 1999, SCIENCE, V284, P1277, DOI 10.1126/science.284.5418.1277; CATTANEO M, 1993, EVALUATION FEDERAL M; CURDIN C, 2000, MED RUNDSCHAU PRAXIS, V89, P1899; DOBLERMIKOLA A, 1998, METHADON HEROINUNTER; *FED OFF PUBL HLTH, 1999, SCHWEIZ DROG STRAT V; Fischer B, 1997, CAN J PUBLIC HEALTH, V88, P367, DOI 10.1007/BF03403907; Frei A, 1998, SOZ PRAVENTIV MED, V43, P185, DOI 10.1007/BF01349248; FREI A, 2000, MED PRESCRIPTION NAR, V2, P37; GSCHWEND P, 1998, PRESCRIPTION NARCOTI; Kilias M, 1998, STUD CRIME PREVENT, V7, P127; Kleber H., 1981, SUBSTANCE ABUSE CLIN, P317; Klingemann H., 1998, DRUG TREATMENT SYSTE; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; RASCHKE P, 1994, SUBSTITUTIONSTHERAPI; REHM J, 1994, ENZYKLOPADIE PSYCH 1, V1, P508; REHM J, 2000, SUCHTMEDIZIN DIALOG, P71; REHM J, 2000, SUCHTTHERAPIE, V1, P57; ROSENBAUM M, 1988, CONTEMP DRUG PROBL, V15, P491; *SCHWEIZ BUND, 1992, VER 812 121 5 FORD W; Steffen T, 2001, SUBST USE MISUSE, V36, P71, DOI 10.1081/JA-100000229; Steffen T, 1999, INTERNIST, V40, P651, DOI 10.1007/s001080050385; Steffen T., 2000, SUCHTTHERAPIE, V1, P27, DOI [10.1055/s-2000-13255, DOI 10.1055/S-2000-13255]; *SWISS FED OFF PUB, 1991, 341F FOPH; UCHTENHAGEN A, 1999, PRESCRIPTION NARCOTI; UCHTENHAGEN A, 1985, HEROINABHANGIGE IHRE; van den Brink W, 1999, J DRUG ISSUES, V29, P587, DOI 10.1177/002204269902900309; ZELTNER T, 1996, ARZTLICHE VERSCHREIB	28	161	161	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2001	358	9291					1417	1420		10.1016/S0140-6736(01)06529-1	http://dx.doi.org/10.1016/S0140-6736(01)06529-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	488MK	11705488				2022-12-24	WOS:000171940100013
J	Hayes, PC; Lee, A				Hayes, PC; Lee, A			What progress with artificial livers?	LANCET			English	Editorial Material							FULMINANT HEPATIC-FAILURE; BIOARTIFICIAL LIVER; CHARCOAL HEMOPERFUSION; TRIAL		Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Hayes, PC (corresponding author), Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland.	phayes@srv1.med.ed.ac.uk						Clemmensen JO, 1997, EUR J GASTROEN HEPAT, V9, P55, DOI 10.1097/00042737-199701000-00014; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; GAZZARD BG, 1974, LANCET, V1, P1301; GERLACH JC, 1994, TRANSPLANTATION, V58, P984, DOI 10.1097/00007890-199411150-00002; KOBAYASHI N, 2000, SCIENCE, V287, P1185; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; NYBERG SL, 1993, CELL TRANSPLANT, V2, P441, DOI 10.1177/096368979300200602; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Patzer JF, 1999, ANN NY ACAD SCI, V875, P340, DOI 10.1111/j.1749-6632.1999.tb08516.x; ROZGA J, 1994, ANN SURG, V219, P538, DOI 10.1097/00000658-199405000-00012; Sorkine P, 2001, CRIT CARE MED, V29, P1332, DOI 10.1097/00003246-200107000-00006; Tisaoussis J, 2001, LIVER TRANSPLANT, V7, P2, DOI 10.1053/jlts.2001.20845	13	7	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1286	1287		10.1016/S0140-6736(01)06454-6	http://dx.doi.org/10.1016/S0140-6736(01)06454-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684205				2022-12-24	WOS:000171702500004
J	Baden, LR; Horowitz, G; Jacoby, H; Eliopoulos, GM				Baden, LR; Horowitz, G; Jacoby, H; Eliopoulos, GM			Quinolones and false-positive urine screening for opiates by immunoassay technology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPPY SEED INGESTION; ANTIBACTERIAL ACTIVITY; PHARMACOKINETICS; TUBERCULOSIS; OFLOXACIN; MORPHINE; CODEINE; LEVOFLOXACIN; PENETRATION; PEFLOXACIN	Context Millions of assays are performed each year to monitor for substance abuse in various settings. When common medications cross-react with frequently used testing assays, false-positive results can lead to invalid conclusions. Objective To evaluate cross-reactivity of quinolone antimicrobials in common opiate screening assays and to assess the in vivo implications of this phenomenon. Design, Setting, and Participants The reactivity of 13 quinolones (levofloxacin, ofloxacin, pefloxacin, enoxacin, moxifloxacin, gatifloxacin, trovafloxacin, sparfloxacin, lomefloxacin, ciprofloxacin, clinafloxacin, norfloxacin, and nalidixic acid) was tested in 5 commercial opiate screening assays from September 1998 to March 1999. In 6 healthy volunteers, we confirmed the cross-reactivity of levofloxacin or ofloxacin with these opiate screening assays. Main Outcome Measure Opiate assay activity (threshold for positive result, 300 ng/mL of morphine). Results Nine of the quinolones caused assay results above the threshold for a positive result in at least 1 of the assays. Four of the assay systems caused false-positive results for at least 1 quinolone. Eleven of the 13 compounds caused some opiate activity by at least 1 assay system. At least 1 compound caused opiate assay activity in all 5 assay systems. Levofloxacin, oflaxacin, and perfloxacin were most likely to lead to a false-positive opiate result. Positive results were obtained in urine from all 6 volunteers. Conclusion Greater attention to the cross-reactivity of quinolones with immunoassays for opiates is needed to minimize the potential for invalid test interpretation.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St,PBB-A400, Boston, MA 02115 USA.	lbaden@partners.org						ANDRIOLE V, 1998, QUINOLONES; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BAILEY GS, 1996, ENV HLTH PERSPECT, V1, P5; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; BORNER K, 1993, DRUGS, V45, P303; Bron NJ, 1996, J ANTIMICROB CHEMOTH, V38, P1023, DOI 10.1093/jac/38.6.1023; Catrou PG, 1996, AM J CLIN PATHOL, V105, P527; Chien SC, 1997, ANTIMICROB AGENTS CH, V41, P1562, DOI 10.1128/AAC.41.7.1562; de Paula M, 1998, CLIN CHEM LAB MED, V36, P241, DOI 10.1515/CCLM.1998.041; ELSOHLY HN, 1988, J FORENSIC SCI, V33, P347; File TM, 1997, ANTIMICROB AGENTS CH, V41, P1965, DOI 10.1128/AAC.41.9.1965; GJERDE H, 1990, FORENSIC SCI INT, V44, P179, DOI 10.1016/0379-0738(90)90248-W; GUIBERT J, 1989, PATHOL BIOL, V37, P406; HAYES LW, 1987, CLIN CHEM, V33, P806; HENDEE WR, 1987, JAMA-J AM MED ASSOC, V257, P3110; HOFFKEN G, 1985, ANTIMICROB AGENTS CH, V27, P375, DOI 10.1128/AAC.27.3.375; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; KARABALUT N, 2000, QUINOLONE ANTIMICROB, P202; KOHNO S, 1992, CHEST, V102, P1815, DOI 10.1378/chest.102.6.1815; Meatherall R, 1997, THER DRUG MONIT, V19, P98, DOI 10.1097/00007691-199702000-00019; MONK JP, 1987, DRUGS, V33, P346, DOI 10.2165/00003495-198733040-00003; MONTAY G, 1984, ANTIMICROB AGENTS CH, V25, P463, DOI 10.1128/AAC.25.4.463; NAKASHIMA M, 1995, ANTIMICROB AGENTS CH, V39, P2635, DOI 10.1128/AAC.39.12.2635; *NAT COMM CLIN LAB, 1997, M100S7 NAT COMM CLIN; Paul BD, 1999, CLIN CHEM, V45, P510; PAUL BD, 1985, J ANAL TOXICOL, V9, P222, DOI 10.1093/jat/9.5.222; PETTITT BC, 1987, CLIN CHEM, V33, P1251; SALERNO C, 1990, THER DRUG MONIT, V12, P210; SELAVKA CM, 1991, J FORENSIC SCI, V36, P685; SLOOP G, 1995, J ANAL TOXICOL, V19, P554, DOI 10.1093/jat/19.7.554; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TREVILLA PH, 1995, J ANAL TOXICOL, V19, P200, DOI 10.1093/jat/19.3.200; Wise R, 1999, ANTIMICROB AGENTS CH, V43, P1508, DOI 10.1128/AAC.43.6.1508; WISE R, 1984, ANTIMICROB AGENTS CH, V26, P17, DOI 10.1128/AAC.26.1.17; YEW WW, 1990, J ANTIMICROB CHEMOTH, V26, P227, DOI 10.1093/jac/26.2.227; 2001, MED LETT DRUGS THER, V43, P87; 1998, MED LETT DRUGS THER, V40, P33; 1997, FED REG, V62, P51118; 1995, FED REG, V60, P57587; 1988, FED REG, V53, P11979	41	44	48	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3115	3119		10.1001/jama.286.24.3115	http://dx.doi.org/10.1001/jama.286.24.3115			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754677	Bronze			2022-12-24	WOS:000172927100029
J	Jin, QL; He, SY				Jin, QL; He, SY			Role of the Hrp pilus in type III protein secretion in Pseudomonas syringae	SCIENCE			English	Article							AVR PROTEINS; EXPRESSION; PROMOTER; VECTORS; CLONING; TOMATO; COLI	Bacterial surface appendages called pili and needle-like filaments are associated with protein and/or DNA transfer to recipient plant, human, or bacterial cells during pathogenesis or conjugation. Although it has long been suspected that pili function as a conduit for protein or DNA transfer, direct evidence has been lacking. The Hrp pilus of Pseudomonas syringae is assembled by the type III secretion system. We used an in situ immunogold labeling procedure to visualize the extrusion of an effector protein, AvrPto, from the tip of the Hrp pilus, providing direct evidence that a bacterial pilus can function as a conduit for protein delivery.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	He, SY (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu		He, Sheng Yang/0000-0003-1308-498X				BRINTON CC, 1964, P NATL ACAD SCI USA, V52, P776, DOI 10.1073/pnas.52.3.776; Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; EMERSON SU, 1970, SCIENCE, V169, P190, DOI 10.1126/science.169.3941.190; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; HUANG HC, 1991, MOL PLANT MICROBE IN, V4, P469, DOI 10.1094/MPMI-4-469; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jin QL, 2001, MOL MICROBIOL, V40, P1129, DOI 10.1046/j.1365-2958.2001.02455.x; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Koebnik R, 2001, TRENDS MICROBIOL, V9, P586, DOI 10.1016/S0966-842X(01)02255-7; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SHEN H, 1993, J BACTERIOL, V175, P5916, DOI 10.1128/JB.175.18.5916-5924.1993; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; YEN KM, 1991, J BACTERIOL, V173, P5328, DOI 10.1128/jb.173.17.5328-5335.1991	22	151	160	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2556	2558		10.1126/science.1066397	http://dx.doi.org/10.1126/science.1066397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752577				2022-12-24	WOS:000172927700061
J	Meier, DE; Back, AL; Morrison, RS				Meier, DE; Back, AL; Morrison, RS			The inner life of physicians and care of the seriously ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOCTOR-PATIENT COMMUNICATION; ASSISTED SUICIDE; MEDICAL-STUDENTS; PALLIATIVE CARE; PERSONAL GROWTH; NATIONAL SURVEY; SEXUAL CONTACT; STRESS; DEATH; COUNTERTRANSFERENCE	Seriously ill persons are emotionally vulnerable during the typically protracted course of an illness. Physicians respond to such patients' needs and emotions with emotions of their own, which may reflect a need to rescue the patient, a sense of failure and frustration when the patient's illness progresses, feelings of powerlessness against illness and its associated losses, grief, fear of becoming ill oneself, or a desire to separate from and avoid patients to escape these feelings. These emotions can affect both the quality of medical care and the physician's own sense of well-being, since unexamined emotions may also lead to physician distress, disengagement, burnout, and poor judgment. In this article, which is intended for the practicing, nonpsychiatric clinician, we describe a model for increasing physician self-awareness, which includes identifying and working with emotions that may affect patient care. Our approach is based on the standard medical model of risk factors, signs and symptoms, differential diagnosis, and intervention. Although it is normal to have feelings arising from the care of patients, physicians should take an active role in identifying and controlling those emotions.	CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, New York, NY 10029 USA; Univ Washington, Sch Med, Dept Med Hist & Eth, Dept Med,VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Meier, DE (corresponding author), CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, Box 1070, New York, NY 10029 USA.							BALINT M, 1972, DOCTOR HIST PATIENT; BECKMAN H, 1990, J GEN INTERN MED, V5, P42, DOI 10.1007/BF02602308; BENOLIEL JQ, 1987, OMEGA-J DEATH DYING, V18, P341, DOI 10.2190/4Y6G-XQAP-0XYN-LRW9; Billings C V, 1992, Am Nurse, V24, P2; Billings JA, 1997, JAMA-J AM MED ASSOC, V278, P733, DOI 10.1001/jama.278.9.733; BILLINGS JA, 1985, OUTPATIENT MANAGEMEN, P309; BLACKSHAW SL, 1994, AM J PSYCHIAT, V151, P293; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Block S, 1998, ACAD MED, V73, P763, DOI 10.1097/00001888-199807000-00012; BLOCK S, 2001, MANAGING DEATH ICU T, P183; Block SD, 1996, ACAD PSYCHIATR, V20, P65, DOI 10.1007/BF03341552; BLOCK SD, 1995, PSYCHOSOMATICS, V36, P445, DOI 10.1016/S0033-3182(95)71625-5; BRADSHAW S, 1976, B MENNINGER CLIN, V40, P665; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; BREWSTER JM, 1986, JAMA-J AM MED ASSOC, V255, P1913, DOI 10.1001/jama.255.14.1913; Buckman R., 1992, BREAK BAD NEWS GUIDE; BUTLER RN, 1975, AM J PSYCHIAT, V132, P893; CAINE ED, 1993, JAMA-J AM MED ASSOC, V270, P875, DOI 10.1001/jama.270.7.875; Casarett D, 2001, ANN INTERN MED, V134, P208, DOI 10.7326/0003-4819-134-3-200102060-00012; Charon R, 2000, ANN INTERN MED, V132, P63, DOI 10.7326/0003-4819-132-1-200001040-00011; Charon R, 2001, ANN INTERN MED, V134, P83, DOI 10.7326/0003-4819-134-1-200101020-00024; CLARKE PJ, 1981, AM J ORTHOPSYCHIAT, V51, P71, DOI 10.1111/j.1939-0025.1981.tb01349.x; Crouch M, 1986, Fam Med, V18, P93; DEBBIE, 1988, JAMA-J AM MED ASSOC, V259, P272; Dozor R B, 1992, Fam Med, V24, P538; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; Farber NJ, 1997, ARCH INTERN MED, V157, P2291, DOI 10.1001/archinte.157.20.2291; FREEBORN DK, 2000, PERMANENTE J, V2, P22; Friedman E, 1990, Healthc Forum J, V33, P9; GABBARD GO, 1995, JAMA-J AM MED ASSOC, V273, P1445, DOI 10.1001/jama.273.18.1445; GARTRELL N, 1986, AM J PSYCHIAT, V143, P1126; GARTRELL NK, 1992, WESTERN J MED, V157, P139; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; GORDON GH, 1986, J GEN INTERN MED, V1, P228, DOI 10.1007/BF02596188; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; Gorlin R, 2001, CAMB Q HEALTHC ETHIC, V10, P7, DOI 10.1017/S0963180101001037; Gundersen L, 2001, ANN INTERN MED, V135, P145, DOI 10.7326/0003-4819-135-2-200107170-00023; Hendin H, 2000, AM J PSYCHIAT, V157, P2022, DOI 10.1176/appi.ajp.157.12.2022; HENDIN H, 1981, AM J PSYCHOTHER, V35, P469, DOI 10.1176/appi.psychotherapy.1981.35.4.469; HOWELLS K, 1982, SOC SCI MED, V16, P1421, DOI 10.1016/0277-9536(82)90137-X; Hurwitz B, 2000, LANCET, V356, P2086, DOI 10.1016/S0140-6736(00)03412-7; JECKER NS, 1995, WESTERN J MED, V163, P287; Liossi C, 1997, PALLIATIVE MED, V11, P455, DOI 10.1177/026921639701100605; Lubitz R M, 1996, JAMA, V275, P414, DOI 10.1001/jama.275.5.414; MALTSBERGER JT, 1974, ARCH GEN PSYCHIAT, V30, P625; Manian FA, 2001, ARCH INTERN MED, V161, P801, DOI 10.1001/archinte.161.6.801; MARSHALL AA, 1995, AM J GASTROENTEROL, V90, P4; MARTIN AR, 1986, J GEN INTERN MED, V1, P252, DOI 10.1007/BF02596195; Martin C A, 1987, Hosp J, V3, P121, DOI 10.1300/J011v03n02_07; MARTIN MJ, 1981, MAYO CLIN PROC, V56, P35; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; MCCUE JD, 1982, NEW ENGL J MED, V306, P458, DOI 10.1056/NEJM198202253060805; MCCUE JD, 1985, NEW ENGL J MED, V312, P449, DOI 10.1056/NEJM198502143120725; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; MEIER D, 2000, ETHNICAL DILEMMAS, P180; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; Mengel MB, 1987, FAM SYST MED, V5, P176; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; MILES SH, 1994, JAMA-J AM MED ASSOC, V271, P1786, DOI 10.1001/jama.271.22.1786; MODESTIN J, 1987, BRIT J MED PSYCHOL, V60, P379, DOI 10.1111/j.2044-8341.1987.tb02757.x; Muskin PR, 1998, JAMA-J AM MED ASSOC, V279, P323, DOI 10.1001/jama.279.4.323; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; NOVACK DH, 1997, MED ENCOUNTER, V13, P2; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PICK IB, 1985, INT J PSYCHOANAL, V66, P157; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Prendergast T J, 1997, New Horiz, V5, P62; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; PUCINSKI J, 1985, BR J HOSP PSYCHIAT, V33, P90; QUILL TE, 1983, ANN INTERN MED, V98, P228, DOI 10.7326/0003-4819-98-2-228; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; QUILL TE, 1991, NEW ENGL J MED, V324, P691, DOI 10.1056/NEJM199103073241010; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; QUILL TE, 1989, ANN INTERN MED, V111, P51, DOI 10.7326/0003-4819-111-1-51; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Rabow MW, 2001, WESTERN J MED, V174, P66, DOI 10.1136/ewjm.174.1.66; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Schon Donald., 1987, ED REFLECTIVE PRACTI; SMITH JW, 1986, JAMA-J AM MED ASSOC, V255, P1155, DOI 10.1001/jama.255.9.1155; SMITH RC, 1988, PSYCHOSOMATICS, V29, P392, DOI 10.1016/S0033-3182(88)72339-7; SNIBBE JR, 1989, PSYCHOL REP, V65, P775, DOI 10.2466/pr0.1989.65.3.775; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; STRASBURGER LH, 1992, AM J PSYCHOTHER, V46, P544, DOI 10.1176/appi.psychotherapy.1992.46.4.544; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; VALIANT GE, 1972, NEW ENGL J MED, V287, P372; von Gunten CF, 2000, JAMA-J AM MED ASSOC, V284, P3051, DOI 10.1001/jama.284.23.3051; Weiner EL, 2001, WESTERN J MED, V174, P19, DOI 10.1136/ewjm.174.1.19; WEISMAN AD, 1974, REALIZATION DEATH; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; YARNEY G, 2001, BRIT MED J, V322, P252; ZINN WM, 1988, JAMA-J AM MED ASSOC, V259, P3296, DOI 10.1001/jama.259.22.3296	95	406	415	2	39	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					3007	3014		10.1001/jama.286.23.3007	http://dx.doi.org/10.1001/jama.286.23.3007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502VY	11743845				2022-12-24	WOS:000172764500036
J	Kojouri, K; Vesely, SK; George, JN				Kojouri, K; Vesely, SK; George, JN			Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							INDUCED IMMUNE THROMBOCYTOPENIA; HYPERSENSITIVITY	Background: Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is thought to be uncommon and to have a good prognosis. Objective: To describe the frequency, clinical features, and longterm outcomes of quinine-associated TTP-HUS. Design: Case series. Setting: Hospitals in central-western Oklahoma. Patients: 225 consecutive patients with TTP-HUS, 1989-2000. Measurements: Presenting features and clinical outcomes. Results: Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome was associated with quinine in 17 patients. Four patients died, and 7 survivors currently have chronic renal failure. Since 1 July 1995, 132 patients with clinically suspected TTP-HUS were explicitly asked about drug exposure. Fourteen (11%) had taken quinine, and 7 had taken other drugs associated with TTP-HUS. Neurologic abnormalities were as severe in patients with quinine-associated TTP-HUS as in the 118 patients who had not taken quinine. Conclusions: Quinine is a common cause of drug-associated TTP-HUS and can cause death and chronic renal failure. When the disorder is described as TTP-HUS rather than only as HUS, the severity of neurologic abnormalities and the occasional absence of renal failure are emphasized. if recurrent disease is to be prevented, clinicians must recognize quinine as a possible cause.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Hematol Oncol Sect, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	George, JN (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Hematol Oncol Sect, Box 26901, Oklahoma City, OK 73190 USA.	Jim-George@OUHSC.edu		Vesely, Sara/0000-0003-3448-0156				BARR E, 1990, BRIT MED J, V301, P323, DOI 10.1136/bmj.301.6747.323; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Crum NF, 2000, SOUTHERN MED J, V93, P726; Farver DK, 1999, ANN PHARMACOTHER, V33, P32, DOI 10.1345/aph.18172; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; GOTTSCHALL JL, 1994, AM J HEMATOL, V47, P283, DOI 10.1002/ajh.2830470407; GOTTSCHALL JL, 1991, BLOOD, V77, P306; Kedia RK, 1999, POSTGRAD MED J, V75, P429, DOI 10.1136/pgmj.75.885.429; Kojouri K, 2000, J Okla State Med Assoc, V93, P519; Medina PJ, 2001, CURR OPIN HEMATOL, V8, P286, DOI 10.1097/00062752-200109000-00004; Moake JL, 1998, THROMBOSIS HEMORRHAG, P583; NAYLOR JR, 1994, AGE AGEING, V23, P418, DOI 10.1093/ageing/23.5.418; Rock GA, 2000, BRIT J HAEMATOL, V109, P496, DOI 10.1046/j.1365-2141.2000.01941.x; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Schattner A, 1998, AM J MED, V104, P488, DOI 10.1016/S0002-9343(98)00082-5; STRONCEK DF, 1992, BLOOD, V80, P241; 1994, FED REG, V59, P43234	18	87	93	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1047	1051		10.7326/0003-4819-135-12-200112180-00008	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747383				2022-12-24	WOS:000172759700004
J	Ren, DJ; Navarro, B; Xu, HX; Yue, LX; Shi, Q; Clapham, DE				Ren, DJ; Navarro, B; Xu, HX; Yue, LX; Shi, Q; Clapham, DE			A prokaryotic voltage-gated sodium channel	SCIENCE			English	Article							FLAGELLAR MOTORS; CA2+ CHANNELS; ION CHANNELS; SELECTIVITY; TETRODOTOXIN; PERMEATION; MUTATIONS; DRIVEN; LOCUS; SITE	The pore-forming subunits of canonical voltage-gated sodium and calcium channels are encoded by four repeated domains of six-transmembrane (6TM) segments. We expressed and characterized a bacterial ion channel (NaChBac) from Bacillus halodurans that is encoded by one 6TM segment. The sequence, especially in the pore region, is similar to that of voltage-gated calcium channels. The expressed channel was activated by voltage and was blocked by calcium channel blockers. However, the channel was selective for sodium. The identification of NaChBac as a functionally expressed bacterial voltage-sensitive ion-selective channel provides insight into both voltage-dependent activation and divalent cation selectivity.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Ctr Int Fis, Lab Biofis, Bogota, Colombia	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; ATSUMI T, 1992, NATURE, V355, P182, DOI 10.1038/355182a0; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BIOCHEM BIOPH RES CO, V281, P741, DOI 10.1006/bbrc.2001.4408; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Krulwich TA, 2001, BBA-BIOENERGETICS, V1505, P158, DOI 10.1016/S0005-2728(00)00285-1; NAVARRO B, UNPUB; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SKRYMA R, 1994, AM J PHYSIOL, V267, pC544, DOI 10.1152/ajpcell.1994.267.2.C544; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Triggle DJ, 1999, EUR J PHARMACOL, V375, P311, DOI 10.1016/S0014-2999(99)00329-5; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yorimitsu T, 2001, BBA-BIOENERGETICS, V1505, P82, DOI 10.1016/S0005-2728(00)00279-6	32	361	373	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2372	2375		10.1126/science.1065635	http://dx.doi.org/10.1126/science.1065635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743207				2022-12-24	WOS:000172817200052
J	Gani, R; Leach, S				Gani, R; Leach, S			Transmission potential of smallpox in contemporary populations	NATURE			English	Article							IMPACT	Despite eradication(1), smallpox still presents a risk to public health whilst laboratory stocks of virus remain(2,3). One factor crucial to any assessment of this risk is R-0, the average number of secondary cases infected by each primary case. However, recently applied estimates have varied too widely (R-0 from 1.5 to >20) to be of practical use, and often appear to disregard contingent factors such as socio-economic conditions and herd immunity(4-8). Here we use epidemic modelling(9) to show a more consistent derivation of R0. In isolated pre-twentieth century populations(10-12) with negligible herd immunity, the numbers of cases initially rose exponentially, with an R-0 between 3.5 and 6. Before outbreak controls were applied, smallpox also demonstrated similar levels of transmission in 30 sporadic outbreaks in twentieth century Europe(1), taking into account pre-existing vaccination levels(13,14) (about 50%) and the role of hospitals in doubling early transmission. Should smallpox recur, such estimates of transmission potential (R-0 from 3.5 to 6) predict a reasonably rapid epidemic rise before the implementation of public health interventions, because little residual herd immunity exists now that vaccination has ceased.	Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England		Leach, S (corresponding author), Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England.	steve.leach@camr.org.uk						ANDERSON R M, 1991; ARITA I, 1986, J HYG-CAMBRIDGE, V96, P459, DOI 10.1017/S0022172400066249; Creighton C., 1891, HIST EPIDEMICS BRITA, V2; Dietz K, 2000, NATURE, V408, P513, DOI 10.1038/35046270; DIXON C.W, 1962, SMALLPOX; Duncan CJ, 1996, J THEOR BIOL, V183, P447, DOI 10.1006/jtbi.1996.0234; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HENDERSON DA, 1994, VACCINES, P13; KOPLAN JP, 1978, TROP GEOGR MED, V30, P355; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; MACK TM, 1972, AM J EPIDEMIOL, V95, P157, DOI 10.1093/oxfordjournals.aje.a121380; MELTZER MI, IN PRESS EMERG INFEC, V7; MOODY J, 1980, 1 BURF BURF SCH TOLS; OTOOLE T, 1999, EMERG INFECT DIS, V4, P488; *REG GEN, 1870, ANN REP REG GEN 1869; WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669; *WHO, 1999, FUT RES SMALLP VIR R; World Health Organization, 1970, HLTH ASP CHEM BIOL W; 1999, NATURE, V399, P628	24	193	196	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					748	751		10.1038/414748a	http://dx.doi.org/10.1038/414748a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742399				2022-12-24	WOS:000172676200047
J	Kuhn, G; Hijri, M; Sanders, IR				Kuhn, G; Hijri, M; Sanders, IR			Evidence for the evolution of multiple genomes in arbuscular mycorrhizal fungi	NATURE			English	Article							INTERNAL TRANSCRIBED SPACERS; SCUTELLOSPORA-CASTANEA; GIGASPORA-MARGARITA; SEXUAL REPRODUCTION; GENETIC DIVERSITY; GLOMUS-MOSSEAE; RIBOSOMAL DNA; SEQUENCES; GLOMALES; SPORES	Ancient asexuals directly contradict the evolutionary theories that explain why organisms should evolve a sexual life history(1,2). The mutualistic, arbuscular mycorrhizal fungi are thought to have been asexual for approximately 400 million years(3,4). In the absence of sex, highly divergent descendants of formerly allelic nucleotide sequences are thought to evolve in a genome(2). In mycorrhizal fungi, where individual offspring receive hundreds of nuclei from the parent, it has been hypothesized that a population of genetically different nuclei should evolve within one individual(5,6). Here we use DNA-DNA fluorescent in situ hybridization to show that genetically different nuclei co-exist in individual arbuscular mycorrhizal fungi. We also show that the population genetics techniques(4) used in other organisms are unsuitable for detecting recombination because the assumptions and underlying processes do not rt the fungal genomic structure shown here. Instead we used a phylogenetic approach to show that the within-individual genetic variation that occurs in arbuscular mycorrhizal fungi probably evolved through accumulation of mutations in an essentially clonal genome, with some infrequent recombination events. We conclude that mycorrhizal fungi have evolved to be multi-genomic.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland	University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Inst Ecol, Biol Bldg, CH-1015 Lausanne, Switzerland.		Hijri, Mohamed/AAL-5737-2021; Sanders, Ian R/T-9988-2017; Hijri, Mohamed/ABC-5969-2021	Sanders, Ian R/0000-0002-9591-8214; Hijri, Mohamed/0000-0001-6112-8372				Antoniolli ZI, 2000, MYCOL RES, V104, P708, DOI 10.1017/S0953756299001860; Clapp JP, 2001, NEW PHYTOL, V149, P539, DOI 10.1046/j.1469-8137.2001.00060.x; Giovannetti M, 2001, NEW PHYTOL, V151, P717, DOI 10.1046/j.0028-646x.2001.00216.x; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Hijri M, 1999, FUNGAL GENET BIOL, V26, P141, DOI 10.1006/fgbi.1998.1112; HOELZEL AR, 1991, MOL GENETIC ECOLOGY, P1; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Lanfranco L, 1999, MOL ECOL, V8, P37, DOI 10.1046/j.1365-294X.1999.00535.x; LloydMacgilp SA, 1996, NEW PHYTOL, V133, P103, DOI 10.1111/j.1469-8137.1996.tb04346.x; MAYNARDSMITH J, 1986, NATURE, V324, P300; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Redecker D, 1999, FUNGAL GENET BIOL, V28, P238, DOI 10.1006/fgbi.1999.1173; Redecker D, 1997, APPL ENVIRON MICROB, V63, P1756, DOI 10.1128/AEM.63.5.1756-1761.1997; Rosendahl S, 1997, MOL ECOL, V6, P821, DOI 10.1046/j.1365-294X.1997.d01-213.x; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Sanders IR, 1996, NEW PHYTOL, V133, P123, DOI 10.1111/j.1469-8137.1996.tb04348.x; Sanders IR, 1999, NATURE, V399, P737, DOI 10.1038/21544; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; vanGemeren IA, 1997, GENE, V198, P43, DOI 10.1016/S0378-1119(97)00290-4; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	24	211	226	0	74	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					745	748		10.1038/414745a	http://dx.doi.org/10.1038/414745a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742398	Green Published			2022-12-24	WOS:000172676200046
J	Davis, JS; Hassanzadeh, S; Winitsky, S; Lin, H; Satorius, C; Vemuri, R; Aletras, AH; Wen, H; Epstein, ND				Davis, JS; Hassanzadeh, S; Winitsky, S; Lin, H; Satorius, C; Vemuri, R; Aletras, AH; Wen, H; Epstein, ND			The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation	CELL			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE; STRETCH-ACTIVATION; LEFT-VENTRICLE; BETA-MYOSIN; MUTATIONS; DEFORMATION; EXPRESSION; FILAMENTS; KINASE	Evolution of the human heart has incorporated a variety of successful strategies for motion used throughout the animal kingdom. One such strategy is to add the efficiency of torsion to compression so that blood is wrung, as well as pumped, out of the heart. Models of cardiac torsion have assumed uniform contractile properties of muscle fibers throughout the heart. Here, we show how a spatial gradient of myosin light chain phosphorylation across the heart facilitates torsion by inversely altering tension production and the stretch activation response. To demonstrate the importance of cardiac light chain phosphorylation, we, cloned a myosin light chain kinase from a human heart and have identified a gain-in-function mutation in two individuals with cardiac hypertrophy.	NHLBI, Mol Physiol Sect, Cardiol Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Epstein, ND (corresponding author), NHLBI, Mol Physiol Sect, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.		Wen, Han/G-3081-2010; Aletras, Anthony/ABE-9967-2020	Wen, Han/0000-0001-6844-2997; Aletras, Anthony/0000-0002-3786-3817	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004996, Z01HL004996] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aletras AH, 2001, MAGNET RESON MED, V46, P523, DOI 10.1002/mrm.1223; ARTS T, 1984, CARDIOVASC RES, V18, P183, DOI 10.1093/cvr/18.3.183; BEYAR R, 1986, ANN BIOMED ENG, V14, P547, DOI 10.1007/BF02484472; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236; Callaghan P. T, 1991, PRINCIPLES NUCL MAGN; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Davis JS, 2000, METHOD ENZYMOL, V321, P23; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; HERRING BP, 1990, J BIOL CHEM, V265, P1724; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Levine RJC, 1998, J STRUCT BIOL, V122, P149, DOI 10.1006/jsbi.1998.3980; LILLEHEI CW, 1964, J THORAC CARDIOV SUR, V47, P532, DOI 10.1016/S0022-5223(19)33587-1; MAIER SE, 1992, CIRCULATION, V86, P1919, DOI 10.1161/01.CIR.86.6.1919; Moon MR, 1996, CIRCULATION, V94, P143; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PERRIE WT, 1972, BIOCHEM J, V128, pP105, DOI 10.1042/bj1280105P; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; RUSHMER RF, 1956, AM J PHYSIOL, V184, P188, DOI 10.1152/ajplegacy.1955.184.1.188; Steiger G.J., 1977, P221; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Vemuri R, 1999, P NATL ACAD SCI USA, V96, P1048, DOI 10.1073/pnas.96.3.1048; YOUNG AA, 1994, CIRCULATION, V90, P854, DOI 10.1161/01.CIR.90.2.854; ZUR Y, 1990, MAGNET RESON MED, V16, P444, DOI 10.1002/mrm.1910160311	30	210	227	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					631	641		10.1016/S0092-8674(01)00586-4	http://dx.doi.org/10.1016/S0092-8674(01)00586-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733062	Bronze			2022-12-24	WOS:000172575300010
J	Lehmann, FA				Lehmann, FA			Matching spiracle opening to metabolic need during flight in Drosophila	SCIENCE			English	Article							MELANOGASTER; PERFORMANCE; INSECT	The respiratory exchange system of insects must maximize the flux of respiratory gases through the spiracles of the tracheal system white minimizing water loss. This trade-off between gas exchange and water Loss becomes crucial when locomotor activity is increased during flight and metabolic needs are greatest. Insects that keep their spiracles mostly closed during flight reduce water Loss but limit the flux of oxygen and carbon dioxide into and out of the tracheal system and thus attenuate locomotor performance. Insects that keep their spiracles completely open allow maximum gas exchange but face desiccation stress more quickly. Experiments in which water vapor was used as a tracer gas to track changes in the conductance of the respiratory system indicated that flying fruit flies minimize potential water Loss by matching the area of the open spiracles to their gas exchange required for metabolic needs. This behavior maintained approximately constant pressure for carbon dioxide (1.35 kilopascals) and oxygen (19.9 kilopascals) within the tracheal. system while reducing respirometric water loss by up to 23% compared with a strategy in which the spiracles are held wide open during flight. The adaptive spiracle-closing behavior in fruit flies has general implications for the ecology of flying insects because it shows how these animals may cope with environmental challenges during high locomotor performance.	Univ Wurzburg, Theodor Boveri Inst, Dept Behav Physiol & Sociobiol, D-97074 Wurzburg, Germany	University of Wurzburg	Lehmann, FA (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dept Behav Physiol & Sociobiol, D-97074 Wurzburg, Germany.							BEAMENT J. W. L., 1964, ADVANCES INSECT PHYSIOL, V2, P67, DOI 10.1016/S0065-2806(08)60072-7; Chan WP, 1996, J EXP BIOL, V199, P2767; DENNY MW, 1993, AIR WATER BIOL PHYSI, P70; EDNEY EB, 1977, WATER BALANCE LAND A; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; GERTHSEN C, 1993, PHYSIK, P238; Kestler P., 1985, P137; Komai Y, 1998, J EXP BIOL, V201, P2359; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 1999, J COMP PHYSIOL B, V169, P165, DOI 10.1007/s003600050207; LEHMANN FO, 1994, THESIS U TUBINGEN GE; LIGHTON JRB, 1993, J EXP BIOL, V179, P233; Manning Gerards, 1993, P609; MARDEN JH, 1987, J EXP BIOL, V130, P235; MILLER PL, 1966, J EXP BIOL, V45, P285; Nikam T.B., 1989, INSECT SPIRACULAR SY, Vfirst; WEISFOGH T, 1964, J EXP BIOL, V41, P229; Wigglesworth V.B., 1983, Advances in Insect Physiology, V17, P85, DOI 10.1016/S0065-2806(08)60217-9; Ziegler R., 1985, P95	20	75	77	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1926	1929		10.1126/science.1064821	http://dx.doi.org/10.1126/science.1064821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729318				2022-12-24	WOS:000172465000059
J	Rape, M; Hoppe, T; Gorr, I; Kalocay, M; Richly, H; Jentsch, S				Rape, M; Hoppe, T; Gorr, I; Kalocay, M; Richly, H; Jentsch, S			Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PROTEIN; FUSION; CDC48P; PROTEOLYSIS; DEGRADATION; PATHWAY; ATPASE; GENES	The OLE pathway of yeast regulates the level of the ER-bound enzyme Delta9-fatty acid desaturase OLE1, thereby, controlling membrane fluidity. A central component of this regulon is the transcription factor SPT23, a homolog of mammalian NF-kappaB. SPT23 is synthesized as an inactive, ER membrane-anchored precursor that is activated by regulated ubiquitin/proteasome-dependent processing (RUP). We now show that SPT23 dimerizes prior to processing and that the processed molecule, p90, retains its ubiquitin modification and initially remains tethered to its unprocessed, membrane-bound SPT23 partner. Subsequently, p90 is liberated from its partner for nuclear targeting by the: activity of the chaperone-like CDC48(UFD1/NPL4) complex. Remarkably, this enzyme binds preferentially ubiquitinated substrates, suggesting that CDC48(UFD1/NPL4) is qualified to selectively remove ubiquitin conjugates from protein complexes.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hoppe, Thorsten/AAC-7880-2020; Kalocsay, Marian/ABH-5959-2020	Kalocsay, Marian/0000-0002-4187-5829; Hoppe, Thorsten/0000-0002-4734-9352; Rape, Michael/0000-0003-4849-6343				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Guthrie C., 1991, METHODS ENZYMOLOGY G; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1996, MOL CELL BIOL, V16, P2248; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; NELSON MK, 1993, GENETICS, V134, P159; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang SR, 1999, GENETICS, V151, P473; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	34	362	373	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					667	677		10.1016/S0092-8674(01)00595-5	http://dx.doi.org/10.1016/S0092-8674(01)00595-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733065	hybrid			2022-12-24	WOS:000172575300013
J	Feduccia, A				Feduccia, A			Palaeoecology - Fossils and avian evolution	NATURE			English	Article							EARLY TERTIARY ORIGIN; ORDERS; BIRDS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Feduccia, A (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Bleiweiss R, 1998, GEOLOGY, V26, P323, DOI 10.1130/0091-7613(1998)026<0323:FGASET>2.3.CO;2; Dyke GJ, 1999, NATURE, V399, P317, DOI 10.1038/20583; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Hou LH, 1996, SCIENCE, V274, P1164, DOI 10.1126/science.274.5290.1164; KAROCHKIN EN, 2000, CRETACEOUS STRATIGRA, P533; Marshall CR, 1999, GEOLOGY, V27, P95, DOI 10.1130/0091-7613(1999)027<0095:FGASET>2.3.CO;2; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; SHUVALOV VF, 2000, CREATACEOUS STRATIGR, P256	9	2	2	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					507	508		10.1038/35107144	http://dx.doi.org/10.1038/35107144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734842				2022-12-24	WOS:000172405900035
J	Hogg, RS; Yip, B; Chan, KJ; Wood, E; Craib, KJP; O'Shaughnessy, MV; Montaner, JSG				Hogg, RS; Yip, B; Chan, KJ; Wood, E; Craib, KJP; O'Shaughnessy, MV; Montaner, JSG			Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; UPDATED RECOMMENDATIONS; IMPROVED SURVIVAL; CONTROLLED-TRIAL; AIDS DIAGNOSIS; VIRUS; ZIDOVUDINE; ADULTS; RNA	Context Current recommendations for initiation of antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts and plasma HIV RNA levels. The relative prognostic value of each marker following initiation of therapy has not been fully characterized. Objective To describe rates of disease progression to death and AIDS or death among patients starting triple-drug antiretroviral therapy, stratified by baseline CD4 cell count and HIV RNA levels. Design, Setting, and Participants Population-based analysis of 1219 antiretroviral therapy-naive HIV-positive men and women aged 18 years or older in British Columbia who initiated triple-drug therapy between August 1, 1996, and September 30, 1999. Main Outcome Measure Cumulative mortality rates from the initiation of triple-drug antiretroviral therapy to September 30, 2000, determined using various CD4 cell and plasma HIV RNA thresholds. Results As of September 30, 2000, 82 patients had died of AIDS-related causes, for a crude AIDS-related mortality rate of 6.7%. The product limit estimate (SE) of the cumulative mortality rate at 12 months was 2.9% (0.5%), In univariate analyses, a prior diagnosis of acquired immunodeficiency syndrome (AIDS), CD4 cell count, use of protease inhibitors, and HIV RNA level were associated with mortality. There was no difference in mortality by age or sex, Only CD4 cell count remained statistically significant in the multivariate analysis. After controlling for AIDS, protease inhibitor use, and plasma HIV RNA level at baseline, patients with CD4 cell counts of less than 50/muL were 6.67 (95% confidence interval [CI], 3.61-12.34) times and those with counts of 50/muL to 199/muL were 3.41 (95% CI, 1.93-6.03) times more likely to die than those with counts of at least 200/muL. Conclusion Our data demonstrate uniformly low rates of disease progression to death and AIDS or death among patients starting antiretroviral therapy with CD4 cell counts of at least 200/muL. In our study, disease progression to death and AIDS or death was clustered among patients starting therapy with CD4 cell counts less than 200/muL.	Univ British Columbia, Fac Med, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Montaner, JSG (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Programme, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@hivnet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012	Hogg, Robert S/0000-0003-3463-5488; 				BINDELS PJE, 1995, J INFECT DIS, V172, P97, DOI 10.1093/infdis/172.1.97; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; CHEN R, 2001, 8 C RETR OPP INF FEB; COX DR, 1972, J R STAT SOC B, V34, P187; Craib KJP, 1997, J INFECT DIS, V176, P798, DOI 10.1086/517305; *CTR EXC HIV AIDS, 1999, THER GUID TREATM HIV; Galli M, 2000, AIDS, V14, pS55; Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; HOGG RS, 2000, 7 C RETR OPP INF JAN; KAPLAN J, 2001, 8 C RETR OPP INF FEB; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P402, DOI 10.1001/jama.263.3.402; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; *PAN CLIN PRACT TR, 2000, GUID US ANT AG HIV I; PEDERSEN C, 1990, AIDS, V4, P1111, DOI 10.1097/00002030-199011000-00009; Phillips AN, 2000, AIDS, V14, pS3; SAAH AJ, 1994, J ACQ IMMUN DEF SYND, V7, P287; STERLING TR, 2001, 8 C RETR OPP INF FEB; VOLBERDING PA, 1995, NEW ENGL J MED, V333, P401, DOI 10.1056/NEJM199508173330701; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221	31	563	577	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2001	286	20					2568	2577		10.1001/jama.286.20.2568	http://dx.doi.org/10.1001/jama.286.20.2568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FH	11722271				2022-12-24	WOS:000172385200031
J	Grantcharov, TP; Bardram, L; Funch-Jensen, P; Rosenberg, J				Grantcharov, TP; Bardram, L; Funch-Jensen, P; Rosenberg, J			Laparoscopic performance after one night on call in a surgical department: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SLEEP-DEPRIVATION; MIST VR; SIMULATOR		Aarhus Univ, Aarhus Kommune Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark; Univ Copenhagen, Hvidovre Hosp, Dept Surg Gastroenterol 435, DK-2650 Hvidovre, Denmark	Aarhus University; University of Copenhagen	Grantcharov, TP (corresponding author), Aarhus Univ, Aarhus Kommune Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark.							Chaudhry A, 1999, ANN ROY COLL SURG, V81, P281; Grantcharov TP, 2001, SURG ENDOSC-ULTRAS, V15, P242, DOI 10.1007/s004640090008; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Wilson MS, 1997, ANN ROY COLL SURG, V79, P403	5	220	221	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1222	1223		10.1136/bmj.323.7323.1222	http://dx.doi.org/10.1136/bmj.323.7323.1222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719413	Green Published, Bronze			2022-12-24	WOS:000172450500019
J	Keely, PJ				Keely, PJ			Rho GTPases as early markers for tumour progression	LANCET			English	Editorial Material							CELL MOTILITY; FAMILY; INVASION; RAC1		Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keely, PJ (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA.							Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; BEARER EL, 1993, AM J RESP CELL MOL, V8, P582, DOI 10.1165/ajrcmb/8.6.582; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MOSCOW JA, 1994, ONCOGENE, V9, P189; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	18	14	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1744	1745		10.1016/S0140-6736(01)06840-4	http://dx.doi.org/10.1016/S0140-6736(01)06840-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734226				2022-12-24	WOS:000172385100004
J	Molino, JF; Sabatier, D				Molino, JF; Sabatier, D			Tree diversity in tropical rain forests: A validation of the intermediate disturbance hypothesis	SCIENCE			English	Article							SPECIES-DIVERSITY; NEOTROPICAL FOREST; GAPS	The "intermediate disturbance hypothesis," which postulates maximum diversity at intermediate regimes of disturbance, has never been clearly proved to apply to species-rich tropical forest tree communities and to local-scale canopy disturbances that modify light environments. This hypothesis was tested on a sample of 17,000 trees in a Guianan forest, 10 years after a silvicultural, experiment that added to natural treefall gaps a wide range of disturbance intensities. Species richness, standardized to eliminate density effects, peaked at intermediate disturbance levels, particularly when disturbance intensity was estimated through the percentage of stems of strongly light-dependent species.	Cirad Foret, Inst Rech Dev, F-34398 Montpellier 5, France	CIRAD; Institut de Recherche pour le Developpement (IRD)	Molino, JF (corresponding author), Cirad Foret, Inst Rech Dev, Campus Int Baillarguet,TA 10-D, F-34398 Montpellier 5, France.		Sabatier, Daniel/D-9117-2011; Molino, Jean-François/C-5011-2009	Molino, Jean-François/0000-0001-8853-7133; Sabatier, Daniel/0000-0003-0883-1530				Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; CHAZDON RL, 1999, SCIENCE, V285, pA1459; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; DENSLOW JS, 1984, BIOTROPICA, V16, P240, DOI 10.2307/2388059; Gentry A.H., 1990, 4 NEOTROPICAL FOREST; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; LIEBERMAN M, 1989, ECOLOGY, V70, P550, DOI 10.2307/1940201; SCHMITT L, 1990, BOIS FOR TROP, V220, P3; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; VANDERMAAREL E, 1993, J VEG SCI, V4, P733, DOI 10.2307/3235608; WHITMORE TC, 1984, BIOTROPICA, V16, P239, DOI 10.2307/2388058	18	269	289	23	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1702	1704		10.1126/science.1060284	http://dx.doi.org/10.1126/science.1060284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721052	Green Submitted			2022-12-24	WOS:000172307400040
J	Parry, J; Stevens, A				Parry, J; Stevens, A			Prospective health impact assessment: pitfalls, problems, and possible ways forward	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Hlth Impact Assessment Res Unit, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Parry, J (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Hlth Impact Assessment Res Unit, Birmingham B15 2TT, W Midlands, England.	J.M.Parry.1@bham.ac.uk		Stevens, Andrew/0000-0003-2079-3397				[Anonymous], 1998, INDEPENDENT INQUIRY; BENTHAM G, 1988, SOC SCI MED, V26, P49, DOI 10.1016/0277-9536(88)90044-5; BORUCH R, 2001, CAMPBELL COLLABORATI; BULUSU L, 1991, 39 OFF POP CENS SURV; Calman KC, 1997, BMJ-BRIT MED J, V315, P939; Campbell D. T., 1966, EXPT QUASIEXPERIMENT; *DEP HLTH, 1999, HLTH IMP ASS REP MET; *DEP HLTH, 1998, SAV LIV OUR HLTH NAT; *EC SOC RES COUNC, 2001, EV BAS POL PRACT IN; European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO; European Parliament, 1957, TREAT AMST AM TREAT; Fotheringham, 1998, DETERMINANTS MIGRATI; ISSON E, 2000, RESOURCE HLTH IMPACT; KEMM J, 1999, DEV HLTH IMPACT ASSE; Khan K.S., 2001, UNDERTAKING SYSTEMAT; Lilford RJ, 1996, BRIT MED J, V313, P603; Macintyre S, 2000, J EPIDEMIOL COMMUN H, V54, P802, DOI 10.1136/jech.54.11.802; Mcintyre L., 1999, METHODS HLTH IMPACT; RHODES J, 1999, HLTH IMP ASS REP MET; Saunders P, 2001, J PUBLIC HEALTH MED, V23, P103, DOI 10.1093/pubmed/23.2.103; *SCOTT NEEDS ASS P, 2000, HLTH IMPA ASS POL PR; SCOTTSAMUEL A, 1996, MERSEYSIDE GUIDELINE; Weiss C, 1995, NEW APPROACHES EVALU, V1; WHO, 1999, HLTH 21 HLTH ALL 21, V68, P146; *WHO REG OFF EUR, 2001, METH IMPL EQ FOC HLT; World Health Organization, 2000, Environ Health Perspect, V108, P997, DOI 10.2307/3435062	26	94	96	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2001	323	7322					1177	1182		10.1136/bmj.323.7322.1177	http://dx.doi.org/10.1136/bmj.323.7322.1177			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495NG	11711414	Green Published			2022-12-24	WOS:000172346800023
J	Vasan, RS; Larson, MG; Leip, EP; Kannel, WB; Levy, D				Vasan, RS; Larson, MG; Leip, EP; Kannel, WB; Levy, D			Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study	LANCET			English	Article							NUTRITION EXAMINATION SURVEY; NORMAL BLOOD-PRESSURE; NATIONAL-HEALTH; UNITED-STATES; POPULATION; PREVALENCE; DISEASE; MEN	Background Patients with optimum (<120/80 mm Hg), normal (120-129/80-84 mm Hg), and high normal (130-139/85-89 mm Hg) blood pressure (BP) may progress to hypertension (<greater than or equal to>140/90 mm Hg) over time. We aimed to establish the best frequency of BP screening by assessing the rates and determinants of progression to hypertension. Methods We assessed repeated BP measurements in individuals without hypertension (BP<140/90 mm Hg) from the Framingham Study (4200 men, 5645 women; mean age 52 years) who attended clinic examinations during 1978-94. The incidence of hypertension (or use of anti hypertensive treatment) and its determinants were studied. Findings A stepwise, increase in hypertension incidence occurred across the three non-hypertensive BP categories; 5.3% (95% CI 4.4-6.3%) of participants with optimum BP, 17.6% (15.2-20.3%) with normal, and 37.3% (33.3-41.5%) with high normal BP aged below age 65 years progressed to hypertension over 4 years. Corresponding 4-year rates of progression for patients 65 years and older were 16.0% (12.0-20.9), 25.5% (20.4-31.4), and 49.5% (42.6-56.4), respectively. Obesity and weight gain also contributed to progression; a 5% weight gain on follow-up was associated with 20-30% increased odds of hypertension. Interpretation High normal BP and normal BP frequently progress to hypertension over a period of 4 years, especially in older adults. These findings support recommendations for monitoring individuals with high normal BP once a year, and monitoring those with normal BP every 2 years, and they emphasise the importance of weight control as a measure for primary prevention of hypertension.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Harvard Univ, Sch Med, Beth Israel Hosp, Div Cardiol, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Hosp, Div Clin Epidemiol, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, K24 HL04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bakx JC, 1999, J CLIN EPIDEMIOL, V52, P531, DOI 10.1016/S0895-4356(99)00023-2; Black HR, 1997, ARCH INTERN MED, V157, P2413; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chalmers J, 1999, J HYPERTENS, V17, P151; CORNONIHUNTLEY J, 1989, ARCH INTERN MED, V149, P780, DOI 10.1001/archinte.149.4.780; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; ECHEVERRIA RF, 1992, MEDICINA-BUENOS AIRE, V52, P145; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; GORDON T, 1976, INT J EPIDEMIOL, V5, P327, DOI 10.1093/ije/5.4.327; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; PERRY HM, 1992, J HYPERTENS, V10, P887; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; ROSNER B, 1983, AM J EPIDEMIOL, V117, P429, DOI 10.1093/oxfordjournals.aje.a113561; ROSNER B, 1977, J CHRON DIS, V30, P7, DOI 10.1016/0021-9681(77)90047-9; SCHECHTER CB, 1988, MED DECIS MAKING, V8, P182, DOI 10.1177/0272989X8800800306; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1991, Ann Epidemiol, V1, P347, DOI 10.1016/1047-2797(91)90045-E; THOMAS J, 1985, AM HEART J, V110, P637, DOI 10.1016/0002-8703(85)90087-0; WEISSFELD JL, 1985, J CHRON DIS, V38, P915, DOI 10.1016/0021-9681(85)90127-4; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; Wood D, 1998, J HYPERTENS, V16, P1407, DOI 10.1097/00004872-199816100-00003; WU M, 1980, J CHRON DIS, V33, P637, DOI 10.1016/0021-9681(80)90006-5	25	714	773	1	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1682	1686		10.1016/S0140-6736(01)06710-1	http://dx.doi.org/10.1016/S0140-6736(01)06710-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728544				2022-12-24	WOS:000172344100012
J	Sereno, MI; Pitzalis, S; Martinez, A				Sereno, MI; Pitzalis, S; Martinez, A			Mapping of contralateral space in retinotopic coordinates by a parietal cortical area in humans	SCIENCE			English	Article							HUMAN VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; SPATIAL WORKING-MEMORY; SURFACE-BASED ANALYSIS; SUPERIOR COLLICULUS; EYE-MOVEMENTS; NEURONS; ATTENTION; FMRI; ORGANIZATION	The internal organization of a higher level visual area in the human parietal cortex was mapped. Functional magnetic resonance images were acquired while the polar angle of a peripheral target for a delayed saccade was gradually changed. A region in the superior parietal cortex showed robust retinotopic mapping of the remembered target angle. The map reversed when the direction of rotation of the remembered targets was reversed and persisted unchanged when study participants detected rare target reappearances while maintaining fixation, or when the eccentricity of successive remembered targets was unpredictable. This region may correspond to the lateral intraparietal area in macaque monkeys.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sereno, MI (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.		Pitzalis, Sabrina/AAA-9406-2019; Martinez, Antigona/X-2317-2019; Sereno, Martin I/F-7657-2012	Sereno, Martin I/0000-0002-7598-7829; pitzalis, sabrina/0000-0002-4445-0391; Martinez, Antigona/0000-0003-4806-5199	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER; NICHD NIH HHS [NICHD22614] Funding Source: Medline; NIMH NIH HHS [MH25594] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1975, BRAIN RES, V100, P473, DOI 10.1016/0006-8993(75)90153-5; Andersen RA, 1998, NOVART FDN SYMP, V218, P109; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Critchley M., 1953, PARIETAL LOBES; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; INGLE D, 1975, SCIENCE, V188, P1033, DOI 10.1126/science.1170636; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KLEIST K, 1916, ERGEB NEUROL PSYCHIA, V1, P342; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno Martin I., 1991, P160; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Sereno MI, 1998, CURR OPIN NEUROBIOL, V8, P188, DOI 10.1016/S0959-4388(98)80139-6; Smith AT, 1998, J NEUROSCI, V18, P3816; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	44	518	521	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1350	1354		10.1126/science.1063695	http://dx.doi.org/10.1126/science.1063695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701930	Green Submitted			2022-12-24	WOS:000172130200052
J	de Fonseca, FR; Navarro, M; Gomez, R; Escuredo, L; Nava, F; Fu, J; Murillo-Rodriguez, E; Giuffrida, A; LoVerme, J; Gaetani, S; Kathuria, S; Gall, C; Piomelli, D				de Fonseca, FR; Navarro, M; Gomez, R; Escuredo, L; Nava, F; Fu, J; Murillo-Rodriguez, E; Giuffrida, A; LoVerme, J; Gaetani, S; Kathuria, S; Gall, C; Piomelli, D			An anorexic lipid mediator regulated by feeding	NATURE			English	Article							ENDOGENOUS CANNABINOID PRECURSOR; FOOD-INTAKE; RAT-BRAIN; MESSENGER-RNA; ANANDAMIDE; RECEPTOR; CHOLECYSTOKININ; AMIDOHYDROLASE; BIOSYNTHESIS; NEURONS	Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandamide, OEA is produced in cells in a stimulus-dependent manner and is rapidly eliminated by enzymatic hydrolysis, suggesting a function in cellular signalling(1). However, OEA does not activate cannabinoid receptors and its biological functions are still unknown(2). Here we show that, in rats, food deprivation markedly reduces OEA biosynthesis in the small intestine. Administration of OEA causes a potent and persistent decrease in food intake and gain in body mass. This anorexic effect is behaviourally selective and is associated with the discrete activation of brain regions (the paraventricular hypothalamic nucleus and the nucleus of the solitary tract) involved in the control of satiety. OEA does not affect food intake when injected into the brain ventricles, and its anorexic actions are prevented when peripheral sensory fibres are removed by treatment with capsaicin. These results indicate that OEA is a lipid mediator involved in the peripheral regulation of feeding.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Complutense, Dept Psychobiol, Madrid 28233, Spain; Fdn Hosp Carlos Haya, Malaga 29010, Spain; Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine; Complutense University of Madrid; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.		Nava, Felice Alfonso/AGM-7177-2022; Nava, Felice Alfonso/K-3920-2016; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Gaetani, Silvana/D-3455-2009; Fu, Jin/A-3510-2012; de Heras, Raquel Gomez/F-3484-2016; Giuffrida, Andrea/H-3770-2013	Nava, Felice Alfonso/0000-0002-3103-0355; de Heras, Raquel Gomez/0000-0002-5846-1059; Giuffrida, Andrea/0000-0002-3773-0694				BACHUR NR, 1965, J BIOL CHEM, V240, P1019; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berdyshev EV, 2000, BIOCHEM J, V346, P369, DOI 10.1042/0264-6021:3460369; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; CURRAN T, 1987, ONCOGENE, V2, P79; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GIUFFRIDA A, 1998, LIPID 2 MESSENGERS, P113; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Kaneko H, 1998, AM J PHYSIOL-GASTR L, V275, pG1056, DOI 10.1152/ajpgi.1998.275.5.G1056; Khanolkar AD, 1999, LIFE SCI, V65, P607, DOI 10.1016/S0024-3205(99)00283-0; LAUTERBORN JC, 1993, MOL BRAIN RES, V17, P59, DOI 10.1016/0169-328X(93)90073-X; Lee MD, 1998, PSYCHOPHARMACOLOGY, V136, P304, DOI 10.1007/s002130050570; MACLEAN DB, 1985, REGUL PEPTIDES, V11, P321, DOI 10.1016/0167-0115(85)90204-6; Navarro M, 1996, J NEUROCHEM, V67, P1982; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143	29	481	506	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					209	212		10.1038/35102582	http://dx.doi.org/10.1038/35102582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700558	Green Published			2022-12-24	WOS:000172029100048
J	Bushby, K; Raybould, S; O'Donnell, S; Steele, JG				Bushby, K; Raybould, S; O'Donnell, S; Steele, JG			Social deprivation in Duchenne muscular dystrophy: population based study	BRITISH MEDICAL JOURNAL			English	Article									Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Urban & Reg Dev Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Bushby, K (corresponding author), Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.							Acheson D., 1998, INDEPENDENT ENQUIRY; Benzeval M, 1996, J PUBLIC HEALTH MED, V18, P33, DOI 10.1093/oxfordjournals.pubmed.a024459; Bushby KMD, 1999, LANCET, V353, P557, DOI 10.1016/S0140-6736(98)05279-9; Gorospe Jose Rafael M., 1992, Current Opinion in Rheumatology, V4, P794; Townsend PP., 1988, HLTH DEPRIVATION INE	5	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1035	1036		10.1136/bmj.323.7320.1035	http://dx.doi.org/10.1136/bmj.323.7320.1035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691762	Green Published, Bronze			2022-12-24	WOS:000172055900018
J	Schoch, S; Deak, F; Konigstorfer, A; Mozhayeva, M; Sara, Y; Sudhof, TC; Kavalali, ET				Schoch, S; Deak, F; Konigstorfer, A; Mozhayeva, M; Sara, Y; Sudhof, TC; Kavalali, ET			SNARE function analyzed in synaptobrevin/VAMP knockout mice	SCIENCE			English	Article							MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; COMPLEX-FORMATION; VESICLES; NEUROTRANSMITTER; SPECIFICITY; EXOCYTOSIS; DISTINCT; CA2+; NSF	SNAREs (soluble NSF-attachment protein receptors) are generally acknowledged as central components of membrane fusion reactions, but their precise function has remained enigmatic. Competing hypotheses suggest roles for SNARES in mediating the specificity of fusion, catalyzing fusion, or actually executing fusion. We generated knockout mice lacking synaptobrevin/VAMP 2, the vesicular SNARE protein responsible for synaptic vesicle fusion in forebrain synapses, to make use of the exquisite temporal resolution of electrophysiology in measuring fusion. in the absence of synaptobrevin 2, spontaneous synaptic vesicle fusion and fusion induced by hypertonic sucrose were decreased similar to 10-fold, but fast Ca2+-triggered fusion was decreased more than 100-fold. Thus, synaptobrevin 2 may function in catalyzing fusion reactions and stabilizing fusion intermediates but is not absolutely required for synaptic fusion.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Howard Hughes Med Inst, Dallas, TX 75390 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu; Ege.Kavalali@UTSouthwestern.edu	Deak, Ferenc/AAE-4324-2019; Schoch, Susanne/F-7741-2012	Sara, Yildirim/0000-0003-1079-0782				Ashton AC, 2000, J NEUROCHEM, V74, P1979, DOI 10.1046/j.1471-4159.2000.0741979.x; Baines RA, 1999, CURR BIOL, V9, P1267, DOI 10.1016/S0960-9822(99)80510-7; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Capogna M, 1997, J NEUROSCI, V17, P7190; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; Mayer A, 1999, CURR OPIN CELL BIOL, V11, P447, DOI 10.1016/S0955-0674(99)80064-7; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Muller JMM, 1999, NAT CELL BIOL, V1, P335, DOI 10.1038/14025; Nonet ML, 1998, J NEUROSCI, V18, P70; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	42	485	496	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1117	1122		10.1126/science.1064335	http://dx.doi.org/10.1126/science.1064335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691998				2022-12-24	WOS:000172013800055
J	Weiss, JB; Suyama, KL; Lee, HH; Scott, MP				Weiss, JB; Suyama, KL; Lee, HH; Scott, MP			Jelly belly: A Drosophila LDL receptor repeat-containing, signal required for mesoderm migration and differentiation	CELL			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTION FACTORS; GENETIC SELECTION; EXPRESSION; PROTEIN; IDENTIFICATION; SPECIFICATION; TINMAN; FATES; EMBRYOGENESIS	Inductive interactions subdivide the Drosophila mesoderm into visceral, somatic, and heart muscle precursors. The muscle precursors form organs by executing tissue-specific migrations and cell fusions. We identified a novel gene, jelly belly (jeb), which is required for visceral mesoderm development. jeb encodes a secreted protein that contains an LDL receptor repeat. In jeb mutants, visceral mesoderm precursors form, but they fail to migrate or differentiate normally; no visceral muscles develop. Jeb protein is produced in somatic muscle precursors and taken up by visceral muscle precursors. jeb reveals a signaling process in which somatic muscle precursors support the proper migration and differentiation of visceral muscle cells. Later in embryogenesis, jeb is transcribed in neurons and Jeb protein is found in axons.	Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Genet, Stanford, CA 94305 USA; CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Weiss, JB (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,NRC3, Portland, OR 97201 USA.			LEE, HSIU-HSIANG/0000-0001-7707-8461	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003627] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [KO8 HL03627-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; BODMER R, 1993, DEVELOPMENT, V118, P719; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CHEN WS, 1995, ONCOL REP, V2, P5; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; Evans SM, 1999, SEMIN CELL DEV BIOL, V10, P73, DOI 10.1006/scdb.1999.0282; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gobron S, 1996, J CELL SCI, V109, P1053; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Griffin KJP, 2000, DEV BIOL, V218, P235, DOI 10.1006/dbio.1999.9571; HAMILTON BA, 1994, DROSOPHILA MELANOGAS, P81; Harlow E, 1999, USING ANTIBODIES LAB; HONG CC, 1995, CELL, V82, P785, DOI 10.1016/0092-8674(95)90475-1; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; Knirr S, 1999, DEVELOPMENT, V126, P4525; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; LIU J, 1993, COMPANION METHODS EN, V5, P127; LORD PCW, 1995, DEV BIOL, V171, P627, DOI 10.1006/dbio.1995.1310; MASTICK GS, 1995, GENETICS, V139, P349; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; REUTER R, 1993, DEVELOPMENT, V119, P1135; Riechmann V, 1997, DEVELOPMENT, V124, P2915; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541	42	66	67	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					387	398		10.1016/S0092-8674(01)00540-2	http://dx.doi.org/10.1016/S0092-8674(01)00540-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701128	Bronze			2022-12-24	WOS:000172022800009
J	Kaplan, EL; Wotton, JT; Johnson, DR				Kaplan, EL; Wotton, JT; Johnson, DR			Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis	LANCET			English	Article							GROUP-A STREPTOCOCCI; RHEUMATIC-FEVER; INFECTIONS; PYOGENES; DISEASE; FAILURE	Background Despite the past 15 years of heightened awareness of the disease-causing potential of group A streptococci, the possible epidemiological influence of rapid changes in prevalent serotypes has not been fully appreciated. Methods We analysed throat cultures collected as part of routine medical care in a semi-closed community of nearly 500 children and adults between January, 1999, and April, 2000. beta -haemolytic streptococci from all positive cultures were characterised by serological grouping, T-agglutination pattern, and serotyping for M protein or opacity factor. Findings We saw an increase in the number of symptomatic individuals with pharyngitis beginning in mid-1999. Between July 1 and Dec 31, 1999, 111 (29%) of 378 throat cultures yielded group A streptococci, 102 (92%) of which were serotype M1. Between Jan 1 and Mar 31, 2000, 126 (45%) of 277 throat cultures yielded group A streptococci. Unexpectedly, 106 (84%) of these throat isolates were serotype M6, and only 16 (13%) were M1. 20 ((28%.) of the 71 individuals with M1 infection subsequently acquired infection with M6. Interpretation This rapid and almost complete shift in predominance of group A streptococcal serotype in this community draws attention to the dynamic epidemiology of these organisms. This change has important implications for further understanding the epidemiology of group A streptococcal infections, and for the development and use of a vaccine.	Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; World Health Organization	Kaplan, EL (corresponding author), Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, MMC 296,420 Delaware St SE, Minneapolis, MN 55455 USA.							ANTHONY BF, 1976, AM J EPIDEMIOL, V104, P652, DOI 10.1093/oxfordjournals.aje.a112344; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; CLEARY PP, 2000, STREPTOCOCCI STREPTO, P437; CORNFELD D, 1961, NEW ENGL J MED, V264, P211, DOI 10.1056/NEJM196102022640502; DALE JB, 2000, STREPTOCOCCI STREPTO, P473; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; FISCHETTI VA, 2000, STREPTOCOCCI STREPTO, P433; GASTANADUY AS, 1980, LANCET, V2, P498; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Johnson DR., 1996, LAB DIAGNOSIS GROUP; JONES KF, 1988, P NATL ACAD SCI USA, V85, P8271, DOI 10.1073/pnas.85.21.8271; KAPLAN EL, 1979, PEDIATRICS, V64, P904; KAPLAN EL, 1981, J LAB CLIN MED, V98, P326; KAPLAN EL, 1993, CIRCULATION, V88, P1964, DOI 10.1161/01.CIR.88.4.1964; MARTIN PR, 1990, SCAND J INFECT DIS, V22, P421, DOI 10.3109/00365549009027073; SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F; Stevens DL., 2000, STREPTOCOCCAL INFECT; WANNAMAKER LW, 1954, STREPTOCOCCAL INFECT	20	81	81	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1334	1337		10.1016/S0140-6736(01)06415-7	http://dx.doi.org/10.1016/S0140-6736(01)06415-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684215				2022-12-24	WOS:000171702500014
J	Balasubramanian, M; Schwartz, EL				Balasubramanian, M; Schwartz, EL			The Isomap algorithm and topological stability	SCIENCE			English	Editorial Material									Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; Boston Univ, Dept Elect & Comp Syst, Boston, MA 02215 USA	Boston University; Boston University	Balasubramanian, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.							Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; SCHWARTZ EL, 1988, IEEE COMPUT GRAPH, V8, P13, DOI 10.1109/38.7745; SCHWARTZ EL, 1989, IEEE T PATTERN ANAL, V11, P1005, DOI 10.1109/34.35506; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; WOLFSON E, 1989, IEEE T PATTERN ANAL, V11, P1001, DOI 10.1109/34.35505	5	469	544	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778013				2022-12-24	WOS:000173143100001
J	Bourc'his, D; Xu, GL; Lin, CS; Bollman, B; Bestor, TH				Bourc'his, D; Xu, GL; Lin, CS; Bollman, B; Bestor, TH			Dnmt3L and the establishment of maternal genomic imprints	SCIENCE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; DNA METHYLTRANSFERASE GENE; EPIGENETIC MODIFICATION; METHYLATION IMPRINT; MOUSE DEVELOPMENT; LOCUS; MECHANISMS; MUTATIONS; FAMILY	Complementary sets of genes are epigenetically silenced in male and female gametes in a process termed genomic imprinting. The Dnmt3L gene is expressed during gametogenesis at stages where genomic imprints are established. Targeted disruption of Dnmt3L caused azoospermia in homozygous mates, and heterozygous progeny of homozygous, females died before midgestation. Bisulfite genomic sequencing of DNA from oocytes and embryos showed that removal of Dnmt3L prevented methylation of sequences that are normally maternally methylated. The defect was specific to imprinted regions, and global genome methylation levels were not affected. Lack of maternal methylation imprints in heterozygous embryos derived from homozygous mutant oocytes caused biallelic expression of genes that are normally expressed only from the allele of paternal origin. The key catalytic motifs characteristic of DNA cytosine methyltransferases have been lost from Dnmt3L, and the protein is more likely to act as a regulator of imprint establishment than as a DNA methyltransferase.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Transgen Anim Facil, New York, NY 10032 USA	Columbia University; Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.			Bourc'his, Deborah/0000-0001-9499-7291	NICHD NIH HHS [HD37687] Funding Source: Medline; NIGMS NIH HHS [GM59377] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059377] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Bartolomei M., COMMUNICATION; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; HALBERT CL, 1995, J VIROL, V69, P1473, DOI 10.1128/JVI.69.3.1473-1479.1995; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; TYCKO B, 1999, PROBL CELL DIFFER, V25, P133; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	29	976	1004	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2536	2539		10.1126/science.1065848	http://dx.doi.org/10.1126/science.1065848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11719692				2022-12-24	WOS:000172927700055
J	Seo, HC; Kube, M; Edvardsen, RB; Jensen, MF; Beck, A; Spriet, E; Gorsky, G; Thompson, EM; Lehrach, H; Reinhardt, R; Chourrout, D				Seo, HC; Kube, M; Edvardsen, RB; Jensen, MF; Beck, A; Spriet, E; Gorsky, G; Thompson, EM; Lehrach, H; Reinhardt, R; Chourrout, D			Miniature genome in the marine chordate Oikopleura dioica	SCIENCE			English	Article									Sara Ctr Marine Mol Biol, N-5020 Bergen, Norway; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Observ Oceanol, LOV, UPMC, CNRS,INSU, F-06234 Villefranche, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Chourrout, D (corresponding author), Sara Ctr Marine Mol Biol, Thormohlensgt 55, N-5020 Bergen, Norway.			Reinhardt, Richard/0000-0001-9376-2132; Edvardsen, Rolf/0000-0001-8430-8042				Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Fraser CM, 1997, ELECTROPHORESIS, V18, P1207, DOI 10.1002/elps.1150180803; Monaghan P, 2000, TRENDS GENET, V16, P331, DOI 10.1016/S0168-9525(00)02051-5; Nishino A, 2001, GENESIS, V29, P36, DOI 10.1002/1526-968X(200101)29:1<36::AID-GENE1003>3.0.CO;2-J; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437	5	135	140	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2506	2506		10.1126/science.294.5551.2506	http://dx.doi.org/10.1126/science.294.5551.2506			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752568				2022-12-24	WOS:000172927700045
J	Bhoo, SH; Davis, SJ; Walker, J; Karniol, B; Vierstra, RD				Bhoo, SH; Davis, SJ; Walker, J; Karniol, B; Vierstra, RD			Bacteriophytochromes are photochromic histidine kinases using a biliverdin chromophore	NATURE			English	Article							EUKARYOTIC PHYTOCHROMES; BIOSYNTHESIS; PROTEIN; GENE; SIMILARITY	Phytochromes comprise a principal family of red/far-red light sensors in plants(1). Although phytochromes were thought originally to be confined to photosynthetic organisms(2,3), we have recently detected phytochrome-like proteins in two heterotrophic eubacteria, Deinococcus radiodurans and Pseudomonas aeruginosa(4). Here we show that these form part of a widespread family of bacteriophytochromes (BphPs) with homology to two-component sensor histidine kinases. Whereas plant phytochromes use phytochromobilin as the chromophore, BphPs assemble with biliverdin, an immediate breakdown product of haem, to generate photochromic kinases that are modulated by red and far-red light. In some cases, a unique haem oxygenase responsible for the synthesis of biliverdin is part of the BphP operon. Co-expression of this oxygenase with a BphP apoprotein and a haem source is sufficient to assemble holo-BphP in vivo. Both their presence in many diverse bacteria and their simplified assembly with biliverdin suggest that BphPs are the progenitors of phytochrome-type photoreceptors.	Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vierstra, RD (corresponding author), Univ Wisconsin, Mol & Cellular Biol Program, 1575 Linden Dr, Madison, WI 53706 USA.							BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; ELICH TD, 1989, J BIOL CHEM, V264, P12902; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Herdman M, 2000, J MOL EVOL, V51, P205, DOI 10.1007/s002390010082; Hughes O, 1999, PLANT PHYSIOL, V121, P1059; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000	19	232	253	1	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					776	779		10.1038/414776a	http://dx.doi.org/10.1038/414776a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742406				2022-12-24	WOS:000172676200054
J	Ahlund, M; Andersson, M				Ahlund, M; Andersson, M			Brood parasitism - Female ducks can double their reproduction	NATURE			English	Article							PATERNITY		Univ Gothenburg, Dept Zool, S-40530 Gothenburg, Sweden	University of Gothenburg	Ahlund, M (corresponding author), Univ Gothenburg, Dept Zool, Box 463, S-40530 Gothenburg, Sweden.							Andersson M, 2000, P NATL ACAD SCI USA, V97, P13188, DOI 10.1073/pnas.220137897; Andersson M, 2001, ECOLOGY, V82, P1433, DOI 10.1890/0012-9658(2001)082[1433:PFANTR]2.0.CO;2; Brown CR, 1998, BEHAV ECOL, V9, P158, DOI 10.1093/beheco/9.2.158; Eadie J.M., 1989, THESIS U BRIT COLUMB; EADIE JM, 1988, CAN J ZOOL, V66, P1709, DOI 10.1139/z88-247; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; McRae SB, 1998, BEHAV ECOL, V9, P93, DOI 10.1093/beheco/9.1.93; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; SORENSON MD, 1991, ANIM BEHAV, V42, P771, DOI 10.1016/S0003-3472(05)80122-8	10	75	77	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					600	601		10.1038/414600b	http://dx.doi.org/10.1038/414600b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740548				2022-12-24	WOS:000172535600036
J	Cywes, C; Wessels, MR				Cywes, C; Wessels, MR			Group A Streptococcus tissue invasion by CD44-mediated cell signalling	NATURE			English	Article							HYALURONIC-ACID CAPSULE; CD44 INTERACTION; M PROTEIN; KERATINOCYTES; RECEPTOR; BINDING; RAC1; SKIN	Streptococcus pyogenes (also known as group A Streptococcus, GAS), the agent of streptococcal sore throat and invasive soft-tissue infections, attaches to human pharyngeal or skin epithelial cells through specific recognition of its hyaluronic acid capsular polysaccharide by the hyaluronic-acid-binding protein CD44 (refs 1, 2). Because ligation of CD44 by hyaluronic acid can induce epithelial cell movement on extracellular matrix(3-5), we investigated whether molecular mimicry by the GAS hyaluronic acid capsule might induce similar cellular responses. Here we show that CD44-dependent GAS binding to polarized monolayers of human keratinocytes induced marked cytoskeletal rearrangements manifested by membrane ruffling and disruption of intercellular junctions. Transduction of the signal induced by GAS binding to CD44 on the keratinocyte surface involved Rac1 and the cytoskeleton linker protein ezrin, as well as tyrosine phosphorylation of cellular proteins. Studies of bacterial translocation in two models of human skin indicated that cell signalling triggered by interaction of the GAS capsule with CD44 opened intercellular junctions and promoted tissue penetration by GAS through a paracellular route. These results support a model of host cytoskeleton manipulation and tissue invasion by an extracellular bacterial pathogen.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Wessels, MR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	mwessels@channing.harvard.edu		Cywes Bentley, Colette/0000-0002-6301-0930				Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; CLINE PR, 1983, CANCER RES, V43, P3203; CROWE DL, 1991, DIFFERENTIATION, V48, P199, DOI 10.1111/j.1432-0436.1991.tb00258.x; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; MCCALLUM SJ, 2000, CELLULAR MICROBIOLOG, P171; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Oliferenko S, 2000, J CELL BIOL, V149, P241; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; RHEINWALD JG, 1979, INT REV CYTOL      S, V10, P25; Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; Tchao R., 1988, ALTERN METHODS TOXIC, V6, P271; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391	22	162	169	5	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					648	652		10.1038/414648a	http://dx.doi.org/10.1038/414648a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740562				2022-12-24	WOS:000172535600050
J	Colicos, MA; Collins, BE; Sailor, MJ; Goda, Y				Colicos, MA; Collins, BE; Sailor, MJ; Goda, Y			Remodeling of synaptic actin induced by photoconductive stimulation	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL AREA CA1; CULTURED NEURONS; POSTSYNAPTIC DENSITIES; PRESYNAPTIC BOUTONS; TRANSMITTER RELEASE; DENDRITIC SPINES; MEMORY STORAGE; N-CADHERIN; LATE-PHASE	Use-dependent synapse remodeling is thought to provide a cellular mechanism for encoding durable memories, yet whether activity triggers an actual structural change has remained controversial. We. use photoconductive stimulation to demonstrate activity dependent morphological synaptic plasticity by video imaging of GFP-actin at individual synapses. A single tetanus transiently moves presynaptic actin toward and postsynaptic actin away from the synaptic junction. Repetitive spaced tetani induce glutamate receptor-dependent stable restructuring of synapses. Presynaptic actin redistributes and forms new puncta that label for an active synapse marker FM5-95 within 2 hr. Postsynaptic actin sprouts projections toward the new presynaptic actin puncta, resembling the axon-dendrite interaction during synaptogenesis. Our results indicate that activity-dependent presynaptic structural plasticity facilitates the formation of new active presynaptic terminals.	Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Goda, Y (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ygoda@biomail.ucsd.edu	Goda, Yukiko/A-6576-2016; Goda, Yukiko/AAR-5641-2020; Sailor, Michael J/H-9044-2017	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Sailor, Michael J/0000-0002-4809-9826				Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; GROSS GW, 1993, J NEUROSCI METH, V50, P131, DOI 10.1016/0165-0270(93)90001-8; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim D, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0004.2001; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maher MP, 1999, J NEUROSCI METH, V87, P45, DOI 10.1016/S0165-0270(98)00156-3; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Merzenich M M, 1993, Curr Opin Neurobiol, V3, P187, DOI 10.1016/0959-4388(93)90209-H; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Parak WJ, 1997, SENSOR ACTUAT A-PHYS, V63, P47, DOI 10.1016/S0924-4247(97)80428-1; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; SUDHOF T, 2000, SYNAPSES, V1, P275; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	56	230	236	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					605	616		10.1016/S0092-8674(01)00579-7	http://dx.doi.org/10.1016/S0092-8674(01)00579-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733060	Bronze			2022-12-24	WOS:000172575300008
J	Jin, RC; Cao, YW; Mirkin, CA; Kelly, KL; Schatz, GC; Zheng, JG				Jin, RC; Cao, YW; Mirkin, CA; Kelly, KL; Schatz, GC; Zheng, JG			Photoinduced conversion of silver nanospheres to nanoprisms	SCIENCE			English	Article							WET CHEMICAL SYNTHESIS; GOLD; SHAPE; SIZE; NANOCRYSTALS; PARTICLES; NANOWIRES; CHEMISTRY; NANORODS; PHYSICS	A photoinduced method for converting large quantities of silver nanospheres into triangular nanoprisms is reported. The photo-process has been characterized by time-dependent ultraviolet-visible spectroscopy and transmission electron microscopy, allowing for the observation of several key intermediates in and characteristics of the conversion process. This light-driven process results in a colloid with distinctive optical properties that directly relate to the nanoprism shape of the particles. Theoretical calculations coupled with experimental observations allow for the assignment of the nanoprism plasmon bands and for the first identification of two distinct quadrupole plasmon resonances for a nanoparticle. Unlike the spherical particles they are derived from that Rayleigh tight-scatter in the blue, these nanoprisms exhibit scattering in the red, which could be useful in developing multicolor diagnostic labels on the basis not only of nanoparticle composition and size but also of shape.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	schatz@chem.nwu.edu	Schatz, George C./ABF-1341-2020; bee, betty/G-1104-2011; Mirkin, Chad A/E-3911-2010					Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bradley JS, 2000, J AM CHEM SOC, V122, P4631, DOI 10.1021/ja992409y; Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; CHERNS D, 1974, PHILOS MAG, V30, P549, DOI 10.1080/14786439808206580; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; FENDLER JH, 1995, ADV MATER, V7, P607, DOI 10.1002/adma.19950070703; FOSS CA, 1994, J PHYS CHEM-US, V98, P2963, DOI 10.1021/j100062a037; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; Henglein A, 2001, LANGMUIR, V17, P2329, DOI 10.1021/la001081f; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Jana NR, 2001, CHEM COMMUN, P617, DOI 10.1039/b100521i; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Kamat PV, 1998, J PHYS CHEM B, V102, P3123, DOI 10.1021/jp980009b; Kirkland A. I., 1990, EMAG-MICRO 89. Proceedings of the Institute of Physics Electron Microscopy and Analysis Group and Royal Microscopical Society Conference, P375; KIRKLAND AI, 1993, P ROY SOC LOND A MAT, V440, P589, DOI 10.1098/rspa.1993.0035; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Li M, 1999, NATURE, V402, P393, DOI 10.1038/46509; Lieber CM, 1998, SOLID STATE COMMUN, V107, P607, DOI 10.1016/S0038-1098(98)00209-9; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Palik E. D., 1985, HDB OPTICAL CONSTANT, P350; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Pinna N, 2001, ADV MATER, V13, P261, DOI 10.1002/1521-4095(200102)13:4<261::AID-ADMA261>3.3.CO;2-O; Prochazka M, 1997, ANAL CHEM, V69, P5103, DOI 10.1021/ac970683+; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Schatz G.C., 2002, HDB VIBRATIONAL SPEC, P759, DOI DOI 10.1002/0470027320.S0601; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Taton TA, 2001, J AM CHEM SOC, V123, P5164, DOI 10.1021/ja0102639; YANG WH, 1995, J CHEM PHYS, V103, P869, DOI 10.1063/1.469787; Yu YY, 1997, J PHYS CHEM B, V101, P6661	38	3064	3207	39	1660	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1901	1903		10.1126/science.1066541	http://dx.doi.org/10.1126/science.1066541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729310				2022-12-24	WOS:000172465000051
J	Connerney, I; Shapiro, PA; McLaughlin, JS; Bagiella, E; Sloan, RP				Connerney, I; Shapiro, PA; McLaughlin, JS; Bagiella, E; Sloan, RP			Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; LONG-TERM; GRAFT-SURGERY; MORTALITY; SURVIVAL; RISK; MEN; ASSOCIATION; PROGNOSIS	Background The association of depression with cardiac events has been investigated mainly in community cohorts, in patients undergoing catheterisation, or in patients who have had myocardial infarction. We have assessed the effect of depression on outcomes after coronary artery bypass graft (CABG) surgery. Methods In a prospective study, we followed up for 1 year 207 men and 102 women, who had undergone coronary artery bypass graft surgery. We assessed depression with a structured psychiatric interview (diagnostic interview schedule) and a questionnaire (Beck depression inventory) before discharge. Cardiac events included angina or heart failure that needed admission to hospital, myocardial infarction, cardiac arrest, percutaneous transluminal coronary angioplasty, repeat CABG, and cardiac mortality. Non-cardiac events consisted of all other reasons for mortality or readmission. Findings 63 patients (20%) met modified diagnostic statistical manual IV criteria for major depressive disorder. At 12 months, 17 (27%) of these patients had a cardiac event compared with 25 of 246 (10%) who were not depressed (p<0.0008). Five variables had significant univariate associations with cardiac events: sex, living alone, low ejection fraction (<0.35), length of hospital stay, and depression. In a Cox proportional-hazard model with these five and two other variables of cardiac severity, major depressive disorder (risk ratio 2.3 [95% Cl 1.17-4.56]), low ejection fraction (2.3 [1.07-5.03]), and female sex (2.4 [1.24-4.44]) were associated with adverse outcomes. Depression did not predict deaths or admissions for noncardiac events. Interpretation Depression is an important independent risk factor for cardiac events after CABG surgery.	Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; Columbia Univ, MAilman Sch Publ Hlth, New York, NY USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Columbia University; Columbia University; University System of Maryland; University of Maryland Baltimore	Connerney, I (corresponding author), Univ Maryland, Med Ctr, 22 S Greene St,Box 316, Baltimore, MD 21201 USA.	iconnerney@umm.edu			NIMH NIH HHS [K02 MH01491] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001491] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHERN DK, 1990, AM J CARDIOL, V66, P59, DOI 10.1016/0002-9149(90)90736-K; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; ANDA R, 1993, EPIDEMIOLOGY, V4, P285, DOI 10.1097/00001648-199307000-00003; AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; CARNEY RM, 1995, AM J CARDIOL, V76, P562, DOI 10.1016/S0002-9149(99)80155-6; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; EAKER ED, 1989, AM HEART J, V117, P71, DOI 10.1016/0002-8703(89)90658-3; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; FRASURESMITH N, 1991, AM J CARDIOL, V67, P121, DOI 10.1016/0002-9149(91)90432-K; Gray RJ, 1996, ARCH INTERN MED, V156, P769, DOI 10.1001/archinte.156.7.769; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; LADWIG KH, 1994, LANCET, V343, P20, DOI 10.1016/S0140-6736(94)90877-X; LANGELUDDECKE P, 1989, J PSYCHOSOM RES, V33, P37, DOI 10.1016/0022-3999(89)90104-9; McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Pirraglia PA, 1999, INT J GERIATR PSYCH, V14, P668, DOI 10.1002/(SICI)1099-1166(199908)14:8<668::AID-GPS988>3.0.CO;2-9; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Scheier MF, 1999, ARCH INTERN MED, V159, P829, DOI 10.1001/archinte.159.8.829; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; SCHROLL M, 1982, DAN MED BULL, V29, P213; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	30	347	367	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2001	358	9295					1766	1771		10.1016/S0140-6736(01)06803-9	http://dx.doi.org/10.1016/S0140-6736(01)06803-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734233				2022-12-24	WOS:000172385100011
J	Beall, CM; Laskowski, D; Strohl, KP; Soria, R; Villena, M; Vargas, E; Alarcon, AM; Gonzales, C; Erzurum, SC				Beall, CM; Laskowski, D; Strohl, KP; Soria, R; Villena, M; Vargas, E; Alarcon, AM; Gonzales, C; Erzurum, SC			Pulmonary nitric oxide in mountain dwellers	NATURE			English	Article							HAN RESIDENTS; OXYGEN; SYNTHASE; EXERCISE; TIBETAN; LHASA		Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Pulm, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Crit Care Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Louis Stokes VA Med Ctr, Dept Med, Cleveland, OH 44106 USA; Inst Boliviano Biol Altura, Dept Resp, La Paz, Bolivia	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Universidad Mayor de San Andres	Beall, CM (corresponding author), Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA.			Beall, Cynthia/0000-0003-1462-8299				AbuSoud HM, 1996, J BIOL CHEM, V271, P32515, DOI 10.1074/jbc.271.51.32515; Brutsaert TD, 2000, AM J PHYS ANTHROPOL, V113, P169, DOI 10.1002/1096-8644(200010)113:2<169::AID-AJPA3>3.3.CO;2-0; Dweik RA, 1998, J CLIN INVEST, V101, P660, DOI 10.1172/JCI1378; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; GUSTAFSSON LE, 1991, BIOCHEM BIOPH RES CO, V181, P852, DOI 10.1016/0006-291X(91)91268-H; HUANG SY, 1992, J APPL PHYSIOL, V73, P2638, DOI 10.1152/jappl.1992.73.6.2638; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; Le Cras TD, 2001, AM J PHYSIOL-LUNG C, V280, pL575, DOI 10.1152/ajplung.2001.280.4.L575; Little M., 1976, MAN ANDES MULTIDISCI, P332; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; SPIELVOGEL H, 1978, RESPIRATION, V35, P125, DOI 10.1159/000193869; SUN SF, 1990, RESP PHYSIOL, V79, P151, DOI 10.1016/0034-5687(90)90015-Q	12	183	197	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					411	412		10.1038/35106641	http://dx.doi.org/10.1038/35106641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719794				2022-12-24	WOS:000172304500032
J	Benenson, Y; Paz-Elizur, T; Adar, R; Keinan, E; Livneh, Z; Shapiro, E				Benenson, Y; Paz-Elizur, T; Adar, R; Keinan, E; Livneh, Z; Shapiro, E			Programmable and autonomous computing machine made of biomolecules	NATURE			English	Article							DNA SOLUTION; COMPUTATION; IMPLEMENTATION; MOLECULES; DESIGN	Devices that convert information from one form into another according to a definite procedure are known as automata. One such hypothetical device is the universal Turing machine(1), which stimulated work leading to the development of modern computers. The Turing machine and its special cases(2), including finite automata(3), operate by scanning a data tape, whose striking analogy to information-encoding biopolymers inspired several designs for molecular DNA computers(4-8). Laboratory-scale computing using DNA and human-assisted protocols has been demonstrated(9-15), but the realization of computing devices operating autonomously on the molecular scale remains rare(16-20). Here we describe a programmable finite automaton comprising DNA and DNA-manipulating enzymes that solves computational problems autonomously. The automaton's hardware consists of a restriction nuclease and ligase, the software and input are encoded by double-stranded DNA, and programming amounts to choosing appropriate software molecules. Upon mixing solutions containing these components, the automaton processes the input molecule via a cascade of restriction, hybridization and ligation cycles, producing a detectable output molecule that encodes the automaton's final state, and thus the computational result. In our implementation 10(12) automata sharing the same software run independently and in parallel on inputs (which could, in principle, be distinct) in 120 mul solution at room temperature at a combined rate of 10(9) transitions per second with a transition fidelity greater than 99.8%, consuming less than 10(-10) W.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, Dept Chem, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Weizmann Institute of Science; Weizmann Institute of Science; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Scripps Research Institute; Scripps Research Institute	Shapiro, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.		Benenson, Yaakov/B-1433-2009		European Research Council [233047] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Adelman Leonard M., 1994, Science (Washington D C), V266, P1021; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Garzon M, 1998, LECT NOTES COMPUT SC, V1436, P56, DOI 10.1007/BFb0031381; Hartemink AJ, 1999, BIOSYSTEMS, V52, P227, DOI 10.1016/S0303-2647(99)00050-7; Hoperoft J., 2000, INTRO AUTOMATA THEOR; Khodor J, 1999, BIOSYSTEMS, V52, P93, DOI 10.1016/S0303-2647(99)00036-2; LANDWEBER LF, 1997, DNA BASED COMPUTERS, V3, P161; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; ROTHEMUND PWK, 1996, DNA BASED COMPUTERS, P75; Ruben AJ, 2000, NAT REV MOL CELL BIO, V1, P69, DOI 10.1038/35036086; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Shapiro E., 2001, US Patent, Patent No. [6266569, US6266569B1]; Smith W. D., 1996, DIMACS SERIES DISCRE, P121; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	21	490	557	3	141	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					430	434		10.1038/35106533	http://dx.doi.org/10.1038/35106533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719800	Green Accepted			2022-12-24	WOS:000172304500038
J	Penuelas, J; Filella, I				Penuelas, J; Filella, I			Phenology - Responses to a warming world	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; TEMPERATURE; TRENDS		Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC)	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain.		Filella, Iolanda/A-2860-2015; Gutierrez, Emilia/O-7568-2014; Penuelas, Josep/D-9704-2011	Gutierrez, Emilia/0000-0002-6085-5700; Penuelas, Josep/0000-0002-7215-0150; Filella, Iolanda/0000-0001-6262-5733				Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Ahas R, 1999, INT J BIOMETEOROL, V42, P119, DOI 10.1007/s004840050094; Beaubien EG, 2000, INT J BIOMETEOROL, V44, P53, DOI 10.1007/s004840000050; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Ellis Willem N., 1997, Entomologische Berichten (Amsterdam), V57, P66; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Fleming R. A., 1995, P505; Gibbs JP, 2001, CONSERV BIOL, V15, P1175, DOI 10.1046/j.1523-1739.2001.0150041175.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Larcher W., 1995, PHYSL PLANT ECOLOGY; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Osborne CP, 2000, PLANT CELL ENVIRON, V23, P701, DOI 10.1046/j.1365-3040.2000.00584.x; PENUELAS J, IN PRESS GLOBAL CHAN; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Spiecker H., 1996, GROWTH TRENDS EUROPE; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walker RD, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.1.1; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	29	595	677	8	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					793	+		10.1126/science.1066860	http://dx.doi.org/10.1126/science.1066860			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679652				2022-12-24	WOS:000171851800027
J	Montgomery, SM; Ekbom, A				Montgomery, SM; Ekbom, A			Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort	BRITISH MEDICAL JOURNAL			English	Article									Karolinska Sjukuset, Klin Epidemiol, SE-17176 Stockholm, Sweden		Montgomery, SM (corresponding author), Karolinska Sjukuset, Klin Epidemiol, SE-17176 Stockholm, Sweden.		Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; EKINSMYTH C, 1992, INTEGRATED APPROACH; FERRI E, 1993, LIFE 33 5 FOLLOW UP; ORAHILLY S, 1987, BRIT MED J, V294, P923, DOI 10.1136/bmj.294.6577.923; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157	5	159	165	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2002	324	7328					26	27		10.1136/bmj.324.7328.26	http://dx.doi.org/10.1136/bmj.324.7328.26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510JV	11777801	Green Published, Bronze			2022-12-24	WOS:000173205700020
J	Bhalla, P; Pippa, S; Williams, G				Bhalla, P; Pippa, S; Williams, G			An inexpensive and edible aid for the diagnosis of puberty in the male: multispecies evaluation of an alternative orchidometer	BRITISH MEDICAL JOURNAL			English	Article									Univ Hosp Aintree, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AE, Merseyside, England	University of Liverpool	Williams, G (corresponding author), Univ Hosp Aintree, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AE, Merseyside, England.							Chen M, 2000, BRIT MED J, V321, P1565, DOI 10.1136/bmj.321.7276.1565; Chipkevitch E, 1996, J UROLOGY, V156, P2050, DOI 10.1016/S0022-5347(01)65433-8; Prader A, 1966, Triangle, V7, P240; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Williams TM, 1995, BRIT MED J, V311, P1700, DOI 10.1136/bmj.311.7021.1700	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1486	1486		10.1136/bmj.323.7327.1486	http://dx.doi.org/10.1136/bmj.323.7327.1486			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751366	Green Published			2022-12-24	WOS:000172979900027
J	Siegert, F; Ruecker, G; Hinrichs, A; Hoffmann, AA				Siegert, F; Ruecker, G; Hinrichs, A; Hoffmann, AA			Increased damage from fires in logged forests during droughts caused by El Nino	NATURE			English	Article							ERS-2 SAR IMAGES; TROPICAL FORESTS; EASTERN AMAZON; RAIN-FOREST; KALIMANTAN; BIOMASS	In 1997-98, fires associated with an exceptional drought caused by the El Nino/Southern Oscillation (ENSO) devastated large areas of tropical rain forests worldwide. Evidence suggests that in tropical rainforest environments selective logging may lead to an increased susceptibility of forests to fire(1-4). We investigated whether this was true in the Indonesian fires, the largest fire disaster ever observed(5,6). We performed a multiscale analysis using coarse- and high-resolution optical and radar satellite imagery assisted by ground and aerial surveys to assess the extent of the fire-damaged area and the effect on vegetation in East Kalimantan on the island of Borneo. A total of 5.2 +/-0.3 million hectares including 2.6 million hectares of forest was burned with varying degrees of damage. Forest fires primarily affected recently logged forests; primary forests or those logged long ago were less affected. These results support the hypothesis of positive feedback between logging and fire occurrence(4). The fires severely damaged the remaining forests and significantly increased the risk of recurrent fire disasters by leaving huge amounts of dead flammable wood.	Univ Munich, Dept Biol, D-80333 Munich, Germany; Remote Sensing Solut GmbH, D-81667 Munich, Germany; ZEBRIS GIS & Consulting, D-81373 Munich, Germany; GTZ, IFFM, Samarinda 75001, Kalimantan Timu, Indonesia; GTZ, MoFEC, SFMP, Samarinda 75123, Kalimantan Timu, Indonesia	University of Munich	Siegert, F (corresponding author), Univ Munich, Dept Biol, Luisenstr 14, D-80333 Munich, Germany.		Nahas, Alberth/C-8379-2013; Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645; Ruecker, Gernot/0000-0001-5995-8895				*ADB, 1999, CAUS EXT IMP COSTS 1; BARBER CV, 2000, TRIAL FIRE, P5; BROOKFIELD H, 1995, PLACE FOREST ENV SOC, P158; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; COLFER C, 2000, 8 E KAL PROV CTR INT, P1; GOLDAMMER JG, 1990, ECOL STU AN, V84, P11; Goldammer JG, 1999, SCIENCE, V284, P1782; Goldammer JG, 1996, DIPTEROCARP FOREST E, P155; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; KAUFFMAN JB, 1988, OIKOS, V53, P167, DOI 10.2307/3566059; Kuntz S, 1999, INT J REMOTE SENS, V20, P2835, DOI 10.1080/014311699211822; LEIGHTON M, 1986, TROPICAL RAIN FOREST, P75; MALINGREAU JP, 1985, AMBIO, V14, P314; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; *PROV FOR DEP E KA, 1999, FOR STAT 1998 98, P27; Siegert F, 2000, INT J REMOTE SENS, V21, P831, DOI 10.1080/014311600210632; Siegert F, 2000, REMOTE SENS ENVIRON, V72, P64, DOI 10.1016/S0034-4257(99)00092-9; SOLICHIN SH, 1999, 7B SFMP GES TECHN ZU, P8; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; ULABY FT, 1986, MICROWAVE REMOTE SEN, V3, P1811	22	430	457	7	160	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					437	440		10.1038/35106547	http://dx.doi.org/10.1038/35106547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719802				2022-12-24	WOS:000172304500040
J	Jungkind, D				Jungkind, D			Molecular testing for infectious disease	SCIENCE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; COBAS AMPLICOR; REACTION ASSAY; LCX; DNA; AMPLIFICATION; SPECIMENS; SYSTEM		Thomas Jefferson Univ, Sch Med, Clin Microbiol Labs, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sch Med, Dept Pathol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sch Med, Dept Microbiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Jungkind, D (corresponding author), Thomas Jefferson Univ, Sch Med, Clin Microbiol Labs, Philadelphia, PA 19107 USA.							BASS CJ, 1993, J OFFSHORE TECHNOL, V1, P31; BEAVIS KG, 1995, J CLIN MICROBIOL, V33, P2582, DOI 10.1128/JCM.33.10.2582-2586.1995; BERMANN JS, 1999, J CLIN MICROBIOL, V37, P1419; Brambilla DJ, 2001, J CLIN MICROBIOL, V39, P1121, DOI 10.1128/JCM.39.3.1121-1123.2001; Carroll KC, 1998, J CLIN MICROBIOL, V36, P1630, DOI 10.1128/JCM.36.6.1630-1633.1998; Foubister V, 2000, CAP TODAY        SEP, P84; Goessens WHF, 1997, J CLIN MICROBIOL, V35, P2628, DOI 10.1128/JCM.35.10.2628-2633.1997; Jungkind D, 1996, J CLIN MICROBIOL, V34, P2778, DOI 10.1128/JCM.34.11.2778-2783.1996; Jungkind D, 2001, J CLIN VIROL, V20, P1, DOI 10.1016/S1386-6532(00)00148-7; Klapper PE, 1998, CLIN CHEM, V44, P1737; Kulkarni A, 2001, CLIN MICROBIOL INFEC, V7, P179, DOI 10.1046/j.1198-743x.2001.00227.x; Little MC, 1999, CLIN CHEM, V45, P777; Lumb R, 1999, J CLIN MICROBIOL, V37, P3102, DOI 10.1128/JCM.37.10.3102-3107.1999; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Pawlotsky JM, 2000, J VIROL METHODS, V85, P11, DOI 10.1016/S0166-0934(99)00149-4; Roth WK, 2001, TRANSFUS CLIN BIOL, V8, P282, DOI 10.1016/S1246-7820(01)00115-X; Wattanamano P, 2000, J CLIN MICROBIOL, V38, P727, DOI 10.1128/JCM.38.2.727-732.2000; WHITE TJ, 1992, ADV CLIN CHEM, V29, P161, DOI 10.1016/S0065-2423(08)60224-3; ZAAIJER HL, 1994, VOX SANG, V66, P78, DOI 10.1111/j.1423-0410.1994.tb00282.x; Zanchetta N, 2000, J CLIN MICROBIOL, V38, P3882, DOI 10.1128/JCM.38.10.3882-3886.2000	20	21	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1553	+		10.1126/science.294.5546.1553	http://dx.doi.org/10.1126/science.294.5546.1553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711681				2022-12-24	WOS:000172240500056
J	Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Ribble, RC; Booze, MW; Rogala, A; Hauser, MA; Zhang, FY; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Pericak-Vance, MA; Vance, JM				Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Ribble, RC; Booze, MW; Rogala, A; Hauser, MA; Zhang, FY; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Pericak-Vance, MA; Vance, JM			Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CLINICAL-DIAGNOSIS; LINKAGE; MUTATIONS; DISEQUILIBRIUM; TRANSMISSION; HAPLOTYPE; ACCURACY; DEMENTIA	Context The human tau gene, which promotes assembly of neuronal microtubules, has been associated with several rare neurologic diseases that clinically include parkinsonian features. We recently observed linkage in idiopathic Parkinson disease (PD) to a region on chromosome 17q21 that contains the tau gene. These factors make tau a good candidate for investigation as a susceptibility gene for idiopathic PD, the most common form of the disease. Objective To: investigate whether the tau gene is involved in idiopathic PD. Design, Setting, and Participants Among a sample of 1056 individuals from 235 families selected from 13 clinical centers in the United States and Australia and from a family ascertainment core center, we tested 5 single-nucleotide polymorphisms (SNPs) within the tau gene for association with PD, using family-based tests of association. Both affected (n=426) and unaffected (n=579) family members were included; 51 individuals had unclear PD status. Analyses were conducted to test individual SNPs and SNP haplotypes within the tau gene. Main Outcome Measure Family-based tests of association, calculated using asymptotic distributions. Results Analysis of association between the SNPs and PD yielded significant evidence of association for 3 of the 5 SNPs tested: SNP 3, P=.03; SNP 9i, P=.04; and SNP 11, P=.04. The 2 other SNPs did not show evidence of significant association (SNP 9ii, P=.11, and SNP 9iii, P=.87). Strong evidence of association was found with haplotype analysis, with a positive association with one haplotype (P=.009) and a negative association with another haplotype (P=.007). Substantial linkage disequilibrium (P<.001) was detected between 4 of the 5 SNPs (SN Ps 3, 9i, 9ii, and 11). Conclusions This integrated approach of genetic linkage and positional association analyses implicates tau as a susceptibility gene for idiopathic PD.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev, Greenford, Middx, England; GlaxoSmithKline Res & Dev, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA	Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; GlaxoSmithKline; GlaxoSmithKline; Vanderbilt University	Vance, JM (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Box 2903, Durham, NC 27710 USA.		Zhang, Fengyu/M-1396-2019; Scott, Burton/L-3951-2019; Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Zhang, Fengyu/0000-0001-8504-0770; Haines, Jonathan/0000-0002-4351-4728; Laing, Nigel/0000-0001-5111-3732; Vance, Jeffery/0000-0003-3815-8199; Scott, William/0000-0001-9336-6404; Gibson, Rachel/0000-0002-1338-1290	NINDS NIH HHS [P01 NS026630, P50 NS039764, P01 NS26630, P50 NS039764-07, 2 P50 NS39764-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, P50NS039764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan W, 1937, ARCH INTERN MED, V60, P424, DOI 10.1001/archinte.1937.00180030041003; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EGGERDING FA, 1995, HUM MUTAT, V5, P153, DOI 10.1002/humu.1380050209; Golbe LI, 2001, MOVEMENT DISORD, V16, P442, DOI 10.1002/mds.1087; Higgins JJ, 1999, NEUROLOGY, V53, P1421, DOI 10.1212/WNL.53.7.1421; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lewis P.O., 2000, GENETIC DATA ANAL CO; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; MARTIN ER, 2001, AM J HUM GENET, V69, pA511; Pastor P, 2000, ANN NEUROL, V47, P242; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Vance Jeffery M., 1998, P213; WARD CD, 1990, ADV NEUROL, V53, P245	29	149	156	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2245	2250		10.1001/jama.286.18.2245	http://dx.doi.org/10.1001/jama.286.18.2245			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710889	Green Accepted			2022-12-24	WOS:000172129700018
J	Fishman, MC				Fishman, MC			Genomics - Zebrafish - The canonical vertebrate	SCIENCE			English	Editorial Material							GENETIC-ANALYSIS		Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div Cardiovasc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fishman, MC (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	mcfishman@partners.org						Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Holley SA, 2000, GENE DEV, V14, P1678; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	11	168	183	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1290	1291		10.1126/science.1066652	http://dx.doi.org/10.1126/science.1066652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701913				2022-12-24	WOS:000172130200030
J	Tomita, K; Weiner, AM				Tomita, K; Weiner, AM			Collaboration between CC- and A-adding enzymes to build and repair the 3 '-terminal CCA of tRNA in Aquifex aeolicus	SCIENCE			English	Article							TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; SULFOLOBUS-SHIBATAE; 3' TERMINUS; ACTIVE-SITE; SUPERFAMILY; SPECIFICITY; POLYMERASES; BINDING	The universal 3'-terminal CCA sequence of all transfer RNAs (tRNAs) is repaired, and sometimes constructed de novo, by the CCA-adding enzyme [ATP(CTP):tRNA nucleotidyltransferase]. This RNA polymerase has no nucleic acid template, yet faithfully builds the CCA sequence one nucleotide at a time using cytidine triphosphate (CTP) and adenosine triphosphate (ATP) as substrates. AU previously characterized CCA-adding enzymes from all three kingdoms are single polypeptides with CCA-adding activity. Here, we demonstrate through biochemical and genetic approaches that CCA addition in Aquifex aeolicus requires collaboration between two related polypeptides, one that adds CC and another that adds A.	Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weiner, AM (corresponding author), Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA.		Tomita, Kozo/J-5746-2013; Tomita, Kozo/E-9390-2017	Tomita, Kozo/0000-0002-7374-3898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059804] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEI M, 1990, J BIOL CHEM, V265, P16216; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MASIAKOWSKI P, 1980, J BIOL CHEM, V255, P1240; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OH BK, 1994, NUCLEIC ACIDS RES, V22, P4087, DOI 10.1093/nar/22.20.4087; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Reuven NB, 1997, J BIOL CHEM, V272, P33255, DOI 10.1074/jbc.272.52.33255; REUVEN NB, 1993, P NATL ACAD SCI USA, V90, P4350, DOI 10.1073/pnas.90.10.4350; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Yue DX, 1996, RNA, V2, P895	22	62	64	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1334	1336		10.1126/science.1063816	http://dx.doi.org/10.1126/science.1063816			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701927				2022-12-24	WOS:000172130200047
J	Smith, O				Smith, O			Development - A SAC of crumbs and stardust	SCIENCE			English	Article																		Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a	2	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2498	2498		10.1126/science.294.5551.2498	http://dx.doi.org/10.1126/science.294.5551.2498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752566				2022-12-24	WOS:000172927700043
J	Tanis, BC; van den Bosch, MAAJ; Kemmeren, JM; Cats, VM; Helmerhorst, FM; Algra, A; van der Graaf, Y; Rosendaal, FR				Tanis, BC; van den Bosch, MAAJ; Kemmeren, JM; Cats, VM; Helmerhorst, FM; Algra, A; van der Graaf, Y; Rosendaal, FR			Oral contraceptives and the risk of myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL CASE-CONTROL; ACTIVATED PROTEIN-C; V LEIDEN MUTATION; YOUNG-WOMEN; VENOUS THROMBOSIS; CARDIOVASCULAR-DISEASE; PROGESTAGEN; RESISTANCE; INCREASES	Background: An association between the use of oral contraceptives and the risk of myocardial infarction has been found in some, but not all, studies. We investigated this association, according to the type of progestagen included in third-generation (i.e., desogestrel or gestodene) and second-generation (i.e., levonorgestrel) oral contraceptives, the dose of estrogen, and the presence or absence of prothrombotic mutations. Methods: In a nationwide, population-based, case-control study, we identified and enrolled 248 women 18 through 49 years of age who had had a first myocardial infarction between 1990 and 1995 and 925 control women who had not had a myocardial infarction and who were matched for age, calendar year of the index event, and area of residence. Subjects supplied information on oral-contraceptive use and major cardiovascular risk factors. An analysis for factor V Leiden and the G20210A mutation in the prothrombin gene was conducted in 217 patients and 763 controls. Results: The odds ratio for myocardial infarction among women who used any type of combined oral contraceptive, as compared with nonusers, was 2.0 (95 percent confidence interval, 1.5 to 2.8). The adjusted odds ratio was 2.5 (95 percent confidence interval, 1.5 to 4.1) among women who used second-generation oral contraceptives and 1.3 (95 percent confidence interval, 0.7 to 2.5) among those who used third-generation oral contraceptives. Among women who used oral contraceptives, the odds ratio was 2.1 (95 percent confidence interval, 1.5 to 3.0) for those without a prothrombotic mutation and 1.9 (95 percent confidence interval, 0.6 to 5.5) for those with a mutation. Conclusions: The risk of myocardial infarction was increased among women who used second-generation oral contraceptives. The results with respect to the use of third-generation oral contraceptives were inconclusive but suggested that the risk was lower than the risk associated with second-generation oral contraceptives. The risk of myocardial infarction was similar among women who used oral contraceptives whether or not they had a prothrombotic mutation. (N Engl J Med 2001;345:1787-93.) Copyright (C) 2001 Massachusetts Medical Society.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Ctr Hemostasis & Thrombosis Res, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Obstet Gynecol & Reprod Med, Leiden, Netherlands; Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Bldg 1,C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.							BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; BOYCE J, 1963, LANCET, V1, P111, DOI 10.1016/S0140-6736(63)91117-6; *CENTR BUR STAT, 1998, STAT JB 1998, P491; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; FARLEY TMM, 1995, LANCET, V346, P1582; FOTHERBY K, 1994, CONTRACEPTION, V49, P1, DOI 10.1016/0010-7824(94)90106-6; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GODSLAND IF, 1990, NEW ENGL J MED, V323, P1375, DOI 10.1056/NEJM199011153232003; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; Herings RMC, 1999, LANCET, V354, P1478; Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8; Jick H, 1996, LANCET, V347, P627, DOI 10.1016/S0140-6736(96)91334-3; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; JICK H, 1978, JAMA-J AM MED ASSOC, V240, P2548, DOI 10.1001/jama.240.23.2548; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lewis MA, 1996, BRIT MED J, V312, P88; MANN JI, 1975, BMJ-BRIT MED J, V2, P241, DOI 10.1136/bmj.2.5965.241; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; ROBINSON GE, 1994, BRIT J OBSTET GYNAEC, V101, P1036, DOI 10.1111/j.1471-0528.1994.tb13578.x; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; SARTWELL PE, 1982, EPIDEMIOL REV, V4, P95, DOI 10.1093/oxfordjournals.epirev.a036253; SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034; Spitzer WO, 1996, BRIT MED J, V312, P83; STADEL BV, 1981, NEW ENGL J MED, V305, P612, DOI 10.1056/NEJM198109103051104; THOROGOOD M, 1990, AM J OBSTET GYNECOL, V163, P274, DOI 10.1016/0002-9378(90)90567-Q; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0	30	262	267	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1787	1793		10.1056/NEJMoa003216	http://dx.doi.org/10.1056/NEJMoa003216			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752354	Green Published			2022-12-24	WOS:000172794800001
J	Saltiel, AR; Kahn, CR				Saltiel, AR; Kahn, CR			Insulin signalling and the regulation of glucose and lipid metabolism	NATURE			English	Review							GLYCOGEN-SYNTHASE KINASE-3; RECEPTOR SUBSTRATE 1; PROTEIN-KINASE; MICE LACKING; PHOSPHATIDYLINOSITOL 3-KINASE; TARGETED DISRUPTION; PHOSPHOINOSITIDE 3-KINASE; DIABETES-MELLITUS; TYROSINE PHOSPHORYLATION; HEPATIC GLUCONEOGENESIS	The epidemic of type 2 diabetes and impaired glucose tolerance is one of the main causes of morbidity and mortality worldwide. In both disorders, tissues such as muscle, fat and liver become less responsive or resistant to insulin. This state is also linked to other common health problems, such as obesity, polycystic ovarian disease, hyperlipidaemia, hypertension and atherosclerosis. The pathophysiology of insulin resistance involves a complex network of signalling pathways, activated by the insulin receptor, which regulates intermediary metabolism and its organization in cells. But recent studies have shown that numerous other hormones and signalling events attenuate insulin action, and are important in type 2 diabetes.	Univ Michigan, Sch Med, Dept Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Saltiel, AR (corresponding author), Univ Michigan, Sch Med, Dept Med, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu; c.ronald.kahn@joslin.harvard.edu	Saltiel, Alan/L-3632-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Saltiel, Alan/0000-0002-9726-9828				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1999, J PEDIATR ENDOCR MET, V12, P475; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bergman RN, 1997, RECENT PROG HORM RES, V52, P359; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Craparo A, 1997, J BIOL CHEM, V272, P11663; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hwang JH, 2001, J APPL PHYSIOL, V90, P1267, DOI 10.1152/jappl.2001.90.4.1267; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kessler A, 2001, AM J PHYSIOL-ENDOC M, V280, pE65, DOI 10.1152/ajpendo.2001.280.1.E65; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Patti Mary-Elizabeth, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P89; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; PONS S, 1995, MOL CELL BIOL, V15, P4453; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stern MP, 2000, J CLIN INVEST, V106, P323, DOI 10.1172/JCI10725; Sutherland C, 1996, PHILOS T ROY SOC B, V351, P191, DOI 10.1098/rstb.1996.0016; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wada T, 1999, ENDOCRINOLOGY, V140, P4585, DOI 10.1210/en.140.10.4585; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; ZIEGLER SF, 1993, ONCOGENE, V8, P663; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	100	3586	3783	46	1415	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					799	806		10.1038/414799a	http://dx.doi.org/10.1038/414799a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742412	Green Published			2022-12-24	WOS:000172676200060
J	Bradley, J; Reuter, D; Frings, S				Bradley, J; Reuter, D; Frings, S			Facilitation of calmodulin-mediated odor adaptation by cAMP-gated channel subunits	SCIENCE			English	Article							CGMP; SENSITIVITY; MODULATION; ACTIVATION; NEURONS; TRANSDUCTION; MECHANISM; RODS	Calcium (Ca(2+)) influx through Ca(2+)-permeable ion channels plays a pivotal role in a variety of neuronal signaling processes, and negative-feed back control of this influx by Ca(2+) itself is often equally important for modulation of such signaling. Negative modulation by Ca(2+) through calmodulin (CaM) on cyclic nucleotide-gated (CNG) channels underlies the adaptation of olfactory receptor neurons to odorants. We show that this feedback requires two additional subunits of the native olfactory channel, CNGA4 and CNGB1b, even though the machinery for CaM binding and modulation is present in the principal subunit CNGA2. This provides a rationale for the presence of three distinct subunits in the native olfactory channel and underscores the subtle link between the molecular make-up of an ion channel and the physiological function it subserves.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany; Ecole Normale Super, Neurobiol Lab, F-75230 Paris, France	Helmholtz Association; Research Center Julich; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Frings, S (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, Postfach 1913, D-52425 Julich, Germany.	s.frings@fz-juelich.de		Bradley, Jonathan/0000-0002-6933-1153				Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Frings S, 2001, CELL MOL LIFE SCI, V58, P510, DOI 10.1007/PL00000876; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Gordon SE, 2000, METHOD ENZYMOL, V315, P772; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Hagen V, 1996, BIOCHEMISTRY-US, V35, P7762, DOI 10.1021/bi952895b; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Muller F, 1998, J NEUROSCI, V18, P164; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	20	81	83	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2176	2178		10.1126/science.1063415	http://dx.doi.org/10.1126/science.1063415			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739960				2022-12-24	WOS:000172647700054
J	Munger, SD; Lane, AP; Zhong, HN; Leinders-Zufall, T; Yau, KW; Zufall, F; Reed, RR				Munger, SD; Lane, AP; Zhong, HN; Leinders-Zufall, T; Yau, KW; Zufall, F; Reed, RR			Central role of the CNGA4 channel subunit in Ca2+-calmodulin-dependent odor adaptation	SCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTOR CELL; CALCIUM-CALMODULIN; ACTIVATED CHANNEL; CATION CHANNEL; BETA-SUBUNIT; NEURONS; SENSITIVITY; RAT; TRANSDUCTION	Heteromultimeric cyclic nucleotide-gated (CNG) channels play a central role in the transduction of odorant signals and subsequent adaptation. The contributions of individual subunits to native channel function in olfactory receptor neurons remain unclear. Here, we show that the targeted deletion of the mouse CNGA4 gene, which encodes a modulatory CNG subunit, results in a defect in odorant-dependent adaptation. Channels in excised membrane patches from the CNGA4 null mouse exhibited slower Ca2+-calmodulin-mediated channel desensitization. Thus, the CNGA4 subunit accelerates the Ca2+-mediated negative feedback in olfactory signaling and allows rapid adaptation in this sensory system.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Leinders-Zufall, Trese/B-4103-2009; Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618	NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837, R37 EY006837-13, R37 EY006837-14] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker H, 1999, J NEUROSCI, V19, P9313; BAKER H, 1983, J NEUROSCI, V3, P69; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; MUNGER SD, UNPUB; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	23	94	99	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2172	2175		10.1126/science.1063224	http://dx.doi.org/10.1126/science.1063224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739959	Green Accepted			2022-12-24	WOS:000172647700053
J	Siegert, MJ; Ellis-Evans, JC; Tranter, M; Mayer, C; Petit, JR; Salamatin, A; Priscu, JC				Siegert, MJ; Ellis-Evans, JC; Tranter, M; Mayer, C; Petit, JR; Salamatin, A; Priscu, JC			Physical, chemical and biological processes in Lake Vostok and other Antarctic subglacial lakes	NATURE			English	Review							WATER EXCHANGE; ICE-CORE; BENEATH; CONSTRAINTS; STATION; MODEL	Over 70 lakes have now been identified beneath the Antarctic ice sheet. Although water from none of the lakes has been sampled directly, analysis of lake ice frozen (accreted) to the underside of the ice sheet above Lake Vostok, the largest of these lakes, has allowed inferences to be made on lake water chemistry and has revealed small quantities of microbes. These findings suggest that Lake Vostok is an extreme, yet viable, environment for life. All subglacial lakes are subject to high pressure (similar to 350 atmospheres), low temperatures (about -3 degreesC) and permanent darkness. Any microbes present must therefore use chemical sources to power biological processes. Importantly, dissolved oxygen is available at least at the lake surface, from equilibration with air hydrates released from melting basal glacier ice. Microbes found in Lake Vostok's accreted ice are relatively modern, but the probability of ancient lake-floor sediments leads to a possibility of a very old biota at the base of subglacial lakes.	Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; British Antarctic Survey, Biosci Div, Freshwater Ecol Grp, Cambridge CB3 0ET, England; Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Kazan VI Lenin State Univ, Dept Appl Math, Kazan 420008, Russia; Montana State Univ, Bozeman, MT 59717 USA	University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); Kazan Federal University; Montana State University System; Montana State University Bozeman	Siegert, MJ (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	m.j.siegert@bristol.ac.uk	Salamatin, Andrey/A-9831-2016; Siegert, Martin/M-9939-2019; Tranter, Martyn/E-3722-2010; Siegert, Martin J/A-3826-2008	Salamatin, Andrey/0000-0002-5988-6024; Siegert, Martin/0000-0002-0090-4806; Tranter, Martyn/0000-0003-2071-3094; Siegert, Martin J/0000-0002-0090-4806				Abyzov SS, 1998, MICROBIOLOGY+, V67, P451; BARKOV NI, 2001, IN PRESS ARKTIKA ANT; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; BELL RE, UNPUB NATURE; BOTTRELL SH, IN PRESS HYDROL PROC; CHRISTNER BC, IN PRESS APPL ENV MI; Dowdeswell JA, 1999, GEOL SOC AM BULL, V111, P254, DOI 10.1130/0016-7606(1999)111<0254:TDATSO>2.3.CO;2; EllisEvans JC, 1996, BIODIVERS CONSERV, V5, P1395, DOI 10.1007/BF00051985; Fang JS, 2000, DEEP-SEA RES PT I, V47, P1173, DOI 10.1016/S0967-0637(99)00080-1; Gaidos EJ, 1999, SCIENCE, V284, P1631, DOI 10.1126/science.284.5420.1631; Gorman MR, 1999, J GEOPHYS RES-SOL EA, V104, P29311, DOI 10.1029/1999JB900271; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Jean-Baptiste P, 2001, NATURE, V411, P460, DOI 10.1038/35078045; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; KENNICUTT MC, 2001, SUBGLACIAL LAKE EXPL; Killawee JA, 1998, GEOCHIM COSMOCHIM AC, V62, P3637, DOI 10.1016/S0016-7037(98)00268-3; Kuhs W.F., 2000, PHYSICS ICE CORE REC, P373; Kwok R, 2000, J GLACIOL, V46, P689, DOI 10.3189/172756500781832710; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lee SY, 2000, ANN NY ACAD SCI, V912, P614; Lipenkov V., 2000, PHYS ICE CORE RECORD, P327; LIPENKOV VY, 2001, IN PRESS MAT ISSLED, V91; Lipenkov VYa, 2000, PROBL ARKT ANTARKT, V72, P197; Lukin V V, 2000, PROBLEMY ARKTIKI ANT, V72, P237; Mayer C, 2000, J GLACIOL, V46, P197, DOI 10.3189/172756500781832981; MAYER C, UNPUB EARTH PLANET S; OSWALD GKA, 1973, NATURE, V245, P251, DOI 10.1038/245251a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Prentice AP, 1998, GSA TODAY, V8, P1; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; ROCHSCHILD LJ, 2001, NATURE, V409, P1092; Salamatin A. N., 1998, MAT GLYATSIOL ISSLED, V85, P233; Salamatin A. N., 2000, PHYS ICE CORE RECORD, P243; Siegert MJ, 2000, EARTH PLANET SC LETT, V179, P227, DOI 10.1016/S0012-821X(00)00121-7; Siegert MJ, 2000, EARTH-SCI REV, V50, P29, DOI 10.1016/S0012-8252(99)00068-9; Siegert MJ, 2000, NATURE, V403, P643, DOI 10.1038/35001049; Siegert MJ, 1998, J GEOPHYS RES-SOL EA, V103, P10195, DOI 10.1029/98JB00390; Siegert MJ, 1996, ANTARCT SCI, V8, P281, DOI 10.1017/S0954102096000405; Souchez R, 2000, EARTH PLANET SC LETT, V181, P529, DOI 10.1016/S0012-821X(00)00228-4; TABACCO IE, UNPUB J GLACIOL; TRANTER M, IN PRESS HYDROL PROC; UCHIDA T, 1994, J GLACIOL, V40, P79, DOI 10.3189/S0022143000003828; Williams MJM, 2001, GEOPHYS RES LETT, V28, P531, DOI 10.1029/2000GL012107; Wuest A, 2000, OCEAN MODEL, V2, P29, DOI 10.1016/S1463-5003(00)00007-X	47	146	156	6	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					603	609		10.1038/414603a	http://dx.doi.org/10.1038/414603a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740551				2022-12-24	WOS:000172535600039
J	Terborgh, J; Lopez, L; Nunez, P; Rao, M; Shahabuddin, G; Orihuela, G; Riveros, M; Ascanio, R; Adler, GH; Lambert, TD; Balbas, L				Terborgh, J; Lopez, L; Nunez, P; Rao, M; Shahabuddin, G; Orihuela, G; Riveros, M; Ascanio, R; Adler, GH; Lambert, TD; Balbas, L			Ecological meltdown in predator-free forest fragments	SCIENCE			English	Article							TROPHIC CASCADES; COMMUNITY STRUCTURE; HYPOTHESIS; VEGETATION; FOOD	The manner in which terrestrial ecosystems are regulated is controversial. The "top-down" school holds that predators Limit herbivores and thereby prevent them from overexploiting vegetation. "Bottom-up" proponents stress the role of plant chemical defenses in limiting plant depredation by herbivores. A set of predator-free islands created by a hydroelectric impoundment in Venezuela allows a test of these competing world views. Limited area restricts the fauna of small (0.25 to 0.9 hectare) islands to predators of invertebrates (birds, lizards, anurans, and spiders), seed predators (rodents), and herbivores (howler monkeys, iguanas, and leaf-cutter ants). Predators of vertebrates are absent, and densities of rodents, howler monkeys, iguanas, and leaf-cutter ants are 10 to 100 times greater than on the nearby mainland, suggesting that predators normally Limit their populations. The densities of seedlings and saplings of canopy trees are severely reduced on herbivore-affected islands, providing evidence of a trophic cascade unleashed in the absence of top-down regulation.	Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Univ Nacl San Antonio de Abad, Herbario Vargas, Cuzco, Peru; Wildlife Conservat Soc, Bronx, NY 10464 USA; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Chintan Environm Res & Act Grp, New Delhi 110014, India; Univ Ricardo Palma, Fac Ciencias Biol, Lima 18, Peru; Fdn Museo Ciencias, Ctr Adolfo Ernst, Caracas 1010, Venezuela; Univ Complutense Madrid, Fac Ciencias Biol, Dept Ecol, E-28040 Madrid, Spain; Univ Toronto, Fac Forestry, Toronto, ON M5S 3B2, Canada; Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA; EDELCA, Puerto Ordaz, Estado Bolivar, Venezuela	Duke University; State University System of Florida; Florida International University; Wildlife Conservation Society; University of Cambridge; Universidad Ricardo Palma; Complutense University of Madrid; University of Toronto; University of Wisconsin System	Terborgh, J (corresponding author), Duke Univ, Ctr Trop Conservat, Box 90381, Durham, NC 27708 USA.	manu@duke.edu	Fahimifar, Sepideh/M-5303-2019; Langerhans, R. Brian/A-7205-2009	Rao, Madhu/0000-0002-5360-4073				ALVAREZ E, 1986, INTERCIENCIA, V11, P325; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; BRAMWELL D, 1979, PLANTS ISLANDS; BREMAN H, 1992, BIOTROPICA, V24, P328, DOI 10.2307/2388526; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; ELLIS J, 1994, BIOSCIENCE, V44, P340, DOI 10.2307/1312384; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hubbell SP, 1998, MAN BIOSPH, V20, P17; HUBER O, 1986, INTERCIENCIA, V11, P301; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; LAMBERT TD, UNPUB POPULATIONS FR; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; Martin PS, 1984, QUATERNARY EXTINCTIO; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; McShea W.J., 1997, SCI OVERABUNDANCE DE; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Rao M, 2000, J TROP ECOL, V16, P209, DOI 10.1017/S026646740000136X; Rao M, 2001, CONSERV BIOL, V15, P624, DOI 10.1046/j.1523-1739.2001.015003624.x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; Terborgh John, 1999, P39; Terborgh John, 1997, P256; White T. C. R., 1993, INADEQUATE ENV NITRO	29	996	1068	14	636	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1923	1926		10.1126/science.1064397	http://dx.doi.org/10.1126/science.1064397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729317				2022-12-24	WOS:000172465000058
J	Estevez, R; Bottger, T; Stein, V; Birkenhager, R; Otto, E; Hildebrandt, F; Jentsch, TJ				Estevez, R; Bottger, T; Stein, V; Birkenhager, R; Otto, E; Hildebrandt, F; Jentsch, TJ			Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion	NATURE			English	Article							CHLORIDE CHANNEL; RAT-KIDNEY; MUTATIONS; GENE; COTRANSPORTER; DEAFNESS; DISEASE; JERVELL; CIC-K1; FAMILY	Renal salt loss in Bartter's syndrome is caused by impaired transepithelial transport in the loop of Henle. Sodium chloride is taken up apically by the combined activity of NKCC2 (Na+-K--2Cl(-) cotransporters) and ROMK potassium channels. Chloride ions exit from the cell through basolateral ClC-Kb chloride channels. Mutations in the three corresponding genes have been identired(1-3) that correspond to Bartter's syndrome types(1-3). The gene(4) encoding the integral membrane protein barttin is mutated in a form of Bartter's syndrome that is associated with congenital deafness and renal failure. Here we show that barttin acts as an essential beta -subunit for ClC-Ka and ClC-Kb chloride channels, with which it colocalizes in basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Disease-causing mutations in either ClC-Kb or barttin compromise currents through heteromeric channels. Currents can be stimulated further by mutating a proline-tyrosine (PY) motif on barttin. This work describes the first known beta -subunit for CLC chloride channels and reveals that heteromers formed by ClC-K and barttin are crucial for renal salt reabsorption and potassium recycling in the inner ear(5).	Univ Hamburg, Zentrum Mol Neurobiol ZMNH, D-20246 Hamburg, Germany; Univ Freiburg, Kinderklin, D-79106 Freiburg, Germany	University of Hamburg; University of Freiburg	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol ZMNH, Falkenried 94, D-20246 Hamburg, Germany.		Estevez, Raul/D-8610-2015; Boettger, Thomas/E-3406-2012	Estevez, Raul/0000-0003-1579-650X; Boettger, Thomas/0000-0003-4280-8449; Stein, Valentin/0000-0003-1222-4928; Otto, Edgar/0000-0002-2387-9973; Jentsch, Thomas/0000-0002-3509-2553				ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Ando M, 2000, NEUROSCI LETT, V284, P171, DOI 10.1016/S0304-3940(00)01021-1; Baloh RW, 1998, LANCET, V352, P1841, DOI 10.1016/S0140-6736(98)05430-0; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	29	421	446	1	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					558	561		10.1038/35107099	http://dx.doi.org/10.1038/35107099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734858				2022-12-24	WOS:000172405900051
J	Burdet, E; Osu, R; Franklin, DW; Milner, TE; Kawato, M				Burdet, E; Osu, R; Franklin, DW; Milner, TE; Kawato, M			The central nervous system stabilizes unstable dynamics by learning optimal impedance	NATURE			English	Article							INTERNAL MODELS; MULTIJOINT ARM; STIFFNESS; MOVEMENT; POSTURE; MUSCLE; TASK	To manipulate objects or to use tools we must compensate for any forces arising from interaction with the physical environment. Recent studies indicate that this compensation is achieved by learning an internal model of the dynamics(1-6), that is, a neural representation of the relation between motor command and movement(5,7). In these studies interaction with the physical environment was stable, but many common tasks are intrinsically unstable(8,9). For example, keeping a screwdriver in the slot of a screw is unstable because excessive force parallel to the slot can cause the screwdriver to slip and because misdirected force can cause loss of contact between the screwdriver and the screw. Stability may be dependent on the control of mechanical impedance in the human arm because mechanical impedance can generate forces which resist destabilizing motion. Here we examined arm movements in an unstable dynamic environment created by a robotic interface. Our results show that humans learn to stabilize unstable dynamics using the skilful and energy-efficient strategy of selective control of impedance geometry.	JST, ERATO, Kawato Dynam Brain Project, Seika, Kyoto 6190288, Japan; Natl Univ Singapore, Dept Mech Engn, Singapore 119260, Singapore; ATR Human Informat Sci Labs, Seika, Kyoto 6190288, Japan; Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada	Japan Science & Technology Agency (JST); National University of Singapore; Simon Fraser University	Kawato, M (corresponding author), JST, ERATO, Kawato Dynam Brain Project, Seika, Kyoto 6190288, Japan.		Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Milner, Theodore/0000-0002-8111-6843				AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; Burdet E., 1999, P 1999 ASME ANN S HA, P421; COLGATE JE, 1988, INT J CONTROL, V48, P65, DOI 10.1080/00207178808906161; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOMI H, 1995, ISRL954 NTT BAS RES; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; McIntyre J, 1996, EXP BRAIN RES, V110, P248; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1995, EXP BRAIN RES, V107, P293; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Rack P.M., 2011, COMPR PHYSIOL, P229, DOI [10.1002/cphy.cp010207, DOI 10.1002/CPHY.CP010207]; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; WON J, 1995, EXP BRAIN RES, V107, P125	26	744	754	6	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					446	449		10.1038/35106566	http://dx.doi.org/10.1038/35106566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719805				2022-12-24	WOS:000172304500043
J	Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M				Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M			The spin temperature of NH3 in Comet C/1999S4 (LINEAR)	SCIENCE			English	Article							O1 HALE-BOPP; DISPERSION SPECTRA; AMMONIA; DEUTERIUM; CATALOG; RATIO; C2	A high-dispersion spectrum of Comet C/1999S4 (LINEAR) was obtained in the optical region with the high-dispersion spectrograph on the Subaru telescope when the comet was 0.863 astronomical units from the Sun before its disintegration. We obtained high signal-to-noise ratio emission tines of the cometary NH2 bands from which an ortho-to-para ratio (OPR) of 3.33 +/- 0.07 was derived on the basis of a fluorescence excitation model. Assuming that cometary NH2 mainly originates from ammonia through photodissociation, the derived OPR of NH2, molecules should reflect that of ammonia, which provides information on the environment of molecular formation or condensation and of the thermal history of cometary ices. Assuming that the OPR of ammonia in comets was unchanged in the nucleus, the derived spin temperature of ammonia (28 +/- 2 kelvin) suggests that a formation region of the cometary ammonia ice was between the orbit of Saturn and that of Uranus in the solar nebula.	Gunma Astron Observ, Gunma 3770702, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; Natl Def Acad, Dept Earth & Ocean Sci, Kanagawa 2398686, Japan; Osaka Kyoiku Univ, Astron Inst, Kashiwara, Osaka 5828582, Japan; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Tokai Univ, Liberal Arts Educ Ctr, Hiratsuka, Kanagawa 2591292, Japan; Komazawa Univ, Setagaya Ku, Tokyo 1548525, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Defence Academy - Japan; Osaka University of Education; University of Tokyo; Tokai University	Kawakita, H (corresponding author), Gunma Astron Observ, 6860-86 Nakayama, Gunma 3770702, Japan.	kawakita@astron.pref.gunma.jp						AHEARN MF, 1978, ASTROPHYS J, V219, P768, DOI 10.1086/155837; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Aikawa Y, 1999, ASTROPHYS J, V519, P705, DOI 10.1086/307400; Bachir IH, 1999, J MOL SPECTROSC, V193, P326, DOI 10.1006/jmsp.1998.7752; Bird MK, 1997, ASTRON ASTROPHYS, V325, pL5; Bird MK, 1997, EARTH MOON PLANETS, V78, P21, DOI 10.1023/A:1006246606131; BIRSS FW, 1985, COMPUT PHYS COMMUN, V38, P83, DOI 10.1016/0010-4655(85)90048-7; Blake GA, 1999, NATURE, V398, P213, DOI 10.1038/18372; Bockelee-Morvan D, 2000, ASTRON ASTROPHYS, V353, P1101; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; Brown ME, 1996, ASTRON J, V112, P1197, DOI 10.1086/118090; BUENKER RJ, 1981, MOL PHYS, V43, P987, DOI 10.1080/00268978100101821; Crovisier J, 1999, NATO ADV SCI I C-MAT, V523, P389; FINK U, 1991, ASTROPHYS J, V383, P356, DOI 10.1086/170794; FUJII M, UNPUB; HIRAOKA K, 1995, ASTROPHYS J, V443, P363, DOI 10.1086/175531; Irvine W. M., 2000, Protostars and planets 4, P1159; Kawakita H, 2000, PUBL ASTRON SOC JPN, V52, P925, DOI 10.1093/pasj/52.5.925; Kawakita H, 1998, ASTROPHYS J, V495, P946, DOI 10.1086/305318; Kawakita H, 2001, PUBL ASTRON SOC JPN, V53, pL5, DOI 10.1093/pasj/53.1.L5; KURUCZ RL, 1984, 1 HARV U NAT SOL OBS; KURUCZ RL, 1984, 1 NAT SOL OBS; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; MUMMA MJ, 1987, ASTRON ASTROPHYS, V187, P419; NOGUCHI K, 1999, SPIE, V3355, P354; QUACK M, 1977, MOL PHYS, V34, P477, DOI 10.1080/00268977700101861; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; Takano S, 2000, PUBL ASTRON SOC JPN, V52, pL67, DOI 10.1093/pasj/52.6.L67; TEGLER S, 1989, ASTROPHYS J, V343, P445, DOI 10.1086/167717; TEGLER SC, 1992, ASTROPHYS J, V384, P292, DOI 10.1086/170872; THEKAEKARA MP, 1974, APPL OPTICS, V13, P518, DOI 10.1364/AO.13.000518; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995; WOMACK M, 1997, 7474 IAU; Zhang HW, 2001, ASTRON ASTROPHYS, V367, P1049, DOI 10.1051/0004-6361:20010008	39	55	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1089	1091		10.1126/science.1064339	http://dx.doi.org/10.1126/science.1064339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691989				2022-12-24	WOS:000172013800046
J	Spahn, CMT; Beckmann, R; Eswar, N; Penczek, PA; Sali, A; Blobel, G; Frank, J				Spahn, CMT; Beckmann, R; Eswar, N; Penczek, PA; Sali, A; Blobel, G; Frank, J			Structure of the 80S ribosome from Saccharomyces cerevisiae - tRNA-ribosome and subunit-subunit interactions	CELL			English	Article							COLI 70S RIBOSOME; ANGSTROM RESOLUTION; CRYOELECTRON MICROSCOPY; TRANSFER-RNA; EXPANSION SEGMENTS; DENSITY MAPS; PSI-BLAST; A-SITE; P-SITE; 30 S	A cryo-EM reconstruction of the translating yeast 80S ribosome was analyzed. Computationally separated rRNA and protein densities were used for docking of appropriately modified rRNA models and homology models of yeast ribosomal proteins. The core of the ribosome shows a remarkable degree of conservation. However, some significant differences in functionally important regions and dramatic changes in the periphery due to expansion segments and additional ribosomal proteins are evident. As in the bacterial ribosome, bridges between the subunits are mainly formed by RNA contacts. Four new bridges are present at the periphery. The position of the P site tRNA coincides precisely with its prokaryotic counterpart, with mainly rRNA contributing to its molecular environment. This analysis presents an exhaustive inventory of an eukaryotic ribosome at the molecular level.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; Humboldt Univ, Charite, Inst Biochem, D-10117 Berlin, Germany; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA; Univ Texas, Sch Med, Houston, TX 77030 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Howard Hughes Medical Institute; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; University of Texas System	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.				NCRR NIH HHS [P41 RR01219] Funding Source: Medline; NIGMS NIH HHS [R01 GM60635, GM 54762, R37 GM29169] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R29GM054762, R01GM060635, R01GM054762] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, CURR OPIN STRUC BIOL, V9, P215, DOI 10.1016/S0959-440X(99)80031-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; DABROWSKI M, 1995, EMBO J, V14, P4872, DOI 10.1002/j.1460-2075.1995.tb00168.x; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 2001, COMP SEQUENCE ANAL P; Hardesty B, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P287; HINGERTY B, 1978, J MOL BIOL, V124, P523, DOI 10.1016/0022-2836(78)90185-7; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; Merryman C, 1999, J MOL BIOL, V285, P107, DOI 10.1006/jmbi.1998.2243; MITCHELL P, 1992, BIOCHEMISTRY-US, V31, P3004, DOI 10.1021/bi00126a023; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Nierhaus KH, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P319; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Spahn CMT, 1999, STRUCT FOLD DES, V7, P1567, DOI 10.1016/S0969-2126(00)88347-1; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Verschoor A, 1998, NUCLEIC ACIDS RES, V26, P655, DOI 10.1093/nar/26.2.655; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326; WOOL IG, 1990, RIBOSOME, P203; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	393	448	0	51	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					373	386		10.1016/S0092-8674(01)00539-6	http://dx.doi.org/10.1016/S0092-8674(01)00539-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701127	Bronze			2022-12-24	WOS:000172022800008
J	Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S				Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S			Metabolism - Partial leptin deficiency and human adiposity	NATURE			English	Article							RECOMBINANT LEPTIN; OBESE		Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England; MRC Human Nutr Res, Cambridge CB1 9NL, England; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Alberta Childrens Prov Gen Hosp, Dept Paediat Endocrinol, Calgary, AB T2T 5C7, Canada	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	sorahill@hgmp.mrc.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Gibson, William/AFL-3634-2022	O'Rahilly, Stephen/0000-0003-2199-4449; Gibson, William/0000-0002-6552-402X; Farooqi, Sadaf/0000-0001-7609-3504; Jebb, Susan/0000-0001-9190-2920				Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	9	285	291	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					34	35		10.1038/35102112	http://dx.doi.org/10.1038/35102112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689931				2022-12-24	WOS:000171898900030
J	Kao, RR; Gravenor, MB; Baylis, M; Bostock, CJ; Chihota, CM; Evans, JC; Goldmann, W; Smith, AJA; McLean, AR				Kao, RR; Gravenor, MB; Baylis, M; Bostock, CJ; Chihota, CM; Evans, JC; Goldmann, W; Smith, AJA; McLean, AR			The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep	SCIENCE			English	Article							GREAT-BRITAIN; PRP GENOTYPE; SCRAPIE; TRANSMISSION; INFECTIVITY; MODEL	Because there is a theoretical possibility that the British national sheep flock is infected with bovine spongiform encephalopathy (BSE), we examined the extent of a putative epidemic. An age cohort analysis based on numbers of infected cattle, dose responses of cattle and sheep to BSE, levels of exposure to infected feed, and number of BSE-susceptible sheep in the United Kingdom showed that at the putative epidemic peak in 1990, the number of cases of BSE-infected sheep would have ranged from fewer than 10 to about 1500. The model predicts that fewer than 20 clinical cases of BSE in sheep would be expected in 2001 if maternal transmission occurred at a rate of 10%. Although there are large uncertainties in the parameter estimates, all indications are that current prevalence is low; however, a simple model of flock-to-flock BSE transmission shows that horizontal transmission, if it has occurred, could eventually cause a large epidemic.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Inst Anim Hlth, Compton Lab, Compton RG20 7NN, Berks, England; Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh	Kao, RR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Baylis, Matthew/S-7694-2019	Baylis, Matthew/0000-0003-0335-187X; Kao, Rowland/0000-0003-0919-6401				ALMOND J, 1999, RES SURVEILLANCE TSE; Balter M, 2000, SCIENCE, V287, P1906, DOI 10.1126/science.287.5460.1906; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BAYLIS M, UNPUB; *DEP ENV FOOD RUR, 2001, PB5796 DEP ENV FOOD; DICKINSON AG, 1975, NATURE, V253, P556, DOI 10.1038/253556a0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gravenor MB, 2000, NATURE, V406, P584, DOI 10.1038/35020692; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hoinville L, 1999, VET REC, V145, P405, DOI 10.1136/vr.145.14.405; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Horn G., 2001, REV ORIGIN BSE, P4; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1994, ANN NY ACAD SCI, V724, P210, DOI 10.1111/j.1749-6632.1994.tb38911.x; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; PHILLIPS N, 1999, REPORT INQUIRY BSE V; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Stevenson MA, 2000, VET REC, V147, P349, DOI 10.1136/vr.147.13.349; Stringer SM, 1998, MATH BIOSCI, V153, P79, DOI 10.1016/S0025-5564(98)10036-6; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0; 1998, C782506 MEAT LIV COM; 2001, VET REC, V149, P164; 1998, 5211 SEAC	29	80	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					332	335		10.1126/science.1067475	http://dx.doi.org/10.1126/science.1067475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11719694				2022-12-24	WOS:000173278600051
J	Arnold, KE; Owens, IPF; Marshall, NJ				Arnold, KE; Owens, IPF; Marshall, NJ			Fluorescent signaling in parrots	SCIENCE			English	Article							PIGMENTS		Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University of Glasgow; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Queensland	Arnold, KE (corresponding author), Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	K.Arnold@bio.gla.ac.uk	Owens, Ian PF/F-1392-2010; Arnold, Kathryn E/F-8683-2016; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Arnold, Kathryn E/0000-0002-6485-6065; Marshall, Justin/0000-0001-9006-6713; Owens, Ian/0000-0001-6080-3321				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Boles WE, 1990, BIRDS INT, V3, P76; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X	5	112	115	6	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					92	92		10.1126/science.295.5552.92	http://dx.doi.org/10.1126/science.295.5552.92			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778040				2022-12-24	WOS:000173143100038
J	Feskanich, D; Singh, V; Willett, WC; Colditz, GA				Feskanich, D; Singh, V; Willett, WC; Colditz, GA			Vitamin A intake and hip fractures among postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETINOIC ACID; HYPERVITAMINOSIS-A; CAROTENOID DATABASE; PROSPECTIVE COHORT; DIETARY-INTAKE; BETA-CAROTENE; BONE; SUPPLEMENTATION; VEGETABLES; RESORPTION	Context Ingestion of toxic amounts of vitamin A affects bone remodeling and can have adverse skeletal effects in animals. The possibility has been raised that long-term high vitamin A intake could contribute to fracture risk in humans. Objective To assess the relationship between high vitamin A intake from foods and supplements and risk of hip fracture among postmenopausal women. Design Prospective analysis begun in 1980 with 18 years of follow-up within the Nurses' Health Study. Setting General community of registered nurses within 11 US states. Participants A total of 72337 postmenopausal women aged 34 to 77 years. Main Outcome Measures Incident hip fractures resulting from low or moderate trauma, analyzed by quintiles of vitamin A intake and by use of multivitamins and vitamin A supplements, assessed at baseline and updated during follow-up. Results From 1980 to 1998, 603 incident hip fractures resulting from low or moderate trauma were identified. After controlling for confounding factors, women in the highest quintile of total vitamin A intake (greater than or equal to 3000 mug/d of retinol equivalents [RE]) had a significantly elevated relative risk (RR) of hip fracture (RR, 1.48; 95% confidence interval [CI], 1.05-2.07; P for trend =.003) compared with women in the lowest quintile of intake (<1250 <mu>g/d of RE). This increased risk was attributable primarily to retinol (RR, 1.89; 95% CI, 1.33-2.68; P for trend <.001 comparing <greater than or equal to>2000 mug/d vs <500 <mu>g/d). The association of high retinol intake with hip fracture was attenuated among women using postmenopausal estrogens. Beta carotene did not contribute significantly to fracture risk (RR, 1.22; 95% CI, 0.90-1.66; P for trend=.10 comparing greater than or equal to 6300 mug/d vs <2550 <mu>g/d). Women currently taking a specific vitamin A supplement had a nonsignificant 40% increased risk of hip fracture (RR, 1.40; 95% CI, 0.99-1.99) compared with those not taking that supplement, and, among women not taking supplemental vitamin A, retinol from food was significantly associated with fracture risk (RR, 1.69; 95% CI, 1.05-2.74; P for trend =.05 comparing greater than or equal to 1000 mug/d vs <400 <mu>g/d). Conclusions Long-term intake of a diet high in retinol may promote the development of osteoporotic hip fractures in women. The amounts of retinol in fortified foods and vitamin supplements may need to be reassessed.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Roche Vitamins Inc, Human Nutr Res, Parsippany, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Roche Holding	Feskanich, D (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	diane.feskanich@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [CA87969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Hijleh G, 1997, EUR J MORPHOL, V35, P327, DOI 10.1076/ejom.35.5.327.13088; [Anonymous], 1999, NUTR REV, V57, P192; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1456, DOI 10.1001/archopht.1993.01090110014001; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; CHUGAHUJA JK, 1993, J AM DIET ASSOC, V93, P318, DOI 10.1016/0002-8223(93)91559-9; CLARK L, 1971, J COMP PATHOL, V81, P365, DOI 10.1016/0021-9975(71)90024-7; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DIGIOVANNA JJ, 1995, ARCH DERMATOL, V131, P1263, DOI 10.1001/archderm.131.11.1263; *FOOD NUTR BOARD I, IN PRESS DIET REF IN; FORSYTH KS, 1989, LIFE SCI, V45, P2149, DOI 10.1016/0024-3205(89)90081-7; FRAME B, 1974, ANN INTERN MED, V80, P44, DOI 10.7326/0003-4819-80-1-44; FREUDENHEIM JL, 1986, AM J CLIN NUTR, V44, P863, DOI 10.1093/ajcn/44.6.863; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; HEYWOOD R, 1985, TOXICOLOGY, V36, P91, DOI 10.1016/0300-483X(85)90043-5; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; Kindmark A, 1998, ACTA DERM-VENEREOL, V78, P266; KOCHHAR DM, 1984, TERATOGEN CARCIN MUT, V4, P377, DOI 10.1002/tcm.1770040407; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; MCGUIRE J, 1987, Dermatologica (Basel), V175, P169; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; METZ AL, 1985, J NUTR, V115, P929, DOI 10.1093/jn/115.7.929; Michaud DS, 1998, CANCER EPIDEM BIOMAR, V7, P283; MOORE T, 1945, BIOCHEM J, V39, P222, DOI 10.1042/bj0390222; MOORE T, 1979, INT J VITAM NUTR RES, V49, P14; Nierenberg DW, 1997, AM J CLIN NUTR, V66, P315, DOI 10.1093/ajcn/66.2.315; Okada Natsuko, 1994, Journal of Dermatology (Tokyo), V21, P308; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P259; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SHARMAN IM, 1985, BMJ-BRIT MED J, V290, P95, DOI 10.1136/bmj.290.6462.95; SOWERS MR, 1990, J CLIN EPIDEMIOL, V43, P693, DOI 10.1016/0895-4356(90)90040-V; TOGARI A, 1991, GEN PHARMACOL, V22, P287, DOI 10.1016/0306-3623(91)90450-K; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT W, 1998, NUTR EPIDEMIOLOGY, P125; WOLBACH SB, 1947, J BONE JOINT SURG, V29, P171; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632	41	273	290	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					47	54		10.1001/jama.287.1.47	http://dx.doi.org/10.1001/jama.287.1.47			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754708	Bronze			2022-12-24	WOS:000172978500025
J	Chien, YC; Chen, JY; Liu, MY; Yang, HI; Hsu, MM; Chen, CJ; Yang, CS				Chien, YC; Chen, JY; Liu, MY; Yang, HI; Hsu, MM; Chen, CJ; Yang, CS			Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-POSITIVE PERSONS; WUZHOU-CITY; CHINA; DNASE	Background It is probable but unproven that Epstein-Barr virus (EBV) has a role in nasopharyngeal carcinoma. We determined whether antibodies against EBV are present before the development of nasopharyngeal carcinoma. Methods A total of 9699 men were enrolled between 1984 and 1986. Blood samples were examined for IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV-specific DNase. During 131,981 person-years of follow-up, 22 pathologically confirmed new cases of nasopharyngeal carcinoma that were diagnosed more than one year after recruitment were ascertained through linkage with the National Cancer Registry of Taiwan. Results The cumulative risk of nasopharyngeal carcinoma per 100,000 person-years was 11.2 for subjects who tested positive for neither serologic marker, 45.0 for those who had one marker, and 371.0 for those who had both markers. After adjustment for age and the presence or absence of a family history of nasopharyngeal carcinoma, the relative risk of nasopharyngeal carcinoma was 32.8 for subjects with both markers (95 percent confidence interval, 7.3 to 147.2; P<0.001) and 4.0 for subjects with one marker (95 percent confidence interval, 1.6 to 10.2; P=0.003), as compared with subjects with neither marker. The longer the duration of follow-up, the greater the difference in the cumulative incidence of nasopharyngeal carcinoma between seropositive and seronegative subjects. Conclusions IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV DNase are predictive of nasopharyngeal carcinoma. (N Engl J Med 2001;345:1877-82.) Copyright (C) 2001 Massachusetts Medical Society.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 100, Taiwan; Natl Taipei Coll Nursing, Dept Gen Educ, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chien, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, 1 Jen Ai Rd,Sec 1, Taipei 100, Taiwan.		Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019; Yang, Hwai-I/A-9470-2008; Chen, Jen-Yang/D-2085-2010	Yang, Hwai-I/0000-0002-3433-942X; 				[Anonymous], 1997, IARC MONOGRAPHS EVAL, V70, P47; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; CHEN KP, 1979, COLOR ATLAS CANC MOR; CHENG SZD, 1991, MACROMOLECULES, V24, P150, DOI 10.1021/ma00001a024; DETHE G, 1975, INT J CANCER, V16, P713, DOI 10.1002/ijc.2910160503; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE W, 1970, J NATL CANCER I, V44, P225; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; JEANNEL D, 1999, INFECT HUMAN CANC, P125; Lin Y-H, 1997, CHINESE J PUBLIC HLT, V16, P466; Liu MY, 1997, J MED VIROL, V52, P262, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;262::AID-JMV5&gt;3.0.CO;2-0; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; WARA WM, 1975, CANCER, V35, P1313, DOI 10.1002/1097-0142(197505)35:5<1313::AID-CNCR2820350510>3.0.CO;2-B; YU MC, 1996, CANC EPIDEMIOLOGY PR, P603; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1983, INTERVIROLOGY, V20, P190, DOI 10.1159/000149391; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204; ZONG YS, 1992, CANCER, V69, P3, DOI 10.1002/1097-0142(19920101)69:1&lt;3::AID-CNCR2820690104&gt;3.0.CO;2-7	19	322	332	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2001	345	26					1877	1882		10.1056/NEJMoa011610	http://dx.doi.org/10.1056/NEJMoa011610			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TY	11756578				2022-12-24	WOS:000172932700003
J	Chabriere, E; Vernede, C; Guigliarelli, B; Charon, MH; Hatchikian, EC; Fontecilla-Camps, JC				Chabriere, E; Vernede, C; Guigliarelli, B; Charon, MH; Hatchikian, EC; Fontecilla-Camps, JC			Crystal structure of the free radical intermediate of pyruvate : ferredoxin oxidoreductase	SCIENCE			English	Article							PYRUVATEFERREDOXIN OXIDOREDUCTASE; PYROCOCCUS-FURIOSUS; THIAMINE ACTION; MECHANISM; ARCHAEON; CRYSTALLOGRAPHY; DIPHOSPHATE; BACTERIUM; BONDS	In anaerobic organisms, the decarboxylation of pyruvate, a crucial component of intermediary metabolism, is catalyzed by the metalloenzyme pyruvate: ferredoxin oxidoreductase (PFOR) resulting in the generation of tow potential electrons and the subsequent acetylation of coenzyme A (CoA). PFOR is the only enzyme for which a stable acetyl thiamine diphosphate (ThDP)-based free radical reaction intermediate has been identified. The 1.87 Angstrom -resolution structure of the radical form of PFOR from Desulfovibrio africanus shows that, despite currently accepted ideas, the thiazole ring of the ThDP cofactor is markedly bent, indicating a drastic reduction of its aromaticity. In addition, the bond connecting the acetyl group to ThDP is unusually tong, probably of the one-electron type already described for several cation radicals but not yet found in a biological system. Taken together, our data, along with evidence from the literature, suggest that acetyl-CoA synthesis by PFOR proceeds via a condensation mechanism involving acetyl (PFOR-based) and thiyl (CoA-based) radicals.	Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Cristallog & Cristallogenese Prot Lab, F-38027 Grenoble 1, France; CNRS, Inst Biol Struct & Microbiol, Unite Bioenerget & Ingn Prot, F-13402 Marseille, France; Univ Henri Poincare, Lab Cristallog & Modelisat Mat Mineraux & Biol, CNRS, Unite Mixte Rech 7036, F-54506 Vandoeuvre Les Nancy, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Fontecilla-Camps, JC (corresponding author), Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Cristallog & Cristallogenese Prot Lab, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	juan@lccp.ibs.fr						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLETTA G, 1990, J AM CHEM SOC, V112, P8144, DOI 10.1021/ja00178a044; BELLVILE DJ, 1985, J AM CHEM SOC, V107, P4978, DOI 10.1021/ja00303a025; BENNETT JE, 1971, T FARADAY SOC, V67, P1587, DOI 10.1039/tf9716701587; Bock AK, 1996, EUR J BIOCHEM, V237, P35, DOI 10.1111/j.1432-1033.1996.0035n.x; Bock AK, 1997, FEBS LETT, V414, P209, DOI 10.1016/S0014-5793(97)00998-8; Bouchev VF, 1999, J AM CHEM SOC, V121, P3724, DOI 10.1021/ja984057l; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; BRESLOW R, 1962, ANN NY ACAD SCI, V98, P445, DOI 10.1111/j.1749-6632.1962.tb30565.x; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton RD, 1996, J AM CHEM SOC, V118, P5655, DOI 10.1021/ja960378q; CAMMACK R, 1980, FEBS LETT, V118, P271, DOI 10.1016/0014-5793(80)80236-5; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; DOCAMPO R, 1987, J BIOL CHEM, V262, P12417; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; KERSCHER L, 1982, TRENDS BIOCHEM SCI, V7, P371, DOI 10.1016/0968-0004(82)90118-9; Kletzin A, 1996, J BACTERIOL, V178, P248, DOI 10.1128/jb.178.1.248-257.1996; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maslak P, 1995, J AM CHEM SOC, V117, P12380, DOI 10.1021/ja00155a002; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Reed LJ, 1998, PROTEIN SCI, V7, P220, DOI 10.1002/pro.5560070125; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; SMITH ET, 1994, BIOCHEMISTRY-US, V33, P1008, DOI 10.1021/bi00170a020; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tersteegen A, 1997, EUR J BIOCHEM, V244, P862, DOI 10.1111/j.1432-1033.1997.00862.x; Vernede X, 1999, J APPL CRYSTALLOGR, V32, P505, DOI 10.1107/S0021889899002678; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; Zhang Q, 1996, J BIOCHEM-TOKYO, V120, P587	37	117	121	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2559	2563		10.1126/science.1066198	http://dx.doi.org/10.1126/science.1066198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752578				2022-12-24	WOS:000172927700062
J	McCarl, BA; Schneider, UA				McCarl, BA; Schneider, UA			Climate change - Greenhouse gas mitigation in US agriculture and forestry	SCIENCE			English	Editorial Material									Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA; Iowa State Univ, Ctr Agr & Rural Dev, Ames, IA 50011 USA	Texas A&M University System; Texas A&M University College Station; Iowa State University	Schneider, UA (corresponding author), Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA.		McCarl, Bruce A/E-9445-2011; Schneider, Uwe A/M-7342-2016	Schneider, Uwe A/0000-0002-6833-9292				CHANG CC, 1992, AM J AGR ECON, V74, P38, DOI 10.2307/1242988; *INT PAN CLIM CHAN, 1991, CLIM CHANG IPCC SCI; Lal R., 1998, POTENTIAL US CROPLAN, P128; McCarl B. A., 2000, REV AGR ECON, V22, P134, DOI 10.1111/1058-195.t01-1-00011; Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069; SCHNEIDER U, 2000, THESIS TEXAS A M U; Weyant JP, 1999, ENERG J, pVII	7	206	219	6	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2481	2482		10.1126/science.1064193	http://dx.doi.org/10.1126/science.1064193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752558				2022-12-24	WOS:000172927700031
J	Schwetz, BA				Schwetz, BA			Remote data pacemaker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-24	WOS:000172488300006
J	Cross, HF; Haarbrink, M; Egerton, G; Yazdanbakhsh, M; Taylor, MJ				Cross, HF; Haarbrink, M; Egerton, G; Yazdanbakhsh, M; Taylor, MJ			Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood	LANCET			English	Article							ADVERSE REACTIONS; ONCHOCERCIASIS; INTERLEUKIN-6; BACTERIA	Wolbachia bacteria seem to have evolved as essential endosymbionts of their filarial nematode hosts. Studies in mice have suggested that these bacteria are associated with systemic inflammatory reactions to filarial chemotherapy. We took blood samples from 15 Indonesian patients before and after treatment with diethylcarbamazine far Brugia malayi infection, and recorded the severity of any post-treatment inflammatory reactions. Blood from all three patients with severe adverse reactions and from one of six with moderate reactions was positive for Wolbachia DNA 4-48 h after diethylcarbamazine treatment. We suggest that these severe inflammatory reactions are associated with the release of endosymbionts into the blood after treatment for filariasis.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Liverpool School of Tropical Medicine; University of Liverpool; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Taylor, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.		Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Taylor, Mark/0000-0003-3396-9275				Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Haarbrink M, 2000, J INFECT DIS, V182, P564, DOI 10.1086/315735; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; TURNER PF, 1994, J INFECT DIS, V169, P1071, DOI 10.1093/infdis/169.5.1071	5	94	99	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1873	1875		10.1016/S0140-6736(01)06899-4	http://dx.doi.org/10.1016/S0140-6736(01)06899-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741630				2022-12-24	WOS:000172463000016
J	Moore, MJ; Rosbash, M				Moore, MJ; Rosbash, M			Cell biology - TAPping into mRNA export	SCIENCE			English	Editorial Material							DELIVERY; PEPTIDES; PROTEINS		Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Moore, MJ (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.							Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Zenklusen D, 2001, FEBS LETT, V498, P150, DOI 10.1016/S0014-5793(01)02482-6	15	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1841	1842		10.1126/science.1067676	http://dx.doi.org/10.1126/science.1067676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729289				2022-12-24	WOS:000172465000031
J	Polis, MA; Sidorov, IA; Yoder, C; Jankelevich, S; Metcalf, J; Mueller, BU; Dimitrov, MA; Pizzo, P; Yarchoan, R; Dimitrov, DS				Polis, MA; Sidorov, IA; Yoder, C; Jankelevich, S; Metcalf, J; Mueller, BU; Dimitrov, MA; Pizzo, P; Yarchoan, R; Dimitrov, DS			Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy	LANCET			English	Article							LYMPHOCYTE COUNTS; PHASE I/II; THERAPY; INFECTION; SUPPRESSION; DURATION; CHILDREN; VIRUS	Background Early assessment of antiretroviral drug efficacy is important for prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective drug regimens. Current US guidelines for changing therapy are based on measurements of plasma HIV-1 RNA concentrations 4 or 8 weeks after the start of treatment with cut-off points of 0.75 or 1.00 log, respectively. We investigated the possibility of assessing drug efficacy from measurements of plasma HIV-1 concentrations made during the first week on therapy. Methods The kinetics of virus decay in plasma during the first 12 weeks of treatment was analysed for 124 HIV-1-infected patients being treated for the first time with a protease inhibitor. Patients with a continuous decline of HIV-1 concentrations and in whom HIV-1 was either undetectable or declined by more than 1.5 log at 12 weeks were defined as good responders; the rest were poor responders. Findings The individual virus decay rate constants (k) at day 6 correlated significantly (r>0.66, p<0.0001) with changes in HIV-1 concentrations at 4, 8, and 12 weeks, and correctly predicted 84% of the responses with a cut-off value of k=0.21 per day (in log scale). Reduction in plasma HIV-1 of less than 0.72 log by day 6 after initiation of therapy predicted poor long-term responses in more than 99% of patients. Interpretation These results suggest that changes in HIV-1 concentration at day 6 after treatment initiation are major correlates of longer-term virological responses. They offer a very early measure of individual long-term responses, suggesting that treatment could be optimised after only a few days of therapy.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NCI, Lab Expt & Computat Biol, NIH, Frederick, MD 21701 USA; NIH, Warren Grant Magnuson Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; Baylor Coll Med, Hematol Serv, Houston, TX 77030 USA; NIH, Ctr Sci Review, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Polis, MA (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10,Room 11C103, Bethesda, MD 20892 USA.			Polis, Michael/0000-0002-9151-2268; Sidorov, Igor/0000-0001-6519-4983	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390, Z01AI000390] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Grossman Z, 1998, IMMUNOL TODAY, V19, P528, DOI 10.1016/S0167-5699(98)01353-X; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Hoetelmans RMW, 1998, AIDS, V12, pF111, DOI 10.1097/00002030-199811000-00002; Huang W, 2001, J INFECT DIS, V183, P1455, DOI 10.1086/320192; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Maggiolo F, 2000, J ACQ IMMUN DEF SYND, V25, P36, DOI 10.1097/00126334-200009010-00005; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MILLER RG, 1974, BIOMETRIKA, V61, P1; Mittler J, 2001, ANTIMICROB AGENTS CH, V45, P1438, DOI 10.1128/AAC.45.5.1438-1443.2001; Mueller BU, 1998, PEDIATRICS, V102, P101, DOI 10.1542/peds.102.1.101; Mueller BU, 1998, AIDS, V12, pF191, DOI 10.1097/00002030-199815000-00004; Mueller BU, 1998, PEDIATRICS, V101, P335, DOI 10.1542/peds.101.3.335; Nelson PW, 2000, MATH BIOSCI, V163, P201, DOI 10.1016/S0025-5564(99)00055-3; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Rizzardi GP, 2000, J CLIN INVEST, V105, P777, DOI 10.1172/JCI9079; *US HLTH HUM SERV, 2001, GUID US ANT AG HIV I; Wein LM, 1998, J THEOR BIOL, V192, P81, DOI 10.1006/jtbi.1997.0622; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Wu H, 1999, AIDS, V13, P429, DOI 10.1097/00002030-199902250-00022; Wu HL, 1999, J INFECT DIS, V179, P799, DOI 10.1086/314670	25	85	86	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1760	1765		10.1016/S0140-6736(01)06802-7	http://dx.doi.org/10.1016/S0140-6736(01)06802-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734232				2022-12-24	WOS:000172385100010
J	Emery, NJ; Clayton, NS				Emery, NJ; Clayton, NS			Effects of experience and social context on prospective caching strategies by scrub jays	NATURE			English	Article							BLACK-CAPPED CHICKADEES; APHELOCOMA-COERULESCENS; MEMORY; BEHAVIOR; PRIMATES; CACHES; SITES; TIME; MIND	Social life has costs associated with competition for resources such as food(1). Food storing may reduce this competition as the food can be collected quickly and hidden elsewhere(2-4); however, it is a risky strategy because caches can be pilfered by others(5-9). Scrub jays (Aphelocoma coerulescens) remember 'what', 'where' and 'when' they cached(10-13). Like other corvids(6-9,14), they remember where conspecifics have cached, pilfering them when given the opportunity, but may also adjust their own caching strategies to minimize potential pilfering. To test this, jays were allowed to cache either in private (when the other bird's view was obscured) or while a conspecific was watching, and then recover their caches in private. Here we show that jays with prior experience of pilfering another bird's caches subsequently re-cached food in new cache sites during recovery trials, but only when they had been observed caching. Jays without pilfering experience did not, even though they had observed other jays caching. Our results suggest that jays relate information about their previous experience as a pilferer to the possibility of future stealing by another bird, and modify their caching strategy accordingly.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X				BAKER MC, 1995, ANIM BEHAV, V49, P1599, DOI 10.1016/0003-3472(95)90081-0; Bednekoff PA, 1996, ANIM BEHAV, V52, P833, DOI 10.1006/anbe.1996.0228; BUGNYAR T, 2001, ADV ETHOL, V36, P106; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; Clayton NS, 2001, J EXP PSYCHOL-ANIM B, V27, P17, DOI 10.1037//0097-7403.27.1.17; Clayton NS, 1999, J EXP PSYCHOL ANIM B, V25, P82, DOI 10.1037/0097-7403.25.1.82; GIBB JOHN A., 1960, IBIS, V102, P163, DOI 10.1111/j.1474-919X.1960.tb07112.x; Goodwin D., 1956, Ibis, V98, P186, DOI 10.1111/j.1474-919X.1956.tb03040.x; HAMPTON RR, 1994, BEHAV ECOL, V5, P44, DOI 10.1093/beheco/5.1.44; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Heinrich B., 1999, MIND RAVEN; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; SHETTLEWORTH SJ, 1995, BEHAV BRAIN RES NATU, P158; STEVENS TA, 1986, IBIS, V128, P513, DOI 10.1111/j.1474-919X.1986.tb02703.x; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Vander Wall SB, 1990, FOOD HOARDING ANIMAL; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; ZENTALL TR, 1998, SOCIAL LEARNING PSYC	24	334	349	4	121	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					443	446		10.1038/35106560	http://dx.doi.org/10.1038/35106560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494UP	11719804				2022-12-24	WOS:000172304500042
J	Katinka, MD; Duprat, S; Cornillot, E; Metenier, G; Thomarat, F; Prensier, G; Barbe, V; Peyretaillade, E; Brottier, P; Wincker, P; Delbac, F; El Alaoui, H; Peyret, P; Saurin, W; Gouy, M; Weissenbach, J; Vivares, CP				Katinka, MD; Duprat, S; Cornillot, E; Metenier, G; Thomarat, F; Prensier, G; Barbe, V; Peyretaillade, E; Brottier, P; Wincker, P; Delbac, F; El Alaoui, H; Peyret, P; Saurin, W; Gouy, M; Weissenbach, J; Vivares, CP			Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi	NATURE			English	Article							MOLECULAR EVIDENCE; MICROSPORIDIA; PROTEIN; AMITOCHONDRIATE; MITOCHONDRIA; PHYLOGENY; ORIGIN; HSP70	Microsporidia are obligate intracellular parasites infesting many animal groups(1). Lacking mitochondria and peroxysomes, these unicellular eukaryotes were first considered a deeply branching protist lineage(2) that diverged before the endosymbiotic event that led to mitochondria. The discovery of a gene for a mitochondrial-type chaperone(3-5) combined with molecular phylogenetic data(6-9) later implied that microsporidia are atypical fungi that lost mitochondria during evolution. Here we report the DNA sequences of the 11 chromosomes of the similar to2.9-megabase (Mb) genome of Encephalitozoon cuniculi (1,997 potential protein-coding genes). Genome compaction is reflected by reduced intergenic spacers and by the shortness of most putative proteins relative to their eukaryote orthologues. The strong host dependence is illustrated by the lack of genes for some biosynthetic pathways and for the tricarboxylic acid cycle. Phylogenetic analysis lends substantial credit to the fungal affiliation of microsporidia. Because the E. cuniculi genome contains genes related to some mitochondrial functions (for example, Fe-S cluster assembly), we hypothesize that microsporidia have retained a mitochondrion-derived organelle.	Univ Clermont Ferrand, Lab Biol Protistes, CNRS, UMR 6023, F-63177 Clermont Ferrand, France; Genoscope, CNRS, UMR 8030, F-91057 Evry, France; Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Vivares, CP (corresponding author), Univ Clermont Ferrand, Lab Biol Protistes, CNRS, UMR 6023, F-63177 Clermont Ferrand, France.	christian.vivares@lbp.univ-bpclermont.fr	Cornillot, Emmanuel/P-9656-2017	Cornillot, Emmanuel/0000-0002-1202-1162; El Alaoui, Hicham/0000-0003-1926-0905; PEYRET, Pierre/0000-0003-3114-0586				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Artiguenave F, 2000, FEBS LETT, V487, P13, DOI 10.1016/S0014-5793(00)02273-0; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Biderre C, 1995, MOL BIOCHEM PARASIT, V74, P229, DOI 10.1016/0166-6851(95)02495-6; Bohne W, 2000, INFECT IMMUN, V68, P2268, DOI 10.1128/IAI.68.4.2268-2275.2000; Brugere JF, 2000, NUCLEIC ACIDS RES, V28, P2026, DOI 10.1093/nar/28.10.2026; Delbac F, 2001, INFECT IMMUN, V69, P1016, DOI 10.1128/IAI.69.2.1016-1024.2001; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; El Alaoui H, 2001, J PARASITOL, V87, P554; Germot A, 1997, MOL BIOCHEM PARASIT, V87, P159, DOI 10.1016/S0166-6851(97)00064-9; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Peyret P, 2001, GENOME RES, V11, P198, DOI 10.1101/gr.164301; Peyretaillade E, 1998, MOL BIOL EVOL, V15, P683, DOI 10.1093/oxfordjournals.molbev.a025971; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; Shirakura T, 2001, MOL BIOCHEM PARASIT, V112, P153, DOI 10.1016/S0166-6851(00)00356-X; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Weidner Earl, 1999, P172; Wittner M., 1999, MICROSPORIDIA MICROS; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	30	767	1266	0	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					450	453		10.1038/35106579	http://dx.doi.org/10.1038/35106579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719806	hybrid			2022-12-24	WOS:000172304500044
J	Gesensway, D				Gesensway, D			Reasons for sex-specific and gender-specific study of health topics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2001	135	10					935	938		10.7326/0003-4819-135-10-200111200-00032	http://dx.doi.org/10.7326/0003-4819-135-10-200111200-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DY	11712902				2022-12-24	WOS:000172267500026
J	Loucks, CJ; Lu, Z; Dinerstein, E; Wang, H; Olson, DM; Zhu, CQ; Wang, DJ				Loucks, CJ; Lu, Z; Dinerstein, E; Wang, H; Olson, DM; Zhu, CQ; Wang, DJ			Ecology - Giant pandas in a changing landscape	SCIENCE			English	Editorial Material									World Wildlife Fund US, Washington, DC 20037 USA; World Wildlife Fund Nat China, Beijing 100020, Peoples R China; Peking Univ, Giant Panda Conservat & Res Ctr, Beijing 100871, Peoples R China	Peking University	Loucks, CJ (corresponding author), World Wildlife Fund US, Washington, DC 20037 USA.	colby.loucks@wwfus.org						Baragona K, 2001, SCIENCE, V293, P603; Brooks T, 2001, SCIENCE, V293, P603; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; *CHIN MIN FOR WWF, 1989, NAT CONS MAN PLAN GI; Liu JG, 2001, SCIENCE, V293, P603; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; LOUCKS CJ, UNPUB; Lu Zhi, 2000, Conservation Biology Series (Cambridge), V3, P325; OBRIEN SJ, 1994, NATURE, V369, P179, DOI 10.1038/369179a0; Pan W., 2001, OPPORTUNITY GIANT PA; Pan W., 1988, GIANT PANDAS NATURAL; Peyton B., 1999, BEARS STATUS SURVEY; *WWF TRAFF, 2001, REP EC SOC ENV IMP C; YAN X, 2000, GIANT PAND CONS ASS; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; ZHU C, IN PRESS CASE STUDY	16	102	118	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1465	1465		10.1126/science.1064710	http://dx.doi.org/10.1126/science.1064710			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711657				2022-12-24	WOS:000172240500026
J	Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T				Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T			Single-molecule analysis of chemotactic signaling in Dictyostelium cells	SCIENCE			English	Article							SURFACE CAMP RECEPTOR; LIVING CELLS; TRANSDUCTION; DISCOIDEUM; LOCALIZATION; DESENSITIZATION; ACTIVATION; AFFINITY; CYCLASE; BINDING	Single-molecule imaging techniques were used to reveal the binding of individual cyclic adenosine 3',5'-monophosphate molecules to heterotrimeric guanine nucleotide-binding protein coupled receptors on the surface of living Dictyostelium discoideum cells, The binding sites were uniformly distributed and diffused rapidly in the plane of the membrane. The probabilities of individual association and dissociation events were greater for receptors at the anterior end of the cell. Agonist-induced receptor phosphorylation had little effect on any of the monitored properties, whereas G protein coupling influenced the binding kinetics. These observations illustrate the dynamic properties of receptors involved in gradient sensing and suggest that these may be polarized in chemotactic cells.	Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Times Arrow & Biosignaling, Kawaguchi, Japan; JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan; Johns Hopkins Med Inst, Dept Cell Biol, Baltimore, MD 21205 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignalling, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Johns Hopkins University; Johns Hopkins Medicine; Osaka University	Ueda, M (corresponding author), Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan.		Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455				CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; JANS DA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P271, DOI 10.1016/0304-4157(92)90001-Q; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; KONIJN TM, 1987, METHOD CELL BIOL, V28, P283; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P3321; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	22	266	287	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					864	867		10.1126/science.1063951	http://dx.doi.org/10.1126/science.1063951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679673				2022-12-24	WOS:000171851800050
J	Tong, AHY; Drees, B; Nardelli, G; Bader, GD; Brannetti, B; Castagnoli, L; Evangelista, M; Ferracuti, S; Nelson, B; Paoluzi, S; Quondam, M; Zucconi, A; Hogue, CWV; Fields, S; Boone, C; Cesareni, G				Tong, AHY; Drees, B; Nardelli, G; Bader, GD; Brannetti, B; Castagnoli, L; Evangelista, M; Ferracuti, S; Nelson, B; Paoluzi, S; Quondam, M; Zucconi, A; Hogue, CWV; Fields, S; Boone, C; Cesareni, G			A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules	SCIENCE			English	Article							DOMAINS; BINDING; SPECIFICITY; ACTIVATION; BEE1P	Peptide recognition modules mediate many protein-protein interactions critical for the assembly of macromolecular complexes. Complete genome sequences have revealed thousands of these domains, requiring improved methods for identifying their physiologically relevant binding partners. We have developed a strategy combining computational prediction of interactions from phage-display ligand consensus sequences with large-scale two-hybrid physical interaction tests. Application to yeast SH3 domains generated a phage-display network containing 394 interactions among 206 proteins and a two-hybrid network containing 233 interactions among 145 proteins. Graph theoretic analysis identified 59 highly likely interactions common to both networks, Las17 (Bee1), a member of the Wiskott-Aldrich Syndrome protein (WASP) family of actin-assembly proteins, showed multiple SH3 interactions, many of which were confirmed in vivo by coimmunoprecipitation.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L6, Canada; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University of Rome Tor Vergata; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Queens University - Canada; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	fields@u.washington.edu; charlie.boone@utoronto.ca; giovanni.cesareni@uniroma2.it	Hogue, Christopher W V/AAZ-3934-2020; Bader, Gary/C-1176-2009; Hogue, Christopher/B-6726-2008; Cesareni, Gianni/AAW-1382-2020	Hogue, Christopher W V/0000-0002-3107-5246; Bader, Gary/0000-0003-0185-8861; Castagnoli, Luisa/0000-0001-5283-8671; , Barbara/0000-0001-9436-0362	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Colwill K, 1999, GENETICS, V152, P881; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Lechler T, 1997, J CELL BIOL, V138, P95, DOI 10.1083/jcb.138.1.95; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mayer BJ, 2001, J CELL SCI, V114, P1253; MOCHIDA J, COMMUNICATION; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	21	532	556	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					321	324		10.1126/science.1064987	http://dx.doi.org/10.1126/science.1064987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11743162				2022-12-24	WOS:000173278600048
J	Cattaneo, A; Buzzetti, R				Cattaneo, A; Buzzetti, R		Breastfeeding Res Training Working	Quality improvement report - Effect on rates of breast feeding of training for the Baby Friendly Hospital Initiative	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PEER COUNSELORS; KNOWLEDGE; ATTITUDES; PROMOTION; DURATION; INTERVENTION; PREVALENCE; INCREASE	Problem Breastfeeding rates and related hospital practices need improvement in Italy and elsewhere. Training of staff is necessary, but its effectiveness needs assessment. Context Eight hospitals in different regions of Italy. Design Controlled, non-randomised study. Data collected in three phases. Training after the first phase ill group 1 hospitals and after the second phase in group 2. Strategies for change Training of trainers and Subsequent training Of health workers with a slightly adapted version of the 18 hour Unicef Course Oil breastfeeding management and promotion. Key measures for improvement Hospital practices, knowledge of 571 health workers, and breastfeeding rates at discharge, three, and six months in 2669 mother and baby pairs. Effects of change After training hospitals improved their compliance with the "ten steps to successful breast feeding," from an average of 2.4 steps at phase one to 7.7 at phase three. Knowledge scores of health professionals increased from 0.41 to 0.72 in group 1 (training after phase one) and from 0.53 to 0.75 in group 2 (after phase two). The rate of exclusive breast feeding at discharge increased significantly after training: 41% to 77% in group 1 mid 23% to 73% in group 2, as did the rates of full (exclusive plus predominant) breast feeding at three months (37% to 50% in group 1 v 40% to 59% in group 2) and any breast feeding at six months (43% to 62% in group 1 v 41% to 64% in group 2 ). Lessons learnt Training for at least three days with a course including practical sessions and counselling skills is effective in changing hospital practices, knowledge of health workers, and breastfeeding rates.	Ist Infanzia, Unit Hlth Serv Res & Int Cooperat, I-34137 Trieste, Italy; CEVEAS, Modena, Italy		Cattaneo, A (corresponding author), Ist Infanzia, Unit Hlth Serv Res & Int Cooperat, Via Istria 65-1, I-34137 Trieste, Italy.	cattanco@burlo.trieste.it	Cattaneo, Adriano/G-6685-2011; Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				Aarts C, 2000, INT J EPIDEMIOL, V29, P1041, DOI 10.1093/ije/29.6.1041; Armitage P., 2001, STAT METHODS MED RES; Becker G E, 1992, J Hum Lact, V8, P137, DOI 10.1177/089033449200800318; BRADLEY JE, 1992, J TROP PEDIATRICS, V38, P228, DOI 10.1093/tropej/38.5.228; Cattaneo A, 2000, ACTA PAEDIATR, V89, P88, DOI 10.1080/080352500750029130; DELSANTO M, 1998, QUADERNI ASS CULTURA, V4, P10; Division of Diarrhoeal and Acute Respiratory Disease Control, 1991, IND ASS BREASTF PRAC; FREED GL, 1995, JAMA-J AM MED ASSOC, V273, P472, DOI 10.1001/jama.273.6.472; FREED GL, 1995, PEDIATRICS, V96, P490; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Henderson L, 2000, BRIT MED J, V321, P1196, DOI 10.1136/bmj.321.7270.1196; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; NHS Center for Reviews and Dissemination, 2000, EFFECTIVE HLTH CARE, V6, P1; PRASAD B, 1995, BRIT MED J, V310, P621, DOI 10.1136/bmj.310.6980.621; Radford A, 2001, BRIT MED J, V322, P555, DOI 10.1136/bmj.322.7285.555; Rea MF, 1999, B WORLD HEALTH ORGAN, V77, P492; Schafer E, 1998, BIRTH-ISS PERINAT C, V25, P101, DOI 10.1046/j.1523-536x.1998.00101.x; Schanler RJ, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e35; SIKORSKI J, 2000, COCHRANE DATABASE SY; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; *UNICEF, 1999, BAB FRIENDL HOSP INT; UNICEF, 1993, BREASTF MAN PROM BAB; Valdes V, 1995, J Hum Lact, V11, P185, DOI 10.1177/089033449501100318; WESTPHAL MF, 1995, B WORLD HEALTH ORGAN, V73, P461; WHO: Global Data Bank on Breastfeeding, 1996, GLOB DAT BANK BREAST; *WHO UNICEF, 1993, IND ASS HLTH FAC PRA; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; WILLIAMS EL, 1995, AM J PREV MED, V11, P26, DOI 10.1016/S0749-3797(18)30497-5; World Health Organization, 1998, COMPL FEED YOUNG CHI; Wright A, 1996, PEDIATRICS, V97, P669	32	135	141	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2001	323	7325					1358	1362		10.1136/bmj.323.7325.1358	http://dx.doi.org/10.1136/bmj.323.7325.1358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739226	Green Published			2022-12-24	WOS:000172716900022
J	Reneman, L; Booij, J; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GL; van den Brink, W				Reneman, L; Booij, J; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GL; van den Brink, W			Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons	LANCET			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BETA-CIT BINDING; IN-VIVO; DOPAMINE TRANSPORTERS; NONHUMAN-PRIMATES; PARTIAL RECOVERY; 52-WEEK PERIOD; NEUROTOXICITY; METHYLENEDIOXYMETHAMPHETAMINE; HUMANS	Background 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug that has been shown to damage brain serotonin neurons in high doses. However, effects of moderate MDMA use on serotonin neurons have not been studied, and sex differences and the longterm effects of MDMA use on serotonin neurons have not been identified. We investigated the effects of moderate and heavy MDMA use, sex differences, and long-term effects of MDMA use on serotonin neurons in different brain regions. Methods By means of flyers posted in "rave" venues in Amsterdam, the Netherlands, we recruited 15 moderate MDMA users, 23 heavy MDMA users, 16 ex-MDMA users who had stopped using MDMA for more than 1 year, and 15 controls who claimed never to have used MDMA. We studied the effects of MDMA on brain serotonin neurons using (123)iodine-2 beta -carbomethoxy-3 beta-(4-iodophenyl) tropane ([I-123][beta -CIT)-a radioligand that binds with high affinity to serotonin transporters. Density of binding (expressed as a ratio of region-of-interest binding over binding in the cerebellum) was calculated by single-photon-emission computed tomography (SPELT). Findings We saw significant effects of group and group by sex (p=0.041 and p=0.022, respectively) on overall [I-123])beta -CIT binding ratios. In heavy MDMA users, significant decreases in overall binding ratios were seen in women (p<0.01) but not men (p=0.587). In female ex-MDMA users, overall densities of serotonin transporters were significantly higher than in heavy MDMA users (p=0.004), but not higher than in controls (p=0.524). Interpretation Our results indicate that heavy use of MDMA is associated with neurotoxic effects on serotonin neurons, that women might be more susceptible than men, and that MDMA-induced neurotoxic changes in several brain regions of female ex-MDMA users are reversible.	Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Toxicol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Child & Adolescent Psychiat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Toxicol Lab, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Reneman, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Booij, Jan/AAD-7159-2019	Reneman, Liesbeth/0000-0002-5912-9971				*ADD RES I US, 1998, ECST DUTCH RAV SCEN; Booij J, 1999, EUR J NUCL MED, V26, P171, DOI 10.1007/s002590050374; Boot BP, 2000, LANCET, V355, P1818, DOI 10.1016/S0140-6736(00)02276-5; Chang L, 1999, AM J PSYCHIAT, V156, P716; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; FARDE L, 1994, SYNAPSE, V16, P93, DOI 10.1002/syn.890160203; Gerra G, 2000, BIOL PSYCHIAT, V47, P127, DOI 10.1016/S0006-3223(99)00180-8; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Hegadoren KM, 1999, NEUROSCI BIOBEHAV R, V23, P539, DOI 10.1016/S0149-7634(98)00046-3; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; INSEL TR, 1989, J PHARMACOL EXP THER, V249, P713; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; LARUELLE M, 1994, J CEREBR BLOOD F MET, V14, P982, DOI 10.1038/jcbfm.1994.131; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Malison RT, 1998, BIOL PSYCHIAT, V44, P1090, DOI 10.1016/S0006-3223(98)00272-8; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; NELSON HE, 1991, REV NATL ADULT READI; Pirker W, 2000, J NUCL MED, V41, P36; PIRKER W, 1995, J NEURAL TRANSM-GEN, V100, P247, DOI 10.1007/BF01276462; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; Sabol KE, 1996, J PHARMACOL EXP THER, V276, P846; Scheffel U, 1998, SYNAPSE, V29, P183, DOI 10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.0.CO;2-3; SCHIFANO F, 1994, BIOL PSYCHIAT, V36, P763, DOI 10.1016/0006-3223(94)90088-4; SCHMIDT CJ, 1987, J PHARMACOL EXP THER, V240, P1; Semple DM, 1999, BRIT J PSYCHIAT, V175, P63, DOI 10.1192/bjp.175.1.63; SWAAB DF, 1985, SCIENCE, V228, P1112, DOI 10.1126/science.3992248	30	173	173	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1864	1869		10.1016/S0140-6736(01)06888-X	http://dx.doi.org/10.1016/S0140-6736(01)06888-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741626				2022-12-24	WOS:000172463000012
J	Lee, R; Kermani, P; Teng, KK; Hempstead, BL				Lee, R; Kermani, P; Teng, KK; Hempstead, BL			Regulation of cell survival by secreted proneurotrophins	SCIENCE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIN; BRAIN; BIOSYNTHESIS; PRECURSOR; COEXPRESSION; EXPRESSION; APOPTOSIS; RECEPTORS; BINDING	Neurotrophins are growth factors that promote cell, survival, differentiation, and cell death. They are synthesized as proforms that can be cleaved intracellularly to release mature, secreted Ligands. Although proneurotrophins have been considered inactive precursors, we show here that the proforms of nerve growth factor (NGF) and the proforms of brain derived neurotrophic factor (BDNF) are secreted and cleaved extracellularly by the serine protease plasmin and by selective matrix metalloproteinases (MMPs). ProNGF is a high-affinity ligand for p75(NTR) with high affinity and induced p75(NTR)-dependent apoptosis in cultured neurons with minimal activation of TrkA-mediated differentiation or survival. The biological action of neurotrophins is thus regulated by proteolytic cleavage, with proforms preferentially activating p75(NTR) to mediate apoptosis and mature forms activating Trk receptors to promote survival.	Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA	Cornell University	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, 1300 York Ave, New York, NY 10021 USA.	blhempst@med.cornell.edu			NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY07138] Funding Source: Medline; NINDS NIH HHS [NS30687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Frade JM, 1996, NATURE, V383, P166; Heinrich G, 2000, INT J DEV NEUROSCI, V18, P1, DOI 10.1016/S0736-5748(99)00071-4; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Schropel A, 1995, MOL CELL NEUROSCI, V6, P544, DOI 10.1006/mcne.1995.0006; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8	24	1270	1335	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1945	1948		10.1126/science.1065057	http://dx.doi.org/10.1126/science.1065057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729324				2022-12-24	WOS:000172465000065
J	Tynan, CT; DeMaster, DP; Peterson, WT				Tynan, CT; DeMaster, DP; Peterson, WT			Endangered right whales an the southeastern Bering Sea shelf	SCIENCE			English	Article									NOAA, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; NOAA, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; NOAA, NWFSC, Newport, OR 97365 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Tynan, CT (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.							BOND NA, IN PRESS DEEP SEA 2; Clapham PJ, 1999, MAMMAL REV, V29, P35; FROST BW, 1974, MAR BIOL, V26, P77, DOI 10.1007/BF00389089; Goddard PD, 1998, MAR MAMMAL SCI, V14, P344, DOI 10.1111/j.1748-7692.1998.tb00725.x; KENNEY RD, 1995, CONT SHELF RES, V15, P373, DOI 10.1016/0278-4343(94)00070-4; Omura H., 1969, Scientific Reports of the Whales Research Institute Tokyo, VNo. 21, P1; SMITH SL, 1986, CONT SHELF RES, V5, P215, DOI 10.1016/0278-4343(86)90016-6	7	25	25	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1894	1894		10.1126/science.1065682	http://dx.doi.org/10.1126/science.1065682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729308				2022-12-24	WOS:000172465000049
J	Wright, DE; Wagers, AJ; Gulati, AP; Johnson, FL; Weissman, IL				Wright, DE; Wagers, AJ; Gulati, AP; Johnson, FL; Weissman, IL			Physiological migration of hematopoietic stem and progenitor Celts	SCIENCE			English	Article							IN-VIVO; CELLS; TRANSPLANTATION; MOBILIZATION	Hematopoietic stem cells (HSCs) reside predominantly in bone marrow, but low numbers of HSCs are also found in peripheral blood. We examined the fate of blood-borne HSCs using genetically marked parabiotic mice, which are surgically conjoined and share a common circulation. Parabionts rapidly established stable, functional cross engraftment of partner-derived HSCs and maintained partner-derived hematopoiesis after surgical separation. Determination of the residence time of injected blood-borne progenitor cells suggests that circulating HSCs/progenitors: are cleared quickly from the blood, These data demonstrate that HSCs rapidly and constitutively migrate through the blood and play a physiological role in, at least, the functional reengraftment of unconditioned bone marrow.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Palo Alto Vet Affairs Hlth Care Syst, Sch Med, Dept Med,Cardiovasc Med Div,Cardiol Sect 111C, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01 HL-58770] Funding Source: Medline; NIAID NIH HHS [5T32 AI-07290] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; DORIE MJ, 1979, EXP HEMATOL, V7, P483; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; LEY K, 2000, PHYSL INFLAMMATION; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; NANAKORN TN, UNPUB; Ramshaw H S, 1995, Biol Blood Marrow Transplant, V1, P74; Rao SS, 1997, EXP HEMATOL, V25, P114; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPENCER R P, 1975, Seminars in Nuclear Medicine, V5, P95, DOI 10.1016/S0001-2998(75)80007-9; Thomas ED, 1999, SEMIN HEMATOL, V36, P95; VANDERLOO JCM, 1994, BLOOD, V83, P1769; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	23	696	743	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1933	1936		10.1126/science.1064081	http://dx.doi.org/10.1126/science.1064081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729320				2022-12-24	WOS:000172465000061
J	Cantalupo, C; Hopkins, WD				Cantalupo, C; Hopkins, WD			Asymmetric Broca's area in great apes - A region of the ape brain is uncannily similar to one linked with speech in humans.	NATURE			English	Article							PLANUM TEMPORALE; LANGUAGE; MRI		Emory Univ, Yerkes Reg Primate Res Ctr, Div Psychobiol, Atlanta, GA 30322 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Living Links Ctr, Atlanta, GA 30322 USA; Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; Berry Coll, Dept Psychol, Mt Berry, GA 30149 USA	Emory University; Emory University; University System of Georgia; Georgia State University	Cantalupo, C (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Div Psychobiol, Atlanta, GA 30322 USA.				NICHD NIH HHS [P01 HD038051, P01 HD038051-050005] Funding Source: Medline; NINDS NIH HHS [R01 NS036605, R01 NS036605-08, R01 NS042867-05, R01 NS042867] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036605, R01NS042867] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Bailey P, 1950, ISOCORTEX CHIMPANZEE; BROCA P, 1861, B SOC ANAT, V2, P330; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Foundas AL, 1998, BRAIN LANG, V64, P282, DOI 10.1006/brln.1998.1974; GALABURDA AM, 1984, CEREBRAL DOMINANCE B, P11; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hopkins WD, 1998, NEUROREPORT, V9, P2913, DOI 10.1097/00001756-199808240-00043; HOSTETTER AB, IN PRESS J COMP PSYC; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; von Bonin G, 1949, PRECENTRAL MOTOR COR, P7; Zolfonoun Ehsan, 2015, CLIN CHEM LAB MED, V103, P835, DOI [10.1515/ract-2015-2466, DOI 10.1515/CCLM-2022-0965]	13	243	243	2	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					505	505		10.1038/35107134	http://dx.doi.org/10.1038/35107134			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734839	Green Accepted			2022-12-24	WOS:000172405900032
J	Joffe, S; Cook, EF; Cleary, PD; Clark, JW; Weeks, JC				Joffe, S; Cook, EF; Cleary, PD; Clark, JW; Weeks, JC			Quality of informed consent in cancer clinical trials: a cross-sectional survey	LANCET			English	Article							INFORMATION; PERCEPTIONS	Background Investigators have to obtain informed consent before enrolling participants in clinical trials. We wanted to measure the quality of understanding among participants in clinical trials of cancer therapies, to identify correlates of increased understanding, and to assess providers' beliefs about clinical research. We also sought evidence of therapeutic misconceptions in participants and providers. Methods We sent a standard questionnaire to 287 adult patients with cancer who had recently enrolled in a clinical trial at one of three affiliated institutions, and surveyed the provider who obtained each patient's consent. Findings 207 of 287 (72%) patients responded. 90% (186) of these respondents were satisfied with the informed consent process and most considered themselves to be well informed. Nevertheless, many did not recognise nonstandard treatment (74%), the potential for incremental risk from participation (63%), the unproven nature of the treatment (70%), the uncertainty of benefits to self (29%), or that trials are done mainly to benefit future patients (25%). In multivariate analysis, increased knowledge was associated with college education, speaking only English at home, use of the US National Cancer Institute consent form template, not signing the consent form at initial discussion, presence of a nurse, and careful reading of the consent form. Only 28 of 61 providers (46%) recognised that the main reason for clinical trials is benefit to future patients. Interpretation Misconceptions about cancer clinical trials are frequent among trial participants, and physician/investigators might share some of these misconceptions. Efforts to educate providers and participants about the underlying goals of clinical trials are needed.	Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Dept Paediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA USA; Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Weeks, JC (corresponding author), Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Dept Paediat Oncol, 454 BRK Suite 21,44 Binney St, Boston, MA 02115 USA.		Cleary, Paul/AAF-7048-2019; Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000063] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS00063] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Aaronson NK, 1996, J CLIN ONCOL, V14, P984, DOI 10.1200/JCO.1996.14.3.984; Advisory Committee on Human Radiation Experiments, 1996, FIN REP; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Beauchamp TL., 1994, PRINCIPLES BIOMEDICA; Bjorn E, 1999, J MED ETHICS, V25, P263, DOI 10.1136/jme.25.3.263; *COMPR WORK GROUP, 2001, REC DEV INF CONS DOC; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; FREEDMAN B, 1992, CLIN RES, V40, P653; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; LEVINE RJ, 1986, ETHICS REGULATION CL; McCarthy CR, 1998, CONSENT SEEKING JUST, P11; MEISEL A, 1977, AM J PSYCHIAT, V134, P285; Miller CK, 1996, PHARMACOTHERAPY, V16, P872; Miller FG, 1998, JAMA-J AM MED ASSOC, V280, P1449, DOI 10.1001/jama.280.16.1449; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; MORROW G, 1978, CANCER, V42, P793, DOI 10.1002/1097-0142(197808)42:2<793::AID-CNCR2820420252>3.0.CO;2-C; *NAT COMM PROT HUM, 1998, ETH RES HUM SUBJ SEL, P19; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PENMAN DT, 1984, J CLIN ONCOL, V2, P849, DOI 10.1200/JCO.1984.2.7.849; RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; SIMES RJ, 1986, BRIT MED J, V293, P1065, DOI 10.1136/bmj.293.6554.1065; SKRUTKOWSKI M, 1998, IRB, P1; SUGARMAN J, 1998, ETHICS RES HUMAN SUB, P12; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; United States Department of Health and Human Services, 1991, FED REGISTER, V56, P28012; *WORLD MED ASS DEC, 1998, ETH RES HUM SUBJ SEL, P14	31	444	460	3	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1772	1777		10.1016/S0140-6736(01)06805-2	http://dx.doi.org/10.1016/S0140-6736(01)06805-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496FG	11734235				2022-12-24	WOS:000172385100013
J	Riolo, RL; Cohen, MD; Axelrod, R				Riolo, RL; Cohen, MD; Axelrod, R			Evolution of cooperation without reciprocity	NATURE			English	Article							SOCIAL-STRUCTURE; GREEN BEARD; GAMES	A long-standing problem in biological and social sciences is to understand the conditions required for the emergence and maintenance of cooperation in evolving populations. For many situations, kin selection(1) is an adequate explanation, although kin-recognition may still be a problem. Explanations of cooperation between non-kin include continuing interactions that provide a shadow of the future (that is, the expectation of an ongoing relationship) that can sustain reciprocity(2-4), possibly supported by mechanisms to bias interactions such as embedding the agents in a two-dimensional space(4-6) or other context-preserving networks(7). Another explanation, indirect reciprocity(8), applies when benevolence to one agent increases the chance of receiving help from others. Here we use computer simulations to show that cooperation can arise when agents donate to others who are sufficiently similar to themselves in some arbitrary characteristic. Such a characteristic, or 'tag', can be a marking, display, or other observable trait. Tag-based donation can lead to the emergence of cooperation among agents who have only rudimentary ability to detect environmental signals and, unlike models of direct(3,4) or indirect reciprocity(9,10), no memory of past encounters is required.	Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Riolo, RL (corresponding author), Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA.	rlriolo@umich.edu	Pepper, John W/O-1662-2013	Pepper, John W/0000-0001-9888-0437				Alexander R., 2008, ESSAYS PEDAGOGY; ALLISON PD, 1992, SOC FORCES, V71, P279, DOI 10.2307/2580012; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1984, EVOLUTION COOPERATIO, P146; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; COHEN M, 1999, 9901002 SANT FE I; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; Dawkins R., 1982, pi; DAWKINS R, 1976, SELFISH GENE 96; Grafen A, 1998, NATURE, V394, P521, DOI 10.1038/28948; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauber Mark E., 2000, Animal Cognition, V3, P113, DOI 10.1007/s100710000071; Hauber ME, 2000, TRENDS ECOL EVOL, V15, P349, DOI 10.1016/S0169-5347(00)01923-6; Holland J. H., 1995, HIDDEN ORDER ADAPTAT; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Lindgren K., 1991, ARTIF LIFE, VX, P295; LINSTER BG, 1992, SOUTH ECON J, V58, P880, DOI 10.2307/1060227; Lomborg B, 1996, AM SOCIOL REV, V61, P278, DOI 10.2307/2096335; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Riolo R, 1997, P 7 INT C GEN ALG IC, P378; ROBSON AJ, 1990, J THEOR BIOL, V144, P379, DOI 10.1016/S0022-5193(05)80082-7; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	27	426	438	0	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					441	443		10.1038/35106555	http://dx.doi.org/10.1038/35106555			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494UP	11719803	Green Published			2022-12-24	WOS:000172304500041
J	Bird, SM; Brown, AJL				Bird, SM; Brown, AJL			Criminalisation of HIV transmission: implications for public health in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HETEROSEXUAL TRANSMISSION; OUTBREAK; INFECTION; ESCAPE		MRC, Biostat Unit, Cambridge CB2 2SR, England; Univ Calif San Diego, Dept Pathol, Treatment Ctr, San Diego, CA 92103 USA	MRC Biostatistics Unit; University of California System; University of California San Diego	Bird, SM (corresponding author), MRC, Biostat Unit, Robinson Way, Cambridge CB2 2SR, England.	sheila.bird@mrc-bsu.cam.ac.uk	Leigh Brown, Andrew/F-3802-2010; Brown, Andrew Leigh/ABF-8269-2020	Leigh Brown, Andrew/0000-0002-5700-3128; Brown, Andrew Leigh/0000-0002-5700-3128				ALLARDICE G, 1992, AIDS, V6, P213, DOI 10.1097/00002030-199202000-00013; BIRD AG, 1991, BRIT MED J, V303, P351, DOI 10.1136/bmj.303.6798.351; BIRD AG, 1993, BRIT MED J, V306, P1013, DOI 10.1136/bmj.306.6884.1013; Dyer C, 2001, BRIT MED J, V322, P633, DOI 10.1136/bmj.322.7287.633; ELLIOTT R, 1999, CANADIAN HIV AIDS PO, V4, P16; *EUR PARTN NOT STU, IN PRESS QJ MED; FIELDING KL, 1995, STAT MED, V14, P1365, DOI 10.1002/sim.4780141209; Goldberg D, 1998, INT J STD AIDS, V9, P25, DOI 10.1258/0956462981920991; GORE SM, 1993, BRIT MED J, V307, P147, DOI 10.1136/bmj.307.6897.147; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; Hutchinson SJ, 1999, EPIDEMIOL INFECT, V123, P271, DOI 10.1017/S0950268899002836; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; MACLAREN L, 2001, HERALD          0317, P10; *MED RES COUNC, 2000, MRC EX SUMM PERS INF; MIR N, IN PRESS SEXUALLY TR; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; PATTMAN RS, 1993, GENITOURIN MED, V69, P94; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; WELLINGS K, 1994, SEXUAL BEHAV BRITAIN, P155; Yirrell DI, 1997, BRIT MED J, V314, P1446, DOI 10.1136/bmj.314.7092.1446; Yirrell DL, 1999, EPIDEMIOL INFECT, V123, P277, DOI 10.1017/S0950268899002848; 2001, SCOTTISH CTR INFECT, V35, P24; 2001, SCOTTISH CTR INFECT, V35, P100; 2000, SCOTTISH CTR INFECT, V34, pS1; 2000, SCOTTISH CTR INFECT, V34, P264; 2000, SCOTTISH CTR INFECT, V34, P92	27	31	32	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2001	323	7322					1174	1177		10.1136/bmj.323.7322.1174	http://dx.doi.org/10.1136/bmj.323.7322.1174			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	495NG	11711413	Green Submitted, Green Published			2022-12-24	WOS:000172346800022
J	Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Slotterbeck, B; Booze, MW; Ribble, RC; Rampersaud, E; West, SG; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Vance, JM; Pericak-Vance, MA				Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Slotterbeck, B; Booze, MW; Ribble, RC; Rampersaud, E; West, SG; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Vance, JM; Pericak-Vance, MA			Complete genomic screen in parkinson disease - Evidence for multiple genes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-DIAGNOSIS; LINKAGE; MUTATIONS; TAU; EPIDEMIOLOGY; ASSOCIATION; FEATURES; ACCURACY; DEMENTIA; MODELS	Context The relative contribution of genes vs environment in idiopathic Parkinson disease (PD) is controversial. Although genetic studies have identified 2 genes in which mutations cause rare single-gene variants of PD and observational studies have suggested a genetic component, twin studies have suggested that little genetic contribution exists in the common forms of PD. Objective To identify genetic risk factors for idiopathic PD. Design, Setting, and Participants Genetic linkage study conducted 1995-2000 in which a complete genomic screen (n=344 markers) was performed in 174 families with multiple individuals diagnosed as having idiopathic PD, identified through probands in 13 clinic populations in the continental United States and Australia. A total of 870 family members were studied: 378 diagnosed as having PD, 379 unaffected by PD, and 113 with unclear status. Main Outcome Measures Logarithm of odds (lod) scores generated from parametric and nonparametric genetic linkage analysis. Results Two-point parametric maximum parametric lod score (MLOD) and multipoint nonparametric lod score (LOD) linkage analysis detected significant evidence for linkage to 5 distinct chromosomal regions: chromosome 6 in the parkin gene (MLOD = 5.07; LOD, = 5.47) in families with at least 1 individual with PD onset at younger than 40 years, chromosomes 17q (MLOD = 2.28; LOD = 2.62), 8p (MLOD = 2.01; LOD = 2.22), and 5q (MLOD = 2.39; LOD = 1.50) overall and in families with late-onset PD, and chromosome 9q (MLOD = 1.52; LOD = 2.59) in families with both levodopa-responsive and levodopa-non responsive patients. Conclusions Our data suggest that the parkin gene is important in early-onset PD and that multiple genetic factors may be important in the development of idiopathic late-onset PD.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev, Greenford, Middx, England; GlaxoSmithKline Res & Dev, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA	Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; GlaxoSmithKline; GlaxoSmithKline; Vanderbilt University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Box 3445, Durham, NC 27710 USA.		Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404; Gibson, Rachel/0000-0002-1338-1290; Vance, Jeffery/0000-0003-3815-8199; Laing, Nigel/0000-0001-5111-3732	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, P50NS039764] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS39764, P01 NS26630] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Allan W, 1937, ARCH INTERN MED, V60, P424, DOI 10.1001/archinte.1937.00180030041003; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GOLBE LI, 1991, NEUROLOGY, V41, P168, DOI 10.1212/WNL.41.2_Part_1.168; Hubble JP, 1999, NEUROLOGY, V52, pA13; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; JOHNSON WG, 1990, MOVEMENT DISORD, V5, P187, DOI 10.1002/mds.870050302; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Langston JW, 1998, ANN NEUROL, V44, pS45, DOI 10.1002/ana.410440707; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1999, ANAL HUMAN GENETIC L; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; RISCH N, 1990, AM J HUM GENET, V46, P222; Scott WK, 2000, AM J HUM GENET, V67, P19; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Vance Jeffery M., 1998, P213; VIEREGGE P, 1992, NEUROLOGY, V42, P1453, DOI 10.1212/WNL.42.8.1453; WARD CD, 1990, ADV NEUROL, V53, P245; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5	31	223	234	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2239	2244		10.1001/jama.286.18.2239	http://dx.doi.org/10.1001/jama.286.18.2239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710888	Bronze			2022-12-24	WOS:000172129700017
J	Chan, CLH; Meyer, FJ; Hay, RJ; Burnand, KG				Chan, CLH; Meyer, FJ; Hay, RJ; Burnand, KG			Toe ulceration associated with compression bandaging: observational study	BRITISH MEDICAL JOURNAL			English	Article							ULCERS	Foot ulcers can be caused by arterial insufficiency, diabetes mellitus, neuropathy, musculoskeletal. disorders, or injury.(1) The clinical features of an ulcer-such as site, shape, edge, base, and state of the surrounding tissues-often give some indication of its aetiology and aid in further management and treatment. Ulceration of the foot is seen in some patients with venous disease but has not been observed in association with any particular treatment regimen.(2) We describe a previously unreported finding of ulceration of the toe and cleft, for which there was no demonstrable ischaemic or vasculitic cause, developing in patients treated with compression bandaging for venous ulcers.	Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, London SE1 7EH, England; Guys & St Thomass NHS Trust, Dept Surg, London SE1 7EH, England	University of London; King's College London	Burnand, KG (corresponding author), Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, London SE1 7EH, England.							Dale J, 1983, Nurs Times, V79, P49; HANSSON C, 1987, ACTA DERM-VENEREOL, V67, P341; NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/bjs.1800810206; PARTSCH H, 1997, FRONTIERS COMPUTER A, P145; Sumpio BE, 2000, NEW ENGL J MED, V343, P787, DOI 10.1056/NEJM200009143431107	5	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1099	1099		10.1136/bmj.323.7321.1099	http://dx.doi.org/10.1136/bmj.323.7321.1099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701575	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000172188400014
J	Bradley, KA; Mogridge, J; Mourez, M; Collier, RJ; Young, JAT				Bradley, KA; Mogridge, J; Mourez, M; Collier, RJ; Young, JAT			Identification of the cellular receptor for anthrax toxin	NATURE			English	Article							PROTECTIVE ANTIGEN; LETHAL FACTOR; CRYSTAL-STRUCTURE; ADENYLATE-CYCLASE; MAMMALIAN-CELLS; EDEMA FACTOR; HIGH-TITER; I-DOMAIN; MACROPHAGES; LIBRARIES	The tripartite toxin secreted by Bacillus anthracis, the causative agent of anthrax, helps the bacterium evade the immune system and can kill the host during a systemic infection. Two components of the toxin enzymatically modify substrates within the cytosol of mammalian cells: oedema factor (OF) is an adenylate cyclase that impairs host defences through a variety of mechanisms including inhibiting phagocytosis(1,2); lethal factor (LF) is a zinc-dependent protease that cleaves mitogen-activated protein kinase kinase and causes lysis of macrophages(3-5). Protective antigen (PA), the third component, binds to a cellular receptor and mediates delivery of the enzymatic components to the cytosol. Here we describe the cloning of the human PA receptor using a genetic complementation approach. The receptor, termed ATR (anthrax toxin receptor), is a type I membrane protein with an extracellular von Willebrand factor A domain that binds directly to PA. In addition, a soluble version of this domain can protect cells from the action of the toxin.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Young, JAT (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.			Collier, R John/0000-0002-2427-4239; Young, John/0000-0003-1824-2561				Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Dickeson SK, 1998, CELL MOL LIFE SCI, V54, P556, DOI 10.1007/s000180050184; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KOEHLER TM, 1991, MOL MICROBIOL, V5, P1501, DOI 10.1111/j.1365-2958.1991.tb00796.x; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2001, J BACTERIOL, V183, P2111, DOI 10.1128/JB.183.6.2111-2116.2001; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Snitkovsky S, 2000, J VIROL, V74, P9540, DOI 10.1128/JVI.74.20.9540-9545.2000; St Croix B, 2000, SCIENCE, V289, P1197; TAFT SA, 1994, ENVIRON MOL MUTAGEN, V23, P96, DOI 10.1002/em.2850230204; Varughese M, 1999, INFECT IMMUN, V67, P1860; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704	31	715	792	3	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					225	229		10.1038/n35101999	http://dx.doi.org/10.1038/n35101999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700562				2022-12-24	WOS:000172029100052
J	Chai, JJ; Wu, Q; Shiozaki, E; Srinivasula, SM; Alnemri, ES; Shi, YG				Chai, JJ; Wu, Q; Shiozaki, E; Srinivasula, SM; Alnemri, ES; Shi, YG			Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding	CELL			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; 3-DIMENSIONAL STRUCTURE; BRAIN INJURY; APOPTOSIS; CASPASE-8; COMPLEX; SYSTEM; DEATH	Apoptosis is primarily executed by active caspases, which are derived from the inactive procaspase zymogens through proteolytic cleavage. Here we report the crystal structures of a caspase zymogen, procaspase-7, and an active caspase-7 without any bound inhibitors. Compared to the inhibitor-bound caspase-7, procaspase-7 zymogen exhibits significant structural differences surrounding the catalytic cleft, which precludes the formation of a productive conformation. Proteolytic cleavage between the large and small subunits allows rearrangement of essential loops in the active site, priming active caspase-7 for inhibitor/substrate binding. Strikingly, binding by inhibitors causes a 180 degrees flipping of the N terminus in the small subunit, which interacts with and stabilizes the catalytic cleft. These analyses reveal the structural mechanisms of caspase activation and demonstrate that the inhibitor/substrate binding is a process of induced fit.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Princeton University; Jefferson University	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu	Alnemri, Emad S/B-4526-2010	Shi, Yigong/0000-0003-2030-168X; Chai, Jijie/0000-0001-7591-3873	NATIONAL CANCER INSTITUTE [R01CA090269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER; NCI NIH HHS [CA90269] Funding Source: Medline; NIA NIH HHS [AG14357] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Horvitz HR, 1999, CANCER RES, V59, p1701S; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; THOMBERRY NA, 1992, NATURE, V356, P768; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	39	194	198	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					399	407		10.1016/S0092-8674(01)00544-X	http://dx.doi.org/10.1016/S0092-8674(01)00544-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701129	Bronze			2022-12-24	WOS:000172022800010
J	Heller, D				Heller, D			Validity of the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MMR VACCINATION; AUTISM 1998; CAUSAL		Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England	University of Manchester	Heller, D (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England.	Dick.Heller@man.ac.uk						Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; Gellin BG, 2001, NEW ENGL J MED, V344, P372, DOI 10.1056/NEJM200102013440509; HELLER RC, IN PRESS J EPIDEMIOL; *I MED, 2001, IMM SAF REV MEASL MU; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Roberts R, 1998, BRIT MED J, V316, P1824, DOI 10.1136/bmj.316.7147.1824; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P1356, DOI 10.1016/S0140-6736(05)79083-8; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wise Jacqui, 2001, BMJ-BRIT MED J, V322, P130	12	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2001	323	7317					839	840						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683152				2022-12-24	WOS:000171650500027
J	Manning, SW; Kromer, B; Kuniholm, PI; Newton, MW				Manning, SW; Kromer, B; Kuniholm, PI; Newton, MW			Anatolian tree rings and a new chronology for the east Mediterranean bronze-iron ages	SCIENCE			English	Article							ICE CORE; BC; C-14; CALIBRATION; TELECONNECTIONS; TERRESTRIAL; SANTORINI; MINOAN; GREECE; BP	We report an extensive program of high-precision radiocarbon dating to establish the best date for a floating 1599-year Anatolian tree ring chronology that spans the later third millennium B.C. through the earlier first millennium B.C. This chronology is directly associated with a number of key sites and ancient personages. A previously suggested dating is withdrawn and is replaced by a robust new date fix 22 (+ 4 or -7) years earlier. These new radiocarbon wiggle-matched dates offer a unique independent resource for establishing the precise chronology of the ancient Near East and Aegean and help resolve, among others, a tong-standing debate in favor of the so-called Middle Mesopotamian chronology.	Univ Reading, Dept Archaeol, Reading RG6 6AA, Berks, England; Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany; Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY 14853 USA	University of Reading; Ruprecht Karls University Heidelberg; Cornell University	Manning, SW (corresponding author), Univ Reading, Dept Archaeol, POB 218 Whiteknights, Reading RG6 6AA, Berks, England.							BRAZIUNAS TF, 1995, GLOBAL BIOGEOCHEM CY, V9, P565, DOI 10.1029/95GB01725; BRONKRAMSEY C, 1995, RADIOCARBON, V37, P425; CHARPIN D, 1985, ANN RECH INTERDISCIP, V4, P293; CILINGIROGLU A., 2001, AYANIS 1 10 YEARS EX; Clausen HB, 1997, J GEOPHYS RES-OCEANS, V102, P26707, DOI 10.1029/97JC00587; Cole-Dai JH, 2000, J GEOPHYS RES-ATMOS, V105, P24431, DOI 10.1029/2000JD900254; Gasche H., 1998, DATING FALL BABYLON; HAAS V., 1986, REICH URARTU ALTORIE; HAMMER CU, 1987, NATURE, V328, P517, DOI 10.1038/328517a0; HAMMER CU, 2000, SYNCHRONISATION CIVI, P35; HAMMER CU, 2001, SCIEM2000EUR HAIND L; KROMER B, 1993, RADIOCARBON, V35, P125, DOI 10.1017/S0033822200013862; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kromer B, 2001, SCIENCE, V294, P2529, DOI 10.1126/science.1066114; Kuniholm P. I., 1992, SYRIA, V69, P379; Kuniholm P.I., 1993, STUDIES HONOR N OZGU, P371; Kuniholm P. I., 1977, THESIS U PENNSYLVANI; Kuniholm PI, 1996, NATURE, V381, P780, DOI 10.1038/381780a0; KUNIHOLM PI, 1993, TILLE HOYUK, V4, P179; Manning S. W., 1999, TEST TIME VOLCANO TH; McCormac FG, 1995, RADIOCARBON, V37, P395, DOI 10.1017/S0033822200030873; Michaud V, 2000, J VOLCANOL GEOTH RES, V99, P195, DOI 10.1016/S0377-0273(00)00173-6; MICHEL C., 1997, JEOL, V35-36, P111; NEWTON M, IN PRESS KAMAN KALEH; Nimet Ozguc, 2001, KULTEPE KANIS SEALED; ozguc N., 1980, ANCIENT ART SEALS, P61; PEARSON GW, 1986, RADIOCARBON, V28, P911, DOI 10.1017/S0033822200060197; PEARSON GW, 1993, RADIOCARBON, V35, P105, DOI 10.1017/S0033822200013850; Prag AJNW, 1989, ANATOLIAN STUDIES, V39, P159; SPARKS RJ, COMMUNICATION; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Stuiver M, 1998, GEOPHYS RES LETT, V25, P329, DOI 10.1029/97GL03694; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; TUNCA O, 1989, ANATOLIA ANCIENT NEA, P481; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; VanGeel B, 1996, J QUATERNARY SCI, V11, P451, DOI 10.1002/(SICI)1099-1417(199611/12)11:6<451::AID-JQS275>3.0.CO;2-9; VEENHOF KR, 2000, AKKADICA, V119, P137; VOIGT MJA, COMMUNICATION; Whiting R. M. J., 1990, TALL AL HAMIDIYA, P167; Young R. S., 1981, 3 GREAT EARLY TUMULI	40	80	83	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2532	2535		10.1126/science.1066112	http://dx.doi.org/10.1126/science.1066112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11743159				2022-12-24	WOS:000172927700054
J	Cobelens, F; Borgdorff, M				Cobelens, F; Borgdorff, M			Boosting, BCG, and time of reading in tuberculin skin testing	LANCET			English	Editorial Material									Royal Netherlands TB Assoc KNCV, NL-2501 CC The Hague, Netherlands	KNCV Tuberculosis Foundation	Cobelens, F (corresponding author), Royal Netherlands TB Assoc KNCV, NL-2501 CC The Hague, Netherlands.			Cobelens, Frank/0000-0002-4367-1133				BASS JB, 1981, AM REV RESPIR DIS, V123, P394; COMSTOCK G W, 1960, Bull World Health Organ, V23, P683; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Singh D, 2001, AM J RESP CRIT CARE, V164, P962, DOI 10.1164/ajrccm.164.6.2102076; *WHO TUB RES OFF, 1955, B WORLD HEALTH ORGAN, V12, P189; *WHO TUB RES OFF, 1955, B WORLD HEALTH ORGAN, V12, P197	8	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2014	2014		10.1016/S0140-6736(01)07137-9	http://dx.doi.org/10.1016/S0140-6736(01)07137-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755604				2022-12-24	WOS:000172722800006
J	Welburn, SC; Picozzi, K; Fevre, EM; Coleman, PG; Odiit, M; Carrington, M; Maudlin, I				Welburn, SC; Picozzi, K; Fevre, EM; Coleman, PG; Odiit, M; Carrington, M; Maudlin, I			Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene	LANCET			English	Article							BRUCEI-RHODESIENSE; EXPRESSION; GAMBIENSE; PCR	Background The expansion of sleeping sickness caused by Trypanosoma brucei rhodesiense beyond its traditional focus in southeast Uganda has been linked with large-scale livestock restocking. To assess the risk presented to the human population by domestic livestock, human-infective T b rhodesiense must be distinguished from non-human-infective T brucei brucei, since both parasites can be present in cattle. We investigated the use of a simple genetic marker to characterise parasites collected from cattle in villages within the new sleeping sickness focus in Soroti District, Uganda. Methods 70 T brucei sl samples of known human infectivity status collected from human beings and cattle in Tororo District, Uganda, from 1989 to 1991 were screened for the presence of the human-serum-resistance-associated (SRA) gene by conventional PCR. In 2000-01, blood samples from 200 randomly selected cattle in six villages and two markets in Soroti District were screened for T brucei sl parasites (ie, both T b brucei and T b rhodesiense) by PCR; positive samples were screened for the presence of the SRA gene. Findings The SRA gene was present in all 29 samples from patients with sleeping sickness in Tororo District. Of the 41 samples collected from cattle at the same time, the SRA gene was present in the eight samples that tested resistant to human serum in vitro, whereas it was absent from all 33 isolates that were sensitive to human serum in vitro. Of the 200 cattle sampled in Soroti District, we estimated that up to 18% (95% CI 12-23) were infected with T b rhodesiense. Interpretation Detection of the SRA gene could provide the basis for a simple diagnostic test to enable targeted control of T b rhodesiense in the domestic livestock reservoir, thereby reducing the public-health burden of sleeping sickness in east Africa.	Univ Edinburgh, Ctr Trop Vet Med, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Livestock Hlth Res Inst, Torono, Uganda; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Welburn, SC (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland.		Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086				ARTAMA WT, 1992, PARASITOLOGY, V104, P67, DOI 10.1017/S0031182000060819; Barrett MP, 2001, LANCET, V358, P603, DOI 10.1016/S0140-6736(01)05817-2; BRUN R, 1987, Z PARASITENKD, V73, P218; de Almeida PP, 1998, ACTA TROP, V70, P269, DOI 10.1016/S0001-706X(98)00031-X; DEGREEF C, 1989, MOL BIOCHEM PARASIT, V36, P169, DOI 10.1016/0166-6851(89)90189-8; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Hide G, 1998, EXP PARASITOL, V89, P21, DOI 10.1006/expr.1998.4265; HIDE G, 1991, EXPERIENTIA, V47, P128, DOI 10.1007/BF01945413; HIDE G, 1990, MOL BIOCHEM PARASIT, V39, P213, DOI 10.1016/0166-6851(90)90060-Y; HIDE G, 1994, PARASITOLOGY, V109, P95, DOI 10.1017/S0031182000077805; Kabiri M, 1999, TROP MED INT HEALTH, V4, P658, DOI 10.1046/j.1365-3156.1999.00465.x; KOERNER T, 1995, PARASITOL TODAY, V11, P303, DOI 10.1016/0169-4758(95)80046-8; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; Milner JD, 1999, MOL BIOCHEM PARASIT, V104, P271, DOI 10.1016/S0166-6851(99)00151-6; Odiit M, 1997, E AFR MED J, V74, P792; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; VANNIEUWENHOVE S, 1999, PROGR HUMAN AFRICAN, P235; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	20	165	168	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2017	2019		10.1016/S0140-6736(01)07096-9	http://dx.doi.org/10.1016/S0140-6736(01)07096-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755607				2022-12-24	WOS:000172722800009
J	Trumpp, A; Refaeli, Y; Oskarsson, T; Gasser, S; Murphy, M; Martin, GR; Bishop, JM				Trumpp, A; Refaeli, Y; Oskarsson, T; Gasser, S; Murphy, M; Martin, GR; Bishop, JM			c-Myc regulates mammalian body size by controlling cell number but not cell size	NATURE			English	Article							DROSOPHILA MYC; MICE; GENE; INACTIVATION; EXPRESSION; GROWTH	Overexpression of the proto-oncogene c-myc has been implicated in the genesis of diverse human tumours. c-Myc seems to regulate diverse biological processes, but its role in tumorigenesis and normal physiology remains enigmatic(1). Here we report the generation of an allelic series of mice in which c-myc expression is incrementally reduced to zero. Fibroblasts from these mice show reduced proliferation and after complete loss of c-Myc function they exit the cell cycle. We show that Myc activity is not needed for cellular growth but does determine the percentage of activated T cells that re-enter the cell cycle. In vivo, reduction of c-Myc levels results in reduced body mass owing to multiorgan hypoplasia, in contrast to Drosophila dmyc mutants, which are smaller as a result of hypotrophy(2). We rnd that dmyc substitutes for c-myc in fibroblasts, indicating they have similar biological activities. This suggests there may be fundamental differences in the mechanisms by which mammals and insects control body size. We propose that in mammals c-Myc controls the decision to divide or not to divide and thereby functions as a crucial mediator of signals that determine organ and body size.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Trumpp, A (corresponding author), Swiss Inst Expt Canc Res, Ch des Boveresses 155, CH-1066 Epalinges, Switzerland.		Trumpp, Andreas/Z-2141-2019; gasser, stephan/A-2309-2013; Oskarsson, Thordur/HBP-9601-2022	Trumpp, Andreas/0000-0002-6212-3466; Oskarsson, Thordur/0000-0002-0983-6969; Gasser, Stephan/0000-0002-5616-0914				Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HOLZEL M, 2001, 21 EMBO; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; STEVENSON RD, 1995, P ROY SOC B-BIOL SCI, V259, P105, DOI 10.1098/rspb.1995.0016; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TRUMPP A, 1992, GENE DEV, V6, P14, DOI 10.1101/gad.6.1.14; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x	27	356	378	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					768	773		10.1038/414768a	http://dx.doi.org/10.1038/414768a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742404				2022-12-24	WOS:000172676200052
J	Heun, P; Laroche, T; Shimada, K; Furrer, P; Gasser, SM				Heun, P; Laroche, T; Shimada, K; Furrer, P; Gasser, SM			Chromosome dynamics in the yeast interphase nucleus	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; IN-VIVO; SCALE; ORC; VISUALIZATION; TERRITORIES; DROSOPHILA	Little is known about the dynamics of chromosomes in interphase nuclei. By tagging four chromosomal regions with a green fluorescent protein fusion to lac repressor, we monitored the movement and subnuclear position of specific sites in the yeast genome, sampling at short time intervals. We found that early and late origins of replication are highly mobile in G(1) phase, frequently moving at or faster than 0.5 micrometers/10 seconds, in an energy-dependent fashion. The rapid diffusive movement of chromatin detected in G(1) becomes constrained in S phase through a mechanism dependent on active DNA replication. In contrast, telomeres and centromeres provide replication-independent constraint on chromatin movement in both G(1) and S phases.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva	Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.		Heun, Patrick/F-3883-2011; Heun, Patrick/AAH-7390-2020	Heun, Patrick/0000-0001-8400-1892; Gasser, Susan/0000-0003-3610-9123				Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Blaszczyk M., UNPUB; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Buchenau P, 1997, J CELL BIOL, V137, P291, DOI 10.1083/jcb.137.2.291; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Csink AK, 1998, J CELL BIOL, V143, P13, DOI 10.1083/jcb.143.1.13; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; JAZWINSKI SM, 1984, J BIOL CHEM, V259, P6852; Kim S, 1997, YEAST, V13, P735, DOI 10.1002/(SICI)1097-0061(19970630)13:8<735::AID-YEA136>3.0.CO;2-V; LAROCHE T, UNPUB; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; MAHY NL, 2000, CHROMATIN STRUCTURE; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Pasero P, 1997, GENE DEV, V11, P1504, DOI 10.1101/gad.11.12.1504; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rubbi L, 1997, BIOCHEM J, V328, P401, DOI 10.1042/bj3280401; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	34	347	349	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2181	2186		10.1126/science.1065366	http://dx.doi.org/10.1126/science.1065366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739961				2022-12-24	WOS:000172647700056
J	Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS				Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS			A transgenic model of visceral obesity and the metabolic syndrome	SCIENCE			English	Article							ADIPOSE-TISSUE; FAT DISTRIBUTION; MICE; EXPRESSION; LEPTIN; BODY; GLUCOCORTICOIDS; TROGLITAZONE; ADIPOCYTES; SYSTEM	The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral, obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11 beta hydroxysteroid dehydrogenase type 1 (11 beta HSD-1). We created transgenic mice overexpressing 11 beta HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11 beta HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Edinburgh, Mol Med Ctr, Endocrinol Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Mol Physiol Lab, Edinburgh EH8 9AG, Midlothian, Scotland	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Edinburgh; University of Edinburgh	Flier, JS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.		Morton, NICHOLAS/ABF-3774-2020; Seckl, Jonathan R/C-3555-2013; Flier, jeffrey/AAG-6223-2019					Abbott BD, 1999, TOXICOL SCI, V47, P76, DOI 10.1093/toxsci/47.1.76; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Kawai T, 1999, METABOLISM, V48, P1102, DOI 10.1016/S0026-0495(99)90122-1; KISSEBAH AH, 1989, DIABETES METAB REV, V5, P83, DOI 10.1002/dmr.5610050202; Kobayashi J, 1999, BRIT J CLIN PHARMACO, V47, P433, DOI 10.1046/j.1365-2125.1999.00920.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; RAHIMY MH, 1989, J STEROID BIOCHEM, V33, P179, DOI 10.1016/0022-4731(89)90292-6; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rooman R, 1999, J ENDOCRINOL, V163, P543, DOI 10.1677/joe.0.1630543; ROSMOND R, 1998, J CLIN ENDOCR METAB, V83, P1806; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR183, DOI 10.1152/ajpregu.1995.268.1.R183; Szymczak J, 1998, STEROIDS, V63, P319, DOI 10.1016/S0039-128X(98)00019-1; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	34	1420	1550	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2166	2170		10.1126/science.1066285	http://dx.doi.org/10.1126/science.1066285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739957				2022-12-24	WOS:000172647700051
J	Kamal, A; Almenar-Queralt, A; LeBlanc, JF; Roberts, EA; Goldstein, LSB				Kamal, A; Almenar-Queralt, A; LeBlanc, JF; Roberts, EA; Goldstein, LSB			Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; SUBCELLULAR-LOCALIZATION; MICE LACKING; CLEAVAGE; DEFICITS; RELEASE; POOL	Proteolytic processing of amyloid precursor protein (APP) generates amyloid-beta peptide and has been implicated in the pathogenesis of Alzheimer's disease(1). However, the normal function of APP, whether this function is related to the proteolytic processing of APP, and where this processing takes place in neurons in vivo remain unknown. We have previously shown that the axonal transport of APP in neurons is mediated by the direct binding of APP to the kinesin light chain subunit of kinesin-I, a microtubule motor protein(2). Here we identify an axonal membrane compartment that contains APP, beta -secretase and presenilin-1. The fast anterograde axonal transport of this compartment is mediated by APP and kinesin-I. Proteolytic processing of APP can occur in the compartment in vitro and in vivo in axons. This proteolysis generates amyloid-beta and a carboxy-terminal fragment of APP, and liberates kinesin-I from the membrane. These results suggest that APP functions as a kinesin-I membrane receptor, mediating the axonal transport of beta -secretase and presenilin-1, and that processing of APP to amyloid-beta by secretases can occur in an axonal membrane compartment transported by kinesin-I.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Ciphergen Biosyst Inc, Fremont, CA 94555 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu						Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; KOO EH, 1994, J BIOL CHEM, V269, P17386; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; POTEMPSKA A, 1991, J BIOL CHEM, V266, P8464; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2000, P NATL ACAD SCI USA, V97, P5690, DOI 10.1073/pnas.97.11.5690; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	30	473	499	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					643	648		10.1038/414643a	http://dx.doi.org/10.1038/414643a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740561				2022-12-24	WOS:000172535600049
J	Assefa, F; Jabarkhil, MZ; Salama, P; Spiegel, P				Assefa, F; Jabarkhil, MZ; Salama, P; Spiegel, P			Malnutrition and mortality in Kohistan dstrict, Afghanistan, April 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The humanitarian situation in Afghanistan has been deteriorating for more than 3 years because of civil war and severe drought. Because of recent events, the international community is predicting a severe worsening of the country's current situation. Objective To assess the magnitude and causes of mortality and prevalence of malnutrition in Kohistan district, Faryab province, Afghanistan. Design Two-stage, 30-cluster household survey conducted April 4 through 10, 2001, which included anthropometric measurements, assessment of food coping mechanisms, and retrospective mortality data collection for November 26, 2000, through April 4, 2001. Setting and Participants A total of 378 households comprising 3165 people living in Kohistan district, Faryab province, Afghanistan. Main Outcome Measures Crude mortality rate, mortality rate among children younger than 5 years, causes of death, prevalence of wasting and stunting among children aged 6 to 59 months (weight-for-height and height-for-age z scores <-2, respectively), and food coping mechanisms. Results The crude mortality rate among the 3165 persons surveyed during the period of interest was 2.6 (95% confidence interval [CI], 1.7-3.5) per 10000 per day and the mortality rate among 763 children younger than 5 years was 5.9 (95% CI, 2.0-8.8) per 10000 per day, Diarrhea (25.0%), respiratory tract infections (19.4%), measles (15.7%), and scurvy (6.5%) caused most of the 108 deaths. The prevalences of wasting and stunting among 708 children aged 6 to 59 months were 7.0% (95% CI, 5.9%-9.0%) and 63.7% (95% CI, 58.6%-68.8%), respectively. Evidence of late-stage food coping mechanisms and prefamine indicators existed among the population. Conclusions These data indicate that, by April 2001, a humanitarian crisis already existed in Kohistan. Essential humanitarian services, including food aid and public health programs, are urgently required in such regions of Afghanistan and will be crucial if a worsening humanitarian crisis is to be avoided. For these services and programs to be implemented, the international community needs to create adequate humanitarian space (ie, a secure and accessible location where humanitarian organizations can provide services to emergency-affected populations) to ensure that humanitarian organizations have access to populations within Afghanistan as well as to refugees who flee to surrounding countries.	Save Children USA, Washington, DC 20036 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA USA	Save the Children; Centers for Disease Control & Prevention - USA	Assefa, F (corresponding author), Save Children USA, 2000 M St NW,Suite 500, Washington, DC 20036 USA.	fassefa1@dc.savechildren.org						*ACT CONTR FAIM, 2000, NUTR SURV MAZ SHER A; *AFGH SAV CHILDR U, 2001, RAP ASS IMP DROUGHT; Ahmed K, 2001, LANCET, V358, P815, DOI 10.1016/S0140-6736(01)06011-1; ASSEFA F, 2001, NUTR SURVEY REPORT K; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; LITTLE RL, 2001, LANCET, V357, P1421; Mason JB, 1984, NUTR SURVEILLANCE; *MED SANS FRONT, 2000, NUTR SURV FAR PROV A; Ronald C, 1999, BMJ, V318; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *STEER COMM HUM RE, 1998, SPHER PROJ HUM CHART; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; *UN SUBC NUTR, 2001, REP NUTR SIT REF DIS; United Nations Children's Fund, 2001, STAT WORLDS CHILDR; United Nations High Commissioner for Refugees, 2000, STAT WORLDS REF 2000; World Health Organization, 1999, WHO REC SURV STAND	19	50	50	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2723	2728		10.1001/jama.286.21.2723	http://dx.doi.org/10.1001/jama.286.21.2723			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730450				2022-12-24	WOS:000172488300034
J	Blackshaw, S; Fraioli, RE; Furukawa, T; Cepko, CL				Blackshaw, S; Fraioli, RE; Furukawa, T; Cepko, CL			Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes	CELL			English	Article							RETINITIS-PIGMENTOSA; NONSENSE MUTATION; DROSOPHILA EYE; HOMEOBOX GENE; CRX; DEGENERATION; PHOSPHODIESTERASE; DIFFERENTIATION; PATTERN; PROTEIN	To identify the full set of genes expressed by mammalian rods, we conducted serial analysis of gene expression (SAGE) by using libraries generated from mature and developing mouse retina. We identified 264 uncharacterized genes that were specific to or highly enriched in rods. Nearly half of all cloned human retinal disease genes are selectively expressed in rod photoreceptors. In silico mapping of the human orthologs of genes identified in our screen revealed that 86 map within intervals containing uncloned retinal disease genes, representing 37 different loci. We expect these data will allow identification of many disease genes, and that this approach may be useful for cloning genes involved in classes of disease where cell type-specific expression of disease genes is observed.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	cepko@rascal.med.harvard.edu			NEI NIH HHS [EY0976] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; Begemann G, 1997, DEVELOPMENT, V124, P4321; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Carmody RJ, 1999, EXP CELL RES, V248, P520, DOI 10.1006/excr.1998.4421; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Clarke G, 2000, CLIN GENET, V57, P313, DOI 10.1034/j.1399-0004.2000.570501.x; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Lu CW, 1999, J NEUROSCI, V19, P7317, DOI 10.1523/JNEUROSCI.19-17-07317.1999; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Specht S, 1999, PHOTOCHEM PHOTOBIOL, V69, P91, DOI 10.1111/j.1751-1097.1999.tb05311.x; St Croix B, 2000, SCIENCE, V289, P1197; Steel KP, 2000, NAT GENET, V24, P104, DOI 10.1038/72737; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; Zack DJ, 1999, MOL VIS, V5, pU37; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	41	254	259	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					579	589		10.1016/S0092-8674(01)00574-8	http://dx.doi.org/10.1016/S0092-8674(01)00574-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733058	Bronze			2022-12-24	WOS:000172575300006
J	Trusolino, L; Bertotti, A; Comoglio, PM				Trusolino, L; Bertotti, A; Comoglio, PM			A signaling adapter function for alpha 6 beta 4 integrin in the control of HGF-dependent invasive growth	CELL			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; TYROSINE KINASE; C-MET; CARCINOMA-CELLS; SCATTER FACTOR; ALPHA(6)BETA(4) INTEGRIN; SOMATIC MUTATIONS; FACTOR-RECEPTOR; DOCKING SITE; MAP KINASE	alpha6 beta4 integrin and the Met receptor for HGF have been shown independently to promote invasive growth. We demonstrate here that Met selectively associates with alpha6 beta4. In carcinoma cells expressing Met alone, HGF does not exert significant biological effects. Ectopic expression of alpha6 beta4 restores HGF-regulated processes. Following Met activation, alpha6 beta4 is tyrosine phosphorylated and combines with Shc and PI3K, generating an additional signaling platform that potentiates HGF-triggered activation of Ras- and PI3K-dependent pathways. In the presence of an alpha6 beta4 mutant defective for Shc recruitment, Met cannot sustain HGF-mediated responses. Surprisingly, a truncated beta4 unable to bind laminins retains the activity of wild-type alpha6 beta4. Such findings invoke an unexpected role for alpha6 beta4 in cancer invasion as a functional amplifier of biochemical outputs rather than a mechanical adhesive device.	Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC, I-10060 Turin, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Trusolino, L (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC, I-10060 Turin, Italy.	ltrusolino@ircc.unito.it	Trusolino, Livio/A-3896-2011; Comoglio, Paolo/G-6323-2011	Comoglio, Paolo/0000-0002-7056-5328; Trusolino, Livio/0000-0002-6379-3365; Bertotti, Andrea/0000-0001-8196-7608				Adelsman MA, 1999, MOL BIOL CELL, V10, P2861, DOI 10.1091/mbc.10.9.2861; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bardelli A, 1999, ONCOGENE, V18, P1139, DOI 10.1038/sj.onc.1202607; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CANTLEY LC, 1994, J CELL SCI, P121; Chao C, 1996, CANCER RES, V56, P4811; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LONGATI P, 1994, ONCOGENE, V9, P49; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; Michieli P, 1999, ONCOGENE, V18, P5221, DOI 10.1038/sj.onc.1202899; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, ONCOGENE, V6, P501; Nievers MG, 1998, J CELL SCI, V111, P1659; PELLEGRINI G, 1992, J CLIN INVEST, V89, P1783, DOI 10.1172/JCI115782; PONZETTO C, 1991, ONCOGENE, V6, P553; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Prat M, 1998, J CELL SCI, V111, P237; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; SONNENBERG A, 1993, J CELL SCI, V106, P1083; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Vigna E, 1999, ONCOGENE, V18, P4275, DOI 10.1038/sj.onc.1202791; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; WEIDNER KM, 1995, P NATL ACAD SCI USA, V92, P2597, DOI 10.1073/pnas.92.7.2597; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	49	350	379	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					643	654		10.1016/S0092-8674(01)00567-0	http://dx.doi.org/10.1016/S0092-8674(01)00567-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733063	Bronze			2022-12-24	WOS:000172575300011
J	Voznesenskaya, EV; Franceschi, VR; Kiirats, O; Freitag, H; Edwards, GE				Voznesenskaya, EV; Franceschi, VR; Kiirats, O; Freitag, H; Edwards, GE			Kranz anatomy is not essential for terrestrial C-4 plant photosynthesis	NATURE			English	Article							MALIC ENZYME; CHENOPODIACEAE; COTYLEDONS; EXPANSION; LEAVES; GENUS; CO2	An important adaptation to CO2-limited photosynthesis in cyanobacteria, algae and some plants was development of CO2-concentrating mechanisms (CCM)(1). Evolution of a CCM occurred many times in flowering plants, beginning at least 15-20 million years ago, in response to atmospheric CO2 reduction, climate change, geological trends, and evolutionary diversification of species(2). In plants, this is achieved through a biochemical inorganic carbon pump called C-4 photosynthesis, discovered 35 years ago(3). C4 photosynthesis is advantageous when limitations on carbon acquisition are imposed by high temperature, drought and saline conditions. It has been thought that a specialized leaf anatomy, composed of two, distinctive photosynthetic cell types (Kranz anatomy), is required for C-4 photosynthesis(4). We provide evidence that C-4 photosynthesis can function within a single photosynthetic cell in terrestrial plants. Borszczowia aralocaspica (Chenopodiaceae) has the photosynthetic features of C-4 plants, yet lacks Kranz anatomy. This species accomplishes C-4 photosynthesis through spatial compartmentation of photosynthetic enzymes, and by separation of two types of chloroplasts and other organelles in distinct positions within the chlorenchyma cell cytoplasm.	Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Russian Acad Sci, VL Komarov Bot Inst, Lab Anat & Morphol, St Petersburg 197376, Russia; Univ Gesamthsch Kassel, D-34109 Kassel, Germany	Washington State University; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Edwards, GE (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	edwardsg@wsu.edu	Voznesenskaya, Elena/H-9098-2013	Voznesenskaya, Elena/0000-0002-5919-3340				Akhani H, 1997, PLANT SYST EVOL, V206, P187, DOI 10.1007/BF00987948; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; CAROLIN RC, 1973, BOT J LINN SOC, V66, P259, DOI 10.1111/j.1095-8339.1973.tb02174.x; CERLING TE, 1994, NATURE, V371, P112, DOI 10.1038/371112a0; Dai ZY, 1996, PLANTA, V198, P563, DOI 10.1007/BF00262643; Edwards G., 1983, C3 C4 MECH CELLULAR; Edwards GE, 2001, PLANT PHYSIOL, V125, P46, DOI 10.1104/pp.125.1.46; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; Freitag H, 2000, PLANT BIOLOGY, V2, P154, DOI 10.1055/s-2000-9462; HATCH M. D., 1971, Photosynthesis and photorespiration, P139; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LONG JJ, 1994, J BIOL CHEM, V269, P2827; Maroco JP, 2000, PLANT CELL ENVIRON, V23, P115, DOI 10.1046/j.1365-3040.2000.00531.x; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; Maurino VG, 1996, BIOCHEM MOL BIOL INT, V38, P239; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Pyankov VI, 2000, PHOTOSYNTH RES, V63, P69, DOI 10.1023/A:1006377708156; Sage RF, 2001, PLANT BIOLOGY, V3, P202, DOI 10.1055/s-2001-15206; Sage RF, 1999, C4 PLANT BIOL; Sheehy J.E., 2000, CROP SCI, DOI DOI 10.2135/CROPSCI2002.2227; VOZNESENSKAYA E V, 1986, Botanicheskii Zhurnal (St. Petersburg), V71, P1291; Voznesenskaya EV, 1999, J EXP BOT, V50, P1779, DOI 10.1093/jexbot/50.341.1779; Voznesenskaya EV, 2001, ANN BOT-LONDON, V88, P337, DOI 10.1006/anbo.2001.1457; Winter K, 1996, CRASSULACEAN ACID ME	26	216	248	6	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					543	546		10.1038/35107073	http://dx.doi.org/10.1038/35107073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734854				2022-12-24	WOS:000172405900047
J	Stoll, M; Cowley, AW; Tonellato, PJ; Greene, AS; Kaldunski, ML; Roman, RJ; Dumas, P; Schork, NJ; Wang, ZT; Jacob, HJ				Stoll, M; Cowley, AW; Tonellato, PJ; Greene, AS; Kaldunski, ML; Roman, RJ; Dumas, P; Schork, NJ; Wang, ZT; Jacob, HJ			A genomic-systems biology map for cardiovascular function	SCIENCE			English	Article							GENETIC SUSCEPTIBILITY; ESSENTIAL-HYPERTENSION; LINKAGE; LOCI; SENSITIVITY	With the draft sequence of the human genome available, there is a need to better define gene function in the context of systems biology. We studied 239 cardiovascular and renal phenotypes in 113 mate rats derived from an F-2 intercross and mapped 81 of these traits onto the genome. Aggregates of traits were identified on chromosomes 1, 2, 7, and 18. Systems biology was assessed by examining patterns of correlations ("physiological profiles") that can be used for gene hunting, mechanism-based physiological studies, and, with comparative genomics, translating these data to the human genome.	Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Med Coll Wisconsin, Bioinformat Res Ctr, Milwaukee, WI 53226 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Medical College of Wisconsin; Medical College of Wisconsin; Case Western Reserve University; Medical College of Wisconsin; Jackson Laboratory; Harvard University; Harvard T.H. Chan School of Public Health	Jacob, HJ (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Greene, Andrew S/B-9696-2015	Schork, Nicholas/0000-0003-0920-5013; Greene, Andrew/0000-0002-3191-2112	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541, R37HL036279, P50HL054998] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL036279, R01 HL064541, 1P50-HL-54998] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bleecker ER, 1997, AM J RESP CRIT CARE, V156, pS113, DOI 10.1164/ajrccm.156.4.12tac7; Cowley AW, 2000, PHYSIOL GENOMICS, V2, P107, DOI 10.1152/physiolgenomics.2000.2.3.107; GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOLLENBERG NK, 1978, MEDICINE, V57, P167, DOI 10.1097/00005792-197803000-00004; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; MINER LL, 1995, PSYCHOPHARMACOLOGY, V117, P62, DOI 10.1007/BF02245099; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Thumma BR, 2001, J EXP BOT, V52, P203, DOI 10.1093/jexbot/52.355.203; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560	16	141	150	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1723	1726		10.1126/science.1062117	http://dx.doi.org/10.1126/science.1062117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721057				2022-12-24	WOS:000172307400046
J	Zhou, XZ; Lu, KP				Zhou, XZ; Lu, KP			The Pin2/TRF1-interacting: Protein PinX1 is a potent telomerase inhibitor	CELL			English	Article							PUTATIVE TUMOR-SUPPRESSOR; IMMORTAL HUMAN-CELLS; CATALYTIC SUBUNIT; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; FISSION YEAST; LIFE-SPAN; GENE; LENGTH; RNA	Telomerase activity is critical for normal and transformed human cells to escape from crisis and is implicated in oncogenesis. Here we describe a novel Pin2/TRF1 binding protein, PinX1 that inhibits telomerase activity and affects tumorigenicity. PinX1 and its small TID domain bind the telomerase catalytic subunit hTERT and potently inhibit its activity. Overexpression of PinX1 or its TID domain inhibits telomerase activity, shortens telomeres, and induces crisis:, whereas depletion of endogenous PinX1 increases telomerase activity and elongates telomeres. Depletion of PinX1 also increases tumorigenicity in nude mice, consistent with its chromosome localization at 8p23, a region with frequent loss of heterozygosity in a number of human cancers. Thus, PinX1 is a potent telomerase inhibitor and a putative tumor suppressor.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lu, KP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, 330 Brookline Ave,HIM 1047, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056230, R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017870] Funding Source: NIH RePORTER; NIA NIH HHS [AG17870] Funding Source: Medline; NIGMS NIH HHS [GM58556, GM56230] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Baffa R, 2000, CLIN CANCER RES, V6, P1372; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bockmuhl U, 2001, OTOLARYNG HEAD NECK, V124, P451, DOI 10.1067/mhn.2001.114794; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EMI M, 1992, CANCER RES, V52, P5368; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gustafson CE, 1996, CANCER RES, V56, P5238; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Ishwad CS, 1999, INT J CANCER, V80, P25, DOI 10.1002/(SICI)1097-0215(19990105)80:1<25::AID-IJC6>3.3.CO;2-7; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lu KP, 1996, NATURE, V380, P544; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Muscheck M, 2000, LAB INVEST, V80, P1089, DOI 10.1038/labinvest.3780114; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nosaka K, 1998, BIOCHEM BIOPH RES CO, V243, P342, DOI 10.1006/bbrc.1997.8097; Perinchery G, 1999, INT J ONCOL, V14, P495; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Sun PC, 1999, GENOMICS, V62, P184, DOI 10.1006/geno.1999.6020; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Young AC, 1997, SOMAT CELL MOLEC GEN, V23, P275, DOI 10.1007/BF02674418; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	71	253	282	2	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					347	359		10.1016/S0092-8674(01)00538-4	http://dx.doi.org/10.1016/S0092-8674(01)00538-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701125	Bronze			2022-12-24	WOS:000172022800006
J	Berneche, S; Roux, B				Berneche, S; Roux, B			Energetics of ion conduction through the K+ channel	NATURE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS; POTASSIUM CHANNEL; SIMULATIONS; PERMEATION; KCSA; SELECTIVITY; MECHANISM; BILAYER; WATER	K+ channels are transmembrane proteins that are essential for the transmission of nerve impulses. The ability of these proteins to conduct K+ ions at levels near the limit of diffusion is traditionally described in terms of concerted mechanisms in which ion-channel attraction and ion-ion repulsion have compensating effects, as several ions are moving simultaneously in single file through the narrow pore(1-4). The efficiency of such a mechanism, however, relies on a delicate energy balance-the strong ion-channel attraction must be perfectly counterbalanced by the electrostatic ion-ion repulsion. To elucidate the mechanism of ion conduction at the atomic level, we performed molecular dynamics free energy simulations on the basis of the X-ray structure of the KcsA K+ channel(4). Here we rnd that ion conduction involves transitions between two main states, with two and three K+ ions occupying the selectivity filter, respectively; this process is reminiscent of the 'knock-on' mechanism proposed by Hodgkin and Keynes in 1955(1). The largest free energy barrier is on the order of 2-3 kcal mol(-1), implying that the process of ion conduction is limited by diffusion. Ion-ion repulsion, although essential for rapid conduction, is shown to act only at very short distances. The calculations show also that the rapidly conducting pore is selective.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada	Cornell University; Universite de Montreal	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	benoit.roux@med.cornell.edu	Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; ARMSTRON.CM, 1968, NATURE, V219, P1262, DOI 10.1038/2191262a0; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Crouzy S, 2001, J GEN PHYSIOL, V118, P207, DOI 10.1085/jgp.118.2.207; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1962, Biophys J, V2, P259; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Roux B, 1999, BIOPHYS J, V77, P139, DOI 10.1016/S0006-3495(99)76878-5; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schlenkrich Michael, 1996, P31; SCHUMAKER MF, 1990, BIOPHYS J, V58, P975, DOI 10.1016/S0006-3495(90)82442-5; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8	30	623	634	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					73	77		10.1038/35102067	http://dx.doi.org/10.1038/35102067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689945				2022-12-24	WOS:000171898900044
J	Salehi-Ashtiani, K; Szostak, JW				Salehi-Ashtiani, K; Szostak, JW			In vitro evolution suggests multiple origins for the hammerhead ribozyme	NATURE			English	Article							HEPATITIS-DELTA-VIRUS; RNA; TRANSCRIPTS	The hammerhead ribozyme was originally discovered in a group of RNAs associated with plant viruses, and has subsequently been identified in the genome of the newt (Notophthalamus viridescens)(1,2), in schistosomes(3) and in cave crickets (Dolichopoda species)(4). The sporadic occurrence of this self-cleaving RNA motif in highly divergent organisms could be a consequence of the very early evolution of the hammerhead ribozyme(4,5), with all extant examples being descended from a single ancestral progenitor. Alternatively, the hammerhead ribozyme may have evolved independently many times. To better understand the observed distribution of hammerhead ribozymes, we used in vitro selection to search an unbiased sample of random sequences for comparably active self-cleaving motifs. Here we show that, under near-physiological conditions, the hammerhead ribozyme motif is the most common (and thus the simplest) RNA structure capable of self-cleavage at biologically observed rates. Our results suggest that the evolutionary process may have been channelled, in nature as in the laboratory, towards repeated selection of the simplest solution to a biochemical problem.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.			Salehi-Ashtiani, Kourosh/0000-0002-6521-5243				BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; BEEN MD, 1994, TRENDS BIOCHEM SCI, V19, P251, DOI 10.1016/0968-0004(94)90151-1; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOULD SJ, 1989, WONDERFUL LIFE BURGE, P292; HAMPEL N, 1998, PROGR NUCL ACIDS RES, P1; LONG DM, 1993, FASEB J, V7, P25, DOI 10.1096/fasebj.7.1.8422971; PABONPENA LM, 1991, MOL CELL BIOL, V11, P6109, DOI 10.1128/MCB.11.12.6109; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; THOMSON JB, 1997, CATALYTIC RNA, P173; WILLS G, 1995, LEARNING ORG, V2, P14; Zhang Y, 1996, GENE, V172, P183, DOI 10.1016/0378-1119(96)00126-6	16	129	143	2	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					82	84		10.1038/35102081	http://dx.doi.org/10.1038/35102081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689947				2022-12-24	WOS:000171898900046
J	Ala'Aldeen, D				Ala'Aldeen, D			Risk of deliberately induced anthrax outbreak	LANCET			English	Editorial Material									Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol, Mol Bacteriol & Immunol Grp, Nottingham NG7 2UH, England	University of Nottingham	Ala'Aldeen, D (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol, Mol Bacteriol & Immunol Grp, Nottingham NG7 2UH, England.							BERKELY RCW, 1997, PRINCIPLES PRACTICE, P184; Dalton R, 2001, NATURE, V413, P657, DOI 10.1038/35099687; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; *US C, 1993, PROL WEAP MASS DESTR, P53; WHO Group of Consultants, 1970, HLTH ASP CHEM BIOL W, P98	5	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1386	1388		10.1016/S0140-6736(01)06492-3	http://dx.doi.org/10.1016/S0140-6736(01)06492-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705480				2022-12-24	WOS:000171940100006
J	Larsen, PL; Clarke, CF				Larsen, PL; Clarke, CF			Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q	SCIENCE			English	Article							C-ELEGANS; INTERMEDIARY METABOLISM; DAUER LARVA; LONGEVITY; DIAPAUSE; MUTANT; DAF-2; GENES; CYCLE	The isoprenylated benzoquinone coenzyme Q is a redox-active lipid essential for electron transport in aerobic respiration. Here, we show that withdrawal of coenzyme Q (Q) from the diet of wild-type nematodes extends adult life-span by similar to 60%. The longevity of clk-1, daf-2, daf-12, and daf-16 mutants is also extended by a Q-less diet. These results establish the importance of Q in life-span determination. The findings suggest that Q and the daf-2 pathway intersect at the mitochondria and imply that a concerted production coupled with enhanced scavenging of reactive oxygen species contributes to the substantial life-span extension.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Larsen, PL (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 951569, Los Angeles, CA 90095 USA.							Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAGAN IVE, 2000, COENZYME Q MOL MECH; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2001, NAT GENET, V28, P102, DOI 10.1038/88797; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	24	199	214	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					120	123		10.1126/science.1064653	http://dx.doi.org/10.1126/science.1064653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778046				2022-12-24	WOS:000173143100047
J	Moine, H; Mandel, JL				Moine, H; Mandel, JL			Biomedicine - Do G quartets orchestrate fragile X pathology?	SCIENCE			English	Editorial Material									CNRS, UPR 9002, F-67084 Strasbourg, France; Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moine, H (corresponding author), CNRS, UPR 9002, F-67084 Strasbourg, France.		Moine, Herve/Q-2328-2016; Mandel, Jean Louis/Q-2668-2016	Moine, Herve/0000-0002-6250-7902; Mandel, Jean Louis/0000-0002-0535-6589				ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bardoni B, 2000, AM J MED GENET, V97, P153, DOI 10.1002/1096-8628(200022)97:2<153::AID-AJMG7>3.0.CO;2-M; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Deng JP, 2001, P NATL ACAD SCI USA, V98, P13665, DOI 10.1073/pnas.241374798; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Kooy RF, 2000, MOL MED TODAY, V6, P193, DOI 10.1016/S1357-4310(00)01674-9; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	13	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2487	2488		10.1126/science.1068352	http://dx.doi.org/10.1126/science.1068352			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752559				2022-12-24	WOS:000172927700035
J	Averhoff, F; Shapiro, CN; Bell, BP; Hyams, I; Burd, L; Deladisma, A; Simard, EP; Nalin, D; Kuter, B; Ward, C; Lundberg, M; Smith, N; Margolis, HS				Averhoff, F; Shapiro, CN; Bell, BP; Hyams, I; Burd, L; Deladisma, A; Simard, EP; Nalin, D; Kuter, B; Ward, C; Lundberg, M; Smith, N; Margolis, HS			Control of hepatitis A through routine vaccination of children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-WIDE OUTBREAK; TRANSMISSION; INFECTION	Context The impact of routine hepatitis A vaccination of children living in large communities with elevated disease rates has not been evaluated. Objective To determine the effect of routine vaccination of children on disease incidence in a community with recurrent hepatitis A epidemics. Design, Setting, and Participants Community-based demonstration project conducted from January 12, 1995, through December 31, 2000, in Butte County, California, among children aged 2 to 17 years. Intervention In 1995, vaccination was offered to children aged 2 to 12 years during vaccination clinics conducted on 2 occasions 6 to 12 months apart at most schools in the county. In 1996-2000, vaccine was distributed to community health care clinicians, who vaccinated eligible children without charge. Vaccine was also available at health department clinics, selected child care centers, and other sites. Main Outcome Measures Hepatitis A vaccination coverage, hepatitis A incidence, and vaccine effectiveness. Results During the study period, 29789 (66.2%) of an estimated 44982 eligible children received at least 1 vaccine dose; 17681 (89.3%) received a second dose. The number of hepatitis A cases among the entire county population declined 93.5% during the study period, from 57 cases in 1995 to 4 in 2000, the lowest number of cases reported in the county since hepatitis A surveillance began in 1966. The 2000 incidence rate of 1.9 per 100000 population was the lowest of any county in the state. Of the 245 cases reported during the 6-year period, 40 (16.3%) occurred among children 17 years of age or younger, of which 16 (40%) occurred in 1995 and only 1 in 2000. One of the 27 case patients eligible for vaccination had been vaccinated, having received the first dose 3 days before symptom onset. The estimated protective vaccine efficacy was 98% (95% confidence interval, 86%-100%). Conclusions In this population, hepatitis A vaccine was highly effective in preventing disease among recipients. Childhood vaccination appears to have decreased hepatitis A incidence among children and adults and controlled the disease in a community with recurrent epidemics.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Butte Cty Dept Publ Hlth, Oroville, CA USA; Calif Dept Hlth Serv, Immunizat Branch, Berkeley, CA 94704 USA; Merck Vaccine Div, West Point, PA USA; Merck Res Labs, West Point, PA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Health Care Services; Merck & Company; Merck & Company	Bell, BP (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G-37,1600 Clifton Rd, Atlanta, GA 30333 USA.		Simard, Edgar/G-4552-2010	Simard, Edgar/0000-0001-8093-2067				*AL DEP HLTH SOC S, 1993, STAT AL EP B, V18; ANDRE FE, 1992, VACCINE, V10, pS160, DOI 10.1016/0264-410X(92)90576-6; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; *CDCP, 1996, HEP SURV, P16; *CDCP, 1987, HEPATITIS SURVEILLAN, V51, P6; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P1; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P600; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; GILDON B, 1992, SOUTHERN MED J, V85, P9, DOI 10.1097/00007611-199201000-00004; GRECO D, 1986, INT J EPIDEMIOL, V15, P108, DOI 10.1093/ije/15.1.108; INNIS BL, 1994, JAMA-J AM MED ASSOC, V271, P1328, DOI 10.1001/jama.271.17.1328; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; MAJEED FA, 1992, EPIDEMIOL INFECT, V109, P167; MANN JM, 1982, PUBLIC HEALTH REP, V97, P516; McMahon BJ, 1996, ARCH PEDIAT ADOL MED, V150, P733, DOI 10.1001/archpedi.1996.02170320079014; NALIN DR, 1993, J HEPATOL, V18, pS51, DOI 10.1016/S0168-8278(05)80379-4; PAVIA AT, 1990, AM J EPIDEMIOL, V131, P1085, DOI 10.1093/oxfordjournals.aje.a115601; SAGLIOCCA L, 1988, EUR J EPIDEMIOL, V4, P470, DOI 10.1007/BF00146400; SHAW FE, 1986, AM J EPIDEMIOL, V123, P1057, DOI 10.1093/oxfordjournals.aje.a114334; SHAW FE, 1990, AM J PUBLIC HEALTH, V80, P1091, DOI 10.2105/AJPH.80.9.1091; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; VANBENEDEN C, 1998, INT C EM INF DIS M M; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; YANG NY, 1988, AM J EPIDEMIOL, V127, P599	25	97	101	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					2968	2973		10.1001/jama.286.23.2968	http://dx.doi.org/10.1001/jama.286.23.2968			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502VY	11743837	Bronze			2022-12-24	WOS:000172764500028
J	van Lommel, P; van Wees, R; Meyers, V; Elfferich, I				van Lommel, P; van Wees, R; Meyers, V; Elfferich, I			Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands	LANCET			English	Article							SYNCOPE	Background Some people report a near-death experience (NDE) after a life-threatening crisis. We aimed to establish the cause of this experience and assess factors that affected its frequency, depth, and content. Methods In a prospective study, we included 344 consecutive cardiac patients who were successfully resuscitated after cardiac arrest in ten Dutch hospitals. We compared demographic, medical, pharmacological, and psychological data between patients who reported NDE and patients who did not (controls) after resuscitation. In a longitudinal study of life changes after NDE, we compared the groups 2 and 8 years later. Findings 62 patients (18%) reported NDE, of whom 41 (12%) described a core experience. Occurrence of the experience was not associated with duration of cardiac arrest or unconsciousness, medication, or fear of death before cardiac arrest. Frequency of NDE was affected by how we defined NDE, the prospective nature of the research in older cardiac patients, age, surviving cardiac arrest in first myocardial infarction, more than one cardiopulmonary resuscitation (CPR) during stay in hospital, previous NDE, and memory problems after prolonged CPR. Depth of the experience was affected by sex, surviving CPR outside hospital, and fear before cardiac arrest. Significantly more patients who had an NDE, especially a deep experience, died within 30 days of CPR (p<0.0001). The process of transformation after NDE took several years, and differed from those of patients who survived cardiac arrest without NDE. Interpretation We do not know why so few cardiac patients report NDE after CPR, although age plays a part. With a purely physiological explanation such as cerebral anoxia for the experience, most patients who have been clinically dead should report one.	Hosp Rijnstate, Div Cardiol, NL-6800 TA Arnhem, Netherlands; Capelle AD, Ijssel, Netherlands	Rijnstate Hospital	van Lommel, P (corresponding author), Hosp Rijnstate, Div Cardiol, POB 9555, NL-6800 TA Arnhem, Netherlands.							AMINOFF MJ, 1988, ANN INTERN MED, V108, P791, DOI 10.7326/0003-4819-108-6-791; [Anonymous], 1998, MED PSYCHIAT, V1, P92; Appelby L., 1989, BMJ-BRIT MED J, V298, P976; Atwater P.M.H., 1988, COMING BACK LIFE AFT; Blackmore S., 1993, DYING LIVE SCI NEAR; CLUTE HL, 1990, ANESTHESIOLOGY, V73, P821, DOI 10.1097/00000542-199011000-00004; DICKEY W, 1992, BRIT HEART J, V67, P334; Greyson B, 2000, LANCET, V355, P460; GREYSON B, 1993, PSYCHIATRY, V56, P390; Greyson B, 1998, PERSPECT BIOL MED, V42, P14; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Grof S., 1977, HUMAN ENCOUNTER DEAT; Groth-Marnat G, 1998, J HUMANIST PSYCHOL, V38, P110, DOI 10.1177/00221678980383005; Jansen K. L. R, 1996, NEAR DEATH EXPERIENC, P265; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; MEDUNA LJ, 1950, CARBON DIOXIDE THERA; Morse M., 1996, NEAR DEATH EXPERIENC, P299; MORSE M, 1990, TRANSFORMED LIGHT; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Penfield W., 1958, EXCITABLE CORTEX CON; Ring K., 1984, HEADING OMEGA SEARCH; Ring K, 1980, LIFE DEATH SCI INVES; Ring K., 1999, MINDSIGHT NEAR DEATH; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; SABOM MB, 1988, LIGHT DEATH 1 DOCTOR, P37; SABORN M, 1982, RECOLLECTIONS DEATH; Schmied I, 1999, TODESNAHE INTERDISZI, P217; SCHOENBECK SB, 1991, J NEAR DEATH STUDIES, V9, P211; SCHROTERKUNHARD.M, 1999, TODESNAHE INTERDISZI, P65; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012	31	268	282	4	123	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2039	2045		10.1016/S0140-6736(01)07100-8	http://dx.doi.org/10.1016/S0140-6736(01)07100-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755611				2022-12-24	WOS:000172722800013
J	Balter, M				Balter, M			Archaeology - Did plaster hold neolithic society together?	SCIENCE			English	News Item																		ROBERTS N, 1998, SCIENCE         1120, P1442	1	3	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2278	+		10.1126/science.294.5550.2278	http://dx.doi.org/10.1126/science.294.5550.2278			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503TT	11743181				2022-12-24	WOS:000172817200017
J	Bouchard, MJ; Wang, LH; Schneider, RJ				Bouchard, MJ; Wang, LH; Schneider, RJ			Calcium signaling by HBx protein in hepatitis B virus DNA replication	SCIENCE			English	Article							X-PROTEIN; TYROSINE PHOSPHORYLATION; ION-CHANNEL; MITOCHONDRIA; ACTIVATION; KINASE; CELLS; PYK2; SRC; INFECTION	Hepatitis B virus (HBV) infects more than 300 million people and is a leading cause of liver cancer and disease. The HBV HBx: protein is essential for infection; HBx activation of Src is important for HBV DNA replication. In our study, HBx activated cytosolic calcium-dependent proline-rich tyrosine kinase-2 (Pyk2), a Src kinase activator. HBx activation of HBV DNA replication was blocked by inhibiting Pyk2 or calcium signaling mediated by mitochondrial calcium channels, which suggests that HBx targets mitochondrial calcium regulation. Reagents that increased cytosolic calcium substituted for HBx protein in HBV DNA replication. Thus, alteration of cytosolic calcium was a fundamental requirement for HBV replication and was mediated by HBx protein.	NYU, Dept Microbiol, New York, NY 10016 USA	New York University	Schneider, RJ (corresponding author), NYU, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.			Schneider, Robert/0000-0001-5807-5564	NCI NIH HHS [F32CA-4476, R0ICA-565633] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Baron KT, 1997, EUR J PHARMACOL, V340, P295, DOI 10.1016/S0014-2999(97)01433-7; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Ganem D, 2001, HEPADNAVIRIDAE VIRUS, P2923; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Henkler F, 2001, J GEN VIROL, V82, P871, DOI 10.1099/0022-1317-82-4-871; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; NATOLI G, 1994, ONCOGENE, V9, P2837; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Takada S, 1999, ONCOGENE, V18, P6965, DOI 10.1038/sj.onc.1203188; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Zhao JH, 2000, J CELL SCI, V113, P3063; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	29	305	330	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2376	2378		10.1126/science.294.5550.2376	http://dx.doi.org/10.1126/science.294.5550.2376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743208				2022-12-24	WOS:000172817200053
J	Tong, AHY; Evangelista, M; Parsons, AB; Xu, H; Bader, GD; Page, N; Robinson, M; Raghibizadeh, S; Hogue, CWV; Bussey, H; Andrews, B; Tyers, M; Boone, C				Tong, AHY; Evangelista, M; Parsons, AB; Xu, H; Bader, GD; Page, N; Robinson, M; Raghibizadeh, S; Hogue, CWV; Bussey, H; Andrews, B; Tyers, M; Boone, C			Systematic genetic analysis with ordered arrays of yeast deletion mutants	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SYNTHETIC LETHAL; BUDDING YEAST; MORPHOGENESIS; MUTATIONS; SCREEN	In Saccharomyces cerevisiae, more than 80% of the similar to 6200 predicted genes are nonessential, implying that the genome is buffered from the phenotypic consequences of genetic perturbation. To evaluate function, we developed a method for systematic construction of double mutants, termed synthetic genetic array (SGA) analysis, in which a query mutation is crossed to an array of similar to 4700 deletion mutants. Inviable double-mutant meiotic progeny identify functional relationships between genes. SGA analysis of genes with roles in cytoskeletal organization (BNI1, ARP2, ARC40, BIM1), DNA synthesis and repair (SGS1, RAD27), or uncharacterized functions (BBC1, NBP2) generated a network of 291 interactions among 204 genes. Systematic application of this approach should produce a global map of gene function.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Virtek Engn Sci Inc, Toronto, ON M5R 2J7, Canada	University of Toronto; University of Toronto; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University	Andrews, B (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.		Robinson, Mark D./O-2254-2019; Bader, Gary/C-1176-2009; Hogue, Christopher W V/AAZ-3934-2020; Robinson, Mark D/A-6432-2015; Tyers, Michael/ABE-3194-2021; Hogue, Christopher/B-6726-2008	Robinson, Mark D./0000-0002-3048-5518; Bader, Gary/0000-0003-0185-8861; Hogue, Christopher W V/0000-0002-3107-5246; Robinson, Mark D/0000-0002-3048-5518; 				Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Chen CY, 1998, GENETICS, V150, P577; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; EVANGELISTA M, IN PRESS NATURE CELL; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kroll ES, 1996, GENETICS, V143, P95; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; MAIOLATESI M, COMMUNICATION; MOCHIDA J, COMMUNICATION; Mullen JR, 2001, GENETICS, V157, P103; NOVICK P, 1989, GENETICS, V121, P659; OOI SL, COMMUNICATION; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; TONG AJ, UNPUB; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wang TT, 1997, GENETICS, V147, P1595; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	29	1554	1588	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2364	2368		10.1126/science.1065810	http://dx.doi.org/10.1126/science.1065810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743205				2022-12-24	WOS:000172817200050
J	Arlettaz, R; Jones, G; Racey, PA				Arlettaz, R; Jones, G; Racey, PA			Effect of acoustic clutter on prey detection by bats	NATURE			English	Article							SPECIES MYOTIS-MYOTIS; LONG-EARED BATS; ECHOLOCATION SIGNALS; FEEDING-BEHAVIOR; GLEANING BAT; DISCRIMINATION; MOTHS; STRATEGY	Bats that capture animal prey from substrates often emit characteristic echolocation calls that are short-duration, frequency-modulated (FM) and broadband(1). Such calls seem to be suited to locating prey in uncluttered habitats, including flying prey, but may be less effective for finding prey among cluttered backgrounds because echoes reflecting from the substrate mask the acoustic signature of prey(2-4). Perhaps these call designs serve primarily for spatial orientation(5-7). Furthermore, it has been unclear whether the acoustic image conveyed by FM echoes enables fine texture discrimination(3,8,9), or whether gleaning bats that forage in echo-cluttering environments must locate prey by using other cues, such as prey-generated sounds(5-7,10-13). Here we show that two species of insectivorous gleaning bats perform badly when compelled to detect silent and immobile prey in clutter, but are very efficient at capturing noisy prey items among highly cluttered backgrounds, and both dead or live prey in uncluttered habitats. These findings suggest that the short, broadband FM echolocation calls associated with gleaning bats are not adapted to detecting prey in clutter.	Univ Bern, Inst Zool, Div Conservat Biol, CH-3012 Bern, Switzerland; Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Bern; University of Lausanne; University of Bristol; University of Aberdeen	Arlettaz, R (corresponding author), Univ Bern, Inst Zool, Div Conservat Biol, Baltzerstr 6, CH-3012 Bern, Switzerland.	raphael.arlettaz@nat.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Jones, Gareth/0000-0002-1904-3735				ANDERSON ME, 1993, ANIM BEHAV, V46, P1151, DOI 10.1006/anbe.1993.1304; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; BRIGHAM RM, 1995, ECOSCIENCE, V2, P276, DOI 10.1080/11956860.1995.11682294; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; FAURE PA, 1994, J COMP PHYSIOL A, V174, P651; FAURE PA, 1992, ANIM BEHAV, V44, P31, DOI 10.1016/S0003-3472(05)80751-1; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; HABERSETZER J, 1983, J COMP PHYSIOL, V152, P275, DOI 10.1007/BF00611192; Jensen ME, 2001, J EXP BIOL, V204, P199; Johnston DS, 2001, J MAMMAL, V82, P362, DOI 10.1644/1545-1542(2001)082<0362:IAPLVI>2.0.CO;2; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Norman AP, 1999, ANIM BEHAV, V57, P829, DOI 10.1006/anbe.1998.1028; Schmidt S, 2000, J COMP PHYSIOL A, V186, P975, DOI 10.1007/s003590000151; SCHMIDT S, 1988, NATURE, V331, P617, DOI 10.1038/331617a0; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHUMM A, 1991, BEHAV ECOL SOCIOBIOL, V28, P255; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; SIMMONS JA, 1988, J ACOUST SOC AM, V84, P551, DOI 10.1121/1.396832; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE	26	152	158	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					742	745		10.1038/414742a	http://dx.doi.org/10.1038/414742a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742397				2022-12-24	WOS:000172676200045
J	Michel, T; Reichhart, JM; Hoffmann, JA; Royet, J				Michel, T; Reichhart, JM; Hoffmann, JA; Royet, J			Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein	NATURE			English	Article							HOST-DEFENSE; INNATE IMMUNITY; ANTIFUNGAL; INFECTION; RECEPTORS; GENE; TLR4	Microbial infection activates two distinct intracellular signalling cascades in the immune-responsive fat body of Drosophila(1,2). Gram-positive bacteria and fungi predominantly induce the Toll signalling pathway, whereas Gram-negative bacteria activate the Imd pathway(3,4). Loss-of-function mutants in either pathway reduce the resistance to corresponding infections(4,5). Genetic screens have identified a range of genes involved in these intracellular signalling cascades(6-12), but how they are activated by microbial infection is largely unknown. Activation of the transmembrane receptor Toll requires a proteolytically cleaved form of an extracellular cytokine-like polypeptide, Spatzle(13), suggesting that Toll does not itself function as a bona fide recognition receptor of microbial patterns. This is in apparent contrast with the mammalian Toll-like receptors(14) and raises the question of which host molecules actually recognize microbial patterns to activate Toll through Spatzle. Here we present a mutation that blocks Toll activation by Gram-positive bacteria and significantly decreases resistance to this type of infection. The mutation semmelweis (seml) inactivates the gene encoding a peptidoglycan recognition protein (PGRP-SA). Interestingly, seml does not affect Toll activation by fungal infection, indicating the existence of a distinct recognition system for fungi to activate the Toll pathway.	Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Royet, J (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			Michel, Tatiana/0000-0002-0146-9236				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; CELINE LF, 1999, SEMMELWEIS IMAGINAIR; Franc NC, 2000, MICROBES INFECT, V2, P243, DOI 10.1016/S1286-4579(00)00304-X; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JANEWAY CA, 1989, COLD SH Q B, V54, P1; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Turner M W, 2000, Rev Immunogenet, V2, P305; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	30	584	617	1	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					756	759		10.1038/414756a	http://dx.doi.org/10.1038/414756a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742401				2022-12-24	WOS:000172676200049
J	White, PD; Thomas, JM; Kangro, HO; Bruce-Jones, WDA; Amess, J; Crawford, DH; Grover, SA; Clare, AW				White, PD; Thomas, JM; Kangro, HO; Bruce-Jones, WDA; Amess, J; Crawford, DH; Grover, SA; Clare, AW			Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis	LANCET			English	Article							EPSTEIN-BARR-VIRUS; GLANDULAR FEVER; PSYCHIATRIC-DISORDERS; RISK-FACTORS; LIFE-EVENTS; SYMPTOMS; PERSONALITY; PERSISTENCE; RELIABILITY; DEPRESSION	Background Certain infections can trigger chronic fatigue syndromes (CFS) in a minority of people infected, but the reason is unknown. We describe some factors that predict or are associated with prolonged fatigue after infectious mononucleosis and contrast these factors with those that predicted mood disorders after the same infection. Methods We prospectively studied a cohort of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-tract infections until 6 months after clinical onset. We sought predictors of both acute and chronic fatigue syndromes and mood disorders from clinical, laboratory, and psychosocial measures. Findings An empirically defined fatigue syndrome 6 months after onset, which excluded comorbid psychiatric disorders, was most reliably predicted by a positive Monospot test at onset (odds ratio 2.1 [95% CI 1.4-3.3]) and lower physical fitness (0.35 [0.15-0.8]). Cervical lymphadenopathy and initial bed rest were associated with, or predicted, a fatigue syndrome up to 2 months after onset. By contrast, mood disorders were predicted by a premorbid psychiatric history (2.3 [1.4-3.9]), an emotional personality score (1.21 [1.11-1.35]), and social adversity (1.7 [1.0-2.9]). Definitions of CFS that included comorbid mood disorders were predicted by a mixture of those factors that predicted either the empirically defined fatigue syndrome or mood disorders. Interpretation The predictors of a prolonged fatigue syndrome after an infection differ with both definition and time, depending particularly on the presence or absence of comorbid mood disorders. The particular infection and its consequent immune reaction may have an early role, but physical deconditioning may also be important. By contrast, mood disorders are predicted by factors that predict mood disorders in general.	St Bartholomews & Royal London Sch Med & Dent, Dept Psychol Med, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Comp Sci, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Virol, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Haematol, London, England; Univ London St Georges Hosp, Sch Med, Dept Virol, London SW17 0RE, England; Univ Edinburgh, Dept Med Microbiol, Edinburgh, Midlothian, Scotland	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; St Georges University London; University of Edinburgh	White, PD (corresponding author), St Bartholomews Hosp, St Bartholomews & Royal London Sch Med, Dept Psychol Med, London EC1A 7BE, England.			White, Peter/0000-0002-8193-5355				Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; BERELOWITZ GJ, 1995, J VIRAL HEPATITIS, V2, P133, DOI 10.1111/j.1365-2893.1995.tb00018.x; Brown GW, 1989, LIFE EVENTS ILLNESS; BRUCEJONES WDA, 1994, PSYCHOL MED, V24, P651, DOI 10.1017/S003329170002780X; Buchwald DS, 2000, AM J MED, V109, P531, DOI 10.1016/S0002-9343(00)00560-X; Buckley L, 1999, J PSYCHOSOM RES, V46, P395, DOI 10.1016/S0022-3999(98)00120-2; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; CLARK MR, 1995, AM J MED, V98, P187, DOI 10.1016/S0002-9343(99)80403-3; COPE H, 1994, LANCET, V344, P864, DOI 10.1016/S0140-6736(94)92833-9; DALRYMPLE W, 1964, Postgrad Med, V35, P345; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; FLEISHER GR, 1983, J CLIN MICROBIOL, V17, P619, DOI 10.1128/JCM.17.4.619-624.1983; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 2000, J NEUROL NEUROSUR PS, V69, P302, DOI 10.1136/jnnp.69.3.302; Harvey V P, 1970, J Sports Med Phys Fitness, V10, P185; HENLE W, 1974, HUM PATHOL, V5, P551, DOI 10.1016/S0046-8177(74)80006-7; HOTOPF M, 1996, J NEUROL NEUROSUR PS, V60, P495; Katon W, 1999, GEN HOSP PSYCHIAT, V21, P21, DOI 10.1016/S0163-8343(98)00068-1; KENDELL RE, 1968, BRIT J PSYCHIAT, V114, P767, DOI 10.1192/bjp.114.511.767; LAMBORE S, 1991, J FAM PRACTICE, V33, P33; LEE CL, 1968, AM J CLIN PATHOL, V49, P12; Lloyd Andrew R., 1998, American Journal of Medicine, V105, p7S, DOI 10.1016/S0002-9343(98)00157-0; *OFF POP CONS SURV, 1980, CLASS OCC COD IND; PERKINS DO, 1994, AM J PSYCHIAT, V151, P233; Ray C, 1995, BRIT J MED PSYCHOL, V68, P323, DOI 10.1111/j.2044-8341.1995.tb01839.x; RILEY MS, 1990, BRIT MED J, V301, P953, DOI 10.1136/bmj.301.6758.953; *ROYAL COLL, 1996, CHRON FAT SYNDR REP, P1; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622; Theorell T, 1999, PSYCHOSOM MED, V61, P304, DOI 10.1097/00006842-199905000-00009; THOMPSON DS, 1969, J AMER COLL HEALTH A, V17, P453; van der Werf SP, 2000, J PSYCHOSOM RES, V49, P373, DOI 10.1016/S0022-3999(00)00197-5; van Os J, 2001, BRIT J PSYCHIAT, V178, pS72, DOI 10.1192/bjp.178.40.s72; Vercoulen JHMM, 1998, J PSYCHOSOM RES, V45, P507, DOI 10.1016/S0022-3999(98)00023-3; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; Wessely S, 1998, CHRONIC FATIGUE ITS; WHITE PD, 1995, PSYCHOL MED, V25, P917, DOI 10.1017/S0033291700037405; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; WHITE PD, 1994, PERS INDIV DIFFER, V16, P801, DOI 10.1016/0191-8869(94)90223-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	113	114	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2001	358	9297					1946	1954		10.1016/S0140-6736(01)06961-6	http://dx.doi.org/10.1016/S0140-6736(01)06961-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500HZ	11747919				2022-12-24	WOS:000172622200012
J	Feinberg, H; Mitchell, DA; Drickamer, K; Weis, WI				Feinberg, H; Mitchell, DA; Drickamer, K; Weis, WI			Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR	SCIENCE			English	Article							MANNOSE-BINDING PROTEIN; CELLS	Dendritic cell specific intracellular adhesion molecule-3 (ICAM-3) grabbing nonintegrin (DC-SIGN), a C-type lectin present on the surface of dendritic cells, mediates the initial interaction of dendritic cells with T cells by binding to ICAM-3. DC-SIGN and DC-SIGNR, a related receptor found on the endothelium of Liver sinusoids, placental capillaries, and Lymph nodes, bind to oligosaccharides that are present on the envelope of human immunodeficiency virus (HIV), an interaction that strongly promotes viral infection of T cells. Crystal structures of carbohydrate-recognition domains of DC-SIGN and of DC-SIGNR bound to oligosaccharide, in combination with binding studies, reveal that these receptors selectively recognize endogenous high-mannose oligosaccharides and may represent a new avenue for developing HIV prophylactics.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Stanford University; Stanford University; University of Oxford	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.		Mitchell, Daniel A/A-6580-2009; Weis, William I/G-1437-2011	Mitchell, Daniel A/0000-0003-0936-6212; Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [GM50565] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Nicholls A., 1992, GRASP GRAPHICAL REPR; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x	19	539	579	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2163	2166		10.1126/science.1066371	http://dx.doi.org/10.1126/science.1066371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739956				2022-12-24	WOS:000172647700050
J	Seisenberger, G; Ried, MU; Endress, T; Buning, H; Hallek, M; Brauchle, C				Seisenberger, G; Ried, MU; Endress, T; Buning, H; Hallek, M; Brauchle, C			Real-time single-molecule imaging of the infection pathway of an adeno-associated virus	SCIENCE			English	Article							ADENOASSOCIATED VIRUS; GENE-THERAPY; MEMBRANE; DIFFUSION; DYNAMICS; TRACKING; TYPE-2; CORECEPTOR; MICROSCOPY; CYTOPLASM	We describe a method, based on single-molecule imaging, that allows the real-time visualization of the infection pathway of single viruses in living cells, each labeled with only one fluorescent dye molecule. The tracking of single viruses removes ensemble averaging. Diffusion trajectories with high spatial and time resolution show various modes of motion of adeno-associated viruses (AAV) during their infection pathway into living HeLa cells: (i) consecutive virus touching at the cell surface and fast endocytosis; (il) free and anomalous diffusion of the endosome and the virus in the cytoplasm and the nucleus; and (iii) directed motion by motor proteins in the cytoplasm and in nuclear tubular structures. The real-time visualization of the infection pathway of single AAVs shows a much faster infection than was generally observed so far.	Univ Munich, Dept Chem, D-81377 Munich, Germany; Univ Munich, Klinikum Grosshadern, Med Klin 3, Lab Mol Biol,Genzentrum, D-81377 Munich, Germany; GSF, Natl Ctr Res & Environm, KKG Gentherapie, D-81377 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Brauchle, C (corresponding author), Univ Munich, Dept Chem, Butenandtstr 11, D-81377 Munich, Germany.		Hallek, Michael/Y-3191-2019; Buening, Hildegard/AAV-9928-2021; Buening, Hildegard/AAJ-2352-2020	Hallek, Michael/0000-0002-7425-4455; Buening, Hildegard/0000-0002-3365-6933; 				Bartlett JS, 1998, NAT MED, V4, P635, DOI 10.1038/nm0598-635; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Berg, 2018, RANDOM WALKS BIOL; Broers JLV, 1999, J CELL SCI, V112, P3463; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Ishii Y., 2000, Single Molecules, V1, P5, DOI 10.1002/(SICI)1438-5171(200004)1:1<5::AID-SIMO5>3.0.CO;2-A; KOTIN RM, 1994, HUM GENE THER, V5, P793, DOI 10.1089/hum.1994.5.7-793; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHMIDT T, 1995, J PHYS CHEM-US, V99, P17662, DOI 10.1021/j100049a030; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Xu XH, 1997, SCIENCE, V275, P1106, DOI 10.1126/science.275.5303.1106	31	646	678	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1929	1932		10.1126/science.1064103	http://dx.doi.org/10.1126/science.1064103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729319				2022-12-24	WOS:000172465000060
J	Moret, Y; Schmid-Hempel, P				Moret, Y; Schmid-Hempel, P			Entomology - Immune defence in bumble-bee offspring	NATURE			English	Article							IMMUNIZATION; HEMOLYMPH; SYSTEM; INSECT		ETH Zurich, ETH Zentrum NW, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Moret, Y (corresponding author), ETH Zurich, ETH Zentrum NW, CH-8092 Zurich, Switzerland.		Moret, Yannick/I-9282-2012					Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Coste A, 2000, J VIROL, V74, P8966, DOI 10.1128/JVI.74.19.8966-8971.2000; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; KATO Y, 1994, INSECT BIOCHEM MOLEC, V24, P539, DOI 10.1016/0965-1748(94)90089-2; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nigam Y, 1997, J INVERTEBR PATHOL, V69, P279, DOI 10.1006/jipa.1996.4652; Rollier C, 2000, VACCINE, V18, P3091, DOI 10.1016/S0264-410X(00)00130-4; SCHIMDHEMPEL P, 1998, PARASITES SOCIAL INS; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; TORNQVIST PO, 1996, DIS ASIAN AQUACULTUR, V3, P203	13	173	177	2	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					506	506		10.1038/35107138	http://dx.doi.org/10.1038/35107138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734840				2022-12-24	WOS:000172405900033
J	Kang-Decker, N; Mantchev, GT; Juneja, SC; McNiven, MA; van Deursen, JMA				Kang-Decker, N; Mantchev, GT; Juneja, SC; McNiven, MA; van Deursen, JMA			Lack of acrosome formation in Hrb-deficient mice	SCIENCE			English	Article							PROTEIN	The sperm acrosome is essential for sperm-egg fusion and is often defective in men with nonobstructive infertility. Here we report that mate mice with a null mutation in Hrb are infertile and display round-headed spermatozoa that Lack an acrosome. In wild-type spermatids, Hrb is associated with the cytosolic surface of proacrosomic transport vesicles that fuse to create a single Large acrosomic vesicle at step 3 of spermiogenesis. Although proacrosomic vesicles form in spermatids that lack Hrb, the vesicles are unable to fuse, blocking acrosome development at step 2. We conclude that Hrb is required for docking and/or fusion of proacrosomic vesicles during acrosome biogenesis.	Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JMA (corresponding author), Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Juneja, Subhash/0000-0002-8536-5724				Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Clermont Y., 1993, FRONT ENDOCRINOL, P332; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Hogan B, 1994, MANIPULATING MOUSE E; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; SCHILL WB, 1991, HUM REPROD, V6, P969, DOI 10.1093/oxfordjournals.humrep.a137471; SINGH G, 1992, INT J FERTIL, V37, P99; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Venables JP, 2000, J ENDOCRINOL INVEST, V23, P584, DOI 10.1007/BF03343780	11	191	205	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1531	1533		10.1126/science.1063665	http://dx.doi.org/10.1126/science.1063665			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711676				2022-12-24	WOS:000172240500050
J	Modiano, D; Luoni, G; Sirima, BS; Simpore, J; Verra, F; Konate, A; Rastrelli, E; Olivieri, A; Calissano, C; Paganotti, GM; D'Urbano, L; Sanou, I; Sawadogo, A; Modiano, G; Coluzzi, M				Modiano, D; Luoni, G; Sirima, BS; Simpore, J; Verra, F; Konate, A; Rastrelli, E; Olivieri, A; Calissano, C; Paganotti, GM; D'Urbano, L; Sanou, I; Sawadogo, A; Modiano, G; Coluzzi, M			Haemoglobin C protects against clinical Plasmodium falciparum malaria	NATURE			English	Article							NATURAL-SELECTION; HEMOGLOBIN-C; P-FALCIPARUM; GLOBIN GENE; RESISTANCE; MECHANISM; MUTATION; ORIGIN; AFRICA; CHILDREN	Haemoglobin C (HbC; beta 6Glu --> Lys) is common in malarious areas of West Africa, especially in Burkina Faso(1,2). Conclusive evidence exists on the protective role against severe malaria of haemoglobin S (HbS; beta 6Glu --> Val) heterozygosity(3), whereas conflicting results for the HbC trait have been reported(4-10) and no epidemiological data exist on the possible role of the HbCC genotype. In vitro studies suggested that HbCC erythrocytes fail to support the growth of P. falciparum(11,12) but HbC homozygotes with high P. falciparum parasitaemias have been observed(10). Here we show, in a large case-control study performed in Burkina Faso on 4,348 Mossi subjects, that HbC is associated with a 29% reduction in risk of clinical malaria in HbAC heterozygotes (P = 0.0008) and of 93% in HbCC homozygotes (P = 0.0011). These findings, together with the limited pathology of HbAC and HbCC(13) compared to the severely disadvantaged HbSS and HbSC genotypes and the low beta (S) gene frequency in the geographic epicentre of beta (C1,2,14), support the hypothesis that, in the long term and in the absence of malaria control, HbC would replace HbS in central West Africa.	Univ Roma La Sapienza, WHO Collaborating Ctr Malaria Epidemiol & Control, Sez Parassitol, Dipartimento Sci Sanita Pubbl, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; Ctr Hosp Natl Yalgado Ouedraogo, Serv Pediat, Ouagadougou, Burkina Faso; Ctr Med St Camille, Ouagadougou, Burkina Faso; Minist Sante, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Rome Tor Vergata	Modiano, D (corresponding author), Univ Roma La Sapienza, WHO Collaborating Ctr Malaria Epidemiol & Control, Sez Parassitol, Dipartimento Sci Sanita Pubbl, I-00185 Rome, Italy.	david.modiano@uniroma1.it	OLIVIERI, ANNA/C-2952-2016; SIMPORE, Jacques/ABA-4873-2020	OLIVIERI, ANNA/0000-0003-3882-8017; SIMPORE, Jacques/0000-0002-0415-9161; Paganotti, Giacomo/0000-0002-0751-0682				Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; FRIEDMAN MJ, 1979, AM J TROP MED HYG, V28, P777, DOI 10.4269/ajtmh.1979.28.777; GILLES HM, 1967, LANCET, V1, P138; Guinet F, 1997, ACTA TROP, V68, P175, DOI 10.1016/S0001-706X(97)00089-2; Haldane J.B.S., 1949, HEREDITAS, V35, P267; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; LABIE D, 1984, HUM GENET, V65, P300, DOI 10.1007/BF00286522; LIVINGSTON FB, 1967, ABNORMAL HEMOGLOBINS; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; MODIANO G, 1981, P NATL ACAD SCI-BIOL, V78, P1110, DOI 10.1073/pnas.78.2.1110; Molineaux L, 2020, GARKI PROJECT RES EP, V8; OLSON JA, 1986, BLOOD, V67, P997; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; RINGELHANN B, 1976, AM J HUM GENET, V28, P270; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sanchaisuriya K, 2001, AM J HEMATOL, V67, P189, DOI 10.1002/ajh.1105; SFORZA C, 1971, GENETICS HUMAN POPUL; SMITH EW, 1959, B JOHNS HOPKINS HOSP, V104, P17; THOMPSON GR, 1963, BMJ-BRIT MED J, P976, DOI 10.1136/bmj.2.5363.976; THOMPSON GR, 1962, BMJ-BRIT MED J, P682, DOI 10.1136/bmj.1.5279.682; TRABUCHET G, 1991, HUM GENET, V87, P597	30	240	251	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					305	308		10.1038/35104556	http://dx.doi.org/10.1038/35104556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713529				2022-12-24	WOS:000172150700043
J	Yarrow, K; Haggard, P; Heal, R; Brown, P; Rothwell, JC				Yarrow, K; Haggard, P; Heal, R; Brown, P; Rothwell, JC			Illusory perceptions of space and time preserve cross-saccadic perceptual continuity	NATURE			English	Article							EYE-MOVEMENTS; INFORMATION; INTEGRATION; OBJECT	When voluntary saccadic eye movements are made to a silently ticking clock, observers sometimes think that the second hand takes longer than normal to move to its next position(1). For a short period, the clock appears to have stopped (chronostasis). Here we show that the illusion occurs because the brain extends the percept of the saccadic target backwards in time to just before the onset of the saccade. This occurs every time we move the eyes but it is only perceived when an external time reference alerts us to the phenomenon. The illusion does not seem to depend on the shift of spatial attention that accompanies the saccade. However, if the target is moved unpredictably during the saccade, breaking perception of the target's spatial continuity, then the illusion disappears. We suggest that temporal extension of the target's percept is one of the mechanisms that 'fill in' the perceptual 'gap' during saccadic suppression. The effect is critically linked to perceptual mechanisms that identify a target's spatial stability.	Inst Neurol, Sobell Dept Neurophysiol, London WC1N 3BG, England; UCL, Dept Psychol, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England	University of London; University College London; University of London; University College London; University of Oxford	Yarrow, K (corresponding author), Inst Neurol, Sobell Dept Neurophysiol, 8-11 Queen Sq, London WC1N 3BG, England.		Brown, Peter/J-4307-2016; Haggard, Patrick/A-5081-2010	Brown, Peter/0000-0002-5201-3044; Rothwell, John/0000-0003-1367-6467; Haggard, Patrick/0000-0001-7798-793X; Yarrow, Kielan/0000-0003-0666-2163				BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Brown EA, 1997, J ART MANAG LAW SOC, V27, P23, DOI 10.1080/10632929709597265; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Deubel H, 1999, CURRENT OCULOMOTOR RESEARCH, P65; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; GELDARD FA, 1986, SCI AM, V255, P84; HAGGARD P, IN PRESS ATTENTION P, P19; HOMMEL B, IN PRESS BEHAV BRAIN; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; KOLERS PA, 1976, VISION RES, V16, P329, DOI 10.1016/0042-6989(76)90192-9; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LIBET B, 1979, BRAIN, V102, P193, DOI 10.1093/brain/102.1.193; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P232; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; TYRELL RA, 1988, BEHAV RES METH INSTR, V20, P137; VOLKMANN FC, 1978, VISUAL PSYCHOPHYSICS, P353	24	171	173	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					302	305		10.1038/35104551	http://dx.doi.org/10.1038/35104551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713528	Green Accepted			2022-12-24	WOS:000172150700042
J	Pannifer, AD; Wong, TY; Schwarzenbacher, R; Renatus, M; Petosa, C; Bienkowska, J; Lacy, DB; Collier, RJ; Park, S; Leppla, SH; Hanna, P; Liddington, RC				Pannifer, AD; Wong, TY; Schwarzenbacher, R; Renatus, M; Petosa, C; Bienkowska, J; Lacy, DB; Collier, RJ; Park, S; Leppla, SH; Hanna, P; Liddington, RC			Crystal structure of the anthrax lethal factor	NATURE			English	Article							PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; FACTOR CLEAVES; TOXIN; MACROPHAGES; PROTEIN; IDENTIFICATION; PROGRAM	Lethal factor (LF) is a protein (relative molecular mass 90,000) that is critical in the pathogenesis of anthrax(1-3). It is a highly specific protease that cleaves members of the mitogen-activated protein kinase kinase (MAPKK) family near to their amino termini, leading to the inhibition of one or more signalling pathways(4-6). Here we describe the crystal structure of LF and its complex with the N terminus of MAPKK-2. LF comprises four domains: domain I binds the membrane-translocating component of anthrax toxin, the protective antigen (PA); domains II, III and IV together create a long deep groove that holds the 16-residue N-terminal tail of MAPKK-2 before cleavage. Domain II resembles the ADP-ribosylating toxin from Bacillus cereus, but the active site has been mutated and recruited to augment substrate recognition. Domain III is inserted into domain II, and seems to have arisen from a repeated duplication of a structural element of domain II. Domain IV is distantly related to the zinc metalloprotease family, and contains the catalytic centre; it also resembles domain I. The structure thus reveals a protein that has evolved through a process of gene duplication, mutation and fusion, into an enzyme with high and unusual specificity.	Burnham Inst, La Jolla, CA 92037 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Leicester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan	Liddington, RC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Wong, Tien Yin/AAC-9724-2020; Lacy, D. Borden/AFQ-2203-2022	Wong, Tien Yin/0000-0002-8448-1264; Lacy, Borden/0000-0003-2273-8121; Collier, R John/0000-0002-2427-4239; Petosa, Carlo/0000-0002-9975-1167	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000677] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARROLL SF, 1984, P NATL ACAD SCI-BIOL, V81, P3307, DOI 10.1073/pnas.81.11.3307; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Goletz TJ, 1997, P NATL ACAD SCI USA, V94, P12059, DOI 10.1073/pnas.94.22.12059; Gupta P, 2001, BIOCHEM BIOPH RES CO, V280, P158, DOI 10.1006/bbrc.2000.4099; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEPPLA SH, 1999, COMPREHENSIVE SOURCE, P243; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; QUINN CP, 1991, J BIOL CHEM, V266, P20124; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wang XM, 1996, BIOCHEMISTRY-US, V35, P14939, DOI 10.1021/bi961518b; [No title captured]	31	323	372	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					229	233		10.1038/n35101998	http://dx.doi.org/10.1038/n35101998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700563	Green Published			2022-12-24	WOS:000172029100053
J	Schaumberg, DA; Buring, JE; Sullivan, DA; Dana, MR				Schaumberg, DA; Buring, JE; Sullivan, DA; Dana, MR			Hormone replacement therapy and dry eye syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; POSTMENOPAUSAL WOMEN; SJOGRENS-SYNDROME; STEROID-HORMONES; EPIDEMIOLOGY; GLANDS; PREVENTION; HEALTH; TRIAL	Context Postmenopausal hormone replacement therapy (HRT) use is common in the United States. Some research suggests that estrogen may have detrimental effects on the tear film and could influence the development of dry eye syndrome, but few data are available on this relationship. Objective To determine the relationship of HRT and dry eye syndrome. Design, Setting, and Participants The Women's Health Study, a large cohort study in which 25665 postmenopausal women provided information about use of HRT at baseline (1992), 12, and 36 months and dry eye syndrome at 48 months. Main Outcome Measures (1) Clinically diagnosed dry eye syndrome, as reported by participants; (2) severe symptoms (both ocular dryness and irritation either constantly or often); and (3) either clinically diagnosed dry eye syndrome or severe symptoms, compared between women who used HRT vs those who did not. Results For the combined end point of either clinically diagnosed dry eye syndrome or severe symptoms, the multivariable-adjusted odds ratios were 1.69 (95% confidence interval [CI], 1.49-1.91) for estrogen use alone and 1.29 (95% Cl, 1.13-1.48) for estrogen plus progesterone/progestin use compared with no HRT use, Each 3-year increase in the duration of HRT use was associated with a significant 15% (95% CI, 11%-19%) elevation in risk of clinically diagnosed dry eye syndrome or severe symptoms. Results were similar for the combined end point of clinically diagnosed dry eye syndrome and severe symptoms. Conclusions These data suggest that women who use HRT, particularly estrogen alone, are at increased risk of dry eye syndrome. Physicians caring for women who are taking or considering HRT should be apprised of this potential complication.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Ophthalmol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Schaumberg, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.			Sullivan, David A/0000-0002-3424-3778	NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY000365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA47988] Funding Source: Medline; NEI NIH HHS [K23 EY000365-04, K23 EY000365-05, EY00365] Funding Source: Medline; NHLBI NIH HHS [HL43851] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELCHETZ PE, 1994, NEW ENGL J MED, V330, P1062; BRENNAN NA, 1989, OPTOMETRY VISION SCI, V66, P834, DOI 10.1097/00006324-198912000-00006; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Caffery BE, 1998, ADV EXP MED BIOL, V438, P805; Davis S, 2001, J REPROD MED, V46, P291; Esmaeli B, 2000, OPHTHALMOLOGY, V107, P180, DOI 10.1016/S0161-6420(99)00040-8; Frieling UM, 2000, ARCH DERMATOL, V136, P179, DOI 10.1001/archderm.136.2.179; GILBARD JP, 1994, PRINCIPLES PRACTICE, P257; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; GURWOOD AS, 1995, OPTOMETRY VISION SCI, V72, P29, DOI 10.1097/00006324-199501000-00006; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunter David J., 1990, Annals of Epidemiology, V1, P13; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; Korb DR, 2000, CORNEA, V19, P483, DOI 10.1097/00003226-200007000-00016; Lemp MA, 1998, ADV EXP MED BIOL, V438, P791; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; McMonnies C W, 1987, J Am Optom Assoc, V58, P296; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nagler RM, 2000, SEMIN ARTHRITIS RHEU, V30, P209, DOI 10.1053/sarh.2000.18234; Nelson JD, 2000, ADV THER, V17, P84, DOI 10.1007/BF02854841; Nichols KK, 2000, CORNEA, V19, P477, DOI 10.1097/00003226-200007000-00015; Oden NL, 1998, ADV EXP MED BIOL, V438, P807; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; SATO EH, 1994, INVEST OPHTH VIS SCI, V35, P2632; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Sullivan DA, 1999, ANN NY ACAD SCI, V876, P312, DOI 10.1111/j.1749-6632.1999.tb07656.x; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P11; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P327; SULLIVAN DA, 1997, RES PREVENT BLINDNES, P57; Taskinen MR, 1998, ANN MED, V30, P443, DOI 10.3109/07853899809002485; Tavani A, 1999, DRUG AGING, V14, P347, DOI 10.2165/00002512-199914050-00003; TAYLOR HR, 1980, ANN OPHTHALMOL, V12, P531; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; *WRIT GROUP PEPI T, 1995, JAMA-J AM MED ASSOC, V274, P1676	35	251	270	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2114	2119		10.1001/jama.286.17.2114	http://dx.doi.org/10.1001/jama.286.17.2114			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694152	Bronze, Green Published			2022-12-24	WOS:000172032100030
J	Schwetz, BA				Schwetz, BA			Grant applications for clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-24	WOS:000172032100009
J	Hypponen, E; Laara, E; Reunanene, A; Jarvelin, MR; Virtanen, SM				Hypponen, E; Laara, E; Reunanene, A; Jarvelin, MR; Virtanen, SM			Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study	LANCET			English	Article							FINNISH CHILDREN; NOD MICE; MELLITUS; ONSET	Background Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes in animals. Our aim was to ascertain whether or not vitamin D supplementation or deficiency in infancy could affect development of type 1 diabetes. Methods A birth-cohort study was done, in which all pregnant women (n=12055) in Oulu and Lapland, northern Finland, who were due to give birth in 1966 were enrolled. Data was collected in the first year of life about frequency and dose of vitamin D supplementation and presence of suspected rickets. Our primary outcome measure was diagnosis of type 1 diabetes by end of December, 1997. Findings 12058 of 12231 represented live births, and 10821 (91% of those alive) children were followed-up at age 1 year. Of the 10366 children included in analyses, 81 were diagnosed with diabetes during the study. Vitamin D supplementation was associated with a decreased frequency of type 1 diabetes when adjusted for neonatal, anthropometric, and social characteristics (rate ratio [RR] for regular vs no supplementation 0.12, 95% CI 0.03-0.51, and irregular vs no supplementation 0.16, 0.04-0.74. Children who regularly took the recommended dose of vitamin D (2000 IU daily) had a RR of 0.22 (0.05-0.89) compared with those who regularly received less than the recommended amount. Children suspected of having rickets during the first year of life had a RR of 3.0 (1.0-9.0) compared with those without such a suspicion. Interpretation Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes. Ensuring adequate vitamin D supplementation for infants could help to reverse the increasing trend in the incidence of type 1 diabetes.	Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, London, England; Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Paediat, Tampere, Finland; Univ Oulu, Dept Math Sci, Oulu, Finland; Univ Oulu, Dept Publ Hlth Sci, Oulu, Finland; Univ Oulu, Dept Gen Practice, Oulu, Finland; Natl Publ Hlth Inst, Helsinki, Finland	University of London; University College London; Imperial College London; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Hypponen, E (corresponding author), Inst Child Hlth, Dept Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Virtanen, Suvi/AAP-1922-2021; Hypponen, Elina/B-2596-2014	Hypponen, Elina/0000-0003-3670-9399; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Virtanen, Suvi/0000-0001-8928-0878				Ala-Houhala M, 1995, Duodecim, V111, P337; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; BAUMGARTI HJ, 1991, DIABETES RES CLIN EX, V16, P145; BLOM L, 1989, DIABETOLOGIA, V32, P7; Casteels K, 1998, CLIN EXP IMMUNOL, V112, P181; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; FISHER KD, 1985, AM J CLIN NUTR, V42, P1318; HALLMAN N, 1964, Duodecim, V80, P185; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; LAITINEN S, 1995, SCAND J SOC MED, V23, P88, DOI 10.1177/140349489502300203; Lemire J, 2000, Z RHEUMATOL, V59, P24; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; RANTAKALLIO P, 1983, GROWTH, V47, P122; RANTAKALLIO P, 1985, EARLY HUM DEV, V11, P141, DOI 10.1016/0378-3782(85)90101-X; REUNANEN A, 1982, ACTA PAEDIATR SCAND, V71, P893, DOI 10.1111/j.1651-2227.1982.tb09545.x; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SAGGESE G, 1989, J ENDOCRINOL INVEST, V12, P329, DOI 10.1007/BF03349999; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Virtanen SM, 1998, DIABETIC MED, V15, P730, DOI 10.1002/(SICI)1096-9136(199809)15:9&lt;730::AID-DIA646&gt;3.0.CO;2-C; VIRTANEN SM, 1993, DIABETES, V42, P1786, DOI 10.2337/diabetes.42.12.1786	24	1338	1408	2	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2001	358	9292					1500	1503		10.1016/S0140-6736(01)06580-1	http://dx.doi.org/10.1016/S0140-6736(01)06580-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705562				2022-12-24	WOS:000172055800012
J	Beckmann, R; Spahn, CMT; Eswar, N; Helmers, J; Penczek, PA; Sali, A; Frank, J; Blobel, G				Beckmann, R; Spahn, CMT; Eswar, N; Helmers, J; Penczek, PA; Sali, A; Frank, J; Blobel, G			Architecture of the protein-conducting channel associated with the translating 80S ribosome	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; COLI 70S RIBOSOME; ESCHERICHIA-COLI; ER MEMBRANE; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; SECRETORY PROTEINS; SEC61P COMPLEX; TRANSLOCATION CHANNEL	In vitro assembled yeast ribosome-nascent chain complexes (RNCs) containing a signal sequence in the nascent chain were immunopurified and reconstituted with the purified protein-conducting channel (PCC) of yeast endoplasmic reticulum, the Sec61 complex. A cryo-EM reconstruction of the RNC-Sec61 complex at 15.4 Angstrom resolution shows a tRNA in the P site. Distinct rRNA elements and proteins of the large ribosomal subunit form four connections with the PCC across a gap of about 10-20 Angstrom. Binding of the PCC influences the position of the highly dynamic rRNA expansion segment 27. The RNC-bound Sec61 complex has a compact appearance and was estimated to be a trimer. We propose a binary model of cotranslational translocation entailing only two basic functional states of the translating ribosome-channel complex.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Humboldt Univ, Charite, Inst Biochem, D-10117 Berlin, Germany	Howard Hughes Medical Institute; Rockefeller University; Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; Rockefeller University; University of Texas System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Beckmann, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R37GM029169] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM60635, R37 GM29169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BERNABEU C, 1983, J CELL BIOL, V96, P1471, DOI 10.1083/jcb.96.5.1471; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; CARSON M, 1991, APPL CRYSTALLOGR, V24, P103; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; SWEENEY R, 1994, MOL CELL BIOL, V14, P4203, DOI 10.1128/MCB.14.6.4203; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wang L, 1999, FEBS LETT, V457, P316, DOI 10.1016/S0014-5793(99)01075-3; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590	54	313	318	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					361	372		10.1016/S0092-8674(01)00541-4	http://dx.doi.org/10.1016/S0092-8674(01)00541-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701126	Bronze			2022-12-24	WOS:000172022800007
J	Ellervik, C; Mandrup-Poulsen, T; Nordestgaard, BG; Larsen, LE; Appleyard, M; Frandsen, M; Petersen, P; Schlichting, P; Saermark, T; Tybjaerg-Hansen, A; Birgens, H				Ellervik, C; Mandrup-Poulsen, T; Nordestgaard, BG; Larsen, LE; Appleyard, M; Frandsen, M; Petersen, P; Schlichting, P; Saermark, T; Tybjaerg-Hansen, A; Birgens, H			Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study	LANCET			English	Article							HEMOCHROMATOSIS GENE-MUTATIONS; C282Y MUTATION; EXPRESSION; POPULATION; HFE	Background Although genotyping studies suggest that hereditary haemochromatosis is one of the most common genetic disorders in white people, it is still thought of as an uncommon disease. Our aim was to test the hypothesis that hereditary haemochromatosis is a disease often overlooked in patients with late-onset type 1 diabetes mellitus, a late manifestation of untreated iron overload. Methods We did a retrospective study in which we genotyped for the C282Y and H63D mutations in the haemochromatosis gene in 716 unselected Danish patients who developed type I diabetes mellitus after age 30 years and 9174 controls from the general Danish population. We also screened for hereditary haemochromatosis by assessment of transferrin saturation. Findings More patients with diabetes (n=9, relative frequency 1.26%, 95% CI 0.58-2.37) than controls (23, 0.25%, 0.16-0.38) were homozygous for C282Y (odds ratio 4.6, 2.0-10.1, p=0.0001). These patients had unrecognised signs of haemochromatosis. Transferrin saturation and ferritin concentrations ranged from 57% to 102% and 17 mug/L to 8125 mug/L, respectively. Frequency of compound heterozygosity (C282Y/H63D) did not differ between patients with diabetes (eight) and controls (131) (odds ratio 0.8, 95% CI 0.4-1.7). Positive and negative predictive values of transferrin saturation greater than 50%, in identification of C282Y homozygosity, were 0.26 and 1.00, respectively. A saturation of less than 50% therefore excluded C282Y homozygosity, whereas a saturation of more than 50% suggested C282Y homozygosity. Interpretation Measurement of transferrin saturation followed by genetic testing could prevent liver and heart problems and improve life expectancy in patients with diabetes. Population screening before the onset of diabetes might improve the outlook of patients even further, but will be less cost effective.	Univ Copenhagen, Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Gastroenterol C, DK-2730 Herlev, Denmark; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Bispebjerg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; Univ Copenhagen, Univ Copenhagen Hosp, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Steno Diabetes Center; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Birgens, H (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark.		Nordestgaard, Borge Gronne/ABF-1310-2020; Ellervik, Christina/H-2977-2019	Ellervik, Christina/0000-0002-3088-4375; Mandrup-Poulsen, Thomas/0000-0002-3215-9273				Adams PC, 1999, HEPATOLOGY, V29, P1324, DOI 10.1002/hep.510290425; APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; Baty D, 1998, J CLIN PATHOL, V51, P73, DOI 10.1136/jcp.51.1.73; BOMFORD A, 1976, Q J MED, V45, P611; Brissot Pierre, 1998, Journal of Hepatology, V28, P14, DOI 10.1016/S0168-8278(98)80369-3; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Crawford DHG, 1998, GASTROENTEROLOGY, V114, P1003, DOI 10.1016/S0016-5085(98)70320-8; Cullen LM, 1997, BLOOD, V90, P4236, DOI 10.1182/blood.V90.10.4236; DAVIS WD, 1952, J LAB CLIN MED, V39, P526; Dubois-Laforgue D, 2000, DIABETES METAB, V26, P65; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Hickman P, 1998, HEPATOLOGY, V28, p422A; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk J, 1998, HEPATOLOGY, V28, p528A; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; PHATAK PD, 1994, BLOOD REV, V8, P193, DOI 10.1016/0268-960X(94)90107-4; PICKUP J, 1997, TXB DIABETES, P7; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; Robson KJH, 2000, BRIT J HAEMATOL, V108, P31; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, P809; Ryan E, 1998, HEPATOLOGY, V28, p527A; Salonen JT, 2000, BRIT MED J, V320, P1706, DOI 10.1136/bmj.320.7251.1706; Sampson MJ, 2000, J LAB CLIN MED, V135, P170, DOI 10.1067/mlc.2000.104464; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; *WHO EXP COMM DIAB, 1980, WHO TECHN SER, V646	29	94	97	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1405	1409		10.1016/S0140-6736(01)06526-6	http://dx.doi.org/10.1016/S0140-6736(01)06526-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705485				2022-12-24	WOS:000171940100010
J	Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T				Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T			Identification of novel genes coding for small expressed RNAs	SCIENCE			English	Article							INTERFERENCE; SEQUENCE; RDE-1	In Caenorhabditis elegans, lin-4 and let-7 encode 22- and 21-nucleotide (nt) RNAs, respectively, which function as key regulators of developmental timing. Because the appearance of these short RNAs is regulated during development, they are also referred to as small temporal RNAs (stRNAs). We show that many 21- and 22-nt expressed RNAs, termed microRNAs, exist in invertebrates and vertebrates and that some of these novel RNAs, similar to let-7 stRNA, are highly conserved. This suggests that sequence-specific, posttranscriptional regulatory mechanisms mediated by small RNAs are more general than previously appreciated.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	ttuschl@mpibpc.gwdg.de	Quintana, Mariana Lagos/A-7919-2010					Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	3663	4289	10	405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					853	858		10.1126/science.1064921	http://dx.doi.org/10.1126/science.1064921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679670	Green Submitted			2022-12-24	WOS:000171851800047
J	Srivatsa, B; Srivatsa, S; Johnson, KL; Samura, O; Lee, SL; Bianchi, DW				Srivatsa, B; Srivatsa, S; Johnson, KL; Samura, O; Lee, SL; Bianchi, DW			Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study	LANCET			English	Article							BONE-MARROW; CELLS; IMMUNOLOGY; PREGNANCY; DNA	Background Some so-called autoimmune diseases in women might be alloimmune and represent a chronic graft-versus-host response attributable to transplacentally acquired fetal cells. Thyroid disease is more common in women than men, and post partum exacerbation of thyroiditis is common. Our aim was to investigate whether there is an association between fetal cell microchimerism and thyroid disease in women. Methods Surgical specimens were obtained from 29 women who underwent thyroidectomy for various thyroid disorders. Control specimens were taken from clinically and histologically normal thyroids obtained at necropsy from eight women who died from unrelated conditions. Medical records and pregnancy histories were reviewed. Fluorescence in-situ hybridisation analysis was done with probes specific for X and Y chromosomes. Slides were examined with a fluorescence microscope to detect the presence of male cells-with one X and one Y signal in the nucleus-among maternal cells containing two X signals. Findings Male cells were seen in thyroid sections from 16 patients but not in those from controls (p=0.01). Male cells (1-165 per slide) were seen individually or in clusters in all thyroid diseases and were not restricted to inflammatory thyroid diseases. In one patient with a progressively enlarging goitre, we noted fully differentiated male thyroid follicles closely attached to and indistinguishable from the rest of the thyroid. Interpretation Our findings suggest a relation between fetal cell microchimerism and thyroid disease. Furthermore, fetal stem cells might be capable of differentiation into mature thyroid follicles in their mothers with favourable environmental and developmental factors.	Tufts Univ, New England Med Ctr,Sch Med, Dept Paediat,Div Genet, Floating Hosp Children, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr,Sch Med, Div Endocrinol Diabet Metab & Mol Med, Dept Med, Boston, MA 02111 USA	Floating Hospital For Children; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Bianchi, DW (corresponding author), Tufts Univ, New England Med Ctr,Sch Med, Dept Paediat,Div Genet, Floating Hosp Children, Box 394,750 Washington St, Boston, MA 02111 USA.	DBianchi@Lifespan.org	Samura, Osamu/AAD-1079-2020	Samura, Osamu/0000-0002-7249-1537	NICHD NIH HHS [HD07492, HD43204] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDO T, 2001, 83 ANN M END SOC JUN; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 2000, AM J MED GENET, V91, P22, DOI 10.1002/(SICI)1096-8628(20000306)91:1<22::AID-AJMG4>3.0.CO;2-3; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Davies TF, 1999, THYROID, V9, P675, DOI 10.1089/thy.1999.9.675; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; DEMOOR G, 1988, ACTA CLIN BELG, V43, P231; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HUTCHINSON DL, 1967, AM J OBSTET GYNECOL, V99, P702, DOI 10.1016/0002-9378(67)90418-8; Johnson KL, 2001, ARTHRITIS RHEUM-US, V44, P1848, DOI 10.1002/1529-0131(200108)44:8<1848::AID-ART323>3.0.CO;2-L; Johnson TC, 2000, AMBIO, V29, P2, DOI 10.1639/0044-7447(2000)029[0002:THHOLV]2.0.CO;2; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Nath J, 1998, BIOTECH HISTOCHEM, V73, P6, DOI 10.3109/10520299809140502; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Schmorl G, 1893, PATHOLOGISCHE ANATOM; SCHRODER J, 1974, TRANSPLANTATION, V17, P346, DOI 10.1097/00007890-197404000-00003; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Tyndall A, 1998, NAT MED, V4, P386, DOI 10.1038/nm0498-386; Vietor HE, 2000, BLOOD, V95, P2709; ZHENG YL, 1995, PRENATAL DIAG, V15, P897, DOI 10.1002/pd.1970151004	23	200	205	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2034	2038		10.1016/S0140-6736(01)07099-4	http://dx.doi.org/10.1016/S0140-6736(01)07099-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755610				2022-12-24	WOS:000172722800012
J	Beroukas, T; Hiscock, J; Jonsson, R; Waterman, SA; Gordon, TP				Beroukas, T; Hiscock, J; Jonsson, R; Waterman, SA; Gordon, TP			Subcellular distribution of aquaporin 5 in salivary glands in primary Sjogren's syndrome	LANCET			English	Article								Secretions from salivary and lacrimal glands are reduced in patients with primary Sjogren's syndrome (PSS). Since aquaporin 5 is involved in transport of water and is present in salivary and lacrimal glands, this protein was thought to have a major role in the pathogenesis of PSS. We used indirect immunofluorescence and an immunoperoxidase technique to assess expression and subcellular localisation of aquaporin 5 in patients and controls. Our results suggest that the distribution and density of aquaporin 5 in salivary glands does not differ between patients with PSS and those without. Thus, the role of aquaporin 5 in the pathogenesis of PSS needs to be reassessed and alternative pathogenetic mechanisms investigated.	Flinders Med Ctr, Dept Immunol Allergy & Arthritis, Bedford Pk, SA 5042, Australia; Univ Bergen, Broegelmann Res Lab, Bergen, Norway	Flinders Medical Centre; University of Bergen	Gordon, TP (corresponding author), Flinders Med Ctr, Dept Immunol Allergy & Arthritis, Bedford Pk, SA 5042, Australia.	imtg@flinders.edu.au		Waterman, Sally/0000-0003-2579-3636; Gordon, Thomas/0000-0003-3232-8249				Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Jonsson R., 2001, ARTHRITIS ALLIED CON, Vp, P1736; NIELSEN S, 1997, AM J PHYSIOL, V42, pC1549; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4	5	75	79	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1875	1876		10.1016/S0140-6736(01)06900-8	http://dx.doi.org/10.1016/S0140-6736(01)06900-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741631				2022-12-24	WOS:000172463000017
J	Fujiwara, M; Caswell, H				Fujiwara, M; Caswell, H			Demography of the endangered North Atlantic right whale	NATURE			English	Article							EUBALAENA-GLACIALIS; SURVIVAL	Northern right whales (Eubalaena glacialis) were formerly abundant in the northwestern Atlantic, but by 1900 they had been hunted to near extinction. After the end of commercial whaling the population was thought to be recovering slowly; however, evidence indicates that it has been declining since about 1990 (ref. 1). There are now fewer than 300 individuals, and the species may already be functionally extinct(2,3) owing to demographic stochasticity or the difficulty of females locating mates in the vast Atlantic Ocean (Allee effect(4)). Using a data set containing over 10,000 sightings of photographically identified individuals we estimated trends in right whale demographic parameters since 1980. Here we construct, using these estimates, matrix population models allowing us to analyse the causes of right whale imperilment. Mortality has increased, especially among mother whales, causing declines in population growth rate, life expectancy and the mean lifetime number of reproductive events between the period 1980-1995. Increased mortality of mother whales can explain the declining population size, suggesting that the population is not doomed to extinction as a result of the Allee effect. An analysis of extinction time shows that demographic stochasticity has only a small effect, but preventing the deaths of only two female right whales per year would increase the population growth rate to replacement level.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Fujiwara, M (corresponding author), Woods Hole Oceanog Inst, Dept Biol, MS34, Woods Hole, MA 02543 USA.	mfujiwara@whoi.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043; Caswell, Hal/0000-0003-4394-6894				Akaike H, 1973, INT S INFORMATION TH, P267; Allee W.C, 1931, ANIMAL AGGREGATION S; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Burnham K.P., 1998, MODEL SELECTION INFE; Caswell H, 1999, P NATL ACAD SCI USA, V96, P3308, DOI 10.1073/pnas.96.6.3308; Caswell H., 2001, MATRIX POPULATION MO, V2nd; Caswell H, 1989, MATRIX POPULATION MO; CRONE MJ, 1990, RIGHT WHALE EUBALAEN; FUJIWARA M, IN PRESS ECOLOGY; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.29.773; HOLDEN C, 2001, SCIENCE, V291, P429; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; KNOWLTON AR, 1994, CAN J ZOOL, V72, P1297, DOI 10.1139/z94-173; KNOWLTON AR, 1997, NEW ENGLAND AQUARIUM, V973, P31; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Krause S. J., 1986, Rapid Thermal Processing, P145; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; NICHOLS JD, 1992, ECOLOGY, V73, P306, DOI 10.2307/1938741; OLESIUK PF, 1990, INDIVIDUAL RECOGNITI, P209; Planque B, 1998, J MAR BIOL ASSOC UK, V78, P1015, DOI 10.1017/S0025315400044969; Tuljapurkar S., 1997, STRUCTURED POPULATIO; WARING GT, 1999, NMFSNE153 NOAA	22	219	240	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					537	541		10.1038/35107054	http://dx.doi.org/10.1038/35107054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734852				2022-12-24	WOS:000172405900045
J	Robinson, RC; Turbedsky, K; Kaiser, DA; Marchand, JB; Higgs, HN; Choe, S; Pollard, TD				Robinson, RC; Turbedsky, K; Kaiser, DA; Marchand, JB; Higgs, HN; Choe, S; Pollard, TD			Crystal structure of Arp2/3 complex	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN NUCLEATION; N-WASP; BINDING-ACTIVITY; ACTIVATION; MECHANISM; NETWORKS; SUBUNITS; GELSOLIN; BRANCHES	We determined a crystal structure of bovine Arp2/3 complex, an assembly of seven proteins that initiates actin polymerization in eukaryotic cells, at 2.0 angstrom resolution. Actin-related protein 2 (Arp2) and Arp3 are folded like actin, with distinctive surface features. Subunits ARPC2 p34 and ARPC4 p20 in the core of the complex associate through long carboxyl-terminal a helices and have similarly folded amino-terminal alpha/beta domains. ARPC1 p40 is a seven-blade beta propeller with an insertion that may associate with the side of an actin filament. ARPC3 p21 and ARPC5 p16 are globular alpha -helical subunits. We predict that WASp/Scar proteins activate Arp2/3 complex by bringing Arp2 into proximity with Arp3 for nucleation of a branch on the side of a preexisting actin filament.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653, R01GM026338, R01GM026132, R37GM026132] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-56653, GM-26132, GM-26338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; DAYEL MJ, IN PRESS P NATL ACAD; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	37	405	427	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1679	1684		10.1126/science.1066333	http://dx.doi.org/10.1126/science.1066333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721045				2022-12-24	WOS:000172307400033
J	Lake, MW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H				Lake, MW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H			Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex	NATURE			English	Article							PROTEIN STRUCTURES; BIOSYNTHESIS; ENZYME; MOLYBDOPTERIN; 4-THIOURIDINE; MUTAGENESIS; REFINEMENT; THIAMIN	The activation of ubiquitin and related protein modifiers(1,2) is catalysed by members of the E1 enzyme family that use ATP for the covalent self-attachment of the modifiers to a conserved cysteine. The Escherichia coli proteins MoeB and MoaD are involved in molybdenum cofactor (Moco) biosynthesis, an evolutionarily conserved pathway(3,4). The MoeB- and E1-catalysed reactions are mechanistically similar, and despite a lack of sequence similarity, MoaD and ubiquitin display the same fold including a conserved carboxy-terminal Gly-Gly motif(5). Similar to the E1 enzymes, MoeB activates the C terminus of MoaD to form an acyl-adenylate. Subsequently, a sulphurtransferase converts the MoaD acyl-adenylate to a thiocarboxylate that acts as the sulphur donor during Moco biosynthesis(6,7). These findings suggest that ubiquitin and E1 are derived from two ancestral genes closely related to moaD and moeB(3,5). Here we present the crystal structures of the MoeB-MoaD complex in its apo, ATP-bound, and MoaD-adenylate forms, and highlight the functional similarities between the MoeB- and E1-substrate complexes. These structures provide a molecular framework for understanding the activation of ubiquitin, Rub, SUMO and the sulphur incorporation step during Moco and thiamine biosynthesis.	SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Struct Biol, Stony Brook, NY 11794 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA.		Schindelin, Hermann/Q-2697-2019					Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; JOHNSON ME, 1987, J BACTERIOL, V169, P110, DOI 10.1128/jb.169.1.110-116.1987; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Rajagopalan KV, 1997, BIOCHEM SOC T, V25, P757, DOI 10.1042/bst0250757; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xi J, 2001, P NATL ACAD SCI USA, V98, P8513, DOI 10.1073/pnas.141226698	28	192	198	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					325	329		10.1038/35104586	http://dx.doi.org/10.1038/35104586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713534	Green Submitted			2022-12-24	WOS:000172150700048
J	Burke, RE				Burke, RE			alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease	LANCET			English	Editorial Material							JUVENILE PARKINSONISM; ENDOPLASMIC-RETICULUM; GENE; MUTATIONS; BETA; FAMILIES; NAC		Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Burke, RE (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.		Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437	17	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2001	358	9293					1567	1568		10.1016/S0140-6736(01)06668-5	http://dx.doi.org/10.1016/S0140-6736(01)06668-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716878				2022-12-24	WOS:000172188300005
J	Walkowiak, J; Wiener, JA; Fastabend, A; Heinzow, B; Kramer, U; Schmidt, E; Steingruber, HJ; Wundram, S; Winneke, G				Walkowiak, J; Wiener, JA; Fastabend, A; Heinzow, B; Kramer, U; Schmidt, E; Steingruber, HJ; Wundram, S; Winneke, G			Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood	LANCET			English	Article							HUMAN-MILK; PCBS; CHILDREN; INFANTS; DIOXINS; NEUROTOXICITY; SYSTEM	Background There is uncertainty whether environmental levels of exposure to polychlorinated biphenyls (PCBs) adversely affect mental and motor development in early childhood. We aimed to establish whether such an effect is of only prenatal or additional postnatal origin, and if a favourable home environment can counteract this effect. Methods Between 1993 and 1995 we recruited 171 healthy mother-infant pairs and prospectively measured psychodevelopment in newborn infants aged 7, 18, 30, and 42 months. We estimated prenatal and perinatal PCB exposure of newborn babies in cord blood and maternal milk. At 42 months we measured postnatal PCB concentrations in serum. At 18 months the quality of the home environment was assessed using the Home Observation for Measurement of the Environment scale. Mental and psychomotor development of the children were assessed using the Bayley Scales of Infant Development until 30 months and the Kaufman Assessment Battery for Children at 42 months. Findings Negative associations between milk PCB and mental/motor development were reported at all ages, becoming significant from 30 months onwards. Over 30 months, for a PCB increase from 173 (5th percentile) to 679 ng/g lipids in milk (95th percentile) there was a decrease of 8.3 points (95% CI -16.5 to 0.0) in the Bayley Scales of Infant Development mental scores, and a 9.1 point decrease (95% CI -17.2 to -1.02) in the Bayley Scales of Infant Development motor scores. There was also a negative effect of postnatal PCB exposure via breastfeeding at 42 months. Home environment had a positive effect from 30 months onwards (Bayley Scales of Infant Development mental score increase of 9.4 points [95% CI 2.2-.16.7]). Interpretation Prenatal PCB exposure at current European background levels inhibits, and a favourable home environment supports, mental and motor development until 42 months of age. PCB exposure also has an effect postnatally.	Univ Dusseldorf, Med Inst Environm Hyg, Div Analyt Chem, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Med Inst Environm Hyg, Div Epidemiol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Med Inst Environm Hyg, Div Neurobehav Toxicol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Med Psychol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Fac Med, Univ Child Clin, D-40225 Dusseldorf, Germany; State Agcy Nat & Environm Schleswig Holstein, Lab Environm Toxicol, Flintbeck, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Winneke, G (corresponding author), Univ Dusseldorf, Med Inst Environm Hyg, Div Analyt Chem, Hennekamp 50, D-40225 Dusseldorf, Germany.	gerhard.winneke@uni-duesseldorf.de						Bayley N., 1993, BAYLEY SCALES INFANT; BELLINGER DC, 1995, NEUROTOXICOL TERATOL, V17, P201, DOI 10.1016/0892-0362(94)00081-N; BRADLEY RH, 1993, GENET SOC GEN PSYCH, V119, P439; BRADLEY RH, 1984, HOME OBSERVATION MEA; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; ELARDO R, 1975, CHILD DEV, V46, P71; FASTEBEND A, 2000, THESIS U CLAUSTHAL; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; HUISMAN M, 1995, EARLY HUM DEV, V41, P111, DOI 10.1016/0378-3782(94)01611-R; JACOBSON JL, 1990, J PEDIATR-US, V116, P38, DOI 10.1016/S0022-3476(05)81642-7; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; JACOBSON SW, 1985, CHILD DEV, V56, P853, DOI 10.2307/1130097; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; LILIENTHAL H, 1991, FUND APPL TOXICOL, V17, P368, DOI 10.1016/0272-0590(91)90226-T; MELCHERS P, 1994, KAUFMAN ASSESSMENT B; Patandin S, 1999, J PEDIATR-US, V134, P33, DOI 10.1016/S0022-3476(99)70369-0; PORTERFIELD SP, 1994, ENVIRON HEALTH PERSP, V102, P125, DOI 10.2307/3431829; Riley EP, 1986, HDB BEHAV TERATOLOGY; ROGAN WJ, 1986, J PEDIATR-US, V109, P335, DOI 10.1016/S0022-3476(86)80397-3; Schade G, 1998, SCI TOTAL ENVIRON, V215, P31, DOI 10.1016/S0048-9697(98)00008-4; Schantz SL, 1996, NEUROTOXICOL TERATOL, V18, P217, DOI 10.1016/S0892-0362(96)90001-X; Seegal RF, 1996, CRIT REV TOXICOL, V26, P709, DOI 10.3109/10408449609037481; Tewes U., 1994, HAMBURG WECHSLER INT; *UMW KOMM HUM BIOM, 1999, BUNDESGESUNDHEITSBLA, V42, P511; WALKOWIAK J, 2000, THESIS U DUSSELDORF; Winneke G, 1998, TOXICOL LETT, V103, P423, DOI 10.1016/S0378-4274(98)00334-8	29	254	262	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2001	358	9293					1602	1607		10.1016/S0140-6736(01)06654-5	http://dx.doi.org/10.1016/S0140-6736(01)06654-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716887				2022-12-24	WOS:000172188300014
J	Lee, RC; Ambros, V				Lee, RC; Ambros, V			An extensive class of small RNAs in Caenorhabditis elegans	SCIENCE			English	Article							INTERFERENCE; CONSERVATION; EXPRESSION; SEQUENCE; GENES	The lin-4 and let-7 antisense RNAs are temporal regulators that control the timing of developmental events in Caenorhabditis elegans by inhibiting translation of target mRNAs. let-7 RNA is conserved among bilaterian animals, suggesting that this class of small RNAs [microRNAs (miRNAs)] is evolutionarily ancient. Using bioinformatics and cDNA cloning, we found 15 new miRNA genes in C. elegans. Several of these genes express small transcripts that vary In abundance during C. elegans larval development, and three of them have apparent homologs in mammals and/or insects. Small noncoding RNAs of the miRNA class appear to be numerous and diverse.	Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	vambros@dartmouth.edu			NIGMS NIH HHS [R01 GM-34028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ERDMANN VA, 1908, NUCLEIC ACIDS RES, V29, P189; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	13	2161	2521	9	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					862	864		10.1126/science.1065329	http://dx.doi.org/10.1126/science.1065329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679672				2022-12-24	WOS:000171851800049
J	Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R				Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R			Tumstatin, an endothelial cell-specific inhibitor of protein synthesis	SCIENCE			English	Article							CAP-DEPENDENT INITIATION; ALPHA(V)BETA(3) INTEGRIN; PHOSPHORYLATION; RAPAMYCIN; KINASE; ANGIOGENESIS; TRANSLATION; TARGET	Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions as an endothelial cell-specific inhibitor of protein synthesis. Through a requisite interaction with alphaV beta3 integrin, tumstatin inhibits activation of focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-binding protein 1. These results establish a rote for integrins in mediating ceti-specific inhibition of cap-dependent protein synthesis and suggest a potential mechanism for tumstatin's selective effects on endothelial cells.	Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Pharmacol, Boston, MA 02215 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1V6, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; McGill University; McGill University	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA.	rkalluri@caregroup.harvard.edu	Kahn, Ronald/AAY-2435-2021; Kalluri, Raghu/E-2677-2015	Kahn, Ronald/0000-0002-7583-9228; Kalluri, Raghu/0000-0002-2190-547X	NHLBI NIH HHS [P01-HL66105] Funding Source: Medline; NIDDK NIH HHS [DK-51711, DK-55001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051711] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beretta L, 1996, J VIROL, V70, P8993, DOI 10.1128/JVI.70.12.8993-8996.1996; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Bushell M, 1999, FEBS LETT, V451, P332, DOI 10.1016/S0014-5793(99)00614-6; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; LIVELY JC, UNPUB; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SUDHAKAR A, UNPUB; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433	26	356	408	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					140	143		10.1126/science.1065298	http://dx.doi.org/10.1126/science.1065298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778052	Green Submitted			2022-12-24	WOS:000173143100053
J	Kiger, AA; Jones, DL; Schulz, C; Rogers, MB; Fuller, MT				Kiger, AA; Jones, DL; Schulz, C; Rogers, MB; Fuller, MT			Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue	SCIENCE			English	Article							DROSOPHILA SPERMATOGENESIS; PROTEIN; KINASE; PROLIFERATION; MELANOGASTER; EXPRESSION; ENCODES; OVARY; FATE; EYE	Stem cells generate many differentiated, short-lived cell types, such as blood, skin, and sperm, throughout adult life. Stem cells maintain a tong-term capacity to divide, producing daughter cells that either self-renew or initiate differentiation. Although the surrounding microenvironment or "niche" influences stem cell fate decisions, few signals that emanate from the niche to specify stem cell self-renewal have been identified. Here we demonstrate that the apical hub cells in the Drosophila testis act as a cellular niche that supports stem cell self-renewal. Hub cells express the ligand Unpaired (Upd), which activates the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway in adjacent germ cells to specify self-renewal and continual maintenance of the germ line stem cell population.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Fuller, Margaret T/0000-0002-3804-4987	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, R01GM078176] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07493] Funding Source: Medline; NIDDK NIH HHS [P01-DK53074] Funding Source: Medline; NIGMS NIH HHS [GM07790-22, R01 GM078176] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Gonczy P, 1996, DEVELOPMENT, V122, P2437; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jones D. B., UNPUB; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; KIGER AA, UNPUB; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li M., UNPUB; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; LUSCHNIG S, UNPUB; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	25	506	532	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2542	2545		10.1126/science.1066707	http://dx.doi.org/10.1126/science.1066707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752574				2022-12-24	WOS:000172927700057
J	Cao, YX; Bonizzi, G; Seagroves, TN; Greten, FR; Johnson, R; Schmidt, EV; Karin, M				Cao, YX; Bonizzi, G; Seagroves, TN; Greten, FR; Johnson, R; Schmidt, EV; Karin, M			IKK alpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development	CELL			English	Article							NF-KAPPA-B; MICE LACKING; LIVER DEGENERATION; BREAST-CANCER; KINASE-ALPHA; BETA SUBUNIT; CELL-GROWTH; ACTIVATION; PHOSPHORYLATION; DIFFERENTIATION	To identify functions of the IKK alpha subunit of I kappaB kinase that require catalytic activity, we generated an Ikk alpha (AA) knockin allele containing alanines instead of serines in the activation loop. Ikk alpha (AA/AA) mice are healthy and fertile, but females display a severe lactation defect due to impaired proliferation of mammary epithelia[ cells. IKK alpha. activity is required for NF-kappaB activation in mammary epithelial cells during pregnancy and in response to RANK ligand but not TNF alpha. IKK alpha and NF-kappaB activation are also required for optimal cyclin Dl induction. Defective RANK signaling or cyclin D1 expression results in the same phenotypic effect as the Ikk alpha (AA) mutation, which is completely suppressed by a mammary specific cyclin D1 transgene. Thus, IKK alpha is a critical intermediate in a pathway that controls mammary epithelial proliferation in response to RANK signaling via cyclin D1.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Childrens Serv, Charlestown, MA 02129 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Bonizzi, Giuseppina/AAD-9042-2022; Johnson, Randall/AAM-1189-2021; Seagroves, Tiffany/AAE-3278-2019; Greten, Florian R/AAF-5196-2020	Johnson, Randall/0000-0002-4084-6639; Seagroves, Tiffany/0000-0002-6937-943X; Greten, Florian R/0000-0002-3928-6080				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Delhase M, 1999, COLD SPRING HARB SYM, V64, P491, DOI 10.1101/sqb.1999.64.491; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Geymayer S, 2000, FASEB J, V14, P1159, DOI 10.1096/fasebj.14.9.1159; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GILMORE TD, 1999, DNA ALTERATIONS CANC; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Nishimura T, 2000, AM J REPROD IMMUNOL, V43, P351, DOI 10.1111/j.8755-8920.2000.430604.x; PULLAN SE, 1997, EPITHELIAL CELL CULT, P97; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	50	391	411	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					763	775		10.1016/S0092-8674(01)00599-2	http://dx.doi.org/10.1016/S0092-8674(01)00599-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747812	Bronze			2022-12-24	WOS:000172771800009
J	Kawano, H; Motoyama, T; Ohgushi, M; Kugiyama, K; Ogawa, H; Yasue, H				Kawano, H; Motoyama, T; Ohgushi, M; Kugiyama, K; Ogawa, H; Yasue, H			Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina	ANNALS OF INTERNAL MEDICINE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; CORONARY-ARTERY SPASM; BRACHIAL-ARTERY; SMOOTH-MUSCLE; NITRIC-OXIDE; ACETYLCHOLINE; PATHOGENESIS; ESTROGEN; DILATATION; RELAXATION	Background: An abundance of ovarian hormones is assumed to be a major contributor to the low incidence of ischemic heart disease in premenopausal women. However, the effects of ovarian hormones remain undetermined. Objective: To examine whether the variation in ovarian hormone levels throughout a menstrual cycle affects myocardial ischemia in women with variant angina. Design: Prospective, observational study. Setting: University medical center in Japan. Participants: 10 premenopausal women with variant angina. Measurements: Frequency of spontaneous ischemic episodes, flow-mediated dilation of brachial artery, and serum levels of estradiol and progesterone. Results: Frequency of ischemic episodes was highest from the end of the luteal phase to the beginning of the menstrual phase and was lowest in the follicular phase. Flow-mediated vasodilation and estradiol levels were lowest from the end of the luteal phase to the beginning of the menstrual phase and were highest in the follicular phase. Conclusions: in premenopausal women with variant angina, we documented a cyclic variation in endothelial function and the frequency of myocardial ischemia that was associated with the variation in estrogen levels.	Kumamoto Univ, Sch Med, Kumamoto Reg Med Ctr, Dept Cardiovasc Med, Kumamoto 8608556, Japan; Kumamoto Aging Res Inst, Kumamoto, Japan	Kumamoto University	Kawano, H (corresponding author), Kumamoto Univ, Sch Med, Kumamoto Reg Med Ctr, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	koumei@gpo.kumamoto-u.ac.jp		Yasue, Hirofumi/0000-0002-9952-9638				ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; BAIM DS, 2000, BROSSMANS CARDIAC CA, P211; English JL, 1998, AM J CARDIOL, V82, P256; Freay AD, 1997, CIRC RES, V81, P242, DOI 10.1161/01.RES.81.2.242; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gerhard M, 1998, CIRCULATION, V98, P1158, DOI 10.1161/01.CIR.98.12.1158; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; HILLIS LD, 1978, NEW ENGL J MED, V299, P695, DOI 10.1056/NEJM197809282991305; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kawano H, 1996, P ASSOC AM PHYSICIAN, V108, P473; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Motoyama T, 1998, J AM COLL CARDIOL, V32, P1672, DOI 10.1016/S0735-1097(98)00447-1; WITTEMAN JCM, 1989, BRIT MED J, V298, P642, DOI 10.1136/bmj.298.6674.642; Yasue H, 1997, INTERNAL MED, V36, P760, DOI 10.2169/internalmedicine.36.760; YASUE H, 1983, CIRC RES, V52, P147; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955	17	77	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2001	135	11					977	981		10.7326/0003-4819-135-11-200112040-00009	http://dx.doi.org/10.7326/0003-4819-135-11-200112040-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PN	11730398				2022-12-24	WOS:000172520000004
J	Apoola, A; tenHof, J; Allan, PS				Apoola, A; tenHof, J; Allan, PS			Access to infertility investigations and treatment in couples infected with HIV: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							NEGATIVE WOMEN; PARTNERS		Coventry & Warwickshire Hosp, Dept Genitourinary Med, Coventry CV1 4FH, W Midlands, England; Univ Utrecht, Med Centrum, NL-3584 Utrecht, Netherlands	Atrium Medical Center; Utrecht University	Apoola, A (corresponding author), Coventry & Warwickshire Hosp, Dept Genitourinary Med, Stoney Stanton Rd, Coventry CV1 4FH, W Midlands, England.		Apoola, Ade/AAT-2097-2021					CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Gilling-Smith C, 2001, BRIT MED J, V322, P566, DOI 10.1136/bmj.322.7286.566; Mandelbrot L, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61754-0; Minkoff H, 2000, NEW ENGL J MED, V342, P1748, DOI 10.1056/NEJM200006083422312; SEMPRINI AE, 1993, LANCET, V341, P1343, DOI 10.1016/0140-6736(93)90850-G	5	12	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2001	323	7324					1285	1285		10.1136/bmj.323.7324.1285	http://dx.doi.org/10.1136/bmj.323.7324.1285			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731391	Green Published, Bronze			2022-12-24	WOS:000172655800018
J	Hu, FH; Wang, YC; Liu, D; Li, YM; Qin, J; Elledge, SJ				Hu, FH; Wang, YC; Liu, D; Li, YM; Qin, J; Elledge, SJ			Regulation of the Bub2/Bfal GAP complex by Cdc5 and cell cycle checkpoints	CELL			English	Article							DNA-DAMAGE CHECKPOINT; POLO-LIKE KINASES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC CHECKPOINT; PHOSPHATASE CDC14; EXIT; PROTEIN; MITOSIS; PATHWAY	During mitosis, a ras-related GTPase (Tem1) binds GTP and activates a signal transduction pathway to allow mitotic exit. During most of the cell cycle, Tem1 function is antagonized by a GTPase-activating protein complex, Bfa1/Bub2. How the Bfa1/Bub2 complex is regulated is not well understood. We find that Polo/ Cdc5 kinase acts upstream of Bfa1/Bub2 in the mitotic exit network. Cdc5 phosphorylates Bfa1 and acts to antagonize Bfa1 function to promote mitotic exit. Bfa1 is regulated by multiple cell cycle checkpoints. The spindle assembly and spindle orientation checkpoints inhibit Bfa1 phosphorylation. DNA damage does not inhibit Bfa1 phosphorylation and instead causes: a Rad53- and Dun1-dependent modification of Bfa1. Regulation of Bfa1 may therefore be a key step controlled by multiple checkpoint pathways to ensure a mitotic arrest.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Wang, Yanchang/0000-0001-6782-0570	NIGMS NIH HHS [GM44664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, R37GM044664] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2001, J CELL BIOL, V153, P159, DOI 10.1083/jcb.153.1.159; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fournier N, 2001, ARCH MICROBIOL, V175, P62, DOI 10.1007/s002030000238; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee SE, 2001, J CELL SCI, V114, P2345; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111	41	207	208	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					655	665		10.1016/S0092-8674(01)00580-3	http://dx.doi.org/10.1016/S0092-8674(01)00580-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733064	Bronze			2022-12-24	WOS:000172575300012
J	Theissen, G				Theissen, G			Genetics of identity	NATURE			English	Editorial Material									Univ Jena, Inst Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Theissen, G (corresponding author), Univ Jena, Inst Genet, Philosophenweg 12, D-07743 Jena, Germany.							Goto K, 2001, CURR OPIN GENET DEV, V11, P449, DOI 10.1016/S0959-437X(00)00216-1; Gutierrez-Cortines ME, 2000, TRENDS PLANT SCI, V5, P471, DOI 10.1016/S1360-1385(00)01761-1; Jack T, 2001, TRENDS PLANT SCI, V6, P310, DOI 10.1016/S1360-1385(01)01987-2; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172	4	15	15	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					491	491		10.1038/35107163	http://dx.doi.org/10.1038/35107163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734829				2022-12-24	WOS:000172405900024
J	Gretch, D				Gretch, D			Mechanism of interferon resistance in hepatitis C	LANCET			English	Editorial Material							NONSTRUCTURAL 5A PROTEIN; ALPHA THERAPY; VIRUS; REGION; SUBSTITUTIONS; SENSITIVITY; KINASE		Univ Washington, Dept Virol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Gretch, D (corresponding author), Univ Washington, Dept Virol, Seattle, WA 98104 USA.							ALTER HJ, 1995, BLOOD, V85, P1681, DOI 10.1182/blood.V85.7.1681.bloodjournal8571681; Asahina Y, 2001, HEPATOLOGY, V34, P377, DOI 10.1053/jhep.2001.26086; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Herion D, 1997, HEPATOLOGY, V25, P769, DOI 10.1002/hep.510250346; Lam NP, 1997, HEPATOLOGY, V26, P226; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Podevin P, 2001, HEPATOLOGY, V33, P1503, DOI 10.1053/jhep.2001.24749; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Polyak SJ, 1999, HEPATOLOGY, V29, P1262, DOI 10.1002/hep.510290438; Rosen HR, 1999, MOL MED TODAY, V5, P393, DOI 10.1016/S1357-4310(99)01523-3; Song J, 1999, J GEN VIROL, V80, P879, DOI 10.1099/0022-1317-80-4-879; Witherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1&lt;8::AID-JMV1001&gt;3.0.CO;2-K	18	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1662	1664		10.1016/S0140-6736(01)06728-9	http://dx.doi.org/10.1016/S0140-6736(01)06728-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728538				2022-12-24	WOS:000172344100006
J	Darnell, JC; Jensen, KB; Jin, P; Brown, V; Warren, ST; Darnell, RB				Darnell, JC; Jensen, KB; Jin, P; Brown, V; Warren, ST; Darnell, RB			Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function	CELL			English	Article							BINDING-PROTEIN; TELOMERIC DNA; DENDRITIC SPINES; IN-VIVO; FMR1 PROTEIN; RAT-BRAIN; KH DOMAIN; NUCLEAR; MICE; RECOGNITION	Loss of fragile X mental retardation protein (FMRP) function causes the fragile X mental retardation syndrome. FMRP harbors three RNA binding domains, associates with polysomes, and is thought to regulate mRNA translation and/or localization, but the RNAs to which it binds are unknown. We have used RNA selection to demonstrate that the FMRP RGG box binds intramolecular G quartets. This data allowed us to identify mRNAs encoding proteins involved in synaptic or developmental neurobiology that harbor FMRP binding elements. The majority of these mRNAs have an altered polysome association in fragile X patient cells. These data demonstrate that G quartets serve as physiologically relevant targets for FMRP and identify mRNAs whose dysregulation may underlie human mental retardation.	Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Rockefeller University; Emory University; Emory University; Emory University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockvax.rockefeller.edu	Darnell, Robert B/B-9022-2008; Jensen, Kirk/AAL-5883-2020; Warren, Stephen T/A-2498-2012; Jensen, Kirk/B-4756-2008	Darnell, Robert B/0000-0002-5134-8088; Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, P01HD035576, R01HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389] Funding Source: NIH RePORTER; NICHD NIH HHS [P01HD35576, R01 HD040647, R01 HD40647, R37HD20521] Funding Source: Medline; NINDS NIH HHS [R01 NS34389] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ABSHER D, 2001, IMPORTANCE KH DOMAIN; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Grabowski PJ, 2000, NEURON, V25, P254, DOI 10.1016/S0896-6273(00)80888-0; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Iino S, 1999, NEUROSCIENCE, V91, P1435, DOI 10.1016/S0306-4522(98)00701-5; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kota RS, 1999, CHROMOSOMA, V108, P278, DOI 10.1007/s004120050379; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lau D, 2000, J NEUROSCI, V20, P9071; LEE JS, 1990, NUCLEIC ACIDS RES, V18, P6057, DOI 10.1093/nar/18.20.6057; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Maekawa S, 1999, J BIOL CHEM, V274, P21369, DOI 10.1074/jbc.274.30.21369; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urban IJA, 1998, PROG BRAIN RES, V119, P285; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	85	750	765	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					489	499		10.1016/S0092-8674(01)00566-9	http://dx.doi.org/10.1016/S0092-8674(01)00566-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719189	Bronze			2022-12-24	WOS:000172272900009
J	Clark, P; Rennie, L; Rawlinson, S				Clark, P; Rennie, L; Rawlinson, S			Quality improvement report - Effect of a formal education transfusions	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Failure of correct identification and insufficient monitoring of patients receiving transfusions continue to be appreciable and avoidable causes of morbidity and mortality. Design A study by a regional transfusion service and a transfusion nurse specialist of the effects of an education programme based on the current national guidelines on identification and monitoring of patients receiving transfusions. Setting A large United Kingdom teaching hospital which houses the headquarters of the regional transfusion service. Key measures for improvement Improvement in compliance with published national guidelines on the prescription and administration of blood transfusions. Strategy for change An audit of current compliance followed by dissemination. by a transfusion nurse specialist of a clinical skills package (based on the best practice for transfusion) to all staff involved in giving transfusions. This was supported by trained instructors and the display of standard operating procedures for transfusion in all clinical areas. Effect of change An improvement in compliance with. the national guidelines to over 95% in six out of seven of the recommendations on best practice was seen 18 months after the initial intervention. Lessons learnt The study shows that education of those who prescribe and administer transfusions, as recommended by bodies concerned with the hazards of transfusion, can improve the safety of transfusions.	Ninewells Hosp, E Scotland Blood Transfus Serv, Dept Transfus Med, Dundee DD1 9SY, Scotland	University of Dundee	Clark, P (corresponding author), Ninewells Hosp, E Scotland Blood Transfus Serv, Dept Transfus Med, Dundee DD1 9SY, Scotland.	peter.clark@snbts.csa.scot.nhs.uk						Dinc L, 2000, INT J NURS STUD, V37, P371, DOI 10.1016/S0020-7489(00)00016-X; Kelsey P, 1999, TRANSFUSION MED, V9, P227; LOVE EM, 2001, SERIOUS HAZARDS TRAN; MCCLELLAND B, 1996, HDB TRANSFUSION MED, P30; ROWNTREE D, 1996, PREPARING MAT OPEN D; van den Arend IJM, 2000, DIABETIC MED, V17, P190, DOI 10.1046/j.1464-5491.2000.00232.x	6	26	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2001	323	7321					1118	1120		10.1136/bmj.323.7321.1118	http://dx.doi.org/10.1136/bmj.323.7321.1118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701582	Green Published			2022-12-24	WOS:000172188400021
J	Jefferis, GSXE; Marin, EC; Stocker, RF; Luo, LQ				Jefferis, GSXE; Marin, EC; Stocker, RF; Luo, LQ			Target neuron prespecification in the olfactory map of Drosophila	NATURE			English	Article							ODORANT RECEPTORS; NERVOUS-SYSTEM; ANTENNAL LOBE; SENSORY MAP; MELANOGASTER; MECHANISMS; INTERNEURONS; CONNECTIVITY; ORGANIZATION; GENERATION	In Drosophila and mice, olfactory receptor neurons (ORNs) expressing the same receptors have convergent axonal projections to specific glomerular targets in the antennal lobe/olfactory bulb, creating an odour map in this first olfactory structure of the central nervous system(1-3). Projection neurons of the Drosophila antennal lobe send dendrites into glomeruli and axons to higher brain centres(4), thereby transferring this odour map further into the brain. Here we use the MARCM method(5) to perform a systematic clonal analysis of projection neurons, allowing us to correlate lineage and birth time of projection neurons with their glomerular choice. We demonstrate that projection neurons are prespecified by lineage and birth order to form a synapse with specific incoming ORN axons, and therefore to carry specific olfactory information. This prespecification could be used to hardwire the fly's olfactory system, enabling stereotyped behavioural responses to odorants. Developmental studies lead us to hypothesize that recognition molecules ensure reciprocally specific connections of ORNs and projection neurons. These studies also imply a previously unanticipated role for precise dendritic targeting by postsynaptic neurons in determining connection specificity.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Univ Fribourg, Program Neurosci, CH-1700 Fribourg, Switzerland	Stanford University; Stanford University; University of Fribourg; University of Fribourg	Luo, LQ (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.		Jefferis, Gregory/C-6386-2012	Jefferis, Gregory/0000-0002-0587-9355; Luo, Liqun/0000-0001-5467-9264				AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8	25	317	321	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					204	208		10.1038/35102574	http://dx.doi.org/10.1038/35102574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11719930	Green Submitted			2022-12-24	WOS:000172029100047
J	Priest, P; Yudkin, P; McNulty, C; Mant, D				Priest, P; Yudkin, P; McNulty, C; Mant, D			Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To quantify the relation between community based antibacterial prescribing and antibacterial resistance in community acquired disease. Design Cross sectional study of antibacterial prescribing and antibacterial resistance of routine isolates within individual practices and primary care groups. Setting 405 general practices (38 groups) in south west and north west England. Main outcome measures Correlation between antibacterial prescribing and resistance for urinary coliforms and Streptococcus pneumoniae. Results Antibacterial resistance in urinary coliform isolates is common but the Correlation with prescribing rates was relatively low for individual practices (ampicillin and amoxicillin r(s) = 0.20, P = 0.001; trimethoprim. r(e) = 0.24, P = 0.0001) and primary care groups (ampicillin and amoxicillin r(s) = 0.44, P = 0.05; trimethoprim r(s) = 0.31, P = 0.09). Regression coefficients were also low; a practice prescribing 20% less ampicillin and amoxicillin than average would have about 1% fewer resistant isolates (0.94/100; 95% confidence interval 0.02 to 1.85). Resistance of S pneumoniae to both penicillin and erythromycin remains uncommon, and no clear relation with prescribing was found. Conclusions Routine microbiological isolates should not be used for surveillance of antibacterial resistance in the community or for monitoring the outcome of any change in antibacterial prescribing by general practitioners. Trying to reduce the overall level of antibiotic prescribing in UK general practice may not be the most effective strategy for reducing resistance in the community.	Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Gloucestershire Royal Hosp, Gloucester Publ Hlth Lab, Gloucester GL1 3NN, England	University of Oxford; Gloucestershire Royal Hospital	Priest, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	patricia.priest@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Carbon C, 1998, BRIT MED J, V317, P663, DOI 10.1136/bmj.317.7159.663; DARDAMISSIS E, ANTIBIOTIC PRESCRIBI; Department of Health and Social Care (DHSC), 2000, UK ANT RES STRAT ACT; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Lindbaek M, 1998, BRIT MED J, V317, P1521; Magee JT, 1999, BMJ-BRIT MED J, V319, P1239, DOI 10.1136/bmj.319.7219.1239; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Steinke DT, 2001, J ANTIMICROB CHEMOTH, V47, P781, DOI 10.1093/jac/47.6.781; van Weel C, 1999, LANCET, V354, P1052, DOI 10.1016/S0140-6736(99)90107-1; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609	13	40	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1037	1041		10.1136/bmj.323.7320.1037	http://dx.doi.org/10.1136/bmj.323.7320.1037			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691763	Green Published, Bronze			2022-12-24	WOS:000172055900019
J	Dennis, PB; Jaeschke, A; Saitoh, M; Fowler, B; Kozma, SC; Thomas, G				Dennis, PB; Jaeschke, A; Saitoh, M; Fowler, B; Kozma, SC; Thomas, G			Mammalian TOR: A homeostatic ATP sensor	SCIENCE			English	Article							TRANSCRIPTION; P70(S6K); TARGET	The bacterial macrolide rapamycin is an efficacious anticancer agent against solid tumors. In a hypoxic environment, the increase in mass of solid tumors is dependent on the recruitment of mitogens and nutrients. When nutrient concentrations change, particularly those of essential amino acids, the mammalian Target of Rapamycin (mTOR) functions in regulatory pathways that control ribosome biogenesis and cell growth. In bacteria, ribosome biogenesis is independently regulated by amino acids and adenosine triphosphate (ATP). Here we demonstrate that the mTOR pathway is influenced by the intracellular concentration of ATP, independent of the abundance of amino acids, and that mTOR itself is an ATP sensor.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Childrens Hosp, CH-4005 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Thomas, G (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149				Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Dennis P.B., UNPUB; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roberts J, 1997, SCIENCE, V278, P2073, DOI 10.1126/science.278.5346.2073; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751	18	761	803	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1102	1105		10.1126/science.1063518	http://dx.doi.org/10.1126/science.1063518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691993				2022-12-24	WOS:000172013800050
J	Jahoda, CAB; Reynolds, AJ				Jahoda, CAB; Reynolds, AJ			Hair follicle dermal sheath cells: unsung participants in wound healing	LANCET			English	Article							SMOOTH MUSCLE ACTIN; EXPRESSION; PROTEIN; SKIN	The dermal sheath that surrounds the outside of the hair follicle contains progenitor cells that maintain and regenerate the dermal papilla, a key component for hair growth. Our contention is that dermal sheath cells have other roles. We believe that they can become wound healing fibroblasts and perform an important function in the repair of skin dermis after injury. The dermal sheath has close developmental and anatomical parallels with follicle outer root sheath, the epithelial component that contains the stem cells responsible for replacing skin epidermis. Dermal sheath cells also have a myofibroblast or wound healing phenotype, and in animals with high follicle densities differences in wound healing are observed in conjunction with changes in the hair growth cycle. Similarly, in human beings there are apparent differences in wound healing responses between hairy and non-hairy body sites. Moreover, clinical and experimental data suggest that the involvement of follicle-derived dermal cells results in qualitatively Improved dermal repair. Therefore, in a therapeutic context, hair follicle dermal cells provide an accessible option for the creation of dermal or full skin equivalents that could both improve wound healing and reduce scarring. Indeed, given the inductive properties of adult hair follicle dermal cells, it is reasonable to envisage a tissue engineering approach for the production of a skin equivalent that will grow hair follicles when grafted.	Univ Durham, Dept Biol Sci, Durham DH1 3HP, England	Durham University	Jahoda, CAB (corresponding author), Univ Durham, Dept Biol Sci, Durham DH1 3HP, England.			Jahoda, Colin/0000-0002-1762-1220				BILLINGHAM RE, 1955, J ANAT, V89, P114; BISHOP GH, 1945, AM J ANAT, V76, P153, DOI 10.1002/aja.1000760202; Desmouliere A, 1996, MOL CELLULAR BIOL WO; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Hasan W, 2000, CELL TISSUE RES, V300, P97, DOI 10.1007/s004410050051; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V83, P95; Jahoda CAB, 1998, EXP DERMATOL, V7, P235; MARTINOT V, 1994, BURNS, V20, P146, DOI 10.1016/S0305-4179(06)80012-4; Mast B.A., 1999, SKIN WOUND HEALING B; Matsumura Hajime, 1997, Journal of Burn Care and Rehabilitation, V18, P306, DOI 10.1097/00004630-199707000-00005; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V16, P231; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P857; REYNOLDS AJ, 1993, J INVEST DERMATOL, V101, P577, DOI 10.1111/1523-1747.ep12366032; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Zawacki B E, 1967, Br J Plast Surg, V20, P347, DOI 10.1016/S0007-1226(67)80065-1	17	173	192	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1445	1448		10.1016/S0140-6736(01)06532-1	http://dx.doi.org/10.1016/S0140-6736(01)06532-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705511				2022-12-24	WOS:000171940100035
J	Xu, W; Chen, HW; Du, KY; Asahara, H; Tini, M; Emerson, BM; Montminy, M; Evans, RM				Xu, W; Chen, HW; Du, KY; Asahara, H; Tini, M; Emerson, BM; Montminy, M; Evans, RM			A transcriptional switch mediated by cofactor methylation	SCIENCE			English	Article							NUCLEAR-RECEPTOR FUNCTION; SOMATOSTATIN GENE; COACTIVATOR; PROTEIN; CBP/P300; CREB; PHOSPHORYLATION; BINDING; CBP; IDENTIFICATION	We describe a molecular switch based on the controlled methylation of nucleosome and the transcriptional cofactors, the CREB-binding proteins (CBP)/ p300. The CBP/p300 methylation site is localized to an arginine residue that is essential for stabilizing the structure of the KIX domain, which mediates CREB recruitment. Methylation of KIX by coactivator-associated arginine methyl-transferase 1 (CARM1) blocks CREB activation by disabling the interaction between KIX and the kinase inducible domain (KID) of CREB. Thus, CARM1 functions as a corepressor in cyclic adenosine monophosphate signaling pathway via its methyltransferase activity while acting as a coactivator for nuclear hormones. These results provide strong in vivo and in vitro evidence that histone methylation plays a key role in hormone-induced gene activation and define cofactor methylation as a new regulatory mechanism in hormone signaling.	Univ Calif Davis, Canc Ctr Basic Sci, Gene Express Lab, Sacramento, CA 95817 USA; Univ Calif Davis, Canc Ctr Basic Sci, Dept Biol Chem, Sacramento, CA 95817 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California Davis; University of California System; University of California Davis; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Univ Calif Davis, Canc Ctr Basic Sci, Gene Express Lab, Sacramento, CA 95817 USA.		, MT/AAU-2370-2020; zhang, shijun/K-3688-2013	Evans, Ronald/0000-0002-9986-5965	NIDDK NIH HHS [9R01DK57978] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Lemon BD, 1999, CURR OPIN GENET DEV, V9, P499, DOI 10.1016/S0959-437X(99)00010-6; McEwan IJ, 2000, BIOCHEM SOC T, V28, P369, DOI 10.1042/0300-5127:0280369; McKenna NJ, 2000, J STEROID BIOCHEM, V74, P351, DOI 10.1016/S0960-0760(00)00112-6; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1986, J NEUROSCI, V6, P1171; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; ONATE SA, 1995, SCIENCE, V270, P1354; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1996, MOL CELL BIOL, V16, P694; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	34	315	328	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2507	2511		10.1126/science.1065961	http://dx.doi.org/10.1126/science.1065961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11701890				2022-12-24	WOS:000172927700046
J	Brown, R; Chaloner, E; Mannion, S; Cheatle, T				Brown, R; Chaloner, E; Mannion, S; Cheatle, T			10-year experience of injuries sustained during clearance of anti-personnel mines	LANCET			English	Article								Clearance of anti-personnel mines and unexploded ordnance In countries recovering from war usually continues long after conflict has ceased. We prospectively recorded 92 traumatic injuries sustained by 73 mineclearers working In seven countries over a period of 10 years. 15% of Injuries were fatal, with an incidence of 116 injuries per 100 000 workers per year. Limb Injury occurred in 59% of cases, with an overall amputation rate of 30%. 44% of Injuries were sustained by workers handling a mine, resulting In severe upper limb and facial Injuries. The Incidence of facial Injuries fell after the Introduction of visors.	Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; Univ Coll Hosp NHS Trust, London, England; Lilongwe Cent Hosp, Lilingwe, Malawi; Malawi Polio, Lilingwe, Malawi	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London	Brown, R (corresponding author), Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.							ASCERIO A, 1995, LANCET, V346, P721; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; *UN MIN ACT SERV, 1997, INT STAND HUM MIN CL	3	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2048	2049		10.1016/S0140-6736(01)07141-0	http://dx.doi.org/10.1016/S0140-6736(01)07141-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755615				2022-12-24	WOS:000172722800016
J	Pawliuk, R; Westerman, KA; Fabry, ME; Payen, E; Tighe, R; Bouhassira, EE; Acharya, SA; Ellis, J; London, IM; Eaves, CJ; Humphries, RK; Beuzard, Y; Nagel, RL; Leboulch, P				Pawliuk, R; Westerman, KA; Fabry, ME; Payen, E; Tighe, R; Bouhassira, EE; Acharya, SA; Ellis, J; London, IM; Eaves, CJ; Humphries, RK; Beuzard, Y; Nagel, RL; Leboulch, P			Correction of sickle cell disease in transgenic mouse models by gene therapy	SCIENCE			English	Article							HUMAN BETA-GLOBIN; LOCUS-CONTROL REGION; ERYTHROID-CELLS; RETROVIRUS VECTORS; MESSENGER-RNA; KNOCKOUT MICE; HEMOGLOBIN-S; EXPRESSION; ELEMENTS; ANEMIA	Sickle Cell disease (SCD) is caused by a single point mutation in the human beta (A) globin gene that results in the formation of an abnormal hemoglobin [HbS (alpha (2)beta (S)(2))]. We designed a beta (A) globin gene variant that prevents HbS polymerization and introduced it into a lentiviral vector we optimized for transfer to hematopoietic stem cells and gene expression in the adult red blood cell lineage. Long-term expression (up to 10 months) was achieved, without preselection, in all transplanted mice with erythroid-specific accumulation of the antisickling protein in up to 52% of total hemoglobin and 99% of circulating red blood cells. In two mouse SCD models, Berkeley and SAD, inhibition of red blood cell dehydration and sickling was achieved with correction of hematological parameters, splenomegaly, and prevention of the characteristic urine concentration defect.	Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Genetix Pharmaceut, Cambridge, MA 02139 USA; Yeshiva Univ Albert Einstein Coll Med, Div Hematol, Bronx, NY 10461 USA; Hop St Louis, INSERM, EMI 0111, F-75010 Paris, France; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ British Columbia, Terry Fox Lab, Vancouver, BC V5Z 3L6, Canada; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Massachusetts Institute of Technology (MIT); University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Leboulch, P (corresponding author), Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.		Payen, Emmanuel/S-5357-2018; Ellis, James/F-4789-2011; Bouhassira, Eric/AAZ-4184-2021	Payen, Emmanuel/0000-0002-1329-2327; Ellis, James/0000-0002-4400-0091; Humphries, Richard/0000-0003-0540-7005	NHLBI NIH HHS [HL554352] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alami R, 1999, BLOOD CELL MOL DIS, V25, P110, DOI 10.1006/bcmd.1999.0235; ALKAN O, 2000, 3 AM SOC GEN THER DE; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Blouin MJ, 2000, NAT MED, V6, P177, DOI 10.1038/72279; BOOKCHIN RM, 1971, J MOL BIOL, V60, P263, DOI 10.1016/0022-2836(71)90292-0; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; BUNN HF, 1994, MOL BASIS BLOOD DIS, P207; Chang JC, 1998, P NATL ACAD SCI USA, V95, P14886, DOI 10.1073/pnas.95.25.14886; CHANG JC, 1992, P NATL ACAD SCI USA, V89, P3107, DOI 10.1073/pnas.89.7.3107; Emery DW, 1999, HUM GENE THER, V10, P877, DOI 10.1089/10430349950018283; Fabry ME, 2001, BLOOD, V97, P410, DOI 10.1182/blood.V97.2.410; GELINAS R, 1992, BONE MARROW TRANSPL, V9, P157; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Kalberer CP, 2000, P NATL ACAD SCI USA, V97, P5411, DOI 10.1073/pnas.100082597; LEBOULCH P, 1994, EMBO J, V13, P3065, DOI 10.1002/j.1460-2075.1994.tb06605.x; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; MILLER JL, 1994, P NATL ACAD SCI USA, V91, P10183, DOI 10.1073/pnas.91.21.10183; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; Nagel RL, 2001, BRIT J HAEMATOL, V112, P19, DOI 10.1046/j.1365-2141.2001.02286.x; Nagel RL, 2001, DISORDERS HEMOGLOBIN, P711; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; PLAVEC I, 1993, BLOOD, V81, P1384; Raftopoulos H, 1997, BLOOD, V90, P3414, DOI 10.1182/blood.V90.9.3414; Rubin JE, 2000, BLOOD, V95, P3242; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sabatino DE, 2000, P NATL ACAD SCI USA, V97, P13294, DOI 10.1073/pnas.230453097; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; TAKEKOSHI KJ, 1995, P NATL ACAD SCI USA, V92, P3014, DOI 10.1073/pnas.92.7.3014; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	33	424	454	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2368	2371		10.1126/science.1065806	http://dx.doi.org/10.1126/science.1065806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743206				2022-12-24	WOS:000172817200051
J	Petersen, S; Casellas, R; Reina-San-Martin, B; Chen, HT; Difilippantonio, MJ; Wilson, PC; Hanitsch, L; Celeste, A; Muramatsu, M; Pilch, DR; Redon, C; Ried, T; Bonner, WM; Honjo, T; Nussenzweig, MC; Nussenzweig, A				Petersen, S; Casellas, R; Reina-San-Martin, B; Chen, HT; Difilippantonio, MJ; Wilson, PC; Hanitsch, L; Celeste, A; Muramatsu, M; Pilch, DR; Redon, C; Ried, T; Bonner, WM; Honjo, T; Nussenzweig, MC; Nussenzweig, A			AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching	NATURE			English	Article							DOUBLE-STRAND BREAKS; CYTIDINE DEAMINASE AID; HEAVY-CHAIN SWITCH; SOMATIC HYPERMUTATION; B-CELLS; IMMUNOGLOBULIN GENES; DNA-DAMAGE; RECOMBINATION; REPAIR; SEQUENCES	Class switch recombination (CSR) is a region-specific DNA recombination reaction that replaces one immunoglobulin heavy-chain constant region (CH) gene with another. This enables a single variable (V) region gene to be used in conjunction with different downstream CH genes, each having a unique biological activity. The molecular mechanisms that mediate CSR have not been defined, but activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme, is required for this reaction(1). Here we report that the Nijmegen breakage syndrome protein (Nbs1) and phosphorylated H2A histone family member X (gamma -H2AX, also known as gamma -H2afx), which facilitate DNA double-strand break (DSB) repair(2-4), form nuclear foci at the CH region in the G1 phase of the cell cycle in cells undergoing CSR, and that switching is impaired in H2AX(-/-) mice. Localization of Nbs1 and gamma -H2AX to the IgH locus during CSR is dependent on AID. In addition, AID is required for induction of switch region (S mu)-specific DNA lesions that precede CSR. These results place AID function upstream of the DNA modifications that initiate CSR.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Kyoto University	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Muramatsu, Masamichi/C-4339-2015; Difilippantonio, Michael/AAF-2839-2021; Honjo, Tasuku/N-4470-2016; Reina-San-Martin, Bernardo/I-9484-2016; Nussenzweig, Michel/AAE-7292-2019; Wilson, Patrick/HGC-3157-2022	Muramatsu, Masamichi/0000-0002-0153-3533; Difilippantonio, Michael/0000-0002-4676-7034; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Hanitsch, Leif G./0000-0002-8181-0093	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010298] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; DUNNICK W, 1989, MOL CELL BIOL, V9, P1850, DOI 10.1128/MCB.9.5.1850; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	30	407	418	1	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					660	665		10.1038/414660a	http://dx.doi.org/10.1038/414660a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740565	Green Accepted			2022-12-24	WOS:000172535600053
J	Ye, YH; Meyer, HH; Rapoport, TA				Ye, YH; Meyer, HH; Rapoport, TA			The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-FUSION; ENDOPLASMIC-RETICULUM; MEDIATED PROTEOLYSIS; UBIQUITIN; DEGRADATION; PROTEASOME; PATHWAY; P97; MECHANISM	In eukaryotic cells, incorrectly folded proteins in the endoplasmic reticulum (ER) are exported into the cytosol and degraded by the proteasome(1). This pathway is co-opted by some viruses. For example, the US11 protein of the human cytomegalovirus targets the major histocompatibility complex class I heavy chain for cytosolic degradation(2). How proteins are extracted from the ER membrane is unknown. In bacteria and mitochondria, members of the AAA ATPase family are involved in extracting and degrading membrane proteins(3,4). Here we demonstrate that another member of this family, Cdc48 in yeast and p97 in mammals, is required for the export of ER proteins into the cytosol. Whereas Cdc48/p97 was previously known to function in a complex with the cofactor p47 (ref. 5) in membrane fusion(6-8), we demonstrate that its role in ER protein export requires the interacting partners Ufd1 and Npl4. The AAA ATPase interacts with substrates at the ER membrane and is needed to release them as polyubiquitinated species into the cytosol. We propose that the Cdc48/p97-Ufd1-Npl4 complex extracts proteins from the ER membrane for cytosolic degradation.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Yale University	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.		Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796				ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Schmidt M, 1999, CURR OPIN CHEM BIOL, V3, P584, DOI 10.1016/S1367-5931(99)00013-7; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	30	860	879	3	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					652	656		10.1038/414652a	http://dx.doi.org/10.1038/414652a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740563				2022-12-24	WOS:000172535600051
J	Liou, TG; Adler, FR; Cahill, BC; FitzSimmons, SC; Huang, D; Hibbs, JR; Marshall, BC				Liou, TG; Adler, FR; Cahill, BC; FitzSimmons, SC; Huang, D; Hibbs, JR; Marshall, BC			Survival effect of lung transplantation among patients with cystic fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH; PREDICTION; MODEL; FEV1	Context Patients with cystic fibrosis (CF) are the second largest group of lung transplant recipients in the United States. The survival effect of transplantation on a general CF population has not previously been measured. Objective To determine the impact of bilateral lung transplantation on survival in patients with CF. Design, Setting, and Patients Retrospective observational cohort study of 11630 CF patients who did not undergo lung transplantation (controls) and 468 transplant recipients with CF from 115 CF centers in the United States, 1992-1998. Patients were stratified into 5 groups based on a 5-year survival prediction model (survival group 1: <30%; survival group 2:30 to <50%; survival groups 3-5: 50 to <100%.) Main Outcome Measure Five-year survival from date of transplantation in 1992-1997 in the transplant group and from January 1, 1993, in the control group. Results Lung transplantation increased 5-year survival of CF patients in survival group 1. Survival group 2 had equivocal survival effects, and groups 3-5 had negative survival effects from transplantation. From 1994-1997, there was a mean annual prevalence of 238 patients in survival group 1 and mean annual incidence of 154 patients entering the group, approximately 1.5 times the number of lung transplantations performed each year in CF patients (mean, 104). Use of the criterion of forced expiratory volume in 1 second of less than 30% resulted in an equivocal survival benefit and identified 1458 potential candidates for transplantation in 1993. Conclusions Cystic fibrosis patients in group 1 have improved 5-year survival after lung transplantation. The majority of patients with CF have equivocal or negative Survival effects from the procedure. Selection of patients with CF for transplantation based on group 1 survival predictions maximizes survival benefits to individuals and may reduce the demand for scarce donor organs.	Univ Utah, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT 84132 USA; Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Lung Transplantat Program, Salt Lake City, UT USA; Univ Utah, Intermt Cyst Fibrosis Program, Salt Lake City, UT USA; Cyst Fibrosis Fdn, Dept Med, Bethesda, MD USA; Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; New York State Dept Hlth, Albany, NY USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Cystic Fibrosis Foundation; US Department of Veterans Affairs; University of California System; University of California Los Angeles; State University of New York (SUNY) System	Liou, TG (corresponding author), Univ Utah, Div Resp Crit Care & Occupat Pulm Med, 50 N Med Dr, Salt Lake City, UT 84132 USA.	ted.liou@m.cc.utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NHLBI NIH HHS [K08 HL003656-03, K08 HL003656-04, K08 HL003656-05, HL-03656] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003656] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1998, Am J Respir Crit Care Med, V158, P335; [Anonymous], 1999, CYST FIBR FDN PAT RE; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Doershuk CF, 1999, CHEST, V115, P782, DOI 10.1378/chest.115.3.782; EGAN TM, 1995, J THORAC CARDIOV SUR, V109, P224, DOI 10.1016/S0022-5223(95)70383-7; Evans R W, 1990, Clin Transpl, P329; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hayllar KM, 1997, THORAX, V52, P313, DOI 10.1136/thx.52.4.313; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kurland G, 2001, PEDIATRICS, V107, P1419, DOI 10.1542/peds.107.6.1419; Lai HC, 1998, J PEDIATR-US, V132, P478, DOI 10.1016/S0022-3476(98)70024-1; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1973, BIOMETRICS, V29, P479, DOI 10.2307/2529171; Mantel N, 1985, Natl Cancer Inst Monogr, V67, P169; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403; RAMIREZ JC, 1992, J THORAC CARDIOV SUR, V103, P287; Robinson W, 2000, PEDIATR PULM, V30, P198, DOI 10.1002/1099-0496(200009)30:3<198::AID-PPUL3>3.0.CO;2-E; SHARPLES L, 1993, J HEART LUNG TRANSPL, V12, P669; Starnes VA, 1996, J THORAC CARDIOV SUR, V112, P1284, DOI 10.1016/S0022-5223(96)70142-3; TAUSSIG LM, 1973, J PEDIATR-US, V82, P380, DOI 10.1016/S0022-3476(73)80110-6; *US DEP HHS, 1999, 1999 ANN REP US SCI; VENABLES WN, 1997, MODERN APPL STAT S P; Yankaskas JR, 1998, CHEST, V113, P217, DOI 10.1378/chest.113.1.217; Zar, 2011, BIOSTAT ANAL	30	133	135	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2683	2689		10.1001/jama.286.21.2683	http://dx.doi.org/10.1001/jama.286.21.2683			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730443	Green Accepted, Bronze			2022-12-24	WOS:000172488300027
J	Poser, CM; Brinar, VV				Poser, CM; Brinar, VV			Problems with diagnostic criteria for multiple sclerosis	LANCET			English	Editorial Material							PREDICT CONVERSION; MRI		Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Zagreb, Fac Med, Dept Neurol, Zagreb 41000, Croatia	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Zagreb	Poser, CM (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	oposer@caregroup.harvard.edu						Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; FAZEKAS F, 1988, NEUROLOGY, V38, P1822, DOI 10.1212/WNL.38.12.1822; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Tintore M, 2000, AM J NEURORADIOL, V21, P702; VINUELA FV, 1982, AM J NEURORADIOL, V3, P277	8	17	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2001	358	9295					1746	1747		10.1016/S0140-6736(01)06842-8	http://dx.doi.org/10.1016/S0140-6736(01)06842-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734228				2022-12-24	WOS:000172385100006
J	Vajda, V; Raine, JI; Hollis, CJ				Vajda, V; Raine, JI; Hollis, CJ			Indication of global deforestation at the Creataceous-Tertiary boundary by New Zealand fern spike	SCIENCE			English	Article							K-T-BOUNDARY; CONTIGUOUS STRATA; WESTERN CANADA; IMPACT; EXTINCTIONS; WILDFIRES	The devastating effect on terrestrial plant communities of a bolide impact at the Cretaceous-Tertiary boundary is shown in fossil pollen and spore assemblages by a diverse flora being abruptly replaced by one dominated by a few species of fern. Well documented in North America, this fern spike signals widespread deforestation due to an impact winter or massive wildfires. A Southern Hemisphere record of a fern spike, together with a large iridium anomaly, indicates that the devastation was truly global. Recovery of New Zealand plant communities followed a pattern consistent with major climatic perturbations occurring after an impact winter that was possibly preceded by global wildfires.	Lund Univ, Dept Geol, SE-22363 Lund, Sweden; Inst Geol & Nucl Sci, Lower Hutt, New Zealand	Lund University; GNS Science - New Zealand	Vajda, V (corresponding author), Lund Univ, Dept Geol, Tomavagen 13, SE-22363 Lund, Sweden.		Hollis, Christopher/D-3560-2011; Raine, James I/D-5124-2009; Vajda, Vivi/N-7693-2018	Hollis, Christopher/0000-0001-8840-9852; Raine, James I/0000-0001-5294-2102; Vajda, Vivi/0000-0003-2987-5559				BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; DHondt S, 1996, GEOLOGY, V24, P611, DOI 10.1130/0091-7613(1996)024<0611:OMRTTC>2.3.CO;2; HEYMANN D, 1996, GEOL SOC AM SPEC PAP, V307, P453; HOLLIS CJ, 1995, GEOLOGY, V23, P835, DOI 10.1130/0091-7613(1995)023<0835:SPBITE>2.3.CO;2; HOLLIS CJ, 2000, GEOL SOC NZ MISC P A, V108, P78; JOHNSON KR, 1989, NATURE, V340, P708, DOI 10.1038/340708a0; JOHNSON KR, 1993, NATURE, V366, P511, DOI 10.1038/366511a0; Jones TP, 2000, PALAEOGEOGR PALAEOCL, V164, P57, DOI 10.1016/S0031-0182(00)00175-9; MELOSH HJ, 1990, NATURE, V343, P251, DOI 10.1038/343251a0; NICHOLS DJ, 1990, GEOLOGICAL SOC AM SP, V247, P445; NICHOLS DJ, 1990, EXTINCTION EVENTS EA, P351; PLAYFORD G, 1978, Pollen et Spores, V20, P513; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; SAITO T, 1986, NATURE, V323, P253, DOI 10.1038/323253a0; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P381, DOI 10.1016/S0031-0182(00)00182-6; SHARPTON VL, 1996, GEOL SOC AM SPEC PAP, V307, P55, DOI DOI 10.1130/0-8137-2307-8.55; STRONG CP, 1984, NEW ZEAL J GEOL GEOP, V27, P231, DOI 10.1080/00288306.1984.10422531; Sweet AR, 1999, CAN J EARTH SCI, V36, P743, DOI 10.1139/e98-061; SWEET AR, 1992, CRETACEOUS RES, V13, P31, DOI 10.1016/0195-6671(92)90027-N; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; Vickers-Rich P, 1991, VERTEBRATE PALAEONTO; Wardle P., 1991, VEGETATION NZ; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; WOLBACH WS, 1988, NATURE, V334, P665, DOI 10.1038/334665a0; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; WOLFE JA, 1991, NATURE, V352, P420, DOI 10.1038/352420a0	26	170	186	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1700	1702		10.1126/science.1064706	http://dx.doi.org/10.1126/science.1064706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721051				2022-12-24	WOS:000172307400039
J	Ajaj, A; Singh, MP; Abdulla, AJJ				Ajaj, A; Singh, MP; Abdulla, AJJ			Should elderly patients be told they have cancer? Questionnaire survey of older people	BRITISH MEDICAL JOURNAL			English	Article									Mid Staffordshire Gen Hosp, Dept Care Elderly, Stafford ST18 3SA, England		Abdulla, AJJ (corresponding author), Orpington Hosp, Dept Elderly Med, Orpington BR6 9JU, Kent, England.							Meredith C, 1996, BMJ-BRIT MED J, V313, P724; MOSCONI P, 1991, ANN ONCOL, V2, P273, DOI 10.1093/oxfordjournals.annonc.a057936; THOMSEN OO, 1993, LANCET, V341, P473, DOI 10.1016/0140-6736(93)90218-6; Wilkes E, 1984, PALLIATIVE CARE MANA	4	41	42	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2001	323	7322					1160	1160		10.1136/bmj.323.7322.1160	http://dx.doi.org/10.1136/bmj.323.7322.1160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495NG	11711408	Bronze, Green Published			2022-12-24	WOS:000172346800017
J	Gong, YQ; Slee, RB; Fukai, N; Rawadi, G; Roman-Roman, S; Reginato, AM; Wang, HW; Cundy, T; Glorieux, FH; Lev, D; Zacharin, M; Oexle, K; Marcelino, J; Suwairi, W; Heeger, S; Sabatakos, G; Apte, S; Adkins, WN; Allgrove, J; Arslan-Kirchner, M; Batch, JA; Beighton, P; Black, GCM; Boles, RG; Boon, LM; Borrone, C; Brunner, HG; Carle, GF; Dallapiccola, B; De Paepe, A; Floege, B; Halfhide, ML; Hall, B; Hennekam, RC; Hirose, T; Jans, A; Juppner, H; Kim, CA; Keppler-Noreuil, K; Kohlschuetter, A; LaCombe, D; Lambert, M; Lemyre, E; Letteboer, T; Peltonen, L; Ramesar, RS; Romanengo, M; Somer, H; Steichen-Gersdorf, E; Steinmann, B; Sullivan, B; Superti-Furga, A; Swoboda, W; van den Boogaard, MJ; Van Hul, W; Vikkula, M; Votruba, M; Zabel, B; Garcia, T; Baron, R; Olsen, BR; Warman, ML				Gong, YQ; Slee, RB; Fukai, N; Rawadi, G; Roman-Roman, S; Reginato, AM; Wang, HW; Cundy, T; Glorieux, FH; Lev, D; Zacharin, M; Oexle, K; Marcelino, J; Suwairi, W; Heeger, S; Sabatakos, G; Apte, S; Adkins, WN; Allgrove, J; Arslan-Kirchner, M; Batch, JA; Beighton, P; Black, GCM; Boles, RG; Boon, LM; Borrone, C; Brunner, HG; Carle, GF; Dallapiccola, B; De Paepe, A; Floege, B; Halfhide, ML; Hall, B; Hennekam, RC; Hirose, T; Jans, A; Juppner, H; Kim, CA; Keppler-Noreuil, K; Kohlschuetter, A; LaCombe, D; Lambert, M; Lemyre, E; Letteboer, T; Peltonen, L; Ramesar, RS; Romanengo, M; Somer, H; Steichen-Gersdorf, E; Steinmann, B; Sullivan, B; Superti-Furga, A; Swoboda, W; van den Boogaard, MJ; Van Hul, W; Vikkula, M; Votruba, M; Zabel, B; Garcia, T; Baron, R; Olsen, BR; Warman, ML		Osteoporosis Pseudoglioma Syndrome	LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development	CELL			English	Article							BETA-CATENIN; OSTEOBLAST LINEAGE; MOLECULAR-CLONING; MINERAL DENSITY; CELL-DEATH; MOUSE; FAMILY; MICE; DIFFERENTIATION; OSTEOPOROSIS	In humans, low peak bone mass is a significant risk factor for osteoporosis. We report that LRP5, encoding the low-density lipoprotein receptor-related protein 5, affects bone mass accrual during growth. Mutations in LRP5 cause the autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPPG). We find that OPPG carriers have reduced bone mass when compared to age- and gender-matched controls. We demonstrate LRP5 expression by osteoblasts in situ and show that LRP5 can transduce Writ signaling in vitro via the canonical pathway. We further show that a mutant-secreted form of LRP5 can reduce bone thickness in mouse calvarial explant cultures. These data indicate that Wnt-mediated signaling via LRP5 affects bone accrual during growth and is important for the establishment of peak bone mass.				mlw14@po.cwru.edu	Roman-Roman, Sergio/K-9993-2014; Carle, Georges/GWC-5240-2022; Ramesar, Raj S/I-6941-2015; wei, wei/HHR-8613-2022; superti-furga, andrea/E-9162-2015; Votruba, Marcela/A-6182-2011; Kohlschütter, Alfried/ABE-3495-2021; Vikkula, Miikka/Q-1038-2018; Kohlschütter, Alfried/ABH-5710-2020; Romanengo, Marta/AAB-5053-2021; Batch, Jennifer/A-6094-2011; Votruba, Marcela/B-7306-2015; Boon, Laurence/HCI-3629-2022; Dallapiccola, Bruno/K-8692-2016; Black, Graeme/K-7374-2015	Roman-Roman, Sergio/0000-0001-6459-2613; Ramesar, Raj S/0000-0001-5688-1634; superti-furga, andrea/0000-0002-3543-7531; Votruba, Marcela/0000-0002-7680-9135; Kohlschütter, Alfried/0000-0002-2700-0401; Vikkula, Miikka/0000-0002-6236-338X; Romanengo, Marta/0000-0002-1833-037X; Votruba, Marcela/0000-0002-7680-9135; Dallapiccola, Bruno/0000-0002-5031-1013; Carle, Georges/0000-0002-3901-1052; Lacombe, Didier/0000-0002-8956-2207; Black, Graeme/0000-0001-8727-6592; Rawadi, Georges/0000-0003-4735-2188; Kim, Chong/0000-0002-1754-1300; Cundy, Timothy/0000-0003-4890-9400; Van Hul, Wim/0000-0002-5065-7858; Oexle, Konrad/0000-0001-7447-2252				Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; BOHME K, 1995, DEV DYNAM, V204, P432; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Gliemann J, 1998, BIOL CHEM, V379, P951; Globus RK, 1998, J CELL SCI, V111, P1385; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Gong YQ, 1996, AM J HUM GENET, V59, P146; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Haertel-Wiesmann M, 2000, J BIOL CHEM, V275, P32046, DOI 10.1074/jbc.M000074200; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KO M-K, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P188; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LI Y, 1992, AM J HUM GENET, V51, P749; Lu PW, 1996, J CLIN ENDOCR METAB, V81, P1586, DOI 10.1210/jc.81.4.1586; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mornet E, 2000, HUM MUTAT, V15, P309, DOI 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C; Moursi AM, 1996, J CELL SCI, V109, P1369; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; SEEMAN E, 1994, J BONE MINER RES, V9, P739; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Uusitalo M, 1999, EXP CELL RES, V253, P336, DOI 10.1006/excr.1999.4710; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844	53	1679	1825	2	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2001	107	4					513	523		10.1016/S0092-8674(01)00571-2	http://dx.doi.org/10.1016/S0092-8674(01)00571-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719191	Bronze			2022-12-24	WOS:000172272900011
J	Mauch, DH; Nagler, K; Schumacher, S; Goritz, C; Muller, EC; Otto, A; Pfrieger, FW				Mauch, DH; Nagler, K; Schumacher, S; Goritz, C; Muller, EC; Otto, A; Pfrieger, FW			CNS synaptogenesis promoted by glia-derived cholesterol	SCIENCE			English	Article							RETINAL GANGLION-CELLS; APOLIPOPROTEIN-E; PROTEINS; LIPOPROTEINS; METABOLISM	The molecular mechanisms controlling synaptogenesis in the central nervous system (CNS) are poorly understood. Previous reports showed that a glia-derived factor strongly promotes synapse development in cultures of purified CNS neurons. Here, we identify this factor as cholesterol complexed to apolipoprotein E-containing lipoproteins. CNS neurons produce enough cholesterol to survive and grow, but the formation of numerous mature synapses demands additional amounts that must be provided by glia. Thus, the availability of cholesterol appears to limit synapse development. This may explain the delayed onset of CNS synaptogenesis after glia differentiation and neurobehavioral manifestations of defects in cholesterol or lipoprotein homeostasis.	Max Delbruck Ctr Mol Med, Synapse Grp, D-13092 Berlin, Germany; Max Delbruck Ctr Mol Med, Prot Chem Grp, D-13092 Berlin, Germany; Ctr Neurochim, Max Planck CNRS Grp, UPR 2396, F-67084 Strasbourg, France; Univ Hamburg, Inst Cell Biochem & Clin Neurobiol, D-20246 Hamburg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre National de la Recherche Scientifique (CNRS); University of Hamburg	Pfrieger, FW (corresponding author), Max Delbruck Ctr Mol Med, Synapse Grp, D-13092 Berlin, Germany.	fw-pfrieger@gmx.de	Pfrieger, Frank/AAX-3208-2020; Göritz, Christian/AAK-5348-2021	Pfrieger, Frank/0000-0001-7085-1431; Göritz, Christian/0000-0003-0799-766X				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; ENDO A, 1977, EUR J BIOCHEM, V77, P31, DOI 10.1111/j.1432-1033.1977.tb11637.x; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Ito J, 1999, J NEUROCHEM, V72, P2362, DOI 10.1046/j.1471-4159.1999.0722362.x; Kabara J J, 1973, Prog Brain Res, V40, P363; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAUCH DH, UNPUB; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; STOLL G, 1989, GLIA, V2, P170, DOI 10.1002/glia.440020306; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Willnow TE, 1998, BIOL CHEM, V379, P1025; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	30	1188	1243	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1354	1357		10.1126/science.294.5545.1354	http://dx.doi.org/10.1126/science.294.5545.1354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701931	Green Submitted			2022-12-24	WOS:000172130200053
J	Turtle, EP; Pierazzo, E				Turtle, EP; Pierazzo, E			Thickness of a European ice shell from impact crater simulations	SCIENCE			English	Article							SUBSURFACE OCEAN; NONSYNCHRONOUS ROTATION; GEOLOGICAL EVIDENCE; LIQUID WATER; CONSTRAINTS; FEATURES; MODEL; STATE	Several impact craters on Jupiter's satellite Europa exhibit central peaks. On the terrestrial planets, central peaks consist of fractured but competent rock uplifted during cratering. Therefore, the observation of central peaks on Europa indicates that an ice layer must be sufficiently thick that the impact events did not completely penetrate it. We conducted numerical simulations of vapor and melt production during cratering of water ice layers overlying liquid water to estimate the thickness of Europa's icy crust. Because impacts disrupt material well beyond the zone of partial melting, our simulations put a lower limit on ice thickness at the locations and times of impact. We conclude that the ice must be more than 3 to 4 kilometers thick.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Turtle, EP (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Turtle, Elizabeth/K-8673-2012	Turtle, Elizabeth/0000-0003-1423-5751				Anderson JD, 1998, SCIENCE, V281, P2019, DOI 10.1126/science.281.5385.2019; Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Brookshaw L., 1998, TECHNICAL REPORT WOR; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; CASSEN PM, 1982, SATELLITES JUPITER, P93; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; Geissler P.E., 2001, LUNAR PLANETARY SCI, V32, P2068, DOI [10.1029/2021GL096939, DOI 10.1029/2021GL096939]; Geissler PE, 1998, NATURE, V391, P368, DOI 10.1038/34869; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Grieve R. B., 1981, Proceedings of the Heartworm Symposium '80, Dallas, Texas, 23-24 February 1980., P37; HELFENSTEIN P, 1985, ICARUS, V61, P175, DOI 10.1016/0019-1035(85)90099-5; Hoppa G, 1999, ICARUS, V137, P341, DOI 10.1006/icar.1998.6065; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; MCEWEN AS, 1986, NATURE, V321, P49, DOI 10.1038/321049a0; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MELOSH HJ, 1982, J GEOPHYS RES, V87, P371, DOI 10.1029/JB087iB01p00371; Moore JM, 1998, ICARUS, V135, P127, DOI 10.1006/icar.1998.5973; Moore JM, 2001, ICARUS, V151, P93, DOI 10.1006/icar.2000.6558; OBRIEN DP, IN PRESS ICARUS; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; PIETERS CM, 1982, SCIENCE, V215, P59, DOI 10.1126/science.215.4528.59; Prockter LM, 2000, SCIENCE, V289, P941, DOI 10.1126/science.289.5481.941; Rathbun JA, 1998, GEOPHYS RES LETT, V25, P4157, DOI 10.1029/1998GL900135; ROSS MN, 1987, NATURE, V325, P133, DOI 10.1038/325133a0; SCHENK PM, 1989, ICARUS, V79, P75, DOI 10.1016/0019-1035(89)90109-7; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; SQUYRES SW, 1983, NATURE, V301, P225, DOI 10.1038/301225a0; THOMPSON SL, 1979, SAND771339; THOMPSON SL, 1972, SAND892951; Zahnle K, 1998, ICARUS, V136, P202, DOI 10.1006/icar.1998.6015; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	35	106	110	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1326	1328		10.1126/science.1062492	http://dx.doi.org/10.1126/science.1062492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701924				2022-12-24	WOS:000172130200044
J	Parker, AR; Lawrence, CR				Parker, AR; Lawrence, CR			Water capture by a desert beetle	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; QinetiQ, Mech Sci Sector, Farnborough GU14 0LX, Hants, England	University of Oxford; Qinetiq Group Plc	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Crawford C.S., 1981, BIOL DESERT INVERTEB; HAMILTON WJ, 1976, NATURE, V262, P284, DOI 10.1038/262284a0; KOCH C., 1962, ANN TRANSVAAL MUS, V24, P61; Louw G.N., 1972, Symposia Zool Soc Lond, VNo. 31, P297; MACHIN J, 1970, J EXP BIOL, V53, P753; MCGILL DJ, 1989, STAT INTRO DYNAMICS; ROBERTS CS, 1991, PHYSIOL ENTOMOL, V16, P463, DOI 10.1111/j.1365-3032.1991.tb00586.x; Watanabe K, 2000, J JPN SOC TRIBOLOGIS, V45, P354; 01098144	9	1422	1496	103	1121	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					33	34		10.1038/35102108	http://dx.doi.org/10.1038/35102108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689930				2022-12-24	WOS:000171898900029
J	Alavi, A; Zhuang, HM				Alavi, A; Zhuang, HM			Finding infection - help from PET	LANCET			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE		Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Alavi, A (corresponding author), Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA.							CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; De Winter F, 2001, J BONE JOINT SURG AM, V83A, P651, DOI 10.2106/00004623-200105000-00002; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639, DOI 10.1002/jlb.59.5.639; Guhlmann A, 1998, RADIOLOGY, V206, P749, DOI 10.1148/radiology.206.3.9494496; Ichiya Y, 1996, Ann Nucl Med, V10, P185; MANTHEY P, 1999, J NUCL MED, V40; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996; Sugawara Y, 1998, EUR J NUCL MED, V25, P1238, DOI 10.1007/s002590050290; WARBURG O, 1930, METABOLISM TUMORS, P75; Zhuang HM, 2000, CLIN NUCL MED, V25, P281, DOI 10.1097/00003072-200004000-00009; Zhuang HM, 2001, J NUCL MED, V42, P44	12	34	35	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1386	1386		10.1016/S0140-6736(01)06491-1	http://dx.doi.org/10.1016/S0140-6736(01)06491-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705481				2022-12-24	WOS:000171940100005
J	Krieger, MJB; Ross, KG				Krieger, MJB; Ross, KG			Identification of a major gene regulating complex social behavior	SCIENCE			English	Article							ANT SOLENOPSIS-INVICTA; FIRE ANT; EVOLUTION; ORGANIZATION; POPULATIONS; SELECTION	Colony queen number, a major feature of social organization in fire ants, is associated with worker genotypes at the gene Gp-9. We sequenced Gp-9 and found that it encodes a pheromone-binding protein, a crucial molecular component in chemical recognition of conspecifics, This suggests that differences in worker Gp-9 genotypes between social forms may cause differences in workers' abilities to recognize queens and regulate their numbers. Analyses of sequence evolution indicate that regulation of social organization by Gp-9 is conserved in South American fire ant species exhibiting social polymorphism and suggest that positive selection has driven the divergence between the alleles associated with alternate social organizations. This study demonstrates that single genes of major effect can underlie the expression of complex behaviors important in social evolution.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Krieger, MJB (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.							DeHeer CJ, 1999, AM NAT, V153, P660, DOI 10.1086/303205; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 1999, J EVOLUTION BIOL, V12, P672, DOI 10.1046/j.1420-9101.1999.00064.x; Nei M., 2000, MOL EVOLUTION PHYLOG; PATIL RV, 1990, NUCLEIC ACIDS RES, V18, P3080, DOI 10.1093/nar/18.10.3080; Robinson GE, 1997, BIOESSAYS, V19, P1099, DOI 10.1002/bies.950191209; Robinson GE, 1999, TRENDS ECOL EVOL, V14, P202, DOI 10.1016/S0169-5347(98)01536-5; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Ross KG, 1997, GENETICS, V147, P643; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, GENETICS, V145, P961; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; ROSS KG, IN PRESS BEHAV ECOL; SHOEMAKER D, UNPUB; Smith J. M., 1995, MAJOR TRANSITIONS EV; SWOFFORD DL, 1998, PAUP STAR PHYLOGENET; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Willett CS, 2000, J MOL EVOL, V50, P175, DOI 10.1007/s002399910019; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	20	256	291	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					328	332		10.1126/science.1065247	http://dx.doi.org/10.1126/science.1065247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11711637				2022-12-24	WOS:000173278600050
J	Nasrin, D; Collignon, PJ; Roberts, L; Wilson, EJ; Pilotto, LS; Douglas, RM				Nasrin, D; Collignon, PJ; Roberts, L; Wilson, EJ; Pilotto, LS; Douglas, RM			Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; CARRIAGE	Objective To examine the relation between use of antibiotics in a cohort of preschool children and nasal carriage of resistant strains of pneumococcus. Design and participants Prospective cohort study over two years of 461 children aged under 4 years living in Canberra, Australia. Main outcome measures Use of drugs, respiratory symptoms, and visits to doctors were documented in a daily diary by parents of the children during 25 months of observation. Isolates of pneumococci, which were cultured from nasal swabs collected approximately six monthly, were tested for antibiotic resistance. Results From the four swab collections 631 positive pneumococcal isolates from 461 children were found, of which 13.6% were resistant to penicillin. Presence of penicillin resistant pneumococci was significantly associated with children's use of a beta lactam antibiotic in the two months before each swab collection (odds ratio 2.03 (95% confidence interval 1.15 to 3.56, P = 0.01)). The odds ratio of the association remained >1 (though did not reach significance at the 0.05 level) for use in the six months before swab collection. The association was seen in children who received only penicillin or only cephalosporin antibiotics in that period. The odds ratio was 4.67 (1.29 to 17.09, P = 0.02) in children who had received both types of beta lactam in the two months before their nasal swab. The modelled odds of carrying penicillin resistant pneumococcus was 4% higher for each additional day 0 of use of beta lactam antibiotics in die six months before swab collection. Conclusions Reduction in beta lactam use could quickly reduce the carriage rates of penicillin resistant pneumococci in early childhood. In view of the propensity of these organisms to be spread among children in the community, the prevalence of penicillin resistant organisms may fall as a consequence.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Canberra Hosp, Infect Dis Unit, Canberra, ACT, Australia; Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia; Flinders Univ S Australia, Dept Gen Practice, Adelaide, SA 5001, Australia	Australian National University; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital; Flinders University South Australia	Nasrin, D (corresponding author), 9C-A Impiana Condo,1 Tasik Ampang, Ampang 68000, Selangor, Malaysia.		Collignon, Peter/U-4846-2019	Collignon, Peter/0000-0001-8648-9203				Arason VA, 1996, BMJ-BRIT MED J, V313, P387; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; DELMAR CB, 2000, COCHRANE DATABASE SY; DOUGLAS RM, 1986, AM J DIS CHILD, V140, P1183, DOI 10.1001/archpedi.1986.02140250109044; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Hennekens C.H., 1987, EPIDEMIOLOGY MED; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; LINARES J, 1992, CLIN INFECT DIS, V15, P99, DOI 10.1093/clinids/15.1.99; Low DE, 1998, JAMA-J AM MED ASSOC, V279, P394, DOI 10.1001/jama.279.5.394; NASRIN D, 2000, THESIS AUSTR NATL U; *NAT COMM CLIN LAB, 1994, M100S5 NCCLS; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; Turnidge JD, 1999, MED J AUSTRALIA, V170, P152, DOI 10.5694/j.1326-5377.1999.tb127710.x; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; [No title captured]	16	101	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2002	324	7328					28	30A		10.1136/bmj.324.7328.28	http://dx.doi.org/10.1136/bmj.324.7328.28			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510JV	11777803	Green Published, Bronze			2022-12-24	WOS:000173205700022
J	Quaini, F; Urbanek, K; Beltrami, AP; Finato, N; Beltrami, CA; Nadal-Ginard, B; Kajstura, J; Leri, A; Anversa, P				Quaini, F; Urbanek, K; Beltrami, AP; Finato, N; Beltrami, CA; Nadal-Ginard, B; Kajstura, J; Leri, A; Anversa, P			Chimerism of the transplanted heart (Publication with Expression of Concern. See vol. 379, pg. 1870, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Publication with Expression of Concern							IN-SITU HYBRIDIZATION; STEM-CELLS; P-GLYCOPROTEIN; VENTRICULAR MYOCYTES; ENDOTHELIAL-CELLS; MUSCLE; ORIGIN; CHROMOSOME; MECHANISMS; EXPRESSION	Background: Cases in which a male patient receives a heart from a female donor provide an unusual opportunity to test whether primitive cells translocate from the recipient to the graft and whether cells with the phenotypic characteristics of those of the recipient ultimately reside in the donor heart. The Y chromosome can be used to detect migrated undifferentiated cells expressing stem-cell antigens and to discriminate between primitive cells derived from the recipient and those derived from the donor. Methods: We examined samples from the atria of the recipient and the atria and ventricles of the graft by fluorescence in situ hybridization to determine whether Y chromosomes were present in eight hearts from female donors implanted into male patients. Primitive cells bearing Y chromosomes that expressed c-kit, MDR1, and Sca-1 were also investigated. Results: Myocytes, coronary arterioles, and capillaries that had a Y chromosome made up 7 to 10 percent of those in the donor hearts and were highly proliferative. As compared with the ventricles of control hearts, the ventricles of the transplanted hearts had markedly increased numbers of cells that were positive for c-kit, MDR1, or Sca-1. The number of primitive cells was higher in the atria of the hosts and the atria of the donor hearts than in the ventricles of the donor hearts, and 12 to 16 percent of these cells contained a Y chromosome. Undifferentiated cells were negative for markers of bone marrow origin. Progenitor cells expressing MEF2, GATA-4, and nestin (which identify the cells as myocytes) and Flk1 (which identifies the cells as endothelial cells) were identified. Conclusions: Our results show a high level of cardiac chimerism caused by the migration of primitive cells from the recipient to the grafted heart. Putative stem cells and progenitor cells were identified in control myocardium and in increased numbers in transplanted hearts. (N Engl J Med 2002;346:5-15.) Copyright (C) 2002 Massachusetts Medical Society.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; Univ Udine, Dept Pathol, I-33100 Udine, Italy	New York Medical College; University of Udine	Anversa, P (corresponding author), New York Med Coll, Dept Med, Vosburgh Pavil, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Finato, Nicoletta/A-7351-2010; beltrami, carlo a/A-8026-2008; Beltrami, Antonio/C-5291-2008; Mordwinkin, Nicholas M/A-4347-2010	Beltrami, Antonio/0000-0002-0679-2710; Quaini, Federico/0000-0003-2377-4810	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038132, R01HL065577, R01HL066923, R01HL065573, R01HL039902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015756, R01AG017042] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-66923, HL-65577, HL-38132, HL-39902, HL-65573] Funding Source: Medline; NIA NIH HHS [AG-17042, AG-15756] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami CA, 1997, J MOL CELL CARDIOL, V29, P2789, DOI 10.1006/jmcc.1997.0514; Bunting Kevin D., 2000, Blood, V96, P902; Byrne JG, 2000, J HEART LUNG TRANSPL, V19, P786, DOI 10.1016/S1053-2498(00)00130-3; Demetris A J, 1997, Ann Transplant, V2, P27; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; Frede S E, 1996, Transpl Immunol, V4, P227, DOI 10.1016/S0966-3274(96)80022-0; Fyfe B, 1996, CIRCULATION, V93, P1133, DOI 10.1161/01.CIR.93.6.1133; Gaetano C, 2001, CIRC RES, V88, pE38; Hafizi S, 1997, CURR OPIN CARDIOL, V12, P495, DOI 10.1097/00001573-199711000-00001; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hessel H, 1996, HISTOCHEM CELL BIOL, V106, P481, DOI 10.1007/BF02473310; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; HRUBAN RH, 1993, AM J PATHOL, V142, P975; Ichikawa N, 2000, LIVER TRANSPLANT, V6, P686, DOI 10.1053/jlts.2000.19029; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; KENNEDY LJ, 1971, NEW ENGL J MED, V285, P884, DOI 10.1056/NEJM197110142851603; Kitagawa-Sakakida S, 2000, J HEART LUNG TRANSPL, V19, P584, DOI 10.1016/S1053-2498(00)00105-4; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Miles C, 1997, DEVELOPMENT, V124, P537; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pauly RR, 1997, METHOD CELL BIOL, V52, P133, DOI 10.1016/S0091-679X(08)60377-5; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Triulzi DJ, 2001, TRANSFUSION, V41, P419, DOI 10.1046/j.1537-2995.2001.41030419.x; Wagoner LE, 1996, CIRCULATION, V93, P111, DOI 10.1161/01.CIR.93.1.111; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wollensak G, 1999, EXP EYE RES, V68, P341, DOI 10.1006/exer.1998.0611; Wu M, 2000, GENE DEV, V14, P301; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	39	945	1054	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					5	15		10.1056/NEJMoa012081	http://dx.doi.org/10.1056/NEJMoa012081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11777997	Bronze			2022-12-24	WOS:000173033600002
J	Parker, RA				Parker, RA			Caring for patients at the end of life: Reflections after 12 years of practice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Physicians have the privilege and authority to assist patients and their families at the end of life. Regardless of diagnosis, commonalities occur in the dying process, and palliative care benefits patients and families. This perspective chronicles my experience over 12 years caring for 95 patients at the end of life, illustrated in part with six vignettes. I describe interactions with families, discuss logistic issues around dying, examine the do-not-resuscitate issue, and highlight experiences with home visits. I also touch on how I communicate with the family after a death. I hope to express the significance of what I have learned while assisting patients and families at this critical juncture.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Healthcare Associates, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Parker, RA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Healthcare Associates, 1 Autumn St, Boston, MA 02215 USA.	raparker@caregroup.harvard.edu							0	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2002	136	1					72	75		10.7326/0003-4819-136-1-200201010-00012	http://dx.doi.org/10.7326/0003-4819-136-1-200201010-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510BF	11777365				2022-12-24	WOS:000173188300007
J	McPhee, S; Markowitz, AJ				McPhee, S; Markowitz, AJ			Psychological considerations, growth, and transcendence at the end of life - The art of the possible	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; Hall D, 1998, WITHOUT POEMS; Kenyon Jane, 1996, OTHERWISE NEW SELECT; Nouwen H. J. M., 1994, OUR GREATEST GIFT ME	4	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					3002	3002		10.1001/jama.286.23.3002	http://dx.doi.org/10.1001/jama.286.23.3002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502VY	11743842				2022-12-24	WOS:000172764500033
J	Goodner, B; Hinkle, G; Gattung, S; Miller, N; Blanchard, M; Qurollo, B; Goldman, BS; Cao, YW; Askenazi, M; Halling, C; Mullin, L; Houmiel, K; Gordon, J; Vaudin, M; Iartchouk, O; Epp, A; Liu, F; Wollam, C; Allinger, M; Doughty, D; Scott, C; Lappas, C; Markelz, B; Flanagan, C; Crowell, C; Gurson, J; Lomo, C; Sear, C; Strub, G; Cielo, C; Slater, S				Goodner, B; Hinkle, G; Gattung, S; Miller, N; Blanchard, M; Qurollo, B; Goldman, BS; Cao, YW; Askenazi, M; Halling, C; Mullin, L; Houmiel, K; Gordon, J; Vaudin, M; Iartchouk, O; Epp, A; Liu, F; Wollam, C; Allinger, M; Doughty, D; Scott, C; Lappas, C; Markelz, B; Flanagan, C; Crowell, C; Gurson, J; Lomo, C; Sear, C; Strub, G; Cielo, C; Slater, S			Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; ALPHA-PROTEOBACTERIA; ESCHERICHIA-COLI; DNA; PLASMID; TUMOR; TRANSFORMATION; EVOLUTION; SYMBIONT; EXPORT	Agrobacterium tumefaciens is a plant pathogen capable of transferring a defined segment of DNA to a host plant, generating a gall tumor. Replacing the transferred tumor-inducing genes with exogenous DNA allows the introduction of any desired gene into the plant. Thus, A. tumefaciens has been critical for the development of modern plant genetics and agricultural biotechnology. Here we describe the genome of A. tumefaciens strain C58, which has an unusual structure consisting of one circular and one linear chromosome. We discuss genome architecture and evolution and additional genes potentially involved in virulence and metabolic parasitism of host plants.	Cereon Genom LLC, Cambridge, MA 02139 USA; Univ Richmond, Dept Biol, Richmond, VA 23173 USA; Hiram Coll, Dept Biol, Hiram, OH 44234 USA; Monsanto Co, St Louis, MO 63167 USA	University of Richmond; Hiram College; Monsanto	Slater, S (corresponding author), Cereon Genom LLC, 45 Sidney St, Cambridge, MA 02139 USA.	steven.c.slater@cereon.com		Qurollo, Barbara/0000-0002-9849-2511; Askenazi, Manor/0000-0003-1646-833X; Miller, Nora/0000-0003-0764-8881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM061690] Funding Source: NIH RePORTER; NIGMS NIH HHS [R15 GM61690-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLARDETSERVENT A, 1993, J BACTERIOL, V175, P7869, DOI 10.1128/JB.175.24.7869-7874.1993; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bhat TK, 1998, BIODEGRADATION, V9, P343, DOI 10.1023/A:1008397506963; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Brassinga AKC, 2001, J BACTERIOL, V183, P1824, DOI 10.1128/JB.183.5.1824-1829.2001; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dessaux Y., 1998, RHIZOBIACEAE MOL BIO, P173, DOI DOI 10.1007/978-94-011-5060-6_9; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Goodner BW, 1999, J BACTERIOL, V181, P5160, DOI 10.1128/JB.181.17.5160-5166.1999; HAMILTON RH, 1971, EXPERIENTIA, V27, P229, DOI 10.1007/BF02145913; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Jumas-Bilak E, 1998, J BACTERIOL, V180, P2749, DOI 10.1128/JB.180.10.2749-2755.1998; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KRISHNAN M, 1991, J BACTERIOL, V173, P903, DOI 10.1128/jb.173.2.903-905.1991; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; LAPOINTE G, 1992, J BACTERIOL, V174, P2631, DOI 10.1128/jb.174.8.2631-2639.1992; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Li PL, 2000, J BACTERIOL, V182, P179, DOI 10.1128/JB.182.1.179-188.2000; Lyi SM, 1999, MOL MICROBIOL, V31, P339, DOI 10.1046/j.1365-2958.1999.01178.x; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; OTTEN L, 1992, MOL PLANT MICROBE IN, V5, P279, DOI 10.1094/MPMI-5-279; PARKE D, 1995, J BACTERIOL, V177, P3808, DOI 10.1128/jb.177.13.3808-3817.1995; Penyalver R, 2001, APPL ENVIRON MICROB, V67, P654, DOI 10.1128/AEM.67.2.654-664.2001; Plano GV, 2001, MOL MICROBIOL, V40, P284, DOI 10.1046/j.1365-2958.2001.02354.x; Purcell M, 1998, INFECT IMMUN, V66, P2245, DOI 10.1128/IAI.66.5.2245-2255.1998; ROSENBERG C, 1984, MOL GEN GENET, V196, P533, DOI 10.1007/BF00436205; SCHLUTER A, 1995, MOL GEN GENET, V247, P206, DOI 10.1007/BF00705651; Schuerman PL, 1997, APPL MICROBIOL BIOT, V47, P560, DOI 10.1007/s002530050973; SHAW CH, 1991, BIOESSAYS, V13, P25, DOI 10.1002/bies.950130105; SKARSTAD K, COMMUNICATION; Smith EF, 1907, SCIENCE, V25, P671, DOI 10.1126/science.25.643.671; Subramaniyan S, 2000, FEMS MICROBIOL LETT, V183, P1, DOI 10.1111/j.1574-6968.2000.tb08925.x; Suzuki K, 2000, GENE, V242, P331, DOI 10.1016/S0378-1119(99)00502-8; Suzuki K, 2001, DNA RES, V8, P141, DOI 10.1093/dnares/8.4.141; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Topping J F, 1995, Methods Mol Biol, V49, P63; Van Montagu M., 1979, DEV GENETICS, P71; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; WILLEMS A, 1993, INT J SYST BACTERIOL, V43, P305, DOI 10.1099/00207713-43-2-305; Willis LB, 1999, J BACTERIOL, V181, P4176, DOI 10.1128/JB.181.14.4176-4184.1999; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	62	492	1177	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2323	2328		10.1126/science.1066803	http://dx.doi.org/10.1126/science.1066803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743194				2022-12-24	WOS:000172817200038
J	Brownlee, M				Brownlee, M			Biochemistry and molecular cell biology of diabetic complications	NATURE			English	Review							PROTEIN-KINASE-C; GLYCATION END-PRODUCTS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIUM-DEPENDENT VASODILATION; ALDOSE REDUCTASE INHIBITION; GLUCOSE-MODIFIED PROTEINS; GROWTH-FACTOR-BETA; FACTOR-KAPPA-B; NITRIC-OXIDE; NERVE-CONDUCTION	Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation. Four main molecular mechanisms have been implicated in glucose-mediated vascular damage. All seem to reflect a single hyperglycaemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain. This integrating paradigm provides a new conceptual framework for future research and drug discovery.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Brownlee, M (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	brownlee@aecom.yu.edu						Abordo EA, 1996, IMMUNOL LETT, V53, P7, DOI 10.1016/0165-2478(96)02601-6; CHARONIS AS, 1990, DIABETES, V39, P807, DOI 10.2337/diabetes.39.7.807; Chen YQ, 1998, J BIOL CHEM, V273, P8225, DOI 10.1074/jbc.273.14.8225; Coppey LJ, 2001, BRIT J PHARMACOL, V134, P21, DOI 10.1038/sj.bjp.0704216; CRAVEN PA, 1994, J CLIN INVEST, V93, P311, DOI 10.1172/JCI116961; Craven PA, 1997, DIABETES, V46, P671, DOI 10.2337/diabetes.46.4.671; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; CRAVEN RP, IN PRESS METABOLISM; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; DU XD, IN PRESS J CLIN INVE; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; ENGERMAN RL, 1994, DIABETOLOGIA, V37, P141, DOI 10.1007/s001250050084; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; FEDEROFF HJ, 1993, DIABETES, V42, P509, DOI 10.2337/diabetes.42.4.509; Feener EP, 1996, CONTRIB NEPHROL, V118, P180; Ganz MB, 2000, AM J PHYSIOL-ENDOC M, V278, pE146, DOI 10.1152/ajpendo.2000.278.1.E146; Gerstein HC, 2000, LANCET, V355, P253; Giardino I, 1996, J CLIN INVEST, V97, P1422, DOI 10.1172/JCI118563; GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Glogowski EA, 1999, KIDNEY INT, V55, P486, DOI 10.1046/j.1523-1755.1999.00284.x; Goldberg HJ, 2000, DIABETES, V49, P863, DOI 10.2337/diabetes.49.5.863; Greene DA, 1999, NEUROLOGY, V53, P580, DOI 10.1212/WNL.53.3.580; HAITOGLOU CS, 1992, J BIOL CHEM, V267, P12404; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; HENNEKENS, 1990, ARCH OPHTHALMOL-CHIC, V108, P1234; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Hsueh Willa A., 1998, American Journal of Medicine, V105, p4S, DOI 10.1016/S0002-9343(98)00205-8; HUIJBERTS MSP, 1993, J CLIN INVEST, V92, P1407, DOI 10.1172/JCI116716; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Keogh RJ, 1997, METABOLISM, V46, P41, DOI 10.1016/S0026-0495(97)90165-7; KIRSTEIN M, 1992, J CLIN INVEST, V90, P439, DOI 10.1172/JCI115879; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; Lu M, 1998, J CLIN INVEST, V101, P1219, DOI 10.1172/JCI1277; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Nakamura S, 1997, DIABETES, V46, P895, DOI 10.2337/diabetes.46.5.895; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Phillips SL, 1999, DIABETES, V48, P2083, DOI 10.2337/diabetes.48.10.2083; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Quinn M, 1996, DIABETOLOGIA, V39, P940; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; SCHMIDT RF, 1996, ESPRIT CACID, V1, P1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; SKOLNIK EY, 1991, J EXP MED, V174, P931, DOI 10.1084/jem.174.4.931; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; Stitt AW, 1997, AM J PATHOL, V150, P523; STUDER RK, 1993, DIABETES, V42, P118, DOI 10.2337/diabetes.42.1.118; Suzuki K, 1998, J BIOCHEM-TOKYO, V123, P353; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; TSILIBARY EC, 1988, J BIOL CHEM, V263, P4302; Tsuji H, 1998, BIOCHEM BIOPH RES CO, V245, P583, DOI 10.1006/bbrc.1998.8489; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Williams B, 1997, DIABETES, V46, P1497, DOI 10.2337/diabetes.46.9.1497; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; WILSON DC, 1992, ACTA PAEDIATR, V81, P84, DOI 10.1111/j.1651-2227.1992.tb12087.x; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; XIA P, 1995, J CLIN INVEST, V96, P733, DOI 10.1172/JCI118117; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855	99	6296	6816	38	1241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					813	820		10.1038/414813a	http://dx.doi.org/10.1038/414813a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742414				2022-12-24	WOS:000172676200062
J	Hunt, GR; Corballis, MC; Gray, RD				Hunt, GR; Corballis, MC; Gray, RD			Laterality in tool manufacture by crows - Neural processing and not ecological factors may influence 'handedness' in these birds.	NATURE			English	Article							MANUAL LATERALITY; CALEDONIAN CROWS; HAND; SPECIALIZATION; PAN		Univ Auckland, Dept Psychol, Auckland 92019, New Zealand	University of Auckland	Hunt, GR (corresponding author), Univ Auckland, Dept Psychol, Auckland 92019, New Zealand.		Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Corballis, Michael/0000-0002-3126-6114				Bradshaw JL., 1993, EVOLUTION LATERAL AS; BYRNE RW, 1991, CORTEX, V27, P521, DOI 10.1016/S0010-9452(13)80003-2; Corballis M.C., 1991, LOPSIDED APE EVOLUTI; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; HARRIS LJ, 1989, CAN J PSYCHOL, V43, P369, DOI 10.1037/h0084228; Hopkins WD, 1996, PSYCHON B REV, V3, P449, DOI 10.3758/BF03214548; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; McGrew WC, 1997, INT J PRIMATOL, V18, P787, DOI 10.1023/A:1026347913888; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0	12	62	64	1	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					707	707		10.1038/414707a	http://dx.doi.org/10.1038/414707a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501GD	11742382	Bronze			2022-12-24	WOS:000172676200030
J	Shi, SH				Shi, SH			Amersham Biosciences & Science Prize: AMPA receptor dynamics and synaptic plasticity	SCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; CHANNELS		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Shi, SH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 1949, ORG BEHAV; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1999, IMAGING LIVING CELLS; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	14	9	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1851	1852		10.1126/science.1067844	http://dx.doi.org/10.1126/science.1067844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729297				2022-12-24	WOS:000172465000039
J	Naylor, RL; Williams, SL; Strong, DR				Naylor, RL; Williams, SL; Strong, DR			Ecology - Aquaculture - A gateway for exotic species	SCIENCE			English	Editorial Material							SALMON SALMO-SALAR; ATLANTIC SALMON; PACIFIC; WILD		Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; Univ Calif Davis, Bodega Bay, CA 94923 USA; Bodega Bay Marine Lab, Bodega Bay, CA 94923 USA; Univ Calif Davis, Davis, CA 95616 USA; Bodega Bay Marine Lab, Davis, CA 95616 USA	Stanford University; University of California System; University of California Davis; University of California System; University of California Davis	Naylor, RL (corresponding author), Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA.							[Anonymous], 1993, OTAF565; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; Dextrase AJ, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P61; *FAO, 2000, FISH STAT 1998, V86; Ferber D, 2001, SCIENCE, V292, P203, DOI 10.1126/science.292.5515.203; Goldburg R.J., 2001, MARINE AQUACULTURE U; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Hansen LP, 1997, ICES J MAR SCI, V54, P963, DOI 10.1016/S1054-3139(97)80000-8; Kuris AM, 1999, INVERTEBR BIOL, V118, P391, DOI 10.2307/3227008; McCoy H.D., 2000, AM INT AQUACULTURE L; McKinnell S, 1997, ICES J MAR SCI, V54, P1221, DOI 10.1016/S1054-3139(97)80029-X; *NAT RES COUNC, 1985, UND MAR BIOD REV AG; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NICOL LG, 2001, RISK ASSESSMENT BLAC; Shatkin G, 1997, J SHELLFISH RES, V16, P463; SHINE C, 2000, ENV POLICY LAW PAPER, V40; Stucky N. P., 2000, 5 YEAR PLAN ELIMINAT; THOM RM, 1990, BOT MAR, V33, P497, DOI 10.1515/botm.1990.33.6.497; Trowbridge C.D, 1999, CRIMP CONSULTANCY RE, P43; Venable DL, 2000, J WORLD AQUACULT SOC, V31, P158, DOI 10.1111/j.1749-7345.2000.tb00349.x; Verspoor E, 1997, ICES J MAR SCI, V54, P965, DOI 10.1006/jmsc.1997.0297; Volpe JP, 2000, CONSERV BIOL, V14, P899, DOI 10.1046/j.1523-1739.2000.99194.x; WELCOMME RL, 1992, ICES MAR SC, V194, P3; [No title captured]; [No title captured]	25	354	375	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1655	1656		10.1126/science.1064875	http://dx.doi.org/10.1126/science.1064875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721035				2022-12-24	WOS:000172307400020
J	Patil, N; Berno, AJ; Hinds, DA; Barrett, WA; Doshi, JM; Hacker, CR; Kautzer, CR; Lee, DH; Marjoribanks, C; McDonough, DP; Nguyen, BTN; Norris, MC; Sheehan, JB; Shen, NP; Stern, D; Stokowski, RP; Thomas, DJ; Trulson, MO; Vyas, KR; Frazer, KA; Fodor, SPA; Cox, DR				Patil, N; Berno, AJ; Hinds, DA; Barrett, WA; Doshi, JM; Hacker, CR; Kautzer, CR; Lee, DH; Marjoribanks, C; McDonough, DP; Nguyen, BTN; Norris, MC; Sheehan, JB; Shen, NP; Stern, D; Stokowski, RP; Thomas, DJ; Trulson, MO; Vyas, KR; Frazer, KA; Fodor, SPA; Cox, DR			Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; INFORMATION	Global patterns of human DNA sequence variation (haplotypes) defined by common single nucleotide polymorphisms (SNPs) have important implications for identifying disease associations and human traits. We have used high-density oligonucleotide arrays, in combination with somatic cell genetics, to identify a large fraction of all common human chromosome 21 SNPs and to directly observe the haplotype structure defined by these SNPs. This structure reveals blocks of limited haplotype diversity in which more than 80% of a global human sample can typically be characterized by only three common haplotypes.	Perlegen Sci Inc, Mountain View, CA 94043 USA		Cox, DR (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	david_cox@perlegen.com		Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FU YX, 1993, GENETICS, V133, P693; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HARTL DL, 1997, PRINCIPLES POPULATIO, P57; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yang ZY, 2000, NAT GENET, V26, P13, DOI 10.1038/79113	24	803	895	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1719	1723		10.1126/science.1065573	http://dx.doi.org/10.1126/science.1065573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721056				2022-12-24	WOS:000172307400045
J	McDevitt, MR; Ma, DS; Lai, LT; Simon, J; Borchardt, P; Frank, RK; Wu, K; Pellegrini, V; Curcio, MJ; Miederer, M; Bander, NH; Scheinberg, DA				McDevitt, MR; Ma, DS; Lai, LT; Simon, J; Borchardt, P; Frank, RK; Wu, K; Pellegrini, V; Curcio, MJ; Miederer, M; Bander, NH; Scheinberg, DA			Tumor therapy with targeted atomic nanogenerators	SCIENCE			English	Article							IN-VITRO; RADIOIMMUNOTHERAPY; ANTIBODY; AC-225; CONSTRUCTS; GROWTH; MICE	A single, high linear energy transfer alpha particle can kill a target cell. We have developed methods to target molecular-sized generators of alpha-emitting isotope cascades to the inside of cancer cells using actinium-225 coupled to internalizing monoclonal antibodies. In vitro, these constructs specifically killed leukemia, lymphoma, breast, ovarian, neuroblastoma, and prostate cancer cells at becquerel (picocurie) levels. Injection of single doses of the constructs at kilobecquerel (nanocurie) levels into mice bearing solid prostate carcinoma or disseminated human lymphoma induced tumor regression and prolonged survival, without toxicity, in a substantial fraction of animals. Nanogenerators targeting a wide variety of cancers may be possible.	Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Therapeut Program, New York, NY 10021 USA; Dow Chem Co USA, Freeport, TX 77541 USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Urol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Dow Chemical Company; Cornell University; NewYork-Presbyterian Hospital	Scheinberg, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Therapeut Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org	Miederer, Matthias/C-4405-2014; Miederer, Matthias/ABA-5988-2020	Miederer, Matthias/0000-0001-5075-5995	NCI NIH HHS [R01 CA55349] Funding Source: Medline; PHS HHS [P01 33049] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055349] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ballangrud AM, 2001, CANCER RES, V61, P2008; Bidart JM, 1999, CLIN CHEM, V45, P1695; Chappell LL, 2000, BIOCONJUGATE CHEM, V11, P510, DOI 10.1021/bc990153f; Davis IA, 1999, NUCL MED BIOL, V26, P581, DOI 10.1016/S0969-8051(99)00024-4; Deal KA, 1999, J MED CHEM, V42, P2988, DOI 10.1021/jm990141f; GEERLINGS MW, 1993, NUCL MED COMMUN, V14, P121, DOI 10.1097/00006231-199302000-00009; GHETIE MA, 1994, BLOOD, V83, P1329; GLEAVE ME, 1992, CANCER RES, V52, P1598; HUMM JL, 1993, RADIAT RES, V134, P143, DOI 10.2307/3578453; Jurcic JG, 1997, BLOOD, V90, P1850; Kennel SJ, 2000, CANCER BIOTHER RADIO, V15, P235, DOI 10.1089/108497800414329; Liu H, 1998, CANCER RES, V58, P4055; Ma D, 2000, J NUCL MED, V41, p268P; MA D, IN PRESS LEUKEMIA; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 2000, CANCER RES, V60, P6095; McDevitt MR, 1999, APPL RADIAT ISOTOPES, V50, P895, DOI 10.1016/S0969-8043(98)00151-1; McDevitt MR, 1999, J NUCL MED, V40, P1722; Nikula TK, 1999, J NUCL MED, V40, P166; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Zalutsky MR, 2000, CURR PHARM DESIGN, V6, P1433, DOI 10.2174/1381612003399275	21	346	399	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1537	1540		10.1126/science.1064126	http://dx.doi.org/10.1126/science.1064126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711678				2022-12-24	WOS:000172240500052
J	Mostoslavsky, R; Singh, N; Tenzen, T; Goldmit, M; Gabay, C; Elizur, S; Qi, PM; Reubinoff, BE; Chess, A; Cedar, H; Bergman, Y				Mostoslavsky, R; Singh, N; Tenzen, T; Goldmit, M; Gabay, C; Elizur, S; Qi, PM; Reubinoff, BE; Chess, A; Cedar, H; Bergman, Y			Asynchronous replication and allelic exclusion in the immune system	NATURE			English	Article							IMMUNOGLOBULIN-KAPPA; X-CHROMOSOMES; GENE REARRANGEMENT; MOUSE EMBRYOS; EXPRESSION; CELLS; DIFFERENTIATION; INACTIVATION	The development of mature B cells involves a series of molecular decisions which culminate in the expression of a single light-chain and heavy-chain antigen receptor on the cell surface(1,2). There are two alleles for each receptor locus, so the ultimate choice of one receptor type must involve a process of allelic exclusion. One way to do this is with a feedback mechanism that downregulates rearrangement after the generation of a productive receptor molecule(3), but recent work suggests that monoallelic epigenetic changes may also take place even before rearrangement(4). To better understand the basis for distinguishing between alleles, we have analysed DNA replication timing. Here we show that all of the B-cell-receptor loci (mu, kappa and lambda) and the TCR beta locus replicate asynchronously. This pattern, which is established randomly in each cell early in development and maintained by cloning, represents an epigenetic mark for allelic exclusion, because it is almost always the early-replicating allele which is initially selected to undergo rearrangement in B cells. These results indicate that allelic exclusion in the immune system may be very similar to the process of X chromosome inactivation.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Natl Inst Genet, Dept Evolutionary Genet, Mishima, Shizuoka 4118540, Japan; Hadassah Ein Kerem Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Hadassah Ein Kerem Univ Hosp, Goldyn Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Massachusetts Institute of Technology (MIT)	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, POB 12272, IL-91120 Jerusalem, Israel.		Schlesinger, Sharon/A-5283-2016	Schlesinger, Sharon/0000-0001-9549-2383; Reubinoff, Benjamin/0000-0003-0353-1299				APEL TW, 1995, GENE, V156, P191, DOI 10.1016/0378-1119(94)00901-4; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; CEBRA JJ, 1966, J EXP MED, V123, P547, DOI 10.1084/jem.123.3.547; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; Chess A, 1998, SCIENCE, V279, P2067, DOI 10.1126/science.279.5359.2067; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; Hogan B, 1994, MANIPULATING MOUSE E; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; LUNINGPRAK E, 1995, J EXP MED, V182, P541; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; MULLINS LJ, 1987, MOL CELL BIOL, V7, P3916, DOI 10.1128/MCB.7.11.3916; NADON N, 1988, SOMAT CELL MOLEC GEN, V14, P541, DOI 10.1007/BF01535309; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; SIMON I, 1996, DNA REPLICATION EUKA, P387; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; Tenzen T, 1997, MOL CELL BIOL, V17, P4043, DOI 10.1128/MCB.17.7.4043	32	197	205	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					221	225		10.1038/35102606	http://dx.doi.org/10.1038/35102606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700561				2022-12-24	WOS:000172029100051
J	Al-Shahi, R; Will, RG; Warlow, CP				Al-Shahi, R; Will, RG; Warlow, CP			Amount of research interest in rare and common neurological conditions: bibliometric study	BRITISH MEDICAL JOURNAL			English	Article									Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Warlow, CP (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.			Al-Shahi Salman, Rustam/0000-0002-2108-9222				Frankel S, 1989, Health Trends, V21, P56; Global Forum for Health Research, 2000, 10 90 REP HLTH RES; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; WARLOW CP, 2001, BRAINS DIS NERVOUS S	5	18	18	3	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1461	1462		10.1136/bmj.323.7327.1461	http://dx.doi.org/10.1136/bmj.323.7327.1461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751355	Green Published, Green Submitted			2022-12-24	WOS:000172979900015
J	Garcia, LR; Mehta, P; Sternberg, PW				Garcia, LR; Mehta, P; Sternberg, PW			Regulation of distinct muscle behaviors controls the C. elegans male's copulatory spicules during mating	CELL			English	Article							LEVAMISOLE RESISTANCE; SYNAPTIC-TRANSMISSION; GENE-TRANSFER; MUTANTS; MUTATIONS; G(Q)ALPHA; ENCODES; CELLS; INTERACTS	We demonstrate through cell ablation, molecular genetic, and pharmacological approaches that during C. elegans male mating behavior, the male inserts his copulatory spicules into the hermaphrodite by regulating periodic and prolonged spicule muscle contractions. Distinct cholinergic neurons use different ACh receptors and calcium channels in the spicule muscles to mediate these contractile behaviors. The PCB and PCC sensory neurons facilitate periodic contraction through muscle-encoded UNC-68 ryanodine receptor calcium channels. The SPC motor neurons trigger prolonged contraction through EGL-19 L-type voltage-gated calcium channels. The male gonad then lengthens the duration of EGL-19-mediated prolonged muscle contraction. This regulation of muscle contraction provides a paradigm to explain how animals initiate, monitor, and maintain a behavioral motor program.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu						ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43913; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; FINNEY D J, 1971, P333; Fleming JT, 1997, J NEUROSCI, V17, P5843; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller LM, 1996, GENETICS, V143, P1181; Moerman Donald G., 1997, Cold Spring Harbor Monograph Series, V33, P417; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TRENT C, 1983, GENETICS, V104, P619; TRIBUT F, 1994, J EXP BIOL, V186, P325; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475	43	81	82	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					777	788		10.1016/S0092-8674(01)00600-6	http://dx.doi.org/10.1016/S0092-8674(01)00600-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747813	Bronze			2022-12-24	WOS:000172771800010
J	Heldin, CH; Ericsson, J				Heldin, CH; Ericsson, J			Signal transduction - RIPping tyrosine kinase receptors apart	SCIENCE			English	Editorial Material							INTRAMEMBRANE PROTEOLYSIS		Ludwig Inst Canc Res, Ctr Biomed, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research	Heldin, CH (corresponding author), Ludwig Inst Canc Res, Ctr Biomed, Box 595, SE-75124 Uppsala, Sweden.		Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065	8	31	32	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2111	+		10.1126/science.1067628	http://dx.doi.org/10.1126/science.1067628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739942				2022-12-24	WOS:000172647700034
J	Zheng, B; Ma, YC; Ostrom, RS; Lavoie, C; Gill, GN; Insel, PA; Huang, XY; Farquhar, MG				Zheng, B; Ma, YC; Ostrom, RS; Lavoie, C; Gill, GN; Insel, PA; Huang, XY; Farquhar, MG			RGS-PX1, a GAP for G alpha(s) and sorting nexin in vesicular trafficking	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEINS; ALPHA-SUBUNITS; RECEPTOR; IDENTIFICATION; HYDROLYSIS; KINASE; FAMILY; RGS4; BETA	Heterotrimeric GTP-binding proteins (G proteins) control cellular functions by transducing signals from the outside to the inside of cells. Regulator of G protein signaling (RGS) proteins are key modulators of the amplitude and duration of G protein-mediated signaling through their ability to serve as guanosine triphosphatase-activating proteins (GAPS). We have identified RGS-PX1, a G alpha (s)-specific GAP. The RGS domain of RGS-PX1 specifically interacted with G alpha (s) accelerated its GTP hydrolysis, and attenuated G alpha (s)-mediated signaling. RGS-PX1 also contains a Phox (PX) domain that resembles those in sorting nexin (SNX) proteins. Expression of RGS-PX1 delayed Lysosomal degradation of the EGF receptor. Because of its bifunctional role as both a GAP and a SNX, RGS-PX1 may link heterotrimeric G protein signaling and vesicular trafficking.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.			Ostrom, Rennolds/0000-0002-7204-0357; Zheng, Bin/0000-0002-0998-7177; Ma, Yongchao/0000-0002-2469-4356	NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773, R01HL063885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017780, R37DK017780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014563] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline; NHLBI NIH HHS [HL63885, HL53773] Funding Source: Medline; NIA NIH HHS [AG14563] Funding Source: Medline; NIDDK NIH HHS [DK17780] Funding Source: Medline; NIGMS NIH HHS [GM56904] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; OSTROM RS, 2001, J BIOL CHEM; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	19	186	190	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1939	1942		10.1126/science.1064757	http://dx.doi.org/10.1126/science.1064757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729322				2022-12-24	WOS:000172465000063
J	Feldman, KA; Enscore, RE; Lathrop, SL; Matyas, BT; McGuill, M; Schriefer, ME; Stiles-Enos, D; Dennis, DT; Petersen, LR; Hayes, EB				Feldman, KA; Enscore, RE; Lathrop, SL; Matyas, BT; McGuill, M; Schriefer, ME; Stiles-Enos, D; Dennis, DT; Petersen, LR; Hayes, EB			An outbreak of primary pneumonic tularemia on martha's vineyard	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: In the summer of 2000, an outbreak of primary pneumonic tularemia occurred on Martha's Vineyard, Massachusetts. The only previously reported outbreak of pneumonic tularemia in the United States also occurred on the island in 1978. Methods: We conducted a case-control study of adults with pneumonic tularemia and investigated the environment to identify risk factors for primary pneumonic tularemia. Patients with confirmed cases were residents of or visitors to Martha's Vineyard who had symptoms suggestive of primary pneumonic tularemia, were ill between May 15 and October 31, 2000, and had a positive laboratory test for tularemia. Controls were adults who had spent at least 15 days on Martha's Vineyard between May 15 and September 28, 2000. Results: We identified 15 patients with tularemia; 11 of these cases were primary pneumonic tularemia. Francisella tularensis type A was isolated from blood and lung tissue of the one man who died. Patients were more likely than controls to have used a lawn mower or brush cutter in the two weeks before the illness (odds ratio, 9.2; 95 percent confidence interval, 1.6 to 68.0) and during the summer (odds ratio, undefined; 95 percent confidence interval, 1.8 to (infinity)). Lawn mowing and brush cutting remained significant risk factors after adjustment for other potentially confounding variables. Only one patient reported being exposed to a rabbit while cutting brush. Of 40 trapped animals, 1 striped skunk and 1 Norway rat were seropositive for antibodies against F. tularensis. Conclusions: Study of this outbreak of primary pneumonic tularemia implicates lawn mowing and brush cutting as risk factors for this infection. (N Engl J Med 2001;345:1601-6.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Ft Collins, CO 80522 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Ft Collins, CO 80522 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Marthas Vineyard Hosp, Oak Bluffs, MA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health	Feldman, KA (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, POB 2087,Rampart Rd, Ft Collins, CO 80522 USA.			Enscore, Russell/0000-0002-1290-1100				[Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; AYRES JC, 1948, NEW ENGL J MED, V238, P187, DOI 10.1056/NEJM194802052380606; Belding DL, 1941, NEW ENGL J MED, V224, P1085, DOI 10.1056/NEJM194106262242602; BELL J F, 1975, Journal of Wildlife Diseases, V11, P421; BELL JF, 1979, CRC HDB SERIES ZOO A, V2, P161; BROWN SL, 1980, J CLIN MICROBIOL, V11, P146, DOI 10.1128/JCM.11.2.146-148.1980; DAHLSTRAND S, 1971, Scandinavian Journal of Infectious Diseases, V3, P7; DEAN A, 1995, EPI INFO VERSION 6 W; DENNIS DT, 1999, INFECT DIS; DENNIS DT, 1998, MAXCY ROSENAU LAST P, P354; HALSTED CC, 1978, PEDIATRICS, V61, P660; Hopla CE, 1994, HDB ZOONOSES, P113; Hornick R. B., 1998, BACTERIAL INFECT HUM, P823; Jellison W.L., 1974, TULAREMIA N AM 1930; LENHART SW, 1997, DHHS PUBLICATION; MARTONE WJ, 1979, JAMA-J AM MED ASSOC, V242, P2315, DOI 10.1001/jama.242.21.2315; MCCARTHY VP, 1990, PEDIATR INFECT DIS J, V9, P298, DOI 10.1097/00006454-199004000-00018; MCDOWELL JW, 1964, TULAREMIA; MEHTA C, 1992, STATXACT VERSION 4 0; Murin S, 2000, CLIN CHEST MED, V21, P121, DOI 10.1016/S0272-5231(05)70012-5; PARKER RR, 1951, NATL I HLTH B, V193, P1; PENN RL, 1995, MANDELL DOUGLAS BENN, V2, P2060; PITTMAN B, 1977, J CLIN MICROBIOL, V5, P621; POMANSKAIA L. A., 1957, Journal of Microbiology, Epidemiology and Immunobiology, V28, P597; *SAS I, 1996, SAS VERS 6 12; SMITH CN, 1946, BIOL CONTROL AM DOG; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; Williams J, 1998, LANCET, V351, P1697, DOI 10.1016/S0140-6736(97)10444-5; 1993, MMWR MORB MORTAL WKL, V42, P1	29	198	205	0	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2001	345	22					1601	1606		10.1056/NEJMoa011374	http://dx.doi.org/10.1056/NEJMoa011374			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496EU	11757506				2022-12-24	WOS:000172383900003
J	Pearson, H				Pearson, H			China caught out as model shows net fall in fish	NATURE			English	News Item																			0	1	1	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					477	477		10.1038/35107216	http://dx.doi.org/10.1038/35107216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734811	Bronze			2022-12-24	WOS:000172405900008
J	Wildermuth, MC; Dewdney, J; Wu, G; Ausubel, FM				Wildermuth, MC; Dewdney, J; Wu, G; Ausubel, FM			Isochorismate synthase is required to synthesize salicylic acid for plant defence	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ARABIDOPSIS; TOBACCO; BIOSYNTHESIS; INDUCTION; MUTANT; PROTEIN	Salicylic acid (SA) mediates plant defences against pathogens, accumulating in both infected and distal leaves in response to pathogen attack(1-5). Pathogenesis-related gene expression and the synthesis of defensive compounds associated with both local and systemic acquired resistance (LAR and SAR) in plants require SA. In Arabidopsis, exogenous application of SA suffices to establish SAR, resulting in enhanced resistance to a variety of pathogens. However, despite its importance in plant defence against pathogens, SA biosynthesis is not well defined. Previous work has suggested that plants synthesize SA from phenylalanine(6-10); however, SA could still be produced when this pathway was inhibited(6,8), and the specirc activity of radiolabelled SA in feeding experiments was often lower than expected(7,8). Some bacteria such as Pseudomonas aeruginosa synthesize SA using isochorismate synthase (ICS) and pyruvate lyase(11). Here we show, by cloning and characterizing an Arabidopsis defence-related gene (SID2) defined by mutation, that SA is synthesized from chorismate by means of ICS, and that SA made by this pathway is required for LAR and SAR responses.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Brandeis Univ, Michtom Sch Comp Sci, Waltham, MA 02254 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Brandeis University; Harvard University; Harvard Medical School	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.							Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coquoz JL, 1998, PLANT PHYSIOL, V117, P1095, DOI 10.1104/pp.117.3.1095; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; LEON J, 1995, P NATL ACAD SCI USA, V92, P10413, DOI 10.1073/pnas.92.22.10413; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Ribnicky DM, 1998, PLANT PHYSIOL, V118, P565, DOI 10.1104/pp.118.2.565; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; van Tegelen LJP, 1999, PLANT PHYSIOL, V119, P705, DOI 10.1104/pp.119.2.705; YALPANI N, 1993, PLANT PHYSIOL, V103, P315, DOI 10.1104/pp.103.2.315; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972	30	1511	1589	7	254	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					562	565		10.1038/35107108	http://dx.doi.org/10.1038/35107108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734859				2022-12-24	WOS:000172405900052
J	Satcher, D				Satcher, D			Global HIV/AIDS revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2001	286	20					2535	2535		10.1001/jama.286.20.2535	http://dx.doi.org/10.1001/jama.286.20.2535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FH	11722254				2022-12-24	WOS:000172385200009
J	Dervyn, E; Suski, C; Daniel, R; Bruand, C; Chapuis, J; Errington, J; Janniere, L; Ehrlich, SD				Dervyn, E; Suski, C; Daniel, R; Bruand, C; Chapuis, J; Errington, J; Janniere, L; Ehrlich, SD			Two essential DNA polymerases at the bacterial replication fork	SCIENCE			English	Article							BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; EPSILON; PAM-BETA-1; INITIATION; GENE	DNA replication in bacteria is carried out by a multiprotein complex, which is thought to contain only one essential DNA polymerase, specified by the dhaE gene in Escherichia coli and the polC gene in Bacillus subtilis. Bacillus subtilis genome analysis has revealed another DNA polymerase gene, dnaE(BS), which is homologous to dnaE. We show that, in B. subtilis, dnaE(BS) is essential for cell viability and for the elongation step of DNA replication, as is polC, and we conclude that there are two different essential DNA polymerases at the replication fork of B. subtilis, as was previously observed in eukaryotes. dnaE(BS) appears to be involved in the synthesis of the tagging DNA strand and to be associated with the replication factory, which suggests that two different polymerases carry out synthesis of the two DNA strands in B. subtilis and in many other bacteria that contain both polC and dnaE genes.	INRA, F-78352 Jouy En Josas, France; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Ehrlich, SD (corresponding author), INRA, F-78352 Jouy En Josas, France.	ehrlich@jouy.mra.fr	Bruand, Claude/AAF-7695-2020; Ehrlich, S./Y-2423-2019; Errington, Jeff/G-1832-2011	Ehrlich, S./0000-0002-7563-4046; Errington, Jeff/0000-0002-6977-9388; Suski Grabowski, Catherine/0000-0002-4892-6633; Bruand, Claude/0000-0002-2367-0782; Janniere, Laurent/0000-0003-2353-3160				ARAKI H, 1992, EMBO J, V11, P733, DOI 10.1002/j.1460-2075.1992.tb05106.x; BAZILL GW, 1973, NATURE-NEW BIOL, V243, P241, DOI 10.1038/newbio243241a0; Bidnenko V, 1998, MOL MICROBIOL, V28, P1005, DOI 10.1046/j.1365-2958.1998.00862.x; BOE L, 1989, J BACTERIOL, V171, P3366, DOI 10.1128/jb.171.6.3366-3372.1989; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; BRUAND C, 1991, EMBO J, V10, P2171, DOI 10.1002/j.1460-2075.1991.tb07752.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BRUAND C, UNPUB; Bruck I, 2000, J BIOL CHEM, V275, P28971, DOI 10.1074/jbc.M003565200; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; DALENCON E, UNPUB; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; GANESAN AT, 1988, GENETICS BIOTECHNOLO, V2, P317; Goodman MF, 2000, TRENDS BIOCHEM SCI, V25, P189, DOI 10.1016/S0968-0004(00)01564-4; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Karthikeyan R, 2000, J MOL BIOL, V299, P405, DOI 10.1006/jmbi.2000.3744; Kornberg A., 1992, DNA REPLICATION; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LeChatelier E, 1996, MOL MICROBIOL, V20, P1099; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; YASBIN RE, 1980, GENE, V12, P155, DOI 10.1016/0378-1119(80)90026-8; Yasbin Ronald E., 1993, P529; YOSHIKAWA H, 1963, P NATL ACAD SCI USA, V49, P559, DOI 10.1073/pnas.49.4.559	29	117	122	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1716	1719		10.1126/science.1066351	http://dx.doi.org/10.1126/science.1066351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721055				2022-12-24	WOS:000172307400044
J	Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY				Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY			Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; GREAT-BRITAIN; BSE; VARIANT; CJD	The size of the variant Creutzfeldt-Jakob Disease (vCJD) epidemic in the United Kingdom is a major public health concern and a subject of speculation. The cases are young (mean age = 28). Assuming that the risk of developing the disease in susceptible exposed subjects decreases exponentially with age after age 15, that all infections occurred between 1980 and 1989, and that the distribution of the incubation period is lognormal, we estimate that the mean duration of the incubation period is 16.7 years [95% confidence interval (CI): 12.4 to 23.2] and that the total number of cases will be 205 (upper limit of the 95% CI: 403).	Univ Paris 06, CHU St Antoine, INSERM, U444, 27 Rue Chaligny, F-75012 Paris, France; Assistance Publ Hop Paris, F-75012 Paris, France; Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Grenoble 1, UFR Med Grenoble, Immun Antiinfect JE 2236, F-38706 La Tronche, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Edinburgh; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Valleron, AJ (corresponding author), Univ Paris 06, CHU St Antoine, INSERM, U444, 27 Rue Chaligny, F-75012 Paris, France.							ANDERSON R M, 1991; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CHEVRET S, 1992, J EPIDEMIOL COMMUN H, V46, P582, DOI 10.1136/jech.46.6.582; Cohen CH, 1999, INT J EPIDEMIOL, V28, P526, DOI 10.1093/ije/28.3.526; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; *EUR UN SCI STEER, 1999, OP SCI STEER COMM HU; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; KLITZMAN R, 1984, NEUROEPIDEMIOLOGY, V3, P20; SARTWELL PE, 1950, AM J HYG, V51, P310, DOI 10.1093/oxfordjournals.aje.a119397	12	158	163	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1726	1728		10.1126/science.1066838	http://dx.doi.org/10.1126/science.1066838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721058				2022-12-24	WOS:000172307400047
J	Cicero, S; Curcio, P; Papageorghiou, A; Sonek, J; Nicolaides, K				Cicero, S; Curcio, P; Papageorghiou, A; Sonek, J; Nicolaides, K			Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study	LANCET			English	Article							FETAL NUCHAL TRANSLUCENCY; DOWNS-SYNDROME; PREGNANCY; SKIN	Background Prenatal diagnosis of trisomy 21 requires an invasive test in women regarded as being at high risk after screening. At present there are four screening tests, and for a 5% false-positive rate, the sensitivities are about 30% for maternal age alone, 60-70% for maternal age and second-trimester maternal serum biochemical testing, 75% for maternal age and first-trimester fetal nuchal translucency scanning, and 85% for maternal age with fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks. In this study, we examined the possible improvement in screening for trisomy 21 by examining the fetal nasal bone with ultrasound at 11-14 weeks of gestation. Methods We did an ultrasound examination of the fetal profile in 701 fetuses at 11-14 weeks' gestation immediately before karyotyping for a possible chromosomal abnormality detected by maternal age and fetal nuchal translucency screening. The presence or absence of a nasal bone was noted. Findings The fetal profile was successfully examined In all cases. The nasal bone was absent in 43 of 59 (73%) trisomy 21 fetuses and in three of 603 (0.5%) chromosomally normal fetuses. The likelihood ratio for trisomy 21 was 146 (95% CI 50-434) for absent nasal bone and 0.27 (0.18-0.40) for present nasal bone. In screening for trisomy 21, by a combination of maternal age and fetal nuchal translucency, we estimated that inclusion of examination of the fetal profile for the presence or absence of nasal bone could increase the sensitivity to 85% and decrease the false-positive rate to about 1%. Interpretation In screening for trisomy 21, examination of the fetal nasal bone could result In major reduction in the need for invasive testing and a substantial increase in sensitivity.	Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England; Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University System of Ohio; Ohio State University	Nicolaides, K (corresponding author), Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 8RX, England.	fmf@fetalmedicine.com		Nicolaides, Kypros/0000-0003-1266-0711; Papageorghiou, Aris T./0000-0001-8143-2232				Bohlandt S, 2000, HUM REPROD, V15, P1155, DOI 10.1093/humrep/15.5.1155; CUCKLE H, 1991, PRENATAL DIAG, V11, P29, DOI 10.1002/pd.1970110106; Cuckle H, 2001, CURR OPIN OBSTET GYN, V13, P175, DOI 10.1097/00001703-200104000-00013; de Graaf IM, 1999, PRENATAL DIAG, V19, P458, DOI 10.1002/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A; Dick PT, 1996, CAN MED ASSOC J, V154, P465; Down J.L., 1866, OBSERVATION ETHNIC C, DOI DOI 10.1038/HDY.1966.69; Moss M.L., 1962, VISTAS ORTHODONTICS; NICOLAIDES KH, 1992, BRIT MED J, V304, P867, DOI 10.1136/bmj.304.6831.867; Nicolaides KH, 1998, PRENATAL DIAG, V18, P519, DOI 10.1002/(SICI)1097-0223(199805)18:5<519::AID-PD398>3.0.CO;2-U; SANDIKCIOGLU M, 1994, J CRAN GENET DEV BIO, V14, P124; SNIDJERS RMJ, 1998, LANCET, V351, P343; Spencer K, 1999, ULTRASOUND OBST GYN, V13, P231, DOI 10.1046/j.1469-0705.1999.13040231.x; von Kaisenberg CS, 1998, ANAT EMBRYOL, V197, P105, DOI 10.1007/s004290050123; Von Kaisenberg CS, 1998, OBSTET GYNECOL, V91, P319, DOI 10.1016/S0029-7844(97)00697-2; WALD NJ, 1992, BMJ-BRIT MED J, V305, P391, DOI 10.1136/bmj.305.6850.391	15	339	367	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2001	358	9294					1665	1667		10.1016/S0140-6736(01)06709-5	http://dx.doi.org/10.1016/S0140-6736(01)06709-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728540				2022-12-24	WOS:000172344100008
J	Yang, ZY; Zhu, QW; Luo, KX; Zhou, Q				Yang, ZY; Zhu, QW; Luo, KX; Zhou, Q			The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; P-TEFB; TERMINAL DOMAIN; POLYMERASE-II; HIV-1 TAT; ELONGATION; ACTIVATION; PROMOTER; PHOSPHORYLATION; MECHANISM	The human positive transcription elongation factor P-TEFb, consisting of a CDK9/cyclin T1 heterodimer, functions as both a general and an HIV-1 Tat-specific transcription factor(1,2). P-TEFb activates transcription by phosphorylating RNA polymerase (Pol) II, leading to the formation of processive elongation complexes. As a Tat cofactor, P-TEFb stimulates HIV-1 transcription by interacting with Tat and the transactivating responsive (TAR) RNA structure located at the 5' end of the nascent viral transcript(3). Here we identified 7SK, an abundant and evolutionarily conserved small nuclear RNA (snRNA) of unknown function(4,5), as a specific P-TEFb-associated factor. 7SK inhibits general and HIV-1 Tat-specific transcriptional activities of P-TEFb in vivo and in vitro by inhibiting the kinase activity of CDK9 and preventing recruitment of P-TEFb to the HIV-1 promoter. 7SK is efficiently dissociated from P-TEFb by treatment of cells with ultraviolet irradiation and actinomycin D. As these two agents have been shown to significantly enhance HIV-1 transcription and phosphorylation of Pol II (refs 6-8), our data provide a mechanistic explanation for their stimulatory effects. The 7SK/P-TEFb interaction may serve as a principal control point for the induction of cellular and HIV-1 viral gene expression during stress-related responses. Our studies demonstrate the involvement of an snRNA in controlling the activity of a Cdk-cyclin kinase.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Yang, Zhiyuan/C-9543-2012	Yang, Zhiyuan/0000-0002-1175-4188				BLACK CC, 1985, WEEK PHYSL, V2, P1; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kretz-Remy C, 1994, FEBS Lett, V353, P339; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Lis JT, 2000, GENE DEV, V14, P792; Luo Y, 1997, J CELL BIOCHEM, V64, P313, DOI 10.1002/(SICI)1097-4644(199702)64:2<313::AID-JCB13>3.0.CO;2-J; MURPHY S, 1984, J MOL BIOL, V177, P575, DOI 10.1016/0022-2836(84)90038-X; Peter M, 1997, Prog Cell Cycle Res, V3, P99; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; VLACH J, 1995, VIROLOGY, V208, P753, DOI 10.1006/viro.1995.1207; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; ZIEVE G, 1977, BIOCHEMISTRY-US, V16, P4520, DOI 10.1021/bi00639a029; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	24	527	549	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					317	322		10.1038/35104575	http://dx.doi.org/10.1038/35104575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713532				2022-12-24	WOS:000172150700046
J	Weggen, S; Eriksen, JL; Das, P; Sagi, SA; Wang, R; Pietrzik, CU; Findlay, KA; Smith, TE; Murphy, MP; Butler, T; Kang, DE; Marquez-Sterling, N; Golde, TE; Koo, EH				Weggen, S; Eriksen, JL; Das, P; Sagi, SA; Wang, R; Pietrzik, CU; Findlay, KA; Smith, TE; Murphy, MP; Butler, T; Kang, DE; Marquez-Sterling, N; Golde, TE; Koo, EH			A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity	NATURE			English	Article							ALZHEIMERS-DISEASE; BETA-PROTEIN; PRECURSOR PROTEIN; INFLAMMATION; PRESENILIN-1; INHIBITION; PATHWAY; DOMAIN; BRAIN	Epidemiological studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs)(1-5). It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved. Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulphide preferentially decrease the highly amyloidogenic A beta 42 peptide (the 42-residue isoform of the amyloid-beta peptide) produced from a variety of cultured cells by as much as 80%. This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacological target of NSAIDs(6). Furthermore, short-term administration of ibuprofen to mice that produce mutant beta -amyloid precursor protein (APP) lowered their brain levels of A beta 42. In cultured cells, the decrease in A beta 42 secretion was accompanied by an increase in the A beta (1-38) isoform, indicating that NSAIDs subtly alter gamma -secretase activity without significantly perturbing other APP processing pathways or Notch cleavage. Our findings suggest that NSAIDs directly affect amyloid pathology in the brain by reducing A beta 42 peptide levels independently of COX activity and that this A beta 42-lowering activity could be optimized to selectively target the pathogenic A beta 42 species.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	University of California System; University of California San Diego; Mayo Clinic; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; California Institute of Technology; Northwestern University	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.		Wang, Rong/A-8721-2009; Kang, David E./E-5234-2012; Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Kang, David E./0000-0002-7132-821X; Bulter, Thomas/0000-0002-7968-5844				ABDELHALIM MS, 1978, ACTA PHARMACOL TOX, V43, P266; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; MCEVOY GK, 1998, AHFS DRUG INFORMATIO; McGeer PL, 2000, DRUG AGING, V17, P1, DOI 10.2165/00002512-200017010-00001; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Piazza GA, 1997, CANCER RES, V57, P2452; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Yuan H, 1999, J NEUROSCI METH, V88, P45, DOI 10.1016/S0165-0270(99)00011-4; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451	30	1179	1300	1	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					212	216		10.1038/35102591	http://dx.doi.org/10.1038/35102591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700559				2022-12-24	WOS:000172029100049
J	Schwetz, BA				Schwetz, BA			Pacemaker for congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-24	WOS:000172032100008
J	Zhang, ZL; Brennan, ML; Fu, XM; Aviles, RJ; Pearce, GL; Penn, MS; Topol, EJ; Sprecher, DL; Hazen, SL				Zhang, ZL; Brennan, ML; Fu, XM; Aviles, RJ; Pearce, GL; Penn, MS; Topol, EJ; Sprecher, DL; Hazen, SL			Association between myeloperoxidase levels and risk of coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC INTIMA; MASS-SPECTROMETRIC QUANTIFICATION; SCAVENGER RECEPTOR CD36; NITRIC-OXIDE; P-HYDROXYPHENYLACETALDEHYDE; LIPID-PEROXIDATION; IN-VITRO; OXIDATION; LDL	Context Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis. Objective To determine the association between MPO levels and prevalence of coronary artery disease (CAD). Design, Setting, and Patients Case-control study conducted from July to September 2000 in a US tertiary care referral center, including 158 patients with established CAD (cases) and 175 patients without angiographically significant CAD (controls). Main Outcome Measures Association of MPO levels per milligram of neutrophil protein (leukocyte-MPO) and MPO levels per milliliter of blood (blood-MPO) with CAD risk. Results Leukocyte- and blood-MPO levels were both significantly greater in patients with CAD than in controls (P<.001). In multivariable models adjusting for traditional cardiovascular risk factors, Framingham risk score, and white blood cell counts, MPO levels were significantly associated with presence of CAD, with an OR of 11.9 (95% CI, 5.5-25.5) for the highest vs lowest quartiles of leukocyte-MPO and an OR of 20.4 (95% CI, 8.9-47.2) for the highest vs lowest quartiles of blood-MPO. Conclusions Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD. These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment.	Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Sect Prevent Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.		Hazen, Stanley L/ABD-5845-2021	Topol, Eric/0000-0002-1478-4729	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062526, R01HL061878] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62526, HL61878] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Abu-Soud Husam M., 2000, Nitric Oxide, V4, P179; AKIYAMA Y, 1983, J CLIN INVEST, V72, P1093, DOI 10.1172/JCI111034; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Biasucci LM, 1996, J AM COLL CARDIOL, V27, P611, DOI 10.1016/0735-1097(95)00524-2; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Capeillere-Blandin C, 1998, BIOCHEM J, V336, P395, DOI 10.1042/bj3360395; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1815, DOI 10.1016/S0891-5849(00)00344-0; Chisolm GM, 1999, J BIOL CHEM, V274, P25959, DOI 10.1074/jbc.274.37.25959; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; ERNST E, 1987, JAMA-J AM MED ASSOC, V257, P2318, DOI 10.1001/jama.257.17.2318; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Hazen SL, 1999, CIRC RES, V85, P950; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J BIOL CHEM, V271, P1861, DOI 10.1074/jbc.271.4.1861; Hazen SL, 2000, BIOCHEM J, V352, P693, DOI 10.1042/0264-6021:3520693; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Heinecke JW, 1999, FASEB J, V13, P1113, DOI 10.1096/fasebj.13.10.1113; Heller JI, 2000, J BIOL CHEM, V275, P9957, DOI 10.1074/jbc.275.14.9957; KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399; Kullo IJ, 2000, MAYO CLIN PROC, V75, P369, DOI 10.4065/75.4.369; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Malech HL, 1997, SEMIN HEMATOL, V34, P279; MALLE E, 1995, ARTERIOSCL THROM VAS, V15, P982, DOI 10.1161/01.ATV.15.7.982; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NAUSEEF WM, 1988, HEMATOL ONCOL CLIN N, V2, P135; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; OWEN CA, 1994, AM J PHYSIOL-LUNG C, V267, pL775, DOI 10.1152/ajplung.1994.267.6.L775; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; PEPPIN GJ, 1986, P NATL ACAD SCI USA, V83, P4322, DOI 10.1073/pnas.83.12.4322; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Shabani F, 1998, FREE RADICAL RES, V28, P115, DOI 10.3109/10715769809065797; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Taylor AJ, 2000, CIRCULATION, V101, P1243, DOI 10.1161/01.CIR.101.11.1243; Yang CY, 1999, J LIPID RES, V40, P686	50	699	762	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2136	2142		10.1001/jama.286.17.2136	http://dx.doi.org/10.1001/jama.286.17.2136			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694155	Bronze			2022-12-24	WOS:000172032100033
J	Norman, RJ				Norman, RJ			Reproductive consequences of COX-2 inhibition	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFERTILITY		Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia	University of Adelaide	Norman, RJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia.		Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896				Akil M, 1996, BRIT J RHEUMATOL, V35, P76; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; Duffy DM, 2001, MOL HUM REPROD, V7, P731, DOI 10.1093/molehr/7.8.731; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; JANSSENCASPERS HAB, 1986, FERTIL STERIL, V46, P823; Joyce IM, 2001, ENDOCRINOLOGY, V142, P3187, DOI 10.1210/en.142.7.3187; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Mendonca LLF, 2000, RHEUMATOLOGY, V39, P880, DOI 10.1093/rheumatology/39.8.880; Pall M, 2001, HUM REPROD, V16, P1323, DOI 10.1093/humrep/16.7.1323; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Smith G, 1996, BRIT J RHEUMATOL, V35, P458; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97	15	20	23	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1287	1288		10.1016/S0140-6736(01)06455-8	http://dx.doi.org/10.1016/S0140-6736(01)06455-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684206				2022-12-24	WOS:000171702500005
J	Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M				Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M			Combined functional genomic maps of the C-elegans DNA damage response	SCIENCE			English	Article							PROTEIN; YEAST; INTERFERENCE; CHECKPOINTS; PATHWAY; REPAIR; LENGTH; RNA	Many human cancers originate from defects in the DNA damage response (DDR). Although much is known about this process, it is likely that additional DDR genes remain to be discovered. To identify such genes, we used a strategy that combines protein-protein interaction mapping and large-scale phenotypic analysis in Caenorhabditis elegans. Together, these approaches identified 12 worm DDR orthologs and 11 novel DDR genes. One of these is the putative ortholog of hBCL3, a gene frequently altered in chronic lymphocytic leukemia. Thus, the combination of functional genomic mapping approaches in model organisms may facilitate the identification and characterization of genes involved in cancer and, perhaps, other human diseases.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Vidal, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Reboul, Jerome/P-9103-2016	Reboul, Jerome/0000-0002-5513-4546; Gartner, Anton/0000-0003-4639-9902; Vaglio, Philippe/0000-0003-2900-5596	NATIONAL CANCER INSTITUTE [P01CA080111, R33CA081658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER; NCI NIH HHS [7 R33 CA81658-02, P01CA80111-02] Funding Source: Medline; NHGRI NIH HHS [5R01HG01715-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Cai RL, 2000, J BIOL CHEM, V275, P27909; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dernburg AF, 2000, GENE DEV, V14, P1578; di Fagagna FD, 1999, NAT GENET, V23, P76; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Sternberg PW, 2001, CELL, V105, P173, DOI 10.1016/S0092-8674(01)00308-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	225	232	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					127	131		10.1126/science.1065986	http://dx.doi.org/10.1126/science.1065986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778048				2022-12-24	WOS:000173143100049
J	Costard, F; Forget, F; Mangold, N; Peulvast, JP				Costard, F; Forget, F; Mangold, N; Peulvast, JP			Formation of recent Martian debris flows by melting of near-surface ground ice at high obliquity	SCIENCE			English	Article							MARS; ATMOSPHERE; BEHAVIOR	The observation of small gullies associated with recent surface runoff on Mars has renewed the question of liquid water stability at the surface of Mars. The gullies could be formed by groundwater seepage from underground aquifers; however, observations of gullies originating from isolated peaks and dune crests question this scenario. We show that these Landforms may result from the melting of water ice in the top few meters of the martian subsurface at high obliquity. Our conclusions are based on the analogy between the martian gullies and terrestrial debris flows observed in Greenland and numerical simulations that show that above-freezing temperatures can occur at high obliquities in the near surface of Mars, and that such temperatures are only predicted at latitudes and for slope orientations corresponding to where the gullies have been observed on Mars.	Univ Paris 06, CNRS, Meteorol Dynam Lab, F-75252 Paris 05, France; Univ Paris 11, CNRS, UMR8616, Equipe Geomorphol Planetaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Forget, F (corresponding author), Univ Paris 06, CNRS, Meteorol Dynam Lab, Boite Postal 99, F-75252 Paris 05, France.	forget@lmd.jussieu.fr						ALLEN PA, 1997, EARTH SURFACE PROCES; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Gaidos EJ, 2001, ICARUS, V153, P218, DOI 10.1006/icar.2001.6649; HARRIS SA, 1993, Z GEOMORPHOL, V37, P41; Hartmann WK, 2001, SPACE SCI REV, V96, P405, DOI 10.1023/A:1011969927462; INNES JL, 1983, PROG PHYS GEOG, V7, P469, DOI 10.1177/030913338300700401; Kieffer H., 1992, MARS; Knauth LP, 2000, SCIENCE, V290, P711; Lewis SR, 1999, J GEOPHYS RES-PLANET, V104, P24177, DOI 10.1029/1999JE001024; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MARTIN TZ, 1979, J GEOPHYS RES, V84, P2830, DOI 10.1029/JB084iB06p02830; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Peulvast J.P., 1988, GEOGR ANN SER B, V70, P351, DOI 10.2307/521268; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	315	321	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					110	113		10.1126/science.1066698	http://dx.doi.org/10.1126/science.1066698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11729267				2022-12-24	WOS:000173143100044
J	Sharp, MD; Pogliano, K				Sharp, MD; Pogliano, K			Rote of cell-specific SpoIIIE assembly in polarity of DNA transfer	SCIENCE			English	Article							BACILLUS-SUBTILIS SPORULATION; MECHANISM; DIVISION; BACTERIA; PROTEIN	SpoIIIE mediates postseptational chromosome partitioning in Bacillus subtilis, but the mechanism controlling the direction of DNA transfer remains obscure. Here, we demonstrated that SpoIIIE acts as a DNA exporter: When SpoIIIE was synthesized in the larger of the two cells necessary for sporulation, the mother cell, DNA was translocated into the smaller forespore; however, when it was synthesized in the forespore, DNA was translocated into the mother cell. Furthermore, the DNA-tracking domain of SpoIIIE inhibited SpoIIIE complex assembly in the forespore. Thus, during sporulation, chromosome partitioning is controlled by the preferential assembly of SpoIIIE in one daughter cell.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.			Pogliano, Kit/0000-0002-7868-3345	NIGMS NIH HHS [R01 GM057045-03, R01 GM057045-02, R01 GM057045-04, GM-57045, R01 GM057045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; POGLIANO J, IN PRESS J BACTERIOL; POGLIANO K, 1995, MOL MICROBIOL, V18, P459, DOI 10.1111/j.1365-2958.1995.mmi_18030459.x; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161	11	78	79	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					137	139		10.1126/science.1066274	http://dx.doi.org/10.1126/science.1066274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778051	Green Accepted			2022-12-24	WOS:000173143100052
J	Petersdorf, EW; Hansen, JA; Martin, PJ; Woolfrey, A; Malkki, M; Gooley, T; Storer, B; Mickelson, E; Smith, A; Anasetti, C				Petersdorf, EW; Hansen, JA; Martin, PJ; Woolfrey, A; Malkki, M; Gooley, T; Storer, B; Mickelson, E; Smith, A; Anasetti, C			Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DONOR MARROW TRANSPLANTATION; UNRELATED DONORS; HLA-C; LYMPHOCYTES-T; MOLECULES; LEUKEMIA; COMPATIBILITY; ENGRAFTMENT; ASSOCIATION; EXPERIENCE	Background: Successful engraftment of hematopoietic stem cells from unrelated donors is influenced by disparities between the donor and recipient for HLA-A, B, and C alleles. Disparities between HLA sequence polymorphisms that are serologically detectable are termed antigen mismatches, whereas those that can be identified only by DNA-based typing methods are termed allele mismatches. Whether both kinds of polymorphisms are important in transplantation is not known. We tested the hypothesis that allele mismatches that are detectable only at the DNA level are less immunogenic than those that are serologically detectable and thereby are associated with a lower risk of graft failure after hematopoietic-cell transplantation. Methods: We used DNA sequencing to define the HLA-A, B, and C alleles in 471 patients who received bone marrow from unrelated donors for the treatment of chronic myeloid leukemia after myeloablative conditioning therapy. The odds ratios for graft failure were determined for recipients of transplants from donors with a single class I allele mismatch, a single class I antigen mismatch, or two or more class I mismatches, as compared with those with no mismatch. Results: A single HLA allele mismatch did not increase the risk of graft failure, whereas a single antigen mismatch significantly increased the risk. The risk was also increased if the recipient was HLA homozygous at the mismatched class I locus or if the donor had two or more class I mismatches. Conclusions: HLA class I antigen mismatches that are serologically detectable confer an enhanced risk of graft failure after hematopoietic-cell transplantation. Transplants from donors with a single class I allele mismatch that is not serologically detectable may be used without an increased risk of graft failure. (N Engl J Med 2001;345:1794-800.) Copyright (C) 2001 Massachusetts Medical Society.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA USA; Seattle Canc Care Alliance, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance	Petersdorf, EW (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.				NATIONAL CANCER INSTITUTE [R29CA072978, P30CA015704, P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484] Funding Source: NIH RePORTER; NCI NIH HHS [CA15704, CA72978, CA18029] Funding Source: Medline; NIAID NIH HHS [AI33484] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANASETTI C, 1989, NEW ENGL J MED, V320, P197, DOI 10.1056/NEJM198901263200401; ANASETTI C, 1994, TRANSFUS SCI, V15, P221, DOI 10.1016/0955-3886(94)90134-1; Anasetti C., 1999, HEMATOPOIETIC CELL T, P904; BEATTY PG, 1991, TRANSPLANTATION, V51, P443, DOI 10.1097/00007890-199102000-00034; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BUNCE M, 1997, GENETIC DIVERSITY HL, V1, P83; DAUSSET J, 1954, C R SOC BIOL, V146, P1539; Davies SM, 2000, BLOOD, V96, P4096; DUPONT B, 1980, HISTOCOMPATIBILITY T, P229; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; FLEISCHHAUER K, 1990, NEW ENGL J MED, V323, P1818, DOI 10.1056/NEJM199012273232607; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KERNAN NA, 1987, TRANSPLANTATION, V43, P842, DOI 10.1097/00007890-198743060-00014; Klein J, 2000, NEW ENGL J MED, V343, P1504; Marsh S. G. E., 2001, Tissue Antigens, V57, P236; McGlave PB, 2000, BLOOD, V95, P2219, DOI 10.1182/blood.V95.7.2219.007k27_2219_2225; Neisig A, 1998, J IMMUNOL, V160, P171; OPELZ G, 1994, NEW ENGL J MED, V330, P816, DOI 10.1056/NEJM199403243301203; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Petersdorf EW, 1997, BLOOD, V89, P1818, DOI 10.1182/blood.V89.5.1818.1818_1818_1823; Petersdorf EW, 1998, BLOOD, V92, P3515, DOI 10.1182/blood.V92.10.3515.422k49_3515_3520; Petersdorf EW, 1996, P NATL ACAD SCI USA, V93, P15358, DOI 10.1073/pnas.93.26.15358; PETERSDORF EW, 1995, BLOOD, V86, P1606, DOI 10.1182/blood.V86.4.1606.bloodjournal8641606; Petersdorf EW, 2001, BRIT J HAEMATOL, V112, P988, DOI 10.1046/j.1365-2141.2001.02655.x; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Schreuder GMT, 1999, HUM IMMUNOL, V60, P1157, DOI 10.1016/S0198-8859(99)00111-1; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Valiante N M, 1997, Biol Blood Marrow Transplant, V3, P229; VANROOD JJ, 1963, J CLIN INVEST, V42, P1382	33	221	230	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1794	U4		10.1056/NEJMoa011826	http://dx.doi.org/10.1056/NEJMoa011826			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752355	Bronze			2022-12-24	WOS:000172794800002
J	McCarter, J; Boge, G; Darlow, G				McCarter, J; Boge, G; Darlow, G			Safeguarding the world's natural treasures	SCIENCE			English	Editorial Material									Field Museum, 1400 Lake Shore Dr, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	McCarter, J (corresponding author), Field Museum, 1400 Lake Shore Dr, Chicago, IL 60605 USA.							MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; WILSON E O, 1992	3	10	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2099	2101		10.1126/science.1067223	http://dx.doi.org/10.1126/science.1067223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739937				2022-12-24	WOS:000172647700026
J	Koehl, MAR; Koseff, JR; Crimaldi, JP; McCay, MG; Cooper, T; Wiley, MB; Moore, PA				Koehl, MAR; Koseff, JR; Crimaldi, JP; McCay, MG; Cooper, T; Wiley, MB; Moore, PA			Lobster sniffing: Antennule design and hydrodynamic filtering of information in an odor plume	SCIENCE			English	Article							PANULIRUS-ARGUS; FLUID-DYNAMICS; SPINY LOBSTER; APPENDAGES; OLFACTION; INSECTS; FLOW	The first step in processing olfactory information, before neural filtering, is the physical capture of odor molecules from the surrounding fluid. Many animals capture odors from turbulent water currents or wind using antennae that bear chemosensory hairs. We used planar laser-induced fluorescence to reveal how lobster olfactory antennules hydrodynamically alter the spatiotemporal patterns of concentration in turbulent odor plumes. As antennules flick, water penetrates their chemosensory hair array during the fast downstroke, carrying fine-scale patterns of concentration into the receptor area. This spatial pattern, blurred by flow along the antennule during the downstroke, is retained during the slower return stroke and is not shed until the next flick.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Civil & Environm Engn, Environm Fluid Mech Lab, Stanford, CA 94305 USA; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; Bowling Green State Univ, JP Scott Ctr Neurosci Mind & Behav, Bowling Green, OH 43403 USA	University of California System; University of California Berkeley; Stanford University; University System of Ohio; Bowling Green State University; University System of Ohio; Bowling Green State University	Koehl, MAR (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	cnidaria@socrates.berkeley.edu		Koseff, Jeffrey/0000-0003-2121-4844				Atema J, 1996, BIOL BULL, V191, P129, DOI 10.2307/1543074; ATEMA J, 1991, MAR ECOL PROG SER, V74, P303, DOI 10.3354/meps074303; BOSSERT WH, 1963, J THEOR BIOL, V5, P443, DOI 10.1016/0022-5193(63)90089-4; CARDE RT, 1984, CHEM ECOLOGY INSECTS, P109; CHEER AYL, 1987, IMA J MATH APPL MED, V4, P185; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GLEESON RA, 1993, CHEM SENSES, V18, P67, DOI 10.1093/chemse/18.1.67; Goldman JA, 2001, CHEM SENSES, V26, P385, DOI 10.1093/chemse/26.4.385; Gomez G, 1996, J EXP BIOL, V199, P1771; GRUNERT U, 1988, CELL TISSUE RES, V251, P95, DOI 10.1007/BF00215452; Koehl M.A.R., 1995, Symposia of the Society for Experimental Biology, V49, P157; Koehl MAR, 1996, MAR FRESHW BEHAV PHY, V27, P127, DOI 10.1080/10236249609378959; Koehl MAR, 2001, IMA V MATH, V124, P97; Loudon C, 2000, J EXP BIOL, V203, P2977; Mead KS, 2000, J EXP BIOL, V203, P3795; MOORE PA, 1991, BIOL BULL, V181, P408, DOI 10.2307/1542361; MOORE PA, 1994, J CHEM ECOL, V20, P255, DOI 10.1007/BF02064435; MOORE PA, 1991, CHEM SENSES, V16, P663, DOI 10.1093/chemse/16.6.663; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Murlis J., 1986, MECH INSECT OLFACTIO, P27; MURRAY JD, 1976, LECT NONLINEAR DIFFE, P83; ORIORDAN CA, 1993, LIMNOL OCEANOGR, V38, P1712, DOI 10.4319/lo.1993.38.8.1712; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; STACEY M, IN PRESS J MATH BIOL; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Weissburg MJ, 2000, BIOL BULL-US, V198, P188, DOI 10.2307/1542523; WESTERBERG J, 1991, P 10 INT S OLF TAST, P45; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZIMMERFAUST RK, 1995, BIOL BULL-US, V188, P111, DOI 10.2307/1542075	31	129	133	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1948	1951		10.1126/science.1063724	http://dx.doi.org/10.1126/science.1063724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729325				2022-12-24	WOS:000172465000066
J	Leishman, AJ; Naidenko, OV; Attinger, A; Koning, F; Lena, CJ; Xiong, Y; Chang, HC; Reinherz, E; Kronenberg, M; Cheroutre, H				Leishman, AJ; Naidenko, OV; Attinger, A; Koning, F; Lena, CJ; Xiong, Y; Chang, HC; Reinherz, E; Kronenberg, M; Cheroutre, H			T cell responses modulated through interaction between CD8 alpha alpha and the nonclassical MHC class I molecule, TL	SCIENCE			English	Article							THYMUS LEUKEMIA ANTIGEN; LYMPHOCYTES; EXPRESSION; CD8; MOUSE; SELECTION; RECEPTORS; MICE; VIVO	The thymus leukemia antigen (TL) is a nonclassical class I molecule, expressed abundantly on intestinal epithelial cells. We show that, in contrast to other major histocompatibility complex (MHC) class I molecules that bind CD8 alpha beta, TL preferentially binds the homotypic form of CD8 alpha (CD8 alpha alpha). Thus, TL tetramers react specifically to CD8 alpha alpha -expressing cells, including most intestinal intraepithelial lymphocytes. Compared with CD8 alpha beta, which recognizes the same MHC as the T cell, receptor (TCR) and thus acts as a TCR coreceptor, high-affinity binding of CD8 alpha alpha to TL modifies responses mediated by TCR recognition of antigen presented by distinct MHC molecules. These findings define a novel mechanism of lymphocyte regulation through CD8 alpha alpha and MHC class I.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA	La Jolla Institute for Immunology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Dana-Farber Cancer Institute	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.			Koning, Frits/0000-0002-4007-5715	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R37AI019807, R56AI019807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054451, R29DK054451] Funding Source: NIH RePORTER; NCI NIH HHS [CA52511] Funding Source: Medline; NIAID NIH HHS [AI 19807, AI50263] Funding Source: Medline; NIDDK NIH HHS [DK54451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; CHEROUTRE H, UNPUB; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; FISHER DA, 1985, J EXP MED, V162, P528, DOI 10.1084/jem.162.2.528; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; HOLCOMBE HR, 1995, J EXP MED, V181, P1433, DOI 10.1084/jem.181.4.1433; HORI T, 1991, INT IMMUNOL, V3, P737, DOI 10.1093/intimm/3.7.737; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LEISHMAN A, UNPUB; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; MICELI MC, 1991, P NATL ACAD SCI USA, V88, P2623, DOI 10.1073/pnas.88.7.2623; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; TEITELL M, 1994, CRIT REV IMMUNOL, V14, P1; TEITELL M, 1991, J EXP MED, V174, P1131, DOI 10.1084/jem.174.5.1131	23	205	210	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1936	1939		10.1126/science.1063564	http://dx.doi.org/10.1126/science.1063564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729321				2022-12-24	WOS:000172465000062
J	Barford, CC; Wofsy, SC; Goulden, ML; Munger, JW; Pyle, EH; Urbanski, SP; Hutyra, L; Saleska, SR; Fitzjarrald, D; Moore, K				Barford, CC; Wofsy, SC; Goulden, ML; Munger, JW; Pyle, EH; Urbanski, SP; Hutyra, L; Saleska, SR; Fitzjarrald, D; Moore, K			Factors controlling long- and short-term sequestration of atmospheric CO2 in a mid-latitude forest	SCIENCE			English	Article							CARBON BUDGET; TEMPERATE FOREST; DECIDUOUS FOREST; EXCHANGE; BIOMASS; ECOSYSTEMS; SINKS; DEPOSITION; CLIMATE; STORAGE	Net uptake of carbon dioxide (CO2) measured by eddy covariance in a 60- to 80-year-old forest averaged 2.0 +/- 0.4 megagrams of carbon per hectare per year during 1993 to 2000, with interannual variations exceeding 50%. Biometry indicated storage of 1.6 +/- 0.4 megagrams of carbon per hectare per year over 8 years, 60% in Live biomass and the balance in coarse woody debris and soils, confirming eddy-covariance results. Weather and seasonal climate (e.g., variations in growing-season length or cloudiness) regulated seasonal and interannual fluctuations of carbon uptake. Legacies of prior disturbance and management, especially stand age and composition, controlled carbon uptake on the decadal time scale, implying that eastern forests could be managed for Sequestration of carbon.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12203 USA	Harvard University; Harvard University; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wofsy, SC (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	steven_wofsy@harvard.edu	Fitzjarrald, David/AAV-2289-2020; Munger, J William/H-4502-2013; Goulden, Michael L/B-9934-2008; Noojipady, Praveen/B-2511-2010; Saleska, Scott R/K-1733-2016	Munger, J William/0000-0002-1042-8452; Saleska, Scott R/0000-0002-4974-3628; Goulden, Michael/0000-0002-9379-3948				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2001, CLIMATE CHANGE 2001; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; BIRDSEY RA, 1993, FOREST ECOL MANAG, V58, P33, DOI 10.1016/0378-1127(93)90129-B; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Foster DR, 1997, BIOSCIENCE, V47, P437, DOI 10.2307/1313059; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Harmon ME, 1996, PUBLICATION US LTER, V20; Holland EA, 1997, J GEOPHYS RES-ATMOS, V102, P15849, DOI 10.1029/96JD03164; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jenkins JC, 2001, ECOL APPL, V11, P1174, DOI 10.1890/1051-0761(2001)011[1174:BANEFT]2.0.CO;2; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lee X, 1999, AGR FOREST METEOROL, V97, P65, DOI 10.1016/S0168-1923(99)00048-9; Lee XH, 1999, J GEOPHYS RES-ATMOS, V104, P15975, DOI 10.1029/1999JD900227; McGee GG, 1999, ECOL APPL, V9, P1316, DOI 10.1890/1051-0761(1999)009[1316:SCOOGM]2.0.CO;2; Munger JW, 1998, J GEOPHYS RES-ATMOS, V103, P8355, DOI 10.1029/98JD00168; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; SAMPSON RN, 1996, FORESTS GLOBAL CHANG, V2; Sander I.L., 1990, AGR HDB, V654; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Schmid HP, 2000, AGR FOREST METEOROL, V103, P357, DOI 10.1016/S0168-1923(00)00140-4; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TRITTON LM, 1982, NE69 USDA FOR SERV; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; WHITTAKER RH, 1974, ECOL MONOGR, V44, P233, DOI 10.2307/1942313; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	36	433	473	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1688	1691		10.1126/science.1062962	http://dx.doi.org/10.1126/science.1062962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721047	Green Published			2022-12-24	WOS:000172307400035
J	Berman-Frank, I; Lundgren, P; Chen, YB; Kupper, H; Kolber, Z; Bergman, B; Falkowski, P				Berman-Frank, I; Lundgren, P; Chen, YB; Kupper, H; Kolber, Z; Bergman, B; Falkowski, P			Segregation of nitrogen fixation and oxygenic photosynthesis in the marine cyanobacterium Trichodesmium	SCIENCE			English	Article							NONHETEROCYSTOUS CYANOBACTERIUM; CHLOROPHYLL FLUORESCENCE; FIXING MICROORGANISMS; N-2 FIXATION; THIEBAUTII; EXPRESSION; OCEANS; RHYTHM; GENES; CELLS	In the modern ocean, a significant amount of nitrogen fixation is attributed to filamentous, nonheterocystous cyanobacteria of the genus Trichodesmium. In these organisms, nitrogen fixation is confined to the photoperiod and occurs simultaneously with oxygenic photosynthesis. Nitrogenase, the enzyme responsible for biological N-2 fixation, is irreversibly inhibited by oxygen in vitro. How nitrogenase is protected from damage by photosynthetically produced O-2 was once an enigma. Using fast repetition rate fluorometry and fluorescence kinetic microscopy, we show that there is both temporal and spatial segregation of N-2 fixation and photosynthesis within the photoperiod. Linear photosynthetic electron transport protects nitrogenase by reducing photosynthetically evolved O-2 in photosystem I (PSI). We postulate that in the early evolutionary phase of oxygenic photosynthesis, nitrogenase served as an electron acceptor for anaerobic heterotrophic metabolism and that PSI was favored by selection because it provided a micro-anaerobic environment for N-2 fixation in cyanobacteria.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Stockholm Univ, Dept Bot, SE-10691 Stockholm, Sweden; Inst Microbiol, Photosynth Res Ctr, CZ-37981 Trebon, Czech Republic; Univ S Bohemia, Lab Biomembranes, CZ-37005 Ceske Budejovice, Czech Republic; Univ Konstanz, Fac Sci, Dept Biol, D-78457 Constance, Germany	Rutgers State University New Brunswick; Stockholm University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Konstanz	Berman-Frank, I (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	irfrank@imcs.rutgers.edu	Küpper, Hendrik/J-5152-2012	Küpper, Hendrik/0000-0003-0712-7023; Berman-Frank, Ilana/0000-0003-3497-1844				Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; BERGMAN B, 1993, APPL ENVIRON MICROB, V59, P3239, DOI 10.1128/AEM.59.10.3239-3244.1993; BERGMAN B, 1999, MARINE NITROGEN FIXI, P158; BERMANFRANK L, UNPUB; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Chen YB, 1999, PLANT MOL BIOL, V41, P89, DOI 10.1023/A:1006231805030; DUGDALE RC, 1961, DEEP-SEA RES, V7, P297, DOI 10.1016/0146-6313(61)90051-X; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; FREDRIKSSON C, 1995, MICROBIOL-UK, V141, P2471, DOI 10.1099/13500872-141-10-2471; Fredriksson C, 1997, PROTOPLASMA, V197, P76, DOI 10.1007/BF01279886; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; JANSON S, 1994, FEMS MICROBIOL LETT, V118, P9, DOI 10.1111/j.1574-6968.1994.tb06796.x; KANA TM, 1992, NATO ADV SCI I C-MAT, V362, P29; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2000, PHOTOSYNTHETICA, V38, P553, DOI 10.1023/A:1012461407557; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Ludden P. W., 1995, Anoxygenic photosynthetic bacteria., P929; LUNDGREN P, UNPUB; MATTHIJS JCP, 1988, BIOCH ALGAE CYANOBAC, P131; PAERL HW, 1994, J PHYCOL, V30, P790, DOI 10.1111/j.0022-3646.1994.00790.x; ROENNEBERG T, 1993, MAR BIOL, V117, P693, DOI 10.1007/BF00349782; SAINO T, 1978, DEEP-SEA RES, V25, P1259, DOI 10.1016/0146-6291(78)90019-X; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	35	274	285	6	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1534	1537		10.1126/science.1064082	http://dx.doi.org/10.1126/science.1064082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711677	Green Submitted			2022-12-24	WOS:000172240500051
J	Silphaduang, U; Noga, EJ				Silphaduang, U; Noga, EJ			Antimicrobials - Peptide antibiotics in mast cells of fish	NATURE			English	Article							INNATE		N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27606 USA	University of North Carolina; North Carolina State University	Silphaduang, U (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27606 USA.							BACCARI GC, 2000, MAST CELLS BASOPHILS, P117; Ganz T, 1997, Curr Opin Hematol, V4, P53; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Jia X, 2000, APPL ENVIRON MICROB, V66, P1928, DOI 10.1128/AEM.66.5.1928-1932.2000; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; MCNEIL HP, 1995, SAMTERS IMMUNOLOGIC, V1, P185; Reite OB, 1998, FISH SHELLFISH IMMUN, V8, P489, DOI 10.1006/fsim.1998.0162; Robinette D, 1998, CELL MOL LIFE SCI, V54, P467, DOI 10.1007/s000180050175; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0	13	287	310	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					268	269		10.1038/35104690	http://dx.doi.org/10.1038/35104690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713517				2022-12-24	WOS:000172150700031
J	Tamaru, H; Selker, EU				Tamaru, H; Selker, EU			A histone H3 methyltransferase controls DNA methylation in Neurospora crassa	NATURE			English	Article							POSITION-EFFECT VARIEGATION; INDUCED POINT MUTATION; FISSION YEAST CENTROMERES; DROSOPHILA-MELANOGASTER; CHROMOSOME SEGREGATION; GENE; PROTEIN; DOMAINS; CELLS; HETEROCHROMATIN	DNA methylation is involved in epigenetic processes such as X-chromosome inactivation, imprinting and silencing of transposons. We have demonstrated previously that dim-2 encodes a DNA methyltransferase that is responsible for all known cytosine methylation in Neurospora crassa. Here we report that another Neurospora gene, dim-5, is required for DNA methylation, as well as for normal growth and full fertility. We mapped dim-5 and identified it by transformation with a candidate gene. The mutant has a nonsense mutation in a SET domain of a gene related to histone methyltransferases that are involved in heterochromatin formation in other organisms. Transformation of a wild-type strain with a segment of dim-5 reactivated a silenced hph gene, apparently by 'quelling' of dim-5. We demonstrate that recombinant DIM-5 protein specifically methylates histone H3 and that replacement of lysine 9 in histone H3 with either a leucine or an arginine phenocopies the dim-5 mutation. We conclude that DNA methylation depends on histone methylation.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Selker, EU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		Hu, Ruogu/B-2203-2008					ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Cambareri EB, 1996, GENETICS, V143, P137; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Colot V, 1999, BIOESSAYS, V21, P402, DOI 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.3.CO;2-2; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Foss HM, 1998, MOL GEN GENET, V259, P60, DOI 10.1007/s004380050789; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hennig W, 1999, CHROMOSOMA, V108, P1, DOI 10.1007/s004120050346; Irelan JT, 1997, GENETICS, V146, P509; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsson J, 1996, GENETICS, V143, P887; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Margolin BS, 1998, GENETICS, V149, P1787; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; Perkins D., 2001, NEUROSPORA COMPENDIU; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Scheid OM, 2000, PLANT MOL BIOL, V43, P235, DOI 10.1023/A:1006487529698; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	50	798	839	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					277	283		10.1038/35104508	http://dx.doi.org/10.1038/35104508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713521				2022-12-24	WOS:000172150700035
J	Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K				Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K			Recruitment of Mec1 and Dcd1 checkpoint proteins to double-strand breaks through distinct mechanisms	SCIENCE			English	Article							DNA-DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BUDDING YEAST; SLIDING CLAMP; COMPLEX; RAD24; RECOMBINATION; ADAPTATION; ARREST	In response to DNA damage, eukaryotic cells activate checkpoint pathways that arrest cell cycle progression and induce the expression of genes required for DNA repair. In budding yeast, the homothallic switching (HO) endonuclease creates a site-specific double-strand break at the mating type (MAT) Locus. Continuous HO expression results in the phosphorylation of Rad53, which is dependent on products of the ataxia telangiectasia mutated-related MEC1 gene and other checkpoint genes, including DDC1, RAD9, and RAD24. Chromatin immunoprecipitation experiments revealed that the Ddc1 protein associates with a region near the MAT locus after HO expression. Ddc1 association required Rad24 but not Mec1 or Rad9. Mec1 also associated with a region near the cleavage site after HO expression, but this association is independent of Ddc1, Rad9, and Rad24. Thus, Mec1 and Ddc1 are recruited independently to sites of DNA damage, suggesting the existence of two separate mechanisms involved in recognition of DNA damage.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan; Japan Sci & Technol Corp, CREST, Nagoya, Aichi 4640814, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan.	j46036a@nucc.cc.nagoya-u.ac.jp						Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KONDO T, UNPUB; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 1998, MOL CELL BIOL, V18, P1891, DOI 10.1128/MCB.18.4.1891; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	219	223	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					867	870		10.1126/science.1063827	http://dx.doi.org/10.1126/science.1063827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679674				2022-12-24	WOS:000171851800051
J	Pattison, S				Pattison, S			Dealing with uncertainty	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales	Cardiff University	Pattison, S (corresponding author), Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales.							Oakley Justin, 1992, MORALITY EMOTIONS; Smith M., 1991, COMPANION ETHICS	2	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					840	840						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683153				2022-12-24	WOS:000171650500028
J	Glasauer, S; Langley, S; Beveridge, TJ				Glasauer, S; Langley, S; Beveridge, TJ			Intracellular iron minerals in a dissimilatory iron-reducing bacterium	SCIENCE			English	Article							REDUCTION; FE3O4; FE3S4	Among prokaryotes, there are few examples of controlled mineral formation; the formation of crystalline iron oxides and sulfides [magnetite (Fe3O4) or greigite (Fe3S4)] by magnetotactic bacteria is an exception. Shewanella putrefaciens CN32, a Gram-negative, facultative anaerobic bacterium that is capable of dissimilatory iron reduction, produced microscopic intracellular grains of iron oxide minerals during growth on two-line ferrihydrite in a hydrogen-argon atmosphere. The minerals, formed at iron concentrations found in the soil and sedimentary environments where these bacteria are active, could represent an unexplored pathway for the cycling of iron by bacteria.	Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	University of Guelph	Glasauer, S (corresponding author), Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada.		Glasauer, Susan/AAY-6599-2021					BAUMINGER ER, 1980, BIOCHIM BIOPHYS ACTA, V623, P237, DOI 10.1016/0005-2795(80)90252-4; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; BEVERIDGE TJ, 1989, BACTERIA NATURE, V3, P1; Cornell R.M., 1996, CORROS SCI, DOI [DOI 10.1016/S0010-938X(99)00005-0, DOI 10.1016/S0010-938X(97)00096-6]; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; KUTERBACH DA, 1982, SCIENCE, V218, P695, DOI 10.1126/science.218.4573.695; MEYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; STEIFEL EI, 1979, NATURE, V279, P81; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; Vainshtein MB, 1998, MICROBIOLOGY+, V67, P670	16	125	137	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					117	119		10.1126/science.1066577	http://dx.doi.org/10.1126/science.1066577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778045				2022-12-24	WOS:000173143100046
J	Skjaerven, R; Wilcox, AJ; Lie, RT				Skjaerven, R; Wilcox, AJ; Lie, RT			The interval between pregnancies and the risk of preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; PRE-ECLAMPSIA; PRETERM DELIVERY; PATERNITY; WOMEN; ABORTION; SMOKING; DONOR	Background: The risk of preeclampsia is generally lower in second pregnancies than in first pregnancies, but not if the mother has a new partner for the second pregnancy. One explanation is that the risk is reduced with repeated maternal exposure and adaptation to specific antigens from the same partner. However, the difference in risk might instead be explained by the interval between births. A longer interbirth interval may be associated with both a change of partner and a higher risk of preeclampsia. Methods: We used data from the Medical Birth Registry of Norway, a population-based registry that includes births that occurred between 1967 and 1998. We studied 551,478 women who had two or more singleton deliveries and 209,423 women who had three or more singleton deliveries. Results: Preeclampsia occurred during 3.9 percent of first pregnancies, 1.7 percent of second pregnancies, and 1.8 percent of third pregnancies when the woman had the same partner. The risk in a second or third pregnancy was directly related to the time that had elapsed since the preceding delivery, and when the interbirth interval was 10 years or more, the risk approximated that among nulliparous women. After adjustment for the presence or absence of a change of partner, maternal age, and year of delivery, the odds ratio for preeclampsia for each one-year increase in the interbirth interval was 1.12 (95 percent confidence interval, 1.11 to 1.13). In unadjusted analyses, a pregnancy involving a new partner was associated with higher risk of preeclampsia, but after adjustment for the interbirth interval, the risk of preeclampsia was reduced (odds ratio for preeclampsia with a change of partner, 0.73; 95 percent confidence interval, 0.66 to 0.81). Conclusions: The protective effect of previous pregnancy against preeclampsia is transient. After adjustment for the interval between births, a change of partner is not associated with an increased risk of preeclampsia. (N Engl J Med 2002;346:33-8.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Med Stat, N-5021 Bergen, Norway; Univ Bergen, Med Birth Registry Norway, Locus Registry Based Epidemiol, N-5021 Bergen, Norway; NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Skjaerven, R (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Med Stat, Armauer Hansens Bldg, N-5021 Bergen, Norway.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049027, ZIAES049027] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], CHESLEYS HYPERTENSIV; Basso O, 1998, INT J EPIDEMIOL, V27, P642, DOI 10.1093/ije/27.4.642; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Dekker GA, 1999, SEMIN PERINATOL, V23, P24, DOI 10.1016/S0146-0005(99)80057-3; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; DUFFUS GM, 1968, LANCET, V1, P994; Eras JL, 2000, EPIDEMIOLOGY, V11, P36, DOI 10.1097/00001648-200001000-00009; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; FEENEY JG, 1980, EUR J OBSTET GYN R B, V11, P35, DOI 10.1016/0028-2243(80)90051-9; Fu HS, 2000, J BIOSOC SCI, V32, P63, DOI 10.1017/S0021932000000638; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Haug K, 1998, ACTA PAEDIATR, V87, P1023, DOI 10.1080/080352598750031310; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Need J A, 1976, Perspect Nephrol Hypertens, V5, P169; NEED JA, 1975, BRIT MED J, V1, P548, DOI 10.1136/bmj.1.5957.548; NEED JA, 1983, J REPROD IMMUNOL, V5, P329, DOI 10.1016/0165-0378(83)90242-5; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBILLARD PY, 1993, J REPROD IMMUNOL, V24, P1, DOI 10.1016/0165-0378(93)90032-D; Robillard PY, 1999, EUR J OBSTET GYN R B, V84, P37, DOI 10.1016/S0301-2115(98)00250-4; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Smith GN, 1997, AM J OBSTET GYNECOL, V177, P455, DOI 10.1016/S0002-9378(97)70215-1; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Tubbergen P, 1999, J REPROD IMMUNOL, V45, P81, DOI 10.1016/S0165-0378(99)00040-6; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	28	270	282	1	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					33	38		10.1056/NEJMoa011379	http://dx.doi.org/10.1056/NEJMoa011379			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11778000	Bronze			2022-12-24	WOS:000173033600005
J	Kane, B				Kane, B			Cancer chemotherapy: Teaching old drugs new tricks	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1107	1110		10.7326/0003-4819-135-12-200112180-00035	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747409				2022-12-24	WOS:000172759700027
J	Thompson, JB; Kindt, JH; Drake, B; Hansma, HG; Morse, DE; Hansma, PK				Thompson, JB; Kindt, JH; Drake, B; Hansma, HG; Morse, DE; Hansma, PK			Bone indentation recovery time correlates with bond reforming time	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; COLLAGEN CROSS-LINKS; SCANNING ELECTRON; FIBRILS; TITIN; IMMUNOGLOBULIN; MICROCRACKING; STRENGTH; DOMAINS; CORNEA	Despite centuries of work, dating back to Galileo(1), the molecular basis of bone's toughness and strength remains largely a mystery. A great deal is known about bone microsctructure(2-5) and the microcracks(6,7) that are precursors to its fracture, but little is known about the basic mechanism for dissipating the energy of an impact to keep the bone from fracturing. Bone is a nanocomposite of hydroxyapatite crystals and an organic matrix. Because rigid crystals such as the hydroxyapatite crystals cannot dissipate much energy, the organic matrix, which is mainly collagen, must be involved. A reduction in the number of collagen cross links has been associated with reduced bone strength(8-10) and collagen is molecularly elongated ('pulled') when bovine tendon is strained(11). Using an atomic force microscope(12-16), a molecular mechanistic origin for the remarkable toughness of another biocomposite material, abalone nacre, has been found(12). Here we report that bone, like abalone nacre, contains polymers with 'sacrircial bonds' that both protect the polymer backbone and dissipate energy. The time needed for these sacrificial bonds to reform after pulling correlates with the time needed for bone to recover its toughness as measured by atomic force microscope indentation testing. We suggest that the sacrificial bonds found within or between collagen molecules may be partially responsible for the toughness of bone.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Thompson, JB (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	jbthomp@physics.ucsb.edu						An Y.H., 2000, MECH TESTING BONE BO; ASCENZI A, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90040-L; Bigi A, 1997, BIOMATERIALS, V18, P657, DOI 10.1016/S0142-9612(96)00156-1; BURSTEIN AH, 1975, J BONE JOINT SURG AM, V57, P956, DOI 10.2106/00004623-197557070-00013; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Charras GT, 2001, ULTRAMICROSCOPY, V86, P85, DOI 10.1016/S0304-3991(00)00076-0; CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736; Currey JD., 1984, MECH ADAPTATIONS BON; Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z; EINBINDER J, 1951, J BIOL CHEM, V188, P335; El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.3.CO;2-C; FULLWOOD NJ, 1995, CURR EYE RES, V14, P529, DOI 10.3109/02713689508998399; GREENE E.C., 1963, AM PHILOS SOC, V2, P227; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Lin H, 1999, BIOCHEMISTRY-US, V38, P9956, DOI 10.1021/bi990800q; Miyagawa A, 2000, JPN J OPHTHALMOL, V44, P591, DOI 10.1016/S0021-5155(00)00272-0; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Paige MF, 2001, MICRON, V32, P355, DOI 10.1016/S0968-4328(00)00038-X; Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0; Reilly GC, 1999, J EXP BIOL, V202, P543; REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127	30	382	398	3	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					773	776		10.1038/414773a	http://dx.doi.org/10.1038/414773a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742405				2022-12-24	WOS:000172676200053
J	Chertow, GM; Lee, J; Kuperman, GJ; Burdick, E; Horsky, J; Seger, DL; Lee, R; Mekala, A; Song, J; Komaroff, AL; Bates, DW				Chertow, GM; Lee, J; Kuperman, GJ; Burdick, E; Horsky, J; Seger, DL; Lee, R; Mekala, A; Song, J; Komaroff, AL; Bates, DW			Guided medication dosing for inpatients with renal insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	31st Congress of the American-Society-of-Nephrology	OCT 24-28, 1998	PHILADELPHIA, PENNSYLVANIA	Amer Soc Nephrol			ADVERSE DRUG EVENTS; FAILURE; INTERVENTION; PREVENTION; MORTALITY	Context Usual drug-prescribing practices may not consider the effects of renal insufficiency on the disposition of certain drugs. Decision aids may help optimize prescribing behavior and reduce medical error. Objective To determine if a system application for adjusting drug close and frequency in patients with renal insufficiency, when merged with a computerized order entry system, improves drug prescribing and patient outcomes. Design, Setting, and Patients Four consecutive 2-month intervals consisting of control (usual computerized order entry) alternating with intervention (computerized order entry plus decision support system), conducted in September 1997-April 1998 with outcomes assessed among a consecutive sample of 17 828 adults admitted to an urban tertiary care teaching hospital. Intervention Real-time computerized decision support system for prescribing drugs in patients with renal insufficiency. During intervention periods, the adjusted dose list, default dose amount, and default frequency were displayed to the order-entry user and a notation was provided that adjustments had been made based on renal insufficiency. During control periods, these recommended adjustments were not revealed to the order-entry user, and the unadjusted parameters were displayed. Main Outcome Measures Rates of appropriate prescription by dose and frequency, length of stay, hospital and pharmacy costs, and changes in renal function, compared among patients with renal insufficiency who were hospitalized during the intervention vs control periods. Results A total of 7490 patients were found to have some degree of renal insufficiency. In this group, 97 151 orders were written on renally cleared or nephrotoxic medications, of which 14440 (15%) had at least 1 dosing parameter modified Ely the computer based on renal function. The fraction of prescriptions deemed appropriate during the intervention vs control periods by dose was 67% vs 54% (P<.001) and by frequency was 59% vs 35% (P<.001). Mean (SD) length of stay was 4.3 (4.5) days vs 4.5 (4.8) days in the intervention vs control periods, respectively (P=.009). There were no significant differences in estimated hospital and pharmacy costs or in the proportion of patients who experienced a decline in renal function during hospitalization. Conclusions Guided medication dosing for inpatients with renal insufficiency appears to result in improved dose and frequency choices. This intervention demonstrates a way in which computer-based decision support systems can improve care.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gen Internal Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, Boston, MA 02115 USA; Partners Healthcare Syst, Dept Informat Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System	Chertow, GM (corresponding author), UCSF Laurel Hts, Dept Med Res, 3333 Calif St,Suite 430, San Francisco, CA 94118 USA.			Horsky, Jan/0000-0001-6326-9427; Kuperman, Gilad/0000-0002-4130-1577; Chertow, Glenn/0000-0002-7599-0534				Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; EDWARDS N, 1994, HEALTH CARE FINANC R, V16, P45; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Nightingale PG, 2000, BMJ-BRIT MED J, V320, P750, DOI 10.1136/bmj.320.7237.750; Nolan CR, 1998, J AM SOC NEPHROL, V9, P710; Obialo CI, 2000, ARCH INTERN MED, V160, P1309, DOI 10.1001/archinte.160.9.1309; RIND DM, 1994, ARCH INTERN MED, V154, P1511, DOI 10.1001/archinte.154.13.1511; Wang R, 1998, ARCH INTERN MED, V158, P2464, DOI 10.1001/archinte.158.22.2464	15	304	311	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2839	2844		10.1001/jama.286.22.2839	http://dx.doi.org/10.1001/jama.286.22.2839			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735759	Bronze			2022-12-24	WOS:000172655400032
J	Strauss, RS; Pollack, HA				Strauss, RS; Pollack, HA			Epidemic increase in childhood overweight, 1986-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; NATIONAL-HEALTH; OBESITY; ADOLESCENTS; INTERVENTION; PREVALENCE; CHILDREN; GROWTH	Context Overweight is the most common health problem facing US children. Data for adults suggest that overweight prevalence has increased by more than 50% in the last 10 years. Data for children also suggest that the prevalence of overweight continues to increase rapidly. Objective To investigate recent changes in the prevalence of overweight within a nationally representative sample of children, Design, Setting, and Participants The National Longitudinal Survey cf Youth, a prospective cohort study conducted from 1986 to 1998 among 8270 children aged 4 to 12 years (24 174 growth points were analyzed). Main Outcome Measures Prevalence of overweight children, defined as body mass index (BMI) greater than the 95th percentile for age and sex, and prevalence of overweight and at-risk children, defined as BMI greater than the 85th percentile for age and sex. The roles of race/ethnicity, sex, income, and region of residence were also examined. Results Between 1986 and 1998, overweight increased significantly and steadily among African American (P<.001), Hispanic (P<.001), and white (P=.03) children. By 1998, overweight prevalence increased to 21.5% among African Americans, 21.8% among Hispanics, and 12.3% among non-Hispanic whites. In addition, overweight children were heavier in 1998 compared with 1986 (P<.001). After adjusting for confounding variables, overweight increased fastest among minorities and Southerners, creating large demographic differences in the prevalence of childhood overweight by 1998. The number of children with BMI greater than the 85th percentile increased significantly from 1986 to 1998 among African American and Hispanic children (P<.001 for both) and nonsignificantly among white children (P=.77). Conclusions Childhood overweight continues to increase rapidly in the Un ted States, particularly among African Americans and Hispanics. Culturally competent treatment strategies as well as other policy interventions are required to increase physical activity and encourage healthy eating patterns among children.	UMDNJ, Robert Wood Johnson Med Sch, Div Pediat Gastroenterol & Nutr,Dept Pediat, Childhood Weight Control Program, New Brunswick, NJ 08903 USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan	Strauss, RS (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Div Pediat Gastroenterol & Nutr,Dept Pediat, Childhood Weight Control Program, 1 Robert Wood Johnson Pl,CN-19, New Brunswick, NJ 08903 USA.		Pollack, Harold A/A-1166-2007		PHS HHS [U48/CCU51577] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; *CTR HUM RES RES, 2000, 1998 CHILD YOUNG AD, P1; *CTR HUM RES RES, 1993, NLSY CHILD HDB, P85; Erlinger TP, 2000, J AM GERIATR SOC, V48, P1486, DOI 10.1111/jgs.2000.48.11.1486; Gauthier BM, 2000, ARCH PEDIAT ADOL MED, V154, P625, DOI 10.1001/archpedi.154.6.625; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GORTMAKER SL, 1987, AM J DIS CHILD, V141, P535, DOI 10.1001/archpedi.1987.04460050077035; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Levine JA, 2001, J MARRIAGE FAM, V63, P355, DOI 10.1111/j.1741-3737.2001.00355.x; MELNICK TA, 1998, MMWR-MORBID MORTAL W, V47, P980; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839; National Center for Health Statistics, 2001, PREV OV CHILDR AD US; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; WHITAKER RC, 1994, J PEDIATR-US, V125, P535, DOI 10.1016/S0022-3476(94)70004-4; 1997, MMWR MORB MORTAL WKL, V46, P199	21	788	804	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2845	2848		10.1001/jama.286.22.2845	http://dx.doi.org/10.1001/jama.286.22.2845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735760	Bronze			2022-12-24	WOS:000172655400033
J	Bachmann, A; Schneider, M; Theilenberg, E; Grawe, F; Knust, E				Bachmann, A; Schneider, M; Theilenberg, E; Grawe, F; Knust, E			Drosophila Stardust is a partner of Crumbs in the control of epithelial cell polarity	NATURE			English	Article							ZONULA ADHERENS FORMATION; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; PLASMA-MEMBRANE; BAZOOKA; PROTEIN; LOCALIZATION; ORGANIZATION; EXPRESSION; ARMADILLO	The polarized architecture of epithelial cells depends on the highly stereotypic distribution of cellular junctions and other membrane-associated protein complexes. In epithelial cells of the Drosophila embryo, three distinct domains subdivide the lateral plasma membrane. The most apical one comprises the subapical complex (SAC). It is followed by the zonula adherens (ZA) and, further basally, by the septate junction(1). A core component of the SAC is the transmembrane protein Crumbs, the cytoplasmic domain of which recruits the PDZ-protein Discs Lost into the complex(2,3). Cells lacking crumbs or the functionally related gene stardust fail to organize a continuous ZA and to maintain cell polarity(4-6). Here we show that stardust provides an essential component of the SAC. Stardust proteins colocalize with Crumbs and bind to the carboxy-terminal amino acids of its cytoplasmic tail. We introduce two different Stardust proteins here: one MAGUK protein, characterized by a PDZ domain, an SH3 domain and a guanylate kinase domain; and a second isoform comprising only the guanylate kinase domain. The Stardust proteins represent versatile candidates as structural and possibly regulatory constituents of the SAC, a crucial element in the control of epithelial cell polarity.	Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Knust, E (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.	knust@uni-duesseldorf.de	Knust, Elisabeth/B-4338-2017	Grawe, Ferdi/0000-0001-6448-4989				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Dimitratos SD, 1997, MECH DEVELOP, V63, P127, DOI 10.1016/S0925-4773(97)00668-0; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Grawe F, 1996, DEVELOPMENT, V122, P951; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HOVEMANN BT, 1991, NUCLEIC ACIDS RES, V19, P4909, DOI 10.1093/nar/19.18.4909; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Lammel U, 2000, DEV GENES EVOL, V210, P525, DOI 10.1007/s004270000096; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Muller HAJ, 2000, DEV DYNAM, V218, P52; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; TOWER J, 1993, GENETICS, V133, P347; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740	30	227	231	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					638	643		10.1038/414638a	http://dx.doi.org/10.1038/414638a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740560				2022-12-24	WOS:000172535600048
J	Hong, Y; Stronach, B; Perrimon, N; Jan, LY; Jan, YN				Hong, Y; Stronach, B; Perrimon, N; Jan, LY; Jan, YN			Drosophila Stardust interacts with Crumbs to control polarity of epithelia but not neuroblasts	NATURE			English	Article							ZONULA ADHERENS FORMATION; LARVAL CUTICLE; ZYGOTIC LOCI; PLASMA-MEMBRANE; CELL POLARITY; LOCALIZATION; MUTATIONS; PROTEIN; MELANOGASTER; BAZOOKA	Establishing cellular polarity is critical for tissue organization and function. Initially discovered in the landmark genetic screen for Drosophila developmental mutants(1-4), bazooka, crumbs, shotgun and stardust mutants exhibit severe disruption in apicobasal polarity in embryonic epithelia, resulting in multilayered epithelia, tissue disintegration, and defects in cuticle formation(5). Here we report that stardust encodes single PDZ domain MAGUK (membrane-associated guanylate kinase) proteins that are expressed in all primary embryonic epithelia from the onset of gastrulation. Stardust colocalizes with Crumbs(6) at the apicolateral boundary, although their expression patterns in sensory organs differ. Stardust binds to the carboxy terminus of Crumbs in vitro, and Stardust and Crumbs are mutually dependent in their stability, localization and function in controlling the apicobasal polarity of epithelial cells. However, for the subset of ectodermal cells that delaminate and form neuroblasts, their polarity requires the function of Bazooka(7,8), but not of Stardust or Crumbs.	Univ Calif San Francisco, Dept Physiol & Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol & Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Stronach, Beth/0000-0002-1699-8683; Perrimon, Norbert/0000-0001-7542-472X				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brenman JE, 1998, J NEUROSCI, V18, P8805; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Grawe F, 1996, DEVELOPMENT, V122, P951; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Muller HAJ, 2000, DEV DYNAM, V218, P52; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rashbass P, 2000, CURR BIOL, V10, pR234, DOI 10.1016/S0960-9822(00)00372-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	29	197	199	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					634	638		10.1038/414634a	http://dx.doi.org/10.1038/414634a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740559				2022-12-24	WOS:000172535600047
J	Hurst, JL; Payne, CE; Nevison, CM; Marie, AD; Humphries, RE; Robertson, DHL; Cavaggioni, A; Beynon, RJ				Hurst, JL; Payne, CE; Nevison, CM; Marie, AD; Humphries, RE; Robertson, DHL; Cavaggioni, A; Beynon, RJ			Individual recognition in mice mediated by major urinary proteins	NATURE			English	Article							HOUSE MOUSE; FEMALE MICE; SYNTHETIC ANALOGS; BINDING; STIMULATION; CHEMISTRY; PHEROMONE; MARKING	The ability to recognize individuals is essential to many aspects of social behaviour, such as the maintenance of stable social groups, parent-offspring or mate recognition, inbreeding avoidance and the modulation of competitive relationships. Odours are a primary mediator of individuality signals among many mammals(1). One source of odour complexity in rodents, and possibly in humans, resides in the highly polymorphic major histocompatibility complex (MHC)(2). The olfactory acuity of mice(3) and rats(4) allows them to distinguish between the urinary odours of congenic strains differing only in single genes within the MHC, although the chemical mediators or odorants are unknown. However, rodent urine also contains a class of proteins, termed major urinary proteins (MUPs)(5), that bind and release small volatile pheromones(6,7). We have shown that the combinatorial diversity of expression of MUPs among wild mice might be as great as for MHC, and at protein concentrations a million times higher(8). Here we show in wild house mice (Mus domesticus) that urinary MUPs play an important role in the individual recognition mechanism.	Univ Liverpool, Dept Vet Clin Sci & Anim Husb, Neston CH64 7TE, England; Univ Liverpool, Dept Preclin Vet Sci, Liverpool L69 3BX, Merseyside, England; Univ Padua, Dipartimento Anat & Fisiol Umana, I-35100 Padua, Italy	University of Liverpool; University of Liverpool; University of Padua	Hurst, JL (corresponding author), Univ Liverpool, Dept Vet Clin Sci & Anim Husb, Neston CH64 7TE, England.	jane.hurst@liverpool.ac.uk	Beynon, Robert J/K-1408-2014; Mariee, Amr/AAA-4370-2022; Hurst, Jane L/G-8793-2015	Beynon, Robert J/0000-0003-0857-495X; Hurst, Jane L/0000-0002-3728-9624; Mariee, Amr/0000-0001-5786-2072				BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2001, CHEM SIGNAL, V9, P149; BEYNON RJ, 1999, ADV CHEM COMMUNICATI, P137; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1-2; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Hurst JL, 2001, CHEM SIGNAL, V9, P43; HURST JL, 1990, ANIM BEHAV, V40, P209, DOI 10.1016/S0003-3472(05)80916-9; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; JEMIOLO B, 1985, ANIM BEHAV, V33, P1114, DOI 10.1016/S0003-3472(85)80170-6; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Lucke C, 1999, EUR J BIOCHEM, V266, P1210, DOI 10.1046/j.1432-1327.1999.00984.x; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; Marie AD, 2001, PROTEIN SCI, V10, P411, DOI 10.1110/ps.31701; Mucignat-Caretta C, 1999, ANIM BEHAV, V57, P765, DOI 10.1006/anbe.1998.1023; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; PAYNE CE, 2000, CHEM SIGNALS VERTEBR, P233; Pearse-Pratt R, 1998, GENETICA, V104, P223, DOI 10.1023/A:1026489524199; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; SINGER AG, 1993, J CHEM ECOL, V19, P569, DOI 10.1007/BF00994326; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; YAMAZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P5685, DOI 10.1073/pnas.80.18.5685; Yamazaki K, 1998, GENETICA, V104, P235, DOI 10.1023/A:1026433925744	30	467	485	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					631	634		10.1038/414631a	http://dx.doi.org/10.1038/414631a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740558				2022-12-24	WOS:000172535600046
J	Schwetz, BA				Schwetz, BA			New drug for HIV-1 infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-24	WOS:000172488300004
J	Opie, LH				Opie, LH			Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension	LANCET			English	Editorial Material							CONVERTING ENZYME-INHIBITION; CALCIUM-CHANNEL BLOCKERS; BLOOD-PRESSURE CONTROL; RENAL-DISEASE; NEPHROPATHY; PROGRESSION; PROTEINURIA; DIET		Univ Cape Town, Dept Med, Cape Heart Ctr, ZA-7925 Cape Town, South Africa	University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Dept Med, Cape Heart Ctr, ZA-7925 Cape Town, South Africa.							Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Bakris GL, 1997, HYPERTENSION, V29, P744, DOI 10.1161/01.HYP.29.3.744; Bakris GL, 1996, KIDNEY INT, V50, P1641, DOI 10.1038/ki.1996.480; Black HR, 1997, ARCH INTERN MED, V157, P2413; BP TRIAL, 2000, LANCET, V355, P1955; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; DiBona GF, 2000, HYPERTENSION, V36, P1083, DOI 10.1161/01.HYP.36.6.1083; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; Lazarus JM, 1997, HYPERTENSION, V29, P641, DOI 10.1161/01.HYP.29.2.641; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2096; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X	19	27	27	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1829	1831		10.1016/S0140-6736(01)06879-9	http://dx.doi.org/10.1016/S0140-6736(01)06879-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741617				2022-12-24	WOS:000172463000003
J	Hirama, M; Oishi, T; Uehara, H; Inoue, M; Maruyama, M; Guri, H; Satake, M				Hirama, M; Oishi, T; Uehara, H; Inoue, M; Maruyama, M; Guri, H; Satake, M			Total synthesis of ciguatoxin CTX3C	SCIENCE			English	Article							RING-CLOSING METATHESIS; GAMBIERDISCUS-TOXICUS; CONVERGENT SYNTHESIS; SODIUM-CHANNELS; BREVETOXIN-A; PTYCHODISCUS-BREVIS; CIGUATERA; DINOFLAGELLATE; SYSTEM; CONFIGURATION	More than 20,000 people suffer annually from ciguatera seafood poisoning in subtropical and tropical regions. The extremely Low content of the causative neurotoxins, designated as ciguatoxins, in fish has hampered the isolation, detailed biological studies, and preparation of anti-ciguatoxin antibodies for detecting these toxins. The large (3 nanometers long) and complicated molecular structure of ciguatoxins has impeded chemists from completing their total synthesis. Our highly convergent strategic approach featuring the chemoselective ring-closing metathesis reaction as a key tactic has enabled the total synthesis of ciguatoxin CTX3C, which will provide a practical supply for further studies.	Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol Corp, CREST, Sendai, Miyagi 9808578, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Appl Bioorgan Chem, Sendai, Miyagi 9808555, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Hirama, M (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.		Oguri, Hiroki/B-7366-2014; Oguri, Hiroki/F-9541-2015	Oguri, Hiroki/0000-0001-8007-1631				Anger T, 2001, J MED CHEM, V44, P115, DOI 10.1021/jm000155h; BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Dechraoui MY, 1999, TOXICON, V37, P125, DOI 10.1016/S0041-0101(98)00169-X; FU GC, 1993, J AM CHEM SOC, V115, P9856, DOI 10.1021/ja00074a085; Fujiwara K, 2001, SYNLETT, P691; FUKUZAWA S, 1995, SYNLETT, P1077; GAWLEY RE, 1995, CHEM BIOL, V2, P533, DOI 10.1016/1074-5521(95)90187-6; Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6; Hokama Y, 1998, J AOAC INT, V81, P727; Imai H, 2001, TETRAHEDRON LETT, V42, P6219, DOI 10.1016/S0040-4039(01)01219-9; Inoue M, 1999, TETRAHEDRON, V55, P10949, DOI 10.1016/S0040-4020(99)00620-1; Inoue M, 1999, J ORG CHEM, V64, P9416, DOI 10.1021/jo990989b; Ishihara K, 1996, SYNLETT, P839; KIM DS, 1994, NEURAL PROCESS LETT, V1, P17, DOI 10.1007/BF02312396; Kira K, 2001, TETRAHEDRON LETT, V42, P2821, DOI 10.1016/S0040-4039(01)00286-6; LEE E, 1993, TETRAHEDRON LETT, V34, P4831, DOI 10.1016/S0040-4039(00)74101-3; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; Maruyama M, 2001, HETEROCYCLES, V54, P93; MURATA M, 1989, J AM CHEM SOC, V111, P8929, DOI 10.1021/ja00206a032; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; Nagumo Y, 2001, BIOORG MED CHEM LETT, V11, P2037, DOI 10.1016/S0960-894X(01)00358-4; Nicolaou KC, 1998, NATURE, V392, P264, DOI 10.1038/32623; NICOLAOU KC, 1995, J AM CHEM SOC, V117, P10252, DOI 10.1021/ja00146a010; Nicolaou KC, 1999, CHEM-EUR J, V5, P646, DOI 10.1002/(SICI)1521-3765(19990201)5:2<646::AID-CHEM646>3.0.CO;2-E; Oguri H, 1999, SYNTHESIS-STUTTGART, P1431; Oishi T, 1998, CHEM COMMUN, P1041, DOI 10.1039/a801678j; Oishi T, 2001, CHEM COMMUN, P381, DOI 10.1039/b009506k; Pauillac S, 2000, TOXICON, V38, P669, DOI 10.1016/S0041-0101(99)00183-X; Rahim MA, 2000, TETRAHEDRON, V56, P763, DOI 10.1016/S0040-4020(99)01091-1; Sabes SF, 1998, J AM CHEM SOC, V120, P2534, DOI 10.1021/ja973286p; Sasaki M, 1998, TETRAHEDRON LETT, V39, P2783, DOI 10.1016/S0040-4039(98)00338-4; Sasaki M, 1999, TETRAHEDRON LETT, V40, P1337, DOI 10.1016/S0040-4039(98)02606-9; SATAKE M, 1993, TETRAHEDRON LETT, V34, P1975, DOI 10.1016/S0040-4039(00)91978-6; Satake M, 1997, J AM CHEM SOC, V119, P11325, DOI 10.1021/ja972482t; SCHEUER PJ, 1994, TETRAHEDRON, V50, P3, DOI 10.1016/S0040-4020(01)80733-X; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Takakura H, 2001, ANGEW CHEM INT EDIT, V40, P1090, DOI 10.1002/1521-3773(20010316)40:6<1090::AID-ANIE10900>3.0.CO;2-W; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yasumoto T, 2000, J AM CHEM SOC, V122, P4988, DOI 10.1021/ja9944204	42	221	224	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1904	1907		10.1126/science.1065757	http://dx.doi.org/10.1126/science.1065757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729311				2022-12-24	WOS:000172465000052
J	Streets, DG; Jiang, KJ; Hu, XL; Sinton, JE; Zhang, XQ; Xu, DY; Jacobson, MZ; Hansen, JE				Streets, DG; Jiang, KJ; Hu, XL; Sinton, JE; Zhang, XQ; Xu, DY; Jacobson, MZ; Hansen, JE			Climate change - Recent reductions in China's greenhouse gas emissions	SCIENCE			English	Editorial Material									Argonne Natl Lab, Decis & Informat Sci Div, Argonne, IL 60439 USA; Energy Res Inst, Ctr Energy Environm & Climate Change, Beijing 100038, Peoples R China; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Energy Anal, Berkeley, CA 94720 USA; Chinese Acad Forestry, Forest Ecol & Environm Inst, Beijing 100091, Peoples R China; Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Streets, DG (corresponding author), Argonne Natl Lab, Decis & Informat Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.			Jacobson, Mark/0000-0002-4315-4128; Streets, David/0000-0002-0223-1350				[Anonymous], 2000, SPECIAL REPORT EMISS; [Anonymous], 1999, CHINA CLIMATE CHANGE; China Statistical Press, 2001, CHINA STAT YB 2001; *DEP EN, 2001, DOEEIA021999; DOU Q, 2000, TECHNOLOGY ASSESSMEN; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Houghton J.T., 1997, CH4 EMISSIONS COAL M; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; *NAT BUR STAT, 2001, ZHONGG TONGJ ZHAIYAO; OLIVIER GJ, 1996, 771060002 NAT I PUBL; Rawski T.G., 2001, CHINA PERSPECTIVES, P25; Sinton JE, 2000, ENERG POLICY, V28, P671, DOI 10.1016/S0301-4215(00)00053-7; SINTON JE, 2001, SINOSPHERE, V4, P3; Streets DG, 2000, ATMOS ENVIRON, V34, P4413, DOI 10.1016/S1352-2310(00)00187-4; Streets DG, 2001, ATMOS ENVIRON, V35, P4281, DOI 10.1016/S1352-2310(01)00179-0; WANG QY, 2001, NENGYUAN ZHENGCE YAN, V1, P57; ZHANG XQ, 2001, POTENTIAL CARBON SEQ; 2001, WASHINGTON POST 0814; 2001, NY TIMES        0615	19	123	152	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1835	+		10.1126/science.1065226	http://dx.doi.org/10.1126/science.1065226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729288	Green Submitted			2022-12-24	WOS:000172465000028
J	Poldrack, RA; Clark, J; Pare-Blagoev, EJ; Shohamy, D; Moyano, JC; Myers, C; Gluck, MA				Poldrack, RA; Clark, J; Pare-Blagoev, EJ; Shohamy, D; Moyano, JC; Myers, C; Gluck, MA			Interactive memory systems in the human brain	NATURE			English	Article							EVENT-RELATED FMRI; CAUDATE-NUCLEUS; HIPPOCAMPUS; ACQUISITION; AMNESIA; LESIONS; PLACE; RATS	Learning and memory in humans rely upon several memory systems, which appear to have dissociable brain substrates(1,2). A fundamental question concerns whether, and how, these memory systems interact. Here we show using functional magnetic resonance imaging (FMRI) that these memory systems may compete with each other during classification learning in humans. The medial temporal lobe and basal ganglia were differently engaged across subjects during classification learning depending upon whether the task emphasized declarative or nondeclarative memory, even when the to-be-learned material and the level of performance did not differ. Consistent with competition between memory systems suggested by animal studies(3,4) and neuroimaging(5), activity in these regions was negatively correlated across individuals. Further examination of classification learning using event-related FMRI showed rapid modulation of activity in these regions at the beginning of learning, suggesting that subjects relied upon the medial temporal lobe early in learning. However, this dependence rapidly declined with training, as predicted by previous computational models of associative learning(6-8).	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02131 USA; Harvard Univ, Sch Med, Charlestown, MA 02131 USA; Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA; Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Poldrack, RA (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02131 USA.		Myers, Catherine E./AAU-5804-2020	Myers, Catherine E./0000-0002-2776-4823; Shohamy, Daphna/0000-0003-4239-4960				Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; EICHENBAUM H, 1988, BEHAV NEUROSCI, V102, P331, DOI 10.1037/0735-7044.102.3.331; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gluck M.A., 2001, GATEWAY MEMORY INTRO; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Gluck MA, 1996, LEARN MEMORY, V3, P326, DOI 10.1101/lm.3.4.326; HOPKINS R, 2001, SOC NEUR ABSTR, V27; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; Kim JJ, 2001, TRENDS NEUROSCI, V24, P324, DOI 10.1016/S0166-2236(00)01818-X; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Knowlton BJ, 1996, NEUROPSYCHOLOGY, V10, P538; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Reber PJ, 1996, BEHAV NEUROSCI, V110, P861, DOI 10.1037/0735-7044.110.5.861; SEARS LL, 1990, BEHAV NEUROSCI, V104, P681, DOI 10.1037/0735-7044.104.5.681; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tagamets MA, 2001, BRAIN RES BULL, V54, P267, DOI 10.1016/S0361-9230(00)00435-4; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; WARRINGTON EK, 1982, NEUROPSYCHOLOGIA, V20, P233, DOI 10.1016/0028-3932(82)90099-9; WINOCUR G, 1976, NEUROPSYCHOLOGIA, V14, P97, DOI 10.1016/0028-3932(76)90011-7	29	783	790	4	79	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					546	550		10.1038/35107080	http://dx.doi.org/10.1038/35107080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	496PV	11734855				2022-12-24	WOS:000172405900048
J	Lauvau, G; Vijh, S; Kong, P; Horng, T; Kerksiek, K; Serbina, N; Tuma, RA; Pamer, EG				Lauvau, G; Vijh, S; Kong, P; Horng, T; Kerksiek, K; Serbina, N; Tuma, RA; Pamer, EG			Priming of memory but not effector CD8 T cells by a killed bacterial vaccine	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; CLONAL EXPANSION; DIFFERENTIATION; IMMUNITY; ANTIGEN; STIMULATION; RESISTANCE	Killed or inactivated vaccines targeting intracellular bacterial and protozoal pathogens are notoriously ineffective at generating protective immunity. For example, vaccination with heat-killed Listeria monocytogenes (HKLM) is not protective, although infection with live L. monocytogenes induces long-lived, CD8 T cell-mediated immunity. We demonstrate that HKLM immunization primes memory CD8 T lymphocyte populations that, although substantial in size, are ineffective at providing protection from subsequent L. monocytogenes infection. In contrast to live infection, which elicits large numbers of effector CD8 T cells, HKLM immunization primes T lymphocytes that do not acquire effector functions. Our studies show that it is possible to dissociate T cell-dependent protective immunity from memory T cell expansion, and that generation of effector T cells may be necessary for long-term protective immunity.	Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, New York, NY 10021 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06511 USA	Memorial Sloan Kettering Cancer Center; Yale University	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	pamere@mskcc.org			NIAID NIH HHS [F32 AI09629-02, AI42135, AI 39031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031, R01AI042135, R01AI039031, F32AI009629] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; DUNN PL, 1991, J INFECT DIS, V164, P878, DOI 10.1093/infdis/164.5.878; Edelson BT, 1999, J IMMUNOL, V163, P4087; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KAUFMANN SHE, 1986, J EXP MED, V164, P363, DOI 10.1084/jem.164.1.363; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MITCHELL T, 2001, NATURE IMMUNOL, V2, P377; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; PAMER EG, 1994, J IMMUNOL, V152, P686; Pape KA, 1997, J IMMUNOL, V159, P591; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rolph MS, 2001, J IMMUNOL, V166, P5115, DOI 10.4049/jimmunol.166.8.5115; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SERBINA N, UNPUB; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vijh S, 1999, INFECT IMMUN, V67, P1303, DOI 10.1128/IAI.67.3.1303-1309.1999; VONKOENIG CHW, 1982, NATURE, V297, P233, DOI 10.1038/297233a0	27	237	252	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1735	1739		10.1126/science.1064571	http://dx.doi.org/10.1126/science.1064571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721060				2022-12-24	WOS:000172307400050
J	Shu, DG; Morris, SC; Han, J; Chen, L; Zhang, XL; Zhang, ZF; Liu, HQ; Li, Y; Liu, JN				Shu, DG; Morris, SC; Han, J; Chen, L; Zhang, XL; Zhang, ZF; Liu, HQ; Li, Y; Liu, JN			Primitive deuterostomes from the Chengjiang Lagerstatte (Lower Cambrian, China)	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; PTYCHODERA-FLAVA; TORNARIA LARVAE; GENE-EXPRESSION; SOUTH CHINA; HEMICHORDATE; CHORDATE; ENTEROPNEUST; EVOLUTION; MOLECULES	Cambrian fossil-Lagerstatten (sites of exceptional fossil preservation), such as those from Chengjiang (Lower Cambrian) and the Burgess Shale (Middle Cambrian), provide our best window into the Cambrian 'explosion'. Such faunas are known from about 40 localities, and have yielded a widely disparate series of taxa ranging from ctenophores to agnathan fish. Recent excavations of the Chengjiang fossil-Lagerstatte, known from a series of sites near Kunming in Yunnan, south China, have resulted in the discovery of several new forms. In conjunction with material described earlier, these provide evidence for a new group of metazoans, the vetulicolians. Several features, notably a series of gill slits, suggest that this group can throw light on an early stage of deuterostome diversification.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Northwest University Xi'an; Northwest University Xi'an; University of Cambridge	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	dgshu@sein.sxgb.com.cn	Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				Bromham LD, 1999, EVOL DEV, V1, P166, DOI 10.1046/j.1525-142x.1999.99026.x; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Chen J-Y, 1996, CHENGJIANG BIOTA UNI; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; FIORONI P, 1980, REV SUISSE ZOOL, V87, P261, DOI 10.5962/bhl.part.85517; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gee H., 1996, BACKBONE VIEWS ORIGI; GILMOUR THJ, 1979, CAN J ZOOL, V57, P1136, DOI 10.1139/z79-143; GILMOUR THJ, 1982, CAN J ZOOL, V60, P3010, DOI 10.1139/z82-384; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Hou X.-g., 1987, Acta Palaeontologica Sinica, V26, P286; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; Lacalli TC, 1997, INVERTEBR BIOL, V116, P363, DOI 10.2307/3226869; LACALLI TC, 1994, AM ZOOL, V34, P533; LUO H., 1999, EARLY CAMBRIAN CHENG; Morris SC, 2000, CELL, V100, P1, DOI 10.1016/S0092-8674(00)81679-7; Nielsen C, 1999, DEV GENES EVOL, V209, P198, DOI 10.1007/s004270050244; Ogasawara M, 1999, ZOOL SCI, V16, P559, DOI 10.2108/zsj.16.559; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Okai N, 2000, DEV DYNAM, V217, P309, DOI 10.1002/(SICI)1097-0177(200003)217:3<309::AID-DVDY9>3.0.CO;2-2; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Romer AS, 1972, EVOLUTIONARY BIOL, P121, DOI DOI 10.1007/978-1-4684-9063-3_5; Romer AS, 1964, VERTEBRATE BODY; Ruppert EE, 1999, INVERTEBR BIOL, V118, P202, DOI 10.2307/3227061; SCHAEFFER B, 1987, EVOL BIOL, V21, P179; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu D, 1999, NATURE, V400, P746, DOI 10.1038/23445; Shu D. G., 2001, ZOOL SCI, V18, P447; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; SHU DG, 1996, PROGR GEOLOGY CHINA, P42; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Tagawa K, 2000, J EXP ZOOL, V288, P23, DOI 10.1002/(SICI)1097-010X(20000415)288:1<23::AID-JEZ3>3.0.CO;2-H; Taguchi S, 2000, DEV GENES EVOL, V210, P11, DOI 10.1007/PL00008181; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Valentine JW, 1999, DEVELOPMENT, V126, P851; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	44	136	153	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					419	424		10.1038/35106514	http://dx.doi.org/10.1038/35106514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719797				2022-12-24	WOS:000172304500035
J	Gusarov, I; Nudler, E				Gusarov, I; Nudler, E			Control of intrinsic transcription termination by N and NusA: The basic mechanisms	CELL			English	Article							COLI RNA-POLYMERASE; ELONGATION-FACTOR NUSA; ARGININE-RICH MOTIF; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; ANTITERMINATION PROTEIN; ALPHA-SUBUNIT; PROCESSIVE ANTITERMINATION; GENE-EXPRESSION	Intrinsic transcription termination plays a crucial role in regulating gene expression in prokaryotes. After a short pause, the termination signal appears in RNA as a hairpin that destabilizes the elongation complex (EC). We demonstrate that negative and positive-termination factors control the efficiency of termination primarily through a direct modulation of hairpin folding and, to a much lesser extent, by changing pausing at the point of termination. The mechanism controlling hairpin formation at the termination point relies on weak protein interactions with single-stranded RNA, which corresponds to the upstream portion of the hairpin. Escherichia coli NusA protein destabilizes these interactions and thus promotes hairpin folding and termination. Stabilization of these contacts by phage lambda N protein leads to antitermination.	NYU Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU Med Ctr, Dept Biochem, New York, NY 10016 USA.		Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRENDEL V, 1986, J BIOMOL STRUCT DYN, V3, P705, DOI 10.1080/07391102.1986.10508457; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; CLERGET M, 1995, J MOL BIOL, V248, P768, DOI 10.1006/jmbi.1995.0259; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; DEVITO J, 1994, P NATL ACAD SCI USA, V91, P8660, DOI 10.1073/pnas.91.18.8660; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; FRANKLIN NC, 1993, J MOL BIOL, V231, P343, DOI 10.1006/jmbi.1993.1287; FRIEDMAN DI, 1983, CELL, V34, P143, DOI 10.1016/0092-8674(83)90144-7; FRIEDMAN DI, 1995, MOL MICROBIOL, V18, P191, DOI 10.1111/j.1365-2958.1995.mmi_18020191.x; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; KASHLEV M, 1990, SCIENCE, V248, P1006, DOI 10.1126/science.1693014; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; Landick R, 1996, METHOD ENZYMOL, V274, P334; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Liu KB, 1996, EMBO J, V15, P150, DOI 10.1002/j.1460-2075.1996.tb00343.x; LIU KB, 1995, P NATL ACAD SCI USA, V92, P5012, DOI 10.1073/pnas.92.11.5012; Mah TF, 1999, MOL MICROBIOL, V34, P523, DOI 10.1046/j.1365-2958.1999.01618.x; Mah TF, 2000, GENE DEV, V14, P2664, DOI 10.1101/gad.822900; MASON SW, 1992, J BIOL CHEM, V267, P19418; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; MOGRIDGE J, 1995, GENE DEV, V9, P2831, DOI 10.1101/gad.9.22.2831; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Neely MN, 2000, MOL MICROBIOL, V38, P1074, DOI 10.1046/j.1365-2958.2000.02217.x; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Rees WA, 1996, P NATL ACAD SCI USA, V93, P342, DOI 10.1073/pnas.93.1.342; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; ROBERTS JW, 1993, CELL, V72, P653, DOI 10.1016/0092-8674(93)90394-6; Sambrook J., 1989, MOL CLONING; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Su LL, 1997, BIOCHEMISTRY-US, V36, P12722, DOI 10.1021/bi971408k; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; VanGilst MR, 1997, BIOCHEMISTRY-US, V36, P1514, DOI 10.1021/bi961920q; VOGEL U, 1994, J BIOL CHEM, V269, P16236; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WHALEN W, 1988, P NATL ACAD SCI USA, V85, P2494, DOI 10.1073/pnas.85.8.2494; WHALEN W, 1990, NEW BIOL, P975; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	56	123	126	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					437	449		10.1016/S0092-8674(01)00582-7	http://dx.doi.org/10.1016/S0092-8674(01)00582-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719185	Bronze			2022-12-24	WOS:000172272900005
J	Rawson, H; Crampin, A; Noah, N				Rawson, H; Crampin, A; Noah, N			Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data	BRITISH MEDICAL JOURNAL			English	Article							AGE	Objective To evaluate the epidemiology and impact of mortality from chickenpox in England and Wales. Design Review of death certificates from the Office for National Statistics on which codes for "chickenpox" or "varicella" were mentioned. Further information ascertained from certifying physician. Participants Those certified as having died from chickenpox in England and Wales, 1995-7. Main outcome measures Diagnosis and age and sex distributions of deaths from chickenpox. Results On average, 25 people a year die from chickenpox. Overall case fatality was 9.22 per 100 000 consultations for chickenpox. Adults accounted for 81% of deaths and 19% of consultations. Deaths were twice as common in men as in women. More of those who died were born outside United Kingdom than expected (12% v 4%). Conclusions Chickenpox is not a mild disease. Deaths in adults are increasing, both in number and proportion.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Guys Kings Coll, London SE1 8AW, England; St Thomas Hosp Sch Med & Dent, London SE1 8AW, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London	Noah, N (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.			Crampin, Amelia/0000-0002-1513-4330				*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P365; *DEP HLTH, 1991, REP CONF ENQ MAT DEA; FAIRLEY CK, 1996, J INFECT DIS S3, V174, P314; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; MILLER E, 1993, LANCET, V341, P308, DOI 10.1016/0140-6736(93)92663-E	7	90	96	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1091	1093		10.1136/bmj.323.7321.1091	http://dx.doi.org/10.1136/bmj.323.7321.1091			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701571	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000172188400010
J	Blackburn, TM; Duncan, RP				Blackburn, TM; Duncan, RP			Determinants of establishment success in introduced birds	NATURE			English	Article							GLOBAL PATTERNS; INVASIONS; CONSEQUENCES; MODELS; RANGE	A major component of human-induced global change is the deliberate or accidental translocation of species from their native ranges to alien environments(1,2), where they may cause substantial environmental and economic damage(3,4). Thus we need to understand why some introductions succeed while others fail. Successful introductions tend to be concentrated in certain regions(2), especially islands and the temperate zone, suggesting that species-rich mainland and tropical locations are harder to invade because of greater biotic resistance(1,5-9). However, this pattern could also reflect variation in the suitability of the abiotic environment at introduction locations for the species introduced(3,9-11), coupled with known confounding effects of non-random selection of species and locations for introduction(8,12-14). Here, we test these alternative hypotheses using a global data set of historical bird introductions, employing a statistical framework that accounts for differences among species and regions in terms of introduction success. By removing these confounding effects, we show that the pattern of avian introduction success is not consistent with the biotic resistance hypothesis. Instead, success depends on the suitability of the abiotic environment for the exotic species at the introduction site.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Lincoln Univ, Soil Plant & Ecol Sci Div, Ecol & Entomol Grp, Canterbury, New Zealand	University of Birmingham; Lincoln University - New Zealand	Blackburn, TM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	t.blackburn@bham.ac.uk	Blackburn, Tim M/A-7685-2011; Blackburn, Tim/AAC-3144-2019; Duncan, Richard P/E-7899-2013; Duncan, Richard/ABD-4099-2020	Blackburn, Tim/0000-0003-0152-2663; Duncan, Richard P/0000-0003-2295-449X; Duncan, Richard/0000-0003-2295-449X				BLACKBURN TM, IN PRESS J BIOGEOGR; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1989, BIOL INVASIONS GLOBA, P85; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; CASE TJ, 1991, BIOL J LINN SOC, V42, P239, DOI 10.1111/j.1095-8312.1991.tb00562.x; Crawley M. J., 1997, P36; CRAWLEY MJ, 1986, PHILOS T ROY SOC B, V314, P711, DOI 10.1098/rstb.1986.0082; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Ehrlich P.R., 1989, BIOL INVASIONS GLOBA, P315; Elton C. S., 1958, ECOLOGY INVASIONS; GASTON KJ, 1994, RARITY, P117; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hodkinson ID, 1999, J ANIM ECOL, V68, P1259, DOI 10.1046/j.1365-2656.1999.00372.x; HOLDGATE MW, 1986, PHILOS T ROY SOC B, V314, P733, DOI 10.1098/rstb.1986.0083; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P606; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Newsome A.E., 1986, P1; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Rejmanek M, 1996, ECOL STU AN, V122, P153; SIMBERLOFF D, 1989, BIOL INVASIONS, P00061; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Sol D, 2000, ECOGRAPHY, V23, P687, DOI 10.1034/j.1600-0587.2000.230606.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Williamson M, 1996, BIOL INVASIONS; WILLIAMSON MH, 1986, PHILOS T R SOC B, V314, P505, DOI 10.1098/rstb.1986.0070; [No title captured]	30	251	259	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					195	197		10.1038/35102557	http://dx.doi.org/10.1038/35102557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700555				2022-12-24	WOS:000172029100044
J	Singer, S; Bergthold, L				Singer, S; Bergthold, L			Cosmetic vs reconstructive surgery for cleft palate: A window into the medical necessity debate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA	Stanford University	Singer, S (corresponding author), Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA.		Singer, Lynn/Q-2045-2019	Singer, Lynn/0000-0003-2950-9460				Cockell A, 2000, PRENATAL DIAG, V20, P149, DOI 10.1002/(SICI)1097-0223(200002)20:2<149::AID-PD764>3.0.CO;2-U; FREUDENHEIM M, 1999, NY TIMES        1109, pA1; LAUDICINA SS, 1999, LEGISLATIVE HLTH CAR; 2001, AETNA US HEALTHCARE	4	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2162	2162		10.1001/jama.286.17.2162	http://dx.doi.org/10.1001/jama.286.17.2162			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694163				2022-12-24	WOS:000172032100041
J	Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M				Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M			Unnecessary school absence after minor injury: case-control study	BRITISH MEDICAL JOURNAL			English	Article									Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales; Iechyd Morgannwg Hlth Author, Dept Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Neath Gen Hosp, Local Accid Ctr, Neath SA11 2LQ, Wales; Morriston Hosp, Swansea NHS Trust, Dept Accid & Emergency, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Maddocks, A (corresponding author), Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales.		Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X				KLERMAN LV, 1988, PEDIATR CLIN N AM, V35, P1253; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; TOWNSEND P, 1998, HLTH DEPRIVATION INE	3	21	21	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1034	1035		10.1136/bmj.323.7320.1034	http://dx.doi.org/10.1136/bmj.323.7320.1034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691761	Bronze, Green Published			2022-12-24	WOS:000172055900017
J	Liu, ZH; Luyten, I; Bottomley, MJ; Messias, AC; Houngninou-Molango, S; Sprangers, R; Zanier, K; Kramer, A; Sattler, M				Liu, ZH; Luyten, I; Bottomley, MJ; Messias, AC; Houngninou-Molango, S; Sprangers, R; Zanier, K; Kramer, A; Sattler, M			Structural basis for recognition of the intron branch site RNA by splicing factor 1	SCIENCE			English	Article							PRE-MESSENGER-RNA; FRAGILE-X-SYNDROME; KH DOMAIN; BINDING-PROTEIN; SEQUENCE; HOMOLOGY; NMR; SPECIFICITY; ACTIVATION; ASSIGNMENT	During spliceosome assembly, splicing factor 1 (SF1) specifically recognizes the intron branch point sequence (BPS) UACUAAC in the pre-mRNA transcripts. We show that the KH-QUA2 region of SF1 defines an enlarged KH (hn RNP K) fold which is necessary and sufficient for BPS binding. The 3' part of the BPS (UAAC), including the conserved branch point adenosine (underlined), is specifically recognized in a hydrophobic cleft formed by the Gly-Pro-Arg-Gly motif and the variable loop of the KH domain. The QUA2 region recognizes the 5' nucleotides of the BPS (ACU). The branch point adenosine acting as the nucleophile in the first biochemical step of splicing is deeply buried. BPS RNA recognition suggests how SF1 may facilitate subsequent formation of the prespliceosomal complex A.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	European Molecular Biology Laboratory (EMBL); University of Geneva	Sattler, M (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Sattler, Michael/A-2407-2012; Sattler, Michael/C-1169-2010	Sattler, Michael/0000-0002-1594-0527; Messias, Ana/0000-0002-5449-9922				Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Berglund JA, 1998, RNA, V4, P998, DOI 10.1017/S1355838298980499; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Berglund JA, 2001, RNA, V7, P682, DOI 10.1017/S1355838201002187; Billeter M, 1995, J BIOMOL NMR, V5, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Klein A, 1998, HUM MOL GENET, V7, P393, DOI 10.1093/hmg/7.3.393; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; Kuivenhoven JA, 1996, J CLIN INVEST, V98, P358, DOI 10.1172/JCI118800; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Musco G, 1997, NAT STRUCT BIOL, V4, P712, DOI 10.1038/nsb0997-712; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	36	185	190	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1098	1102		10.1126/science.1064719	http://dx.doi.org/10.1126/science.1064719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691992				2022-12-24	WOS:000172013800049
J	Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT			Dynamics of the 2001 UK foot and mouth epidemic: Stochastic dispersal in a heterogeneous landscape	SCIENCE			English	Article							DISEASE EPIDEMIC; GREAT-BRITAIN; SPREAD; VACCINATION; STRATEGIES; MODELS; RATES; SHEEP; RISK; FMD	Foot-and-mouth is one of the world's most economically important livestock diseases. We developed an individual farm-based stochastic model of the current UK epidemic. The fine grain of the epidemiological data reveals the infection dynamics at an unusually high spatiotemporal resolution. We show that the spatial distribution, size, and species composition of farms all influence the observed pattern and regional variability of outbreaks. The other key dynamical component is long-tailed stochastic dispersal of infection, combining frequent local movements with occasional long jumps. We assess the history and possible duration of the epidemic, the performance of control strategies, and general implications for disease dynamics in space and time.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	University of Cambridge; University of Edinburgh; University of Guelph; Veterinary Laboratories Agency	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Matthews, Louise/E-2913-2013; Cornell, Stephen J/D-3955-2009; Keeling, Matt J/J-9280-2012	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Shaw, Darren/0000-0003-2016-1541; Haydon, Daniel/0000-0002-1240-1886				ANDERSON R M, 1991; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Bates TW, 2001, AM J VET RES, V62, P1121, DOI 10.2460/ajvr.2001.62.1121; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Brownlie J, 2001, VET REC, V148, P358; Cannon RM, 1999, ENVIRON INT, V25, P713, DOI 10.1016/S0160-4120(99)00049-5; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; Enserink M, 2001, SCIENCE, V292, P410, DOI 10.1126/science.292.5516.410; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Giles J, 2001, NATURE, V410, P727, DOI 10.1038/35071239; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; HUGHJONES ME, 1972, RES VET SCI, V13, P411, DOI 10.1016/S0034-5288(18)33984-5; HUGHJONES ME, 1970, J HYG-CAMB, V68, P253, DOI 10.1017/S0022172400028722; Hutber AM, 2000, TROP ANIM HEALTH PRO, V32, P285, DOI 10.1023/A:1005212922884; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kitching R. P., 1994, State Veterinary Journal, V4, P7; Mason PW, 2001, AUST VET J, V79, P342, DOI 10.1111/j.1751-0813.2001.tb12009.x; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Nielen M, 1996, PREV VET MED, V28, P143, DOI 10.1016/0167-5877(96)01042-2; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Salt J. S., 1997, VET VACCINOLOGY, P641; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699	30	649	661	6	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					813	817		10.1126/science.1065973	http://dx.doi.org/10.1126/science.1065973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679661				2022-12-24	WOS:000171851800036
J	Ooi, SL; Shoemaker, DD; Boeke, JD				Ooi, SL; Shoemaker, DD; Boeke, JD			A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; REPAIR; YEAST; MAINTENANCE; DELETION; PROTEIN; GENOME; XRCC4	We describe a microarray-based screen performed by imposing different genetic selections on thousands of yeast mutants in parallel, representing most genes in the yeast genome. The presence or absence of mutants was detected by oligonucleotide arrays that hybridize to 20-nucleotide "barcodes." We used this method to screen for components of the nonhomologous end-joining (NHEJ) pathway. Known components of the pathway were identified, as well as a gene not previously known to be involved in NHEJ, NEJ1. Nej1 protein interacts with the amino terminus of LIF1/XRCC4, a recently recognized "guardian of the genome" against cancer.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Rosetta Inpharmat Inc, Kirkland, WA 98034 USA	Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 617 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.			Boeke, Jef/0000-0001-5322-4946	NHGRI NIH HHS [HG01627] Funding Source: Medline; NIGMS NIH HHS [GM36481] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036481] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; de la Torre-Ruiz MA, 2000, FEBS LETT, V467, P311, DOI 10.1016/S0014-5793(00)01180-7; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; GLAEVER G, 1999, NAT GENET, V21, P278; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Roth DB, 2000, NATURE, V404, P823, DOI 10.1038/35009180; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Tsukamoto Y, 1997, MOL GEN GENET, V255, P543, DOI 10.1007/s004380050527; VALENCIA M, IN PRESS NATURE; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	22	117	121	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2552	2556		10.1126/science.1065672	http://dx.doi.org/10.1126/science.1065672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11701889				2022-12-24	WOS:000172927700060
J	Reich, DS; Mechler, F; Victor, JD				Reich, DS; Mechler, F; Victor, JD			Independent and redundant information in nearby cortical neurons	SCIENCE			English	Article							VISUAL-CORTEX; SPIKE TRAINS; DISCHARGE	In the primary visual cortex (V1), nearby neurons are tuned to similar stimulus features, and, depending on the manner and time scale over which neuronal signals are analyzed, the resulting redundancy may mitigate deleterious effects of response variability. We estimated information rates in the short-time scale responses of clusters of up to six simultaneously recorded nearby neurons in monkey V1. Responses were almost independent if we kept track of which neuron fired each spike but were redundant if we summed responses over the cluster. Redundancy was independent of cluster size. Summing neuronal responses to reduce variability discards potentially useful information, and the discarded information increases with cluster size.	Rockefeller Univ, Biophys Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Rockefeller University; Cornell University	Reich, DS (corresponding author), Rockefeller Univ, Biophys Lab, 1230 York Ave, New York, NY 10021 USA.		Victor, Jonathan D./D-2931-2009; Reich, Daniel S./E-5701-2010	Victor, Jonathan D./0000-0002-9293-0111; Reich, Daniel S./0000-0002-2628-4334	NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NEI NIH HHS [EY07138, EY9314] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; De Angelo J, 1999, Expert Opin Pharmacother, V1, P19; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; Reich DS, 2001, J NEUROPHYSIOL, V85, P305, DOI 10.1152/jn.2001.85.1.305; Reich DS, 2000, J NEUROSCI, V20, P1964; REICH DS, 2001, THESIS ROCKEFELLER U; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	21	204	207	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2566	2568		10.1126/science.1065839	http://dx.doi.org/10.1126/science.1065839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752580				2022-12-24	WOS:000172927700064
J	Kuo, HC; Cheng, CF; Clark, RB; Lin, JJC; Lin, JLC; Hoshijima, M; Nguyen-Tran, VTB; Gu, YS; Ikeda, Y; Chu, PH; Ross, J; Giles, WR; Chien, KR				Kuo, HC; Cheng, CF; Clark, RB; Lin, JJC; Lin, JLC; Hoshijima, M; Nguyen-Tran, VTB; Gu, YS; Ikeda, Y; Chu, PH; Ross, J; Giles, WR; Chien, KR			A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I-to and confers susceptibility to ventricular tachycardia	CELL			English	Article							TRANSIENT OUTWARD CURRENT; SUDDEN CARDIAC DEATH; K+ CHANNEL; HEART-FAILURE; MOUSE HEARTS; EXPRESSION; MYOCYTES; SUBUNIT; MICE; REPOLARIZATION	KChIP2, a gene encoding three auxiliary subunits of Kv4.2 and Kv4.3, is preferentially expressed in the adult heart, and its expression is downregulated in cardiac hypertrophy. Mice deficient for KChIP2 exhibit normal cardiac structure and function but display a prolonged elevation in the ST segment on the electrocardiogram. The KChIP2(-/-) mice are highly susceptible to the induction of cardiac arrhythmias. Single-cell analysis revealed a substrate for arrhythmogenesis, including a complete absence of transient outward potassium current, It., and a marked increase in action potential duration. These studies demonstrate that a defect in KChIP2 is sufficient to confer a marked genetic susceptibility to arrhythmias, establishing a novel genetic pathway for ventricular tachycardia via a loss of the transmural gradient of I-to.	Univ Calif San Diego, Sch Med, UCSD Salk Program Mol Med, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of Calgary; University of Iowa	Chien, KR (corresponding author), Univ Calif San Diego, Sch Med, UCSD Salk Program Mol Med, Inst Mol Med, La Jolla, CA 92093 USA.		gu, yu/GSD-4507-2022; CHENG, Ching-Feng/AAB-8861-2019; Chu, Pao-Hsien/P-5249-2019	CHENG, Ching-Feng/0000-0003-0104-0146; Chu, Pao-Hsien/0000-0003-0361-6348; Ikeda, Yasuhiro/0000-0002-2970-7304; Nguyen-Tran, Van/0000-0001-5678-1908				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Antzelevitch C, 2001, CURR OPIN CARDIOL, V16, P1, DOI 10.1097/00001573-200101000-00001; Antzelevitch C, 2001, EUR HEART J, V22, P356, DOI 10.1053/euhj.2000.2461; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Berul CI, 1997, J CLIN INVEST, V99, P570, DOI 10.1172/JCI119197; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; ELSHERIF N, 2000, CARDIAC ELECTROPHYSI, P662; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Giese KP, 1998, LEARN MEMORY, V5, P257; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; TOMITA F, 1994, CIRC RES, V75, P296, DOI 10.1161/01.RES.75.2.296; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wickenden AD, 1999, CIRC RES, V85, P1067; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	33	358	367	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					801	813		10.1016/S0092-8674(01)00588-8	http://dx.doi.org/10.1016/S0092-8674(01)00588-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747815	Bronze			2022-12-24	WOS:000172771800012
J	Norio, P; Schildkraut, CL				Norio, P; Schildkraut, CL			Visualization of DNA replication on individual Epstein-Barr virus episomes	SCIENCE			English	Article							DIHYDROFOLATE-REDUCTASE DOMAIN; HIGH-RESOLUTION; FIBER-FISH; SITES; HYBRIDIZATION; INITIATION; ORIGIN; GENOME; PAUSE; FORKS	The duplication of the mammalian genome is an organized event, but there is limited information about the precision of the duplication program at specific genetic loci. We developed an approach that allows DNA replication events to be visualized in individual DNA molecules. Studying the latent replication of Epstein-Barr virus episomes, we show that different initiation sites are used to commence DNA replication from a specific portion of the viral genome (zone), whereas termination does not seem to be genomically defined. We conclude that initiation zones and pausing sites are major organizers of the duplication program, but initiation, fork progression, and termination of replication can vary in each molecule.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Norio, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NCI NIH HHS [P30CA13330] Funding Source: Medline; NIGMS NIH HHS [GM45751] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; HUBERMAN JA, 1966, P NATL ACAD SCI USA, V55, P599, DOI 10.1073/pnas.55.3.599; HUBERMAN JA, 1968, J MOL BIOL, V32, P327, DOI 10.1016/0022-2836(68)90013-2; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kalejta RF, 1996, MOL CELL BIOL, V16, P4923; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NORIO P, UNPUB; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; van de Rijke FM, 2000, J HISTOCHEM CYTOCHEM, V48, P743, DOI 10.1177/002215540004800602; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; Yates J.L, 1996, DNA REPLICATION EUKA, P751; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	24	115	120	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2361	2364		10.1126/science.1064603	http://dx.doi.org/10.1126/science.1064603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743204				2022-12-24	WOS:000172817200049
J	Wang, ZR; Kiledjian, M				Wang, ZR; Kiledjian, M			Functional link between the mammalian exosome and mRNA decapping	CELL			English	Article							MESSENGER-RNA DEGRADATION; PROTEIN COMPLEX; ENDORIBONUCLEASE ACTIVITY; ENDONUCLEOLYTIC CLEAVAGE; SACCHAROMYCES-CEREVISIAE; CAP STRUCTURE; YEAST-CELLS; STABILITY; TURNOVER; TRANSLATION	Mechanistic understanding of mammalian mRNA turnover remains incomplete. We demonstrate that the 3' to 5' exoribonuclease decay pathway is a major contributor to mRNA decay both in cells and in cell extract. An exoribonuclease-dependent scavenger decapping activity was identified that follows decay of the mRNA and hydrolyzes the residual cap. The decapping activity is associated with a subset:Of the exosome proteins in vivo, implying a higher-order degradation complex consisting of exoribonucleases and a decapping activity, which together coordinate the decay of an mRNA. These findings indicate that following deadenylation of mammal mRNA, degradation proceeds by a coupled 3' to 5' exoribonucleolytic activity and subsequent hydrolysis of the cap structure by a scavenger decapping activity.	Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	kiledjia@biology.rutgers.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051611] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51611] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brewer G, 1998, J BIOL CHEM, V273, P34770, DOI 10.1074/jbc.273.52.34770; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; BROWN BD, 1993, GENE DEV, V7, P1620, DOI 10.1101/gad.7.8.1620; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; DRUMMOND DR, 1985, NUCLEIC ACIDS RES, V13, P7375, DOI 10.1093/nar/13.20.7375; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; FURUICHI Y, 1989, METHOD ENZYMOL, V180, P164; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; GELPI C, 1990, CLIN EXP IMMUNOL, V81, P59; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GREEN MR, 1983, CELL, V32, P681, DOI 10.1016/0092-8674(83)90054-5; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Kiledjian M, 1999, METHODS, V17, P84, DOI 10.1006/meth.1998.0710; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; NUSS DL, 1975, CELL, V6, P21, DOI 10.1016/0092-8674(75)90069-0; NUSS DL, 1977, J BIOL CHEM, V252, P2815; REIMER G, 1986, J IMMUNOL, V137, P3802; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHOENBERG DR, 1997, MRNA METABOLISM POST, P217; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; STOECKLE MY, 1989, MOL CELL BIOL, V9, P4738, DOI 10.1128/MCB.9.11.4738; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Wang ZR, 2000, EMBO J, V19, P295, DOI 10.1093/emboj/19.2.295; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WICKENS MP, 1983, J MOL BIOL, V163, P1, DOI 10.1016/0022-2836(83)90027-X; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhang S, 1999, MOL CELL BIOL, V19, P7568; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706	57	200	208	4	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					751	762		10.1016/S0092-8674(01)00592-X	http://dx.doi.org/10.1016/S0092-8674(01)00592-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747811	Bronze			2022-12-24	WOS:000172771800008
J	Gandon, S; Mackinnon, MJ; Nee, S; Read, AF				Gandon, S; Mackinnon, MJ; Nee, S; Read, AF			Imperfect vaccines and the evolution of pathogen virulence	NATURE			English	Article								Vaccines rarely provide full protection from disease. Nevertheless, partially effective (imperfect) vaccines may be used to protect both individuals and whole populations(1-3). We studied the potential impact of different types of imperfect vaccines on the evolution of pathogen virulence (induced host mortality) and the consequences for public health. Here we show that vaccines designed to reduce pathogen growth rate and/or toxicity diminish selection against virulent pathogens. The subsequent evolution leads to higher levels of intrinsic virulence and hence to more severe disease in unvaccinated individuals. This evolution can erode any population-wide benefits such that overall mortality rates are unaffected, or even increase, with the level of vaccination coverage. In contrast, infection-blocking vaccines induce no such effects, and can even select for lower virulence. These findings have policy implications for the development and use of vaccines that are not expected to provide full immunity, such as candidate vaccines for malaria(4).	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Gandon, S (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	Sylvain.Gandon@ed.ac.uk	Mackinnon, Margaret/L-3155-2013; GANDON, Sylvain/AHC-0976-2022	Mackinnon, Margaret/0000-0003-1279-9625; GANDON, Sylvain/0000-0003-2624-7856				ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Caswell H., 2001, MATRIX POPULATION MO, V2nd; *CDC, 2000, MROB MORTAL WKLY REP, V46, P1094; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; DIECKMANN U, 2001, VIRULENCE MANAGEMENT; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; GUPTA S, 1997, P ROY SOC LOND B BIO, V266, P1435; HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6; Hoffman SL, 1996, MALARIA VACCINE DEV; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI 10.1111/j.1558-5646.1999.tb05364.x; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; MCLEAN AR, 1995, P ROY SOC B-BIOL SCI, V261, P389, DOI 10.1098/rspb.1995.0164; MCLEAN SA, 1993, P ROY SOC LOND B BIO, V256, P9; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Regoes RR, 2000, EVOLUTION, V54, P64, DOI 10.1111/j.0014-3820.2000.tb00008.x; Ronce O, 2001, EVOLUTION, V55, P1520, DOI 10.1111/j.0014-3820.2001.tb00672.x; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Witter RL, 1997, ACTA VET HUNG, V45, P251; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Zuckerman AJ, 2000, LANCET, V355, P1382, DOI 10.1016/S0140-6736(00)02132-2	30	442	449	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					751	756		10.1038/414751a	http://dx.doi.org/10.1038/414751a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742400	Green Published			2022-12-24	WOS:000172676200048
J	Parsons, TJ; Power, C; Manor, O				Parsons, TJ; Power, C; Manor, O			Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							CATCH-UP GROWTH; CORONARY HEART-DISEASE; WEIGHT-FOR-HEIGHT; CARDIOVASCULAR RISK; BLOOD-PRESSURE; IN-UTERO; CHILDHOOD; OBESITY; ADOLESCENCE; WOMEN	Objectives To determine the influence of birth weight on body mass index at different stages of later life; whether this relation persists after accounting for potential confounding factors; and the role of indicators of fetal growth (birth weight relative to parental size) and childhood growth. Design Longitudinal study of the 1958 British birth cohort. Setting England, Scotland, and Wales. Participants All singletons born 3-9 March 1958 (10 683 participants with data available at age 33). Main outcome measures Body mass index at ages 7, 11, 16, 23, and 33 years. Results The relation between birth weight and body mass index was positive and weak, becoming more J shaped with increasing age. When adjustments were made for maternal weight, there was no relation between birth weight and boyd mass index at age 33. Indicators of poor fetal growth based on the mother's body size were not predictive, but the risk of adult obesity was higher among participants who had grown to a greater proportion of their eventual adult height by age 7. In men only, the effect of childhood growth was strongest in those with lower birth weights and, to a lesser extend, those born to lighter mothers. Conclusions Maternal weight (or body mass index) largely explains the association between birth weight and adult body mass index, and it may be a more important risk factor for obesity in the child than birth weight. Birth weight and maternal weight seem to modify the effect of childhood linear growth on adult obesity in men. Intergenerational associations between the mother's and her offspring's body mass index seem to underlie the well documented association between birth weight and body mass index. Other measures of fetal growth are needed for a fuller understanding of the role of the intrauterine environment in the development of obesity.	Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Hebrew Univ Jerusalem, Sch Publ Hlth & Community Med, IL-91120 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Parsons, TJ (corresponding author), Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England.							BEUNEN G, 1994, INT J OBESITY, V18, P670; Butler N.R., 1963, PERINATAL MORTALITY; *CTR LONG STUD I E, 1994, NAT CHILD DEV STUD C; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; FERRI E, 1993, LIFE 33 5 FOLLOW UP; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; FREEMAN JV, 1995, INT J EPIDEMIOL, V24, P970, DOI 10.1093/ije/24.5.970; *GREAT BRIT GEN RE, 1956, CENS 1951 CLASS OCC; Hulman S, 1998, J PEDIATR-US, V132, P90, DOI 10.1016/S0022-3476(98)70491-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; LAKE JK, 1998, THESIS U COLL LONDON; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Ong KKL, 2000, BRIT MED J, V320, P1244; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; POWER C, 1988, INT J OBESITY, V12, P445; SEIDMAN DS, 1991, AM J DIS CHILD, V145, P782; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6	24	363	373	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1331	1335		10.1136/bmj.323.7325.1331	http://dx.doi.org/10.1136/bmj.323.7325.1331			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739217	Bronze, Green Published			2022-12-24	WOS:000172716900014
J	Goodlad, RA; Englyst, HN				Goodlad, RA; Englyst, HN			Redefining dietary fibre: potentially a recipe for disaster	LANCET			English	Editorial Material							RECURRENCE		Imperial Canc Res Fund, Histopathol Unit, London WC2A 3PX, England	Cancer Research UK	Goodlad, RA (corresponding author), Imperial Canc Res Fund, Histopathol Unit, 35-43 Lincolns Inn Fields, London WC2A 3PX, England.	goodlad@icrf.icnet.uk		Goodlad, Robert/0000-0002-7660-4287				Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; [Anonymous], 1998, FAO Food Nutr Pap, V66, P1; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Englyst HN, 1996, FOOD CHEM, V57, P15, DOI 10.1016/0308-8146(96)00056-8; Goodlad RA, 2001, GUT, V48, P587, DOI 10.1136/gut.48.5.587; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Michels KB, 2000, JNCI-J NATL CANCER I, V92, P1740, DOI 10.1093/jnci/92.21.1740; *PAN DEF DIET FIB, 2001, PROP DEF DIET FIB; PELL JD, 1995, GASTROENTEROLOGY, V108, P1745, DOI 10.1016/0016-5085(95)90136-1; SOUTHGATE DAT, 1985, DIETARY FIBRE FIBRE, P31; TROWELL H, 1985, DIETARY FIBRE FIBRE, P1; Wasan HS, 1996, LANCET, V348, P319, DOI 10.1016/S0140-6736(96)01401-8; Wasan HS, 1998, J PATHOL, V185, P246; Williamson SLH, 1999, CARCINOGENESIS, V20, P805, DOI 10.1093/carcin/20.5.805	14	24	27	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1833	1834		10.1016/S0140-6736(01)06882-9	http://dx.doi.org/10.1016/S0140-6736(01)06882-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741620				2022-12-24	WOS:000172463000006
J	Lewin, S; Meyer, IH				Lewin, S; Meyer, IH			Torture, ill-treatment, and sexual identity	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Columbia Univ, Mailman Sch Publ Hlth, Div Sociomed Sci, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University	Lewin, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.		Meyer, Ilan H/A-2142-2009					ALTMAN D, 1997, HLTH HUMAN RIGHTS, V2, P15; *AM PSYCH ASS, 2001, GAY LESB BIS ISS; *AMN INT, 2001, EGYPT REL CHILD IMPR; Amnesty International, 2001, CRIM HAT CONSP SIL T; Meyer IH, 2001, AM J PUBLIC HEALTH, V91, P856, DOI 10.2105/AJPH.91.6.856	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1899	1900		10.1016/S0140-6736(01)06894-5	http://dx.doi.org/10.1016/S0140-6736(01)06894-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497NU	11741651				2022-12-24	WOS:000172463000035
J	Gallouzi, IE; Steitz, JA				Gallouzi, IE; Steitz, JA			Delineation of mRNA export pathways by the use of cell-permeable peptides	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEAR-PROTEIN EXPORT; REV ACTIVATION DOMAIN; RNA-BINDING-PROTEINS; AU-RICH ELEMENTS; MESSENGER-RNA; HNRNP A1; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; ANTENNAPEDIA HOMEODOMAIN	The transport of messenger RNAs (mRNAs) from the nucleus to the cytoplasm involves adapter proteins that bind the mRNA as well as receptor proteins that interact with the nuclear pore complex. We demonstrate the utility of cell-permeable peptides designed to interfere with interactions between potential adapter and receptor proteins to define the pathways accessed by particular mRNAs. We show that HuR, a protein implicated in the stabilization of short-lived mRNAs containing AU-rich elements (AREs), serves as an adapter for c-fos mRNA export through two pathways. One involves the HuR shuttling domain, HNS, which exhibits a heat shock-sensitive interaction with transportin 2 (Trn2); the other involves two protein ligands of HuR-pp32 and APRIL-which contain leucine-rich nuclear export signals (NES) recognized by the export receptor CRM1. Heterokaryon and in situ hybridization experiments reveal that the peptides selectively block the nucleocytoplasmic shuttling of their respective adapter proteins without perturbing the overall cellular distribution of polyadenylated mRNAs.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu			NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Cullen BR, 2000, MOL CELL BIOL, V20, P4181, DOI 10.1128/MCB.20.12.4181-4187.2000; Dahlberg JE, 1998, CURR OPIN CELL BIOL, V10, P400, DOI 10.1016/S0955-0674(98)80017-3; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; LAZO PA, 1987, EUR J BIOCHEM, V165, P393, DOI 10.1111/j.1432-1033.1987.tb11452.x; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pasquinelli AE, 1997, P NATL ACAD SCI USA, V94, P14394, DOI 10.1073/pnas.94.26.14394; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; PINOLROMA S, 1989, METHOD ENZYMOL, V180, P410; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; SCHNEIDERGADICKE A, 1988, CANCER RES, V48, P2969; Siomi MC, 1998, MOL CELL BIOL, V18, P4141, DOI 10.1128/MCB.18.7.4141; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Stutz F, 1998, GENE DEV, V12, P3303, DOI 10.1101/gad.12.21.3303; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Veyrune J L, 1997, Prog Mol Subcell Biol, V18, P35; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	72	239	246	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1895	1901		10.1126/science.1064693	http://dx.doi.org/10.1126/science.1064693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729309				2022-12-24	WOS:000172465000050
J	Harms, J; Schluenzen, F; Zarivach, R; Bashan, A; Gat, S; Agmon, I; Bartels, H; Franceschi, F; Yonath, A				Harms, J; Schluenzen, F; Zarivach, R; Bashan, A; Gat, S; Agmon, I; Bartels, H; Franceschi, F; Yonath, A			High resolution structure of the large ribosomal subunit from a mesophilic Eubacterium	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI; ANGSTROM-RESOLUTION; CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; PROTEIN L1; RNA; LOCATION; 23-S; CRYSTALLOGRAPHY	We describe the high resolution structure of the large ribosomal subunit from Deinococcus radiodurans (D50S), a gram-positive mesophile suitable for binding of antibiotics and functionally relevant ligands. The overall structure of D50S is similar to that from the archae bacterium Haloarcula marismortui (H50S); however, a detailed comparison revealed significant differences, for example, in the orientation of nucleotides in peptidyl transferase center and in the structures of many ribosomal proteins. Analysis of ribosomal features involved in dynamic aspects of protein biosynthesis that are partially or fully disordered in H50S revealed the conformations of intersubunit bridges in unbound subunits, suggesting how they may change upon subunit association and how movements of the L1-stalk may, facilitate the exit of tRNA.	Max Planck Res Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society; Weizmann Institute of Science; Max Planck Society	Yonath, A (corresponding author), Max Planck Res Unit Ribosomal Struct, Notkestr 85, D-22603 Hamburg, Germany.		Schluenzen, Frank/P-9177-2019; Franceschi, Francois/AAF-5860-2021; Harms, Joerg/K-8786-2012; ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/H-6274-2014	Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Franceschi, Francois/0000-0002-1554-7944				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Baranov PV, 1999, NUCLEIC ACIDS RES, V27, P184, DOI 10.1093/nar/27.1.184; Berg J M, 2001, Science, V291, P203; Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; BISCHOF O, 1995, J BIOL CHEM, V270, P23060, DOI 10.1074/jbc.270.39.23060; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; CUNDLIFFE E, 1979, J MOL BIOL, V132, P235, DOI 10.1016/0022-2836(79)90393-0; Davies C, 1996, STRUCTURE, V4, P55, DOI 10.1016/S0969-2126(96)00009-3; DELAFORTELLE E, 1997, METHODS ENZYMOLOGY; Fedorov R, 1999, ACTA CRYSTALLOGR D, V55, P1827, DOI 10.1107/S0907444999010227; Fedorov R, 2001, ACTA CRYSTALLOGR D, V57, P968, DOI 10.1107/S0907444901006291; GINZBURG M, 1970, J GEN PHYSIOL, V55, P178; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GuhaThakurta D, 2000, J MOL BIOL, V295, P569, DOI 10.1006/jmbi.1999.3372; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; HALL CC, 1988, BIOCHEMISTRY-US, V27, P3983, DOI 10.1021/bi00411a014; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; HINCK AP, 1997, J MOL BIOL, V234, P1013; Hoffman DW, 1996, J MOL BIOL, V264, P1058, DOI 10.1006/jmbi.1996.0696; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lu M, 2000, P NATL ACAD SCI USA, V97, P2023, DOI 10.1073/pnas.97.5.2023; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; MANKIN AS, 1991, J BACTERIOL, V173, P3559, DOI 10.1128/jb.173.11.3559-3563.1991; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nakashima T, 2001, RNA, V7, P692, DOI 10.1017/S1355838201002345; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P57; Nikonov S, 1996, EMBO J, V15, P1350, DOI 10.1002/j.1460-2075.1996.tb00477.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ostergaard P, 1998, J MOL BIOL, V284, P227, DOI 10.1006/jmbi.1998.2185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; SABATINI DD, 1970, J CELL BIOL, V45, P146, DOI 10.1083/jcb.45.1.146; Sanyal SC, 2000, CURR OPIN STRUC BIOL, V10, P633, DOI 10.1016/S0959-440X(00)00143-3; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; SONENBERG N, 1973, P NATL ACAD SCI USA, V70, P1423, DOI 10.1073/pnas.70.5.1423; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; WALLECZEK J, 1989, BIOCHEMISTRY-US, V28, P4099, DOI 10.1021/bi00435a071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANN HG, 1983, ANNU REV BIOCHEM, V52, P35, DOI 10.1146/annurev.bi.52.070183.000343; Worbs M, 2000, EMBO J, V19, P807, DOI 10.1093/emboj/19.5.807; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	733	792	0	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					679	688		10.1016/S0092-8674(01)00546-3	http://dx.doi.org/10.1016/S0092-8674(01)00546-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733066	Bronze			2022-12-24	WOS:000172575300014
J	McDonald, MJ; Rosbach, M				McDonald, MJ; Rosbach, M			Microarray analysis and organization of circadian gene expression Drosophila	CELL			English	Article							CLOCK MUTANTS; COMPLEMENT ACTIVATION; TRANSCRIPTION; RHYTHMS; MELANOGASTER; PROTEIN; PERIOD; COMPONENT; PACEMAKER; FEEDBACK	We have used high-density oligonucleotide arrays to study global circadian gene expression in Drosophila melanogaster. Coupled with an analysis of clock mutant (Clk) flies, a cell line designed to identify direct targets of the CLOCK (CLK) transcription factor and differential display, we uncovered several striking features of circadian gene networks. These include the identification of 134 cycling genes, which contribute to a wide range of diverse processes. Many of these clock or clock-regulated genes are located in gene clusters, which appear subject to transcriptional coregulation. All oscillating gene expression is under clk control, indicating that Drosophila has no clk-independent circadian systems. An even larger number of genes is affected in Clk flies, suggesting that clk affects other genetic networks. As we identified a small number of direct target genes, the data suggest that most of the circadian gene network is indirectly regulated by clk.	Natl Sci Fdn, Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	National Science Foundation (NSF); NSF - Center for Biological Timing; Brandeis University; Howard Hughes Medical Institute	Rosbach, M (corresponding author), Natl Sci Fdn, Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NIGMS NIH HHS [GM33205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRIERLEY CH, 1993, BIOESSAYS, V15, P749, DOI 10.1002/bies.950151108; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DEAR TN, 1991, EMBO J, V10, P2813, DOI 10.1002/j.1460-2075.1991.tb07830.x; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hedlund E, 2001, CURR DRUG METAB, V2, P245, DOI 10.2174/1389200013338513; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Isaac RE, 2000, BIOCHEM SOC T, V28, P460, DOI 10.1042/0300-5127:0280460; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KOMMANN B, 2001, NUCLEIC ACIDS RES, V29, pE51; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAZARD D, 1990, BIOCHEMISTRY-US, V29, P7433, DOI 10.1021/bi00484a012; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Lee C, 1999, MOL CELL BIOL, V19, P5316; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; Meyer UA, 1996, J PHARMACOKINET BIOP, V24, P449, DOI 10.1007/BF02353473; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Naylor E, 2000, J NEUROSCI, V20, P8138; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Petersen SV, 2001, MOL IMMUNOL, V38, P133; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ripperger JA, 2000, GENE DEV, V14, P679; RIZKI TM, 1978, GENETICS BIOL DROS B, V2, P398; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Saunders DS, 1982, INSECT CLOCKS; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Stover C, 2001, GENES IMMUN, V2, P119, DOI 10.1038/sj.gene.6363745; Taylor CAM, 1996, GENE, V181, P191, DOI 10.1016/S0378-1119(96)00503-3; Theopold U, 1999, BIOCHEM BIOPH RES CO, V261, P923, DOI 10.1006/bbrc.1999.1121; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zimmer S, 2000, J BIOL CHEM, V275, P25672, DOI 10.1074/jbc.M000851200	76	484	508	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					567	578		10.1016/S0092-8674(01)00545-1	http://dx.doi.org/10.1016/S0092-8674(01)00545-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733057	Green Submitted, Bronze			2022-12-24	WOS:000172575300005
J	Zhang, YQ; Bailey, AM; Matthies, HJG; Renden, RB; Smith, MA; Speese, SD; Rubin, GM; Broadie, K				Zhang, YQ; Bailey, AM; Matthies, HJG; Renden, RB; Smith, MA; Speese, SD; Rubin, GM; Broadie, K			Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function	CELL			English	Article							MENTAL-RETARDATION PROTEIN; DENDRITIC SPINES; RNA-BINDING; FMR-1; LOCALIZATION; MELANOGASTER; EXPRESSION; PRODUCT	Fragile X mental retardation gene (FMR1) encodes an RNA binding protein that acts as a negative translational regulator. We have developed a Drosophila fragile X syndrome model using loss-of-function mutants and overexpression of the FMR1 homolog (dfxr). dfxr nulls display enlarged synaptic terminals, whereas neuronal overexpression results in fewer and larger synaptic boutons. Synaptic structural defects are accompanied by altered neurotransmission, with synapse type-specific regulation in central and peripheral synapses. These phenotypes mimic those observed in mutants of microtubule-associated Futsch. Immunoprecipitation of dFXR shows association with futsch mRNA, and Western analyses demonstrate that dFXR inversely regulates Futsch expression. dfxr futsch double mutants restore normal synaptic structure and function. We propose that dFXR acts as a translational repressor of Futsch to regulate microtubule-dependent synaptic growth and function.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Broadie, K (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	broadie@biology.utah.edu	Renden, Robert/AAC-8294-2020; Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Renden, Robert/0000-0001-7905-4789; Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Speese, Sean/0000-0002-3965-9828; Rubin, Gerald/0000-0001-8762-8703; Zhang, Yong Q./0000-0003-0581-4882	NICHD NIH HHS [HD40654] Funding Source: Medline; OHS HRSA HHS [ST32 HD07491] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040654] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OHS HRSA HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 2000, DROSOPHILA PROTOCOLS, P297; BROADIE KS, 1993, J NEUROSCI, V13, P144; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Rodesch CK, 2000, NEUROREPORT, V11, pR45, DOI 10.1097/00001756-200012180-00002; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395	37	507	522	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					591	603		10.1016/S0092-8674(01)00589-X	http://dx.doi.org/10.1016/S0092-8674(01)00589-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733059	Bronze			2022-12-24	WOS:000172575300007
J	Nizet, V; Ohtake, T; Lauth, X; Trowbridge, J; Rudisill, J; Dorschner, RA; Pestonjamasp, V; Piraino, J; Huttner, K; Gallo, RL				Nizet, V; Ohtake, T; Lauth, X; Trowbridge, J; Rudisill, J; Dorschner, RA; Pestonjamasp, V; Piraino, J; Huttner, K; Gallo, RL			Innate antimicrobial peptide protects the skin from invasive bacterial infection	NATURE			English	Article							ANTIBACTERIAL PEPTIDE; CYSTIC-FIBROSIS; STREPTOLYSIN-S; IDENTIFICATION; RESISTANCE; VIRULENCE; IMMUNITY; NEUTROPHILS; DEFENSINS; PRECURSOR	In mammals, several gene families encode peptides with antibacterial activity, such as the beta -defensins and cathelicidins(1-3). These peptides are expressed on epithelial surfaces and in neutrophils, and have been proposed to provide a first line of defence against infection by acting as 'natural antibiotics'(4,5). The protective effect of antimicrobial peptides is brought into question by observations that several of these peptides are easily inactivated(6-8) and have diverse cellular effects that are distinct from antimicrobial activity demonstrated in vitro(9-13). To investigate the function of a specific antimicrobial peptide in a mouse model of cutaneous infection, we applied a combined mammalian and bacterial genetic approach to the cathelicidin antimicrobial gene family(14). The mature human (LL-37)(15) and mouse (CRAMP)(16) peptides are encoded by similar genes (CAMP and Cnlp, respectively), and have similar alpha -helical structures, spectra of antimicrobial activity and tissue distribution. Here we show that cathelicidins are an important native component of innate host defence in mice and provide protection against necrotic skin infection caused by Group A Streptococcus (GAS).	Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA; Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; Massachusetts Gen Hosp, Div Neonatol, Boston, MA 02114 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Massachusetts General Hospital	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA.	rgallo@vapop.ucsd.edu	Nizet, Victor/AAF-3190-2019; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Dorschner, Robert/0000-0002-4773-4461; Nizet, Victor/0000-0003-3847-0422				Bals R, 1999, J CLIN INVEST, V103, P1113, DOI 10.1172/JCI6570; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Cole AM, 2001, BLOOD, V97, P297, DOI 10.1182/blood.V97.1.297; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1999, MOL MED TODAY, V5, P292, DOI 10.1016/S1357-4310(99)01490-2; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; Lencer WI, 1997, P NATL ACAD SCI USA, V94, P8585, DOI 10.1073/pnas.94.16.8585; MILLER SI, 1990, INFECT IMMUN, V58, P3706, DOI 10.1128/IAI.58.11.3706-3710.1990; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Peekhaus N, 1998, J BACTERIOL, V180, P1777, DOI 10.1128/JB.180.7.1777-1785.1998; Risso A, 1998, CELL IMMUNOL, V189, P107, DOI 10.1006/cimm.1998.1358; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	30	949	996	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					454	457		10.1038/35106587	http://dx.doi.org/10.1038/35106587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719807				2022-12-24	WOS:000172304500045
J	Sanders, GD; Hlatky, MA; Every, NR; McDonald, KM; Heidenreich, PA; Parsons, LS; Owens, DK				Sanders, GD; Hlatky, MA; Every, NR; McDonald, KM; Heidenreich, PA; Parsons, LS; Owens, DK			Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC DEATH; LOW-DOSE AMIODARONE; CONGESTIVE-HEART-FAILURE; PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; BYPASS GRAFT-SURGERY; RANDOMIZED-TRIAL; HIGH-RISK; PREMATURE DEPOLARIZATIONS	Background. Clinical trials have shown; that implantable cardioverter defibrillators (ICDs) improve survival in patients with sustained ventricular arrhythmias. Objective: To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction. Design: Markov model-based cost utility analysis. Data Sources: survival, cardiac death, and inpatient costs were estimated on the basis of the Myocardial Infarction Triage and intervention registry. Other data were derived; from the literature. Target Population: Patients with: past myocardial infarction who did not have sustained ventricular arrhythmia. Time Horizon: Lifetime. Perspective: societal. Interventions, ICD or amiodarone compared with no treatment. Outcome Measures- Life-years, quality-adjusted life-years (QALYs), costs, number needed to treat, and! incremental cost-effectiveness. Results of Base-Case Analysis: Compared with no treatment, ICD use led to the greatest QALYs and the highest expenditures. Amiodarone use resulted in intermediate QALYs and costs. To obtain acceptable cost-effectiveness thresholds (less than or equal to $75 000/ QALY), ICDs had to reduce arrhythmic death by 50% and amiodarone had to reduce total death by 7% in patients with depressed election fraction. Results of Sensitivity Analysis: For moderate efficacies, in patients with ejection fractions less than or equal to 0.3, 0.31 to 0.4, and greater than 0.4, the cost-effectiveness of amiodarone compared with no therapy was $43 100/QALY, $66 500/QALY, and $132 500/QALY, respectively, and the cost-effectiveness of ICD compared with amiodarone was $71 800/QALY, $195 700/QALY, and $557 900/QALY, respectively. Conclusions: Use of ICD or amiodarone in patients with past myocardial infarction and severely depressed left ventricular function may provide substantial clinical benefit at an acceptable cost. These results highlight the importance of clinical trials of ICDs in patients with low ejection fractions who have had myocardial infarction.	Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Seattle Vet Affairs Med Ctr, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Washington; University of Washington Seattle	Sanders, GD (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 179 Encina Commons, Stanford, CA 94305 USA.	sanders@stanford.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490; Hlatky, Mark/0000-0003-4686-9441	AHRQ HHS [HS 08362] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008362] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AHERN TS, 1994, J AM COLL CARDIOL, V23, P1521; BAKKER PFA, 1992, PACE, V15, P654, DOI 10.1111/j.1540-8159.1992.tb05158.x; BARDY GH, 1999, AM J CARDIOL, V83, pD91; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Bigger JT, 1999, CIRCULATION, V99, P1416, DOI 10.1161/01.CIR.99.11.1416; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; *BUR LAB STAT, 1998, CONS PRIC IND ALL UR; BURKART F, 1990, J AM COLL CARDIOL, V16, P1711, DOI 10.1016/0735-1097(90)90324-I; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; BUXTON AE, 1993, PROG CARDIOVASC DIS, V36, P215, DOI 10.1016/0033-0620(93)90015-6; BUXTON AE, 1984, AM J CARDIOL, V53, P1275, DOI 10.1016/0002-9149(84)90078-X; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; CAIRNS JA, 1991, CIRCULATION, V84, P550, DOI 10.1161/01.CIR.84.2.550; CAMM AJ, 1993, AM J CARDIOL, V72, pF95, DOI 10.1016/0002-9149(93)90970-N; CEREMUZYNSKI L, 1992, J AM COLL CARDIOL, V20, P1056, DOI 10.1016/0735-1097(92)90357-S; COBB LA, 1992, CIRCULATION, V85, P98; Connolly SJ, 1997, LANCET, V350, P1417; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Domanski MJ, 1999, J AM COLL CARDIOL, V34, P1090, DOI 10.1016/S0735-1097(99)00327-7; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; EPSTEIN AE, 1991, J AM COLL CARDIOL, V18, P14, DOI 10.1016/S0735-1097(10)80210-4; Every NR, 1997, AM HEART J, V134, P1129, DOI 10.1016/S0002-8703(97)70035-8; Every NR, 1997, CIRCULATION, V96, P1770, DOI 10.1161/01.CIR.96.6.1770; EVERY NR, IN PRESS AM HEART J; Farre J, 1999, AM J CARDIOL, V83, p55D; GABRY MD, 1987, J AM COLL CARDIOL, V9, P1349, DOI 10.1016/S0735-1097(87)80477-1; GREENE HL, 1993, AM J CARDIOL, V72, P280; Grimm W, 1999, PACE, V22, P206, DOI 10.1111/j.1540-8159.1999.tb00334.x; HAMER AWF, 1989, J AM COLL CARDIOL, V14, P1768, DOI 10.1016/0735-1097(89)90030-2; HLATKY MA, 1987, IN PRESS AM HEART J; HOCKINGS BEF, 1987, AM J CARDIOL, V60, P967, DOI 10.1016/0002-9149(87)90334-1; Jafri SM, 1998, PROG CARDIOVASC DIS, V41, P65, DOI 10.1016/S0033-0620(98)80023-6; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; KLEMAN JM, 1994, CIRCULATION, V90, P2833, DOI 10.1161/01.CIR.90.6.2833; KUPERSMITH J, 1995, AM HEART J, V130, P507, DOI 10.1016/0002-8703(95)90359-3; KUPPERMANN M, 1990, CIRCULATION, V81, P91, DOI 10.1161/01.CIR.81.1.91; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MCDONALD KM, 2000, MED DECIS MAKING, V20, P501; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; MOYE LA, 1991, AM J CARDIOL, V68, pD70; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; Mushlin AI, 1998, CIRCULATION, V97, P2129, DOI 10.1161/01.CIR.97.21.2129; NAVARROLOPEZ F, 1993, AM J CARDIOL, V72, P1243, DOI 10.1016/0002-9149(93)90291-J; NICKLAS JM, 1991, AM HEART J, V122, P1016, DOI 10.1016/0002-8703(91)90466-U; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; NUNAIN SO, 1995, CIRCULATION, V91, P2204, DOI 10.1161/01.CIR.91.8.2204; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; RITCHIE JL, 1985, AM J CARDIOL, V55, P645, DOI 10.1016/0002-9149(85)90129-8; Rosenqvist M, 1998, CIRCULATION, V98, P663, DOI 10.1161/01.CIR.98.7.663; Roy D, 1998, CIRCULATION, V98, P495; RUBERMAN W, 1981, CIRCULATION, V64, P297, DOI 10.1161/01.CIR.64.2.297; SAKSENA S, 1992, J AM COLL CARDIOL, V19, P490, DOI 10.1016/S0735-1097(10)80260-8; Sanders G D, 1995, Proc Annu Symp Comput Appl Med Care, P258; SIEBELS J, 1994, AM HEART J, V127, P1139, DOI 10.1016/0002-8703(94)90101-5; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sim I, 1997, CIRCULATION, V96, P2823, DOI 10.1161/01.CIR.96.9.2823; SINGH SN, 1993, AM J CARDIOL, V72, pF99, DOI 10.1016/0002-9149(93)90971-E; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stevenson WG, 1997, JPN CIRC J, V61, P727, DOI 10.1253/jcj.61.727; TANNENBAUM TN, 1990, CAN MED ASSOC J, V143, P875; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; WEINBERG BA, 1993, AM HEART J, V125, P109, DOI 10.1016/0002-8703(93)90063-F; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wever EFD, 1996, CIRCULATION, V93, P489, DOI 10.1161/01.CIR.93.3.489; ZIPES DP, 1995, CIRCULATION, V92, P59, DOI 10.1161/01.CIR.92.1.59; 1999, DRUG TOPICS RED BOOK; 1998, VITAL STAT US, V2; 1998, 1999 HEART STROKE ST	75	61	61	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2001	135	10					870	883		10.7326/0003-4819-135-10-200111200-00007	http://dx.doi.org/10.7326/0003-4819-135-10-200111200-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DY	11712877				2022-12-24	WOS:000172267500003
J	Gray, WM; Kepinski, S; Rouse, D; Leyser, O; Estelle, M				Gray, WM; Kepinski, S; Rouse, D; Leyser, O; Estelle, M			Auxin regulates SCFTIR1-dependent degradation of AUX/IAA proteins	NATURE			English	Article							SCF UBIQUITIN-LIGASE; ARABIDOPSIS-THALIANA; RESPONSE ELEMENTS; GENE; YEAST; TRANSCRIPTION; PATHWAY; FAMILY; NEDD8; RUB1	The plant hormone auxin is central in many aspects of plant development. Previous studies have implicated the ubiquitin-ligase SCFTIR1 and the AUX/IAA proteins in auxin response. Dominant mutations in several AUX/IAA genes confer pleiotropic auxin-related phenotypes, whereas recessive mutations affecting the function of SCFTIR1 decrease auxin response. Here we show that SCFTIR1 is required for AUX/IAA degradation. We demonstrate that SCFTIR1 interacts with AXR2/IAA7 and AXR3/IAA17, and that domain II of these proteins is necessary and sufficient for this interaction. Further, auxin stimulates binding of SCFTIR1 to the AUX/IAA proteins, and their degradation. Because domain II is conserved in nearly all AUX/IAA proteins in Arabidopsis, we propose that auxin promotes the degradation of this large family of transcriptional regulators, leading to diverse downstream effects.	Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Texas System; University of Texas Austin; University of York - UK	Estelle, M (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	mestelle@mail.utexas.edu	Rouse, Dean/B-3636-2009; Estelle, Mark/ABD-6742-2021; Gray, William M/F-9402-2010; Leyser, Ottoline/AAC-5577-2019	Gray, William M/0000-0002-1320-290X; Leyser, Ottoline/0000-0003-2161-3829				ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; BERLETH T, 1993, DEVELOPMENT, V118, P575; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Gray WM, 2000, TRENDS BIOCHEM SCI, V25, P133, DOI 10.1016/S0968-0004(00)01544-9; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SMART CM, 1991, PLANT CELL, V3, P647, DOI 10.1105/tpc.3.7.647; STOMP AM, 1991, GUS PROTOCOLS, P103; Tian Q, 1999, DEVELOPMENT, V126, P711; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x	30	981	1068	12	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					271	276		10.1038/35104500	http://dx.doi.org/10.1038/35104500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713520	Green Accepted			2022-12-24	WOS:000172150700034
J	Shine, R; Phillips, B; Waye, H; LeMaster, M; Mason, RT				Shine, R; Phillips, B; Waye, H; LeMaster, M; Mason, RT			Benefits of female mimicry in snakes	NATURE			English	Article							THAMNOPHIS-SIRTALIS-PARIETALIS; GARTER SNAKES; SIZE		Univ Sydney, Dept Biol Sci, Sydney, NSW 2006, Australia; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University of Sydney; Oregon State University	Shine, R (corresponding author), Univ Sydney, Dept Biol Sci, Sydney, NSW 2006, Australia.	rics@bio.usyd.edu.au	Phillips, Ben/C-7957-2009; Shine, Richard/B-8711-2008	Phillips, Ben/0000-0003-2580-2336; 				Andersson Malte, 1994; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HECKROTTE C, 1967, COPEIA, P759; MASON RT, 1985, NATURE, V316, P59, DOI 10.1038/316059a0; OLSON DH, 1989, COPEIA, P391, DOI 10.2307/1445435; Shine R, 2000, PHYSIOL BIOCHEM ZOOL, V73, P508, DOI 10.1086/317734; Shine R, 2000, CAN J ZOOL, V78, P1391, DOI 10.1139/cjz-78-8-1391; Shine R, 2000, ANIM BEHAV, V59, P349, DOI 10.1006/anbe.1999.1321; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; WHITTIER JM, 1985, BEHAV ECOL SOCIOBIOL, V16, P257, DOI 10.1007/BF00310989	11	48	49	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					267	267		10.1038/35104687	http://dx.doi.org/10.1038/35104687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713516				2022-12-24	WOS:000172150700030
J	Mason, J; Freemantle, N; Browning, G				Mason, J; Freemantle, N; Browning, G			Impact of Effective Health Care bulletin on treatment of persistent glue ear in children: time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Newcastle Univ, Ctr Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England	Newcastle University - UK	Mason, J (corresponding author), Newcastle Univ, Ctr Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.		Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Freemantle, Nick/0000-0001-5807-5740				BLACK N, 1984, LANCET, V1, P835; Department of Health, 1996, HLTH PERS SOC SERV S; Mason J, 1998, HLTH TRENDS, V30, P120; SHELDON TA, 1992, LANCET, V340, P1324; 1992, EFFECTIVE HLTH CARE	5	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2001	323	7321					1096	1097		10.1136/bmj.323.7321.1096	http://dx.doi.org/10.1136/bmj.323.7321.1096			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701573	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000172188400012
J	Sanders, DS; Carter, MJ; Hurlstone, DP; Pearce, A; Ward, AM; McAlindon, ME; Lobo, AJ				Sanders, DS; Carter, MJ; Hurlstone, DP; Pearce, A; Ward, AM; McAlindon, ME; Lobo, AJ			Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care	LANCET			English	Article							CELIAC-DISEASE; CLINICAL-FEATURES; SYMPTOMS; PREVALENCE; DIAGNOSIS; ANTIENDOMYSIUM; SENSITIVITY; DEFICIENCY; ANTIBODIES; COMMUNITY	Background Irritable bowel syndrome has a high prevalence. Consensus diagnostic criteria (ROME II) based on symptoms have been established to aid diagnosis. Although coeliac disease can be misdiagnosed as irritable bowel syndrome, no prospective study has been published in which patients with this disorder are investigated for coeliac disease. We aimed to assess the association of coeliac disease with irritable bowel syndrome in patients fulfilling ROME II criteria. Methods We undertook a case-control study at a university hospital. 300 consecutive new patients who fulfilled Rome II criteria for irritable bowel syndrome, and 300 healthy controls (age and sex matched) were investigated for coeliac disease by analysis of serum IgA antigliadin, IgG antigliadin, and endomysial antibodies (EMA). Patients and controls with positive antibody results were offered duodenal biopsy to confirm the possibility of coeliac disease. Findings 66 patients with irritable bowel syndrome had positive antibody results, of whom 14 had coeliac disease (11 EMA positive, three EMA negative). Nine patients with positive antibody results were lost to follow-up or refused biopsy (only one EMA-positive patient refused biopsy), and 43 had normal duodenal mucosa. Two controls, both of whom were EMA positive, had coeliac disease. Compared with matched controls, irritable bowel syndrome was significantly associated with coeliac disease (p=0.004, odds ratio=7.0 [95% CI 1.7-28.0]). Interpretation Patients with irritable bowel syndrome referred to secondary care should be investigated routinely for coeliac disease. With only EMA, three of 14 cases would have been missed.	Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England; No Gen Hosp, Suprareg Prot Reference Unit, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; University of Sheffield; Northern General Hospital	Sanders, DS (corresponding author), Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Room P14,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	d.s.sanders28@btopenworld.com						*AM GASTR ASS, 1997, GASTROENTEROLOGY, V112, P2118; Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; Collin P, 1999, DIGEST DIS, V17, P100, DOI 10.1159/000016911; Collin P, 1996, GUT, V39, P382, DOI 10.1136/gut.39.3.382; Dahele A., 2000, P R COLL PHYSICIANS, V30, P100; Drossman D., 1990, GASTR INT, V3, P159; Feighery C, 1999, BMJ-BRIT MED J, V319, P236, DOI 10.1136/bmj.319.7204.236; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1; Hamm LR, 1999, AM J GASTROENTEROL, V94, P1279, DOI 10.1016/S0002-9270(99)00133-1; HARVEY RF, 1987, LANCET, V1, P963; HEATON KW, 1992, GASTROENTEROLOGY, V102, P1962, DOI 10.1016/0016-5085(92)90320-X; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; ISGAR B, 1983, GUT, V24, P190, DOI 10.1136/gut.24.3.190; Johnston SD, 1997, LANCET, V350, P1370, DOI 10.1016/S0140-6736(05)65142-2; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Longstreth GF, 1997, DIGEST DIS SCI, V42, P1105, DOI 10.1023/A:1018864915375; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; MCFARLANE XA, 1995, GUT, V36, P710, DOI 10.1136/gut.36.5.710; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; TALLEY NJ, 1991, GASTROENTEROLOGY, V101, P927, DOI 10.1016/0016-5085(91)90717-Y; Taub E, 1995, DIGEST DIS SCI, V40, P2647, DOI 10.1007/BF02220455; Thompson WG, 1999, GUT, V45, P43; THOMPSON WG, 1984, GUT, V25, P1089, DOI 10.1136/gut.25.10.1089; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Thompson WG, 1997, EUR J GASTROEN HEPAT, V9, P299; TOLLIVER BA, 1994, AM J GASTROENTEROL, V89, P176; Troncone R, 1996, ACTA PAEDIATR, V85, P10, DOI 10.1111/j.1651-2227.1996.tb14240.x; Volta U, 1998, LANCET, V352, P26, DOI 10.1016/S0140-6736(97)11222-3; West J, 2001, GUT, V48, pA63; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P336, DOI 10.1016/0016-5085(90)90822-I	35	290	304	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2001	358	9292					1504	1508		10.1016/S0140-6736(01)06581-3	http://dx.doi.org/10.1016/S0140-6736(01)06581-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705563				2022-12-24	WOS:000172055800013
J	Bynum, WF				Bynum, WF			Nature's helping hand	NATURE			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of London; University College London	Bynum, WF (corresponding author), UCL, Wellcome Trust Ctr Hist Med, 24 Eversholt St, London NW1 1AD, England.							NESSE RM, 1995, EVOLUTION HEALING; Neuburger Max, 1932, DOCTRINE HEALING POW; Warner J.H., 1986, THERAPEUTIC PERSPECT	3	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					21	21		10.1038/35102123	http://dx.doi.org/10.1038/35102123			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689921	Bronze			2022-12-24	WOS:000171898900022
J	Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R				Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R			Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 angstrom resolution	NATURE			English	Article							POTASSIUM CHANNEL; CONDUCTION; PORE	Ion transport proteins must remove an ion's hydration shell to coordinate the ion selectively on the basis of its size and charge. To discover how the K+ channel solves this fundamental aspect of ion conduction, we solved the structure of the KcsA K+ channel in complex with a monoclonal Fab antibody fragment at 2.0 Angstrom resolution. Here we show how the K+ channel displaces water molecules around an ion at its extracellular entryway, and how it holds a K+ ion in a square antiprism of water molecules in a cavity near its intracellular entryway. Carbonyl oxygen atoms within the selectivity filter form a very similar square antiprism around each K+ binding site, as if to mimic the waters of hydration. The selectivity filter changes its ion coordination structure in low K+ solutions. This structural change is crucial to the operation of the selectivity filter in the cellular context, where the K+ ion concentration near the selectivity filter varies in response to channel gating.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clare Speakman J., 1972, STRUCTURE BONDING, P141; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; Harlow E., 1989, ANTIBODIES LAB MANUA; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	30	1623	1659	10	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					43	48		10.1038/35102009	http://dx.doi.org/10.1038/35102009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689936				2022-12-24	WOS:000171898900035
J	Chao, W; Huynh, KD; Spencer, RJ; Davidow, LS; Lee, JT				Chao, W; Huynh, KD; Spencer, RJ; Davidow, LS; Lee, JT			CTCF, a candidate trans-acting factor for X-inactivation choice	SCIENCE			English	Article							ENHANCER-BLOCKING ACTIVITY; XIST EXPRESSION; CHROMOSOME; GENE; METHYLATION; MOUSE; TSIX; INSULATOR; REGION; PARENT	In mammals, X-inactivation silences one of two female X chromosomes. Silencing depends on the noncoding gene, Xist ((i) under bar nactive (X) under bar-(s) under bar pecific (t) under bar ranscript), and is blocked by the antisense gene, Tsix. Deleting the choice/imprinting center in Tsix affects X-chromosome selection. Here, we identify the insulator and transcription factor, CTCF, as a candidate trans-acting factor for X-chromosome selection. The choice/imprinting center contains tandem CTCF binding sites that function in an enhancer-blocking assay. In vitro binding is reduced by CpG methylation and abolished by including non-CpG methylation. We postulate that Tsix and CTCF together establish a regulatable epigenetic switch for X-inactivation.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Genet, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Genet, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA.			Chao, Wendy/0000-0002-9418-8723				Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Prissette M, 2001, HUM MOL GENET, V10, P31, DOI 10.1093/hmg/10.1.31; Sado T, 2001, DEVELOPMENT, V128, P1275; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0	27	220	239	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					345	347		10.1126/science.1065982	http://dx.doi.org/10.1126/science.1065982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11743158				2022-12-24	WOS:000173278600055
J	Bateman, DN; Clark, R; Azuara-Blanco, A; Bain, M; Forrest, J				Bateman, DN; Clark, R; Azuara-Blanco, A; Bain, M; Forrest, J			The impact of new drugs on management of glaucoma in Scotland: observational study	BRITISH MEDICAL JOURNAL			English	Article							OPEN-ANGLE GLAUCOMA		Royal Edinburgh & Associated Hosp, Scottish Poisons Informat Bur, Natl Poisons Informat Serv Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland; Common Serv Agcy NHS, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Aberdeen Royal Infirm, Dept Ophthalmol, Aberdeen AB25 2ZN, Scotland	Royal Infirmary of Edinburgh; University of Aberdeen	Bateman, DN (corresponding author), Royal Edinburgh & Associated Hosp, Scottish Poisons Informat Bur, Natl Poisons Informat Serv Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland.			Bateman, David Nicholas/0000-0002-8971-862X; Azuara-Blanco, Augusto/0000-0002-4805-9322				Evans J., 1996, HEALTH TRENDS, V28, P5; Harley K, 1996, Health Bull (Edinb), V54, P410; HARRISON RJ, 1988, BRIT MED J, V297, P1162, DOI 10.1136/bmj.297.6657.1162; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83	5	37	38	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2001	323	7326					1401	1402		10.1136/bmj.323.7326.1401	http://dx.doi.org/10.1136/bmj.323.7326.1401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505EX	11744564	Bronze, Green Published			2022-12-24	WOS:000172900400017
J	Oh, J; Takahashi, R; Kondo, S; Mizoguchi, A; Adachi, E; Sasahara, RM; Nishimura, S; Imamura, Y; Kitayama, H; Alexander, DB; Ide, C; Horan, TP; Arakawa, T; Yoshida, H; Nishikawa, SI; Itoh, Y; Seiki, M; Itohara, S; Takahashi, C; Noda, M				Oh, J; Takahashi, R; Kondo, S; Mizoguchi, A; Adachi, E; Sasahara, RM; Nishimura, S; Imamura, Y; Kitayama, H; Alexander, DB; Ide, C; Horan, TP; Arakawa, T; Yoshida, H; Nishikawa, SI; Itoh, Y; Seiki, M; Itohara, S; Takahashi, C; Noda, M			The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis	CELL			English	Article							BLOOD-VESSEL FORMATION; TISSUE INHIBITOR; SUPPRESSOR GENE; MESSENGER-RNA; IN-VIVO; METALLOPROTEINASES; RAS; ACTIVATION; EXPRESSION; CELLS	Matrix metalloproteinases (MMPs) are essential for proper extracellular matrix remodeling. We previously found that a membrane-anchored glycoprotein, RECK, negatively regulates MMP-9 and inhibits tumor invasion and metastasis. Here we show that RECK regulates two other MMPs, MMP-2 and MT1-MMP, known to be involved in cancer progression, that mice lacking a functional RECK gene die around E10.5 with defects in collagen fibrils, the basal lamina, and vascular development, and that this phenotype is partially suppressed by MMP-2 null mutation. Also, vascular sprouting is dramatically suppressed in tumors derived from RECK,expressing fibrosarcoma cells grown in nude mice. These results support a role for RECK in the regulation of MMP-2 in vivo and implicate RECK downregulation in tumor angiogenesis.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068501, Japan; Kitasato Univ, Grad Sch Med Sci, Dept Mol Morphol, Kanagawa 2288555, Japan; RIKEN, Brain Res Inst, Wako, Saitama 3510198, Japan; Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA; Univ Tokyo, Inst Med Sci, Dept Canc Res, Tokyo 1080071, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kitasato University; RIKEN; Amgen; University of Tokyo	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.		Itohara, Shigeyoshi/I-8769-2012; Seiki, Motoharu/K-9443-2015	Itohara, Shigeyoshi/0000-0002-2410-9989; Oh, Junseo/0000-0002-0754-4946; Itoh, Yoshifumi/0000-0002-2128-2823				BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; CANETESOLER R, 1995, DEV DYNAM, V204, P30, DOI 10.1002/aja.1002040105; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DAVIES B, 1993, CANCER RES, V53, P5365; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO;2-A; FAGAN JB, 1981, J BIOL CHEM, V256, P520; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; GARBISA S, 1987, CANCER RES, V47, P1523; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; HOWARD BH, 1978, J BIOL CHEM, V253, P5869; Ikeda M, 2000, CLIN CANCER RES, V6, P3290; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kahari VM, 1999, ANN MED, V31, P34, DOI 10.3109/07853899909019260; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; Nothnick WB, 1997, BIOL REPROD, V56, P1181, DOI 10.1095/biolreprod56.5.1181; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; REPONEN P, 1992, J BIOL CHEM, V267, P7856; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Takahashi C, 1996, ONCOGENE, V12, P2137; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Thant AA, 1997, FEBS LETT, V406, P28, DOI 10.1016/S0014-5793(97)00230-5; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamamoto M, 1996, CANCER RES, V56, P384; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	48	538	580	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					789	800		10.1016/S0092-8674(01)00597-9	http://dx.doi.org/10.1016/S0092-8674(01)00597-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747814	Bronze, Green Submitted			2022-12-24	WOS:000172771800011
J	Smith, O				Smith, O			Biomedicine - In the nic of time	SCIENCE			English	Editorial Material																		Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; HU Y, 2001, DEV CELL        1130; LOPEZSCHIER H, 2001, DEV CELL        1130	3	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2118	2118		10.1126/science.294.5549.2118	http://dx.doi.org/10.1126/science.294.5549.2118			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739946				2022-12-24	WOS:000172647700038
J	De Smaele, E; Zazzeroni, F; Papa, S; Nguyen, DU; Jin, RG; Jones, J; Cong, R; Franzoso, G				De Smaele, E; Zazzeroni, F; Papa, S; Nguyen, DU; Jin, RG; Jones, J; Cong, R; Franzoso, G			Induction of gadd45 beta by NF-kappa B downregulates pro-apoptotic JNK signalling	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH; TERMINAL KINASE; ACTIVATION; PROTEIN; FAMILY; STRESS; PATHWAY; C-IAP2; MYD118	In addition to coordinating immune and inflammatory responses, NF-kappaB/Rel transcription factors control cell survival(1). Normally, NF-kappaB dimers are sequestered in the cytoplasm by binding to inhibitory I kappaB proteins, and can be activated rapidly by signals that induce the sequential phosphorylation and proteolysis of I kappa Bs(1). Activation of NF-kappaB antagonizes apoptosis or programmed cell death by numerous triggers, including the ligand engagement of 'death receptors' such as tumour-necrosis factor (TNF) receptor(2). The anti-apoptotic activity of NF-kappaB is also crucial to oncogenesis and to chemo- and radio-resistance in cancer(2). Cytoprotection by NF-kappaB involves the activation of pro-survival genes(2); however, its basis remains poorly understood. Here we report that NF-kappaB complexes downregulate the c-Jun aminoterminal kinase (JNK) cascade(3), thus establishing a link between the NF-kappaB and the JNK pathways. This link involves the transcriptional upregulation of gadd45 beta /myd118 (ref. 4), which downregulates JNK signalling induced by the TNF receptor (TNF-R). This NF-kappaB-dependent inhibition of the JNK pathway is central to the control of cell death. Our findings define a protective mechanism that is mediated by NF-kappaB complexes and establish a role for the persistent activation of JNK in the apoptotic response to TNF-alpha.	Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Franzoso, G (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, 924 E 57th St, Chicago, IL 60637 USA.		De Smaele, Enrico/C-1124-2013; Papa, Salvatore/J-9413-2012; Franzoso, Guido/GRR-8628-2022	De Smaele, Enrico/0000-0003-4524-4423; Papa, Salvatore/0000-0002-8369-6538; Franzoso, Guido/0000-0002-0778-988X; Zazzeroni, Francesca/0000-0002-4474-3274				Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen YR, 2000, INT J ONCOL, V16, P651; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vairapandi M, 1996, ONCOGENE, V12, P2579; VAN AD, 1996, SCIENCE, V274, P787; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XT, 1999, J BIOL CHEM, V274, P29599, DOI 10.1074/jbc.274.42.29599; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	30	615	627	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					308	313		10.1038/35104560	http://dx.doi.org/10.1038/35104560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713530				2022-12-24	WOS:000172150700044
J	Gillespie, IA; O'Brien, S; Adak, GK				Gillespie, IA; O'Brien, S; Adak, GK			General outbreaks of infectious intestinal diseases linked with private residences in England and Wales, 1992-9: questionnaire study	BRITISH MEDICAL JOURNAL			English	Article									Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Gastrointestinal Dis Div, London NW9 5EQ, England	Public Health England	O'Brien, S (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Gastrointestinal Dis Div, London NW9 5EQ, England.			O'Brien, Sarah Jane/0000-0003-2896-8999; Gillespie, Iain A/0000-0002-2265-9506				Cogan TA, 1999, LETT APPL MICROBIOL, V29, P354, DOI 10.1046/j.1472-765X.1999.00656.x; DERBYSHIRE D, 2000, DAILY TELEGRAPH 1206, P7; Evans J., 1996, SPORT EDUC SOC, V1, P165, DOI [DOI 10.1080/1357332960010203, https://doi.org/10.1080/1357332960010203]; POPPE C, 1999, SALMONELLA ENTERICA	4	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1097	1098		10.1136/bmj.323.7321.1097	http://dx.doi.org/10.1136/bmj.323.7321.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701574	Bronze, Green Published			2022-12-24	WOS:000172188400013
J	Davies, SJ; Grogan, JL; Blank, RB; Lim, KC; Locksley, RM; McKerrow, JH				Davies, SJ; Grogan, JL; Blank, RB; Lim, KC; Locksley, RM; McKerrow, JH			Modulation of blood fluke development in the liver by hepatic CD4(+) lymphocytes	SCIENCE			English	Article							T-CELL RECEPTOR; SCHISTOSOMA-MANSONI; DEFICIENT MICE; GENES	We have identified an alternate developmental pathway in the life cycle of the trematode pathogen Schistosoma mansoni. This pathway is used in immunodeficient hosts in which the parasite fails to receive appropriate signals from the host immune system. Helminth development is altered at an early stage during infection, resulting in the appearance of attenuated forms that prolong survival of host and parasite. Hepatic CD4(+) T lymphocyte populations are an integral component of the immune signal recognized by the parasite.	Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Pathol, Trop Dis Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Liver Ctr Microscopy Core, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Pathol, Trop Dis Res Unit, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010424] Funding Source: NIH RePORTER; NIAID NIH HHS [AI10424, F32 AI010424-02, F32 AI010424] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; CLEGG JA, 1965, EXP PARASITOL, V16, P133, DOI 10.1016/0014-4894(65)90037-8; Davies SJ, UNPUB; DORSHKIND K, 1984, J IMMUNOL, V132, P1804; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HARRISON RA, 1983, PARASITOLOGY, V86, P429, DOI 10.1017/S0031182000050629; Harvey SC, 2000, P ROY SOC B-BIOL SCI, V267, P2057, DOI 10.1098/rspb.2000.1249; IACOMINI J, 1995, EUR J IMMUNOL, V25, P884, DOI 10.1002/eji.1830250404; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ravindran B, 2001, TRENDS PARASITOL, V17, P70, DOI 10.1016/S1471-4922(00)01835-3; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wolowczuk I, 1999, INFECT IMMUN, V67, P4183, DOI 10.1128/IAI.67.8.4183-4190.1999; ZIJLSTRA M, 1990, NATURE, V344, P1742	21	121	129	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1358	1361		10.1126/science.1064462	http://dx.doi.org/10.1126/science.1064462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701932				2022-12-24	WOS:000172130200054
J	Baron, CL; Malhotra, V				Baron, CL; Malhotra, V			Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane	SCIENCE			English	Article							KINASE-C; PHOSPHATIDATE PHOSPHOHYDROLASE; SPHINGOLIPID BIOSYNTHESIS; GOLGI-COMPLEX; DOMAIN; INHIBITION; ACTIVATION	Protein kinase D (PKD) is a cytosolic serine-threonine kinase that binds to the trans-Golgi network (TGN) and regulates the fission of transport carriers specifically destined to the cell surface. PKD was found to bind diacylglycerol (DAG), and this binding was necessary for its recruitment to the TGN. Reducing cellular levels of DAG inhibited PKD recruitment and blocked protein transport from the TGN to the cell surface. Thus, a DAG-dependent, PKD-mediated signaling regulates the formation of transport carriers from the TGN in mammalian cells.	Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.		Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053747] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46224, GM53747] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARON C, UNPUB; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHENG CHK, 1978, FEBS LETT, V93, P120, DOI 10.1016/0014-5793(78)80818-7; CONN PM, 1985, BIOCHEM BIOPH RES CO, V126, P532, DOI 10.1016/0006-291X(85)90638-2; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; LAPETINA EG, 1985, J BIOL CHEM, V260, P1358; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Sanchez-Pinera P, 1999, BIOCHEM J, V337, P387, DOI 10.1042/0264-6021:3370387; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; WANG E, 1991, J BIOL CHEM, V266, P14486; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	23	322	329	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					325	328		10.1126/science.1066759	http://dx.doi.org/10.1126/science.1066759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11729268				2022-12-24	WOS:000173278600049
J	Ascherio, A; Munger, KL; Lennette, ET; Spiegelman, D; Hernan, MA; Olek, MJ; Hankinson, SE; Hunter, DJ				Ascherio, A; Munger, KL; Lennette, ET; Spiegelman, D; Hernan, MA; Olek, MJ; Hankinson, SE; Hunter, DJ			Epstein-Barr virus antibodies and risk of multiple sclerosis - A prospective study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CD8(+) T-CELLS; NUCLEAR ANTIGEN; INFECTION; EBV; VARIANT; HUMAN-HERPESVIRUS-6; ASSOCIATION; AUTOIMMUNE; RESPONSES; DISEASE		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Multiple Sclerosis Unit, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Virolab Inc, Berkeley, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	Alberto.Ascherio@channing.harvard.edu		Olek, Michael/0000-0002-3840-2772	NCI NIH HHS [CA67262, CA49449] Funding Source: Medline; NINDS NIH HHS [NS35624] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA049449, R01CA049449, R01CA067262, U01CA067262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035624] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; COMPSTON DAS, 1986, BRAIN, V109, P325, DOI 10.1093/brain/109.2.325; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Flamand L, 1996, J VIROL, V70, P1784, DOI 10.1128/JVI.70.3.1784-1791.1996; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P00281; Haahr S, 1995, Mult Scler, V1, P73; Hafler DA, 1999, J CLIN INVEST, V104, P527, DOI 10.1172/JCI8193; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; HILTON DA, 1994, J NEUROL NEUROSUR PS, V57, P975, DOI 10.1136/jnnp.57.8.975; Hunter SF, 2000, NEUROLOGY, V55, P164, DOI 10.1212/WNL.55.2.164; Jabs WJ, 1999, CLIN EXP IMMUNOL, V116, P468; Knox KK, 2000, CLIN INFECT DIS, V31, P894, DOI 10.1086/318141; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; LENNETTE E, 2000, IMMUNE ADHERENCE HEM; LENNETTE ET, 1993, EUR J CANCER, V29A, P1584, DOI 10.1016/0959-8049(93)90299-U; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; LINDBERG C, 1991, NEUROEPIDEMIOLOGY, V10, P62, DOI 10.1159/000110248; Marrie RA, 2000, NEUROLOGY, V54, P2307, DOI 10.1212/WNL.54.12.2307; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; MARTYN CN, 1991, MCALPINES MULTIPLE S, P2; Morre SA, 2001, NEUROLOGY, V56, P692, DOI 10.1212/WNL.56.5.692; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; OPERSKALSKI EA, 1989, NEUROLOGY, V39, P825, DOI 10.1212/WNL.39.6.825; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Tan LC, 1999, J IMMUNOL, V162, P1827; van Sechel AC, 1999, J IMMUNOL, V162, P129; VAUGHAN JH, 1995, SPRINGER SEMIN IMMUN, V17, P203; Vaughan JH, 1996, J NEUROIMMUNOL, V69, P95; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; WARNER HB, 1981, LANCET, V2, P1290; Winer S, 2001, J IMMUNOL, V166, P4751, DOI 10.4049/jimmunol.166.7.4751	45	368	383	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3083	3088		10.1001/jama.286.24.3083	http://dx.doi.org/10.1001/jama.286.24.3083			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754673	Bronze			2022-12-24	WOS:000172927100025
J	Schlecht, NF; Kulaga, S; Robitaille, J; Ferreira, S; Santos, M; Miyamura, RA; Duarte-Franco, E; Rohan, TE; Ferenczy, A; Villa, LL; Franco, EL				Schlecht, NF; Kulaga, S; Robitaille, J; Ferreira, S; Santos, M; Miyamura, RA; Duarte-Franco, E; Rohan, TE; Ferenczy, A; Villa, LL; Franco, EL			Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATURAL-HISTORY; WOMEN; RISK; DNA; LESIONS	Context Human papillomavirus (HPV) infection is believed to be the central cause of cervical cancer, although most of the epidemiological evidence has come from retrospective, case-control studies, which do not provide information on the dynamics of cumulative or persistent exposure to HPV infection. Objective To assess the risks of cervical neoplasia related to prior persistent HPV infections. Design and Setting Longitudinal study of the natural history of HPV infection and cervical neoplasia in women residing in the city of Sao Paulo, Brazil, which was conducted between November 1993 and March 1997 and involved repeated measurements of HPV and lesions with follow-up until June 2000. Participants A total of 1611 women with no cytological lesions at enrollment and HPV test results available from the first 2 visits. Main Outcome Measure Cervical specimens taken for Papanicolaou cytology and HPV testing every 4 months in the first year and twice yearly thereafter. Incident cervical cancer precursor lesions ascertained by expert review of all cytology smears. Results The incidence rate of squamous intraepithelial lesions (SILs) was 0.73 per 1000 women-months (95% confidence interval [CII, 0.5-0.9) among women free of HPV at the 2 initial visits and 8.68 (95% Cl, 2.3-15.1) among women with HPV type 16 or 18 infections persisting over both visits. Relative to those negative for HPV oncogenic types at both initial visits, the relative risk (RR) of incident SIL was 10.19 (95% Cl, 5.9-17.6) for persistent infections with any known oncogenic HPV types. The equivalent RR of incident high-grade SIL was 11.67 (95% Cl, 4.1-33.3). The RRs of lesions were considerably higher for persistent infections with HPV type 16 or 18. Conclusion A strong relationship exists between persistent HPV infections and SIL incidence, particularly for HPV types 16 and 18.	McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; McGill Univ, Dept Pathol, Montreal, PQ, Canada; Ludwig Inst Canc Res, Sao Paulo, Brazil; Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA	McGill University; McGill University; McGill University; Ludwig Institute for Cancer Research; Yeshiva University; Albert Einstein College of Medicine	Franco, EL (corresponding author), McGill Univ, Dept Oncol, 546 Pine Ave W, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	VILLA, LUISA/AAH-4761-2019; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Franco, Eduardo/0000-0002-4409-8084; Schlecht, Nicolas/0000-0003-2482-244X	NCI NIH HHS [CA70269] Funding Source: Medline; PHS HHS [MA13647] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070269] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FRANCO EL, 1994, JNCI-J NATL CANCER I, V86, P1558, DOI 10.1093/jnci/86.20.1558; Franco EL, 1999, JNCI-J NATL CANCER I, V91, P506, DOI 10.1093/jnci/91.6.506; FRANCO EL, 1999, PAN AM J PUBLIC HLTH, V6, P223; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; *IARC, 1995, IARC MON EV CARC RIS, V64; KATAJA V, 1989, EUR J EPIDEMIOL, V5, P1, DOI 10.1007/BF00145037; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Londesborough P, 1996, INT J CANCER, V69, P364; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; SOLOMON D, 1989, ACTA CYTOL, V33, P567; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8	22	401	439	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3106	3114		10.1001/jama.286.24.3106	http://dx.doi.org/10.1001/jama.286.24.3106			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754676	Bronze			2022-12-24	WOS:000172927100028
J	Kromer, B; Manning, SW; Kuniholm, PI; Newton, MW; Spurk, M; Levin, I				Kromer, B; Manning, SW; Kuniholm, PI; Newton, MW; Spurk, M; Levin, I			Regional (CO2)-C-14 offsets in the troposphere: Magnitude, mechanisms, and consequences	SCIENCE			English	Article							RADIOCARBON TIME SCALE; PRECISION BIDECADAL CALIBRATION; ANATOLIAN TREE-RINGS; AGE CALIBRATION; SOLAR; TERRESTRIAL; CHRONOLOGY; CYCLE	Radiocarbon dating methods typically assume that there are no significant tropospheric (CO2)-C-14 gradients within the low- to mid-latitude zone of the Northern Hemisphere. Comparison of tree ring C-14 data from southern Germany and Anatolia supports this assumption in general but also documents episodes of significant short-term regional (CO2)-C-14 offsets. We suggest that the offset is caused by an enhanced seasonal (CO2)-C-14. cycle, with seasonally peaked flux of stratospheric C-14 into the troposphere during periods of low solar magnetic activity, coinciding with substantial atmospheric cooling. Short-term episodes of regional (CO2)-C-14, offsets are important to palaeoclimate studies and to high-resolution archaeological dating.	Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany; Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany; Univ Reading, Dept Archaeol, Reading RG6 6AA, Berks, England; Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY 14853 USA; Univ Hohenheim, Inst Bot 210, D-70593 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Reading; Cornell University; University Hohenheim	Kromer, B (corresponding author), Heidelberger Akad Wissensch, Neuenheimer Feld 229, D-69120 Heidelberg, Germany.	bernd.kromer@iup.uni-heidelberg.de						BALACHANDRAN NK, 1995, J CLIMATE, V8, P2058, DOI 10.1175/1520-0442(1995)008<2058:MTEOUV>2.0.CO;2; Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; BOND G, 2001, SCIENCE         1115; BRAZIUNAS TF, 1995, GLOBAL BIOGEOCHEM CY, V9, P565, DOI 10.1029/95GB01725; BRIFF AKR, 2001, J GEOPHYS RES, V106, P2929; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; HESSHAIMER V, 1997, THESIS U HEIDELBERG; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; KROMER B, 1993, RADIOCARBON, V35, P125, DOI 10.1017/S0033822200013862; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kuniholm PI, 1996, NATURE, V381, P780, DOI 10.1038/381780a0; Lamb H.H., 1995, CLIMATE HIST MODERN, P211; Lean J, 1998, J CLIMATE, V11, P3069, DOI 10.1175/1520-0442(1998)011<3069:CFBCSR>2.0.CO;2; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Manning S. W., 1999, TEST TIME VOLCANO TH; Manning SW, 2001, SCIENCE, V294, P2532, DOI 10.1126/science.1066112; Masarik J, 1999, J GEOPHYS RES-ATMOS, V104, P12099, DOI 10.1029/1998JD200091; McCormac FG, 1995, RADIOCARBON, V37, P395, DOI 10.1017/S0033822200030873; NESMERIBES E, 1994, NATO ASI SER, V1, P71; PEARSON GW, 1993, RADIOCARBON, V35, P25, DOI 10.1017/S0033822200013795; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Shindell DT, 2001, J GEOPHYS RES-ATMOS, V106, P7193, DOI 10.1029/2000JD900547; SPURK M, 1998, RADIOCARBON, V40, P1; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; STUIVER M, 1980, SCIENCE, V207, P11, DOI 10.1126/science.207.4426.11; Stuiver M, 1998, GEOPHYS RES LETT, V25, P329, DOI 10.1029/97GL03694; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; van Loon H, 1998, J CLIMATE, V11, P1529, DOI 10.1175/1520-0442(1998)011<1529:TGROTS>2.0.CO;2; VOGEL JC, 1993, RADIOCARBON, V35, P73, DOI 10.1017/S0033822200013825	32	62	62	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2529	2532		10.1126/science.1066114	http://dx.doi.org/10.1126/science.1066114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11743160				2022-12-24	WOS:000172927700053
J	Kagawa-Singer, M; Blackhall, LJ				Kagawa-Singer, M; Blackhall, LJ			Negotiating cross-cultural issues at the end of life - "You got to go where he lives"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RACIAL-DIFFERENCES; DECISION-MAKING; HEALTH-CARE; CANCER; ATTITUDES; ETHNICITY; BLACK; PHYSICIANS; RACE; PREFERENCES	Culture fundamentally shapes how individuals make meaning out of illness, suffering, and dying. With increasing diversity in the United States, encounters between patients and physicians of different backgrounds are becoming more common. Thus the risk for cross-cultural misunderstandings surrounding care at the end of life is also increasing. Studies have shown cultural differences in attitudes toward truth telling, life-prolonging technology, and decision-making styles at the end of life. Using 2 case studies of patients, one of an African American couple in the southern United States and the other of a Chinese-American family in Hawaii, we outline some of the major issues involved in cross-cultural care and indicate how the patient, family, and clinician can navigate among differing cultural beliefs, values, and practices. Skilled use of cross-cultural understanding and communication techniques increases the likelihood that both the process and outcomes of care are satisfactory for all involved.	Univ Calif Los Angeles, Sch Publ Hlth & Asian Amer Studies, Los Angeles, CA 90095 USA; Univ Virginia, Ctr Palliat Care & Res, Charlottesville, VA USA; Univ Virginia, Ctr Biomed Eth, Charlottesville, VA USA	University of California System; University of California Los Angeles; University of Virginia; University of Virginia	Kagawa-Singer, M (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth & Asian Amer Studies, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.		Wang, Zi Dan/GZH-3012-2022					ABRAHAM J, 2000, PHYSICIANS GUIDE PAI; ANNAS GJ, 1979, AM J LAW MED, V4, P367; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; BARKER JC, 1992, WESTERN J MED, V157, P248; BERLIN EA, 1983, WESTERN J MED, V139, P934; BEYENE Y, 1992, W J MED, P328; Blackhall LJ, 2001, J URBAN HEALTH, V78, P59, DOI 10.1093/jurban/78.1.59; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; Braun K. L, 2000, CULTURAL ISSUES END; BUCHMAN R, 1992, BREAK BAD NEWS; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Chadwick G L, 1997, J Int Assoc Physicians AIDS Care, V3, P27; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Clinton WJ., 2000, OFF PRES FED REGIST, V65, P67249; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; *COUNC EC ADV, 1997, CHANG AM IND SOC EC, P40; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; CRAWLEY L, 2001, INNOVATIONS END LIFE; CRAWLEY L, 2001, RESPECTING CULTURAL; DALLAVORGIA P, 1992, J MED ETHICS, V18, P67, DOI 10.1136/jme.18.2.67; Dana R., 1993, MULTICULTURAL ASSESS; DAVIDSON MN, 1991, TRANSPLANT P, V23, P2531; DEVORE W, 1990, SOCIAL WORK PRACTICE; EMANUEL LL, 1993, HASTINGS CENT REP, V23, P6, DOI 10.2307/3562059; Emanuel LL, 2000, ARCH FAM MED, V9, P1181, DOI 10.1001/archfami.9.10.1181; Ersek M, 1998, Oncol Nurs Forum, V25, P1683; Fadiman A., 1997, SPIRIT CATCHES YOU Y; Fang J, 1996, NEW ENGL J MED, V335, P1545, DOI 10.1056/NEJM199611213352101; Fielding R, 1996, PSYCHO-ONCOL, V5, P321, DOI 10.1002/(SICI)1099-1611(199612)5:4<321::AID-PON226>3.0.CO;2-K; Francis CK, 2001, J NATL MED ASSOC, V93, P157; FRIEDMAN L C, 1988, Journal of Psychosocial Oncology, V6, P75; Gilbert Daniel Todd, 1998, HDB SOCIAL PSYCHOL, V2; Hallowell A. Irving, 1955, CULTURE EXPERIENCE; Haynes MA, 1999, UNEQUAL BURDEN CANC, DOI 10.17226/6377; Hern HE, 1998, CAMB Q HEALTHC ETHIC, V7, P27, DOI 10.1017/S0963180198701045; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; IRISH D, 1993, ETHNIC VARIATIONS; Ishii S., 1984, CROSS CURR, V11, P49; Kagawa-Singer M., 1994, GERONTOLOGY GERIATRI, V15, P101; KAGAWASINGER M, 1994, J COMMUNITY PSYCHOL, P192; KATON W, 1980, WESTERN J MED, V133, P9; Kim MS, 1996, COMMUN MONOGR, V63, P29, DOI 10.1080/03637759609376373; Kleinman A., 1980, PATIENTS HEALERS CON; Kleinman Arthur, 1988, ILLNESS NARRATIVES; KOENIG BA, 1995, WESTERN J MED, V163, P244; KOENIG BA, 1993, I MED WORKSH DYING D; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lebra TS., 1976, JAPANESE PATTERNS BE, DOI [10.1515/9780824846404, DOI 10.1515/9780824846404]; LIKE RC, 2000, PATIENT CARE, P189; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Morrison RS, 1998, ARCH INTERN MED, V158, P2493, DOI 10.1001/archinte.158.22.2493; Mouton C., 2000, CULTURAL ISSUES END, P71; MULLER JH, 1992, WESTERN J MED, V157, P323; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, P250; *NAT BIOETH ADV CO, 2001, ENS VOL INF CONS PRO, P103; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V263, P2344; PARRY JK, 1990, SOCIAL WORK PRACTICE; Paul Benjamin, 1955, HLTH CULTURE COMMUNI; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; ROTHENBERG LS, 1996, ANN REV LAW ETHICS, V4, P335; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Stuart MR, 1993, 15 MINUTE HOUR APPL; Surbone A, 2000, ANN NY ACAD SCI, V913, P52; Takayama T, 2001, SOC SCI MED, V53, P1335, DOI 10.1016/S0277-9536(00)00413-5; THOMSEN OO, 1993, LANCET, V341, P473, DOI 10.1016/0140-6736(93)90218-6; Tong K L, 1994, J Palliat Care, V10, P26; Uba L, 1994, ASIAN AM PERSONALITY; Veatch, 2000, CROSS CULTURAL PERSP; Wellisch D, 1999, PSYCHO-ONCOL, V8, P207, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<207::AID-PON357>3.0.CO;2-B; YEO G, 2000, CULTURAL ISSUES END, P356; ZANE N, IN PRESS ASIAN AM ME	80	368	369	2	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					2993	3001		10.1001/jama.286.23.2993	http://dx.doi.org/10.1001/jama.286.23.2993			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502VY	11743841				2022-12-24	WOS:000172764500032
J	Joutel, A; Favrole, P; Labauge, P; Chabriat, H; Lescoat, C; Andreux, F; Domenga, V; Cecillon, M; Vahedi, K; Ducros, A; Cave-Riant, F; Bousser, MG; Tournier-Lasserve, E				Joutel, A; Favrole, P; Labauge, P; Chabriat, H; Lescoat, C; Andreux, F; Domenga, V; Cecillon, M; Vahedi, K; Ducros, A; Cave-Riant, F; Bousser, MG; Tournier-Lasserve, E			Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis	LANCET			English	Article								CADASIL (cerebral autosomal dominant arteriopathy with subcortical Infarcts and leucoencephalopathy) Is a small-artery disease of the brain caused by NOTCH3 mutations that lead to an abnormal accumulation of NOTCH3 within the vasculature. We aimed to establish whether immunostaining skin biopsy samples with a monoclonal antibody specific for NOTCH3 could form the basis of a reliable and easy diagnostic test. We compared the sensitivity and specificity of this method In two groups of patients suspected of having CADASIL with complete scanning of mutation-ca using exons of NOTCH3 (in a retrospective series of 39 patients) and with limited scanning of four exons that are mutation hotspots (prospective series of 42 patients). In the retrospective series skin biopsy was positive in 21 (96%) of the 22 CADASIL patients examined and negative In all others; In the prospective series, seven of the 42 patients had a positive skin biopsy whereas only four had a mutation detected by limited NOTCH3 scanning. Our Immunostaining technique Is highly sensitive (96%) and specific (100%) for diagnosis of CADASIL.	Fac Med Lariboisiere, INSERM, F-75010 Paris, France; Hop Lariboisiere, Lab Cytogenet, F-75475 Paris, France; Cent Hosp Univ Caremeau, Serv Neurol, Nimes, France; Hop Lariboisiere, Serv Neurol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Joutel, A (corresponding author), Fac Med Lariboisiere, INSERM, EPI 99-21,10 Ave Verdun, F-75010 Paris, France.		Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017; DUCROS, Anne/D-1899-2010; Chabriat, Hugues/G-5699-2010	Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; DUCROS, Anne/0000-0001-5560-5013; Chabriat, Hugues/0000-0001-8436-6074				BAUDRIMONT M, 1998, NEUROPATHOL APPL NEU, V24, P148; Joutel A, 2000, ANN NEUROL, V47, P388, DOI 10.1002/1531-8249(200003)47:3<388::AID-ANA19>3.3.CO;2-H; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500	5	161	180	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2049	2051		10.1016/S0140-6736(01)07142-2	http://dx.doi.org/10.1016/S0140-6736(01)07142-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755616				2022-12-24	WOS:000172722800017
J	Heard, E; Rougeulle, C; Arnaud, D; Avner, P; Allis, CD; Spector, DL				Heard, E; Rougeulle, C; Arnaud, D; Avner, P; Allis, CD; Spector, DL			Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation	CELL			English	Article							XIST RNA; DOSAGE COMPENSATION; H4 ACETYLATION; GENE; CHROMATIN; HYPOACETYLATION; INITIATION; MACROH2A1; PROMOTER; COMPLEX	Coating of the X chromosome by Xist RNA is an essential trigger for X inactivation. However, little is known about the early chromatin remodeling events: that transform this signal into transcriptional silencing. Here we report that methylation of histone H3 lysine 9 on the inactive X chromosome occurs immediately after Xist RNA coating and before transcriptional inactivation of X-linked genes. X-chromosomal H3 Lys-9 methylation occurs during the same window of time as H3 Lys-9 hypoacetylation and H3 Lys-4 hypomethylation. Histone H3 modifications thus represent the earliest known chromatin changes during X inactivation. We also identify a unique "hotspot" of H3 Lys-9 methylation 5' to Xist, and we propose that this acts as a nucleation center for Xist RNA-dependent spread of inactivation along the X chromosome via H3 Lys-9 methylation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Inst Pasteur, F-75724 Paris 15, France; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Virginia	Heard, E (corresponding author), Inst Curie, CNRS, UMR 218, 26 Rue Ulm, F-75248 Paris 05, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Rougeulle, Claire/0000-0003-3861-4940	NIGMS NIH HHS [GM53512, GM42694, R01 GM042694] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694, R37GM053512, R01GM053512] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BOGGS BA, 2001, IN PRESS NAT GENET; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Heard E, 1999, MOL CELL BIOL, V19, P3156; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hogan B, 1994, MANIPULATING MOUSE E; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCBURNEY MW, 1988, BIOESSAYS, V9, P85, DOI 10.1002/bies.950090211; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RIGGS AD, 1985, BIOCH BIOL DNA METHY, P211; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/bf01666137, DOI 10.1007/BF01666137, 10.1007/BF01666137]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	46	401	412	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					727	738		10.1016/S0092-8674(01)00598-0	http://dx.doi.org/10.1016/S0092-8674(01)00598-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747809				2022-12-24	WOS:000172771800006
J	Navarro, M; Gull, K				Navarro, M; Gull, K			A pol I transcriptional body associated with VSG mono-allelic expression in Trypanosoma brucei	NATURE			English	Article							VARIANT SURFACE GLYCOPROTEIN; AMANITIN-RESISTANT TRANSCRIPTION; GENE-EXPRESSION; AFRICAN TRYPANOSOMES; RNA; SITES; DIFFERENTIATION; VISUALIZATION; LOCALIZATION; ORGANIZATION	In the mammalian host, African trypanosomes generate consecutive waves of parasitaemia by changing their antigenic coat. Because this coat consists of a single type of variant surface glycoprotein (VSG), the question arises of how a trypanosome accomplishes the transcription of only one of a multi-allelic family of VSG expression site loci to display a single VSG type on the surface at any one time(1). No major differences have been detected between the single active expression site and the cohort of inactive expression sites(2). Here we identify an extranucleolar body containing RNA polymerase I (pol I) that is transcriptionally active and present only in the bloodstream form of the parasite. Visualization of the active expression site locus by tagging with green fluorescent protein(3) shows that it is specifically located at this unique pol I transcriptional factory. The presence of this transcriptional body in postmitotic nuclei and its stability in the nucleus after DNA digestion provide evidence for a coherent structure. We propose that the recruitment of a single expression site and the concomitant exclusion of inactive loci from a discrete transcriptional body define the mechanism responsible for VSG mono-allelic expression.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Navarro, M (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		Navarro, Miguel/C-3685-2009	Navarro, Miguel/0000-0003-2301-2699				Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Borst P, 1999, TRENDS GENET, V15, P95, DOI 10.1016/S0168-9525(98)01680-1; Chaves I, 1998, P NATL ACAD SCI USA, V95, P12328, DOI 10.1073/pnas.95.21.12328; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; HARTSHORNE T, 1993, MOL CELL BIOL, V13, P144, DOI 10.1128/MCB.13.1.144; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Laufer G, 1999, MOL CELL BIOL, V19, P5466; MATTHEWS KR, 1994, J CELL BIOL, V125, P1147, DOI 10.1083/jcb.125.5.1147; Navarro M, 1996, MOL CELL BIOL, V16, P3615; Navarro M, 1998, MOL BIOCHEM PARASIT, V94, P53, DOI 10.1016/S0166-6851(98)00049-8; Navarro M, 1999, EMBO J, V18, P2265, DOI 10.1093/emboj/18.8.2265; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; RUDENKO G, 1992, NUCLEIC ACIDS RES, V20, P303, DOI 10.1093/nar/20.2.303; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZOMERDIJK JCBM, 1991, NATURE, V353, P772, DOI 10.1038/353772a0; ZOMERDIJK JCBM, 1990, EMBO J, V9, P2791, DOI 10.1002/j.1460-2075.1990.tb07467.x	30	248	248	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					759	763		10.1038/414759a	http://dx.doi.org/10.1038/414759a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742402				2022-12-24	WOS:000172676200050
J	Jackson, GS; Beck, JA; Navarrete, C; Brown, J; Sutton, PM; Contreras, M; Collinge, J				Jackson, GS; Beck, JA; Navarrete, C; Brown, J; Sutton, PM; Contreras, M; Collinge, J			Pathogenesis - HLA-DQ7 antigen and resistance to variant CJD	NATURE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; BSE		UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; N London Ctr, Natl Blood Serv, London NW9 5BG, England; Royal Free & Univ Coll Med Sch, Dept Immunol, London NW3 2PF, England; Royal Free & Univ Coll Med Sch, Dept Haematol, London NW3 2PF, England; Oxford Radcliffe Hosp, Nuffield Dept Surg, Oxford Transplant Ctr, Oxford OX3 7LJ, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Oxford	Jackson, GS (corresponding author), UCL, Inst Neurol, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@ic.ac.uk		Jackson, Graham/0000-0002-3125-2011				Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	10	43	45	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					269	270		10.1038/35104694	http://dx.doi.org/10.1038/35104694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713518				2022-12-24	WOS:000172150700032
J	Ladabaum, U; Chopra, CL; Huang, G; Scheiman, JM; Chernew, ME; Fendrick, AM				Ladabaum, U; Chopra, CL; Huang, G; Scheiman, JM; Chernew, ME; Fendrick, AM			Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer - A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							GASTROINTESTINAL BLOOD-LOSS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LARGE-BOWEL; COLON-CANCER; REDUCED RISK; POLYPS; HEALTH; COLONOSCOPY; PREVALENCE; GUIDELINES	Background: Aspirin may decrease colorectal cancer incidence, but its role as an adjunct to or substitute for screening has not been evaluated. Objective: To examine the potential cost-effectiveness of aspirin chemoprophylaxis in relation to screening. Design: Markov model. Data Sources: Literature on colorectal cancer epidemiology, screening, costs, and aspirin chemoprevention (1980-1999). Target Population: General U.S. population. Time Horizon: 50 to 80 years of age. Perspective: Third-party payer. Intervention: Aspirin therapy in patients screened with sigmoidoscopy every 5 years and fecal occult blood testing every year (FS/FOBT) or colonoscopy every 10 years (COLO). Outcome Measures: Discounted cost per life-year gained. Results of Base-Case Analysis: When a 30% reduction in colorectal cancer risk was assumed, aspirin increased costs and decreased life-years because of related complications as an adjunct to FS/FOBT and cost $149 161 per life-year gained as an adjunct to COLO. In patients already taking aspirin, screening with FS/FOBT or COLO cost less than $31 000 per life-year gained. Results of Sensitivity Analysis: cost-effectiveness estimates depended highly on the magnitude of colorectal cancer risk reduction with aspirin, aspirin-related complication rates, and the screening adherence rate in the population. However, when the model's inputs were varied over wide ranges, aspirin chemoprophylaxis remained generally non-cost-effective for patients who adhere to screening. Conclusions: in patients undergoing colorectal cancer screening, aspirin use should not be based on potential chemoprevention. Aspirin chemoprophylaxis alone cannot be considered a substitute for colorectal cancer screening. Public policy should focus on improving screening adherence, even in patients who are already taking aspirin.	Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; Univ Michigan, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Ladabaum, U (corresponding author), Univ Calif San Francisco, Div Gastroenterol, S-357,Box 0538,513 Parnassus Ave, San Francisco, CA 94143 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042, M01RR000079] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHLQUIST DA, 1985, NEW ENGL J MED, V312, P1422, DOI 10.1056/NEJM198505303122204; ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; ARNOLD JD, 1983, PHARMACOLOGY, V27, P14, DOI 10.1159/000137895; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; BROWN ML, 1990, PREV MED, V19, P562, DOI 10.1016/0091-7435(90)90054-N; Burt RW, 2000, GASTROENTEROLOGY, V119, P837, DOI 10.1053/gast.2000.16508; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Cohen A, 1995, CLIN THER, V17, P1110, DOI 10.1016/0149-2918(95)80089-1; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; ELTA GH, 1995, TXB GASTROENTEROLOGY, P671; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FLEMING JL, 1987, MAYO CLIN PROC, V62, P159, DOI 10.1016/S0025-6196(12)62437-9; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Greenberg PD, 1996, AM J MED, V100, P598, DOI 10.1016/S0002-9343(96)00009-5; Greenberg PD, 1999, GASTROINTEST ENDOSC, V50, P618, DOI 10.1016/S0016-5107(99)80008-X; Griffin MR., 1998, AM J MED, V104, p23S; *HCIA, 1997, DRG HDB COMP CLIN FI; Hennekens CH, 1999, AM HEART J, V137, pS9, DOI 10.1016/S0002-8703(99)70391-1; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lewis JD, 2000, ANN INTERN MED, V133, P647, DOI 10.7326/0003-4819-133-8-200010170-00017; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; LOEBL DH, 1977, JAMA-J AM MED ASSOC, V237, P976, DOI 10.1001/jama.237.10.976; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; LYNCH NM, 1989, AUST NZ J MED, V19, P89, DOI 10.1111/j.1445-5994.1989.tb00210.x; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MIELANTS H, 1984, CLIN RHEUMATOL, V3, P47, DOI 10.1007/BF02715695; MULLER AD, 1994, DIGEST DIS SCI, V39, P2480, DOI 10.1007/BF02087670; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; *NAT CTR HLTH STAT, 1998, LIF TABL VIT STAT A, V2; NORFLEET RG, 1983, J CLIN GASTROENTEROL, V5, P123, DOI 10.1097/00004836-198304000-00006; NORRVING B, 1991, LANCET, V338, P1345; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Ries LAG, 1997, NIH PUB, V97-2789; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; THUN MJ, 1993, CANCER RES, V53, P1322; Thun MJ, 1996, GASTROENTEROL CLIN N, V25, P333, DOI 10.1016/S0889-8553(05)70250-8; TORIBARA NW, 1995, NEW ENGL J MED, V332, P861, DOI 10.1056/NEJM199503303321306; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Wagner JL, 1996, PREVENTION EARLY DET, P321; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; 1999, MMWR MORB MORTAL WKL, V48, P116	62	97	97	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					769	781		10.7326/0003-4819-135-9-200111060-00007	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694102				2022-12-24	WOS:000172013700002
J	Zambon, MC; Stockton, JD; Clewley, JP; Fleming, DM				Zambon, MC; Stockton, JD; Clewley, JP; Fleming, DM			Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study	LANCET			English	Article							VIROLOGICAL SURVEILLANCE; MONOCLONAL-ANTIBODIES; VIRAL-INFECTIONS; EPIDEMICS; DIAGNOSIS; DURATION; EFFICACY; STRAINS; ENGLAND; ADULTS	Background Respiratory syncytial virus (RSV) is an important cause of lower-respiratory-tract infection in children and elderly people, but its effect in other age-groups is uncertain. We did a community-based observational study of RSV infection in community-dwelling individuals of all ages who presented to general practices in the UK with influenza-like illnesses during three successive winters (1995-96,1996-97, and 1997-98). Methods Nasopharyngeal swabs routinely submitted for virological surveillance were examined by multiplex reverse transcription PCR for influenza A and B viruses and, RSV A and B, and findings were related to the clinical incidence of influenza-like illness and acute bronchitis at that time. RSV strains identified were compared with those obtained from hospital admissions. Findings 480 RSV and 709 influenza viruses were identified from a total of 2226 swabs submitted. Both types of virus were found in all age-groups for between 12 and 20 weeks In each winter. RSV A accounted for 60% of RSV detections. Similar strains of RSV were present in hospital and community patients within the same year, but there were different lineages each year. Interpretation In individuals diagnosed with Influenza-like illness, there is a substantial potential for confusion between illnesses caused by influenza and those caused by RSV. The burden of illness attributable to each needs to be clarified to define optimum management routines.	Cent Publ Hlth Lab, PHLS, Div Virus Reference, London NW9 5HT, England; Royal Coll Gen Practitioners Res Unit, Birmingham, W Midlands, England	Public Health England	Zambon, MC (corresponding author), Cent Publ Hlth Lab, PHLS, Div Virus Reference, 61 Colindale Ave, London NW9 5HT, England.							ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; ANDRADE HR, 2000, EPIDEMIOL INFECT, V124, P515; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Carman WF, 2000, BRIT MED J, V321, P736, DOI 10.1136/bmj.321.7263.736; Chonmaitree T, 2000, PEDIATR INFECT DIS J, V19, P258, DOI 10.1097/00006454-200003000-00020; Clewley J P, 1998, Commun Dis Public Health, V1, P132; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Ellis JS, 1997, J CLIN MICROBIOL, V35, P2076, DOI 10.1128/JCM.35.8.2076-2082.1997; Englund JA, 1999, J PEDIATR-US, V135, pS38; Falsey AR, 1996, J AM GERIATR SOC, V44, P71, DOI 10.1111/j.1532-5415.1996.tb05641.x; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleming D M, 2000, Commun Dis Public Health, V3, P32; FLEMING DM, 1995, BRIT MED J, V311, P290, DOI 10.1136/bmj.311.7000.290; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; GARCIA O, 1994, J VIROL, V68, P5448; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; Hutchinson E J, 1996, Commun Dis Rep CDR Rev, V6, pR163; Irmen KE, 2000, CLIN DIAGN LAB IMMUN, V7, P396, DOI 10.1128/CDLI.7.3.396-403.2000; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Ross A M, 2000, Commun Dis Public Health, V3, P256; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Treanor J, 1999, ANTIVIR RES, V44, P79, DOI 10.1016/S0166-3542(99)00062-5; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Zambon M, 1998, Euro Surveill, V3, P29	32	281	294	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1410	1416		10.1016/S0140-6736(01)06528-X	http://dx.doi.org/10.1016/S0140-6736(01)06528-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705487				2022-12-24	WOS:000171940100012
J	Huelsenbeck, JP; Ronquist, F; Nielsen, R; Bollback, JP				Huelsenbeck, JP; Ronquist, F; Nielsen, R; Bollback, JP			Evolution - Bayesian inference of phylogeny and its impact on evolutionary biology	SCIENCE			English	Review							MAXIMUM-LIKELIHOOD-ESTIMATION; AMINO-ACID SITES; MARKOV-CHAINS; SEQUENCES; GENE; SUBSTITUTION; MODELS; RATES; SELECTION; TREES	As a discipline, phylogenetics is becoming transformed by a flood of molecular data. These data allow broad questions to be asked about the history of life, but also present difficult statistical and computational problems. Bayesian inference of phyto logeny brings a new perspective to a number of outstanding issues in evolutionary biology, including the analysis of large phylogenetic trees and complex evolutionary models and the detection of the footprint of natural selection in DNA sequences.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Uppsala Univ, Evolutionary Biol Ctr, Dept Syst Zool, SE-75236 Uppsala, Sweden; Cornell Univ, Dept Biometr, Ithaca, NY 14853 USA	University of Rochester; Uppsala University; Cornell University	Huelsenbeck, JP (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.		Nielsen, Rasmus/D-4405-2009; Ronquist, Fredrik/Q-2013-2015; Huelsenbeck, John P/C-6398-2013	Nielsen, Rasmus/0000-0003-0513-6591; Ronquist, Fredrik/0000-0002-3929-251X; 				Atrian S, 1998, J MOL EVOL, V47, P211, DOI 10.1007/PL00006378; Beerli P, 1999, GENETICS, V152, P763; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1968, THESIS U CHIGAGO; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; GELMAN A, 1995, BAYASIAN DATA ANAL; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; Gilks WR, 1996, MARKOV CHAIN MONTE C; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Jukes T. H., 1969, MAMMALIAN PROTEIN ME; KUHNER MK, 1995, GENETICS, V140, P1421; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Losos Jonathan B., 1994, P60; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2000, GENETICS, V154, P931; NIELSEN R, IN PRESS P PAC S BIO; Nielsen R. D., UNPUB; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2001, MOL BIOL EVOL, V18, P376, DOI 10.1093/oxfordjournals.molbev.a003813; Tavare S, 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	40	2102	2186	5	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2310	2314		10.1126/science.1065889	http://dx.doi.org/10.1126/science.1065889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743192	Green Submitted			2022-12-24	WOS:000172817200036
J	Siris, ES; Miller, PD; Barrett-Connor, E; Faulkner, KG; Wehren, LE; Abbott, TA; Berger, ML; Santora, AC; Sherwood, LM				Siris, ES; Miller, PD; Barrett-Connor, E; Faulkner, KG; Wehren, LE; Abbott, TA; Berger, ML; Santora, AC; Sherwood, LM			Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women - Results from the National Osteoporosis Risk Assessment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; ELDERLY WOMEN; PERIMENOPAUSAL WOMEN; GENETIC-DIFFERENCES; SELF-REPORTS; OLDER WOMEN; MASS; POPULATION; VALIDITY; HOSPITALIZATION	Context Large segments of the population at risk for osteoporosis and fracture have not been evaluated, and the usefulness of peripheral measurements for short-term prediction of fracture risk is uncertain. Objectives To describe the occurrence of low bone mineral density (BMD) in postmenopausal women, its risk factors, and fracture incidence during short-term follow-up. Design The National Osteoporosis Risk Assessment, a longitudinal observational study initiated September 1997 to March 1999, with approximately 12 months of subsequent follow-up. Setting and Participants A total of 200160 ambulatory postmenopausal women aged 50 years or older with no previous osteoporosis diagnosis, derived from 4236 primary care practices in 34 states. Main Outcome Measures Baseline BMD T scores, obtained from peripheral bone densitometry performed at the heel, finger, or forearm; risk factors for low BMD, derived from questionnaire responses; and clinical fracture rates at 12-month follow-up. Results Using World Health Organization criteria, 39.6% had osteopenia (T score of -1 to -2.49) and 7.2% had osteoporosis (T score less than or equal to -2.5). Age, personal or family history of fracture, Asian or Hispanic heritage, smoking, and cortisone use were associated with significantly increased likelihood of osteoporosis; higher body mass index, African American heritage, estrogen or diuretic use, exercise, and alcohol consumption significantly decreased the likelihood. Among the 163 979 participants with follow-up information, osteoporosis was associated with a fracture rate approximately 4 times that of normal BMD (rate ratio, 4.03; 95% confidence interval [CII, 3.59-4.53) and osteopenia was associated with a 1.8-fold higher rate (95% Cl, 1.49-2.18). Conclusions Almost half of this population had previously undetected low BMD, including 7% with osteoporosis. Peripheral BMD results were highly predictive of fracture risk. Given the economic and social costs of osteoporotic fractures, strategies to identify and manage osteoporosis in the primary care setting need to be established and implemented.	Columbia Univ, Coll Phys & Surg, New York, NY USA; Colorado Ctr Bone Res, Lakewood, CO USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Synarc, Portland, OR USA; Univ Maryland, Baltimore, MD 21201 USA; Merck & Co Inc, W Point, PA USA	Columbia University; Colorado Center For Bone Research; University of California System; University of California San Diego; Synarc; University System of Maryland; University of Maryland Baltimore; Merck & Company	Siris, ES (corresponding author), Columbia Presbyterian Med Ctr, Toni Stabile Osteoporosis Ctr, 180 Ft Washington Ave, New York, NY 10032 USA.							ANDERSON JJB, 1994, ADV NUTR RES, V9, P129; BAUER RL, 1988, AM J EPIDEMIOL, V127, P145, DOI 10.1093/oxfordjournals.aje.a114774; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; BLACK DM, 1992, J BONE MINER RES, V7, P633; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DAVIS JW, 1994, J BONE MINER RES, V9, P305; DAVIS JW, 1994, CALCIFIED TISSUE INT, V55, P249, DOI 10.1007/BF00310400; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; FASANO G, 1998, BONE, V23, pS590; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063, DOI 10.2106/00004623-200008000-00001; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; GREENDALE GA, 1995, J AM GERIATR SOC, V43, P955, DOI 10.1111/j.1532-5415.1995.tb05557.x; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; HOLBROOK TL, 1993, BMJ-BRIT MED J, V306, P1506, DOI 10.1136/bmj.306.6891.1506; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Johnell O, 1997, Am J Med, V103, p20S, DOI 10.1016/S0002-9343(97)90023-1; Kamel HK, 2000, AM J MED, V109, P326, DOI 10.1016/S0002-9343(00)00457-5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; KROGER H, 1994, CALCIFIED TISSUE INT, V55, P1, DOI 10.1007/BF00310160; Lips Paul, 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)90021-8; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Miller P, 2001, J BONE MINER RES, V16, pS193; MILLER P, 2001, INT SOC CLIN DENS AN; Miller PD, 1998, J CLIN DENSITOM, V1, P211, DOI 10.1385/JCD:1:3:211; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS1; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NGUYEN TV, 1994, J BONE MINER RES, V9, P1339; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; Pothuaud L, 1998, OSTEOPOROSIS INT, V8, P618, DOI 10.1007/s001980050108; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Ross PD, 1996, CALCIFIED TISSUE INT, V59, P339, DOI 10.1007/s002239900137; ROSS PD, 1991, AM J EPIDEMIOL, V133, P801, DOI 10.1093/oxfordjournals.aje.a115959; SCHOTT AM, 1995, J BONE MINER RES, V10, P243; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SILVERMAN SL, 1988, AM J PUBLIC HEALTH, V78, P1482, DOI 10.2105/AJPH.78.11.1482; Siris E, 1998, OSTEOPOROSIS INT, V8, pS62; TURNER CH, 1995, OSTEOPOROSIS INT, V5, P130, DOI 10.1007/BF01623314; World Health Organization, 1994, ASS FRACT RISK APPL	43	893	931	2	49	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2815	2822		10.1001/jama.286.22.2815	http://dx.doi.org/10.1001/jama.286.22.2815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735756	Bronze			2022-12-24	WOS:000172655400029
J	Kinoshita, T; Doi, M; Suetsugu, N; Kagawa, T; Wada, M; Shimazaki, K				Kinoshita, T; Doi, M; Suetsugu, N; Kagawa, T; Wada, M; Shimazaki, K			phot1 and phot2 mediate blue light regulation of stomatal opening	NATURE			English	Article							GUARD-CELL PROTOPLASTS; VICIA-FABA; SIGNAL-TRANSDUCTION; ACTION SPECTRUM; PHOSPHORYLATION; PHOTORECEPTOR; PROTEIN; BINDING; MUTANTS; PLANTS	The stomatal pores of higher plants allow for gaseous exchange into and out of leaves. Situated in the epidermis, they are surrounded by a pair of guard cells which control their opening in response to many environmental stimuli, including blue light(1,2). Opening of the pores is mediated by K+ accumulation in guard cells through a K+ channel and driven by an inside-negative electrical potential(3). Blue light causes phosphorylation and activation of the plasma membrane H+-ATPase that creates this potential(1,2,4-6). Thus far, no blue light receptor mediating stomatal opening has been identified(7), although the carotenoid, zeaxanthin, has been proposed(2,8). Arabidopsis mutants deficient in specific blue-light-mediated responses have identified(7,9-14) four blue light receptors, cryptochrome 1 (cry1), cryptochrome 2 (cry2), phot1 and phot2. Here we show that in a double mutant of phot1 and phot2 stomata do not respond to blue light although single mutants are phenotypically normal. These results demonstrate that phot1 and phot2 act redundantly as blue light receptors mediating stomatal opening.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & Combined Circuit, Kawaguchi, Saitama 3320012, Japan	Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Shimazaki, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan.		Suetsugu, Noriyuki/AAB-5274-2019; Kinoshita, Toshinori/C-2891-2012	Suetsugu, Noriyuki/0000-0002-3328-3313; Kinoshita, Toshinori/0000-0001-7621-1259				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; ASSMANN SM, 1993, ANNU REV CELL BIOL, V9, P345, DOI 10.1146/annurev.cb.09.110193.002021; ASSMANN SM, 1985, NATURE, V318, P285, DOI 10.1038/318285a0; BALLIO A, 1964, NATURE, V203, P297, DOI 10.1038/203297a0; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Eckert M, 2000, J EXP BOT, V51, P1435, DOI 10.1093/jexbot/51.349.1435; Eisinger W, 2000, PLANT PHYSIOL, V122, P99, DOI 10.1104/pp.122.1.99; HUALA E, 1997, SCIENCE, V278, P2121; IINO M, 1985, P NATL ACAD SCI USA, V82, P8019, DOI 10.1073/pnas.82.23.8019; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; KARLSSON PE, 1986, PHYSIOL PLANTARUM, V66, P207, DOI 10.1111/j.1399-3054.1986.tb02410.x; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; KONDO N, 1978, PLANT CELL PHYSIOL, V19, P365, DOI 10.1093/oxfordjournals.pcp.a075604; Lasceve G, 1999, PLANT PHYSIOL, V120, P605, DOI 10.1104/pp.120.2.605; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SCHWARTZ A, 1984, PLANTA, V161, P129, DOI 10.1007/BF00395472; SHIMAZAKI K, 1986, NATURE, V319, P324, DOI 10.1038/319324a0; Shimazaki K, 1999, PHYSIOL PLANTARUM, V105, P554, DOI 10.1034/j.1399-3054.1999.105322.x; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8; Zeiger E, 1998, J EXP BOT, V49, P433, DOI 10.1093/jexbot/49.suppl_1.433	30	663	695	4	188	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					656	660		10.1038/414656a	http://dx.doi.org/10.1038/414656a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740564				2022-12-24	WOS:000172535600052
J	Roberts, CM; Bohnsack, JA; Gell, F; Hawkins, JP; Goodridge, R				Roberts, CM; Bohnsack, JA; Gell, F; Hawkins, JP; Goodridge, R			Effects of marine reserves on adjacent fisheries	SCIENCE			English	Article							SPOTTED SEA-TROUT; FLORIDA WATERS; MANAGEMENT; PHILIPPINES; MORTALITY; GROWTH; PARK; DRUM; FISH	Marine reserves have been widely promoted as conservation and fishery management tools. There are robust demonstrations of conservation benefits, but fishery benefits remain controversial. We show that marine reserves in Florida (United States) and St. Lucia have enhanced adjacent fisheries. Within 5 years of creation, a network of five small reserves in St. Lucia increased adjacent catches of artisanal fishers by between 46 and 90%, depending on the type of gear the fishers used. In Florida, reserve zones in the Merritt island National Wildlife Refuge have supplied increasing numbers of world record-sized fish to adjacent recreational fisheries since the 1970s. Our study confirms theoretical predictions that marine reserves can play a key role in supporting fisheries.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; Natl Ocean & Atmospher Adm Fisheries, SE Fisheries Sci Ctr, Miami, FL 33149 USA; Univ W Indies, Fac Nat Sci, Dept Marine Resource & Environm Management, Cave Hill, Barbados	Harvard University; University of York - UK; National Oceanic Atmospheric Admin (NOAA) - USA; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Roberts, CM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.		Ruimy, Raymond/P-6068-2016					Alcala A. C., 1990, J CONS INT EXPLOR ME, V46, P40; ANDERSON WW, 1965, US FISH WILDLIFE SER, V514; [Anonymous], 1988, NMFSSEFC215 NOAA; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; BOHNSACK JA, 1986, 41 NOAA NAT MAR FISH; GOODRIDGE R, 1997, P GULF CARIBBEAN FIS, V49, P316; GOODRIDGE R, 1996, THESIS U W INDIES BA; HALPERN B, IN PRESS ECOL APPL; *INT GAM FISH ASS, 2000, IGFA RUL BOOK FRESHW; Johnson Darlene R., 1999, North American Journal of Fisheries Management, V19, P436, DOI 10.1577/1548-8675(1999)019<0436:EOAEEN>2.0.CO;2; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Murawski SA, 2000, B MAR SCI, V66, P775; MURPHY MD, 1994, T AM FISH SOC, V123, P482, DOI 10.1577/1548-8659(1994)123<0482:AGAMOS>2.3.CO;2; MURPHY MD, 1990, FISH B-NOAA, V88, P531; Murphy MD, 1998, FISH B-NOAA, V96, P382; National Research Council, 1999, SUST MAR FISH; National Research Council, 2001, MAR PROT AR TOOLS SU; Nowlis JS, 1999, FISH B-NOAA, V97, P604; PALSSON WA, 1995, RESPONSE ROCKY REEF, V1; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; POLOVINA JJ, 1995, CRUSTACEANA, V68, P203, DOI 10.1163/156854095X00106; Roberts C., 2000, WWF ENDANGERED SEAS; ROBERTS CJ, UNPUB; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Russ GR, 1999, CORAL REEFS, V18, P307, DOI 10.1007/s003380050203; SCHIRRIPA MJ, 1994, B MAR SCI, V54, P1019; [No title captured]	30	695	720	2	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1920	1923		10.1126/science.294.5548.1920	http://dx.doi.org/10.1126/science.294.5548.1920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729316				2022-12-24	WOS:000172465000057
J	Wu, LZ; Timmers, C; Maiti, B; Saavedra, HI; Sang, L; Chong, GT; Nuckolls, F; Giangrande, P; Wright, FA; Field, SJ; Greenberg, ME; Orkin, S; Nevins, JR; Robinson, ML; Leone, G				Wu, LZ; Timmers, C; Maiti, B; Saavedra, HI; Sang, L; Chong, GT; Nuckolls, F; Giangrande, P; Wright, FA; Field, SJ; Greenberg, ME; Orkin, S; Nevins, JR; Robinson, ML; Leone, G			The E2F1-3 transcription factors are essential for cellular proliferation	NATURE			English	Article							RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; S-PHASE; REPRESS TRANSCRIPTION; E2F-1; APOPTOSIS; INDUCTION; MECHANISM; COMPLEX; EXTENDS	The retinoblastoma tumour suppressor (Rb) pathway is believed to have a critical role in the control of cellular proliferation by regulating E2F activities(1,2). E2F1, E2F2 and E2F3 belong to a subclass of E2F factors thought to act as transcriptional activators important for progression through the G1/S transition(3). Here we show, by taking a conditional gene targeting approach, that the combined loss of these three E2F factors severely affects E2F target expression and completely abolishes the ability of mouse embryonic fibroblasts to enter S phase, progress through mitosis and proliferate. Loss of E2F function results in an elevation of p21(Cip1) protein, leading to a decrease in cyclin-dependent kinase activity and Rb phosphorylation. These findings suggest a function for this subclass of E2F transcriptional activators in a positive feedback loop, through down-modulation of p21(Cip1), that leads to the inactivation of Rb-dependent repression and S phase entry. By targeting the entire subclass of E2F transcriptional activators we provide direct genetic evidence for their essential role in cell cycle progression, proliferation and development.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Childrens Res Inst, Div Mol & Human Genet, Columbus, OH 43210 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurosci, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Duke University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA.			Field, Seth/0000-0002-8893-4806				Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Humbert PO, 2000, GENE DEV, V14, P690; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NEVINS JR, 1997, METHOD ENZYMOL, P678; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	30	478	491	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					457	462		10.1038/35106593	http://dx.doi.org/10.1038/35106593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719808				2022-12-24	WOS:000172304500046
J	Ackerman, MJ; Siu, BL; Sturner, WQ; Tester, DJ; Valdivia, CR; Makielski, JC; Towbin, JA				Ackerman, MJ; Siu, BL; Sturner, WQ; Tester, DJ; Valdivia, CR; Makielski, JC; Towbin, JA			Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-QT SYNDROME; SLEEP POSITION; PROLONGATION; INTERVAL; MECHANISMS; KVLQT1	Context Fatal arrhythmias from occult long QT syndrome may be responsible for some cases of sudden infant death syndrome (SIDS). Because patients who have long QT syndrome with sodium channel gene (SCN5A) defects have an increased frequency of cardiac events during sleep, and a recent case is reported of a sporadic SCN5A mutation in an infant with near SIDS, SCN5A has emerged as the leading candidate ion channel gene for SIDS. Objective To determine the prevalence and functional properties of SCN5A mutations in SIDS. Design, Setting, and Subjects Postmortem molecular analysis of 93 cases of SIDS or undetermined infant death identified by the Medical Examiner's Office of the Arkansas State Crime Laboratory between September 1997 and August 1999. Genomic DNA was extracted from frozen myocardium and subjected to SCN5A mutational analyses. Missense mutations were incorporated into the human heart sodium channel a subunit by mutagenesis, transiently transfected into human embryonic kidney cells, and characterized electrophysiologically. Main Outcome Measures Molecular and functional characterization of SCN5A defects. Results Two of the 93 cases of SIDS possessed SCN5A mutations: a 6-week-old white male with an A997S missense mutation in exon 17 and a 1-month old white male with an R1826H mutation in exon 28. These 2 distinct mutations occurred in highly conserved regions of the sodium channel and were absent in 400 control patients (800 alleles). Functionally, the A997S and R1826H mutant channels expressed a sodium current characterized by slower decay and a 2- to 3-fold increase in late sodium current. Conclusion Approximately 2% of this prospective, population-based cohort of SIDS cases had an identifiable SCN5A channel defect, suggesting that mutations in cardiac ion channels may provide a lethal arrhythmogenic substrate in some infants at risk for SIDS.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Mayo Clin, Mayo Eugenio Litta Childrens Hosp, Div Cardiovasc Dis, Rochester, MN USA; Mayo Clin, Mayo Eugenio Litta Childrens Hosp, Div Pediat Cardiol, Rochester, MN USA; Mayo Clin, Dept Internal Med, Rochester, MN USA; Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; Arkansas State Crime Lab, Med Examiners Off, Little Rock, AR USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Sect Cardiovasc Med, Madison, WI 53706 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat, 1 Baylor Plaza,Room 333E, Houston, TX 77030 USA.	ackerman.michael@mayo.edu	Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; /0000-0003-1224-3088				*AAP TASK FORC INF, 1992, PEDIATRICS, V87, P1120; Ackerman MJ, 1998, PEDIATR RES, V44, P148, DOI 10.1203/00006450-199808000-00002; Ackerman MJ, 1997, NEW ENGL J MED, V336, P1575, DOI 10.1056/NEJM199705293362207; Ackerman MJ, 1998, MAYO CLIN PROC, V73, P250, DOI 10.4065/73.3.250; Ali RHH, 2000, AM J CARDIOL, V85, P457, DOI 10.1016/S0002-9149(99)90772-5; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; GIBSON E, 1995, PEDIATRICS, V96, P69; GUNTHEROTH WG, 1989, J AM COLL CARDIOL, V14, P443, DOI 10.1016/0735-1097(89)90200-3; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; HUNT CE, 1992, CLIN PERINATOL, V19, P757, DOI 10.1016/S0095-5108(18)30429-9; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Lucey JF, 1999, PEDIATRICS, V103, P812, DOI 10.1542/peds.103.4.812; MARON BJ, 1986, AM J CARDIOL, V58, P1104, DOI 10.1016/0002-9149(86)90122-0; MARON BJ, 1976, CIRCULATION, V54, P423, DOI 10.1161/01.CIR.54.3.423; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; PERTICONE F, 1991, CLIN CARDIOL, V14, P417, DOI 10.1002/clc.4960140510; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; SADEH D, 1987, NEW ENGL J MED, V317, P1501, DOI 10.1056/NEJM198712103172404; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STEINSCHNEIDER A, 1978, AM J DIS CHILD, V132, P688, DOI 10.1001/archpedi.1978.02120320048011; STRAMBABADIALE M, 1992, AM J PHYSIOL, V263, pH1514, DOI 10.1152/ajpheart.1992.263.5.H1514; Towbin JA, 1998, NEW ENGL J MED, V338, P1760, DOI 10.1056/NEJM199806113382409; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VALDESDA.MA, 1973, NEW ENGL J MED, V289, P1195, DOI 10.1056/NEJM197311292892213; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; WILLINGER M, 1994, PEDIATRICS, V93, P814; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404	35	317	330	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2264	2269		10.1001/jama.286.18.2264	http://dx.doi.org/10.1001/jama.286.18.2264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710892	Bronze			2022-12-24	WOS:000172129700021
J	Liotta, LA; Kohn, EC; Petricoin, EF				Liotta, LA; Kohn, EC; Petricoin, EF			Clinical proteomics - Personalized molecular medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							2-DIMENSIONAL ELECTROPHORESIS; QUANTITATIVE-ANALYSIS; PROTEIN; CANCER; COMPLEXES		NCI, CCR, NIH, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Liotta, LA (corresponding author), 10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.	lance@helix.nih.gov						Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.3.CO;2-F; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hanash SM, 2000, ELECTROPHORESIS, V21, P1202, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1202::AID-ELPS1202>3.3.CO;2-9; Humphery-Smith I, 1998, J PROTEIN CHEM, V17, P524; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ji JY, 2000, J CHROMATOGR B, V745, P197, DOI 10.1016/S0378-4347(00)00192-4; Legrain P, 2000, CURR OPIN BIOTECH, V11, P402, DOI 10.1016/S0958-1669(00)00117-8; Li JJ, 2000, ELECTROPHORESIS, V21, P198, DOI 10.1002/(SICI)1522-2683(20000101)21:1<198::AID-ELPS198>3.3.CO;2-M; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1; Paweletz CP, 2000, DRUG DEVELOP RES, V49, P34, DOI 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.3.CO;2-N; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shen YF, 2001, ANAL CHEM, V73, P3011, DOI 10.1021/ac001393n; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	25	170	184	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2211	2214		10.1001/jama.286.18.2211	http://dx.doi.org/10.1001/jama.286.18.2211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710876				2022-12-24	WOS:000172129700001
J	Conway, KA; Rochet, JC; Bieganski, RM; Lansbury, PT				Conway, KA; Rochet, JC; Bieganski, RM; Lansbury, PT			Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct	SCIENCE			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LEWY BODIES; FIBRILLIZATION; TOXICITY; MICE; LEVODOPA; MUTATION; MODEL	The substantia nigra in Parkinson's disease (PD) is depleted of dopaminergic neurons and contains fibrillar Lewy bodies comprising primarily alpha -synuclein. We screened a library to identify drug-like molecules to probe the relation between neurodegeneration and alpha -synuctein fibrilization. All but one of 15 fibril inhibitors were catecholamines related to dopamine. The inhibitory activity of dopamine depended on its oxidative ligation to alpha -synuctein and was selective for the protofibril-to-fibril conversion, causing accumulation of the alpha -synuctein protofibril. Adduct formation provides an explanation for the dopaminergic selectivity of alpha -synuctein-associated neurotoxicity in PD and has implications for current and future PD therapeutic and diagnostic strategies.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Lansbury, PT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.	plansbury@rics.bwh.harvard.edu		Rochet, Jean-Christophe/0000-0002-6484-1541	NINDS NIH HHS [NS38375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agid Y, 1998, NEUROLOGY, V50, P858, DOI 10.1212/WNL.50.4.858; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Fahn S, 1999, ARCH NEUROL-CHICAGO, V56, P529, DOI 10.1001/archneur.56.5.529; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuhn DM, 1998, J NEUROSCI, V18, P7111; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; TOMITA K, UNPUB DATA; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	31	900	938	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1346	1349		10.1126/science.1063522	http://dx.doi.org/10.1126/science.1063522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701929				2022-12-24	WOS:000172130200051
J	Kinoshita, K; Arnal, I; Desai, A; Drechsel, DN; Hyman, AA				Kinoshita, K; Arnal, I; Desai, A; Drechsel, DN; Hyman, AA			Reconstitution of physiological microtubule dynamics using purified components	SCIENCE			English	Article							KINESIN-RELATED PROTEIN; XENOPUS EGG EXTRACTS; SPINDLE POLE BODY; MITOTIC SPINDLE; INDIVIDUAL MICROTUBULES; CYTOPLASMIC EXTRACTS; PLUS-END; INSTABILITY; VISUALIZATION; IDENTIFICATION	Microtubules are dynamically unstable polymers that interconvert stochastically between polymerization and depolymerization. Compared with microtubules assembled from purified tubulin, microtubules in a physiological environment polymerize faster and transit more frequently between polymerization and depolymerization. These dynamic properties are essential for the functions of the microtubule cytoskeleton during diverse cellular processes. Here, we have reconstituted the essential features of physiological microtubule dynamics by mixing three purified components: tubulin; a microtubule-stabilizing protein, XMAP215; and a microtubule-destabitizing kinesin, XKCM1. This represents an essential first step in the reconstitution of complex microtubule dynamics-dependent processes, such as chromosome segregation, from purified components.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Kinoshita, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Hyman, Anthony A/B-3917-2017; Arnal, Isabelle/X-6559-2019; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Arnal, Isabelle/0000-0001-6149-8189; Kinoshita, Kazuhisa/0000-0002-0882-4296				BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Cha BJ, 1999, J CELL SCI, V112, P4337; Charrasse S, 1998, J CELL SCI, V111, P1371; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Graf R, 2000, J CELL SCI, V113, P1747; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Hunter AW, 2000, J CELL SCI, V113, P4379; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	27	173	175	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1340	1343		10.1126/science.1064629	http://dx.doi.org/10.1126/science.1064629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701928				2022-12-24	WOS:000172130200049
J	Schwetz, BA				Schwetz, BA			New combination therapy for advanced breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-24	WOS:000172032100006
J	Silverman, DHS; Small, GW; Chang, CY; Lu, CS; de Aburto, MAK; Chen, W; Czernin, J; Rapoport, SI; Pietrini, P; Alexander, GE; Schapiro, MB; Jagust, WJ; Hoffman, JM; Welsh-Bohmer, KA; Alavi, A; Clark, CM; Salmon, E; de Leon, MJ; Mielke, R; Cummings, JL; Kowell, AP; Gambhir, SS; Hoh, CK; Phelps, ME				Silverman, DHS; Small, GW; Chang, CY; Lu, CS; de Aburto, MAK; Chen, W; Czernin, J; Rapoport, SI; Pietrini, P; Alexander, GE; Schapiro, MB; Jagust, WJ; Hoffman, JM; Welsh-Bohmer, KA; Alavi, A; Clark, CM; Salmon, E; de Leon, MJ; Mielke, R; Cummings, JL; Kowell, AP; Gambhir, SS; Hoh, CK; Phelps, ME			Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; COGNITIVE DECLINE; FDG PET	Context Deficits in cerebral glucose utilization have been identified in patients with cognitive dysfunction attributed to various disease processes, but their prognostic and diagnostic value remains to be defined. Objective To assess the sensitivity and specificity with which cerebral metabolic patterns at a single point in time forecast subsequent documentation of progressive dementia. Design, Setting, and Patients Positron emission tomography (PET) studies of [F-18]fluorodeoxyglucose in 146 patients undergoing evaluation for dementia with at least 2 years' follow-up for disease progression at the University of California, Los Angeles, from 1991 to 2000, and PET studies in 138 patients undergoing evaluation for dementia at an international consortium of facilities, with histopathological diagnoses an average of 2.9 years later, conducted from 1984 to 2000. Main Outcome Measures Regional distribution of [F-18]fluorodeoxyglucose in each patient, classified by criteria established a priori as positive or negative for presence of a progressive neurodegenerative disease in general and of Alzheimer disease (AD) specifically, compared with results of longitudinal or neuropathologic analyses. Results Progressive dementia was detected by PET with a sensitivity of 93% (191/206) and a specificity of 76% (59/78). Among patients with neu ro pathologically based diagnoses, PET identified patients with AD and patients with any neurodegenerative disease with a sensitivity of 94% and specificities of 73% and 78%, respectively. The negative likelihood ratio of experiencing a progressive vs nonprogressive course over the several years following a single negative brain PET scan was 0.10 (95% confidence interval, 0.06-0.16), and the initial pattern of cerebral metabolism was significantly associated with the subsequent course of progression overall (P<.001). Conclusion In patients presenting with cognitive symptoms of dementia, regional brain metabolism was a sensitive indicator of AD and of neurodegenerative disease in general. A negative PET scan indicated that pathologic progression of cognitive impairment during the mean 3-year follow-up was unlikely to occur.	Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Kaiser Permanente, Dept Internal Med, Los Angeles, CA USA; NIA, NIH, Bethesda, MD 20892 USA; Univ Pisa, Dept Clin Biochem, Pisa, Italy; Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; Duke Univ, Dept Radiol, Durham, NC 27710 USA; Duke Univ, Dept Psychiat, Durham, NC 27710 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Univ Liege, Cyclotron Res Ctr, Liege, Belgium; NYU, Sch Med, Dept Psychiat, New York, NY USA; Max Planck Inst Neurol Res, Dept Neurol, D-50931 Cologne, Germany; Univ Calif San Diego, Div Nucl Med, San Diego, CA 92103 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pisa; University of California System; University of California Davis; Duke University; Duke University; University of Pennsylvania; University of Liege; New York University; Max Planck Society; University of California System; University of California San Diego	Silverman, DHS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, CHS AR-144, Los Angeles, CA 90095 USA.		de Leon, Mony/AAP-7890-2021; Jagust, William/ABE-6426-2020; Welsh-Bohmer, Kathleen/AAA-3178-2020; Pietrini, Pietro/Z-4202-2019; Salmon, Eric/AAE-4901-2020	Salmon, Eric/0000-0003-2520-9241; de Leon, Mony/0000-0003-2245-4380; Pietrini, Pietro/0000-0002-6768-5556	NATIONAL INSTITUTE ON AGING [P50AG016570, P50AG005128, P30AG010129, Z01AG000148] Funding Source: NIH RePORTER; NIA NIH HHS [AG10129, AG16570, P50 AG05128-07] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENSON DF, 1981, T AM NEUROL ASSOC, V106, P68; Carr D. B., 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)00262-3; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; FERRIS SH, 1980, NEUROBIOL AGING, V1, P127, DOI 10.1016/0197-4580(80)90005-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; FRIEDLAND RP, 1990, POSITRON EMISSION TO, P161; HAXBY JV, 1990, POSITRON EMISSION TO, P93; HERHOLZ K, 1995, ALZ DIS ASSOC DIS, V9, P6, DOI 10.1097/00002093-199505000-00004; Herholz K, 1999, DEMENT GERIATR COGN, V10, P494, DOI 10.1159/000017196; Hoffman JM, 2000, J NUCL MED, V41, P1920; MAZZIOTTA JC, 1992, SEMIN NUCL MED, V22, P233, DOI 10.1016/S0001-2998(05)80118-7; Mielke R, 1996, ACTA NEUROPATHOL, V91, P174, DOI 10.1007/s004010050410; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; *NAT I AG, 1996, PROGR REP ALZH DIS; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; Pietrini P, 2000, INT J PSYCHOPHYSIOL, V37, P87, DOI 10.1016/S0167-8760(00)00097-0; SALMON E, 1994, J NUCL MED, V35, P391; Silverman Daniel H.S., 1999, Clin Positron Imaging, V2, P119, DOI 10.1016/S1095-0397(99)00020-5; Silverman DHS, 2000, J NUCL MED, V41, P1929; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142, DOI 10.1001/archneur.1992.00530350056020	26	632	660	2	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2120	2127		10.1001/jama.286.17.2120	http://dx.doi.org/10.1001/jama.286.17.2120			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490CD	11694153				2022-12-24	WOS:000172032100031
J	Ammash, NM; Warnes, CA				Ammash, NM; Warnes, CA			Ventricular septal defects in adults	ANNALS OF INTERNAL MEDICINE			English	Review							CONGENITAL HEART-DISEASE; TWO-DIMENSIONAL ECHOCARDIOGRAPHY; TERM FOLLOW-UP; PULMONARY VASCULAR-RESISTANCE; AORTIC REGURGITATION; SURGICAL CLOSURE; NATURAL-HISTORY; DOPPLER-ECHOCARDIOGRAPHY; INFECTIVE ENDOCARDITIS; BACTERIAL-ENDOCARDITIS	Because congenital ventricular septal defects are of different sizes and locations, their clinical presentation, natural history, and treatment vary greatly. This review discusses the different types of ventricular septal defects commonly seen in adults in the authors' experience and in published literature. Ventricular septal defects are either isolated small defects or larger defects associated with pulmonary stenosis, pulmonary hypertension, or aortic regurgitation. These associations play an important role in the pathophysiologic consequences of the defect, its long-term complications, and treatment options. Knowledge of the different clinical presentations in adulthood and the specific features pertinent to these defects will help in the assessment and the care of adult patients with one of the most common congenital cardiac malformations.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Ammash, NM (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1St St Sw, Rochester, MN 55905 USA.							ABBOTT ME, 1931, NELSONS LOOSELEAF ME, V4, P207; ALPERT BS, 1973, AM J DIS CHILD, V125, P194, DOI 10.1001/archpedi.1973.04160020028005; Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; Ammash NM, 1999, J AM COLL CARDIOL, V33, P222, DOI 10.1016/S0735-1097(98)00554-3; ANDERSON RH, 1983, AM J CARDIOL, V52, P341, DOI 10.1016/0002-9149(83)90135-2; ANDO M, 1986, Heart and Vessels, V2, P117, DOI 10.1007/BF02059966; ANDRADE JL, 1991, ECHOCARDIOGR-J CARD, V8, P501, DOI 10.1111/j.1540-8175.1991.tb01010.x; BACKER CL, 1991, J THORAC CARDIOV SUR, V102, P288; BAKER EJ, 1988, BRIT HEART J, V59, P339; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; BECU LM, 1956, CIRCULATION, V14, P349, DOI 10.1161/01.CIR.14.3.349; BIRCKS W, 1971, BRIT HEART J       S, V33, P88; BLACKSTONE EH, 1976, J THORAC CARDIOV SUR, V72, P661; BLAKE RS, 1982, BRIT HEART J, V47, P305; BLOOMFIELD DK, 1964, CIRCULATION, V29, P914, DOI 10.1161/01.CIR.29.6.914; Breckenridge I M, 1972, Ann Thorac Surg, V13, P128; CAMPBELL M, 1971, BRIT HEART J, V33, P246; CAPELLI H, 1983, AM J CARDIOL, V51, P1474, DOI 10.1016/0002-9149(83)90660-4; CHANG CH, 1988, SCAND J THORAC CARD, V22, P221, DOI 10.3109/14017438809106066; CHUNG KJ, 1974, AM HEART J, V87, P435, DOI 10.1016/0002-8703(74)90167-7; CLARKSON MB, 1968, CIRCULATION, V38, P129, DOI 10.1161/01.CIR.38.1.129; DAJANI AS, 1990, JAMA-J AM MED ASSOC, V264, P2919, DOI 10.1001/jama.264.22.2919; DRISCOLL DJ, 1993, CIRCULATION, V87, P102; ELLIS FH, 1963, CIRCULATION, V27, P789, DOI 10.1161/01.CIR.27.4.789; ELLIS JH, 1987, AM HEART J, V114, P115, DOI 10.1016/0002-8703(87)90315-2; FRIEDLI B, 1974, AM J CARDIOL, V33, P403, DOI 10.1016/0002-9149(74)90323-3; FRIEDMAN WF, 1965, CIRCULATION, V32, P35, DOI 10.1161/01.CIR.32.1.35; FRYDA RJ, 1971, BRIT HEART J, V33, P456; GARG A, 1990, CLIN CARDIOL, V13, P717, DOI 10.1002/clc.4960131009; GERSONY WM, 1993, CIRCULATION, V87, P52; GERSONY WM, 1993, CIRCULATION, V87, P121; GERSONY WM, 1977, CIRCULATION, V56, P84; GOOR DA, 1970, CHEST, V58, P468, DOI 10.1378/chest.58.5.468; Graham T P Jr, 1974, Adv Cardiol, V11, P81; GRAHAM TP, 1994, J AM COLL CARDIOL, V24, P867, DOI 10.1016/0735-1097(94)90842-7; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; HAGLER DJ, 1985, MAYO CLIN PROC, V60, P741, DOI 10.1016/S0025-6196(12)60416-9; HISATOMI K, 1987, ANN THORAC SURG, V43, P363, DOI 10.1016/S0003-4975(10)62804-4; HOFFMAN IE, 1968, CIRCULATION, V37, P97, DOI 10.1161/01.CIR.37.1.97; HUDSPETH AS, 1962, J THORAC CARDIOV SUR, V43, P157; JABLONSKY G, 1983, AM J CARDIOL, V51, P293, DOI 10.1016/S0002-9149(83)80053-8; KAGAWA Y, 1987, TOHOKU J EXP MED, V151, P1, DOI 10.1620/tjem.151.1; KIDD L, 1993, CIRCULATION, V87, P38; KULBERTUS HE, 1969, AM HEART J, V77, P123, DOI 10.1016/0002-8703(69)90136-7; KUROKAWA S, 1988, AM HEART J, V116, P1033, DOI 10.1016/0002-8703(88)90156-1; LAUBRY C, 1933, SOUFFLES MALADIE ROG, V50, P439; LEUNG MP, 1987, AM J CARDIOL, V60, P890, DOI 10.1016/0002-9149(87)91042-3; LILLEHEI CW, 1968, J AMER MED ASSOC, V205, P822, DOI 10.1001/jama.205.12.822; LUDOMIRSKY A, 1986, CIRCULATION, V74, P1317, DOI 10.1161/01.CIR.74.6.1317; Mahoney Larry T., 1993, Cardiology Clinics, V11, P603; MARON BJ, 1973, CIRCULATION, V48, P864, DOI 10.1161/01.CIR.48.4.864; MARTIN GR, 1989, PEDIATRICS, V83, P200; MCNAMARA DG, 1982, AM J CARDIOL, V50, P560, DOI 10.1016/0002-9149(82)90325-3; MEIJBOOM F, 1994, J AM COLL CARDIOL, V24, P1358, DOI 10.1016/0735-1097(94)90120-1; MENAHEM S, 1986, BRIT HEART J, V56, P242; MOE DG, 1987, AM J CARDIOL, V60, P674, DOI 10.1016/0002-9149(87)90380-8; MOMMA K, 1984, AM HEART J, V108, P1312, DOI 10.1016/0002-8703(84)90759-2; MORENOCABRAL RJ, 1977, J THORAC CARDIOV SUR, V73, P358; NADAS AS, 1964, CIRCULATION, V29, P862, DOI 10.1161/01.CIR.29.6.862; NEUTZE JM, 1989, AM J CARDIOL, V63, P327, DOI 10.1016/0002-9149(89)90340-8; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; OHKITA Y, 1986, ANN THORAC SURG, V41, P489, DOI 10.1016/S0003-4975(10)63024-X; OKOROMA EO, 1975, AM HEART J, V90, P14, DOI 10.1016/0002-8703(75)90251-3; OTTERSTAD JE, 1986, ACTA MED SCAND, P1; PERASALO O, 1961, Acta Chir Scand Suppl, VSuppl 283, P123; PERLOFF JK, 1988, ANN INTERN MED, V109, P406, DOI 10.7326/0003-4819-109-5-406; PERLOFF JK, 1991, CONGENITAL HEART DIS, P313; PERLOFF JK, 1991, CONGENITAL HEART DIS, P21; PERLOFF JK, 1991, CONGENITAL HEART DIS, P124; Perloff JK, 1994, CLIN RECOGNITION CON, P396; PIERONI DR, 1993, CIRCULATION, V87, P80; PITTS JA, 1977, AM HEART J, V93, P321, DOI 10.1016/S0002-8703(77)80251-2; PLAUTH WH, 1965, AM J MED, V39, P552, DOI 10.1016/0002-9343(65)90079-3; ROBINSON G, 1962, J THORAC CARDIOV SUR, V43, P785, DOI 10.1016/S0022-5223(19)33017-X; SANTAMARIA H, 1983, AM J ROENTGENOL, V141, P273, DOI 10.2214/ajr.141.2.273; SCHMIDT KG, 1988, J AM COLL CARDIOL, V12, P1538, DOI 10.1016/S0735-1097(88)80023-8; SHEPHERD RL, 1972, AM J MED, V53, P446, DOI 10.1016/0002-9343(72)90140-4; SOMERVILLE J, 1970, CIRCULATION, V41, P317, DOI 10.1161/01.CIR.41.2.317; SOMERVILLE J, 1979, BRIT HEART J, V41, P1; SOTO B, 1987, PAEDIAT CARDIOLOGY, P125; SPENCER FC, 1973, J THORAC CARDIOV SUR, V65, P15; STEVENSON JG, 1978, CIRCULATION, V58, P322, DOI 10.1161/01.CIR.58.2.322; SUTHERLAND GR, 1982, BRIT HEART J, V47, P316; SUTHERLAND GR, 1989, BRIT HEART J, V62, P43; TATSUNO K, 1973, CIRCULATION, V48, P1028, DOI 10.1161/01.CIR.48.5.1028; TAYLOR JFN, 1971, BRIT HEART J, V33, P285; TRUSLER GA, 1973, J THORAC CARDIOV SUR, V66, P394; VANHARE GF, 1987, AM HEART J, V114, P606, DOI 10.1016/0002-8703(87)90759-9; VANPRAAGH R, 1989, J AM COLL CARDIOL, V14, P1298, DOI 10.1016/0735-1097(89)90431-2; VANPRAAGH R, 1968, AM HEART J, V75, P604, DOI 10.1016/0002-8703(68)90321-9; VETTER VL, 1982, AM J CARDIOL, V50, P588, DOI 10.1016/0002-9149(82)90328-9; VICKERS CW, 1960, RADIOLOGY, V75, P69, DOI 10.1148/75.1.69; Vogel J H, 1974, Adv Cardiol, V11, P108; WARNES CA, 1984, AM J CARDIOL, V54, P460, DOI 10.1016/0002-9149(84)90226-1; WARNES CA, 1991, CARDIOLOGY FUNDAMENT, V2, P1639; WEIDMAN WH, 1977, CIRCULATION, V56, P56; WOLFE RR, 1993, CIRCULATION, V87, P89	97	36	41	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					812	824		10.7326/0003-4819-135-9-200111060-00011	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00011			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694106				2022-12-24	WOS:000172013700006
J	Lipardi, C; Wei, Q; Paterson, BM				Lipardi, C; Wei, Q; Paterson, BM			RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; C-ELEGANS; GENETIC INTERFERENCE; SYNTHASE GENE; NEUROSPORA; TRANSGENE; PLANTS; VIRUS; POLYMERASE	In posttranscriptional gene silencing (PTGS), "quelling," and RNA interference (RNAi), 21-25 nucleotide RNA fragments are produced from the initiating dsRNA. These short interfering RNAs (siRNAs) mediate RNAi by an unknown mechanism. Here, we show that GFP and Pp-Luc siRNAs, isolated from a protein complex in Drosophila embryo extract, target mRNA degradation in vitro. Most importantly, these siRNAs, as well as a synthetic 21-nucleotide duplex GFP siRNA, serve as primers to transform the target mRNA into dsRNA. The nascent dsRNA is degraded to eliminate the incorporated target mRNA while generating new siRNAs in a cycle of dsRNA synthesis and degradation. Evidence is presented that mRNA-dependent siRNA incorporation to form dsRNA is carried out by an RNA-dependent RNA polymerase activity (RdRP).	NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Paterson, BM (corresponding author), NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA.	patersob@mail.nih.gov						Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe D, 1999, ARCH VIROL, P189; Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 2000, CURR BIOL, V10, pR137, DOI 10.1016/S0960-9822(00)00325-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; KRUPP G, 1979, NUCLEIC ACIDS RES, V6, P3481, DOI 10.1093/nar/6.11.3481; MAINE EM, 2000, GENOME BIOL, V1, P1018; Marx J, 2000, SCIENCE, V288, P1370, DOI 10.1126/science.288.5470.1370; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; Meins F, 2000, PLANT MOL BIOL, V43, P261, DOI 10.1023/A:1006443731515; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; MOSSNER E, 1980, H-S Z PHYSIOL CHEM, V361, P543, DOI 10.1515/bchm2.1980.361.1.543; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sonoda S, 2000, PLANT J, V21, P1, DOI 10.1046/j.1365-313x.2000.00645.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; WANG MJ, 1990, NUCLEIC ACIDS RES, V18, P6625, DOI 10.1093/nar/18.22.6625; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	52	294	450	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					297	307		10.1016/S0092-8674(01)00537-2	http://dx.doi.org/10.1016/S0092-8674(01)00537-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701121	Bronze			2022-12-24	WOS:000172022800002
J	Stebbins, CE; Galan, JE				Stebbins, CE; Galan, JE			Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion	NATURE			English	Article							PROTEIN; MODULATION; PROGRAM; SYSTEM; MODEL; SPTP	Many bacterial pathogens use a type III protein secretion system to deliver virulence effector proteins directly into the host cell cytosol, where they modulate cellular processes(1,2). A requirement for the effective translocation of several such effector proteins is the binding of specific cytosolic chaperones, which typically interact with discrete domains in the virulence factors(3,4,5). We report here the crystal structure at 1.9 Angstrom resolution of the chaperone-binding domain of the Salmonella effector protein SptP with its cognate chaperone SicP. The structure reveals that this domain is maintained in an extended, unfolded conformation that is wound around three successive chaperone molecules. Short segments from two different SptP molecules are juxtaposed by the chaperones, where they dimerize across a hydrophobic interface. These results imply that the chaperones associated with the type III secretion system maintain their substrates in a secretion-competent state that is capable of engaging the secretion machinery to travel through the type III apparatus in an unfolded or partially folded manner.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308				Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SMITH CL, IN PRESS MOL MICROBI; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x	24	247	254	2	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					77	81		10.1038/35102073	http://dx.doi.org/10.1038/35102073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689946				2022-12-24	WOS:000171898900045
